Citrus Sinensis ID: 038345
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LMP1 | 732 | Wall-associated receptor | yes | no | 0.881 | 0.826 | 0.460 | 1e-152 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.852 | 0.782 | 0.445 | 1e-146 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.874 | 0.818 | 0.444 | 1e-144 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.865 | 0.790 | 0.456 | 1e-144 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.865 | 0.825 | 0.454 | 1e-142 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.873 | 0.756 | 0.430 | 1e-142 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.860 | 0.796 | 0.445 | 1e-141 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.862 | 0.810 | 0.454 | 1e-141 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.880 | 0.821 | 0.430 | 1e-139 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.857 | 0.772 | 0.434 | 1e-139 |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 540 bits (1390), Expect = e-152, Method: Compositional matrix adjust.
Identities = 297/645 (46%), Positives = 404/645 (62%), Gaps = 40/645 (6%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F +TCN+ K L ++ V+N+S+ G L V ++ CY+++G D TL
Sbjct: 56 FNLTCNEQEK-----LFFGNMPVINMSLSGQLRVRLVRSRVCYDSQGKQTDYIAQRTTLG 110
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEI 120
FT+S NRF V+GC+SYA++R G +Y GC+S+CDS NGSC G GCCQI +
Sbjct: 111 NFTLSEL-NRFTVVGCNSYAFLRTS-GVEKYSTGCISICDSAT-TKNGSCSGEGCCQIPV 167
Query: 121 PRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPD-----DFPI 166
PRG SF NH V FNPCTYAF+V+ F F A + + + FP+
Sbjct: 168 PRGYSFVRVKPHSFHNHPTVHLFNPCTYAFLVEDGMFDFH----ALEDLNNLRNVTTFPV 223
Query: 167 VLDWEI--TTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV 224
VLDW I T + E +CG N++C S T +GY+CKC +G+EGNPYL +GC+D+
Sbjct: 224 VLDWSIGDKTCKQVEYRGVCGGNSTCFDS----TGGTGYNCKCLEGFEGNPYLPNGCQDI 279
Query: 225 NEFEDPSLNNCTH--ICDNTAGNYTCRCPKGFRGDGRRDGGGCI-PNQKNLIKVALGAGC 281
NE S +NC+ C+NT G++ C CP G+R D + P ++ LG
Sbjct: 280 NECIS-SRHNCSEHSTCENTKGSFNCNCPSGYRKDSLNSCTRKVRPEYFRWTQIFLGTT- 337
Query: 282 SGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTS 341
+G +++GI L + K R+ + +QKFF++NGG +L Q +S S K+FT
Sbjct: 338 ---IGFSVIMLGISCLQQKIKHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTE 394
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
K +++AT+ Y+ +RILGQGGQGTVYKG+L D IVA+KK++L + + VEQFINEV++LSQ
Sbjct: 395 KGMKEATNGYHESRILGQGGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQ 454
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
INHRN+VK+LGCCLETEVPLLVYEF+ +GTL+ ++H + + +TWE LRIA EV+G+L
Sbjct: 455 INHRNVVKVLGCCLETEVPLLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSL 514
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLHS+ASI I RDIK+ANILLD AKV+DFG SR I +D+ LTT VQGT GY+DP
Sbjct: 515 AYLHSSASIPIIHRDIKTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDP 574
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
EY+ + EKSDVYSFGVVL+E+L+GQK + ++LV F A NR E++D
Sbjct: 575 EYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIID 634
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626
V+ E + EI A +A C L G+ RP MKEVA EL +R
Sbjct: 635 GQVMNEDNQREIQEAARIAAECTRLMGEERPRMKEVAAELEALRV 679
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 518 bits (1334), Expect = e-146, Method: Compositional matrix adjust.
Identities = 300/674 (44%), Positives = 409/674 (60%), Gaps = 89/674 (13%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNV-LQYTAKDCYNAKGYSVDSNLPTITL 59
+ + CN T PFL++ + E+VNIS++G +++ T+ C + G S P + +
Sbjct: 61 YEVVCNSTNS--VPFLSRINRELVNISLNGVVHIKAPVTSSGC--STGTSQPLTPPPLNV 116
Query: 60 ----SKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVT----NGSCI 111
S + +++ +N V +GC A + G + C S C+ + + N C
Sbjct: 117 AGQGSPYFLTD-KNLLVAVGCKFKAVMAGITSQ---ITSCESSCNERNSSSQEGRNKICN 172
Query: 112 GTGCCQIEIPRGS---------FKNHTNVSSFNPCTYAF----------VVDQSQFHFTS 152
G CCQ IP G N + C AF V + +FH
Sbjct: 173 GYKCCQTRIPEGQPQVISVDIEIPQGNNTTGEGGCRVAFLTSDKYSSLNVTEPEKFH-GH 231
Query: 153 NYLAFDGIPDDFPIVLDWEITTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCN---- 208
Y A + L W T ++ + I SC + D T +S C C+
Sbjct: 232 GYAAVE---------LGWFFDTSDSRDTQPI-----SCKNASDTTPYTSDTRCSCSYGYF 277
Query: 209 ------------KGYEGNPYLSDGCRDVNEFE-DPSLNNCT-HICDNTAGNYTCRCPKGF 254
GY+GNP+L GC DV+E + D N C C N G + C+ K
Sbjct: 278 SGFSYRDCYCNSPGYKGNPFLPGGCVDVDECKLDIGRNQCKDQSCVNLPGWFDCQPKK-- 335
Query: 255 RGDGRRDGGGCIPNQ-KNLIKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKF 313
P Q K +I+ G G LL GI+GLYKF +KRR++ +KF
Sbjct: 336 ------------PEQLKRVIQ-----GVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKF 378
Query: 314 FKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADG 373
F+RNGG+LL+Q+L+ + +VE +++F+S +LEKATDN+N NR+LGQGGQGTVYKGML DG
Sbjct: 379 FRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDG 438
Query: 374 RIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433
RIVAVK+SK VDE+ VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYEFVPNG L
Sbjct: 439 RIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLC 498
Query: 434 QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493
+ +H+ +++ +TWE+ L IA+E++GAL YLHSAAS IY RDIK+ NILLD++ RAKVS
Sbjct: 499 KRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVS 558
Query: 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553
DFGTSRS+T+DQTHLTT+V GTFGYVDPEYFQSS+FTEKSDVYSFGVVLVE+LTG+KP
Sbjct: 559 DFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSS 618
Query: 554 AINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT 613
+ +E+R L +F++A+ ENR+ +++D + E +++M+VA LA+RCLN GK RP
Sbjct: 619 RVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPN 678
Query: 614 MKEVAFELGGIRAS 627
M+EV+ EL IR+S
Sbjct: 679 MREVSIELEMIRSS 692
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1321), Expect = e-144, Method: Compositional matrix adjust.
Identities = 291/654 (44%), Positives = 405/654 (61%), Gaps = 54/654 (8%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F ITC + KP + S+IEV+N + G L L + CY+ + +++ ++
Sbjct: 56 FNITCEED----KPNVL-SNIEVLNFNHSGQLRGLIPRSTVCYDQQ---TNNDFESLWFR 107
Query: 61 KFTVS-NTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE 119
+S + N+F ++GC+++A + + G Y GCMS+CD+ N C G GCC+ E
Sbjct: 108 LDNLSFSPNNKFTLVGCNAWALLSTF-GIQNYSTGCMSLCDTPP-PPNSKCNGVGCCRTE 165
Query: 120 --IPRGS---------FKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPD-----D 163
IP S F+N T+V FNPC+YAF V+ F+F+S + + D
Sbjct: 166 VSIPLDSHRIETQPSRFENMTSVEHFNPCSYAFFVEDGMFNFSS----LEDLKDLRNVTR 221
Query: 164 FPIVLDWEITTIETCEEA---KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG 220
FP++LDW I +TCE+ ICG N++C S T GY+CKC +G++GNPYLSDG
Sbjct: 222 FPVLLDWSIGN-QTCEQVVGRNICGGNSTCFDS----TRGKGYNCKCLQGFDGNPYLSDG 276
Query: 221 CRDVNEFEDPSLNNC--THICDNTAGNYTCRCPKGFRGDGRRDGGGCI------PNQKNL 272
C+D+NE ++NC T C+NT G++ C+CP G D CI P
Sbjct: 277 CQDINECTT-RIHNCSDTSTCENTLGSFHCQCPSG--SDLNTTTMSCIDTPKEEPKYLGW 333
Query: 273 IKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSS 332
V LG +G L +++ I + + + R+ + +Q+FF++NGG +L Q LS S
Sbjct: 334 TTVLLGTT----IGFLIILLTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPS 389
Query: 333 VEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQF 392
K+FT + +++ATD YN +RILGQGGQGTVYKG+L D IVA+KK++L D + VEQF
Sbjct: 390 NVDVKIFTEEGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQF 449
Query: 393 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLR 452
INEV++LSQINHRN+VKLLGCCLETEVPLLVYEF+ +GTL+ ++H + + +TWE LR
Sbjct: 450 INEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLR 509
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
IA+EV+G L YLHS ASI I RD+K+ANILLD+ AKV+DFG SR I +DQ LTT V
Sbjct: 510 IAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMV 569
Query: 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572
QGT GY+DPEY+ + EKSDVYSFGVVL+E+L+G+K + + LV YF+ AM
Sbjct: 570 QGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMK 629
Query: 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626
ENRL E++D V+ E + EI A +A C + G+ RP+MKEVA EL +R
Sbjct: 630 ENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRV 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 511 bits (1317), Expect = e-144, Method: Compositional matrix adjust.
Identities = 305/668 (45%), Positives = 421/668 (63%), Gaps = 74/668 (11%)
Query: 1 FLITCNDTF--KPPKPFLTKSSIEVVNI----SIDGHLNVLQ----YTAKDCYNAKGYSV 50
+ + CN T K PFL K + E+V+I SID V+ T+ C +
Sbjct: 63 YEVVCNSTTSGKSLAPFLYKINRELVSITLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPL 122
Query: 51 DSNLPTITLSKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSC 110
NL T S F ++++ NR V +GCD+ A + + GC S CD + C
Sbjct: 123 PLNL-TGKGSPFFITDS-NRLVSVGCDNRALITDIESQ---ITGCESSCDGDKSRLDKIC 177
Query: 111 IGTGCCQIEIPRGSFK--------NHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPD 162
G CCQ +IP + + N + C AF+ +++ + +N P+
Sbjct: 178 GGYTCCQAKIPADRPQVIGVDLESSGGNTTQGGNCKVAFLTNET--YSPANVTE----PE 231
Query: 163 DF------PIVLDWEITTIETCEEAKICGPNASCDKSKDNTTTSS-------------GY 203
F I L W T ++++ P + ++ TS+ GY
Sbjct: 232 QFYTNGFTVIELGWYFDT----SDSRLTNPVGCVNLTETGIYTSAPSCVCEYGNFSGFGY 287
Query: 204 -HCKCNK-GYEGNPYLSDGCRDVNEFED-PSLNNCTHI-CDNTAGNYTCRCPKGFRGDGR 259
+C CN+ GY GNPYL GC D++E E+ L++C + C N G++ C G G+
Sbjct: 288 SNCYCNQIGYRGNPYLPGGCIDIDECEEGKGLSSCGELTCVNVPGSWRCE----LNGVGK 343
Query: 260 RDGGGCIPNQKNLIKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGG 319
IK L G G LLFL++GIWGL KF KKRR+I K+ FFKRNGG
Sbjct: 344 -------------IK-PLFPGLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGG 389
Query: 320 LLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVK 379
LLL+Q+L++ +V+ +K+F+SK+LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK
Sbjct: 390 LLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVK 449
Query: 380 KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH 439
+SK++DE+ VE+FINEV +LSQINHRNIVKL+GCCLETEVP+LVYE +PNG L++ +H+
Sbjct: 450 RSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHD 509
Query: 440 IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499
+++ +TW++ LRI+VE++GAL YLHSAAS +Y RD+K+ NILLD+KYRAKVSDFGTSR
Sbjct: 510 SDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSR 569
Query: 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
SI VDQTHLTT V GTFGY+DPEYFQ+SQFT+KSDVYSFGVVLVE++TG+KP + +E
Sbjct: 570 SINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEE 629
Query: 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619
+R LV +F +AM +NR+ +++D+ + + E+++ VA LA+RCL+L GK RP M+EV+
Sbjct: 630 NRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSV 689
Query: 620 ELGGIRAS 627
EL IR+S
Sbjct: 690 ELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 507 bits (1305), Expect = e-142, Method: Compositional matrix adjust.
Identities = 299/658 (45%), Positives = 400/658 (60%), Gaps = 64/658 (9%)
Query: 42 CYNAKGYSVDSNLPTITLSKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMC-- 99
C N GYS S + S F +S N+F +GC++ A++ GC + C
Sbjct: 109 CPNRDGYSSSS--LNLKGSPFFISEN-NKFTAVGCNNKAFMNV---TGLQIVGCETTCGN 162
Query: 100 --DSFDFVTNGSCIGTGCCQIEIPRGSFKN--HTNVSSFNP----CTYAFVVDQSQFHFT 151
S+ N SC+G CCQ+ IP V P C AF+ +QF +
Sbjct: 163 EIRSYK-GANTSCVGYKCCQMTIPPLLQLQVFDATVEKLEPNKQGCQVAFL---TQFTLS 218
Query: 152 SNYLAFDGIPDDFPIVLDW-EITTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKG 210
+ P P ++++ E TTIE + + K NT Y C C+ G
Sbjct: 219 GSLFT----P---PELMEYSEYTTIELEWRLDLSYMTSKRVLCKGNTFFEDSYQCSCHNG 271
Query: 211 YEGNPYLSDGCRDVNEFEDPSLNNC-THICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQ 269
YEGNPY+ GC+D++E DP LN C C N G+Y C +
Sbjct: 272 YEGNPYIPGGCQDIDECRDPHLNKCGKRKCVNVLGSYRC--------------------E 311
Query: 270 KNLIKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSN 329
K + G SG L L+F G+W L K +KR+ K K+KFF+RNGGLLLQQ+ S
Sbjct: 312 KTWPAILSGTLSSGLLLLIF---GMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFL 368
Query: 330 KSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV 389
SV +TK+F+S DLE ATD +NA+RILGQGGQGTVYKGML DG IVAVKKSK + E N+
Sbjct: 369 HGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENL 428
Query: 390 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL 449
E+FINE+++LSQINHRN+VK+LGCCLETEVP+LVYEF+PN L+ ++HN E+FP++WE+
Sbjct: 429 EEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEV 488
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
L IA EV+ AL YLHSA SI IY RD+KS NILLD+K+RAKVSDFG SRS+ +D THLT
Sbjct: 489 RLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLT 548
Query: 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569
T VQGT GYVDPEY QS+ FT KSDVYSFGV+L+E+LTG+KP+ + E R L YFL+
Sbjct: 549 TIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLE 608
Query: 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629
AM +RL E+LDA + +E +REE++ VA LA+RCL+LN ++RPTM++V EL +++
Sbjct: 609 AMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRK 668
Query: 630 ASILQQNCGVIDCVNGDISEHYLESDLVSMGTSI-LNNSAAFSIDAGPAFSIDARPLL 686
+ Q NG+ H ++M S+ L+ S+ + +FS+D +PL+
Sbjct: 669 GTQSQAQ-------NGEEHAHI----QIAMPESMSLSYSSPNIVVENSSFSLDTKPLM 715
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 505 bits (1300), Expect = e-142, Method: Compositional matrix adjust.
Identities = 307/713 (43%), Positives = 417/713 (58%), Gaps = 114/713 (15%)
Query: 1 FLITCN-DTFKPPKPFLTKSSIEVVNISIDGHLNVLQY-------------TAKDCYNAK 46
+ ITCN T P+L+ + EVV IS+ +Y +K+C ++
Sbjct: 56 YEITCNTSTSGKLVPYLSVINKEVVGISLPTEGRGSRYNNPYQSVNIKNPIASKEC-SSN 114
Query: 47 GYSVDSNLPTITLSKFTVSNTENRFVVIGCDSYA----------------------YVRG 84
G + S L +T + F VS N V +GC++ A +++
Sbjct: 115 GEELGS-LLNLTGTPFYVSQ-HNELVAVGCNNTASLTNVKPSIVQCTSSCSTKPHTHIKD 172
Query: 85 YLG------ENRYRAGC---MSMCDSFDFVTNGSCIGTGCCQIEIPRGSFKNHTNVSSFN 135
YL N Y C SM +S + SC G GCC + GS + V+ N
Sbjct: 173 YLAVLNCQNYNGYEKNCNEDSSMDESI--MDETSCNGIGCCNAYMRGGSIQQIVGVTIEN 230
Query: 136 P----CTYAFVVDQSQFHFTSNYLAFDGIPDDF------PIVLDWEITTIE--------- 176
C AF+ ++++ YL+ P + L W I T
Sbjct: 231 TITRGCKVAFLTNKAE------YLSNKSDPQKLHARGYSTVELGWFIHTTNHSFIKSLGC 284
Query: 177 -----------TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225
T + +I + CD DN S C C +G++GNPY GC+D+N
Sbjct: 285 YSVKEYNNERYTSTQRRINITSCICD---DNAYLSYA-RCSCTRGFQGNPYRLGGCKDIN 340
Query: 226 EF-EDPSLNNC-THICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSG 283
E E+ + C T+ C N G++ C + N + + LGA
Sbjct: 341 ECKEEEGMTYCGTNKCVNLQGHFKC-----------------VYNNHRPLAIGLGAS--- 380
Query: 284 GLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKD 343
G L +VGI+ LYKF KK+R++ K+KFFKRNGGLLLQQ+L S VEKT +F+S++
Sbjct: 381 -FGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRE 439
Query: 344 LEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN 403
LEKAT+N+++NRILGQGGQGTVYKGML DGRIVAVKKSK+VDE+ +E+FINEVVILSQIN
Sbjct: 440 LEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQIN 499
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALF 462
HRNIVKLLGCCLET+VP+LVYEF+PNG L++++H+ +E TW + LRIA++++GAL
Sbjct: 500 HRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALS 559
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
YLHS+AS IY RD+KS NI+LD+KYRAKVSDFGTSR++TVD THLTT V GT GY+DPE
Sbjct: 560 YLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPE 619
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582
YFQSSQFT+KSDVYSFGVVLVE++TG+K I + E+R+L YF+ AM EN+LF+++DA
Sbjct: 620 YFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDA 679
Query: 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQ 635
+ ++ A +A++CLNL G+ RP+M+EV+ EL IR G LQ+
Sbjct: 680 RIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQE 732
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-141, Method: Compositional matrix adjust.
Identities = 282/633 (44%), Positives = 396/633 (62%), Gaps = 43/633 (6%)
Query: 21 IEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLSKFTVSNTENRFVVIGCDSYA 80
I+V NIS GH++VL +CY K + + L S F++S + N+F ++GC++ +
Sbjct: 74 IQVTNISHSGHVSVLFERFSECYEQKNETNGTALGYQLGSSFSLS-SNNKFTLVGCNALS 132
Query: 81 YVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE---IP-------------RGS 124
+ + G+ Y GC+S+C+S NG C G GCC E +P R
Sbjct: 133 LLSTF-GKQNYSTGCLSLCNS-QPEANGRCNGVGCCTTEDFSVPFDSDTFQFGSVRLRNQ 190
Query: 125 FKN-----HTNVSSFNPCTYAFVVDQSQFHF-TSNYLAFDGIPDDFPIVLDWEITTIETC 178
N +T+V FNPCTYAF+V+ +F+F +S L FP+ LDW I +TC
Sbjct: 191 VNNSLDLFNTSVYQFNPCTYAFLVEDGKFNFDSSKDLKNLRNVTRFPVALDWSIGN-QTC 249
Query: 179 EEA---KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNC 235
E+A +ICG N+SC N+TT +GY CKCN+GY+GNPY S+GC+D++E + +NC
Sbjct: 250 EQAGSTRICGKNSSCY----NSTTRNGYICKCNEGYDGNPYRSEGCKDIDECISDT-HNC 304
Query: 236 T--HICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSGGLGLLFLIVG 293
+ C N G + C+CP G+ + C + ++ L +G+L L++
Sbjct: 305 SDPKTCRNRDGGFDCKCPSGYDLNSSMS---CTRPEYKRTRIFLVII----IGVLVLLLA 357
Query: 294 IWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNA 353
+ TK+R+ K +++FF++NGG +L Q LS S K+FT + +++AT+ Y+
Sbjct: 358 AICIQHATKQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDE 417
Query: 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
+RILGQGGQGTVYKG+L D IVA+KK++L D V+QFI+EV++LSQINHRN+VK+LGC
Sbjct: 418 SRILGQGGQGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGC 477
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
CLETEVPLLVYEF+ NGTL+ ++H I + +TWE LRIA+EV+G L YLHS+ASI I
Sbjct: 478 CLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPII 537
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RDIK+ANILLD+ AKV+DFG S+ I +D+ LTT VQGT GY+DPEY+ + EKS
Sbjct: 538 HRDIKTANILLDENLTAKVADFGASKLIPMDKEQLTTMVQGTLGYLDPEYYTTGLLNEKS 597
Query: 534 DVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEI 593
DVYSFGVVL+E+L+GQK + + LV YF+ A ENRL E++D VL E +EI
Sbjct: 598 DVYSFGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNEDNLKEI 657
Query: 594 MTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626
A +A C L G+ RP MKEVA +L +R
Sbjct: 658 QEAARIAAECTRLMGEERPRMKEVAAKLEALRV 690
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 501 bits (1291), Expect = e-141, Method: Compositional matrix adjust.
Identities = 294/647 (45%), Positives = 404/647 (62%), Gaps = 55/647 (8%)
Query: 14 PFLTKSSIEVVNISI---DGHLNVLQ----YTAKDCYNAKGYSVDSNLPTITL----SKF 62
P L+ + EVVNIS+ + ++Q T+ C + ++LP + + S +
Sbjct: 81 PLLSMINREVVNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPY 140
Query: 63 TVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCD---SFDFVTNGSCIGTGCCQIE 119
+++ ENR V +GC A + E GC S C+ S + VTN C G CCQ
Sbjct: 141 FLTD-ENRLVAVGCGIKALMTDTESE---ILGCESSCEHRKSGEEVTNLICTGYRCCQAR 196
Query: 120 IPRGSFKNHT-NVSSFN----PCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLD--WEI 172
+P G + T N+ + + C AF+ D+ + SN + ++ +VL+ W
Sbjct: 197 LPVGRPQAITVNIENSSGGEETCKVAFLTDKR--YSPSNVTEPEQFHNNGYVVLELGWYF 254
Query: 173 TTIETCEEAKICGPNAS----------CDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR 222
T + ++ + N S C D + S +C C+ GY GNPYL GC
Sbjct: 255 ATSNSRFKSLLGCTNMSRKGSGFSDDNCSCEYDYFSGMSYRNCYCDYGYTGNPYLRGGCV 314
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQK--NLIKVALGAG 280
D + E H C A P C PN K K + G
Sbjct: 315 DTDSCEG------NHNCGEDAHCVNMPGPMSM----------CRPNPKITKPTKPPVLQG 358
Query: 281 CSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFT 340
GL L VG++ L+K KKRR I +KFFKRNGGLLL+Q+L++ +VE +K+F+
Sbjct: 359 ILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFS 418
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILS 400
SK+L KATDN++ +R+LGQGGQGTVYKGML DG IVAVK+SK+VDE+ +E+FINE+V+LS
Sbjct: 419 SKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLS 478
Query: 401 QINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
QINHRNIVKLLGCCLETEVP+LVYE++PNG L++ +H+ +++ +TWE+ LRIA+E++GA
Sbjct: 479 QINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGA 538
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
L Y+HSAAS I+ RDIK+ NILLD+KYRAKVSDFGTSRS+T+DQTHLTT V GTFGY+D
Sbjct: 539 LTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMD 598
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580
PEYF SSQ+T KSDVYSFGVVLVE++TG+KP+ + +E R L +FL+AM ENR+ +++
Sbjct: 599 PEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDII 658
Query: 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
D + E++ E++M VA LA++CLN GKNRP MKEV+ EL IR+S
Sbjct: 659 DIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-139, Method: Compositional matrix adjust.
Identities = 278/646 (43%), Positives = 392/646 (60%), Gaps = 42/646 (6%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F ITC K +P + S IEV N + G L VL + CY+ +G + + + TL
Sbjct: 59 FSITC----KEDRPHVL-SDIEVANFNHSGQLQVLLNRSSTCYDEQGKKTEED-SSFTLE 112
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEI 120
++S N+ +GC++ + + + G Y C+S+CDS +G C G GCC++++
Sbjct: 113 NLSLS-ANNKLTAVGCNALSLLDTF-GMQNYSTACLSLCDSPP-EADGECNGRGCCRVDV 169
Query: 121 P-----------RGSFKNHTNVSSFNPCTYAFVVDQSQFHFTS--NYLAFDGIPDDFPIV 167
G K+ T+ F+PCTYAF+V+ +F+F+S + L + FP++
Sbjct: 170 SAPLDSYTFETTSGRIKHMTSFHDFSPCTYAFLVEDDKFNFSSTEDLLNLRNVMR-FPVL 228
Query: 168 LDWEITTIETCEEA---KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV 224
LDW + +TCE+ ICG N++C S T +GY C+CN+G++GNPYLS GC+DV
Sbjct: 229 LDWSVGN-QTCEQVGSTSICGGNSTCLDS----TPRNGYICRCNEGFDGNPYLSAGCQDV 283
Query: 225 NEFEDPSL---NNCT--HICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGA 279
NE S +NC+ C N G + C+C G+R D C + + L
Sbjct: 284 NECTTSSTIHRHNCSDPKTCRNKVGGFYCKCQSGYRLDTTT--MSCKRKEFAWTTILLVT 341
Query: 280 GCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLF 339
+G L +++G+ + + K ++ K +++FF++NGG +L Q LS S K+F
Sbjct: 342 T----IGFLVILLGVACIQQRMKHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIF 397
Query: 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVIL 399
T ++KAT+ Y +RILGQGGQGTVYKG+L D IVA+KK++L D + VEQFINEV++L
Sbjct: 398 TEDGMKKATNGYAESRILGQGGQGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVL 457
Query: 400 SQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
SQINHRN+VKLLGCCLETEVPLLVYEF+ NGTL+ ++H + + +TWE L+IA+EV+G
Sbjct: 458 SQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAG 517
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
L YLHS+ASI I RDIK+ANILLD AKV+DFG SR I +D+ L T VQGT GY+
Sbjct: 518 TLAYLHSSASIPIIHRDIKTANILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYL 577
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
DPEY+ + EKSDVYSFGVVL+E+L+GQK + + LV YF A ENRL E+
Sbjct: 578 DPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEI 637
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+ V+ E +EI A +A C L G+ RP MKEVA +L +R
Sbjct: 638 IGGEVMNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALR 683
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 494 bits (1272), Expect = e-139, Method: Compositional matrix adjust.
Identities = 296/681 (43%), Positives = 391/681 (57%), Gaps = 93/681 (13%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
+ + CN T PFL++ + E+VNI + + +Y + + KG S T T
Sbjct: 59 YEVVCNTTTS--VPFLSRINRELVNIYLP---DPTEYYSNGVVHIKGPVTSSGCSTGTSQ 113
Query: 61 KFTVS-------------NTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCD----SFD 103
T +N + +GC+ A + + GC S CD S
Sbjct: 114 PLTPQPLNVAGQGSPYFLTDKNLLMAVGCNVKAVM---MDVKSQIIGCESSCDERNSSSQ 170
Query: 104 FVTNGSCIGTGCCQIEIPRGS---------FKNHTNVSSFNPCTYAF----------VVD 144
V N C G CCQ IP G + N + C AF V +
Sbjct: 171 VVRNKICSGNKCCQTRIPEGQPQVIGVNIEIPENKNTTE-GGCKVAFLTSNKYSSLNVTE 229
Query: 145 QSQFHFTSNYLAFDGIPDDFPIV-LDWEITTIETCEEAKICGPNASCDKSKDN------- 196
+FH D + +V L W T ++ + I N S D S+D
Sbjct: 230 PEEFH-----------SDGYAVVELGWYFDTSDSRVLSPIGCMNVS-DASQDGGYGSETI 277
Query: 197 TTTSSGY-------HCKCNK-GYEGNPYLSDGCRDVNEFE-DPSLNNCT-HICDNTAGNY 246
S GY C CN GY GNP+L GC D++E + + C C N G +
Sbjct: 278 CVCSYGYFSGFSYRSCYCNSMGYAGNPFLPGGCVDIDECKLEIGRKRCKDQSCVNKPGWF 337
Query: 247 TCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRRE 306
TC P + IK G G LL GI+GLYKF KK+R
Sbjct: 338 TCE-----------------PKKPGQIKPVF-QGVLIGSALLLFAFGIFGLYKFIKKQRR 379
Query: 307 IKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVY 366
+ FF+RNGG+LL+Q+L+ + +VE +K+F+S +LEKATDN+N NR+LGQGGQGTVY
Sbjct: 380 SSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQGGQGTVY 439
Query: 367 KGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426
KGML DGRIVAVK+SK +DE+ VE+FINEVV+L+QINHRNIVKLLGCCLETEVP+LVYEF
Sbjct: 440 KGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEF 499
Query: 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD 486
VPNG L + + + +++ +TWE+ L IA+E++GAL YLHSAAS IY RDIK+ NILLD+
Sbjct: 500 VPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDE 559
Query: 487 KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
KY+ KVSDFGTSRS+T+DQTHLTT+V GTFGYVDPEYFQSS+FT+KSDVYSFGVVLVE++
Sbjct: 560 KYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGVVLVELI 619
Query: 547 TGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNL 606
TG+ P + +E+R +F+ A+ ENR +++D + E +++M VA LAKRCLN
Sbjct: 620 TGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLAKRCLNR 679
Query: 607 NGKNRPTMKEVAFELGGIRAS 627
GK RP M+EV+ EL IR+S
Sbjct: 680 KGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| 255558508 | 1433 | ATP binding protein, putative [Ricinus c | 0.944 | 0.452 | 0.512 | 0.0 | |
| 359492353 | 820 | PREDICTED: wall-associated receptor kina | 0.902 | 0.754 | 0.523 | 0.0 | |
| 225456209 | 736 | PREDICTED: wall-associated receptor kina | 0.896 | 0.835 | 0.525 | 0.0 | |
| 359492355 | 745 | PREDICTED: wall-associated receptor kina | 0.892 | 0.821 | 0.521 | 0.0 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.883 | 0.815 | 0.548 | 0.0 | |
| 359492347 | 722 | PREDICTED: wall-associated receptor kina | 0.874 | 0.831 | 0.507 | 1e-179 | |
| 225459705 | 742 | PREDICTED: wall-associated receptor kina | 0.897 | 0.830 | 0.532 | 1e-179 | |
| 224092689 | 743 | predicted protein [Populus trichocarpa] | 0.903 | 0.834 | 0.509 | 1e-178 | |
| 449455742 | 738 | PREDICTED: wall-associated receptor kina | 0.890 | 0.827 | 0.498 | 1e-177 | |
| 449485245 | 717 | PREDICTED: wall-associated receptor kina | 0.890 | 0.852 | 0.498 | 1e-177 |
| >gi|255558508|ref|XP_002520279.1| ATP binding protein, putative [Ricinus communis] gi|223540498|gb|EEF42065.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 673 bits (1737), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 348/679 (51%), Positives = 464/679 (68%), Gaps = 31/679 (4%)
Query: 1 FLITCNDTFKP---PKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDS-NLPT 56
FLITCND+ P P+L KS+I+V NIS+DG L ++Q A+DCYN G
Sbjct: 764 FLITCNDSLTANSTPVPYLRKSNIKVTNISLDGRLEIVQVAARDCYNKSGIRQPGFRRRF 823
Query: 57 ITLSKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCC 116
+TLSKFT+S + N+F VIGCDSYAY+ G+ YR+GCMS+C D V SC G+GCC
Sbjct: 824 LTLSKFTISKSHNKFTVIGCDSYAYLDGFRYGKFYRSGCMSLCADPDLVDGKSCSGSGCC 883
Query: 117 QIEIPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDD--FP 165
QIEIP G SFKNHTN+SSFNPCTYAF+V+ S+F+F+ YL + IP D FP
Sbjct: 884 QIEIPDGLYHANATAYSFKNHTNISSFNPCTYAFIVEDSRFNFSFEYL--ENIPTDKEFP 941
Query: 166 IVLDWEITTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225
+VLDW + T + A C +A+ + +N SGY CKC +GY+GNPYL GC DVN
Sbjct: 942 MVLDWAVNN--TLKHA--CKDHANSYQPDNN----SGYLCKCQEGYQGNPYL--GCEDVN 991
Query: 226 EFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSGGL 285
E ++ + N CT C N G+YTC CPKG+ GDGR+DG GCIP+Q +LIK+ LG G
Sbjct: 992 ECKNENQNKCTDRCTNLDGSYTCSCPKGYHGDGRKDGQGCIPDQLSLIKIILGVGIGF-- 1049
Query: 286 GLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLE 345
++F++V W +Y +KR+ IK K+KF+++NGG +LQQ+LS + + K+FT+++L+
Sbjct: 1050 -IVFIVVSSW-IYLVLRKRKLIKLKEKFYQKNGGAILQQKLSRRDGNTDAAKVFTAEELK 1107
Query: 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHR 405
KAT+NY+ + I+G+GG GTVYKG++ D R+VA+KKS+ VD+ VEQFINEV++LSQINHR
Sbjct: 1108 KATNNYDESNIIGKGGFGTVYKGIVTDNRVVAIKKSRTVDQAQVEQFINEVIVLSQINHR 1167
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
N+V+LLGCCLETEVPLLVYEF+ NGTL+ IH ++WE LRIA E +GAL YLH
Sbjct: 1168 NVVRLLGCCLETEVPLLVYEFITNGTLFDYIHCESNASALSWETRLRIAAETAGALSYLH 1227
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
SAA+I I RD+KS NILLD + AKVSDFG SR + VD+ L+T VQGT+GY+DPEY
Sbjct: 1228 SAATIPIIHRDVKSTNILLDANHAAKVSDFGASRLVPVDENQLSTMVQGTWGYLDPEYLH 1287
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
++Q T+KSDVYSFGVVLVE+LT K + +EDRSL YFL ++ + LF +LD+ ++
Sbjct: 1288 TNQLTDKSDVYSFGVVLVELLTSMKALCFDRPEEDRSLAMYFLSSVRKGDLFGILDSRIV 1347
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQNCGVIDCVNG 645
+ +E+I VA +A+ CL L G+ RPTMKEVA EL G+R +Q N G + +
Sbjct: 1348 DQRNKEQIEEVAKVAEGCLTLKGEERPTMKEVAVELEGLRKMEVHPWVQVNQGETEYLLS 1407
Query: 646 DISEHYLESDLVSMGTSIL 664
+ S D SM ++
Sbjct: 1408 EQSNDLGHGDYDSMKDQVI 1426
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492353|ref|XP_002284691.2| PREDICTED: wall-associated receptor kinase 3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 350/669 (52%), Positives = 449/669 (67%), Gaps = 50/669 (7%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
FLITC+++ PK FLT+ +I V NIS+DG L++L A +CYN G D+ P LS
Sbjct: 103 FLITCDNSTSLPKAFLTEGNINVTNISLDGELHLLSLIAHNCYNRNGTLQDNLEPYFRLS 162
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEI 120
F++S T N+FV +GCD+YA + GY GE+ YR GCMS+C S V +GSC G GCCQI
Sbjct: 163 IFSISGTLNKFVAVGCDTYALLSGYQGEDLYRTGCMSICSSKKQVQDGSCSGAGCCQISF 222
Query: 121 PRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLDWE 171
P G S+ NHT V FNPC+YAF+V+++ F+F+S L+ + P+V+DW
Sbjct: 223 PEGLKNTTLILSSYFNHTEVHDFNPCSYAFIVEEAAFNFSSKNLSNLQDIEKLPMVVDWS 282
Query: 172 ITTIETCEEAKI------CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225
I ETC+ AK C N++C +S + GY CKC GY GNPYL DGC+D++
Sbjct: 283 IGN-ETCQVAKTNQTSYACKENSTCYES----NSRPGYLCKCFDGYHGNPYL-DGCQDID 336
Query: 226 EFEDPSLNNCTHI--CDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAG--- 280
E ++ SLN C C NT GNYTC C KG+ GDGR DG GC PN+ LI+V+LG
Sbjct: 337 ECKNSSLNKCVKKARCKNTPGNYTCSCSKGYHGDGRDDGDGCNPNELQLIQVSLGMIFFF 396
Query: 281 ---------------------CSG---GLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKR 316
CS G+GL+ L++G LY KKR+ IK K++FF++
Sbjct: 397 ALSILLKRKFNYDIFHLLVLICSNVGVGIGLISLLIGSSWLYWGLKKRKFIKLKEEFFQQ 456
Query: 317 NGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIV 376
NGGL+LQ++LS + S E K+FT +LEKAT+ YN ++I+G GG GTVYKG L DGRIV
Sbjct: 457 NGGLMLQKQLSKREGSTETIKIFTGAELEKATNKYNESKIIGHGGYGTVYKGTLTDGRIV 516
Query: 377 AVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNI 436
A+KKSK+VD++ +EQFINEV++LSQINHRN+VKLLGCCLET+VPLLVYEF+ NGTL+ +I
Sbjct: 517 AIKKSKMVDKSQIEQFINEVLVLSQINHRNVVKLLGCCLETKVPLLVYEFITNGTLFDHI 576
Query: 437 HNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496
HN I WE+ LRIA E +G L YLHSAASI I RD+KS NILLDD Y AKVSDFG
Sbjct: 577 HNKSNTSIIPWEIRLRIATETAGVLSYLHSAASIPIIHRDVKSTNILLDDNYTAKVSDFG 636
Query: 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
SR + +DQT L+T VQGT GY+DPEY +SQ TEKSDVYSFGVVLVE+LTG+K +
Sbjct: 637 ASRLVPLDQTQLSTMVQGTLGYLDPEYLLTSQLTEKSDVYSFGVVLVELLTGEKALSFDR 696
Query: 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
++ RSL YFL ++ ++RLF+VLD ++ E E++ A LAKRCL L G RPTMKE
Sbjct: 697 PEDKRSLAMYFLFSLRDDRLFQVLDEHIVNEENIEQLKEAAKLAKRCLRLKGDERPTMKE 756
Query: 617 VAFELGGIR 625
V EL G+R
Sbjct: 757 VVMELEGLR 765
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456209|ref|XP_002282887.1| PREDICTED: wall-associated receptor kinase 2-like isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/639 (52%), Positives = 446/639 (69%), Gaps = 24/639 (3%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F I CN T + FLT S+I+V++IS+ G L VL Y A+DCYN G V +N P +TL+
Sbjct: 54 FFINCNSTHQA---FLTDSNIDVLSISVSGQLRVLSYVARDCYNKSGQRVANNDPWMTLA 110
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEI 120
KF +S+T N+F+ +GCD+YA+++G G+ +Y+ GC+S+C+S D V NGSC G GCCQ I
Sbjct: 111 KFPISHTRNKFMTVGCDTYAFIKGSSGK-KYKTGCLSLCESKDSVINGSCSGIGCCQTTI 169
Query: 121 PRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLDWE 171
P S+ ++T V FNPC +AFV + F+F+S L P VLDW
Sbjct: 170 PVNVTSIDISVDSYDSYTGVWEFNPCGFAFVAEDGYFNFSSADLLDLQNKTKVPTVLDWT 229
Query: 172 ITTIETCEEAKICGPNASCDKSKDNT-----TTSSGYHCKCNKGYEGNPYLSDGCRDVNE 226
I E C++AK G + +C KDN+ GY C C++GYEGNPYL +GC+D++E
Sbjct: 230 IGD-EKCDQAKENGTSYAC---KDNSYCYDPDNGPGYRCNCSEGYEGNPYLLNGCKDIDE 285
Query: 227 FEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSGGLG 286
E + N TH C N G+++C CP G+ GDG + G GC N +++ +
Sbjct: 286 CEVDNPCNVTHTCRNLPGSFSCFCPAGYEGDGFKIGTGC--NHVLMLQFYFILFAGISIS 343
Query: 287 LLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEK 346
LL L++ LY +KR+ IK K+KFF++NGG++LQQ LS ++ E TK+FT++DL+K
Sbjct: 344 LLVLLLVSSWLYWGFRKRKLIKLKEKFFEQNGGIMLQQLLSKHEGFAEATKIFTTEDLKK 403
Query: 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
AT+NY+ R+LG+GGQGTVYKG+LAD R+VAVKKSK++D++ VEQFINEV+ILSQ+NHRN
Sbjct: 404 ATNNYDERRVLGRGGQGTVYKGILADNRVVAVKKSKIMDQSQVEQFINEVIILSQVNHRN 463
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+VKLLGCCLETEVPLLVYEFV NGTLY ++HN + + I+WE LRIA E +GAL+YLHS
Sbjct: 464 VVKLLGCCLETEVPLLVYEFVINGTLYDHLHNQDQTYSISWETRLRIATETAGALWYLHS 523
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
AAS I RD+KS NILLD+ Y AKVSDFG SR I +DQ LTT VQGT GY+DPEYF S
Sbjct: 524 AASTPIIHRDVKSTNILLDNNYTAKVSDFGASRLIPLDQAQLTTLVQGTLGYLDPEYFHS 583
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
SQ TEKSDVYSFGVVLVE+LTG+K + ++E+R+L +F+ +M ++RLFE+LD VL
Sbjct: 584 SQLTEKSDVYSFGVVLVELLTGKKALSFDRLEEERNLAMFFVSSMKDDRLFEILDDRVLN 643
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
E + + VA LAKRCL + G+ RPTMKEVA EL G+R
Sbjct: 644 EGNTKHLKEVAILAKRCLMVKGEERPTMKEVAMELEGLR 682
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492355|ref|XP_002284688.2| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 650 bits (1678), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 338/648 (52%), Positives = 438/648 (67%), Gaps = 36/648 (5%)
Query: 1 FLITCNDTFKPPKPFLTKSS--IEVVNISIDGH-LNVLQYTAKDCYNAKGYSVDS-NLPT 56
FLI CN + PPKP L SS ++V+NISI+ H L + + +DCY+ G D L
Sbjct: 56 FLIACNHSLSPPKPLLWNSSFNLQVLNISIEDHRLRIYTFVGRDCYDKMGKQYDQPTLAY 115
Query: 57 ITLSKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCC 116
L +F S+ NRF IGCD+ A G G + + GC+S+C+S VTNGSC G GCC
Sbjct: 116 ANLPRFPFSDKGNRFTAIGCDTIAVFNGLNGADDFTTGCLSLCNSIRSVTNGSCSGIGCC 175
Query: 117 QIE-IPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPI 166
Q IP+G SF NHT V SFNPC+YAF+ ++ F+F+S L FP
Sbjct: 176 QTSNIPKGLFSYYASVGSFYNHTKVWSFNPCSYAFLAEEESFNFSSADLKDLQNRTVFPT 235
Query: 167 VLDWEITTIETCEEAK------ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG 220
+LDW + +TCEEAK C N+ C N+ GY C C+ G++GNPYL +G
Sbjct: 236 LLDWAVGN-KTCEEAKKNLTSYACKDNSYCY----NSDNGPGYRCNCSSGFQGNPYLPNG 290
Query: 221 CRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRD--GGGCIPNQKNLIKVALG 278
C+D++E DP N CT +C NT G+YTC CPKG+ G+GRRD G GC P L ++ +G
Sbjct: 291 CQDIDECADPKRNECTKVCINTPGSYTCSCPKGYHGNGRRDENGDGCTP----LFELNVG 346
Query: 279 AGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKL 338
+GL+ L++ LY KKR+ IK K+KFF++NGGL+LQQ+L + S E K+
Sbjct: 347 IF----IGLIALLITSSWLYWGLKKRKFIKLKEKFFQQNGGLMLQQQLHGREGSSESVKI 402
Query: 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVI 398
FT+++LEKAT+ Y+ + I+G+GG GTVYKG+LADGR+VA+KKSKLVD+ +EQFINEVV+
Sbjct: 403 FTAEELEKATNKYDEDTIIGRGGYGTVYKGILADGRVVAIKKSKLVDQTQIEQFINEVVV 462
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVS 458
LSQINHRN+VKLLGCCLETEVPLLVYEF+ NGTL+ IHN + I+WE LRIA E +
Sbjct: 463 LSQINHRNVVKLLGCCLETEVPLLVYEFITNGTLFDYIHNKSKASSISWETRLRIAAETA 522
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
G L YLHS+ASI I RD+KS NILLDD Y AKVSDFG SR + +DQT L+T VQGT GY
Sbjct: 523 GVLSYLHSSASIPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQTQLSTMVQGTLGY 582
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
+DPEY +SQ TEKSDVYSFGVVLVE+LTG+K + +E+RSL +FL ++ +RLF+
Sbjct: 583 LDPEYLHTSQLTEKSDVYSFGVVLVELLTGKKALSFDRPEEERSLAMHFLSSLKNDRLFQ 642
Query: 579 VL-DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+L D +V + E++ VA LAKRCL + G+ RPTMKEVA EL G+R
Sbjct: 643 ILEDYIVPNDENMEQLKDVAKLAKRCLEVKGEERPTMKEVARELDGMR 690
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1654), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/643 (54%), Positives = 443/643 (68%), Gaps = 37/643 (5%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F +TCN T P +P+LT ++E++ +S++ L + + N + S+L
Sbjct: 57 FAVTCNKTSLPYRPYLTSINLELLRVSLESTLVRVNNPVLNS-NCQDRPPVSDLSFSGSP 115
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEI 120
N NRF +GC++ A + ++ GC+S+C+ VT SC G CCQ I
Sbjct: 116 FSFSDN--NRFTALGCNNLALI---YRQDMVIGGCLSICNVT--VTESSCYGINCCQTSI 168
Query: 121 PRGSFKNHTNVSSFNP-----CTYAFVVDQSQF--HFTSNYLAFDGIPDDFPIVLDWEIT 173
P + ++ S +P C AF+VD+ F + + N A G P VL+W I+
Sbjct: 169 PPYLKFINASLRSIDPVPDEQCRVAFMVDREWFSSNASDNISALLGA-KQVPAVLEWGIS 227
Query: 174 TIETCEEAK-------ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNE 226
TC ++ ICG NASC + Y C CN+GYEGNPYLS C+D+NE
Sbjct: 228 N-GTCADSPGAENSTDICGSNASC-----SVKVGINYQCSCNQGYEGNPYLS--CQDINE 279
Query: 227 FEDPSLNNCTHICDNTAGNYTCRCPKGF--RGDGRRDGGGCIPNQKNLIKVALGAGCSGG 284
ED N C+ IC NT G+Y C CP G+ G+ G + +I + L S G
Sbjct: 280 CEDSQKNKCSMICVNTPGSYKCSCPDGYISMGNNCYLTDGYTERFRPVIAIVL----SAG 335
Query: 285 LGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDL 344
LG+ FL++G W LYK K+R++ K +Q+FFKRNGGLLLQQ+LSS++SS+EKT +FT+K+L
Sbjct: 336 LGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTAKEL 395
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH 404
EKATD+YN NRILGQGGQGTVYKGML DG++VA+KKSK+ DE+ EQFINEVVILSQINH
Sbjct: 396 EKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILSQINH 455
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
RN+VKLLGCCLETEVPLLVYEF+PNGTLYQ++H+ EEFPITWE+ LRIA+E AL YL
Sbjct: 456 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALSYL 515
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HSAAS+ IY RDIKS NILLDDKYRAKVSDFGTS+SI VDQTH+TT+VQGTFGY+DPEYF
Sbjct: 516 HSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPEYF 575
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
QSSQFTEKSDVYSFGVVLVE+LTGQKPI + E+RSL YFL +M +NRLFE+LDA V
Sbjct: 576 QSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILDARV 635
Query: 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
LKE +EEI+ VA LA+RCLNLNGK RPTM+ V E+ IRAS
Sbjct: 636 LKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492347|ref|XP_003634400.1| PREDICTED: wall-associated receptor kinase 2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 326/642 (50%), Positives = 424/642 (66%), Gaps = 42/642 (6%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITL- 59
FL+ CND+ PPK L + + VV+IS+ G L +L + +DCYN+ G V N P + L
Sbjct: 58 FLLHCNDSVMPPKLTLGMN-LHVVSISL-GELKILNFLGRDCYNSYGGLVYENDPWLRLG 115
Query: 60 SKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE 119
S +T+S N+F+ +GCD+YA VR Y GE RY GCMS+CDS V +GSC G GCC+
Sbjct: 116 SGYTISGKRNKFIAVGCDTYAIVRAYKGEERYTTGCMSVCDSITNVKSGSCSGIGCCETS 175
Query: 120 IPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLDW 170
IP G S+ NH +V +FNPC+YAFVV+++ F F+SN ++ P+VLDW
Sbjct: 176 IPEGTTNFTVKLSSYNNHRSVWAFNPCSYAFVVEETHFKFSSNQFRDLNNTENLPVVLDW 235
Query: 171 EITTIETCEEAK-----ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225
I E C+ A+ C + C + D SGY CKC GY GNPYL DGC+D+N
Sbjct: 236 RIGK-ERCKAARKTETYACKGKSECYEPDD----WSGYLCKCLDGYHGNPYLPDGCQDIN 290
Query: 226 EFEDPSLNNCTHI--CDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSG 283
E +DPSLN C C NT GNYTC CPKG + + + +
Sbjct: 291 ECDDPSLNKCVKKGRCKNTPGNYTCSCPKGS------------------LTILICSNVGA 332
Query: 284 GLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKD 343
G+G + L++ I LY KKR+ I+ K+KFF++NGGL+LQQ+LS + S E K+FT+ +
Sbjct: 333 GIGFMILLLSISWLYWGLKKRKFIRLKEKFFQQNGGLMLQQQLSRQEGSDETIKIFTAGE 392
Query: 344 LEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN 403
LEKAT+ Y+ + I+G+GG GTVYKG L +GRIVAVKKSK++D++ +EQFINEV++LSQIN
Sbjct: 393 LEKATNKYDESNIVGRGGYGTVYKGTLTNGRIVAVKKSKMIDKSQIEQFINEVLVLSQIN 452
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
HRN+VKLLGCCLETEVPLLVYEF+ NGTL+ IH + I+WE+ LRIA E +G L Y
Sbjct: 453 HRNVVKLLGCCLETEVPLLVYEFITNGTLFNYIHGERKASTISWEVRLRIATETAGVLSY 512
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
LHSA S I RD+KS NILLDD Y AKVSDFG SR + +DQ L+T VQGT GY+DPEY
Sbjct: 513 LHSATSTPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQAQLSTLVQGTLGYLDPEY 572
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+SQ TEKSDVYSFGVV VE+LTG+K + +E+RSL YFL + ++ LF+VLD
Sbjct: 573 LLTSQLTEKSDVYSFGVVFVELLTGEKALSFDRSEEERSLAMYFLSSWKDDNLFQVLDKH 632
Query: 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
++ E E++ A LAKRCL L G RPTMKEV+ EL I+
Sbjct: 633 IVNEGNIEQLREAANLAKRCLRLKGDERPTMKEVSMELERIK 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225459705|ref|XP_002284700.1| PREDICTED: wall-associated receptor kinase 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1633), Expect = e-179, Method: Compositional matrix adjust.
Identities = 342/642 (53%), Positives = 442/642 (68%), Gaps = 26/642 (4%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGY-SVDSNLPTITL 59
FLITC+++ PPK FLT S+I V NI+ DG L+VL A++CY G +S + +L
Sbjct: 58 FLITCDNSTSPPKAFLTNSNINVTNINFDGELHVLSLMARNCYYPNGTEQPNSTTASFSL 117
Query: 60 SKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE 119
S F++S+T N+F +GCD+YA ++GY G + Y GCMS+C S V +GSC G GCCQ+
Sbjct: 118 SIFSISDTLNKFFAVGCDTYALLQGYQGGDLYTTGCMSICSSEKQVQDGSCSGAGCCQVS 177
Query: 120 IPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLDW 170
P G S+ NHT V FNPC+YAF+ ++S F+F+S L + P V+DW
Sbjct: 178 FPEGLDDTTLTLSSYFNHTKVHDFNPCSYAFIAEESAFNFSSKNLTNLQDMEKLPRVVDW 237
Query: 171 EITTIETCEEAKICGPNASCDKSKDNTTTS-----SGYHCKCNKGYEGNPYLSDGCRDVN 225
I ETC+ AK N S K+N+T S SGY CKC GY GNPYL DGC+D++
Sbjct: 238 SIGN-ETCQVAKT---NPSSYACKENSTCSEPSGRSGYLCKCFDGYHGNPYL-DGCQDID 292
Query: 226 EFEDPSLNNCTHI--CDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSG 283
E E+ SLN C C N GNYTC C KG+ GDGR DG GC PN +I++ALG
Sbjct: 293 ECENSSLNKCVEKARCKNIPGNYTCSCRKGYHGDGREDGDGCNPNMLQVIQIALGVS--- 349
Query: 284 GLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKD 343
+GL+ L++G LY KKR+ IK K+KFF++NGGL+L+Q+LSS + S E K+F++++
Sbjct: 350 -IGLISLLMGSSWLYWGLKKRKFIKLKKKFFEQNGGLMLRQQLSSQEGSNETVKIFSAEE 408
Query: 344 LEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN 403
LEKATD Y N+I+GQGG GTVYKG L +GRIVA+KKSK+VD++ +EQFINEV++LSQIN
Sbjct: 409 LEKATDKYAENKIIGQGGYGTVYKGTLTNGRIVAIKKSKMVDKSQIEQFINEVLVLSQIN 468
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
HRN+VKLLGCCLETEVPLLVYEF+ NGTL+ IH + +WE+ LRIA E + L Y
Sbjct: 469 HRNVVKLLGCCLETEVPLLVYEFITNGTLFDYIHKGKKISTSSWEVRLRIATETAEVLSY 528
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
LHSAAS I RD+KS NILLDD Y AKVSDFG SR + +DQT L+T VQGT GY+DPEY
Sbjct: 529 LHSAASTPIIHRDVKSTNILLDDNYTAKVSDFGASRLVPLDQTQLSTMVQGTLGYLDPEY 588
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+SQ TEKSDVYSFGVVLVE+LT +K + +E+RSL YFL ++ ++RLF+VLD
Sbjct: 589 LLTSQLTEKSDVYSFGVVLVELLTAKKALSFDKPEEERSLAMYFLSSLKDDRLFQVLDER 648
Query: 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
++ E E++ A LAK+CL L G RPTMKEVA +L +R
Sbjct: 649 IVNEENIEQLKETANLAKKCLKLKGDERPTMKEVAMKLERMR 690
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224092689|ref|XP_002309699.1| predicted protein [Populus trichocarpa] gi|222855675|gb|EEE93222.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 631 bits (1627), Expect = e-178, Method: Compositional matrix adjust.
Identities = 329/646 (50%), Positives = 434/646 (67%), Gaps = 26/646 (4%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITL- 59
FLITCN TF PPK FL ++ V I++DG L ++QY AKDCYN G N+P I L
Sbjct: 54 FLITCNHTFNPPKAFLGNGNLSVTEITLDGKLRLMQYIAKDCYNRAGARTTRNIPWINLP 113
Query: 60 --SKFTVSNTENRFVVIGCDSYAYVRGYLGE--NRYRAGCMSMCDSFDFVTNGSCIGTGC 115
+ S+T+N FV IGCD+YA + G + + Y GC+S C + V N +C G GC
Sbjct: 114 VQGPYVFSDTDNMFVAIGCDTYAGLLGIREDTNDTYLVGCISECSNKTVVPN-TCSGVGC 172
Query: 116 CQIEIPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPI 166
CQ I +G S NHT + FNPC++AF++++ QF F + L+ PI
Sbjct: 173 CQTSIAKGMKYFEVRLSSETNHTGIWEFNPCSFAFMIEKKQFSFFPSNLSDLEQVRKVPI 232
Query: 167 VLDWEI--TTIETCEEAKICGPNASCDKSK-DNTTTSSGYHCKCNKGYEGNPYLSDGCRD 223
++DW I ET E+ K+ NA +SK + SGY CKC GY+GNPYL +GC++
Sbjct: 233 IVDWSIGRNKCETLEKNKM--SNACQGQSKCHDPENGSGYICKCLDGYQGNPYLPNGCQN 290
Query: 224 VNEFEDPSL-NNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCS 282
+NE DP + NC+H C +T GNYTC CPKG+ GDGR DG CI N+ ++I+VA+G G
Sbjct: 291 INECSDPKVARNCSHNCIDTEGNYTCSCPKGYHGDGRIDGERCIRNRSSVIQVAVGIGA- 349
Query: 283 GGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKT-KLFTS 341
GL L++GI LY K + +K K+KFF++NGGL+L+Q+LS + V +T K+F++
Sbjct: 350 ---GLTSLLMGITWLYWGYSKWKLMKLKEKFFRQNGGLMLEQQLSRREGPVTETAKIFSA 406
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
+LEKATD Y+ +RILG+GG GTVYKG L DGR VA+KKSK +D + +EQFINEVV+L Q
Sbjct: 407 AELEKATDKYHESRILGRGGFGTVYKGTLTDGRTVAIKKSKTIDHSQIEQFINEVVVLYQ 466
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
INHRN+VKLLGCCLETEVPLLVYE+V NGTLY +IH+ + +TWE+ L+IA E +G L
Sbjct: 467 INHRNVVKLLGCCLETEVPLLVYEYVANGTLYDHIHDKSKVSALTWEIRLKIASETAGVL 526
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLHSAAS+ I RD+KS NILLD+ Y AKVSDFGTSR I +DQ L+T VQGT GY+DP
Sbjct: 527 SYLHSAASVPIIHRDVKSTNILLDNSYTAKVSDFGTSRLIPLDQVELSTMVQGTLGYLDP 586
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
EY +SQ T+KSDVYSFGVVLVE+LTG K I + +R+L YFL A+ E+RL +L
Sbjct: 587 EYLHTSQLTDKSDVYSFGVVLVELLTGMKAISFHKPEGERNLSSYFLCALKEDRLVHILQ 646
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
++ + ++ VA +AK+CL + G+ RP MK VA EL G+R S
Sbjct: 647 DCMVNQDNIRQLKGVANIAKKCLRVKGEERPYMKNVAMELEGLRTS 692
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455742|ref|XP_004145610.1| PREDICTED: wall-associated receptor kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-177, Method: Compositional matrix adjust.
Identities = 320/642 (49%), Positives = 434/642 (67%), Gaps = 31/642 (4%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F ITCN T+ PP PFL S+++V IS + +L + + + +CY G S+ +I L
Sbjct: 71 FDITCNSTYDPPLPFLGTSNLQVEEIS-EANLRIRNFVSFNCYTQTGALTKSSASSINLG 129
Query: 61 KFTVS-NTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE 119
+ +T N+F VIGCD+ A + G G Y +GC+S+C S + V NGSC G GCCQ +
Sbjct: 130 HLPMFFSTANKFTVIGCDTMALITGSEGL-FYTSGCVSLCSSKETVINGSCSGIGCCQTD 188
Query: 120 IPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPD---DFPIV 167
+PRG + NHT +NPC+YAF+VD+ ++ F + LA + P+V
Sbjct: 189 VPRGLKRFQSMIGNLNNHTKTWQYNPCSYAFLVDRDRYTFQVSDLADPNVISTIKSLPVV 248
Query: 168 LDWEITTIETCEEAK------ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC 221
LDW + TCEEA+ +C N+ C S+ + SGY C+C++G+ GNPYLS GC
Sbjct: 249 LDWVVGN-RTCEEARKELSTYVCQANSECYDSE----SESGYQCRCSRGFSGNPYLSSGC 303
Query: 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGC 281
+D++E P+ N C IC NT G+Y C CP G GDG+++G GCI K + L G
Sbjct: 304 QDIDECAGPN-NPCEGICVNTPGSYYCSCPHGSYGDGKKEGKGCINKTKQFPLIQLTVGL 362
Query: 282 SGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTS 341
+ L LFL+V LY KKR IK ++KFF +NGG LL+Q+ S ++++V+ TK+FT+
Sbjct: 363 ASTL--LFLVVTATWLYFTIKKRNLIKLREKFFHQNGGFLLRQQSSQHEAAVDSTKIFTA 420
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
++LEKATDNY RILG+GG GTVYKG+L DG+ VA+KKSK+ D++ +EQFINEV+IL+Q
Sbjct: 421 EELEKATDNYAETRILGRGGNGTVYKGILPDGKTVAIKKSKIADKSQIEQFINEVIILTQ 480
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH--NHIEEFPITWELLLRIAVEVSG 459
I HRN+VKL+GCCLETEVPLLVYEFV NGTL+ +IH N ++WE +RIA E +G
Sbjct: 481 IKHRNVVKLMGCCLETEVPLLVYEFVSNGTLHSHIHDENRFNNNSLSWEDRMRIATETAG 540
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
AL YLHSAAS+ I RD+KSANILLD K AKV+DFG S+ I +DQ+ +TT VQGTFGY+
Sbjct: 541 ALAYLHSAASVPIIHRDVKSANILLDRKCTAKVADFGASKFIPMDQSQITTLVQGTFGYL 600
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
DPEYFQ+SQ TEKSDVYSFGVVLVE+LTG+ P+ + +R+L YF+ ++ E RLF +
Sbjct: 601 DPEYFQTSQLTEKSDVYSFGVVLVELLTGELPVSFERSETERNLSSYFVASLREKRLFRI 660
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
LD VL+E +RE+++ A LA+RCL L G++RP M+EV EL
Sbjct: 661 LDGRVLREGKREQVIAAAELARRCLKLKGEDRPRMREVVSEL 702
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485245|ref|XP_004157111.1| PREDICTED: wall-associated receptor kinase 2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1620), Expect = e-177, Method: Compositional matrix adjust.
Identities = 320/642 (49%), Positives = 434/642 (67%), Gaps = 31/642 (4%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F ITCN T+ PP PFL S+++V IS + +L + + + +CY G S+ +I L
Sbjct: 50 FDITCNSTYDPPLPFLGTSNLQVEEIS-EANLRIRNFVSFNCYTQTGALTKSSASSINLG 108
Query: 61 KFTVS-NTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE 119
+ +T N+F VIGCD+ A + G G Y +GC+S+C S + V NGSC G GCCQ +
Sbjct: 109 HLPMFFSTANKFTVIGCDTMALITGSEGL-FYTSGCVSLCSSKETVINGSCSGIGCCQTD 167
Query: 120 IPRG---------SFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPD---DFPIV 167
+PRG + NHT +NPC+YAF+VD+ ++ F + LA + P+V
Sbjct: 168 VPRGLKRFQSMIGNLNNHTKTWQYNPCSYAFLVDRDRYTFQVSDLADPNVISTIKSLPVV 227
Query: 168 LDWEITTIETCEEAK------ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC 221
LDW + TCEEA+ +C N+ C S+ + SGY C+C++G+ GNPYLS GC
Sbjct: 228 LDWVVGN-RTCEEARKELSTYVCQANSECYDSE----SESGYQCRCSRGFSGNPYLSSGC 282
Query: 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGC 281
+D++E P+ N C IC NT G+Y C CP G GDG+++G GCI K + L G
Sbjct: 283 QDIDECAGPN-NPCEGICVNTPGSYYCSCPHGSYGDGKKEGKGCINKTKQFPLIQLTVGL 341
Query: 282 SGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTS 341
+ L LFL+V LY KKR IK ++KFF +NGG LL+Q+ S ++++V+ TK+FT+
Sbjct: 342 ASTL--LFLVVTATWLYFTIKKRNLIKLREKFFHQNGGFLLRQQSSQHEAAVDSTKIFTA 399
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
++LEKATDNY RILG+GG GTVYKG+L DG+ VA+KKSK+ D++ +EQFINEV+IL+Q
Sbjct: 400 EELEKATDNYAETRILGRGGNGTVYKGILPDGKTVAIKKSKIADKSQIEQFINEVIILTQ 459
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH--NHIEEFPITWELLLRIAVEVSG 459
I HRN+VKL+GCCLETEVPLLVYEFV NGTL+ +IH N ++WE +RIA E +G
Sbjct: 460 IKHRNVVKLMGCCLETEVPLLVYEFVSNGTLHSHIHDENRFNNNSLSWEDRMRIATETAG 519
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
AL YLHSAAS+ I RD+KSANILLD K AKV+DFG S+ I +DQ+ +TT VQGTFGY+
Sbjct: 520 ALAYLHSAASVPIIHRDVKSANILLDRKCTAKVADFGASKFIPMDQSQITTLVQGTFGYL 579
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
DPEYFQ+SQ TEKSDVYSFGVVLVE+LTG+ P+ + +R+L YF+ ++ E RLF +
Sbjct: 580 DPEYFQTSQLTEKSDVYSFGVVLVELLTGELPVSFERSETERNLSSYFVASLREKRLFRI 639
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
LD VL+E +RE+++ A LA+RCL L G++RP M+EV EL
Sbjct: 640 LDGRVLREGKREQVIAAAELARRCLKLKGEDRPRMREVVSEL 681
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 686 | ||||||
| TAIR|locus:2014912 | 732 | WAK2 "wall-associated kinase 2 | 0.542 | 0.508 | 0.496 | 2.7e-141 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.548 | 0.522 | 0.569 | 2.8e-135 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.886 | 0.829 | 0.445 | 6e-135 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.561 | 0.489 | 0.570 | 4.9e-134 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.479 | 0.427 | 0.618 | 1.2e-130 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.870 | 0.808 | 0.434 | 2.2e-130 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.874 | 0.821 | 0.444 | 4.5e-130 | |
| TAIR|locus:2014902 | 735 | WAK1 "cell wall-associated kin | 0.472 | 0.440 | 0.546 | 8.8e-130 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.876 | 0.803 | 0.441 | 1.2e-129 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.467 | 0.420 | 0.628 | 1.7e-129 |
| TAIR|locus:2014912 WAK2 "wall-associated kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 2.7e-141, Sum P(2) = 2.7e-141
Identities = 188/379 (49%), Positives = 254/379 (67%)
Query: 302 KKRREIKSKQKFFKRNGG-LLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQG 360
K R+ + +QKFF++NGG +L+Q+ + S+V+ K+FT K +++AT+ Y+ +RILGQG
Sbjct: 355 KHRKNTELRQKFFEQNGGGMLIQRVSGAGPSNVD-VKIFTEKGMKEATNGYHESRILGQG 413
Query: 361 GQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420
GQGTVYKG+L D IVA+KK++L + + VEQFINEV++LSQINHRN+VK+LGCCLETEVP
Sbjct: 414 GQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVLGCCLETEVP 473
Query: 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSA 480
LLVYEF+ +GTL+ ++H + + +TWE LRIA EV+G+L YLHS+ASI I RDIK+A
Sbjct: 474 LLVYEFINSGTLFDHLHGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDIKTA 533
Query: 481 NILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGV 540
NILLD AKV+DFG SR I +D+ LTT VQGT GY+DPEY+ + EKSDVYSFGV
Sbjct: 534 NILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYSFGV 593
Query: 541 VLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLA 600
VL+E+L+GQK + ++LV F A NR E++D V+ E + EI A +A
Sbjct: 594 VLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNEDNQREIQEAARIA 653
Query: 601 KRCLNLNGKNRPTMKEVAFELGGIRASIGA---SILQQNCGVIDCVNG-DISEHYLESDL 656
C L G+ RP MKEVA EL +R S + G I+ + G I E+
Sbjct: 654 AECTRLMGEERPRMKEVAAELEALRVKTTKYKWSDQYRETGEIEHLLGVQILSAQGETSS 713
Query: 657 VSMGTSILNNSAAFSIDAG 675
S+G + N I+AG
Sbjct: 714 -SIGYDSIRNVTTLDIEAG 731
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 2.8e-135, Sum P(2) = 2.8e-135
Identities = 222/390 (56%), Positives = 294/390 (75%)
Query: 299 KFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILG 358
K +KR+ K K+KFF+RNGGLLLQQ+ S SV +TK+F+S DLE ATD +NA+RILG
Sbjct: 338 KANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILG 397
Query: 359 QGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418
QGGQGTVYKGML DG IVAVKKSK + E N+E+FINE+++LSQINHRN+VK+LGCCLETE
Sbjct: 398 QGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETE 457
Query: 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478
VP+LVYEF+PN L+ ++HN E+FP++WE+ L IA EV+ AL YLHSA SI IY RD+K
Sbjct: 458 VPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVK 517
Query: 479 SANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 538
S NILLD+K+RAKVSDFG SRS+ +D THLTT VQGT GYVDPEY QS+ FT KSDVYSF
Sbjct: 518 STNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSF 577
Query: 539 GVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598
GV+L+E+LTG+KP+ + E R L YFL+AM +RL E+LDA + +E +REE++ VA
Sbjct: 578 GVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAK 637
Query: 599 LAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQNCGVIDCVNGDISEH-YLESDLV 657
LA+RCL+LN ++RPTM++V EL +++ + Q NG+ EH +++ +
Sbjct: 638 LARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQ-------NGE--EHAHIQ---I 685
Query: 658 SMGTSI-LNNSAAFSIDAGPAFSIDARPLL 686
+M S+ L+ S+ + +FS+D +PL+
Sbjct: 686 AMPESMSLSYSSPNIVVENSSFSLDTKPLM 715
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1322 (470.4 bits), Expect = 6.0e-135, P = 6.0e-135
Identities = 287/644 (44%), Positives = 390/644 (60%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLS 60
F ITC + KP + S+IEV+N + G L L + CY+ + + +L L
Sbjct: 56 FNITCEED----KPNVL-SNIEVLNFNHSGQLRGLIPRSTVCYDQQTNNDFESL-WFRLD 109
Query: 61 KFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIE- 119
+ S N+F ++GC+++A + + G Y GCMS+CD+ N C G GCC+ E
Sbjct: 110 NLSFS-PNNKFTLVGCNAWALLSTF-GIQNYSTGCMSLCDTPP-PPNSKCNGVGCCRTEV 166
Query: 120 -IPRGS---------FKNHTNVSSFNPCTYAFVVDQSQFHFTSNYLAFD-GIPDDFPIVL 168
IP S F+N T+V FNPC+YAF V+ F+F+S D FP++L
Sbjct: 167 SIPLDSHRIETQPSRFENMTSVEHFNPCSYAFFVEDGMFNFSSLEDLKDLRNVTRFPVLL 226
Query: 169 DWEITTIETCEEA---KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225
DW I +TCE+ ICG N++C S T GY+CKC +G++GNPYLSDGC+D+N
Sbjct: 227 DWSIGN-QTCEQVVGRNICGGNSTCFDS----TRGKGYNCKCLQGFDGNPYLSDGCQDIN 281
Query: 226 EFEDPSLNNC--THICDNTAGNYTCRCPKXXXXXXXXXXXXCIPNQKNLIKVAXXXXXXX 283
E ++NC T C+NT G++ C+CP CI K K
Sbjct: 282 ECTT-RIHNCSDTSTCENTLGSFHCQCPSGSDLNTTTMS--CIDTPKEEPKYLGWTTVLL 338
Query: 284 XXXXXXXXXXXXXXY--KFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTS 341
Y + + R+ + +Q+FF++NGG +L Q LS S K+FT
Sbjct: 339 GTTIGFLIILLTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTE 398
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
+ +++ATD YN +RILGQGGQGTVYKG+L D IVA+KK++L D + VEQFINEV++LSQ
Sbjct: 399 EGMKEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQ 458
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
INHRN+VKLLGCCLETEVPLLVYEF+ +GTL+ ++H + + +TWE LRIA+EV+G L
Sbjct: 459 INHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRIAIEVAGTL 518
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLHS ASI I RD+K+ANILLD+ AKV+DFG SR I +DQ LTT VQGT GY+DP
Sbjct: 519 AYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDP 578
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
EY+ + EKSDVYSFGVVL+E+L+G+K + + LV YF+ AM ENRL E++D
Sbjct: 579 EYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIID 638
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
V+ E + EI A +A C + G+ RP+MKEVA EL +R
Sbjct: 639 GQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1097 (391.2 bits), Expect = 4.9e-134, Sum P(4) = 4.9e-134
Identities = 223/391 (57%), Positives = 289/391 (73%)
Query: 299 KFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILG 358
KF KRR K K+KFFKRNGGLLLQQEL++ + VEK ++FTSK+LEKAT+N++ NR+LG
Sbjct: 392 KFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLG 451
Query: 359 QGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418
GGQGTVYKGML DGR VAVKKSK++DE+ +++FINEVVILSQINHR++VKLLGCCLETE
Sbjct: 452 HGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETE 511
Query: 419 VPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDI 477
VP+LVYEF+ NG L+++IH +++ + W + LRIAV+++GAL YLHSAAS IY RDI
Sbjct: 512 VPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDI 571
Query: 478 KSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 537
KS NILLD+KYRAKV+DFGTSRS+T+DQTH TT + GT GYVDPEY++SSQ+TEKSDVYS
Sbjct: 572 KSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYS 631
Query: 538 FGVVLVEILTGQKPIRAI-NIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTV 596
FGV+L E++TG KP+ + N E +L +F AM E RL +++DA + +++ E++M V
Sbjct: 632 FGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAV 691
Query: 597 ATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQNCGVIDCVNGDISEHYLESDL 656
A LA +CL+ G+NRP M+EV EL I S S +Q + +G + E +
Sbjct: 692 ANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDEEEEEDG-VEEEEEVVTI 750
Query: 657 VSMGTS--ILNNSAAFSIDAGPAFSIDARPL 685
V G S I + A SI A P S D PL
Sbjct: 751 VHRGDSWSIGVTAPASSIVASPPSS-DVEPL 780
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1116 (397.9 bits), Expect = 1.2e-130, Sum P(3) = 1.2e-130
Identities = 204/330 (61%), Positives = 273/330 (82%)
Query: 298 YKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRIL 357
YKF +++R + K+KFFKRNGGLLLQQ+L++ + +V+ T++F S++LEKAT+N++ RIL
Sbjct: 380 YKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRIL 439
Query: 358 GQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET 417
G+GGQGTVYKGML DGRIVAVKKSK+VDE+ +E+FINEVVILSQINHRNIVKLLGCCLET
Sbjct: 440 GEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 499
Query: 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPIT-WELLLRIAVEVSGALFYLHSAASISIYRRD 476
+VP+LVYEF+PNG L++++H+ +++ +T WE+ LRIAV+++GAL YLHSAAS IY RD
Sbjct: 500 DVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRD 559
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
IKS NI+LD+K+RAKVSDFGTSR++TVD THLTT V GT GY+DPEYFQSSQFT+KSDVY
Sbjct: 560 IKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVY 619
Query: 537 SFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTV 596
SFGVVL E++TG+K + + E R+L YF AM ENRL +++DA + + ++
Sbjct: 620 SFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAA 679
Query: 597 ATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626
A +A++CLN+ G+ RP+M++V+ EL IR+
Sbjct: 680 AKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1279 (455.3 bits), Expect = 2.2e-130, P = 2.2e-130
Identities = 273/628 (43%), Positives = 365/628 (58%)
Query: 21 IEVVNISIDGHLNVLQYTAKDCYNAKGYSVDSNLPTITLSKFTVSNTENRFVVIGCDSYA 80
+EVV IS L VL + CYN+KG L T+S N +GC+SYA
Sbjct: 69 LEVVEISHSSQLRVLYPASYICYNSKGKFAKGTYYWSNLGNLTLSGN-NTITALGCNSYA 127
Query: 81 YVRGYLGENRYRAGCMSMCDSFDFVTNGSCIGTGCCQIEIPRGS---------FKNHTNV 131
+V G R GC+S CD+ NG C G GCCQ +P G+ F N T+V
Sbjct: 128 FVSSN-GTRRNSVGCISACDALSHEANGECNGEGCCQNPVPAGNNWLIVRSYRFDNDTSV 186
Query: 132 S--SFNPCTYAFVVDQSQFHFTSN--YLAFDGIPDDFPIVLDWEITTIETCEEA--KICG 185
S C YAF+V+ +F + ++ Y FP+VLDW I ETC + K CG
Sbjct: 187 QPISEGQCIYAFLVENGKFKYNASDKYSYLQNRNVGFPVVLDWSIRG-ETCGQVGEKKCG 245
Query: 186 PNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE--DP-SLNNCT--HICD 240
N C N+ + GY CKC G++GNPYL +GC+D+NE +P +NC+ C+
Sbjct: 246 VNGICS----NSASGIGYTCKCKGGFQGNPYLQNGCQDINECTTANPIHKHNCSGDSTCE 301
Query: 241 NTAGNYTCRCPKXXXXXXXXXXXXCIPN-QKNLIKVAXXXXXXXXXXXXXXXXXXXXXYK 299
N G++ C C C P ++ +K
Sbjct: 302 NKLGHFRCNC--RSRYELNTTTNTCKPKGNPEYVEWTTIVLGTTIGFLVILLAISCIEHK 359
Query: 300 FTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQ 359
K ++ + +Q+FF++NGG +L Q LS S K+FT + +++ATD Y+ NRILGQ
Sbjct: 360 M-KNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQ 418
Query: 360 GGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419
GGQGTVYKG+L D IVA+KK++L D + VEQFINEV++LSQINHRN+VKLLGCCLETEV
Sbjct: 419 GGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETEV 478
Query: 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKS 479
PLLVYEF+ +GTL+ ++H + + +TWE LR+AVE++G L YLHS+ASI I RDIK+
Sbjct: 479 PLLVYEFISSGTLFDHLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRDIKT 538
Query: 480 ANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 539
ANILLD+ AKV+DFG SR I +D+ L T VQGT GY+DPEY+ + EKSDVYSFG
Sbjct: 539 ANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEYYNTGLLNEKSDVYSFG 598
Query: 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATL 599
VVL+E+L+GQK + + +V YF A ENRL E++D V+ E + EI A +
Sbjct: 599 VVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENNQREIQKAARI 658
Query: 600 AKRCLNLNGKNRPTMKEVAFELGGIRAS 627
A C L G+ RP MKEVA EL +R +
Sbjct: 659 AVECTRLTGEERPGMKEVAAELEALRVT 686
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 295/664 (44%), Positives = 404/664 (60%)
Query: 3 ITCNDTFKPPK---PFLTKSSIEVVNISI-DGH--LNVLQY----TAKDCYNAKGYSVDS 52
+ CN T P L+ + EVVNIS+ D + ++Q T+ C + +
Sbjct: 67 VICNTTTSDSNTTVPLLSMINREVVNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGPQN 126
Query: 53 NLPTITL----SKFTVSNTENRFVVIGCDSYAYVRGYLGENRYRAGCMSMCD---SFDFV 105
+LP + + S + +++ ENR V +GC A + E GC S C+ S + V
Sbjct: 127 SLPVLNVTGKGSPYFLTD-ENRLVAVGCGIKALMTDTESEI---LGCESSCEHRKSGEEV 182
Query: 106 TNGSCIGTGCCQIEIPRGSFKNHT-NVSSFN----PCTYAFVVDQSQFHFTSNYLAFDGI 160
TN C G CCQ +P G + T N+ + + C AF+ D+ + SN +
Sbjct: 183 TNLICTGYRCCQARLPVGRPQAITVNIENSSGGEETCKVAFLTDKR--YSPSNVTEPEQF 240
Query: 161 PDDFPIVLD--WEITTIETCEEAKICGPNAS---CDKSKDNTTTSSGY-------HCKCN 208
++ +VL+ W T + ++ + N S S DN + Y +C C+
Sbjct: 241 HNNGYVVLELGWYFATSNSRFKSLLGCTNMSRKGSGFSDDNCSCEYDYFSGMSYRNCYCD 300
Query: 209 KGYEGNPYLSDGCRDVNEFEDPSLNNC---THICDNTAGNYTCRCPKXXXXXXXXXXXXC 265
GY GNPYL GC D + E +NC H C N G P C
Sbjct: 301 YGYTGNPYLRGGCVDTDSCEGN--HNCGEDAH-CVNMPG------PMSM----------C 341
Query: 266 IPNQK--NLIKVAXXXXXXXXXXXXXXXXXXXXXYKFTKKRREIKSKQKFFKRNGGLLLQ 323
PN K K +K KKRR I +KFFKRNGGLLL+
Sbjct: 342 RPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLK 401
Query: 324 QELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKL 383
Q+L++ +VE +K+F+SK+L KATDN++ +R+LGQGGQGTVYKGML DG IVAVK+SK+
Sbjct: 402 QQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKV 461
Query: 384 VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF 443
VDE+ +E+FINE+V+LSQINHRNIVKLLGCCLETEVP+LVYE++PNG L++ +H+ +++
Sbjct: 462 VDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDY 521
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
+TWE+ LRIA+E++GAL Y+HSAAS I+ RDIK+ NILLD+KYRAKVSDFGTSRS+T+
Sbjct: 522 TMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTL 581
Query: 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
DQTHLTT V GTFGY+DPEYF SSQ+T KSDVYSFGVVLVE++TG+KP+ + +E R L
Sbjct: 582 DQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGL 641
Query: 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623
+FL+AM ENR+ +++D + E++ E++M VA LA++CLN GKNRP MKEV+ EL
Sbjct: 642 ATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELER 701
Query: 624 IRAS 627
IR+S
Sbjct: 702 IRSS 705
|
|
| TAIR|locus:2014902 WAK1 "cell wall-associated kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 8.8e-130, Sum P(2) = 8.8e-130
Identities = 177/324 (54%), Positives = 229/324 (70%)
Query: 302 KKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGG 361
K ++ K +++FF++NGG +L Q LS S K+FT ++KAT+ Y +RILGQGG
Sbjct: 360 KHLKDTKLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGG 419
Query: 362 QGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421
QGTVYKG+L D IVA+KK++L D + VEQFINEV++LSQINHRN+VKLLGCCLETEVPL
Sbjct: 420 QGTVYKGILPDNSIVAIKKARLGDSSQVEQFINEVLVLSQINHRNVVKLLGCCLETEVPL 479
Query: 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481
LVYEF+ NGTL+ ++H + + +TWE L+IA+EV+G L YLHS+ASI I RDIK+AN
Sbjct: 480 LVYEFITNGTLFDHLHGSMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTAN 539
Query: 482 ILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVV 541
ILLD AKV+DFG SR I +D+ L T VQGT GY+DPEY+ + EKSDVYSFGVV
Sbjct: 540 ILLDVNLTAKVADFGASRLIPMDKEELETMVQGTLGYLDPEYYNTGLLNEKSDVYSFGVV 599
Query: 542 LVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAK 601
L+E+L+GQK + + LV YF A ENRL E++ V+ E +EI A +A
Sbjct: 600 LMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNEDNLKEIQEAARIAA 659
Query: 602 RCLNLNGKNRPTMKEVAFELGGIR 625
C L G+ RP MKEVA +L +R
Sbjct: 660 ECTRLMGEERPRMKEVAAKLEALR 683
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
Identities = 289/654 (44%), Positives = 389/654 (59%)
Query: 3 ITCNDTFKPPKPFLTKSSIEVVNISIDGHLNV-LQYTAKDCYNAKGYSVDSNLPTITL-- 59
+ CN T P FL++ + E+VNIS++G +++ T+ C + G S P + +
Sbjct: 63 VVCNSTNSVP--FLSRINRELVNISLNGVVHIKAPVTSSGC--STGTSQPLTPPPLNVAG 118
Query: 60 --SKFTVSNTENRFVVIGCDSYAYVRGYLGE-NRYRAGCMSMCDSFDFVTNGSCIGTGCC 116
S + +++ +N V +GC A + G + + C S N C G CC
Sbjct: 119 QGSPYFLTD-KNLLVAVGCKFKAVMAGITSQITSCESSCNERNSSSQEGRNKICNGYKCC 177
Query: 117 QIEIPRGS---------FKNHTNVSSFNPCTYAFVVDQ--SQFHFTSNYLAFDGIPDDFP 165
Q IP G N + C AF+ S + T F G +
Sbjct: 178 QTRIPEGQPQVISVDIEIPQGNNTTGEGGCRVAFLTSDKYSSLNVTEPE-KFHG--HGYA 234
Query: 166 IV-LDWEITTIETCEEAKICGPNASCDKSKDNTTTSS---GYH-------CKCNK-GYEG 213
V L W T ++ + I NAS + T S GY C CN GY+G
Sbjct: 235 AVELGWFFDTSDSRDTQPISCKNASDTTPYTSDTRCSCSYGYFSGFSYRDCYCNSPGYKG 294
Query: 214 NPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKXXXXXXXXXXXXCIPNQKNLI 273
NP+L GC DV+E C G C K C P + +
Sbjct: 295 NPFLPGGCVDVDE------------CKLDIGRNQC---KDQSCVNLPGWFDCQPKKPEQL 339
Query: 274 KVAXXXXXXXXXXXXXXXXXXXXXYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSV 333
K YKF +KRR++ +KFF+RNGG+LL+Q+L+ + +V
Sbjct: 340 K-RVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNV 398
Query: 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFI 393
E +++F+S +LEKATDN+N NR+LGQGGQGTVYKGML DGRIVAVK+SK VDE+ VE+FI
Sbjct: 399 EMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFI 458
Query: 394 NEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI 453
NEVV+L+QINHRNIVKLLGCCLETEVP+LVYEFVPNG L + +H+ +++ +TWE+ L I
Sbjct: 459 NEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHI 518
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
A+E++GAL YLHSAAS IY RDIK+ NILLD++ RAKVSDFGTSRS+T+DQTHLTT+V
Sbjct: 519 AIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVA 578
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573
GTFGYVDPEYFQSS+FTEKSDVYSFGVVLVE+LTG+KP + +E+R L +F++A+ E
Sbjct: 579 GTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKE 638
Query: 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
NR+ +++D + E +++M+VA LA+RCLN GK RP M+EV+ EL IR+S
Sbjct: 639 NRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 1.7e-129, Sum P(3) = 1.7e-129
Identities = 205/326 (62%), Positives = 261/326 (80%)
Query: 299 KFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILG 358
K +KRR K+KFFKRNGGLLLQQ+L++ + VEKTKLF+S++LEKATDN+N NR++G
Sbjct: 402 KLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIG 461
Query: 359 QGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418
QGGQGTVYKGML DGR VAVKKS +VDE+ +++FINEV+ILSQINHR++VKLLGCCLETE
Sbjct: 462 QGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETE 521
Query: 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478
VP+LVYEF+PNG L+Q++H +++ W + +RIAV++SGA YLH+AA IY RDIK
Sbjct: 522 VPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIK 581
Query: 479 SANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 538
S NILLD+KYRAKVSDFGTSRS+++D TH TT + GT GYVDPEY+ SS FTEKSDVYSF
Sbjct: 582 STNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSF 641
Query: 539 GVVLVEILTGQKPIRAINIDEDRSLVG---YFLQAMNENRLFEVLDALVLKEAEREEIMT 595
GVVLVE++TG+KP+ I + E + + G YF AM ENRLFE++DA + + + E+++
Sbjct: 642 GVVLVELITGEKPV--ITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIA 699
Query: 596 VATLAKRCLNLNGKNRPTMKEVAFEL 621
VA LA RCL GK RP M+EV+ L
Sbjct: 700 VANLALRCLKKTGKTRPDMREVSTAL 725
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LMP1 | WAK2_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4604 | 0.8819 | 0.8265 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 686 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-26 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-22 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-20 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| pfam12947 | 36 | pfam12947, EGF_3, EGF domain | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| cd00053 | 36 | cd00053, EGF, Epidermal growth factor domain, foun | 8e-04 | |
| smart00181 | 35 | smart00181, EGF, Epidermal growth factor-like doma | 8e-04 | |
| cd00054 | 38 | cd00054, EGF_CA, Calcium-binding EGF-like domain, | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 | |
| smart00179 | 39 | smart00179, EGF_CA, Calcium-binding EGF-like domai | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-50
Identities = 88/271 (32%), Positives = 132/271 (48%), Gaps = 21/271 (7%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINHRNI 407
Y R LG G GTVYK G+IVAVK K E + + E+ IL +++H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
V+L+ + + LV E+ G L+ + P++ + +IA+++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQS 526
I RD+K NILLD+ K++DFG ++ + + LTT V GT Y+ PE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
+ + K DV+S GV+L E+LTG+ P NI + L E + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL--IRRILGPPLEFDEPKWSSGSE 231
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
EA+ L K+CLN + RPT +E+
Sbjct: 232 EAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 2e-49
Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 32/277 (11%)
Query: 354 NRILGQGGQGTVYKGML-----ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNI 407
+ LG+G G VYKG L VAVK K E +E+F+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
VKLLG C E E +V E++ G L + + + ++ LL A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
S + RD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
+FT KSDV+SFGV+L EI T G++P ++ +E + N RL
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------KNGYRL---------- 222
Query: 587 EAEREEIMT--VATLAKRCLNLNGKNRPTMKEVAFEL 621
+ + L +C + ++RPT E+ L
Sbjct: 223 --PQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 80/273 (29%), Positives = 131/273 (47%), Gaps = 31/273 (11%)
Query: 354 NRILGQGGQGTVYKGML----ADGRI-VAVKKSKL-VDENNVEQFINEVVILSQINHRNI 407
+ LG+G G VYKG L + VAVK K E +E+F+ E I+ +++H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
VKLLG C E E ++V E++P G L + + + ++ LL A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE-- 120
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
S + RD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
+FT KSDV+SFGV+L EI T G++P ++ E + RL
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------KKGYRL---------- 223
Query: 587 EAEREEIMT--VATLAKRCLNLNGKNRPTMKEV 617
+ + L +C + ++RPT E+
Sbjct: 224 --PKPPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 6e-49
Identities = 74/193 (38%), Positives = 111/193 (57%), Gaps = 10/193 (5%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCC 414
LG+GG GTVY G+ VA+K K D + +E+ + E+ IL ++NH NIVKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ LV E+ G+L + + E ++ + +LRI +++ L YLH S I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 475 RDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 532
RD+K NILLD D + K++DFG S+ +T D++ L T V GT Y+ PE ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174
Query: 533 SDVYSFGVVLVEI 545
SD++S GV+L E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 23/265 (8%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
LG+G G VY G++VA+K K + + E+ + E+ IL ++ H NIV+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
+ + LV E+ G L+ + ++ + ++ AL YLHS I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSK---GI 118
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RD+K NILLD+ K++DFG +R + D T GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
D++S GV+L E+LTG+ P D L+ F + F + + EA+
Sbjct: 177 VDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD-- 229
Query: 593 IMTVATLAKRCLNLNGKNRPTMKEV 617
L ++ L + + R T +E
Sbjct: 230 ------LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 2e-46
Identities = 86/283 (30%), Positives = 135/283 (47%), Gaps = 43/283 (15%)
Query: 354 NRILGQGGQGTVYKGML-----ADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNI 407
+ LG+G G VYKG L VAVK K E E+F+ E I+ +++H NI
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
V+LLG C + E +V E++P G L + H E+ + LL++A++++ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG---YVDPEYF 524
S + RD+ + N L+ + K+SDFG SR I D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 525 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+ +FT KSDV+SFGV+L EI T G++P M+ EVL+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP----------------YPGMS---NEEVLEL- 216
Query: 584 VLKEAEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
L++ R + L +C + ++RPT E+ +L
Sbjct: 217 -LEDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 6e-46
Identities = 83/284 (29%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 355 RILGQGGQGTVYKGMLADG----RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
+ LG+G G VYKG L VAVK K E + F+ E ++ ++ H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 410 LLGCCLETEVPLLVYEFVPNGTL------YQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
LLG C E E LV E++ G L + + E+ ++ + LL A++++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDP 521
L S RD+ + N L+ + K+SDFG SR + D + K G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAP 176
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE-NRLFEV 579
E + FT KSDV+SFGV+L EI T G P ++ +E L+ + + RL
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL--- 226
Query: 580 LDALVLKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEVAFEL 621
+ E + L C L+ ++RPT E+ L
Sbjct: 227 ---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 16/205 (7%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLL 411
+LG+G G+VY + D G ++AVK +L E +E E+ ILS + H NIV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 412 GCCL-ETEVPLLVY-EFVPNGTLYQNIHNHIEEFPITWELLLRIAVE--VSGALFYLHSA 467
G E + L ++ E+V G+L +++F E ++R + G L YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS----LLKKFGKLPEPVIRKYTRQILEG-LAYLHSN 120
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIK ANIL+D K++DFG ++ + ++ T V+GT ++ PE +
Sbjct: 121 ---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKP 551
++ +D++S G ++E+ TG+ P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 66/201 (32%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G+GG G VYK G+ VA+K KL + E+ INE+ IL + H NIVK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV---EVSGALFYLHSAASISI 472
+ + +V EF G+L + + + + IA E+ L YLH S I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLH---SNGI 119
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RDIK+ANILL K+ DFG S + T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 533 SDVYSFGVVLVEILTGQKPIR 553
+D++S G+ +E+ G+ P
Sbjct: 178 ADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 80/274 (29%), Positives = 120/274 (43%), Gaps = 38/274 (13%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLL 411
+ +G+G G VY +DG++ +K+ L + E E +NEV IL ++NH NI+K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 412 GCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSAASI 470
E +V E+ G L Q I +E P E +L V++ AL YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT 530
I RDIK NI L K+ DFG S+ ++ T V GT Y+ PE Q+ +
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 531 EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK--EA 588
KSD++S G VL E+ T + P N L L LK +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGEN-----------------------LLELALKILKG 218
Query: 589 EREEIMT-----VATLAKRCLNLNGKNRPTMKEV 617
+ I + + L L + + RP++ ++
Sbjct: 219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 3e-33
Identities = 81/280 (28%), Positives = 119/280 (42%), Gaps = 22/280 (7%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH-R 405
+Y R LG+G G VY D ++VA+K K VE+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
NIVKL + LV E+V G+L + + P++ L I ++ AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 466 SAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTH-----LTTKVQGTFGYV 519
S I RDIK NILLD D K+ DFG ++ + + L + GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 520 DPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576
PE + SD++S G+ L E+LTG P S +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231
Query: 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
L + + + L K+ L + KNR +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-33
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRN 406
NY ++G+G G VYKG+ L G VA+K+ L + E ++ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSGALFYLH 465
IVK +G ++ ++ E+ NG+L Q I FP E L+ + V +V L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+ RDIK+ANIL K++DFG + + D + V GT ++ PE +
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKP 551
S + SD++S G ++E+LTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 80/288 (27%), Positives = 129/288 (44%), Gaps = 47/288 (16%)
Query: 355 RILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQ-FINEVVILSQINHRNI 407
R LG+G G V+ G D +VAVK K N+ + F E +L+ H NI
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH-----------IEEFPITWELLLRIAVE 456
VK G C E + P++V+E++ +G L + + +H +T LL+IAV+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGT 515
++ + YL AS RD+ + N L+ K+ DFG SR + T D +V G
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY----YRVGGH 183
Query: 516 ----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570
++ PE +FT +SDV+SFGVVL EI T G++P ++
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY--G 227
Query: 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618
++ + E + L + R V + C + + R +K++
Sbjct: 228 LSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 76/209 (36%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
LG+G G V G++ A+K K K++ VE + E ILS+INH IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASI 470
+TE L LV E+ P G L +H+ E + E A E+ AL YLHS I
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGI 114
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT 530
IY RD+K NILLD K++DFG ++ ++ + + T GT Y+ PE +
Sbjct: 115 -IY-RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 531 EKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D +S GV+L E+LTG+ P A + E
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 24/259 (9%)
Query: 357 LGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQ--FINEVVILSQINHRNIVKLLGC 413
+G+G G V+K + AD R+ A+K+ L N E+ I+E +L++++ I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
L+ +V E+ NG L++ + P+ + + R +++ L +LHS I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSK---KIL 123
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RDIKS N+ LD K+ D G ++ ++ D T+ + GT Y+ PE + + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 534 DVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEI 593
DV++ GVVL E TG+ P A N+ L + V +
Sbjct: 183 DVWALGVVLYECCTGKHP----------------FDANNQGALILKIIRGVFPPVSQMYS 226
Query: 594 MTVATLAKRCLNLNGKNRP 612
+A L +CL + + RP
Sbjct: 227 QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 14/215 (6%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
+ Y +G+G G VYK A G+ VA+KK +L + N E INE++I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IV L + +V E++ G+L I + + + + EV L YLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIKS NILL K++DFG + +T +++ + V GT ++ PE +
Sbjct: 135 QNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 527 SQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 555
+ K D++S G++ +E+ G+ P+RA+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKK---SKLVDENNVEQFINEVVILSQINHRNIVKLL 411
+G+G GTV K +DG+I+ K+ + E +Q ++EV IL ++ H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 412 GCCL--ETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLH--S 466
+ + +V E+ G L Q I +E I E + RI ++ AL+ H S
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
++ RD+K ANI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV--GYF--LQAMNENRLFEVLDA 582
+ EKSD++S G ++ E+ P A N + S + G F + + L EV+
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI-- 242
Query: 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
K LN++ RP+ +E
Sbjct: 243 ------------------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 72/212 (33%), Positives = 114/212 (53%), Gaps = 15/212 (7%)
Query: 355 RILGQGGQGTVYKGMLADG----RIVAVKK-SKLVDENNVEQFINEVVILSQINHRNIVK 409
R++G+G G VY G L D AVK +++ D VEQF+ E +I+ +H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 410 LLGCCLETE-VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
LLG CL +E PL+V ++ +G L I + E T + L+ ++V+ + YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSI---TVDQTHLTTKVQGTFGYVDPEYFQ 525
S RD+ + N +LD+ + KV+DFG +R I H T + ++ E Q
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 556
+ +FT KSDV+SFGV+L E++T G P ++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN- 403
D++ +I+G+G TV + A+K K +L+ E V+ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
H I+KL + E V E+ PNG L Q I A E+ AL Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRF--YAAEILLALEY 117
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ---------- 513
LHS I RD+K NILLD K++DFGT++ + + + + K
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 514 ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
GT YV PE + SD+++ G ++ ++LTG+ P R N
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 38/292 (13%)
Query: 355 RILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQ-FINEVVILSQINHRNIV 408
+ LG+G G V G VAVK E F E+ IL ++H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 409 KLLGCCLET--EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
K G C + L+ E++P+G+L + H ++ I + LL + ++ + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG---TFGYVDPEY 523
I RD+ + NIL++ + K+SDFG ++ + D+ + K G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA-PEC 183
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
++S+F+ SDV+SFGV L E+ T D +S FL+ + + ++ L
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT--------YGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 584 V--LKEAER--------EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+ LKE ER +E V L K C ++RP+ ++ + +R
Sbjct: 236 LELLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 79/283 (27%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 350 NYNANRILGQG--GQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
+Y R+LG+G G+ T+Y+ D +V K+ L + E +NE+VILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNI----HNHIEEFPITWELLLRIAVEVSGAL 461
NI+ ++ L+ E+ GTLY I EE + W L ++ A+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF-----QIVSAV 114
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
Y+H A I RDIK+ NI L K+ DFG S+ + + + T V GT Y+ P
Sbjct: 115 SYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSP 170
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
E Q ++ KSD+++ G VL E+LT ++ A N
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----------------------PL 207
Query: 582 ALVLK--EAEREEIMTVATLAKR-----CLNLNGKNRPTMKEV 617
LV+K + +++V + L + + RPT EV
Sbjct: 208 NLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 12/222 (5%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G VYKG+L VAVK +S L + +F+ E IL Q +H NIVKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C++ + +V E VP G+L + + + LL+++++ + + YL S I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV-QGTFGYVDPEYFQSSQFTE 531
RD+ + N L+ + K+SDFG SR ++ + Q + PE ++T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 532 KSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQA 570
+SDV+S+G++L E + G P ++ + R + GY + A
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 70/212 (33%), Positives = 118/212 (55%), Gaps = 23/212 (10%)
Query: 356 ILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENN-------VEQFINEVVILSQINHR 405
++G G G+VY GM A G ++AVK+ +L V ++ ++ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSGALFYL 464
NIV+ LG L+ + + E+VP G++ + N+ F E L+R V ++ L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK-----VQGTFGYV 519
H+ I RDIK ANIL+D+K K+SDFG S+ + + T +QG+ ++
Sbjct: 123 HNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 31/268 (11%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416
+G+G G V G G+ VAVK K D + F+ E +++ + H N+V+LLG L+
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476
+V E++ G+L + + IT L A++V + YL + RD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
+ + N+L+ + AKVSDFG ++ + Q V+ T PE + +F+ KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 537 SFGVVLVEILT-GQKPIRAINIDE--DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEI 593
SFG++L EI + G+ P I + + GY ++A E E+
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA---------------PEGCPPEV 228
Query: 594 MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
V K C L+ RPT K++ +L
Sbjct: 229 YKV---MKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 72/269 (26%), Positives = 119/269 (44%), Gaps = 34/269 (12%)
Query: 357 LGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFI-NEVVILSQINHRNIVKLLGCC 414
LGQG G VYK G+I A+KK + + + + E+ L +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLL-RIAVEVSGALFYLHSAASISIY 473
+ +V E++ G+L ++ + + P E +L IA ++ L YLH+ I I+
Sbjct: 69 YKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHI-IH 123
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSI--TVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
R DIK +N+L++ K K++DFG S+ + T+DQ + T V GT Y+ PE Q ++
Sbjct: 124 R-DIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGESYSY 179
Query: 532 KSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER- 590
+D++S G+ L+E G+ P + FE++ A+
Sbjct: 180 AADIWSLGLTLLECALGKFP----------------FLPPGQPSFFELMQAICDGPPPSL 223
Query: 591 EEIMTVATLA---KRCLNLNGKNRPTMKE 616
CL + K RP+ E
Sbjct: 224 PAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 35/271 (12%)
Query: 357 LGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNV---EQFINEVVILSQINHRNIVKLL 411
LG G G+V KG ++ G+ V V L E+ ++F+ E +++Q++H IV+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 412 GCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
G C E +LV E P G L + + E I L +A +V+ + YL S +
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKHFV- 117
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSSQF 529
RD+ + N+LL ++++AK+SDFG SR++ + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 530 TEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN--RLFEVLDALVLK 586
+ KSDV+S+GV L E + G KP + G + AM E+ RL
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYGEMK--------GAEVIAMLESGERL---------- 217
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E + ++ C ++RPT E+
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 21/207 (10%)
Query: 357 LGQGGQGTVYKG--MLADGRI--VAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
LG G G V +G + G++ VAVK KS + + ++ F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIH-NHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
G L T ++V E P G+L + + + F I+ L AV+++ + YL S
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT----KVQGTFGYVDPEYFQ 525
I RD+ + NILL + K+ DFG R++ ++ H KV F + PE +
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ F+ SDV+ FGV L E+ T G++P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 22/222 (9%)
Query: 357 LGQGGQGTVYK-GMLADGRIVAVKKSKLVDENNVEQF--INEVVILSQINHRNIVK---- 409
LG+G G+VYK L+D + A+K+ L + E+ +NE+ IL+ +NH NI+
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 410 -LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSA 467
L G L +V E+ P G L + I ++ I + + RI +++ L LH
Sbjct: 68 FLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE- 121
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
I RD+KSANILL K+ D G S+ + + T++ GT Y+ PE ++
Sbjct: 122 --QKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGR 176
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV--GYF 567
++ KSD++S G +L E+ T P A ++ + R V G +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 78/287 (27%), Positives = 135/287 (47%), Gaps = 42/287 (14%)
Query: 355 RILGQGGQGTVYKGMLA--DGRI--VAVKKSKL--VDENNVEQFINEVVILSQINHRNIV 408
+ILG+G G+V +G L+ DG VAVK KL + +E+F++E + +H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 409 KLLGCCLETE------VPLLVYEFVPNGTLYQNI-HNHIEEFP--ITWELLLRIAVEVSG 459
KL+G C E P+++ F+ +G L+ + ++ + P + + LL+ V+++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD----QTHLTTKVQGT 515
+ YL + I RD+ + N +L + V+DFG S+ I Q + +
Sbjct: 125 GMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMP 178
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574
++ E +T KSDV++FGV + EI T GQ P + E+ + Y N
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV---ENHEIYDYLRHG---N 232
Query: 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
RL + D L E ++M C + K+RPT ++ L
Sbjct: 233 RLKQPEDCL----DELYDLMY------SCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 5e-26
Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQINHRNIVKL 410
LG+G G VYK G IVA+KK +L +E E + E+ +L ++ H NIVKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVSGALFYL 464
L LV+E+ L + + I ++LL L Y
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLR--------GLAYC 114
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS I RD+K NIL++ K++DFG +R+ + T +V T Y PE
Sbjct: 115 HS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEIL 170
Query: 525 QSSQFTEKS-DVYSFGVVLVEILTGQKPI 552
S+ + D++S G + E++TG KP+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITG-KPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 354 NRILGQGGQGTVYKGM---LADGRI-VAVKKSKLVDENNV-EQFINEVVILSQINHRNIV 408
R +G+G G VY+G+ + +I VAVK K +V E+F+ E I+ Q +H +IV
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 409 KLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
KL+G TE P+ +V E P G L + + + L+ + ++S AL YL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLES- 125
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
RDI + N+L+ K+ DFG SR + + + +K + ++ PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+ FGV + EIL G KP
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 30/234 (12%)
Query: 354 NRILGQGGQGTVYKGMLA----DGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNI 407
+++G G G V +G L VA+K K+ D+ ++ F+ E I+ Q +H NI
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
++L G ++ +++ E++ NG+L + + + +F T L+ + ++ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYL--- 122
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFGYVDPEYFQS 526
+ ++ RD+ + NIL++ KVSDFG SR + + T+ T + + PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKP---------IRAINIDEDRSLVGYFLQA 570
+FT SDV+SFG+V+ E+++ G++P I+A+ GY L
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GYRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-26
Identities = 75/280 (26%), Positives = 134/280 (47%), Gaps = 40/280 (14%)
Query: 355 RILGQGGQGTVYKGM-LADGR----IVAVK--KSKLVDENNVEQFINEVVILSQINHRNI 407
++LG G GTVYKG+ + +G VA+K + + + N E ++E +++ ++H ++
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKE-ILDEAYVMASVDHPHV 71
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
V+LLG CL + L+ + +P G L + NH + I + LL V+++ + YL
Sbjct: 72 VRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK 128
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG---TFGYVDPEYF 524
+ RD+ + N+L+ K++DFG ++ + VD+ +G ++ E
Sbjct: 129 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESI 183
Query: 525 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+T KSDV+S+GV + E++T G KP I E L+ RL
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------EKGERL------- 230
Query: 584 VLKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEVAFEL 621
+ I T V + +C ++ ++RPT KE+ E
Sbjct: 231 -----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGC 413
+G G G VY + L G ++AVK+ ++ D +++ +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHN-HIEEFPITWELLLRI-AVEVSGALFYLHSAASIS 471
+ E + E+ GTL + + + I + E ++R+ +++ L YLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG---YVDPEYFQSSQ 528
I RDIK ANI LD K+ DFG + + + T + +VQ G Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 529 FTEK---SDVYSFGVVLVEILTGQKP 551
+D++S G V++E+ TG++P
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 27/269 (10%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
LG G G VY+G+ VAVK K D VE+F+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 416 ETEVPL-LVYEFVPNGTLYQNIH-NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
E P ++ EF+ G L + + +E +LL +A ++S A+ YL I
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAV--VLLYMATQISSAMEYLEKKNFI--- 126
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RD+ + N L+ + + KV+DFG SR +T D + + PE ++F+ KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 534 DVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
DV++FGV+L EI T G P I++ + ++E+L+ E
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEGC 230
Query: 593 IMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
V L + C N +RP+ E+
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDEN--NVEQFINEVVILSQINHRNIVKLLGCC 414
LG G G V+ G VA+K ++ E + + FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V E++ NG L + + E LL + +V A+ YL S I
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---FGYVDPEYFQSSQFTE 531
RD+ + N L+ + KVSDFG +R + DQ T QGT + PE F S+F+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 532 KSDVYSFGVVLVEILTGQK 550
KSDV+SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 8/217 (3%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
R LG G G V++G+ + VA+K K D + F EV L ++ H++++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
E ++ E + G+L + + E + L+ +A +V+ + YL SI
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI---H 127
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RD+ + NIL+ + KV+DFG +R I + +L++ + + + PE F+ KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 535 VYSFGVVLVEILT-GQKPIRAINIDE--DRSLVGYFL 568
V+SFG++L E+ T GQ P +N E D+ GY +
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM 223
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 356 ILGQGGQGTVYKGMLADGRIVAVKK------SKLVDENNVEQFINEVVILSQINHRNIVK 409
+LG+G GTVY G+ G+++AVK+ + L E E+ EV +L + H NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLL-RIAVEVSGALFYLHSAA 468
LG CL+ + EFVP G++ I N P E + + ++ + YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISS-ILNRFGPLP---EPVFCKYTKQILDGVAYLHNNC 122
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSR-----SITVDQTHLTTKVQGTFGYVDPEY 523
+ RDIK N++L K+ DFG +R + +++ + GT ++ PE
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
S + KSD++S G + E+ TG+ P+ +++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 78/281 (27%), Positives = 138/281 (49%), Gaps = 42/281 (14%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKS-KLVDEN-----NVEQFINEVVILSQINHRNI 407
++LG G GTVYKG+ + +G V + + K+++E NVE F++E +I++ ++H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
V+LLG CL + LV + +P+G L +H H + I +LLL V+++ + YL
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 128
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK-VQGTFGYVDPEYFQS 526
+ RD+ + N+L+ K++DFG +R + D+ + ++ E
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
+FT +SDV+S+GV + E++T G KP I E L L
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL---------------------L 224
Query: 586 KEAEREEIMTVATL-----AKRCLNLNGKNRPTMKEVAFEL 621
++ ER + T+ +C ++ +RP KE+A E
Sbjct: 225 EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 50/269 (18%)
Query: 374 RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432
+VAVK + +N E F+ EV ILS+++ NI +LLG C ++ E++ NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 433 YQNIHNHIEE--------FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484
Q + H+ E +++ LL +A +++ + YL S++ RD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 485 DDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP------EYFQSSQFTEKSDVYSF 538
Y K++DFG SR++ + +VQG P E +FT KSDV++F
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYY---RVQGR--APLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 539 GVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD--ALVLKEAEREEIM-- 594
GV L EILT + Q +V++ ++ R+ +
Sbjct: 219 GVTLWEILTLCR-----------------EQPYEHLTDQQVIENAGHFFRDDGRQIYLPR 261
Query: 595 ------TVATLAKRCLNLNGKNRPTMKEV 617
+ L C + ++RPT +E+
Sbjct: 262 PPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 357 LGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
LG+G G V+ D +VAVK K E+ + F E +L+ + H++IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNH------IEEF------PITWELLLRIAVEVS 458
G C E L+V+E++ +G L + + +H + +T +L IA +++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFG 517
+ YL AS+ RD+ + N L+ K+ DFG SR I + D + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
++ PE +FT +SD++SFGVVL EI T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 29/271 (10%)
Query: 356 ILGQGGQGTVYKGMLADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
+LG+G G V+KG L D VAVK K L E + +F++E IL Q +H NIVKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
C + + +V E VP G + +E + L++ A++ + + YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RD+ + N L+ + K+SDFG SR + Q + PE +++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 534 DVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNENRLFEVLDALVLKEAER 590
DV+S+G++L E + G P + + R V GY + +
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---------------PQKCP 220
Query: 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+++ V +RC + +NRP E+ EL
Sbjct: 221 DDVYKV---MQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 36/289 (12%)
Query: 357 LGQGGQGTVYK---GMLAD--GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLL 411
LG+G G+V L D G +VAVKK + ++ F E+ IL + H NIVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 412 GCCLETEVP--LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
G C LV E++P G+L + H E + LL A ++ + YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRY 129
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG---TFGYVDPEYFQS 526
+ RD+ + NIL++ + R K+ DFG ++ + D+ + + G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR-----LFEVLD 581
S+F+ SDV+SFGVVL E+ T D+ S F++ M ++ ++ +++
Sbjct: 186 SKFSVASDVWSFGVVLYELFT--------YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 582 ALVLKEAEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+LK R + + K C N + RP+ E+A ++ IR
Sbjct: 238 --LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+G G G V+ G + R VA+K + + E E FI E ++ +++H +V+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
E LV+EF+ +G L + +F + E LL + ++V + YL S+ I
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---H 123
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RD+ + N L+ + KVSDFG +R + DQ +T + + PE F S+++ KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 535 VYSFGVVLVEILT-GQKP 551
V+SFGV++ E+ + G+ P
Sbjct: 184 VWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSK---LVDENNVEQFINEVVILSQIN 403
N+ + +G+G VYK + L DGR+VA+KK + ++D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH------IEEFPITWELLLRIAVEV 457
H N++K L +E +V E G L + I + I E W+ V++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTIWKYF----VQL 115
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
AL ++HS I RDIK AN+ + K+ D G R + T + V GT
Sbjct: 116 CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
Y+ PE + + KSD++S G +L E+ Q P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 36/272 (13%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENN-----VEQFINEVVILSQINHRNIV 408
+LG G G+VY+G+ L DG AVK+ L D+ V+Q E+ +LS++ H NIV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 409 KLLGCCLETEVPLLVY-EFVPNGTLYQNIHNHIEEFPITWELLLRIAVE--VSGALFYLH 465
+ LG E + L ++ E VP G+ + ++++ E ++R+ + G L YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLG-LEYLH 119
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF- 524
++ RDIK ANIL+D K++DFG ++ + + K G+ ++ PE
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK--GSPYWMAPEVIA 174
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
Q + +D++S G ++E+ TG+ P V + L + D L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPPIPDHLS 228
Query: 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
+ ++ I+ +CL + RPT E
Sbjct: 229 DE--AKDFIL-------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+GQG GTVY + +A G+ VA+K+ L + E INE++++ + H NIV L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 416 ETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V E++ G+L + ++E I + E AL +LHS I
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSNQVI---H 138
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIKS NILL K++DFG IT +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 535 VYSFGVVLVEILTGQKP 551
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 8e-23
Identities = 73/267 (27%), Positives = 119/267 (44%), Gaps = 28/267 (10%)
Query: 357 LGQGGQGTVYKG-MLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G G G VYK +A G +VA+K KL ++ E E+ +L + H NIV G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
+ +V E+ G+L Q+I+ P++ + + E L YLH I R
Sbjct: 71 RRDKLWIVMEYCGGGSL-QDIYQVTRG-PLSELQIAYVCRETLKGLAYLHETGKI---HR 125
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ---SSQFTEK 532
DIK ANILL + K++DFG S +T + + GT ++ PE + K
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYDGK 184
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER-- 590
D+++ G+ +E+ Q P+ ++ R+L + + N LK+ E+
Sbjct: 185 CDIWALGITAIELAELQPPM--FDLHPMRAL--FLISKSN-------FPPPKLKDKEKWS 233
Query: 591 -EEIMTVATLAKRCLNLNGKNRPTMKE 616
+ K+CL + K RPT +
Sbjct: 234 PVFHDFI----KKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN--EVVILSQINHRNI 407
Y +G+G G VYK G IVA+KK KL E+ E+ +L ++NH NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVSGAL 461
+KLL LV+EF+ + LY+ I + P ++LL +A
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA------- 112
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
+ HS I RD+K N+L++ + K++DFG +RS T V T Y P
Sbjct: 113 -FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 522 E-YFQSSQFTEKSDVYSFGVVLVEILTGQ 549
E ++ D++S G + E+L+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 354 NRILGQGGQGTVYKGMLADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKLL 411
R LG G G V+ G VAVK K + E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLY 67
Query: 412 GCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
C E E +V E++ G+L + + E + L+ +A +++ + YL S I
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYI- 125
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSSQF 529
RD+ + NIL+ + K++DFG +R I D T + F + PE +F
Sbjct: 126 --HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRF 181
Query: 530 TEKSDVYSFGVVLVEILT-GQKP 551
T KSDV+SFG++L EI+T G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 9e-23
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDE-----NNVEQFINEVVILSQIN 403
N+ ++LGQG G VY D GR +AVK+ + V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALF 462
H IV+ GC + E + E++P G+ + + ++ + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR---SITVDQTHLTTKVQGTFGYV 519
YLHS I RDIK ANIL D K+ DFG S+ +I T + + V GT ++
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
PE + K+DV+S G +VE+LT + P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 61/212 (28%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENN--VEQFINEVVILSQINHRNIVKLL 411
+G+G G VYK G +VA+KK ++ +E I E+ +L ++ H NIV+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 412 GCCLETEVP--LLVYEFVP---NGTLYQNIHN----HIEEFPITWELLLRIAVEVSGALF 462
+V+E++ G L I+ +LL L
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC--YMKQLLE--------GLQ 114
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDP 521
YLHS I RDIK +NIL+++ K++DFG +R T + T +V T Y P
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 522 E-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
E ++++ + D++S G +L E+ G KPI
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 78/282 (27%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 355 RILGQGGQGTVYKGMLAD------GRIVAVK---KSKLVDENNVEQFINEVVILSQINHR 405
R LGQG G VY+G+ VA+K ++ + E +F+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEFNCH 69
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTL--YQNIHNHIEEF-----PITWELLLRIAVEVS 458
++V+LLG + L+V E + G L Y E P T + +++A E++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFG 517
+ YL A+ RD+ + N ++ + K+ DFG +R I D K
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRL 576
++ PE + FT KSDV+SFGVVL E+ T ++P + ++ NE L
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---------------NEEVL 231
Query: 577 FEVLDALVLKEAER-EEIMTVATLAKRCLNLNGKNRPTMKEV 617
V+D L E + + L + C N K RPT E+
Sbjct: 232 KFVIDGGHLDLPENCPDKLL--ELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 71/233 (30%), Positives = 108/233 (46%), Gaps = 32/233 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
DN+ +G+G G V + GR VAVKK L + E NEVVI+ H NI
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYLHS 466
V++ L + +V EF+ G L + H + E E + + + V AL +LH+
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLAVLKALSFLHA 133
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIKS +ILL R K+SDFG ++ + + V GT ++ PE
Sbjct: 134 QGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF----LQAMNENR 575
+ + D++S G++++E++ G+ P YF LQAM R
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP--------------YFNEPPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 63/206 (30%), Positives = 112/206 (54%), Gaps = 15/206 (7%)
Query: 355 RILGQGGQGTVYKGML-ADGR---IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
+++G G G V++G+L GR VA+K K E + F++E I+ Q +H NI++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSAA 468
L G + + +++ E++ NG L + + +H EF +LR ++ + YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD--QTHLTTKVQGTFGYVDPEYFQS 526
++ RD+ + NIL++ KVSDFG SR + D T+ T+ + + PE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 51/303 (16%)
Query: 350 NYNANRILGQGGQGTVYKGM------LADGRIVAVKKSKLVDENNVE--QFINEVVILSQ 401
N + LG+G G V K A VAVK K + ++ E ++E +L Q
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTL---------------------YQNIHNHI 440
+NH +++KL G C + LL+ E+ G+L + ++
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 441 EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+E +T L+ A ++S + YL A + + RD+ + N+L+ + + K+SDFG SR
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 501 ITVDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINID 558
+ + +++ +K + ++ E +T +SDV+SFGV+L EI+T G P I
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI--- 233
Query: 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618
RLF +L E + L C RPT +++
Sbjct: 234 -------------APERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 619 FEL 621
EL
Sbjct: 281 KEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 6/198 (3%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
R LG G G V++G+ + VAVK K + + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
E +V E + G+L + + + L+ +A +V+ + YL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RD+ + N+L+ + KV+DFG +R I D + + PE ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 535 VYSFGVVLVEILT-GQKP 551
V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 37/271 (13%)
Query: 356 ILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
I+G+G G V +G G+ VAVK K + + F+ E ++++++H+N+V+LLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
+ +V E + G L N ++ LL+ +++V+ + YL S + R
Sbjct: 70 HNGL-YIVMELMSKGNLV-NFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 476 DIKSANILLDDKYRAKVSDFGTSR--SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
D+ + NIL+ + AKVSDFG +R S+ VD + L K + PE + +F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 534 DVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNENRLFEVLDALVLKEAER 590
DV+S+GV+L E+ + G+ P +++ E + V GY + E
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM------------------EPPE 220
Query: 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
V L C K RP+ ++ +L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 357 LGQGGQGTVYKGML------ADGRIVAVKKSKLVDENNV---EQFINEVVILSQINHRNI 407
LG+G G VYKG L VA+K L + ++F E ++S + H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKT--LKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNI--HNHIEEFPITWEL-----------LLRIA 454
V LLG C + + +++E++ +G L++ + ++ + L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQ 513
++++ + YL +S RD+ + N L+ + K+SDFG SR I + D + +K
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
++ PE +FT +SD++SFGVVL EI + G +P
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 7e-22
Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 19/213 (8%)
Query: 357 LGQGGQGTVYKG---MLADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIVKLL 411
LG G GTV KG M + VAVK K+ D ++ + E ++ Q+++ IV+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 412 GCCLETEVPLLVYEFVPNGTL--YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
G C E E +LV E G L + + H+ E IT EL+ +VS + YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVH----QVSMGMKYLEET-- 114
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSS 527
+ RD+ + N+LL ++ AK+SDFG S+++ D+ + K G + + PE
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559
+F+ KSDV+SFGV++ E + GQKP + + +E
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRN 406
D+Y ++G G VY + L + VA+K+ L +V++ EV +SQ NH N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH------IEEFPITWELLLRIAVEVSGA 460
+VK + + LV ++ G+L +I ++E I +L+ EV
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIA--TVLK---EVLKG 114
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI--TVDQTHLTTK-VQGTFG 517
L YLHS I RDIK+ NILL + K++DFG S S+ D+T K GT
Sbjct: 115 LEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171
Query: 518 YVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKP 551
++ PE + + K+D++SFG+ +E+ TG P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 77/299 (25%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNV--EQFINEVVILSQINHR 405
+ Y ++G+G G V K A G IVA+KK K +++ + + EV +L Q+ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP----------ITWELLLRIAV 455
NIV L LV+E+V + + +E P W+LL
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVE-----RTLLELLEASPGGLPPDAVRSYIWQLL----- 110
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD-QTHLTTKVQG 514
A+ Y HS +I RDIK NIL+ + K+ DFG +R++ + LT V
Sbjct: 111 ---QAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163
Query: 515 TFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED-----RSLVGYFL 568
T Y PE + + + DV++ G ++ E+L G+ P+ + D D + +G
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLP 222
Query: 569 QAMNE----------NRLFEVLDALVLKEAEREEIMTVA-TLAKRCLNLNGKNRPTMKE 616
+ E E L+ ++ + A K CL ++ K R T E
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 84/276 (30%), Positives = 126/276 (45%), Gaps = 28/276 (10%)
Query: 355 RILGQGGQGTV--YKGMLAD---GRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIV 408
R+LG+G G V Y A+ G +VAVK K + N + E+ IL + H NIV
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 409 KLLGCCLET--EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
K GCC E + L+ E+VP G+L + H + LL A ++ + YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHS 125
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG---TFGYVDPEY 523
I RD+ + N+LLD+ K+ DFG ++++ + + G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 524 FQSSQFTEKSDVYSFGVVLVEILT----GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
+ ++F+ SDV+SFGV L E+LT Q P + ++G M RL E+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-----EEMIGPKQGQMTVVRLIEL 236
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615
L+ + + V L K C K RPT +
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGRIV-AVK---KSKLVDENNVEQFINEVVILSQINHR 405
++ R++G+G G V D + + A+K K K V++ +V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTL-YQNIHNHIEE-FPITWELLLRIAVEVSGALFY 463
+V L + E LV + + G L Y H+ + + E + E+ AL Y
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRY-----HLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
LHS I RDIK NILLD++ ++DF + +T D LTT GT GY+ PE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEV 170
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI 555
++ D +S GV E L G++P R
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 62/204 (30%), Positives = 112/204 (54%), Gaps = 13/204 (6%)
Query: 357 LGQGGQGTVYKGM--LADGRI-VAVKKSKLVDENNV-EQFINEVVILSQINHRNIVKLLG 412
LG G G V KG+ + +I VA+K K +E +V ++ + E I+ Q+++ IV+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C E E +LV E G L + + +E IT ++ + +VS + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGK---NF 116
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 530
RD+ + N+LL +++ AK+SDFG S+++ D ++ + G + + PE +F+
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 531 EKSDVYSFGVVLVEILT-GQKPIR 553
+SDV+S+G+ + E + GQKP +
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 78/225 (34%), Positives = 113/225 (50%), Gaps = 30/225 (13%)
Query: 355 RILGQGGQGTVYKGMLAD------GRI-VAVK--KSKLVDENNVEQFINEVVILSQINHR 405
LG G G VY+G D G I VAVK + D+ E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN-HIEEFP---ITWELLLRIAVEVSGAL 461
NIVKLLG CL E ++ E + G L + + +E F +T + LL I ++V+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 462 FYLHSAASISIYRRDIKSANILLDDK-YRA----KVSDFGTSRSITVDQTHLTTKVQG-- 514
YL I RD+ + N L+ +K Y A K+ DFG +R I + + +G
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173
Query: 515 --TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 556
++ PE +FT +SDV+SFGV++ EILT GQ+P A+N
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINH---RNIVKL 410
++G+G G VY+G + GR+VA+K L +++V EV +LSQ+ NI K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
G L+ ++ E+ G+ + ++ PI + + I EV AL Y+H I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGS----VRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ-F 529
RDIK+ANIL+ + K+ DFG + + + + +T V GT ++ PE + +
Sbjct: 124 ---HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYY 179
Query: 530 TEKSDVYSFGVVLVEILTGQKP 551
K+D++S G+ + E+ TG P
Sbjct: 180 DTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 29/279 (10%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQ------FINEVVILSQI 402
+ + LG G + Y+ + G ++AVK+ V + EQ E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
NH +I+++LG E L E++ G++ + + +++ ++ L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLS 117
Query: 463 YLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSITVDQT---HLTTKVQGTFGY 518
YLH I RD+K AN+L+D R +++DFG + + T ++ GT +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
+ PE + Q+ DV+S G V++E+ T + P A +L+ A + E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L R+ + RCL L ++RP +E+
Sbjct: 235 HL-----SPGLRD-------VTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 67/286 (23%), Positives = 127/286 (44%), Gaps = 42/286 (14%)
Query: 356 ILGQGGQGTVYKGML------ADGRIVAVKKSKLVDENNVEQ-FINEVVILSQINHRNIV 408
LG+G G V+ +V VK + + N++ F E+ + +++H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNI------HNHIEEFPITWELLLRIAVEVSGALF 462
+LLG C E E ++ E+ G L Q + ++ P++ + + + +++ +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
+L +A + RD+ + N L+ + KVS S+ + + + ++ PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
Q F+ KSDV+SFGV++ E+ T G+ P ++ +E L + +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGK------ 235
Query: 582 ALVLKEAER-----EEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
L L E ++MT RC +N K+RP+ E+ LG
Sbjct: 236 -LELPVPEGCPSRLYKLMT------RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLGCC 414
LG G G V G VA+K ++ E ++ ++FI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V E++ NG L + H + F LL + +V + YL S I
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---H 123
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSSQFTEK 532
RD+ + N L+DD+ KVSDFG SR + D+ T+ V F + PE S+F+ K
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 533 SDVYSFGVVLVEILT-GQKPIRAINIDE 559
SDV++FGV++ E+ + G+ P N E
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
LG+G G+VYK + G++VA+K + E ++++ I E+ IL Q + IVK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V E+ G++ + I +T E + I + L YLHS I
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLHSNKKI---H 122
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIK+ NILL+++ +AK++DFG S D V GT ++ PE Q + K+D
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKAD 181
Query: 535 VYSFGVVLVEILTGQ------KPIRAI 555
++S G+ +E+ G+ P+RAI
Sbjct: 182 IWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 21/225 (9%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILS 400
DLE +D LG G G+V K V KK + + +Q + E+ I+
Sbjct: 6 DLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH 58
Query: 401 QINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
+ IV G L + EF+ G+L I+ + PI E+L +IAV V
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK--KGGPIPVEILGKIAVAVVEG 115
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI--TVDQTHLTTKVQGTFGY 518
L YL++ I RDIK +NIL++ + + K+ DFG S + ++ T + GT Y
Sbjct: 116 LTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTY 168
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
+ PE Q ++T KSDV+S G+ ++E+ G+ P NID+D
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 357 LGQGGQGTVYKGML--ADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGC 413
LG G G V K +L G+I+AVK +L ++E +Q + E+ IL + N IV G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 414 CL-ETEVPLLVYEFVPNGTL---YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
++ + + E++ G+L + + I E L +IAV V L YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERI-----LGKIAVAVLKGLTYLHE--K 119
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K +NIL++ + + K+ DFG S + L GT Y+ PE Q + +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYMAPERIQGNDY 176
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589
+ KSD++S G+ L+E+ TG+ P N D +FE+L +V +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPD--------------GIFELLQYIVNEPPP 222
Query: 590 R-------EEIMTVATLAKRCLNLNGKNRPTMKE 616
R + CL + + RP+ KE
Sbjct: 223 RLPSGKFSPDFQ---DFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 26/213 (12%)
Query: 356 ILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENN----------VEQFINEVVILSQINH 404
++G+G G VY + G ++AVK+ +L V+ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 405 RNIVKLLGCCLETEVPLLVY-EFVPNGTLYQNIHNH--IEEFPITWELLLRIAVEVSGAL 461
NIV+ LG TE L ++ E+VP G++ + + EE +L+ +V L
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGL 121
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFGYVD 520
YLHS I RD+K+ N+L+D K+SDFG S+ S + +QG+ ++
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 521 PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 551
PE S ++ K D++S G V++E+ G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 71/224 (31%), Positives = 103/224 (45%), Gaps = 30/224 (13%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLADGRIVAVK---KSKLVDENNVEQ----FINEVV 397
E D+ R LG G G VY+G+ AV+ K + E+ EQ F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 398 ILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGT----LYQNIHNHIEEFPITWELLLRI 453
I+S+ NH+NIV+L+G E ++ E + G L +N +T + LL
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRSI-------TV 503
A +V+ YL I RDI + N LL K AK++DFG +R I
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547
+ L K ++ PE F FT K+DV+SFGV+L EI +
Sbjct: 179 GRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 21/223 (9%)
Query: 355 RILGQGGQGTVYKGML------ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
R LG+G G V+ D +VAVK K +N + F E +L+ + H +IV
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNH-------IEEFP---ITWELLLRIAVEVS 458
K G C+E + ++V+E++ +G L + + H E +T +L IA +++
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFG 517
+ YL AS RD+ + N L+ + K+ DFG SR + + D +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559
++ PE +FT +SDV+S GVVL EI T G++P ++ +E
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 64/214 (29%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL----VDENNVEQFINEVVILSQINH 404
Y R++G+G G V+ AD ++V +K+ + DE Q NE +L ++H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLSH 58
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
NI++ LE + ++V E+ P GTL + I + + +L V++ AL ++
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHV 117
Query: 465 HSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
H+ I RD+K+ NILLD K K+ DFG S+ ++ T V GT Y+ PE
Sbjct: 118 HTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPEL 172
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557
+ + +KSD+++ G VL E+ + ++ A N+
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 78/283 (27%), Positives = 142/283 (50%), Gaps = 35/283 (12%)
Query: 355 RILGQGGQGTVYKGML-ADGRI--VAVKKSKLV--DENNVEQFINEVVILSQINHRNIVK 409
+ LG+G G+V +G L D I VAVK K+ + +E F++E V + + +H N+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 410 LLGCCLETE------VPLLVYEFVPNGTLYQN-IHNHIEEFP--ITWELLLRIAVEVSGA 460
L+G CL+T P+++ F+ +G L+ +++ + + P + ++L++ +++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV-QGTFGYV 519
+ YL S + I RD+ + N +L++ V+DFG S+ I + ++ + ++
Sbjct: 125 MEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
E +T KSDV+SFGV + EI T GQ P + E+ + Y Q NRL +
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQG---NRLKQ 235
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
D L + +L C LN K+RP+ + + EL
Sbjct: 236 PPDCL----------DGLYSLMSSCWLLNPKDRPSFETLRCEL 268
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 77/284 (27%), Positives = 135/284 (47%), Gaps = 53/284 (18%)
Query: 355 RILGQGGQGTVYKGMLAD--GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+ +G+G G V ML D G VAVK K ++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
+E + L +V E++ G+L + + + + LL+ +++V A+ YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---N 122
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSR--SITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
RD+ + N+L+ + AKVSDFG ++ S T D L K + PE + +F
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKF 176
Query: 530 TEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
+ KSDV+SFG++L EI + G+ P I + + V+
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------------------VVPRV 212
Query: 589 EREEIM--------TVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
E+ M V + K+C +L+ RP+ ++ +L I
Sbjct: 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD----GRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
D++ + LG G G V ML G+ A+K K+K+V VE +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
I H +V L G + LV E+VP G L+ FP A +V AL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFY--AAQVVLAL 114
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLHS I RD+K N+LLD K++DFG ++ + +T+ GT Y+ P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYTLC---GTPEYLAP 167
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
E S + + D ++ G+++ E+L G P N
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 27/216 (12%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN-----EVVILSQIN 403
Y + LG+G VYK GRIVA+KK KL + + IN E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF------PITWELLLRIAVEV 457
H NI+ LL LV+EF+ L + I + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR------ 113
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
L YLHS I RD+K N+L+ K++DFG +RS +T +V T
Sbjct: 114 --GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 518 YVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Y PE F + + D++S G + E+L + P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 10/214 (4%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQ 401
+ E D +LG+G G VY L+ +A+K+ D V+ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ HRNIV+ LG E + E VP G+L + + + ++ ++ L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
YLH I RDIK N+L+ + Y K+SDFGTS+ + T GT Y+
Sbjct: 122 KYLHDN---QIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYM 176
Query: 520 DPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 551
PE + +D++S G +VE+ TG+ P
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVD----ENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G V+KG+ D R V K++D E+ +E E+ +LSQ + + K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
L+ ++ E++ G+ + +E P+ + I E+ L YLHS I
Sbjct: 70 SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI-- 123
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RDIK+AN+LL + K++DFG + +T Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
+D++S G+ +E+ G+ P E + FL N E + LKE
Sbjct: 182 ADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 231
Query: 593 IMTVATLAKRCLNLNGKNRPTMKEV 617
+ CLN RPT KE+
Sbjct: 232 ------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 75/288 (26%), Positives = 142/288 (49%), Gaps = 36/288 (12%)
Query: 355 RILGQGGQGTVYKGML----ADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIV 408
R+LG+G G+V + L + VAVK K+ + +++E+F+ E + + +H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 409 KLLGCCLETE------VPLLVYEFVPNGTLYQN-IHNHIEEFPITWEL--LLRIAVEVSG 459
KL+G L + +P+++ F+ +G L+ + + I E P T L L+R ++++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFGY 518
+ YL +S + RD+ + N +L++ V+DFG S+ I + D + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
+ E + +T SDV++FGV + EI+T GQ P + E+ + Y ++ NRL
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLIKG---NRLK 235
Query: 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+ D L + E+M +C + K RP+ + + +L I
Sbjct: 236 QPPDCL----EDVYELMC------QCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVD----ENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G V+KG+ D R V K++D E+ +E E+ +LSQ + + K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIH-NHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
L+ ++ E++ G+ + +EF I L E+ L YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML-----KEILKGLDYLHSEKKI- 123
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
RDIK+AN+LL ++ K++DFG + +T Q T V GT ++ PE Q S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 532 KSDVYSFGVVLVEILTGQKP 551
K+D++S G+ +E+ G+ P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 30/265 (11%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVD----ENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G VYKG+ D R V K++D E+ +E E+ +LSQ + I + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
L+ ++ E++ G+ + ++ P+ + I E+ L YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI-- 123
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RDIK+AN+LL ++ K++DFG + +T Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
+D++S G+ +E+ G+ P ++ R L FL N E + KE
Sbjct: 182 ADIWSLGITAIELAKGEPPNS--DLHPMRVL---FLIPKNSPPTLEGQYSKPFKE----- 231
Query: 593 IMTVATLAKRCLNLNGKNRPTMKEV 617
+ CLN + + RPT KE+
Sbjct: 232 ------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 357 LGQGGQGTVYKGMLA----DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G V +A GR VAVK L + E NEVVI+ H+N+V++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
L E ++ EF+ G L + + + + E + + V AL YLHS I
Sbjct: 86 SYLVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI-- 139
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RDIKS +ILL R K+SDFG I+ D + V GT ++ PE + + +
Sbjct: 140 -HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197
Query: 533 SDVYSFGVVLVEILTGQKP 551
D++S G++++E++ G+ P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 355 RILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
++LG+G G V +LA+ + + +KK ++ +++VE + E +L+
Sbjct: 1 KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 408 VKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLH 465
+ L C +T+ L V E+V G L +I F E R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFGYVDPEYF 524
I RD+K N+LLD + K++DFG + I T T+ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D ++ GV+L E+L GQ P + DE
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+GQG GTVY + +A G+ VA+K+ L + E INE++++ + + NIV L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
+ +V E++ G+L + + E + + + E AL +LHS I R
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVI---HR 139
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 535
DIKS NILL K++DFG IT +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 536 YSFGVVLVEILTGQKP 551
+S G++ +E++ G+ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+G+G G VYK + ++VA+K L E+ +E E+ LSQ I K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
L+ ++ E+ G+ + ++ + + I EV L YLH I
Sbjct: 69 LKGSKLWIIMEYCGGGSCL----DLLKPGKLDETYIAFILREVLLGLEYLHEEGKI---H 121
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIK+ANILL ++ K++DFG S +T + T V GT ++ PE + S + EK+D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 535 VYSFGVVLVEILTGQKP 551
++S G+ +E+ G+ P
Sbjct: 181 IWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 79/282 (28%), Positives = 136/282 (48%), Gaps = 23/282 (8%)
Query: 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINE 395
KL T + Y +GQG GTV+ + +A G+ VA+K+ L + E INE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 396 VVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV 455
++++ ++ + NIV L L + +V E++ G+L + + E + + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
E AL +LH+ I RDIKS N+LL K++DFG IT +Q+ +T V GT
Sbjct: 123 ECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
++ PE + K D++S G++ +E++ G+ P +N + R+L +L A N
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRAL---YLIATNGTP 233
Query: 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E+ + L R+ RCL ++ + R + KE+
Sbjct: 234 --ELQNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 357 LGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G+G G V + + G++VAVKK L + E NEVVI+ H N+V++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 416 ETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V EF+ G L + H + E E + + + V AL LH+ I
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIAAVCLAVLKALSVLHAQGVI---H 139
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIKS +ILL R K+SDFG ++ + + V GT ++ PE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 535 VYSFGVVLVEILTGQKP 551
++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 27/264 (10%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+GQG GTVY M +A G+ VA+++ L + E INE++++ + + NIV L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
+ +V E++ G+L + + E + + + E AL +LHS I R
Sbjct: 88 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVI---HR 140
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 535
DIKS NILL K++DFG IT +Q+ +T V GT ++ PE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 536 YSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMT 595
+S G++ +E++ G+ P +N + R+L +L A N E + E ++
Sbjct: 200 WSLGIMAIEMIEGEPPY--LNENPLRAL---YLIATNGT-----------PELQNPEKLS 243
Query: 596 VA--TLAKRCLNLNGKNRPTMKEV 617
RCL+++ + R + KE+
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-19
Identities = 76/312 (24%), Positives = 140/312 (44%), Gaps = 25/312 (8%)
Query: 313 FFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDN-----YNANRILGQGGQGTVYK 367
F + L L++ N+ + + F SK + T N ++ +G +G YK
Sbjct: 651 FIRGRNNLELKR--VENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYK 708
Query: 368 GMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427
G + V K ++ D N++ +E+ + ++ H NIVKL+G C + L++E++
Sbjct: 709 GKSIKNGMQFVVK-EINDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK 487
L + + N ++WE +IA+ ++ AL +LH S ++ ++ I++D K
Sbjct: 766 EGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK 819
Query: 488 YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547
+ + D + YV PE ++ TEKSD+Y FG++L+E+LT
Sbjct: 820 DEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLT 873
Query: 548 GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA--EREEIMTVATLAKRCLN 605
G+ P A S+V + ++ L +D + + + EI+ V LA C
Sbjct: 874 GKSPADA-EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTA 932
Query: 606 LNGKNRPTMKEV 617
+ RP +V
Sbjct: 933 TDPTARPCANDV 944
|
Length = 968 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 52/294 (17%)
Query: 356 ILGQGGQGTVYKGMLAD-----GRI-VAVKKSKL-VDENNVEQFINEVVILSQI-NHRNI 407
LG+G G V K VAVK K E ++ ++E+ ++ I H+NI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 408 VKLLGCCLETEVPLLVYEFV-------------PNGTLYQNIHNHIEEFPITWELLLRIA 454
+ LLG C + +V E+ P G E +T + L+ A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQ 513
+V+ + +L AS RD+ + N+L+ + + K++DFG +R I +D TT +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMN 572
++ PE +T +SDV+SFGV+L EI T G P I ++E
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------------- 242
Query: 573 ENRLFEVLDALVLKEAEREE-----IMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
LF+ +LKE R E + L + C + RPT K++ +L
Sbjct: 243 ---LFK-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 68/280 (24%), Positives = 135/280 (48%), Gaps = 40/280 (14%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKS-KLVDENNVEQFINEV----VILSQINHRNIV 408
++LG G GTV+KG+ + +G + + + K + + + Q E+ + + ++H IV
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG C + L V + P G+L ++ H + + + LL V+++ ++YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD-QTHLTTKVQGTFGYVDPEYFQSS 527
+ R++ + NILL +++DFG + + D + + ++ + ++ E
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
++T +SDV+S+GV + E+++ G +P + R EV D +L+
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGM-------------------RPHEVPD--LLE 225
Query: 587 EAER---EEIMT--VATLAKRCLNLNGKNRPTMKEVAFEL 621
+ ER +I T V + +C ++ RPT KE+A E
Sbjct: 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 357 LGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVK 409
+ +G G V+ LA G I A+K K+ ++ +N V+Q + E ILSQ +VK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 410 LLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSA 467
L + + L LV E++P G L + N + E + RI E+ AL YLHS
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLEN-VGSLD---EDVARIYIAEIVLALEYLHS- 111
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ-------THLTTKVQGTFGYVD 520
I RD+K NIL+D K++DFG S+ V + ++ GT Y+
Sbjct: 112 --NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
PE ++ D +S G +L E L G P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 75/285 (26%), Positives = 130/285 (45%), Gaps = 37/285 (12%)
Query: 350 NYNANRILGQGGQGTVYKGMLADG--RIVAVK----------KSKLVDENNVEQFINEVV 397
Y LG G G VYK + ++A+K K K + ++ ++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 398 IL-SQINHRNIVKLLGCCLETEVPLLVYEFV---PNGTLYQNIHNHIEEFPITWELLLRI 453
I+ Q+ H NIV+ LE + +V + + P G + ++ + F E + I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
V++ AL YLH I RD+ NI+L + + ++DFG ++ ++ LT+ V
Sbjct: 119 FVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV- 174
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573
GT Y PE ++ + EK+DV++FG +L ++ T Q P + N+ SL ++A+ E
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYE 231
Query: 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618
L E E +T + CL + + RP + +V+
Sbjct: 232 P----------LPEGMYSEDVTD--VITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLG 412
+ LG G G V+ G VA+K ++E + E FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C + + +V EF+ NG L + + + ++LL + +V + YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RD+ + N L+ KVSDFG +R + D+ ++ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 533 SDVYSFGVVLVEILT-GQKP 551
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 76/263 (28%), Positives = 120/263 (45%), Gaps = 37/263 (14%)
Query: 373 GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYEFVPN 429
G VAVK K N++ E+ IL + H NIVK G C E L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489
G+L + + + + I + L+ AV++ + YL S + RD+ + N+L++ +++
Sbjct: 93 GSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 490 AKVSDFGTSRSITVDQTHLTTK---VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
K+ DFG +++I D+ + T K F Y PE S+F SDV+SFGV L E+L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVTLYELL 206
Query: 547 TGQKPIRAINIDEDRSLVGYFLQ-------AMNENRLFEVLDALVLKEAEREEI-----M 594
T D + S + FL+ M RL VL+E +R
Sbjct: 207 T--------YCDSESSPMTLFLKMIGPTHGQMTVTRLVR-----VLEEGKRLPRPPNCPE 253
Query: 595 TVATLAKRCLNLNGKNRPTMKEV 617
V L ++C R T + +
Sbjct: 254 EVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-19
Identities = 71/214 (33%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 355 RILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNI 407
R+LG+G G V MLA GR+ AVK K ++ +++VE + E ILS +
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 408 VKLLGCCLET-EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLH 465
+ L CC +T + V EFV G L HI++ E R A E++ AL +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLM----FHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
I RD+K N+LLD + K++DFG + + T+ GT Y+ PE Q
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D ++ GV+L E+L G P A N D+
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 44/282 (15%)
Query: 355 RILGQGGQGTVYKGMLA-DGRIVAVKKS-KLVDENNV----EQFINEVVILSQINHRNIV 408
++LG G GTVYKG+ DG V + + K++ EN ++ ++E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG CL + V L V + +P G L + + + I + LL V+++ + YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT---KVQGTFGYVDPEYFQ 525
+ + RD+ + N+L+ K++DFG +R + +D+T KV ++ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESIL 184
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+FT +SDV+S+GV + E++T G KP I E L
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL--------------------- 223
Query: 585 LKEAEREEIMTVAT-----LAKRCLNLNGKNRPTMKEVAFEL 621
L++ ER + T + +C ++ + RP +E+ E
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 357 LGQGGQGTVYK-GMLADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
+G+G G V+K G VA+KK + ++ Q + E+ L H +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+LV E++P L + + + EE P+ + + + Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHAN---GIM 121
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEK 532
RD+K AN+L+ K++DFG +R + ++ L + T Y PE + + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 533 SDVYSFGVVLVEILTGQ 549
D+++ G + E+L G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 37/290 (12%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLAD---GRIVAVKKSKLVDEN-----NVEQFINEV 396
E + + R LGQG G VY+G D G K V+E+ +E F+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60
Query: 397 VILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG-------TLYQNIHNHIEEFPITWEL 449
++ ++V+LLG + + L+V E + +G +L N+ P T +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHL 508
++++A E++ + YL++ + RD+ + N ++ + K+ DFG +R I D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYF 567
K ++ PE + FT SD++SFGVVL EI + ++P + ++
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS----------- 226
Query: 568 LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
NE L V+D L + + V L + C N K RPT E+
Sbjct: 227 ----NEQVLKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLG 412
LG+G G+V K L + ++ K+ D N +Q + E+ I IVK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 413 CCL---ETEVPLLVYEFVPNGTL---YQNIH---NHIEEFPITWELLLRIAVEVSGALFY 463
L + + + + E+ G+L Y+ + I E L +IA V L Y
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKV-----LGKIAESVLKGLSY 120
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG----YV 519
LHS I RDIK +NILL K + K+ DFG S L + GTF Y+
Sbjct: 121 LHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYM 170
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
PE Q ++ SDV+S G+ L+E+ + P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 55/187 (29%), Positives = 99/187 (52%), Gaps = 20/187 (10%)
Query: 375 IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433
+VAVK + V + F+ E+ I+S++ + NI++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 434 QNIHN--------HIEEFP-ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484
Q + H P ++ LL +AV+++ + YL AS++ RD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 485 DDKYRAKVSDFGTSRSITVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGV 540
+ Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 541 VLVEILT 547
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGC 413
ILG G GTVYK L RI+AVK L + +Q ++E+ IL + + I+ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 414 CLETEVPLLVYEFVPNGTL--YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
+ EF+ G+L Y+ I H+ L RIAV V L YL S +
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHV---------LGRIAVAVVKGLTYLWS---LK 115
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
I RD+K +N+L++ + + K+ DFG S + + GT Y+ PE Q+
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 532 KSDVYSFGVVLVEILTGQKP 551
SDV+S G+ +E+ G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/219 (29%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 357 LGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQ---FINEVVILSQINHRNIV 408
LG+ G +YKG L ++VA+K K D NN +Q F E ++++++H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNI-----HNHI-----EEFPITWEL----LLRIA 454
LLG + + +++E++ G L++ + H+ + E+ + L L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQ 513
++++ + YL S + +D+ + NIL+ ++ K+SD G SR I + D + K
Sbjct: 131 IQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
++ PE +F+ SD++SFGVVL EI + G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 62/213 (29%), Positives = 105/213 (49%), Gaps = 11/213 (5%)
Query: 357 LGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGCC 414
+G+G G V+ G L AD VAVK + +++ +F+ E IL Q +H NIV+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ + +V E V G + E + + L+++ + + YL S I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK--VQGTFGYVDPEYFQSSQFTEK 532
RD+ + N L+ +K K+SDFG SR D + +T Q + PE +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 533 SDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV 564
SDV+SFG++L E + G P ++ + R +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 76/292 (26%), Positives = 140/292 (47%), Gaps = 41/292 (14%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLADGRI-------VAVK---KSKLVDENNVEQFIN 394
E A + +R LGQG G VY+G +A G + VA+K ++ + E +F+N
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRER--IEFLN 58
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG-------TLYQNIHNHIEEFPITW 447
E ++ + N ++V+LLG + + L++ E + G +L + N+ + P +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 448 ELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQT 506
+ ++++A E++ + YL++ + RD+ + N ++ + + K+ DFG +R I D
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175
Query: 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVG 565
K ++ PE + FT SDV+SFGVVL EI T ++P + ++
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------- 226
Query: 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
NE L V++ +L + + M + L + C N K RP+ E+
Sbjct: 227 ------NEQVLRFVMEGGLLDKPDNCPDM-LFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 77/273 (28%), Positives = 122/273 (44%), Gaps = 37/273 (13%)
Query: 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G+G G V G+ VAVKK L + E NEVVI+ +H N+V + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 416 ETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V EF+ G L + H + E E + + + V AL YLH+ I
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQGVI---H 141
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIKS +ILL R K+SDFG ++ + + V GT ++ PE + + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 535 VYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF----LQAMNENRLFEVLDALVLKEAER 590
++S G++++E++ G+ P YF LQAM R D L
Sbjct: 201 IWSLGIMVIEMIDGEPP--------------YFNEPPLQAMRRIR-----DNL---PPRV 238
Query: 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623
++ V+++ + L+L P+ + A EL
Sbjct: 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN-----NVEQFINEVVILSQIN 403
N+ ++LGQG G VY AD GR +AVK+ + E+ V E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 404 HRNIVKLLGCCLET-EVPLLVY-EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
H IV+ GC + E L ++ E +P G++ + ++ +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGV 119
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR---SITVDQTHLTTKVQGTFGY 518
YLHS I RDIK ANIL D K+ DFG S+ +I + T + + V GT +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYW 175
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ PE + K+D++S G +VE+LT + P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 37/288 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRI-------VAVKKSK-LVDENNVEQFINEVVILS 400
+N + + LG G G V + A G VAVK K + E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 401 QI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
+ NH NIV LLG C L++ E+ G L + E F + LL + +V+
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED-LLSFSYQVAK 152
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---- 515
+ +L AS + RD+ + N+LL K+ DFG +R I D ++ V+G
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLP 206
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574
++ PE + +T +SDV+S+G++L EI + G P + +D F + + E
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG 260
Query: 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
+ + AE +IM K C + + RPT K++ +G
Sbjct: 261 --YR-MAQPEHAPAEIYDIM------KTCWDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 355 RILGQGGQGTVYKGM------LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
R LG+G G V+ D +VAVK K + F E +L+ + H +IV
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNH-------IEEFPI--TWEL----LLRIAV 455
K G C + + ++V+E++ +G L + + H ++ P EL +L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQG 514
+++ + YL AS RD+ + N L+ K+ DFG SR + + D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 515 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
++ PE +FT +SDV+SFGV+L EI T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416
LG G G V+ G VA+K K + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 417 TEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
T+ P+ ++ E++ NG+L + E +T L+ +A +++ + ++ I R
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYI---HR 126
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDV 535
D+++ANIL+ + K++DFG +R I ++ + + PE FT KSDV
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 536 YSFGVVLVEILT-GQKP 551
+SFG++L EI+T G+ P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 70/282 (24%), Positives = 131/282 (46%), Gaps = 44/282 (15%)
Query: 355 RILGQGGQGTVYKGM-LADG---RI-VAVKKSKLVDENNVEQFI-NEVVILSQINHRNIV 408
++LG G GTVYKG+ + +G +I VA+K+ + + I +E +++ +++ ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG CL + V L + + +P G L + H + + LL V+++ + YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEER- 128
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT---KVQGTFGYVDPEYFQ 525
+ RD+ + N+L+ K++DFG ++ + D+ KV ++ E
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMALESIL 184
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+T +SDV+S+GV + E++T G KP I E S +
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---------------------I 223
Query: 585 LKEAER---EEIMT--VATLAKRCLNLNGKNRPTMKEVAFEL 621
L++ ER I T V + +C ++ +RP +E+ E
Sbjct: 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 355 RILGQGGQGTVYKGMLA-DGR---IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
+++G G G V G L G+ VA+K K E F++E I+ Q +H NI+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L G +++ ++V E++ NG+L + H +F + L+ + ++ + YL +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYL---SD 124
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG--YVDPEYFQSS 527
+ RD+ + NIL++ KVSDFG SR + D T G + PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 17/207 (8%)
Query: 356 ILGQGGQGTVYKGML-ADGR---IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKL 410
++G G G V +G L G+ VA+K K E F++E I+ Q +H NI+ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
G ++ +++ EF+ NG L + + +F + L+ + ++ + YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL---SEM 125
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSI---TVDQTHLTTKVQGTFG--YVDPEYFQ 525
+ RD+ + NIL++ KVSDFG SR + T D T+ T+ + G + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY-TSSLGGKIPIRWTAPEAIA 184
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKL-VDENNVEQFIN----EVVILSQIN 403
N+ ++LG+G G VY AD GR +AVK+ D + +N E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 404 HRNIVKLLGCCLE-TEVPLLVY-EFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGA 460
H IV+ GC + E L ++ E++P G+ I + ++ + +T + R ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQG 118
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTK-VQGTFGY 518
+ YLHS I RDIK ANIL D K+ DFG S+ I T+ + K V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ PE + K+DV+S +VE+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 53/198 (26%), Positives = 98/198 (49%), Gaps = 6/198 (3%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ LG G G V+ G + VAVK K +V+ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ E ++ E++ G+L + + E + L+ + +++ + Y+ I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RD+++AN+L+ + K++DFG +R I ++ + + PE FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 535 VYSFGVVLVEILT-GQKP 551
V+SFG++L EI+T G+ P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-17
Identities = 28/79 (35%), Positives = 49/79 (62%), Gaps = 2/79 (2%)
Query: 1 FLITCNDTFKPPKPFLTKSSIEVVNISI-DGHLNVLQYTAKDCYNAKGYSVDSNLPTITL 59
F +TCN+T PP+ L + EV++IS+ +G + VL + +CYN+ G D+ ++
Sbjct: 29 FELTCNNTTSPPRLLLGNGNYEVLSISLANGTVRVLDPISSNCYNSSGKRTDNGSLSLGG 88
Query: 60 SKFTVSNTENRFVVIGCDS 78
F S++ N+FVV+GC++
Sbjct: 89 P-FFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQF-INEVVILSQI---NHRNIVK 409
+G+G GTVYK L GR VA+KK ++ + E + + E+ +L Q+ H NIV+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 410 LLGCC----LETEVPL-LVYEFVPNGTLYQNIHNHIEEFP---ITWELLLRIAVEVSGAL 461
LL C + E+ L LV+E V Q++ ++ + P + E + + ++ +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
+LHS I RD+K NIL+ + K++DFG +R I + LT+ V T Y P
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-TLWYRAP 175
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEI 545
E S + D++S G + E+
Sbjct: 176 EVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 48/290 (16%)
Query: 356 ILGQGGQGTVYKGMLA-DGRIV--AVKKSK-LVDENNVEQFINEVVILSQI-NHRNIVKL 410
++G+G G V + M+ DG + A+K K EN+ F E+ +L ++ +H NI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHN-------------HIEEFPITWELLLRIAVEV 457
LG C + E+ P G L + H +T + LL+ A +V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
+ + YL I RD+ + N+L+ + +K++DFG SR V V+ T G
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKKTMG 178
Query: 518 -----YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572
++ E S +T KSDV+SFGV+L EI+ SL G M
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV---------------SLGGTPYCGMT 223
Query: 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
L+E L E R V L ++C RP +++ +L
Sbjct: 224 CAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 355 RILGQGGQGTVY---KGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNI 407
++LGQG G V+ K D G++ A+K K+ L + V E IL+++NH I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60
Query: 408 VKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
VKL +TE L L+ +F+ G L+ + +E T E + E++ AL +LHS
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHS 116
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
+ I RD+K NILLD++ K++DFG S+ ++D GT Y+ PE
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNR 172
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKP 551
T+ +D +SFGV++ E+LTG P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 67/213 (31%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+GQGG G V+ D G IVA+K KS L N V + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 413 CCLETEVPLLVYEFVPNG---TLYQN---IHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+ E L E+VP G TL N + F + E+ AV+ L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EMFE--AVDALHELGYIH- 124
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
RD+K N L+D K++DFG S+ I V + V G+ Y+ PE +
Sbjct: 125 --------RDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPEVLRG 172
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D +S G +L E L G P +E
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 7/204 (3%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416
LG G G V+ G VAVK K + E F+ E I+ ++ H +V+L E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476
+ +V E++ G+L + + E + L+ +A +V+ + Y+ I RD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYI---HRD 127
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
++SANIL+ D K++DFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 537 SFGVVLVEILT-GQKPIRAINIDE 559
SFG++L E++T G+ P +N E
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 74/239 (30%), Positives = 114/239 (47%), Gaps = 46/239 (19%)
Query: 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKL-VDENNVEQFINEV 396
FT++DL+ + +G+G GTV K + G I+AVK+ + VDE ++ + ++
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 397 -VILSQINHRNIVKLLG-------C--CLE-TEVPL-LVYEFVPNGTLYQNIHNHIEEFP 444
V++ + IVK G C C+E ++ L Y++V Y+ + + I E
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYV-----YEVLKSVIPE-- 106
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS----RS 500
E+L +IAV AL YL + I RD+K +NILLD K+ DFG S S
Sbjct: 107 ---EILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAIN 556
I T+ G Y+ PE S + +SDV+S G+ L E+ TG+ P N
Sbjct: 162 IA------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSK---LVDENNVEQFINEVVILSQINHR 405
N+ + +G+G VY+ L DG VA+KK + L+D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYL 464
N++K +E +V E G L + I H ++ I + + + V++ AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS + RDIK AN+ + K+ D G R + T + V GT Y+ PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 55/193 (28%), Positives = 103/193 (53%), Gaps = 27/193 (13%)
Query: 375 IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433
+VAVK + ++N F+ EV ILS++ NI++LLG C++ + ++ E++ NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 434 QNI-HNHIEE---------------FPITWELLLRIAVEVSGALFYLHSAASISIYRRDI 477
Q + +H+++ I++ LL +A++++ + YL +S++ RD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 478 KSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKS 533
+ N L+ + K++DFG SR++ + ++QG ++ E +FT S
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 534 DVYSFGVVLVEIL 546
DV++FGV L EIL
Sbjct: 222 DVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGRI----VAVKKSKL----VDENNVEQFINEVVILSQ 401
Y + +G+G G +Y LA + +K+ L V E + EV++L++
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAK 55
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ H NIV E +V E+ G L + I N + + +L V++S L
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGL 114
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYR-AKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
++H I RDIKS NI L AK+ DFG +R + D L GT Y+
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLS 170
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
PE Q+ + K+D++S G VL E+ T + P N+ +
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 350 NYNANRILGQG--GQGTVYKGMLADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRN 406
YN R++G+G G+ + + + +D + A+K+ +L + VE E V+L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 407 IVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
IV E + L +V E+ G L Q I + + +L+ V++ + ++H
Sbjct: 60 IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIH 117
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+ RDIKS NI L + K+ DFG++R +T + T V GT YV PE ++
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWE 173
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
+ + KSD++S G +L E+ T + P +A
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 22/178 (12%)
Query: 385 DENNVEQFINEVVILSQINHRNIVKLL--GCCLETEVPLL--VYEFVPNGTLYQNIHNHI 440
+E+ +F E + +++ H NIV LL G E LL V+E+VP TL + +
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFEYVPGRTLREVLAA-- 72
Query: 441 EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGT 497
+ + R+ ++V AL H+ I RD+K NI++ + AKV DFG
Sbjct: 73 -DGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 498 S------RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
R V TT+V GT Y PE + T SD+Y++G++ +E LTGQ
Sbjct: 129 GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416
LGQG G V+ G VA+K K + E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476
+ +V E++ G+L + + ++ + L+ +A +++ + Y+ ++ RD
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
+++ANIL+ + KV+DFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 537 SFGVVLVEILT-GQKP 551
SFG++L E+ T G+ P
Sbjct: 188 SFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 76/303 (25%), Positives = 134/303 (44%), Gaps = 51/303 (16%)
Query: 345 EKATDNYNANRILGQGGQGTVYK----GMLA--DGRIVAVKKSKLVDENNVE---QFINE 395
E +N R +GQG G V++ G+L +VAVK K +E + + F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 58
Query: 396 VVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL------------YQNIHNHIE-- 441
++++ +H NIVKLLG C + L++E++ G L H+
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 442 -----EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496
P++ L IA +V+ + YL + RD+ + N L+ + K++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFG 175
Query: 497 TSRSI-TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 554
SR+I + D + ++ PE +++T +SDV+++GVVL EI + G +P
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP--- 232
Query: 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614
Y+ A +E ++ V D VL + + + L + C + +RP+
Sbjct: 233 -----------YYGMA-HEEVIYYVRDGNVLSCPDNCP-LELYNLMRLCWSKLPSDRPSF 279
Query: 615 KEV 617
+
Sbjct: 280 ASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN-----NVEQFINEVVILSQIN 403
N+ ++LGQG G VY D GR +A K+ + E+ V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 404 HRNIVKLLGCCLE-TEVPLLVY-EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
H IV+ GC + E L ++ E++P G++ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGM 119
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR---SITVDQTHLTTKVQGTFGY 518
YLHS I RDIK ANIL D K+ DFG S+ +I + T + + V GT +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYW 175
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ PE + K+DV+S G +VE+LT + P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 39/231 (16%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQF----INEVVIL 399
++ D ++ +G+G G VYK D G +VA+KK +L +N E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKIL 60
Query: 400 SQINHRNIVKLLGCCLETEVPL----------LVYEFVPN---GTLYQNI----HNHIEE 442
Q+NHRNIV L + + L LV+E++ + G L + +HI+
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 443 FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502
F + LL L Y H + RDIK +NILL++K + K++DFG +R
Sbjct: 121 F---MKQLLE-------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 503 VDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 552
+++ T T Y PE + + DV+S G +L E+ T +KPI
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
LG G G VYK + G A K ++ E +E F+ E+ ILS+ H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
++ EF G L +I +E +T + + ++ AL +LHS I R
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELER-GLTEPQIRYVCRQMLEALNFLHSHKVI---HR 127
Query: 476 DIKSANILLDDKYRAKVSDFGTS-RSITVDQTHLTTKVQGTFGYVDPEY-----FQSSQF 529
D+K+ NILL K++DFG S ++ + Q T GT ++ PE F+ + +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPY 185
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAIN 556
K+D++S G+ L+E+ + P +N
Sbjct: 186 DYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 65/262 (24%), Positives = 128/262 (48%), Gaps = 30/262 (11%)
Query: 375 IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433
+VAVK + ++N F+ E+ I+S++ NI++LL C+ ++ ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 434 QNIHNHIEEFP--------ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485
Q + H + I++ L+ +A +++ + YL +S++ RD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 486 DKYRAKVSDFGTSRSITVDQTHLTTKVQG----TFGYVDPEYFQSSQFTEKSDVYSFGVV 541
Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 542 LVEILT--GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATL 599
L EILT ++P ++ ++ G F + ++ R + + + ++ L
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFR--DQGRQVYLPKPALCPD-------SLYKL 272
Query: 600 AKRCLNLNGKNRPTMKEVAFEL 621
C N K RP+ +E+ L
Sbjct: 273 MLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSK---LVDENNVEQFINEVVILSQINHR 405
N+ + +G+G VY+ L D + VA+KK + ++D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYL 464
N++K L +E +V E G L Q I + ++ I + + V++ A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS + RDIK AN+ + K+ D G R + T + V GT Y+ PE
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 76/310 (24%), Positives = 134/310 (43%), Gaps = 54/310 (17%)
Query: 345 EKATDNYNANRILGQGGQGTVY--------KGMLADGRIVAVKKSK-LVDENNVEQFINE 395
E + D + LG+G G V K + VAVK K E ++ ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 396 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH-------------NHIE 441
+ ++ I H+NI+ LLG C + ++ E+ G L + + +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 442 EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501
+ +T++ L+ +V+ + YL S I RD+ + N+L+ + K++DFG +R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 502 -TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559
+D TT + ++ PE +T +SDV+SFGV++ EI T G P I ++E
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT-----LAKRCLNLNGKNRPTM 614
LF+ +LKE R + T + + C + +RPT
Sbjct: 248 ----------------LFK-----LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF 286
Query: 615 KEVAFELGGI 624
K++ +L I
Sbjct: 287 KQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQFIN--EVVILSQIN-HRNIVKL 410
LG G G+VY G +VA+K K K + E+ +N EV L ++N H NIVKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
E + V+E++ G LYQ + + + P + ++ I ++ L ++H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG-- 119
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF-QSSQF 529
+ RD+K N+L+ K++DFG +R I + T V T Y PE +S+ +
Sbjct: 120 -FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-STRWYRAPEILLRSTSY 176
Query: 530 TEKSDVYSFGVVLVEILTGQKPI 552
+ D+++ G ++ E+ T +P+
Sbjct: 177 SSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 357 LGQGGQGTVYK-GMLADGRIVAVKK--SKLVDENNVEQF-INEVVILSQINHRNIVKLLG 412
LG+GG G V + A G++ A KK K + + EQ +NE IL +++ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALFYLHSAASI 470
ET+ L LV + G L +I+N E FP + A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFY--AAQIICGLEHLHQ---R 114
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT 530
I RD+K N+LLDD ++SD G + + + GT GY+ PE Q +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172
Query: 531 EKSDVYSFGVVLVEILTGQKPIRA 554
D ++ G L E++ G+ P R
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 81/312 (25%), Positives = 139/312 (44%), Gaps = 54/312 (17%)
Query: 345 EKATDNYNANRILGQG--GQGTVYKGMLAD----GRI--VAVKKSKL-VDENNVEQFINE 395
E D + LG+G GQ + + + D R+ VAVK K E ++ I+E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 396 VVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH-------------NHIE 441
+ ++ I H+NI+ LLG C + ++ E+ G L + + +
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 442 EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501
E ++++ L+ A +V+ + YL S I RD+ + N+L+ + K++DFG +R I
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 502 T-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559
+D TT + ++ PE +T +SDV+SFGV+L EI T G P + ++E
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT-----LAKRCLNLNGKNRPTM 614
LF+ +LKE R + + T + + C + RPT
Sbjct: 251 ----------------LFK-----LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 289
Query: 615 KEVAFELGGIRA 626
K++ +L I A
Sbjct: 290 KQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNV-EQFINEVVILSQINHRNIVKLLGC 413
+G+G G VYKG G+IVA+KK +L +E V I E+ +L ++ H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFP----ITWELLLRIAVEVSGALFYLHSAAS 469
++ L++EF L ++ +++ P + EL+ ++ + + HS
Sbjct: 68 LMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR-- 120
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ- 528
+ RD+K N+L+D+K K++DFG +R+ + T +V T Y PE S
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPR 178
Query: 529 FTEKSDVYSFGVVLVEILTGQKPI 552
++ D++S G + E+ T +KP+
Sbjct: 179 YSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-16
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 47/227 (20%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINHRNI 407
Y + +G G G V + GR VA+KK V ++ ++ + + E+ +L + H NI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 408 VKLLGCCLETEVPL-----------LVYEFVPNGT-LYQNIHN-------HIEEFPITWE 448
+ LL ++ +V E + T L++ I + HI+ F ++
Sbjct: 62 IGLL------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQPLTDDHIQYF--LYQ 111
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
+L L YLHSA ++ RD+K +NIL++ K+ DFG +R + D+
Sbjct: 112 ILR--------GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 509 TTKVQG--TFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ T Y PE SS++T+ D++S G + E+LT KP+
Sbjct: 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVKK--SKLVDENNVEQF-INEVVILSQINHRNIVKL 410
R+LG+GG G V + A G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
ET+ L LV + G L +I+ H+ E + A E+ L LH
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K NILLDD ++SD G + + QT + +V GT GY+ PE ++ ++
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERY 178
Query: 530 TEKSDVYSFGVVLVEILTGQKPIR 553
T D ++ G +L E++ GQ P +
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 357 LGQGGQGTVYKGMLA-DGRIVA---VKKSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
LG GG G V + R A VKK +V+ E +E IL + NH IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIH--NHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
+ + ++ E+ G L+ + +E + IA V A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIACVVL-AFEYLHN---R 112
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT 530
I RD+K N+LLD K+ DFG ++ + Q T GT YV PE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYD 170
Query: 531 EKSDVYSFGVVLVEILTGQKPIRAINID 558
D +S G++L E+LTG+ P + D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 354 NRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF--INEVVILSQINHRNIVKL 410
NRI G+G G VY+ G IVA+KK ++ +E + + E+ +L + H NIV+L
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 411 L----GCCLETEVPLLVYEFVPN--GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
G L++ LV E+ +L N+ P + + + +++ L YL
Sbjct: 72 KEVVVGKHLDS--IFLVMEYCEQDLASLLDNMPT-----PFSESQVKCLMLQLLRGLQYL 124
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-Y 523
H I RD+K +N+LL DK K++DFG +R+ + +T KV T Y PE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ +T D+++ G +L E+L KP+
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 31/235 (13%)
Query: 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF 392
E +LF+ D EK + R +G G G VY + +VA+KK + + E++
Sbjct: 3 EIAELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 59
Query: 393 ---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-VPNGTLYQNIHNH-IEEFPITW 447
I EV L Q+ H N ++ GC L LV E+ + + + +H ++E
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE----- 114
Query: 448 ELLLRIAVEVSGAL---FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504
+ IA GAL YLHS I RDIK+ NILL + K++DFG++ ++
Sbjct: 115 ---VEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPA 168
Query: 505 QTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ + GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 169 NSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 20/214 (9%)
Query: 355 RILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
++LG+G G V MLA+ + I +KK ++ +++V+ + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 408 VKLLGCCLETEVPLL-VYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLH 465
+ L CC +T+ L V E+V G L I +F E R A EV+ AL +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFD---EPRSRFYAAEVTLALMFLH 113
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
I RD+K NILLD + K++DFG + + TT GT Y+ PE Q
Sbjct: 114 RHGVIY---RDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQ 169
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
++ D ++ GV++ E++ GQ P A N D+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 31/279 (11%)
Query: 356 ILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFI--NEVVILSQINHRNIVKLLG 412
++G+G G V K + G+IVA+KK +++ + + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP--ITWELLLRIAVEVSGALFYLHSAASI 470
+ LV+EFV + L + +E++P + + + ++ + + HS
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSH--- 119
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF-QSSQF 529
+I RDIK NIL+ K+ DFG +R++ T V T Y PE +++
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKY 178
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAINIDEDR-----SLVGYFLQA----MNENRLFEVL 580
D+++ G ++ E+LTG+ P+ + D D+ +G + +N LF +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 581 DALVLKEAEREEIM------TVATLAKRCLNLNGKNRPT 613
+KE E E V LAK+CL ++ +RP+
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 62/243 (25%), Positives = 95/243 (39%), Gaps = 59/243 (24%)
Query: 347 ATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQ 401
+Y LG+G G VYK + GR+VA+KK + +E + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 402 INHRNIVKLLGCCLE-----TEVPLLVYEFVP------NGTLYQNIHNHIEEFPITWELL 450
+ H N+V L+ +E VY P +G L N
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL----ENP----------- 108
Query: 451 LRIAVEVSGA----------LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+ + S + YLH I RDIK+ANIL+D++ K++DFG +R
Sbjct: 109 -SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 501 ITVDQTHLTTKVQG----------TFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 549
+ G T Y PE ++T D++ G V E+ T
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223
Query: 550 KPI 552
+PI
Sbjct: 224 RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 74/287 (25%), Positives = 121/287 (42%), Gaps = 42/287 (14%)
Query: 356 ILGQGGQGTVYKGMLA-DGRIV--AVKKSK-LVDENNVEQFINEVVILSQINHR-NIVKL 410
++G+G G V K + DG + A+K+ K +++ F E+ +L ++ H NI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHN-------------HIEEFPITWELLLRIAVEV 457
LG C L E+ P+G L + + ++ + LL A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR--SITVDQTHLTTKVQGT 515
+ + YL I RD+ + NIL+ + Y AK++DFG SR + V +T V+
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
++ E S +T SDV+S+GV+L EI+ SL G M
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIV---------------SLGGTPYCGMTCAE 219
Query: 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
L+E L E V L ++C RP+ ++ L
Sbjct: 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 73/282 (25%), Positives = 129/282 (45%), Gaps = 50/282 (17%)
Query: 376 VAVK--KSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV-YEFVPNGT 431
VAVK K D++ + I+E+ ++ I H+NI+ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 432 LYQNIH-------------NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478
L + + + E ++++ L+ A +V+ + YL S I RD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 479 SANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 537
+ N+L+ + K++DFG +R + +D T+ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 538 FGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTV 596
FG+++ EI T G P I ++E LF+ +L+E R + +
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE----------------LFK-----LLREGHRMDKPSN 260
Query: 597 AT-----LAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633
T L + C + RPT K++ L + A++ L
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVKK--SKLVDENNVEQF-INEVVILSQINHRNIVKL 410
R+LG+GG G V + A G++ A K+ K + + E +NE IL ++N + +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNH----IEEFPITWELLLRIAVEVSGALFYLHS 466
+ LV + G L +I+N EE E L A E+ L LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE-----ERALFYAAEILCGLEDLHR 120
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
++ RD+K NILLDD ++SD G + + + + GT GY+ PE +
Sbjct: 121 ENTVY---RDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNN 175
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRA 554
++T D + G ++ E++ GQ P R
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGC 413
+G G G VYK G ++AVK+ + E N ++ V+L + IVK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 414 CL-ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL---HSAAS 469
+ +++V + E + T + I+ PI ++L ++ V + AL YL H
Sbjct: 83 FITDSDV-FICMELM--STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG--- 135
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
+ RD+K +NILLD K+ DFG S + + T+ G Y+ PE
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDP 191
Query: 530 TEK----SDVYSFGVVLVEILTGQKPIRAINID 558
K +DV+S G+ LVE+ TGQ P + +
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G G G VYK + G + A+K KL + E++++ H NIV G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
+ + EF G+L Q+I+ H+ P++ + ++ E L+YLHS + R
Sbjct: 77 RRDKLWICMEFCGGGSL-QDIY-HVTG-PLSESQIAYVSRETLQGLYYLHSKGKM---HR 130
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF---QSSQFTEK 532
DIK ANILL D K++DFG S IT + + GT ++ PE + + +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQL 189
Query: 533 SDVYSFGVVLVEILTGQKPI 552
D+++ G+ +E+ Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 355 RILGQGGQGTVYKGMLADGR-----IVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK 409
++LG+G G V L G+ + A+KK ++ +++VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 410 LLGCCLETEVPLL-VYEFVPNGTLYQNIHN--HIEEFPITWELLLRIAVEVSGALFYLHS 466
L C +T+ L V EF+ G L +I + + + T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RD+K N++LD K++DFG + +T GT Y+ PE Q
Sbjct: 115 KGIIY---RDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
++T D +SFGV+L E+L GQ P + DE
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVKK--SKLVDENNVEQF-INEVVILSQINHRNIVKL 410
R+LG+GG G V + A G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNH----IEEFPITWELLLRIAVEVSGALFYLH 465
ET+ L LV + G L +I+N +E E + A E++ L LH
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-----ERAVFYAAEITCGLEDLH 119
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
I RD+K NILLDD ++SD G + I +T + +V GT GY+ PE +
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVK 174
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
+ ++T D + G ++ E++ G+ P R
Sbjct: 175 NERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQI 402
++N +LG+G G V MLA+ + I +KK ++ +++VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 403 NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE-LLLRIAVEVSGA 460
+ L C +T L V E+V G L HI++ E + A E++
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMY----HIQQVGKFKEPHAVFYAAEIAIG 113
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV-QGTFGYV 519
LF+LHS I RD+K N++LD + K++DFG + TT+ GT Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYI 168
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
PE + + D ++FGV+L E+L GQ P + DE
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-15
Identities = 90/327 (27%), Positives = 150/327 (45%), Gaps = 46/327 (14%)
Query: 342 KDLEKATDNYNANRILGQGGQGTV----YKGMLADGRIVAVK---KSKLVDENNVEQFIN 394
+ L+ ++Y+ +++G+G G V +K + ++ A+K K +++ ++ F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI 453
E I++ N +V+L C + + L +V E++P G L + N+ + P W
Sbjct: 93 ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFY-- 147
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT---HLTT 510
EV AL +HS + + RD+K N+LLD K++DFGT + +D+T T
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDT 202
Query: 511 KVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566
V GT Y+ PE +S + + D +S GV L E+L G P A SLVG
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGT 255
Query: 567 FLQAMN-ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNL--NG----KNRPTMKEVAF 619
+ + M+ +N L D + K A+ + A L R + L NG K P K +
Sbjct: 256 YSKIMDHKNSLNFPEDVEISKHAKN---LICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312
Query: 620 ELGGIRASIGASILQQNCGVIDCVNGD 646
IR + A ++ + ID N D
Sbjct: 313 NWDNIRETA-APVVPELSSDIDSSNFD 338
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 9e-15
Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 38/242 (15%)
Query: 351 YNANRILGQGGQGTV-YKGMLADGRIVAVKKSKLVD-ENNVEQFIN----EVVILSQINH 404
Y +R+LG G GTV ++DG AVK +VD E E N EV L +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 405 RNIVKLLGCCLE------------TEVPLLVYEFVPNGTLYQNIHNHIEE---FPITWEL 449
+IVK C E + LV ++ G L Q I + + F
Sbjct: 91 FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR--SITVDQTH 507
LL I V L +H S + RDIKSANILL K+ DFG S+ + TV
Sbjct: 147 LLFIQV-----LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201
Query: 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE--DRSLVG 565
T GT YV PE ++ +++K+D++S GV+L E+LT ++P N++E ++L G
Sbjct: 202 GRT-FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260
Query: 566 YF 567
+
Sbjct: 261 RY 262
|
Length = 496 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK---SKLVDENNVEQFINEVVILSQINH 404
D+ + +G G G V+ A+K +++ + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
I++L + ++ E+VP G L+ + N F + L A E+ AL YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFY--ASEIVCALEYL 117
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS I RD+K NILLD + K++DFG ++ + D+T + GT Y+ PE
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVI 170
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
QS + D ++ G+++ E+L G P N
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 357 LGQGGQGTVYK-GMLADGRIVAVKK---SKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
LG+GG G V M A G++ A KK +L E + E IL++++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE--LLLRIAVEVSGALFYLHSAAS 469
+T+ L LV + G L +I+N EE P E A +SG L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG-LEHLHQR-- 116
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K N+LLD+ ++SD G + + Q+ T GT G++ PE Q ++
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEY 174
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRA 554
D ++ GV L E++ + P RA
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 7/196 (3%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416
LGQG G V+ G VA+K K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476
+ +V EF+ G+L + ++ + L+ +A +++ + Y+ I RD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
+++ANIL+ D K++DFG +R I ++ + + PE +FT KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 537 SFGVVLVEILT-GQKP 551
SFG++L E++T G+ P
Sbjct: 188 SFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 32/211 (15%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLG 412
+G G GTVYK + GR+ A+K E+ V Q E+ IL +NH N+VK
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK--- 136
Query: 413 CCLET-----EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
C + E+ +L+ EF+ G+L + H E+F L +A ++ + YLH
Sbjct: 137 -CHDMFDHNGEIQVLL-EFMDGGSL-EGTHIADEQF------LADVARQILSGIAYLHRR 187
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI--TVDQTHLTTKVQGTFGYVDPEYFQ 525
I RDIK +N+L++ K++DFG SR + T+D + + GT Y+ PE
Sbjct: 188 ---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV---GTIAYMSPERIN 241
Query: 526 SSQFTEK-----SDVYSFGVVLVEILTGQKP 551
+ D++S GV ++E G+ P
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 357 LGQGGQGTVYK------GMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
LG G G VYK G LA +++ K E +E ++ E+ IL+ NH IVKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 411 LGCCLETEVPLLVYEFVPNG---TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
LG ++ EF P G + + + E I +++ R +E AL YLH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLE---ALQYLH-- 127
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY---- 523
S+ I RD+K+ N+LL K++DFG S + V GT ++ PE
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 524 -FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ + + K+D++S G+ L+E+ + P +N
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 344 LEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQI 402
L T + ++G+G G VYK G++VA+K ++++ E E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKY 59
Query: 403 -NHRNIVKLLGCCLETEVPL------LVYEFVPNGT---LYQNIHNHIEEFPITWELLLR 452
NH NI G ++ P LV E G+ L + + + + E +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--RLKEEWIAY 117
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
I E L YLH I RDIK NILL K+ DFG S + T +
Sbjct: 118 ILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 513 QGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKP 551
GT ++ PE + + +SDV+S G+ +E+ G+ P
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 25/218 (11%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCC 414
LG+G TVYKG G IVA+K+ L +E I E+ ++ ++ H NIV+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 415 LETEVPL-LVYEFVPNG-TLYQNIHNHIEEFP------ITWELLLRIAVEVSGALFYLHS 466
+ TE L LV+E++ Y + H T++LL IA + H
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA--------FCHE 118
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
+ RD+K N+L++ + K++DFG +R+ + + +V T Y P+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLG 174
Query: 527 SQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
S+ ++ D++S G ++ E++TG +P+ +ED+ L
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLL 211
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 10/211 (4%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLGCC 414
LG G G V K ++ +K ++ Q I E+ +L + N IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ E + G+L Q + E I E+L ++++ V L YL I
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKHQI--MH 127
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RD+K +NIL++ + K+ DFG S + +D + GT Y+ PE Q + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 535 VYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565
++S G+ LVE+ G+ PI + E ++ G
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 92/361 (25%), Positives = 151/361 (41%), Gaps = 38/361 (10%)
Query: 326 LSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTV----YKGMLADGRIVAVKKS 381
L+ K ++ K + DL ++Y +++G+G G V +K + + K
Sbjct: 25 LNRYKDTINKIR-----DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 382 KLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIE 441
+++ ++ F E I++ N +V+L + +V E++P G L + N+
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-- 137
Query: 442 EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501
+ P W EV AL +HS I RD+K N+LLD K++DFGT +
Sbjct: 138 DVPEKWARFY--TAEVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKM 192
Query: 502 TVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINI 557
+ GT Y+ PE +S + + D +S GV L E+L G P A
Sbjct: 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--- 249
Query: 558 DEDRSLVGYFLQAMN-ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNL--NG----KN 610
SLVG + + MN +N L D + KEA+ + A L R + L NG K
Sbjct: 250 ---DSLVGTYSKIMNHKNSLTFPDDNDISKEAKN---LICAFLTDREVRLGRNGVEEIKR 303
Query: 611 RPTMKEVAFELGGIRASIGASILQQNCGVIDCVN-GDISEHYLESDLVSMGTSILNNSAA 669
K + +R ++ A ++ ID N DI E E + + + + N
Sbjct: 304 HLFFKNDQWAWETLRDTV-APVVPDLSSDIDTSNFDDIEEDKGEEETFPIPKAFVGNQLP 362
Query: 670 F 670
F
Sbjct: 363 F 363
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQI 402
++N +LG+G G V MLA+ + I +KK ++ +++VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57
Query: 403 NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ L C +T L V E+V G L I + F + A E++ L
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFY--AAEIAIGL 114
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV-QGTFGYVD 520
F+LHS I RD+K N++LD + K++DFG + D +TTK GT Y+
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIA 169
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
PE + + D ++FGV+L E+L GQ P + DE
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 18/199 (9%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENN--VEQFINEVVILSQINHRNIVKLLGC 413
+G+G G VYK G +VA+KK +L E I E+ +L ++NH NIVKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 414 CLETEVPL-LVYEFVPNGTLYQNIHNHIEEFP---ITWELLLRIAVEVSGALFYLHSAAS 469
+ TE L LV+EF L+Q++ ++ P I L+ ++ L + HS
Sbjct: 68 -IHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH-- 119
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
+ RD+K N+L++ + K++DFG +R+ V T +V T Y PE ++
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKY 177
Query: 530 -TEKSDVYSFGVVLVEILT 547
+ D++S G + E++T
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 44/300 (14%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNV-EQFINEVVILS 400
D EK + LG G G V K + G I+A K L + + Q I E+ +L
Sbjct: 2 DFEKLGE-------LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH 54
Query: 401 QINHRNIVKLLGCCL-ETEVPLLVYEFVPNGTLYQNIHN--HIEEFPITWELLLRIAVEV 457
+ N IV G + E+ + + E + G+L Q + I E +L +I++ V
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE-----NILGKISIAV 108
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
L YL I RD+K +NIL++ + K+ DFG S + +D + GT
Sbjct: 109 LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRS 163
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA------- 570
Y+ PE Q + +T +SD++S G+ LVE+ G+ PI + E ++ G +
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223
Query: 571 -------MNENR---LFEVLDALVLKEAER--EEIMT--VATLAKRCLNLNGKNRPTMKE 616
+ R +FE+LD +V + + + +CL N K R +KE
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 355 RILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
++LG+G G V MLA+ + I A+KK ++++++VE + E +L+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 408 VKLLGCCLETEVPLL-VYEFVPNGTLYQNIHN--HIEEFPITWELLLRIAVEVSGALFYL 464
+ L C +T+ L V E++ G L +I + +E + A E+ L +L
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-----YAAEIICGLQFL 112
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFGYVDPEY 523
H I RD+K N+LLD K++DFG + ++ + + GT Y+ PE
Sbjct: 113 HKKGIIY---RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEI 167
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ ++ E D +SFGV+L E+L GQ P + DE
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 356 ILGQGGQGTVYKGML-ADG-RI-VAVKKSK-LVDENNVEQFINEVVILSQIN-HRNIVKL 410
++G+G G V K + DG R+ A+K+ K +++ F E+ +L ++ H NI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNH--IEEFP-----------ITWELLLRIAVEV 457
LG C L E+ P+G L + +E P ++ + LL A +V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
+ + YL I RD+ + NIL+ + Y AK++DFG SR V V+ T G
Sbjct: 134 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 183
Query: 518 -----YVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547
++ E S +T SDV+S+GV+L EI++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL 415
+G G G VYK L G + AVK KL ++ E+ ++ + H NIV G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475
E + E+ G+L Q+I+ H+ P++ + + E L YLHS + R
Sbjct: 77 SREKLWICMEYCGGGSL-QDIY-HVTG-PLSELQIAYVCRETLQGLAYLHSKGKM---HR 130
Query: 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF---QSSQFTEK 532
DIK ANILL D K++DFG + IT + + GT ++ PE ++ + +
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYNQL 189
Query: 533 SDVYSFGVVLVEILTGQKPI 552
D+++ G+ +E+ Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 64/218 (29%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQI 402
++N +LG+G G V MLA+ + I +KK ++ +++VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 403 NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ + L C +T L V E+V G L +I + +F + A E+S L
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGL 114
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
F+LH I RD+K N++LD + K++DFG + VD T GT Y+ P
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRTFCGTPDYIAP 170
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
E + + D +++GV+L E+L GQ P + DE
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 70/269 (26%), Positives = 122/269 (45%), Gaps = 48/269 (17%)
Query: 376 VAVK--KSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432
VAVK K D++ + ++E+ ++ I H+NI+ LLG C + ++ E+ G L
Sbjct: 47 VAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 433 YQNIHNH-------------IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKS 479
+ + + E +T++ L+ A +V+ + YL S I RD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162
Query: 480 ANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 538
N+L+ + K++DFG +R + +D TT + ++ PE +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 539 GVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVA 597
GV+L EI T G P I ++E LF+ +LKE R +
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEE----------------LFK-----LLKEGHRMDKPANC 261
Query: 598 T-----LAKRCLNLNGKNRPTMKEVAFEL 621
T + + C + RPT K++ +L
Sbjct: 262 THELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 71/283 (25%), Positives = 135/283 (47%), Gaps = 45/283 (15%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL--- 410
R LG G G V+ + +D + VAVKK L D +V+ + E+ I+ +++H NIVK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 411 -----------LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
+G E +V E++ ++ N +E+ P++ E ++
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-----DLANVLEQGPLSEEHARLFMYQLLR 125
Query: 460 ALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQG--TF 516
L Y+HSA ++ RD+K AN+ ++ + K+ DFG +R + +H +G T
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 517 GYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
Y P + +T+ D+++ G + E+LTG KP+ A + L+ M
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHE---------LEQMQ--- 229
Query: 576 LFEVLDAL-VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+L+++ V++E +R E++ V + N G+ R ++++
Sbjct: 230 --LILESVPVVREEDRNELLNV--IPSFVRNDGGEPRRPLRDL 268
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVKK--SKLVDENNVEQF-INEVVILSQINHRNIVKL 410
R+LG+GG G V + A G++ A KK K + + E +NE IL ++N R +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
ET+ L LV + G L +I+N + + + A E+ L L
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K NILLDD+ ++SD G + I +T + +V GT GY+ PE + ++
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKY 178
Query: 530 TEKSDVYSFGVVLVEILTGQKPIR 553
T D + G ++ E++ GQ P R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 7/199 (3%)
Query: 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
+ LG G G V+ VAVK K +VE F+ E ++ + H +VKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+ E ++ EF+ G+L + + E L+ + +++ + ++ I
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 124
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RD+++ANIL+ K++DFG +R I ++ + + PE FT KS
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 534 DVYSFGVVLVEILT-GQKP 551
DV+SFG++L+EI+T G+ P
Sbjct: 185 DVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNV-EQFINEVVILSQINHR 405
D Y +G+G G VYK G++VA+KK++L +DE + + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 406 N-IVKLLGCCLETEVPL------LVYEFVPNG------TLYQNIHNHIEEFPI---TWEL 449
IV+LL E LV+E++ + + + + I ++L
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHL 508
L +A + H + RD+K N+L+D K K++D G R+ ++
Sbjct: 120 LKGVA--------HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY 168
Query: 509 TTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 549
T ++ T Y PE S+ ++ D++S G + E+ Q
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 69/237 (29%), Positives = 110/237 (46%), Gaps = 35/237 (14%)
Query: 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGR---IVAVKKSKLVDENNVE 390
E +LF +D EK + R +G G G VY D R +VA+KK + + E
Sbjct: 13 EIAELFFKEDPEKL---FTDLREIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNE 67
Query: 391 QF---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-VPNGTLYQNIHNH-IEEFPI 445
++ I EV L +I H N ++ GC L LV E+ + + + +H ++E
Sbjct: 68 KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE--- 124
Query: 446 TWELLLRIAVEVSGAL---FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502
+ IA GAL YLHS I RDIK+ NILL + + K++DFG++ +
Sbjct: 125 -----VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIAS 176
Query: 503 VDQTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ + GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 177 PANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 58/245 (23%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
D++ +++G+G G V+ L G++ A+K KS ++ N + E IL+
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTL------YQNIHNHIEEFPITWELLLRIA 454
+ IVKL + E L LV E++P G L F I EL+L A
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVL--A 113
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI------------- 501
++ L ++H RDIK NIL+D K++DFG + +
Sbjct: 114 LDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 502 ------TVDQTHLTTKVQ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
Q GT Y+ PE + + + + D +S GV+L E+L
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 547 TGQKP 551
G P
Sbjct: 225 YGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGC 413
+G+G G VYK G IVA+KK +L DE I E+ +L ++NH NIV+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 414 CLETEVPLLVYEFVPNGTLYQNIH---NHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
LV+EF L ++ + + L+ ++ + Y HS
Sbjct: 67 VHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--- 118
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSSQF 529
+ RD+K N+L+D + K++DFG +R+ V T +V T Y PE S Q+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 530 TEKSDVYSFGVVLVEILTGQKPI 552
+ D++S G + E++ ++P+
Sbjct: 178 STPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-13
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 64/229 (27%)
Query: 357 LGQGGQGTVYKGMLAD---GRIVAVKKSKLVDENNVEQFIN---------EVVILSQI-N 403
LG+G G V+K + D +VA+KK + D F N E++ L ++ +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKK--IFD-----AFRNATDAQRTFREIMFLQELGD 65
Query: 404 HRNIVKLLGCCLETEVP--------LLVYEF-------VPNGTLYQNIHNHIEEFPITWE 448
H NIVKLL V LV+E+ V + +++H I ++
Sbjct: 66 HPNIVKLL------NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY----IMYQ 115
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
LL AL Y+HS I RD+K +NILL+ R K++DFG +RS++ + +
Sbjct: 116 LL--------KALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164
Query: 509 TTKVQ----GTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
V T Y PE S+++T+ D++S G +L E+L G KP+
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 356 ILGQGGQGTVYKGMLADG-----RIVAVKKSKLVDENNVEQ---FINEVVILSQINHRNI 407
+L +G G ++ G+L D V VK + D + Q + E +L ++H+NI
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 408 VKLLGCCLE-TEVPLLVYEFVPNGTL--YQNIHNHIEEFP---ITWELLLRIAVEVSGAL 461
+ +L C+E E P ++Y ++ G L + E ++ + L+ +A++++ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVD 520
YLH + +DI + N ++D++ + K++D SR + H L ++
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559
E + +++ SDV+SFGV+L E++T GQ P I+ E
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 355 RILGQGGQGTVY----KGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
++LG+G G V+ KG I A+KK ++ +++VE + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 411 LGCCLETEVPLL-VYEFVPNGTLYQNIHN-HIEEFPITWELLLRIAVEVSGALFYLHSAA 468
L C +T+ L V E++ G L +I + H + P A E+ L +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA----TFYAAEIICGLQFLHSKG 116
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
I RD+K NILLD K++DFG + + T GT Y+ PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQK 172
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D +SFGV+L E+L GQ P + +E
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 32/243 (13%)
Query: 362 QGTVYKGMLADGRIVA--VKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419
G ++GM + R+V ++ S DE F+ EV ++NH N+++ LG C+E+
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 420 PLLVYEFVPNGTLYQNIHN---HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476
LLV EF P G L + + + + ++L R+A EV+ L +LH A I D
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRMACEVASGLLWLHQADFIHS---D 125
Query: 477 IKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG--YVDPEYFQSSQ------ 528
+ N L K+ D+G + + + TK ++ PE +
Sbjct: 126 LALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPK 184
Query: 529 -FTEKSDVYSFGVVLVEI----------LTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
T+KS+++S GV + E+ L+ ++ ++ + ++D L L +R +
Sbjct: 185 DQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWY 244
Query: 578 EVL 580
EV+
Sbjct: 245 EVM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 357 LGQGGQGTVYKG--MLADGRIVAVKKSKL--VDENNVEQFINEVVILSQIN---HRNIVK 409
+G+G G V+K + GR VA+K+ ++ +E I EV +L + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 410 LLGCCL------ETEVPLLVYEFVPNGTLYQNIHNHIEEFP---ITWELLLRIAVEVSGA 460
L C ET++ L V+E V Q++ ++++ P + E + + ++
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHVD-----QDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
L +LHS + RD+K NIL+ + K++DFG +R + T V T Y
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRA 177
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR 561
PE S + D++S G + E+ +KP+ + D D+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 59/234 (25%), Positives = 100/234 (42%), Gaps = 49/234 (20%)
Query: 354 NRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENN----VEQFIN----------EVVI 398
LG+G G V K G+IVA+KK K+++ +N Q + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHI-----EEFPITWELLLRI 453
+++I H NI+ L+ +E + LV + + L + + I + I ++L +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGL 132
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD--------- 504
V LH RD+ ANI ++ K K++DFG +R
Sbjct: 133 NV--------LHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 505 -----QTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ +T+KV T Y PE + ++ D++S G + E+LTG KP+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 361 GQGTVYKGMLA----DGRIVAVKKSKLVDENNVE--QFINEVVILSQINHRNIVKLLGCC 414
G+G+ K +L DG+ +K+ + + E + EV +LS + H NIV+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
E +V ++ G LY+ I N + +L V++ AL ++H I
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHDR---KILH 124
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSD 534
RDIKS NI L K+ DFG +R + L GT Y+ PE ++ + KSD
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPYNNKSD 183
Query: 535 VYSFGVVLVEILTGQKPIRAINI 557
+++ G VL E+ T + A N+
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 361 GQGTVYKGMLA----DGRIVAVKK-SKLVDENNVEQ---FINEVVILSQINHRNIVKLLG 412
G+G+ K +LA DG+ AVK K + N EQ V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASIS 471
TE V +FV G L+ ++ FP E R A E++ AL YLHS I+
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQRE-RSFP---EPRARFYAAEIASALGYLHS---IN 116
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
I RD+K NILLD + ++DFG + + Q+ TT GT Y+ PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 532 KSDVYSFGVVLVEILTGQKPIRAINIDE 559
D + G VL E+L G P ++ E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 378 VKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH 437
+KK +++ V+ E IL +++H IV ++ + + EFV G L+ ++
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 438 ------NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491
N + +F E+ A YLHS I RD+K N+LLD+K K
Sbjct: 111 KAGRFPNDVAKF---------YHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVK 158
Query: 492 VSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
V+DFG ++ + D+T + GT Y+ PE QS + D ++ GV+L E + G P
Sbjct: 159 VTDFGFAKKVP-DRTF---TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 44/301 (14%)
Query: 349 DNYNANRILGQGGQGTVY----KGMLADGRIVA---VKKSKLVDENNVEQFINEVVILSQ 401
+++ ++G+G G V K A G I A +KKS L+ + V F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
N I +L + + LV E+ P G L ++ + ++F + A
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF------------DEDMAQ 105
Query: 462 FYL-------HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG 514
FYL HS + RDIK N+L+D K++DFG++ +T ++ + G
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVG 165
Query: 515 TFGYVDPEYFQSSQFTEKS------DVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568
T Y+ PE + K D +S GV+ E++ G+ P E S Y
Sbjct: 166 TPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP-----FHEGTSAKTYN- 219
Query: 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNG-KNRPTMKEVAFELGGIRAS 627
MN R + + + + I ++ K L G P ++ + IR S
Sbjct: 220 NIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKI--DWNNIRNS 277
Query: 628 I 628
+
Sbjct: 278 L 278
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRN 406
D+Y LG+G TVYKG +G++VA+K +L +E I E +L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLH 465
IV L E LV+E+V + L Q + H P +L L ++ L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YF 524
I RD+K N+L+ D K++DFG +R+ +V +H + T Y P+
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176
Query: 525 QSSQFTEKSDVYSFGVVLVEILTG 548
S++++ D++ G + VE++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 46/270 (17%)
Query: 356 ILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVILSQIN---HR 405
+LG+G G V +LA+ + I A+KK ++ + VE + E I N H
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 406 NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
+V L C +TE + V E+ G L +IH + F + A V L YL
Sbjct: 63 FLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFY--AACVVLGLQYL 117
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS-ITVDQTHLTTKVQGTFGYVDPEY 523
H I RD+K N+LLD + K++DFG + + T+ GT ++ PE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+ +T D + GV++ E+L G+ P DE+ EV D++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPG--DDEE-----------------EVFDSI 213
Query: 584 VLKEAEREEIMTVATLA--KRCLNLNGKNR 611
V E ++ ++ +R L N + R
Sbjct: 214 VNDEVRYPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 60/212 (28%), Positives = 87/212 (41%), Gaps = 28/212 (13%)
Query: 359 QGGQGTVYKGMLADGR-------IVAVKKSKLVDENNVEQFINEVVIL-SQINHRNIVKL 410
+G G+VY LA R I +KKS ++ +N V E I+ Q + KL
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 411 LGCCLETEVPLLVYEFVPNG---TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
+ LV E++ G +L + + P W + EV + LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGG----LPEDW--AKQYIAEVVLGVEDLHQR 116
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
I RDIK N+L+D K++DFG SR+ ++ K GT Y+ PE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGV 168
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ SD +S G V+ E L G P A D
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 350 NYNANRILGQGGQGTVY----KGMLADGRIVAVK---KSKLVDE-NNVEQFINEVVILSQ 401
N+ R+LG G G V+ G G++ A+K K+ +V + E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSG 459
+ + L +T+ L L+ ++V G L+ +++ E F E +R+ + E+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT---ESEVRVYIAEIVL 116
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
AL +LH + I RDIK NILLD + ++DFG S+ ++ GT Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 520 DPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 551
PE + S + D +S GV+ E+LTG P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQF---INEVVILSQINHRNIVKLLG 412
+G G G VY + +VAVKK + E++ I EV L Q+ H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 413 CCLETEVPLLVYEF-VPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGAL---FYLHSA 467
C L+ LV E+ + + + +H ++E + IA GAL YLHS
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE--------VEIAAITHGALQGLAYLHSH 140
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY---F 524
I RDIK+ NILL + + K++DFG++ + + + GT ++ PE
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-13
Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNV--EQFINEVVILSQINHRN 406
Y+ R++G+GG G VY R VA+KK + + EN + ++F+ E I + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL--------LLRIAVEVS 458
IV + C + + ++ TL + + ++ ++ EL L I ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT-------- 510
+ Y+HS + RD+K NILL + D+G + +++ L
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 511 ---------KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553
K+ GT Y+ PE +E +D+Y+ GV+L ++LT P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 78/311 (25%), Positives = 129/311 (41%), Gaps = 86/311 (27%)
Query: 328 SNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK----GMLADGRI--VAVKKS 381
+N + ++ T+L ++ E DN + LG G G V + G+ + + VAVK
Sbjct: 17 NNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML 76
Query: 382 KL-VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTL------- 432
K + E ++E+ ILS + H+NIV LLG C L++ E+ G L
Sbjct: 77 KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
Query: 433 --------------------YQNIH------------------NHIEEFPIT-------- 446
Y+NI ++E P++
Sbjct: 137 AETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196
Query: 447 ----------WEL----LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492
W L LLR + +V+ + +L S I RD+ + N+LL D AK+
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKI 253
Query: 493 SDFGTSRSITVDQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT- 547
DFG +R I D ++ V+G ++ PE +T +SDV+S+G++L EI +
Sbjct: 254 CDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 310
Query: 548 GQKPIRAINID 558
G+ P I ++
Sbjct: 311 GKSPYPGILVN 321
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 356 ILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLL 411
I+G+GG G VY AD G++ A+K K ++ + +NE ++LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 412 GCCLETEVP---LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSA 467
P + + + G L H H+ + + E +R A E+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFYATEIILGLEHMHN- 115
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS- 526
+YR D+K ANILLD+ ++SD G + + + H + GT GY+ PE Q
Sbjct: 116 -RFVVYR-DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIR 553
+ + +D +S G +L ++L G P R
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 355 RILGQGGQGTVYKGMLADG----RIVAVK---KSKLV-DENNVEQFINEVVILSQINHRN 406
++LG+GG G V++ G +I A+K K+ +V ++ + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 407 IVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSGALFYL 464
IV L+ +T L L+ E++ G L+ H+E I E + E+S AL +L
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFM----HLEREGIFMEDTACFYLSEISLALEHL 116
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
H I RD+K NILLD + K++DFG + ++ + +T GT Y+ PE
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEIL 172
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
S + D +S G ++ ++LTG P A N
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 345 EKATDNYNANRILGQGGQGTVYK-GMLADGRIVAVKKSKLVDENNVE-QFINEVVILSQI 402
E D++ LG G G V+K G I+A K L + + Q I E+ +L +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
N IV G + E + G+L Q + + I ++L ++++ V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLT 117
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
YL I RD+K +NIL++ + K+ DFG S + +D + GT Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Q + ++ +SD++S G+ LVE+ G+ PI
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 25/241 (10%)
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIV-AVK---KSKLVDENNVEQFINEVV 397
L ++++ +++G+G G V + V A+K K +++ ++ F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVE 456
I++ N IV+L + + L +V E++P G L + N+ + P W E
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFY--TAE 150
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD-QTHLTTKVQGT 515
V AL +HS I RD+K N+LLD K++DFGT + + T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 516 FGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571
Y+ PE +S + + D +S GV L E+L G P A SLVG + + M
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA------DSLVGTYSKIM 260
Query: 572 N 572
+
Sbjct: 261 D 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGC 413
LG G G VYK + ++A +K++D E +E ++ E+ IL+ +H NIVKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
++ EF G + + +E P+T + + + AL YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAV-DAVMLELER-PLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 474 RRDIKSANILLDDKYRAKVSDFGTS----RSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
RD+K+ NIL K++DFG S R+I + + T V E + +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAIN 556
K+DV+S G+ L+E+ + P +N
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 11/203 (5%)
Query: 355 RILGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNVEQ---FINEVVILSQINHRNIVK 409
RILG G G + +G L R + V L + +Q F+ E + L Q +H NIV+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L G ++V E++ NG L + H E + L+ + ++ + YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYL---SE 125
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
+ + + + +L++ K+S F + + + T + + PE Q F
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 530 TEKSDVYSFGVVLVEILT-GQKP 551
+ SDV+SFG+V+ E+++ G++P
Sbjct: 186 SSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 15/236 (6%)
Query: 324 QELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRI--VAVK-- 379
+ L +K + + + +++N R LG G G V + VA+K
Sbjct: 5 KNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF 64
Query: 380 -KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN 438
KSK++ + V+ +E IL+ INH V L G + LV EFV G + +
Sbjct: 65 EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR 124
Query: 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
+ + FP ++ A ++ YL S++I RD+K N+LLD K++DFG +
Sbjct: 125 N-KRFPN--DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
Query: 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
+ + T + GT Y+ PE + + +D ++ G+ + EIL G P A
Sbjct: 179 KVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDE--------NNVEQFINEVVILSQINHRNIV 408
LG+G GTVY ++ D + VA ++ K++ E N Q E +LS+++H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 409 KLLGCCLETEVPLLVYEFVPNGTL---YQNIHNHIEEFP----ITWELLLRIAVEVSGAL 461
K LE + ++ E+ L + + + + W + L + V
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
Y+H I RD+K+ NI L + K+ DFG SR + + L T GT Y+ P
Sbjct: 121 -YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSR-LLMGSCDLATTFTGTPYYMSP 174
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEI 545
E + + KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 31/235 (13%)
Query: 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF 392
+ +LF D EK + R +G G G VY + + +VA+KK + + E++
Sbjct: 3 DVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 393 ---INEVVILSQINHRNIVKLLGCCLETEVPLLVYEF-VPNGTLYQNIHNH-IEEFPITW 447
I EV L ++ H N ++ GC L LV E+ + + + +H ++E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE----- 114
Query: 448 ELLLRIAVEVSGAL---FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504
+ IA GAL YLHS I RD+K+ NILL + K+ DFG++ +
Sbjct: 115 ---VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 505 QTHLTTKVQGTFGYVDPEY---FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ GT ++ PE Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 169 NXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 31/222 (13%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVIL---SQINHRNIV 408
+G G GTVYK G VA+K ++ + N + + EV +L +H NIV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 409 KLLGCCL------ETEVPLLVYEFVPNGTLYQNIHNHIEEFP---ITWELLLRIAVEVSG 459
+L+ C ET+V L V+E V Q++ ++++ P + E + + +
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
L +LH+ I RD+K NIL+ + K++DFG +R I Q LT V T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV-TLWYR 174
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR 561
PE S + D++S G + E+ +KP+ N + D+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFI--NEVVILSQINHRNIVKLLGC 413
+G+G G V+K + G+IVA+KK +++ V + I E+ +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFP----------ITWELLLRIAVEVSGALFY 463
LV+E+ + L N +E+ P I W+ L A+ +
Sbjct: 69 FRRKRKLHLVFEYCDHTVL-----NELEKNPRGVPEHLIKKIIWQTLQ--------AVNF 115
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
H I RD+K NIL+ + + K+ DFG +R +T T V T Y PE
Sbjct: 116 CHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPEL 171
Query: 524 F-QSSQFTEKSDVYSFGVVLVEILTGQ 549
+Q+ DV++ G V E+LTGQ
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLG 412
+ + K +VAVKK L + +++ E++ Q+ H NI+ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEE-FPITWELLLR-IAVEVSGALFYLHSAASI 470
+ +V + G+ + H E P EL + I +V AL Y+HS I
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKGFI 123
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSIT---------VDQTHLTTKVQGTFGYVDP 521
R +K+++ILL + +S S S+ D + K ++ P
Sbjct: 124 ---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSP 177
Query: 522 EYFQSS--QFTEKSDVYSFGVVLVEILTGQKP 551
E Q + + EKSD+YS G+ E+ G P
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINE-VVILSQINHRNIVK 409
+++G+G G V ADG+ AVK K ++ + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAA 468
L + V ++V G L+ ++ FP E R A E++ AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFP---EPRARFYAAEIASALGYLHS-- 114
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
++I RD+K NILLD + ++DFG + ++ + T+ GT Y+ PE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D + G VL E+L G P + + E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQIN 403
Y +GQG G V+K +IVA+KK + EN E F + E+ IL +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM--ENEKEGFPITALREIKILQLLK 69
Query: 404 HRNIVKLLGCCLETEVP--------LLVYEFVPN---GTL-YQNIHNHIEEFPITWELLL 451
H N+V L+ C P LV+EF + G L +N+ + E ++LL
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI---TVDQTHL 508
+G L+Y+H I RD+K+ANIL+ K++DFG +R+ + +
Sbjct: 130 ------NG-LYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 509 TTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
T T Y PE + D++ G ++ E+ T + PI
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 349 DNYNA-NRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQI 402
D Y NRI +G G VY+ G IVA+KK K+ E E F + E+ IL ++
Sbjct: 5 DEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKL 61
Query: 403 NHRNIVKLLGCCLETEVPL--------LVYEFVPNGTLYQNIHNHIEEFPI------TWE 448
H NIV + EV + +V E+V + L + + F +
Sbjct: 62 QHPNIVTV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQ 114
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
LL +A +LH I RD+K++N+LL+++ K+ DFG +R
Sbjct: 115 LLSGVA--------HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 509 TTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
T V T Y PE + +++ D++S G + E+LT +KP+
Sbjct: 164 TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 350 NYNANRILGQGGQGTVY---KGMLAD-GRIVAVK---KSKLVD-ENNVEQFINEVVILSQ 401
N+ ++LG G G V+ K D G++ A+K K+ LV VE E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSG 459
+ + L +TE L L+ ++V G ++ +++ + F E +R E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFS---EDEVRFYSGEIIL 116
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
AL +LH + I RDIK NILLD + ++DFG S+ ++ T GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 520 DPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKP 551
PE + K+ D +S G+++ E+LTG P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
D Y +G+G G VYK +A+KK +L DE I E+ +L ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP-----------ITWELLLRIA 454
NIV+L + LV+E+ L ++ H++ P +++L IA
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA-KVSDFGTSRSITVDQTHLTTKVQ 513
Y HS + RD+K N+L+D + A K++DFG +R+ + T +V
Sbjct: 117 --------YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 514 GTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
T Y PE S ++ D++S G + E++ QKP+
Sbjct: 166 -TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 37/273 (13%)
Query: 355 RILGQGGQGTV-YKGMLADGRIVAVKKSKLVDENNVEQFI--NEVVILSQINHRNIVKLL 411
R++G+G G V DG+ +KK L + + E+ E +LSQ+ H NIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 412 GCCLETEVPLL--VYEFVPNGTLYQNIHNH-----IEEFPITWELLLRIAVEVSGALFYL 464
E E LL V F G LY + E + W V+++ AL YL
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQYL 118
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
H I RD+K+ N+ L KV D G +R + +Q + + + GT Y+ PE F
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELF 174
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+ + KSDV++ G + E+ T + A N + SLV ++
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSLVYRIIEGK------------- 218
Query: 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L ++ + L L+ + RP++K +
Sbjct: 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQ-FINEVVILSQINHRN 406
Y +G+G G V G VA+KK + Q + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 407 IVKLLGC----CLET--EVPLLVYEFVPNGTLY-----QNIHN-HIEEFPITWELLLRIA 454
I+ +L E+ +V +V E + LY Q++ N HI+ F +++L R
Sbjct: 65 IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--LYQIL-R-- 117
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH---LTTK 511
L Y+HSA ++ RD+K +N+LL+ K+ DFG +R + H LT
Sbjct: 118 -----GLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 512 VQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
V T Y PE S +T+ D++S G +L E+L+ +P+
Sbjct: 170 V-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 25/217 (11%)
Query: 357 LGQGGQGTVYKGML---ADG---RIVAVKKSKLVDENNV-EQFINEVVILSQINHRNIVK 409
LG+ G VYKG L A G + VA+K K E + E+F +E ++ S++ H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNI-----HNHI----EEFPITWEL----LLRIAVE 456
LLG + + +++ + + L++ + H+ + ++ + L + I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI-TVDQTHLTTKVQGT 515
++ + +L +S + +D+ + N+L+ DK K+SD G R + D L
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVA---VKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
R++G+G V L RI A VKK + D+ +++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 411 LGCCLETEVPLL-VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L C +TE L V E+V G L ++ + P E + E+S AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYSAEISLALNYLHERG- 116
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K N+LLD + K++D+G + + T+ GT Y+ PE + +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAINIDE--DRSLVGYFLQAMNENRLFEVLDALVLKE 587
D ++ GV++ E++ G+ P + + D++ Y Q + E ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223
Query: 588 AEREEIMTVATLAKRCLNLNGKNR 611
R + A++ K LN + K R
Sbjct: 224 IPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKK---SKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
LG+GG G V + + G++ A KK +L ++ + + E IL ++N IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
E++ L LV + G L +I+ ++ E + E ++ + +++ + +LHS +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
I RD+K N+LLDD+ ++SD G ++ + T+ GT GY+ PE + ++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 532 KSDVYSFGVVLVEILTGQKPIR 553
D ++ G + E++ G+ P +
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLG 412
++G G G VYKG + G++ A+K + +E ++Q IN + S +HRNI G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70
Query: 413 CCLETEVP------LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
++ P LV EF G++ I N + + E + I E+ L +LH
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQ 129
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIK N+LL + K+ DFG S + T + GT ++ PE
Sbjct: 130 HKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIAC 185
Query: 527 SQ-----FTEKSDVYSFGVVLVEILTGQKPI 552
+ + KSD++S G+ +E+ G P+
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 55/187 (29%), Positives = 88/187 (47%), Gaps = 19/187 (10%)
Query: 376 VAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQN 435
V K L DE +E+ L+ +H IVK + LL+ E+ G L +
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 436 IHNHIEEFPITWELLLRIAVEVSGALFY-----LHSAASISIYRRDIKSANILLDDKYRA 490
I ++E L G LFY L S + RD+KSANI L
Sbjct: 156 IKQRLKEH-------LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGII 208
Query: 491 KVSDFGTSR----SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
K+ DFG S+ S+++D + + GT Y+ PE ++ ++++K+D++S GV+L E+L
Sbjct: 209 KLGDFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 547 TGQKPIR 553
T +P +
Sbjct: 266 TLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 40/213 (18%)
Query: 355 RILGQGGQGT---VYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN------- 403
+ILG+ G+GT V K G+ A+K K + + +V L +I
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-----KHFKSLEQVNNLREIQALRRLSP 56
Query: 404 HRNIVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAV 455
H NI++L+ + T LV+E + + LY+ I P ++LL
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLK---- 111
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
+L ++H I+ RDIK NIL+ D K++DFG+ R I + T+ T
Sbjct: 112 ----SLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYIST 161
Query: 516 FGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILT 547
Y PE + + K D+++ G V EIL+
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/242 (25%), Positives = 104/242 (42%), Gaps = 17/242 (7%)
Query: 355 RILGQGGQGTVYKGMLADGRIV----AVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
R++G+G V L + VKK + D+ +++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L C +T L LV E+V G L ++ + P E A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP--EEHARFYAAEICIALNFLHERG- 116
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
I RD+K N+LLD K++D+G + + T+ GT Y+ PE + ++
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEEY 173
Query: 530 TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-----RLFEVLDALV 584
D ++ GV++ E++ G+ P I + D + Y Q + E R V + V
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHV 233
Query: 585 LK 586
LK
Sbjct: 234 LK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 356 ILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
I+G+GG G VY AD G++ A+K +D+ ++ E + L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLAL---NERIMLSLVST- 53
Query: 415 LETEVPLLV---YEF-VPNGTLY-------QNIHNHIEEFPITWELLLRI-AVEVSGALF 462
+ P +V Y F P+ + ++H H+ + + E +R A E+ L
Sbjct: 54 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
++H+ +YR D+K ANILLD+ ++SD G + + + H + GT GY+ PE
Sbjct: 112 HMHN--RFVVYR-DLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPE 165
Query: 523 YFQSS-QFTEKSDVYSFGVVLVEILTGQKPIR 553
Q + +D +S G +L ++L G P R
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 37/215 (17%)
Query: 357 LGQGGQGTVYKGML--ADGRIVAVKKSKL-VDENNVEQFINEV-VILSQINHRNIVKLLG 412
LG+G G V K M G I+AVK+ + V+ ++ + ++ + + ++ V G
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 413 C---------CLETEVPLLVYEFVPNGTLYQNIHNH---IEEFPITWELLLRIAVEVSGA 460
C+E L +F Y+ +++ I E ++L +IAV + A
Sbjct: 68 ALFREGDVWICMEVMDTSL-DKF------YKKVYDKGLTIPE-----DILGKIAVSIVKA 115
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
L YLHS +S+ RD+K +N+L++ + K+ DFG S + VD T G Y+
Sbjct: 116 LEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDA-GCKPYMA 171
Query: 521 PEYF----QSSQFTEKSDVYSFGVVLVEILTGQKP 551
PE + KSDV+S G+ ++E+ TG+ P
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 61/228 (26%), Positives = 110/228 (48%), Gaps = 30/228 (13%)
Query: 357 LGQGGQGTVYKGM---LADGRIVAVKKS--KLVDE---NNVEQFINEVVILSQINHRNIV 408
LGQG ++KG+ + D + + K++D+ N E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
G C+ + ++V E+V G+L + + I+W+ L +A +++ AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLEDK- 119
Query: 469 SISIYRRDIKSANILL----DDKYRA----KVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
+ ++ + N+LL D K K+SD G SITV + + +V
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLE---RIPWVP 172
Query: 521 PEYFQSSQ-FTEKSDVYSFGVVLVEILTG-QKPIRAINIDEDRSLVGY 566
PE ++ Q + +D +SFG L EI +G KP+ A +D + L Y
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA--LDSQKKLQFY 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDE-NNVEQFINEVVILSQINHR 405
Y +G G G V + G+ VA+KK D ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 406 NIVKLLGCCLETEVPL-----LVYEFVPNGTLYQNIHN-------HIEEFPITWELLLRI 453
NI+ + L +V + + + L+ IH+ HI F LLR
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQ---LLR- 118
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI----TVDQTHLT 509
L Y+HSA ++ RD+K +N+L+++ ++ DFG +R + T + +T
Sbjct: 119 ------GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 510 TKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
V T Y PE ++T D++S G + E+L G++ +
Sbjct: 170 EYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHRNI 407
Y + +G G QG V G VAVKK ++ + ++ E+V+L +NH+NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 408 VKLLGCCL------ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ LL E + LV E + + L Q IH ++ +++ LL ++ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLCGIK--- 137
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
+LHSA I RD+K +NI++ K+ DFG +R T + T T Y P
Sbjct: 138 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAP 191
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTG 548
E + E D++S G ++ E++ G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 357 LGQGGQGTVYKGMLADG-RIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G V + D RI A+K K+ +V + V + E +L+Q+N IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIH-----NHIEEFPITWELLLRIAVEVSGALFYLHSA 467
E LV F+ G L+ ++ + T ELL AL LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLC--------ALENLHK- 111
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
++ RD+K NILLD + + DFG + + + T GT Y+ PE
Sbjct: 112 --FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+T+ D ++ GV+L E+LTG P N++E
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGR-------IVAVKKSKLVDE-NNVEQFINEVVILSQ 401
N+ ++LG G G V+ G + +KK+ +V + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
I + L +T+ L L+ +++ G L+ ++ E F E+ + E+ A
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFK-EQEVQIYSG-EIVLA 117
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
L +LH + I RDIK NILLD ++DFG S+ D+ GT Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 521 PEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKP 551
P+ + + D +S GV++ E+LTG P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENN-VEQF-INEVVILSQINHRNIVKLLGC 413
+G+G GTV+K + IVA+K+ +L D++ V + E+ +L ++ H+NIV+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 414 CLETEVPLLVYEFVP----------NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
+ LV+E+ NG + I ++ F ++LL +A +
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI---VKSF--MFQLLKGLA--------F 114
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE- 522
HS ++ RD+K N+L++ K++DFG +R+ + + +V T Y P+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDV 170
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
F + ++ D++S G + E+ +P+
Sbjct: 171 LFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 63/263 (23%)
Query: 356 ILGQGGQGT---VYKGML---ADGRIVAVKKSKLVDENNVEQF-------INEVVILSQI 402
I G G+GT VYK DG+ A+KK K + EQ+ E+ +L ++
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK----GDKEQYTGISQSACREIALLREL 59
Query: 403 NHRNIVKLLGCCLE-TEVPL-LVYEFVPNGTLYQNIHNHIE----EFP------ITWELL 450
H N+V L+ LE + + L++++ + L+Q I H + P + W++L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSR------- 499
+G + YLHS + RD+K ANIL+ ++ K+ D G +R
Sbjct: 119 -------NG-VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 500 -SITVDQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINI 557
+D V T Y PE ++ +T+ D+++ G + E+LT + +
Sbjct: 168 PLADLD------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221
Query: 558 DEDRSLVGYFLQAMNENRLFEVL 580
+S Q R+FEVL
Sbjct: 222 KIKKSNPFQRDQLE---RIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCC 414
LG+G G+VYK + G +A+K+ +L +DE+ Q I E+ IL + IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ E++ G+L + + I ++L RI V L +L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIH 126
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSI--TVDQTHLTTKVQGTFGYVDPEYFQS------ 526
RD+K N+L++ + K+ DFG S ++ ++ +T++ G Y+ PE +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKP 551
+T +SDV+S G+ ++E+ G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEV-VILSQINHRNIVK 409
+++G+G G V A+ + AVK K ++ + + ++E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAA 468
L + V +++ G L+ H++ E R A E++ AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFY----HLQRERCFLEPRARFYAAEIASALGYLHS-- 114
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
++I RD+K NILLD + ++DFG + ++ T+ GT Y+ PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ D + G VL E+L G P + N E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINH-RNIVKLLG 412
++G G G VYKG + G++ A+K V E+ E+ E+ +L + +H RNI G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 413 CCLETEVP------LLVYEFVPNGT---LYQNIH-NHIEEFPITWELLLRIAVEVSGALF 462
++ P LV EF G+ L +N N ++E I + I E+ L
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-----ICREILRGLA 135
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
+LH+ I RDIK N+LL + K+ DFG S + T + GT ++ PE
Sbjct: 136 HLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 191
Query: 523 YFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ + +SD++S G+ +E+ G P+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK--SKLVDENNVEQFINEVVILSQINH 404
T+ Y + +G G G V G+ VA+KK ++ E+ +L + H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
NI+ L + PL FV L ++H + P+ + + ++ L Y+
Sbjct: 69 ENIISLSDIFIS---PLEDIYFVTE-LLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HSA + RD+K +NIL+++ K+ DFG +R + +T GYV Y+
Sbjct: 125 HSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVSTRYY 171
Query: 525 QSSQ-------FTEKSDVYSFGVVLVEILTGQKPI 552
++ + + + D++S G + E+L G KP+
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 39/119 (32%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
P+T E L+ + +V+ + +L S I RD+ + NILL + K+ DFG +R I
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 504 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + IDE+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGCC 414
LG+G TV+KG +VA+K+ +L E I EV +L + H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 415 LETEVPL-LVYEFVPNGTLYQNIHN-----HIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+ TE L LV+E++ + L Q + N + I LLR L Y H
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYCHKR- 122
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSS 527
I RD+K N+L+++K K++DFG +R+ +V + +V T Y P+ S+
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564
+++ D++ G +L E+ TG+ + E+ L+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 21/245 (8%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVK--KSKLV-DENNVEQFINEVVILSQINHRNIVKL 410
R++G+G V L RI A+K K +LV D+ +++ E + ++ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAA 468
L C +TE L V EFV G L ++ + P E R + E+S AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNFLHERG 116
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
I RD+K N+LLD + K++D+G + + T+ GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 529 FTEKSDVYSFGVVLVEILTGQKP--IRAINIDEDRSLVGYFLQAMNEN-----RLFEVLD 581
+ D ++ GV++ E++ G+ P I ++ + D++ Y Q + E R V
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 582 ALVLK 586
+ VLK
Sbjct: 233 SSVLK 237
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 65/253 (25%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
D++ + +++G+G G V D G I A+K KS+++++ V E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNG---TL---YQNIHNHIEEFPITWELLLRIAVEV 457
+VKL + E L L+ E++P G TL F I E +L A++
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL--AIDS 116
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ---- 513
L Y+H RDIK N+LLD K K+SDFG + ++H T +
Sbjct: 117 IHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTG--LKKSHRTEFYRILSH 165
Query: 514 -----------------------------------GTFGYVDPEYFQSSQFTEKSDVYSF 538
GT Y+ PE F + + ++ D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 539 GVVLVEILTGQKP 551
GV++ E+L G P
Sbjct: 226 GVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGCC 414
LG+G TVYKG+ +G++VA+K + E V I E +L + H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSAASISIY 473
E V+E++ + L Q + H P L + ++ L Y+H I
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM---FQLLRGLAYIHGQ---HIL 125
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITV-DQTHLTTKVQGTFGYVDPEYFQ-SSQFTE 531
RD+K N+L+ K++DFG +R+ ++ QT+ + V T Y P+ ++ ++
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183
Query: 532 KSDVYSFGVVLVEILTGQ 549
D++ G + +E+L GQ
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/199 (27%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 361 GQGTVYKGML----ADGRIVA---VKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
G+GT K +L A G+ A +KK ++ ++ V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISI 472
+ V E+V G L+ H+ + E R E+ AL YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELF----FHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KI 116
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RD+K N++LD K++DFG + D + T GT Y+ PE + + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 533 SDVYSFGVVLVEILTGQKP 551
D + GVV+ E++ G+ P
Sbjct: 176 VDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 14/229 (6%)
Query: 335 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLADGRIVAVKKSKLVDENNVEQFI 393
+ + + L TD + +G+G G VYK DG + AVK + + + E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 394 NEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFVPNGTLYQNIHNHIEEFPITWE 448
++ S NH N+VK G + + + LV E G++ + + + E
Sbjct: 68 EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
+ I+ + GAL L + I RD+K NILL + K+ DFG S +T +
Sbjct: 128 AM--ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185
Query: 509 TTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 552
T V GT ++ PE Q + + DV+S G+ +E+ G P+
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 357 LGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGC 413
LG+G TVYKG L D +VA+K+ +L E I EV +L + H NIV L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CLETEVPL-LVYEFVPNGTLYQNIHN-----HIEEFPITWELLLRIAVEVSGALFYLHSA 467
+ TE L LV+E++ + L Q + + ++ + LLR L Y H
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHRR 123
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQS 526
+ RD+K N+L++++ K++DFG +R+ ++ + +V T Y P+ S
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
+ ++ + D++ G + E+ TG+ ++E
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 16/208 (7%)
Query: 361 GQGTVYKGML----ADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
G+GT K +L A GR A+K K ++ ++ V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+ V E+ G L+ ++ E T E E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVV 117
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
RDIK N++LD K++DFG + D + T GT Y+ PE + + +
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 534 DVYSFGVVLVEILTGQKPIRAINIDEDR 561
D + GVV+ E++ G+ P N D +R
Sbjct: 177 DWWGLGVVMYEMMCGRLPF--YNQDHER 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 66/305 (21%), Positives = 132/305 (43%), Gaps = 37/305 (12%)
Query: 325 ELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIV--AVKKSK 382
+ +S + K S D+ D Y + ++ + Q ++YKG+ + ++ KK
Sbjct: 1 QNIITRSYINDIKCIESDDI----DKYTS-VLIKENDQNSIYKGIFNNKEVIIRTFKKFH 55
Query: 383 LVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL----LVYEFVPNGTLYQNIHN 438
+ ++ NE+ L +I+ NI+K+ G ++ L L+ E+ G L + +
Sbjct: 56 KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK 115
Query: 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
E ++++ L +A++ L+ L+ + +++ S + L+ + Y+ K+ G
Sbjct: 116 ---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLE 170
Query: 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ ++ K Y + S++T K D+YS GVVL EI TG+ P +
Sbjct: 171 KILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226
Query: 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
E L+ +N+N ++L L EI + C + + RP +KE
Sbjct: 227 TKEIYDLI------INKN------NSLKLPLDCPLEIKCIVE---ACTSHDSIKRPNIKE 271
Query: 617 VAFEL 621
+ + L
Sbjct: 272 ILYNL 276
|
Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 361 GQGTVYKGMLA----DGRIVAVK----KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
G+G+ K +LA DG AVK K+ L + V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASIS 471
E V ++V G L+ H++ E R A EV+ A+ YLHS ++
Sbjct: 64 SFQTAEKLYFVLDYVNGGELFF----HLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
I RD+K NILLD + ++DFG + V+ T+ GT Y+ PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 532 KSDVYSFGVVLVEILTGQKP 551
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 350 NYNANRILGQGGQGTV----YKGMLADGRIVAVKKSKLVDENNV--EQFINEVVILSQI- 402
Y + LGQG G V ++ VA+KK V + ++ + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 403 NHRNIVKLLGCCLETEVP-------LLVYEFVPNGTLYQNIHN-------HIEEFPITWE 448
H+NI C + ++ L +YE + L+Q I + H + F ++
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSF--IYQ 113
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD---- 504
+L L Y+HSA + RD+K N+L++ K+ DFG +R + +
Sbjct: 114 ILC--------GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162
Query: 505 QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 552
+T V T Y PE S Q +T+ DV+S G +L E+L G+KP+
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 68/255 (26%), Positives = 122/255 (47%), Gaps = 35/255 (13%)
Query: 314 FKRNGGLLLQQELS--SNKSSVEKTKLFTSKDLEKATD-NYNANRILGQGGQGTVYKGML 370
F+ N L ++E S +N E + D+ ++ + +Y I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 371 AD-GRIVAVKKSKLVDENNVEQFIN-EVVILSQINHRNIVKL-----LGCCLETEVPL-- 421
D VA+KK L D Q+ N E++I+ +NH NI+ L C + E +
Sbjct: 88 IDTSEKVAIKKV-LQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 422 -LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG-----ALFYLHSAASISIYRR 475
+V EF+P Q +H +++ + L V++ AL Y+HS I R
Sbjct: 143 NVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHR 194
Query: 476 DIKSANILLDDK-YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSSQFTEKS 533
D+K N+L+D + K+ DFG+++++ Q ++ + F Y PE ++ +T
Sbjct: 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHI 252
Query: 534 DVYSFGVVLVEILTG 548
D++S G ++ E++ G
Sbjct: 253 DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 38/119 (31%), Positives = 63/119 (52%), Gaps = 5/119 (4%)
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
P+T E L+ + +V+ + +L S I RD+ + NILL + K+ DFG +R I
Sbjct: 170 PLTMEDLICYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 504 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + I+E+
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 38/119 (31%), Positives = 62/119 (52%), Gaps = 5/119 (4%)
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
+T E L+ + +V+ + +L S I RD+ + NILL + K+ DFG +R I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 504 DQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560
D ++ + ++ PE +T +SDV+SFGV+L EI + G P + IDE+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 15/197 (7%)
Query: 372 DGRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429
DG+ VA+KK V +N V ++ E+ +L H N++ L + +V
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83
Query: 430 GTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488
+ ++H I P++ + + ++ L YLHSA I RDIK N+L++
Sbjct: 84 ELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNC 140
Query: 489 RAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEIL 546
K+ DFG +R D++ H+T +V + Y PE S+ +T D++S G + E+L
Sbjct: 141 VLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
Query: 547 TG------QKPIRAINI 557
Q PI+ +++
Sbjct: 200 GRRILFQAQSPIQQLDL 216
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 62/259 (23%), Positives = 104/259 (40%), Gaps = 68/259 (26%)
Query: 349 DNYNANRILGQGGQGTV-YKGMLADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
++++ +++G+G G V G+I A+K KS++ ++ + E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTL------YQNIHNHIEEFPITWELLLRIAVEVS 458
+V L + + L+ EF+P G L Y + F + E +L A+E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMA-ECVL--AIEAV 117
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS-------------------- 498
L ++H RDIK NIL+D K+SDFG S
Sbjct: 118 HKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 499 --------RSITVDQTHLT--TKVQ----------------GTFGYVDPEYFQSSQFTEK 532
S+ VD +LT +K Q GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 533 SDVYSFGVVLVEILTGQKP 551
D +S G ++ E L G P
Sbjct: 229 CDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 351 YNANRILGQGGQGTV---YKGMLADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHR 405
Y + +G G QG V Y +L R VA+KK ++ + ++ E+V++ +NH+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTL--YQNIHNHIE----------EFPITWELLLRI 453
NI+ LL F P +L +Q+++ +E + + E + +
Sbjct: 77 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
++ + +LHSA I RD+K +NI++ K+ DFG +R T + + T
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 179
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
T Y PE + E D++S G ++ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410
+++ G G VY + R + + K L+ N ++Q E IL+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 411 LGCCLETEVPL-LVYEFVPNG---TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
C ET+ L +V E+V G TL +NI + ++ E AL YLH+
Sbjct: 67 F-CSFETKRHLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHN 119
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSR-------------SITVD-QTHLTTKV 512
I RD+K N+L+ K++DFG S+ I D + L +V
Sbjct: 120 YG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
GT Y+ PE + + D ++ G++L E L G P
Sbjct: 177 CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP--NGTLYQNIHNHIEEFPITWELLLR 452
E ++L +NH +++++ + + +V +P + LY + PI L+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALI-- 161
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
I ++ L YLH+ I RD+K+ NI ++D + + D G ++ V L +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--GL 216
Query: 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
GT PE ++ K+D++S G+VL E+L
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 67/287 (23%), Positives = 127/287 (44%), Gaps = 51/287 (17%)
Query: 357 LGQGGQGTVYKGML---ADGRIVAVKKSKLV-------DENNVEQFINEVVILSQINHRN 406
LGQG +YKG+L +D IV + V D + F ++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+VKL G C+ E ++V E+V G L ++ H E+ ++ L +A +++ AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 467 AASISIYRRDIKSANILL-----DDKYR--AKVSDFGTSRSI-TVDQTHLTTKVQGTFGY 518
+ + NIL+ ++ Y K+SD G ++ + ++ +
Sbjct: 120 KKLVHGN---VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP------W 170
Query: 519 VDPEYFQ--SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENR 575
+ PE + + T +D +SFG L+EI + G++P+ ++ E + R
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------------KER 217
Query: 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
++ D L + E+ A L +C + RP+ + + +L
Sbjct: 218 FYQ--DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 18/200 (9%)
Query: 361 GQGTVYKGML----ADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
G+GT K +L A G+ A+K K ++ ++ V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISI 472
+ V E+ G L+ H+ + E R E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELF----FHLSRERVFSEDRARFYGAEIVSALGYLHSC---DV 116
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRS-ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
RD+K N++LD K++DFG + I+ T GT Y+ PE + + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGR 174
Query: 532 KSDVYSFGVVLVEILTGQKP 551
D + GVV+ E++ G+ P
Sbjct: 175 AVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 356 ILGQGGQGTVYKGMLADGR-IVAVKKSKLVDENN--VEQFINEVVILSQINHRNIVKLLG 412
++G+G G V K + + IVA+KK K +EN E + E+ +L + NIV+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
LV+E+V +N+ +EE P ++ + + +H I
Sbjct: 68 AFRRRGKLYLVFEYVE-----KNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RDIK N+L+ K+ DFG +R+++ T+ T Y PE + + +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 533 SDVYSFGVVLVEILTGQ 549
D++S G +L E+ GQ
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 50/257 (19%)
Query: 386 ENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEF 443
E Q + EV ++ ++ H+NIV+ + L + ++ EF G L +NI + F
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 444 -PITWELLLRIAVEVSGALFYLHSAAS----ISIYRRDIKSANILLDDKYR--------- 489
I ++ I ++ AL Y H+ + RD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 490 --------AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFG 539
AK+ DFG S++I ++ + GT Y PE ++ + +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD---ALVLKEAEREEIMTV 596
++ E+ +G+ P F +A N ++L L L +K +E +
Sbjct: 231 CIIYELCSGKTP---------------FHKANNFSQLISELKRGPDLPIKGKSKE----L 271
Query: 597 ATLAKRCLNLNGKNRPT 613
L K LNL+ K RP+
Sbjct: 272 NILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 15/199 (7%)
Query: 361 GQGTVYKGML----ADGRIVA---VKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
G+GT K +L A GR A +KK +V ++ V + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISI 472
+ V E+ G L+ H+ + E R E+ AL YLHS ++ +
Sbjct: 64 FQTHDRLCFVMEYANGGELF----FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV-V 118
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
YR D+K N++LD K++DFG + D + T GT Y+ PE + + +
Sbjct: 119 YR-DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176
Query: 533 SDVYSFGVVLVEILTGQKP 551
D + GVV+ E++ G+ P
Sbjct: 177 VDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 48/243 (19%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
++LG+G G V+ L G++ A+K K +++ N V++ + E IL+ ++H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 411 LGCCLETEVPL-LVYEFVPNGTLY-----QNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
+TE L LV ++ P G L+ Q + E + A EV AL YL
Sbjct: 67 Y-ASFQTETYLCLVMDYCPGGELFRLLQRQP-GKCLSEEVARF-----YAAEVLLALEYL 119
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDF-------------------GTSRSITVDQ 505
H I +YR D+K NILL + +SDF G+ RS
Sbjct: 120 H-LLGI-VYR-DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 506 THLTTKVQ---------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
T + GT Y+ PE D ++ G++L E+L G P + N
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 557 IDE 559
DE
Sbjct: 237 RDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 50/218 (22%), Positives = 92/218 (42%), Gaps = 36/218 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRI-VAVKK--SKLVDENNVEQFINEVVILSQINHR 405
D Y +G G G V VA+KK + ++ E+ +L ++H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTL------Y-------QNIHNHIEEFPITWELLLR 452
N++ LL F P +L Y +++N ++ ++ + +
Sbjct: 75 NVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
+ ++ L Y+HSA I RD+K +NI +++ K+ DFG +R + +T V
Sbjct: 123 LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYV 176
Query: 513 QGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 549
T Y PE + + D++S G ++ E+LTG+
Sbjct: 177 A-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 351 YNANRILGQGGQGTV---YKGMLADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHR 405
Y + +G G QG V Y +L R VA+KK ++ + ++ E+V++ +NH+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 406 NIVKLLGC-----CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
NI+ LL LE + + + + L Q I ++ +++ LL ++ +
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK-- 140
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
+LHSA I RD+K +NI++ K+ DFG +R T + + T T Y
Sbjct: 141 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
PE + E D++S G ++ E++ G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 20/231 (8%)
Query: 335 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFI 393
KT +F S +D + +G+G G V+K + +G AVK + + + E+
Sbjct: 6 KTIIFDS--FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIE 62
Query: 394 NEVVILSQI-NHRNIVKLLGCCLETEVP-----LLVYEFVPNGTLYQNIHNHIEEFPITW 447
E IL + +H N+VK G + +V LV E G++ + ++
Sbjct: 63 AEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME 122
Query: 448 ELLLR-IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506
E ++ I E L +LH +I RD+K NILL + K+ DFG S +T +
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 507 HLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPI 552
T V GT ++ PE Q + + DV+S G+ +E+ G P+
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDEN--NVEQFINEVVILSQINHRNI 407
Y ++G+G G V + G VA+KK V E+ + + + E+ +L + H +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 408 VKLLGCCL-----ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
V++ L E + +V+E + L+Q I + + P + L ++ AL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFL---YQLLRALK 117
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD--QTHLTTKVQGTFGYVD 520
Y+H+A +++ RD+K NIL + + K+ DFG +R D T T Y
Sbjct: 118 YIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 521 PEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPI 552
PE S S++T D++S G + E+LTG KP+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 74/267 (27%), Positives = 107/267 (40%), Gaps = 51/267 (19%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G VY+ D RI A+K K ++V + V I E RNI L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGE---------RNI---LV 48
Query: 413 CCLETEVPLLV---YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY------ 463
L E P +V + F + LY + +++ + W L A FY
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYL-VTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 464 -LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS-ITVDQTHLTTKVQGTFGYVDP 521
L I RD+K NILLD + DFG S++ +T ++T T GT Y+ P
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAP 165
Query: 522 E-YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI--------------------DED 560
E +T+ D +S GV++ E+ G P A + DE
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEG 225
Query: 561 RSLVGYFLQAMNENRLFEVLDALVLKE 587
R V L ++RL DA+ LKE
Sbjct: 226 RQFVKGLLNRNPQHRLGAHRDAVELKE 252
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 55/217 (25%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 357 LGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGC 413
LG+G TV+KG L + +VA+K+ +L E I EV +L + H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHN-----HIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+ LV+E++ + L Q + + + I +LR L Y H
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILR-------GLAYCHRR- 123
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE-YFQSS 527
+ RD+K N+L++++ K++DFG +R+ +V + +V T Y P+ SS
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564
+++ + D++ G + E+ +G+ ++++ L+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 56/247 (22%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
D++ + +++G+G G V D G I A+K K+ ++++ V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNG---TLYQNIHNHIEE---FPITWELLLRIAVEVS 458
+VK+ + L+ EF+P G TL EE F I +L A++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL---AIDAI 117
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS------------RSIT---- 502
L ++H RDIK N+LLD K K+SDFG R++T
Sbjct: 118 HQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 503 ------------------VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 544
++ L GT Y+ PE F + + + D +S GV++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 545 ILTGQKP 551
+L G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 11/120 (9%)
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
+HS + RDIK N+LLD +++DFG+ + D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 524 FQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
Q+ ++ + D +S GV + E+L G+ P A SLV + + MN F+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 67/251 (26%), Positives = 109/251 (43%), Gaps = 44/251 (17%)
Query: 391 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL- 449
+F+ E + H N+++ LG C E LLV EF P G L + + + +T +
Sbjct: 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100
Query: 450 -LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS-------I 501
L R+A E++ L +LH I D+ N LL K+ D+G S + +
Sbjct: 101 TLQRMACEIALGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
Query: 502 TVDQT---------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
T DQ L +V G VD T++S+V+S GV + E+ G +P
Sbjct: 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQ--------TKESNVWSLGVTIWELFELGSQP 209
Query: 552 IRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER-EEIMTVATLAKRCLNLNGKN 610
R ++ D ++ Y ++ E +L L L ++R E+M + C L +
Sbjct: 210 YRHLS---DEQVLTYTVR---EQQLKLPKPRLKLPLSDRWYEVM------QFC-WLQPEQ 256
Query: 611 RPTMKEVAFEL 621
RP+ +EV L
Sbjct: 257 RPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE-QFIN 394
KL T K L+K LG+G TVYKG G++VA+K+ +L E I
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFV-----------PNGTLYQNIHNHIEEF 443
E +L + H NIV L + LV+E++ G ++HN + F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGL---SMHN-VRLF 108
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
LLR L Y H + RD+K N+L+ ++ K++DFG +R+ +V
Sbjct: 109 LFQ---LLR-------GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV 155
Query: 504 DQTHLTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQ 549
+ +V T Y P+ S++++ D++ G + E+ TG+
Sbjct: 156 PSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 351 YNANRILGQGGQGTV---YKGMLADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHR 405
Y + +G G QG V Y + G+ VA+KK + + ++ E+V++ +NH+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 406 NIVKLLGC-----CLET--EVPLLVYEFVPNGTLYQNIH---NHIEEFPITWELLLRIAV 455
NI+ LL LE +V LV E + + L Q I +H + +++L I
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHERMSYLLYQMLCGIK- 132
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
+LHSA I RD+K +NI++ K+ DFG +R T + + T T
Sbjct: 133 -------HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 180
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
Y PE + E D++S G ++ E++ G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 20/131 (15%)
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
IA++ L Y+H RDIK NIL+D +++DFG+ + D T ++
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163
Query: 513 QGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF 567
GT Y+ PE Q+ ++ + D +S GV + E+L G+ P A SLV +
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETY 217
Query: 568 LQAMNENRLFE 578
+ MN F+
Sbjct: 218 GKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 32/212 (15%)
Query: 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVE--QFINEVVILSQINHRNIVKLLGC 413
+G+G G V ++ VA+KK +N ++ + + E+ +L ++H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 414 CLET-----EVPLLVYEFVPNGTLYQNI-------HNHIEEFPITWELLLRIAVEVSGAL 461
+VYE + + L+Q I +H + F LLR L
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQ---LLR-------GL 121
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
Y+HSA ++ RD+K +N+LL+ K+ DFG +R+ + +T V T Y P
Sbjct: 122 KYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
Query: 522 E-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
E S++T DV+S G + E+L G+KP+
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 26/182 (14%)
Query: 441 EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+E + E LL + +V+ + +L S I RD+ + NILL K+ DFG +R
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLARD 263
Query: 501 ITVDQTHLTTKVQGT----FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAI 555
I D ++ V+G ++ PE + +T +SDV+S+G++L EI + G P +
Sbjct: 264 IRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
Query: 556 NIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615
+D F + + E + + +E +IM K C + + RPT K
Sbjct: 321 PVDSK------FYKMIKEGYR---MLSPECAPSEMYDIM------KSCWDADPLKRPTFK 365
Query: 616 EV 617
++
Sbjct: 366 QI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 76/320 (23%), Positives = 121/320 (37%), Gaps = 68/320 (21%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
+ LG G G V D + A+K K +++ N V E IL++ ++ +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSGALFYLHSAAS 469
+ + V +++P G + ++ +E FP E+L R + E++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDM-MSLLIRMEVFP---EVLARFYIAELTLAIESVHKMGF 122
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFG--------------------------------- 496
I RDIK NIL+D K++DFG
Sbjct: 123 I---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 497 -------------TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 543
R+ Q L + GT Y+ PE +T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 544 EILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRC 603
E+L GQ P A E + L+ +N + + L + I + A+
Sbjct: 240 EMLVGQPPFLAPTPTETQ------LKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293
Query: 604 LNLNG----KNRPTMKEVAF 619
L NG K P EV F
Sbjct: 294 LGRNGADDIKAHPFFSEVDF 313
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 36/205 (17%)
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN--HIEEFPITWELLLRIAVEVSGALFY 463
N+V L + + LV + G L+ +I +I E E + R A E+ AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE-----ECVKRWAAEMVVALDA 100
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
LH I RD+ NILLDD+ +++ F R V+ + V+ Y PE
Sbjct: 101 LHREG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEV 153
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRA----------INI-----DEDRSLVGYFL 568
S+ TE D +S G +L E+LTG+ + +NI +E RSL+ L
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLL 213
Query: 569 QAMNENRLFEVLDALVLKEAEREEI 593
Q F + L A E+I
Sbjct: 214 Q-------FNPTERLGAGVAGVEDI 231
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 50/244 (20%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
+++ + +++G+G G V D G + A+K K+ ++++ V E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNG---TLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+VK+ + L+ EF+P G TL EE + +A++ L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG----------------TSRSITVDQ 505
++H RDIK N+LLD K K+SDFG + S+ D
Sbjct: 121 GFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 506 T------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547
T L GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 548 GQKP 551
G P
Sbjct: 232 GYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 39/159 (24%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
++ N +KL + +L+ +++ +G L+ + E ++ + +I ++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALN 123
Query: 463 YLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
LH I DIK N+L D K R + D+G + I + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
E + + D ++ GV+ E+LTG+ P + + DE+
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEE 213
|
Length = 267 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 67/260 (25%), Positives = 114/260 (43%), Gaps = 38/260 (14%)
Query: 349 DNYNANRILGQG--GQGTVYKGMLADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN 403
D++ +++G+G G+ V K M G++ A+K K +++ F E +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNG---TLYQNIHNHIEE----FPITWELLLRIAVE 456
R I L + LV ++ G TL + + E F + E++L A++
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVL--AID 116
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
L Y+H RDIK N+LLD +++DFG+ + D T + GT
Sbjct: 117 SVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 517 GYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571
Y+ PE Q+ ++ + D +S GV + E+L G+ P A SLV + + M
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIM 221
Query: 572 N-ENRL-FEVLDALVLKEAE 589
N + F V +EA+
Sbjct: 222 NHKEHFQFPPDVTDVSEEAK 241
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 48/211 (22%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHRNI 407
Y + + +G G G+V + G VA+KK E ++ E+ +L + H N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 408 VKLLGCCLETEVPLL--VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
+ LL + T +F Q I P++ + + + ++ L Y+H
Sbjct: 77 IGLLD--VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
SA I RD+K N+ +++ K+ DFG +R + T GYV +++
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTRWYR 181
Query: 526 SSQ-------FTEKSDVYSFGVVLVEILTGQ 549
+ + + + D++S G ++ E+LTG+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 37/125 (29%), Positives = 68/125 (54%), Gaps = 10/125 (8%)
Query: 440 IEEFP-ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
I E P +++ L+ + +V+ + +L AS + RD+ + N+L+ + K+ DFG +
Sbjct: 230 INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLA 286
Query: 499 RSITVDQTHLTTKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 554
R I D +++ TF ++ PE ++ +T SDV+SFG++L EI T G P
Sbjct: 287 RDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
Query: 555 INIDE 559
+ ++E
Sbjct: 345 LPMNE 349
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 42/163 (25%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 391 QFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFVPNGTLYQNIHN---HIEEFP 444
Q NE++ L ++NH NI+K+ L T + Y+F LY +++ ++ P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504
+ + I ++ A+ Y+H I RDIK NI L+ + + DFGT+ +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547
+ GT PE + E +D++S G++L+++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 55/239 (23%), Positives = 102/239 (42%), Gaps = 37/239 (15%)
Query: 392 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLL 451
F ++ Q++H++IV L G C+ ++V EFV G L +H + W+
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--F 108
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILL-----DDKYRA--KVSDFGTSRSITVD 504
++A +++ AL YL + + + NILL D + K+SD G ++
Sbjct: 109 KVAKQLASALSYLEDKDLVHGN---VCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 505 QTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEI-LTGQKPIRAINIDEDRS 562
Q + ++ PE + S+ + +D +SFG L EI G+ P++ D++
Sbjct: 166 QECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKT 214
Query: 563 LVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
L + R +E LV + +A L C+N + RP + + ++
Sbjct: 215 LA-------EKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRI 453
E+ IL I+HR I+ L+ +V +P ++ +++ P+ E + I
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK--CDLFTYVDRSGPLPLEQAITI 190
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
+ AL YLH I RD+K+ NI LD+ A + DFG + +D T +
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPDTPQCY 245
Query: 514 GTFGYVD---PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
G G ++ PE + K+D++S G+VL E+ +
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 56/248 (22%)
Query: 355 RILGQGGQGTVYKGMLADGRIV-AVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
+ +G G G V D + A+K K+ ++ N E IL++ ++ +VKL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLR--IAVEVSGALFYLHSAA 468
+ + V +++P G + ++ + F E L R IA E++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDM-MSLLIRLGIFE---EDLARFYIA-ELTCAIESVHKMG 121
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFG-------------------------------- 496
I RDIK NIL+D K++DFG
Sbjct: 122 FI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 497 ---TSRSITVDQTH-------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
R +++ L + GT Y+ PE + +T+ D +S GV+L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 547 TGQKPIRA 554
GQ P A
Sbjct: 239 VGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 65/304 (21%), Positives = 120/304 (39%), Gaps = 72/304 (23%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQ------------------------- 391
LGQG + +Y G L ++ ++ DE+ + +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 392 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLL 451
F ++SQ++H ++ + G C+ ++V EFV +G L + P+ W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT- 121
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA-------KVSDFGT-----SR 499
+A +++ AL YL ++ ++ + NILL A K+SD G SR
Sbjct: 122 -VAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 500 SITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEI-LTGQKPIRAINI 557
V++ ++ PE + + +D +SFG L+EI G+ P++
Sbjct: 178 EERVER----------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227
Query: 558 DEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E + R +E L E +E+ ATL +CL RP+ + +
Sbjct: 228 SE-------------KERFYE--KKHRLPEPSCKEL---ATLISQCLTYEPTQRPSFRTI 269
Query: 618 AFEL 621
+L
Sbjct: 270 LRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 359 QGGQGTVYKGMLA-DGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+G G VY G + ++ AVK K+ ++++N V Q E L+ IV L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 415 LETEVPLLVYEFVPNGTLYQ--NIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
LV E++ G + +I+ + +E E+ ++ EV+ AL YLH I
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDE-----EMAVKYISEVALALDYLHRH---GI 125
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSR 499
RD+K N+L+ ++ K++DFG S+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGCCL 415
+G+G G VYK DG+ K ++ + E+ +L ++ H N++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 416 ---ETEVPLLVYEFVPNGTLYQNIHNH------IEEFPITWELLLRIAVEVSGALFYLHS 466
+ +V LL +++ + L+ I H + + ++ + ++ + YLH+
Sbjct: 69 SHSDRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 467 AASISIYRRDIKSANILL----DDKYRAKVSDFGTSRSITVDQTHLTT--KVQGTFGYVD 520
+ RD+K ANIL+ ++ R K++D G +R L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 521 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 552
PE ++ +T+ D+++ G + E+LT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLL-RIAVEVSGA 460
+ H NI++ LG C+E LLV+E+ G L + + LLL R+A E++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT--KVQGTFGY 518
+ ++H + D+ N L KV D+G S + ++ T +
Sbjct: 112 VTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRW 167
Query: 519 VDPEY---FQ----SSQFTEKSDVYSFGVVLVEIL 546
+ PE F +++ T+ S+V++ GV L E+
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 48/224 (21%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN--NVEQFINEVV 397
+K + + + Y +G G G+V G VAVKK ++ + ++ E+
Sbjct: 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 68
Query: 398 ILSQINHRNIVKLLGCCLETEVPLLVYE-----FVPNGTLYQNIHNHIEEFPITWELLLR 452
+L + H N++ LL + P E ++ + +++N ++ +T + +
Sbjct: 69 LLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
+ ++ L Y+HSA I RD+K +N+ +++ K+ DFG +R + T
Sbjct: 125 LIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------ 175
Query: 513 QGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 549
GYV ++++ + + + D++S G ++ E+LTG+
Sbjct: 176 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
LL +V+ + +L AS + RD+ + N+LL K+ DFG +R I D +++
Sbjct: 239 LLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 510 TKVQGTF---GYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINID 558
TF ++ PE + +T SDV+S+G++L EI + G P + +D
Sbjct: 296 KG--STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVE-QFINEVVILSQINHRNIVKLLGCCL 415
+G+G G VYK DG+ K ++ + E+ +L ++ H N++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 416 ---ETEVPLLVYEFVPNGTLYQNIHNH----IEEFPITWE--LLLRIAVEVSGALFYLHS 466
+ +V LL +++ + L+ I H + P+ ++ + ++ + YLH+
Sbjct: 69 SHADRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 467 AASISIYRRDIKSANILL----DDKYRAKVSDFGTSRSITVDQTHLTT--KVQGTFGYVD 520
+ RD+K ANIL+ ++ R K++D G +R L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 521 PEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPI 552
PE ++ +T+ D+++ G + E+LT + PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLADGRI---VAVKK--SKLVDENNVEQFINE 395
+K + + D Y + +G G GTV + D R VA+KK E ++ E
Sbjct: 7 NKTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRE 64
Query: 396 VVILSQINHRNIVKLLGCCLETEVPL-------LVYEFVPNGTLYQNIHNHIEEFPITWE 448
+ +L + H N++ LL ++ L LV F+ GT + H + ++ +
Sbjct: 65 LRLLKHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK---LSED 118
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
+ + ++ L Y+H+A I RD+K N+ +++ K+ DFG +R + T
Sbjct: 119 RIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY 175
Query: 509 TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPI 552
T Y PE + +T+ D++S G ++ E+LTG KP+
Sbjct: 176 VV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPL 215
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 58/258 (22%), Positives = 92/258 (35%), Gaps = 72/258 (27%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
+ LG G G V D + A+K K ++ N V E IL++ ++ +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV-EVSGALFYL----- 464
+ + V +++P G + LL+R+ + A FY+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMS--------------LLIRMGIFPEDLARFYIAELTC 112
Query: 465 --HSAASISIYRRDIKSANILLDDKYRAKVSDFGTS------------------------ 498
S + RDIK NIL+D K++DFG
Sbjct: 113 AVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 499 ----------------------RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY 536
R+ Q L + GT Y+ PE + +T+ D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 537 SFGVVLVEILTGQKPIRA 554
S GV+L E+L GQ P A
Sbjct: 233 SVGVILYEMLVGQPPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 44/160 (27%), Positives = 64/160 (40%), Gaps = 13/160 (8%)
Query: 393 INEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP--NGTLYQNIHNHIEEFPITWELL 450
E IL INH +I++L G + L+ +P LY + I +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAIC--DI 184
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT-HLT 509
L I V A+ YLH I RDIK+ NI ++ + DFG + VD +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKY 240
Query: 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
GT PE + D++S G+VL E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|205157 pfam12947, EGF_3, EGF domain | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 4e-04
Identities = 11/22 (50%), Positives = 14/22 (63%)
Query: 238 ICDNTAGNYTCRCPKGFRGDGR 259
C NT G++TC C G+ GDG
Sbjct: 13 TCTNTGGSFTCTCKSGYTGDGV 34
|
This family includes a variety of EGF-like domain homologues. This family includes the C-terminal domain of the malaria parasite MSP1 protein. Length = 36 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 49/233 (21%), Positives = 101/233 (43%), Gaps = 42/233 (18%)
Query: 339 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGMLADGR-IVAVKK-----SKLVDENN 388
F ++L K + Y +G G G+V R VAVKK L+ +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI---H 57
Query: 389 VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE-----FVPNGTLYQNIHNHIEEF 443
+ E+ +L + H N++ LL + P E ++ + +++N ++
Sbjct: 58 ARRTYRELRLLKHMKHENVIGLL----DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ 113
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
++ E + + ++ L Y+HSA I RD+K +N+ +++ ++ DFG +R
Sbjct: 114 KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADD 170
Query: 504 DQTHLTTKVQGTFGYVDPEYFQSSQ-------FTEKSDVYSFGVVLVEILTGQ 549
+ T GYV ++++ + + + D++S G ++ E+L G+
Sbjct: 171 EMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 46/215 (21%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVI--------------- 398
++++G GG G VY+ A + + ++ E + E ++
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQN---IHNHIEEFPITWELLLRIAV 455
+ I+H I K GC + + Y F+ L +N I I+ +L+ I
Sbjct: 77 IHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK--KLIKNIMK 133
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-TKVQ- 513
++ L Y+H I DIK NI++D R + D+G + + H+ +K Q
Sbjct: 134 DMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 514 ----GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 544
GT Y + + T + D+ S G +++
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|238010 cd00053, EGF, Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 8e-04
Identities = 13/29 (44%), Positives = 15/29 (51%), Gaps = 2/29 (6%)
Query: 233 NNC--THICDNTAGNYTCRCPKGFRGDGR 259
N C C NT G+Y C CP G+ GD
Sbjct: 6 NPCSNGGTCVNTPGSYRCVCPPGYTGDRS 34
|
Length = 36 |
| >gnl|CDD|214544 smart00181, EGF, Epidermal growth factor-like domain | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 8e-04
Identities = 15/30 (50%), Positives = 19/30 (63%), Gaps = 1/30 (3%)
Query: 231 SLNNCTH-ICDNTAGNYTCRCPKGFRGDGR 259
S C++ C NT G+YTC CP G+ GD R
Sbjct: 4 SGGPCSNGTCINTPGSYTCSCPPGYTGDKR 33
|
Length = 35 |
| >gnl|CDD|238011 cd00054, EGF_CA, Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.001
Identities = 15/37 (40%), Positives = 19/37 (51%), Gaps = 4/37 (10%)
Query: 223 DVNEFEDPSLNNC--THICDNTAGNYTCRCPKGFRGD 257
D++E S N C C NT G+Y C CP G+ G
Sbjct: 1 DIDECA--SGNPCQNGGTCVNTVGSYRCSCPPGYTGR 35
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. Length = 38 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 46/178 (25%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQI 402
D++ + LG+G G VYK L +G+ V +KK+ + VE ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 403 NHRN-IVKLLGCCLET-----EVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE--LLLRI 453
N + LE E LV+ + TL + + +EFP E LL ++
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQS--KEFPYNVEPYLLGKV 243
Query: 454 AVEVSGA--------------LFYLHSAASISIYRRDIKSANILLDDKYRA-KVSDFG 496
G LF L S I RD+K NI+ + + K+ D G
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|214542 smart00179, EGF_CA, Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Score = 35.3 bits (82), Expect = 0.003
Identities = 17/46 (36%), Positives = 22/46 (47%), Gaps = 9/46 (19%)
Query: 223 DVNEFEDPSLNNCTH--ICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
D++E S N C + C NT G+Y C CP G+ DG C
Sbjct: 1 DIDECA--SGNPCQNGGTCVNTVGSYRCECPPGY-----TDGRNCE 39
|
Length = 39 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.74 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 98.26 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.13 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.11 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| KOG1214 | 1289 | consensus Nidogen and related basement membrane pr | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.93 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.81 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.73 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.66 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.65 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.62 | |
| KOG4260 | 350 | consensus Uncharacterized conserved protein [Funct | 97.57 | |
| KOG4260 | 350 | consensus Uncharacterized conserved protein [Funct | 97.46 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.39 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 97.34 | |
| PF14670 | 36 | FXa_inhibition: Coagulation Factor Xa inhibitory s | 97.32 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.31 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.3 | |
| KOG1214 | 1289 | consensus Nidogen and related basement membrane pr | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.24 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.14 | |
| KOG4289 | 2531 | consensus Cadherin EGF LAG seven-pass G-type recep | 97.11 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 96.78 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.77 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.49 | |
| KOG4289 | 2531 | consensus Cadherin EGF LAG seven-pass G-type recep | 96.46 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.45 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 96.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.35 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=473.42 Aligned_cols=291 Identities=45% Similarity=0.736 Sum_probs=258.9
Q ss_pred cccccChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 038345 335 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414 (686)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 414 (686)
..+.|+++++..+|++|...++||+|+||.||+|.+.++..||||++........++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999987765443145699999999999999999999999
Q ss_pred eeCC-cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 415 LETE-VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 415 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
.+.+ .++||||||++|+|.++|+..... +|+|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999986544 89999999999999999999999988899999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||++|.+.........+..|+...+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765541222111117999999999999999999999999999999999999999876656667799999999999
Q ss_pred chhhhhhhhhcc-ChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 574 NRLFEVLDALVL-KEAER-EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 574 ~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
+++.+++|+.+. ..... +....+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999987 55553 678889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=402.46 Aligned_cols=261 Identities=34% Similarity=0.535 Sum_probs=215.8
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-cceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV~e~~ 427 (686)
....+.||+|+||+||+|.++....||||++.... ....+.|.+|+.+|++++|||||+++|+|.+.. ...+||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 33445699999999999999865569999977533 222568999999999999999999999999887 789999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEeeCCCCCCeeecCCC-cEEEEecCCcccccCCC
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS-IYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~ 505 (686)
++|+|.++|++. ....+++..+++||.|||+||.|||+. + ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999975 345799999999999999999999999 6 99999999999999997 99999999998765332
Q ss_pred ceeeeeeeccccccCccccc--cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 506 THLTTKVQGTFGYVDPEYFQ--SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
...+...||+.|||||++. ...++.|+||||||++||||+||+.||...... ..+..... ..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~---------~~ 262 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVV---------GG 262 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh---------cC
Confidence 2233467999999999999 669999999999999999999999999865431 11111111 11
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccc
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~ 631 (686)
.+...+......+..|+.+||+.||+.||++.+++..|+.+.......
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 222333346778999999999999999999999999999998765543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=400.42 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=223.0
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+...+.||+|-||.||.|.+.....||+|.++.. ....+.|.+|+++|.+|+|+|||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456899999999999999988889999998765 334478999999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
+|.++|... ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||||....+......
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999973 344689999999999999999999999 9999999999999999999999999999966655555555
Q ss_pred eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
...-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.++... ++.+.++...+-..+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCCC
Confidence 5566789999999999999999999999999999999 99998765432 233444444444556
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..++.++.+|+..||+.+|++|||++.+...|+.+...
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 67888999999999999999999999999999887653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=369.55 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=207.7
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-ceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV~e~~ 427 (686)
....+.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|++++++.+||+||+++|.|..... ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 344678999999999999976 588999998743 445566889999999999999999999999999884 99999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|++++... ..+++..+.+|+.+|++||.|||+.. +||||||||+|||++..|.+||+|||.++.+...
T Consensus 161 DgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 999999999865 35999999999999999999999632 9999999999999999999999999999876543
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc--
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL-- 585 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-- 585 (686)
....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||...... . ..++++++..+.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~----------~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----Y----------LDIFELLCAIVDEP 298 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----C----------CCHHHHHHHHhcCC
Confidence 456678999999999999999999999999999999999999999754110 0 112222222221
Q ss_pred -ChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 -KEAER-EEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 -~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+. ..+.+++.++..||++||.+||+++|+++
T Consensus 299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12222 36778999999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=406.31 Aligned_cols=260 Identities=30% Similarity=0.468 Sum_probs=223.5
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
+.+....+.||+|+||+||+|... +...||||.++..... ..++|.+|++++..++|||||+|+|.|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566789999999999999843 3467999999986665 678999999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIE-----------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
+||+|||.+|+|.+||.-... ..+|+..+.+.||.|||.||+||-++ .+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999975321 22489999999999999999999999 8999999999999999999
Q ss_pred EEEEecCCcccccCCCceeee-eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhh
Q 038345 490 AKVSDFGTSRSITVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYF 567 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~ 567 (686)
|||+||||+|.+...+.+... ...-+.+||+||.+..++||.+||||||||+|||+++ |+.||.+...+| +
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------V 714 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------V 714 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------H
Confidence 999999999987655544433 4446789999999999999999999999999999999 999998776544 3
Q ss_pred HHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 568 LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 568 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.+.++.+++ -..++.++.++..|+..||+.+|++||+++||-..|+....
T Consensus 715 Ie~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 334444433 34566788899999999999999999999999999988654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=365.51 Aligned_cols=202 Identities=31% Similarity=0.497 Sum_probs=182.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..+|...+.||+|+||+||+|+++ ++..||||.+... .+...+.+..|+.+|+.++|||||.|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888899999999999999976 5789999986654 5666778899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC------CcEEEEecCCc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK------YRAKVSDFGTS 498 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~------~~~kl~DfGla 498 (686)
||+.+|+|.+||++.. .+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999764 599999999999999999999999 99999999999999764 56899999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCc
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~ 557 (686)
|.+.. .......+|++.|||||++..++|+.|+|+||+|++|||+++|+.||+....
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 98763 3344567899999999999999999999999999999999999999985443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=361.81 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=203.3
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC-------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD-------ENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||+++... ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 446788899999999999999995 479999999865421 112233569999999999999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEEec
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDF 495 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Df 495 (686)
..||||||+.||.|.+.+-.+. .+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999997653 477778889999999999999999 99999999999999665 78999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCC---CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
|+|+... ....+.+.+||+.|.|||++.+... ..|.|+||+||+||-+|+|.+||...... .++. +.+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~----eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLK----EQIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHH----HHHh
Confidence 9999765 4455677899999999999987543 34789999999999999999999854321 1111 2222
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.++.... ...-.+..++..+||.+||..||++|||+.|++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 2221110 111234566788999999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.87 Aligned_cols=259 Identities=28% Similarity=0.438 Sum_probs=210.9
Q ss_pred cccccccccCccceEEEEEEE-eCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEe-EEeeCCc-ceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLG-CCLETEV-PLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~lV 423 (686)
.+|.+.++||+|.||+|||+. +.+|..||.|.++. .+....+....|+.+|++|+|||||++++ .+.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458889999999999999998 66899999998764 45566778999999999999999999998 4555544 8999
Q ss_pred EEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 424 YEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASI-SIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~-~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
||++..|+|...|+... .+..+++..+++++.|++.||..+|+.... .|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997643 345689999999999999999999993321 3899999999999999999999999999987
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
..... .....+|||.||+||.+....|+.||||||+||++|||..-+.||.+.+ +. .....+..+....+.|
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~-~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LL-SLCKKIEQGDYPPLPD 250 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HH-HHHHHHHcCCCCCCcH
Confidence 65443 3456789999999999999999999999999999999999999998642 21 1222333332221111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...+..+..|+..|+..||+.||+...++..+..
T Consensus 251 --------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 251 --------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3456789999999999999999996555554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.00 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=210.7
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.+|...++||+|||+.||+++. ..|+.||+|++.. ......+...+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4689999999999999999996 7899999998654 34455678899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|++++++|..++++ +.++++.+++.++.||+.||.|||+. +|+|||||..|++|+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999883 34799999999999999999999999 9999999999999999999999999999887644
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. ...+.+||+-|+|||++....++-.+||||+|||||-||.|++||+.....+ ....++...
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~--------- 234 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNE--------- 234 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcC---------
Confidence 33 3455789999999999999999999999999999999999999997432211 111111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
-..+.....+..+||.++|+.+|.+|||+.+|+.
T Consensus 235 -Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 -YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122344567889999999999999999999984
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=399.36 Aligned_cols=266 Identities=29% Similarity=0.489 Sum_probs=220.7
Q ss_pred ccccccccccCccceEEEEEEEeCC--Cc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD--GR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
..+....+.||+|+||.||.|...+ +. .||||.++.. +.++..+|.+|..+|+.++|||||+++|.|.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456667899999999999999654 33 4899987764 566778999999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIE----EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
++++|||.+|+|..||++... ...|+..+++.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987521 34699999999999999999999999 89999999999999999999999999
Q ss_pred CcccccCCCceeee-eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 497 TSRSITVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 497 la~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
||+.+...+.+... ...-+..|||||.+..+.+|.|+|||||||+|||++| |..||...+..+ .+......+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC
Confidence 99966544433322 2234579999999999999999999999999999999 999997654322 111112222
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
+-+.+..++..+.+|+.+||+.+|++||++..+++.+..+........
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 234456778889999999999999999999999999988876554443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=381.29 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=220.4
Q ss_pred cccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 351 YNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..+.++||.|.||.|++|.++- ...||||.+|.. .+.+..+|+.|+.||.+++||||++|.|........++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999763 457999999874 45566789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
||+||+|+.||+.+.. .+++.++..++++||.||.||.+. ++|||||.++|||++.+..+||+||||+|.+.++.
T Consensus 711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998653 599999999999999999999998 99999999999999999999999999999775544
Q ss_pred ceeeeee--eccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 506 THLTTKV--QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 506 ~~~~~~~--~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
....+.. .-+.+|.|||.+..+++|.+|||||||++|||.++ |.+||..+... .....+..
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHHHHHh
Confidence 2222222 23579999999999999999999999999999998 99998754432 22333344
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
..+-..+.+++..|.+|++.||++|-.+||.+.+|+..|+++..+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 4445566788899999999999999999999999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=349.11 Aligned_cols=242 Identities=29% Similarity=0.410 Sum_probs=203.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.+.|.+.++||+|+||+||.++.. +++.+|+|.++. ....+.+..++|..+|.+++||.||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999965 588999997654 3445667889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
+||+.||.|..+|.+.. .+++..+.-++.+|+.||.|||+. +||||||||+|||||++|.++|+||||++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998643 589999999999999999999999 999999999999999999999999999986432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ...+..++||+.|||||++.+..++.++|.||||+++|||++|.+||...+..+ ..+.+..++
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGK-------- 241 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCc--------
Confidence 2 233455899999999999999999999999999999999999999998644221 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP 612 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 612 (686)
....+.-...+.++++.+.|+.||++|.
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 0111222456688999999999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=350.60 Aligned_cols=253 Identities=30% Similarity=0.467 Sum_probs=205.3
Q ss_pred cccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--cceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV~e 425 (686)
.+|...+.||+|+||.||++...+ |...|||.....+....+.+.+|+.+|++++|||||+.+|.....+ ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999999764 8999999877654444677899999999999999999999855544 6899999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCcccccC-
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITV- 503 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~- 503 (686)
|+++|+|.+++.+... .|++..+.+++.||++||.|||++ +|||+||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999998654 599999999999999999999999 9999999999999999 79999999999987653
Q ss_pred -CCceeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 504 -DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 504 -~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
..........||+.|||||++..+. ...++|||||||+++||+||+.||... .....+........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------- 239 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------- 239 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence 2222344578999999999998643 335999999999999999999999753 11111111111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.....+...+.+..+++.+|++.+|++|||+.++++.
T Consensus 240 --~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 --SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred --CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 1113344456678899999999999999999999954
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=354.63 Aligned_cols=264 Identities=27% Similarity=0.371 Sum_probs=209.0
Q ss_pred ccccccccccCccceEEEEEEE-eCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 422 (686)
.+.|..+++||+|+||.||+|+ ..+|+.||+|++.... +.......+|+.||++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3568888999999999999999 5579999999976644 44455677999999999999999999999876 68999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|+|||++ +|.-++... ...+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999976 777777653 23599999999999999999999999 99999999999999999999999999999888
Q ss_pred CCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH--hhcc-----
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA--MNEN----- 574 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~--~~~~----- 574 (686)
.......+..+-|.+|.|||++.+ ..|+.+.|+||.||+|.||++|++.|.+...-+. +...|.-. ..++
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ--l~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ--LHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH--HHHHHHHhCCCChhccccc
Confidence 777666677778999999999887 4799999999999999999999999987653322 22222111 0111
Q ss_pred hhh--hhhhhhc-----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 RLF--EVLDALV-----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 ~~~--~~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++. ..+.+.. ..+.-........+|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 110 1111000 01111223456789999999999999999999884
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.18 Aligned_cols=264 Identities=24% Similarity=0.362 Sum_probs=206.7
Q ss_pred cccccccccCccceEEEEEEEeCC-CcEEEEEEccccCh-h-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDE-N-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+.|+...++|+|+||+|||.+.++ |+.||||++..... . -.+-.++|+++|++|+|+|+|.|+..|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457778899999999999999764 99999999765433 2 23457899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++..-| +-|.+... .++...+.+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 82 ~~dhTvL-~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVL-HELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHH-HHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 9987444 44555433 388999999999999999999999 999999999999999999999999999998764 3
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCC--------chhHhhHHHhhcchh
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR--------SLVGYFLQAMNENRL 576 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~--------~l~~~~~~~~~~~~~ 576 (686)
....+..+.|.+|+|||.+.+ .+|+...||||+||++.||++|.+-|.+...-+.. ++.....+....+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 344566778999999999987 78999999999999999999999999875433221 111111222222222
Q ss_pred hh-hhhhhc-----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FE-VLDALV-----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~-~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+. +.-+.. .+..-+....-+.++++.||+.||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 111111 11111233456889999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=360.20 Aligned_cols=262 Identities=29% Similarity=0.451 Sum_probs=207.0
Q ss_pred hccccccccccCccceEEEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 418 (686)
..++|.+.++||+|+||.||+|.+ .++..||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346799999999999999999974 235689999876532 33456799999999999 8999999999887644
Q ss_pred -cceEEEEeccCCchhhhhhccCC--------------------------------------------------------
Q 038345 419 -VPLLVYEFVPNGTLYQNIHNHIE-------------------------------------------------------- 441 (686)
Q Consensus 419 -~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 441 (686)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999875321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce-eeeeeecccc
Q 038345 442 ---EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFG 517 (686)
Q Consensus 442 ---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 517 (686)
..++++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 13588899999999999999999998 9999999999999999999999999999865432221 1222346678
Q ss_pred ccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHH
Q 038345 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTV 596 (686)
Q Consensus 518 y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 596 (686)
|+|||++.+..++.++||||||++||||++ |..||......+ .+......+.. ...+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCCHHH
Confidence 999999999999999999999999999997 999997543211 11111111111 01112334568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 597 ATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 597 ~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.24 Aligned_cols=251 Identities=30% Similarity=0.396 Sum_probs=209.3
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
+..++|...+.||+|+|++|++|+.. .++.+|||++.. ..+...+-...|-.+|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34467999999999999999999954 689999998653 2334445567899999999 899999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
|+|+||.+||+|.++|++.+ .+++.....+|.||+.||+|||+. |||||||||+|||||.++.+||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999764 599999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCce------------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 501 ITVDQTH------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 501 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
+...... ....++||..|.+||++..+..+..+|+|+|||+||+|+.|++||.+.+. ...|.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFq 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQ 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHH
Confidence 7533221 11458899999999999999999999999999999999999999986431 11111
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+. +.-+++...++.+.+|+.+.|..||++|+|.++|-+
T Consensus 298 kI~~-----------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 KIQA-----------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHH-----------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111 112334444567889999999999999999988775
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=356.71 Aligned_cols=267 Identities=26% Similarity=0.459 Sum_probs=214.5
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
.++++...+.+.+...||+|.||+||+|.+.+ .||||.++.. ..+..+.|++|+.++++-+|.||+-++|+|....
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 45666666777888999999999999999875 5999998764 4557789999999999999999999999999887
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
. .+|..+++|-+|+.+||.... .+...+.+.||.||++||.|||.+ +|||||||..||+|.+++.|||+||||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 7 999999999999999997553 588899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCC-CceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 499 RSITVD-QTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 499 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
.....- .........|...|||||++.. .+|+..+||||||+++|||++|..||.....+. .+. ++..+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--Iif-----mVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIF-----MVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEE-----Eeccc
Confidence 543211 1112223447789999999853 579999999999999999999999998322211 111 01111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
-++ .|. ........++|.+|+..||..++++||.+.+|+..|+.+...
T Consensus 609 ~l~--pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLM--PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccC--ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 000 000 112234567899999999999999999999999999888764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=359.94 Aligned_cols=266 Identities=28% Similarity=0.438 Sum_probs=217.3
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCC--C--cE-EEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLAD--G--RI-VAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCC 414 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 414 (686)
.++..-++....++||+|+||.||+|.+.. + .. ||||..+. ..+....+|++|++++++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344444556666899999999999999653 2 23 89998774 4577789999999999999999999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
.....++||||+++||+|.++|.+... .++..++++++.+.|.||+|||++ +++||||.++|+|++.++.+||+|
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999997654 599999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCceeee-eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhh
Q 038345 495 FGTSRSITVDQTHLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 495 fGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
|||++... ...... ...-+..|+|||.+....++.++|||||||++||+++ |..||.+....+ ....+
T Consensus 306 FGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~kI- 375 (474)
T KOG0194|consen 306 FGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAKI- 375 (474)
T ss_pred cccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHHH-
Confidence 99987643 111111 2235789999999999999999999999999999999 899998654321 11111
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
+-.......+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 376 -------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 -------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 011111222335566788999999999999999999999999998876554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=337.26 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=211.3
Q ss_pred ccccccccccCccceEEEEEEE-eCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.+.|.+..+||.|..++||+|+ ...+..||||++.... ..+.+.+.+|+..++.++||||++++-.|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568889999999999999999 4568999999977643 3346889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
||.+|++.+++...-.. .+.+..+..|++++++||.|||.+ |.||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999876544 499999999999999999999999 99999999999999999999999999886654333
Q ss_pred ceee---eeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 506 THLT---TKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 506 ~~~~---~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.... ..++||+.|||||++.. ..|+.|+||||||++..||.+|..||....+-+ .....+.... ...+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vLl~tLqn~p-p~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VLLLTLQNDP-PTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HHHHHhcCCC-CCcc
Confidence 2211 45689999999999543 468999999999999999999999998655321 1111222111 1000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
-..+..+........|.+++..||+.||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111223334455668999999999999999999999885
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=350.50 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=208.7
Q ss_pred hccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhH-HHHHHHHHHHHhcC-CCCeeeEEeEEeeCC-cceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNV-EQFINEVVILSQIN-HRNIVKLLGCCLETE-VPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~l 422 (686)
..++|...++||.|+||.||+|+ ...+..||||+++..-.... -.-++|+..|++|+ ||||++|...+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34689999999999999999999 45689999998775322221 22368999999998 999999999999988 8999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|||||+ .+|++++++. +.++++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+||||||.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc
Confidence 999996 6999999876 55899999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeeeeeccccccCccccc-cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc------h
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN------R 575 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------~ 575 (686)
.. ...+..+.|.+|+|||++. .+.|+.+.|+||+|++++||.+-++-|.+....+...-+-.+....... .
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 3356678899999999864 5789999999999999999999999998765332221111111111111 1
Q ss_pred hhhhhh---hh----ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 576 LFEVLD---AL----VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 576 ~~~~~d---~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
+...+. +. -....-.....+..+|+.+|+++||++|||+.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111110 00 0111222356788999999999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.79 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=212.2
Q ss_pred cccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
..|....+||+|+.|.||.|. ..+++.||||++........+-+++|+.+|+..+|+|||+++..|...+.+++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457777899999999999998 4568899999988877777788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+.+... .+++.++..|..++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999988754 399999999999999999999999 9999999999999999999999999999888765543
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....||+.|||||++....|+.|.||||||+|++||+-|++||-...+ +.. ...+..+ ....-.
T Consensus 426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrA-lyLIa~n-------g~P~lk 490 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRA-LYLIATN-------GTPKLK 490 (550)
T ss_pred -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHH-HHHHhhc-------CCCCcC
Confidence 4456799999999999999999999999999999999999999964221 111 1111111 011122
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......|.+++.+||+.|+++||+++|+|+
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 33455678999999999999999999999995
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=359.22 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=214.0
Q ss_pred ccccccCccceEEEEEEEe-CCC----cEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 352 NANRILGQGGQGTVYKGML-ADG----RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
...++||+|+||+||+|.+ ..| -+||||.+.. ...+...++++|+-+|.+++|||+++|+|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468999999999999984 333 4789998654 34455688999999999999999999999998776 889999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
||+.|+|.+|++.+. ..+-.+..+.|..|||+||.|||.+ .+|||||.++|||+..-..+||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999998754 4588899999999999999999999 99999999999999999999999999999987665
Q ss_pred ceeee-eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 506 THLTT-KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 506 ~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
..... ...-.+.|||-|.+....|+.++|||||||++|||+| |..|+.+...+|. .+++...
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------------~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------------PDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh----------------hHHHhcc
Confidence 54433 2334678999999999999999999999999999999 9999987765442 2222222
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.+-..++.+..++..++.+||..|+..||+++++..++.+..+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 22344566778899999999999999999999999999876553
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=349.71 Aligned_cols=244 Identities=32% Similarity=0.525 Sum_probs=204.3
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
...++-||.|+.|.||+|+++ ++.||||+++...+ .+++-|++|+|+||+.+.|+|......+|||||++.|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 334568999999999999996 78999998764333 4678899999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
.|...|+.. .+++...+..|.++||.||.|||.+ .|||||||.-||||..+..+||+|||.++..... ....
T Consensus 198 qL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkM 269 (904)
T KOG4721|consen 198 QLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKM 269 (904)
T ss_pred cHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhh
Confidence 999999853 4688899999999999999999999 9999999999999999999999999999876533 2234
Q ss_pred eeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
.+.||..|||||++...+.+.|.|||||||||||||||..||...+. ..+ ++.+-...+.-..+.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAI-----------IwGVGsNsL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAI-----------IWGVGSNSLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----hee-----------EEeccCCcccccCcc
Confidence 57899999999999999999999999999999999999999974321 111 111111112223455
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.++..|.-|+++||+..|..||++++++..|+-..
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 66778999999999999999999999999887544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=316.82 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=207.0
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChh--hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDEN--NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|...++||+|.||.||+|+. .+|+.||||+++..... -.....+|++.|+.++|+||+.|+++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999994 57999999998764332 23567899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
||+ .+|+..|++. ...++..++..++.++++||+|||++ .|+||||||+|+|+++++.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 5899888864 34799999999999999999999999 89999999999999999999999999999887554
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh---hhh
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE---VLD 581 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~d 581 (686)
...+.. +-|.+|.|||.+.+ +.|+...|+||.||++.||+.|.+-|.+...-+....+-.......++++.+ +.|
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 443333 57999999999876 5799999999999999999999887776543322211111111111111111 111
Q ss_pred hh--------ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 AL--------VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~--------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
-. .....-........+|+..+|..||.+|++++|+++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 10 011122234456789999999999999999999984
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.56 Aligned_cols=262 Identities=22% Similarity=0.405 Sum_probs=206.6
Q ss_pred cccccChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhh---HHHHHHHHHHHHhcCCCCeeeEE
Q 038345 335 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENN---VEQFINEVVILSQINHRNIVKLL 411 (686)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~ 411 (686)
..+.++.++++. .....||+|++|.||+|.+ +|+.||||.++...... .+.|.+|+.+|++++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344455555532 2235799999999999998 58899999876543322 57788999999999999999999
Q ss_pred eEEee----CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC
Q 038345 412 GCCLE----TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK 487 (686)
Q Consensus 412 g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 487 (686)
|++.+ ....++||||+++|+|.+++... ..+++...++++.|++.||.|||+.. +++||||||+|||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCC
Confidence 99977 34678999999999999999754 35899999999999999999999743 67799999999999999
Q ss_pred CcEEEEecCCcccccCCCceeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH
Q 038345 488 YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~ 565 (686)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+
T Consensus 160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------ 229 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------ 229 (283)
T ss_pred CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------
Confidence 999999999998654221 22357899999999976 689999999999999999999999997543211
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
........+. ....+...+..+.+++.+||+.||++|||++||++.|+.++.
T Consensus 230 ~~~~i~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 230 IYDLIINKNN---------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHHHhcCC---------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111111110 011122345678999999999999999999999999998763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=336.01 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=205.8
Q ss_pred cccccccccCccceEEEEEEEeC----CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999853 35689999877642 33456799999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999997643 3589999999999999999999998 999999999999999999999999998765432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
..........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +...+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~------- 225 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGF------- 225 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC-------
Confidence 22111222335678999999999999999999999999999875 999997543211 111111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
....+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus 226 --~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 --RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0111223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=346.78 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=226.0
Q ss_pred HHhhccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++--..+....++||-|-||.||.|.|+. ...||||.++.. ....++|+.|+.+|+.++|||+|+|+|.|..+...||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33333445667899999999999999875 678999998864 4567899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|.|||.+|+|.+||++... ..++.-.++.+|.||+.||+||..+ .+|||||.++|.|+.++..+||+||||++++.
T Consensus 341 iTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999997643 3577788899999999999999999 89999999999999999999999999999998
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.+.........-++.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+. .+..+++.
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY~LLE 480 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYGLLE 480 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHHHHHh
Confidence 766555555556789999999999999999999999999999999 9999876432 23445565
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
...+-+.+..++..+.+|++.||+++|.+||++.|+-+.++.+.
T Consensus 481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 55666677788999999999999999999999999999987654
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=351.61 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred ccccccccccCccceEEEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||+++++++.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 235689999986432 33456789999999999 89999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCC----------------------------------------------------------
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE---------------------------------------------------------- 441 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 441 (686)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 442 --------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 442 --------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
...+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 12478999999999999999999998 9999999999999999999999999999866433221
Q ss_pred e-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 508 L-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 508 ~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
. .....++..|+|||++.+..++.++||||||+++|||++ |..||....... .+...+..+ ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~---------~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEG---------YR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhC---------cc
Confidence 1 122335668999999999999999999999999999998 889986543211 111111111 00
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...+...+.++.+|+.+||+.||++||++.+|++.|+.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11111224568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.67 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=203.0
Q ss_pred cccccccccCccceEEEEEEEeCC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-----------------GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKL 410 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 410 (686)
++|.+.++||+|+||.||++.+.+ +..||+|.+... ......+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999998532 336999987653 23345679999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCchhhhhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038345 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHI----------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474 (686)
Q Consensus 411 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 474 (686)
++++.+.+..++||||+++|+|.+++.... ....+++..+++++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999886532 112478899999999999999999998 9999
Q ss_pred eCCCCCCeeecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh--CCCC
Q 038345 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKP 551 (686)
Q Consensus 475 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt--g~~p 551 (686)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 1223345788999999998899999999999999999987 5677
Q ss_pred CccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 552 IRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 552 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
|......+ ............. .......+...+..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76433211 1111111111100 00001111233467899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=351.23 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=205.5
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|+.. ++..||||+++.. .....+.+.+|+.+++.+ +|+||+++++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999998842 2457999998653 233456788999999999 89999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCC----------------------------------------------------------
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE---------------------------------------------------------- 441 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 441 (686)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce-eeee
Q 038345 442 ---------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTK 511 (686)
Q Consensus 442 ---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~ 511 (686)
..++++..+++++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 12478899999999999999999998 9999999999999999999999999999765433221 1122
Q ss_pred eeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 512 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
..++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .+....... .....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCccCCC
Confidence 235678999999999999999999999999999997 999997533211 011111111 0011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+.++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 22457899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=342.70 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=207.6
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc----Ch-hhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV----DE-NNVEQFINEVVILSQIN-HRNIVKLLGCCLETE 418 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 418 (686)
....+|...+.||+|+||+|++|... ++..||+|..... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44568999999999999999999854 6899999965542 11 23456778999999999 999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCC
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGT 497 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGl 497 (686)
..++||||+.+|+|++++.+. ..+.+..+.+++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 999999999999999999873 3588999999999999999999999 99999999999999999 9999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCC-CC-ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ-FT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.... ....+. .+..++
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------~~~l~~-ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------VPNLYR-KIRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------HHHHHH-HHhcCC
Confidence 98764 2223345578999999999999877 75 78999999999999999999997521 111111 111111
Q ss_pred hhhhhhhhccChhhHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 576 LFEVLDALVLKEAEREE-IMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~-~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
. ..+... ..++..|+.+||..+|.+|+++.+++ .-.-++
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 0 111122 56789999999999999999999999 444444
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.83 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=208.8
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888899999876532 34578999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999997642 33588999999999999999999998 9999999999999999999999999999876433222
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++....++.++||||||+++|||++ |+.||......+ ....+.... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY---------RM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 2233346778999999998899999999999999999998 999996432111 111111110 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
......+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=314.02 Aligned_cols=236 Identities=28% Similarity=0.380 Sum_probs=201.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|...+.||.|+||+|.+.+.+ +|..+|+|.++. ....+.+...+|..+|+.+.||.+++|.+.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 588999998765 34455677889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||++||.|+.+|++.. .+++..+.-+|.||+.||+|||+. +|++|||||+|||||.+|.+||+|||.|+.....
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 9999999999998654 599999999999999999999999 9999999999999999999999999999876422
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
+-+.+||+.|+|||.++...+..++|.|||||++|||+.|.+||...++.. ..+. ++...
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~K--------I~~~~- 257 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEK--------ILEGK- 257 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHH--------HHhCc-
Confidence 556789999999999999999999999999999999999999998554311 1111 11111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCC
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNR 611 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~R 611 (686)
-.++.-....+.+|+...|+.|-.+|
T Consensus 258 -v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 -VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 13445556678899999999999888
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=330.32 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=208.9
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..++|.+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788999999999999999998778899999876533 2356799999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997643 33589999999999999999999998 999999999999999999999999999987653222
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
........+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQG---------YR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC---------CC
Confidence 21222223467999999999999999999999999999999 999986532111 11111111 00
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
...+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=339.30 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=209.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+... .+.+.+.+.+|++++++++|||||.++..|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999954 5789999986543 34456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+.+ +|..+|.... .++++.+..|+.+++.||.|||+. +|+|||+||.||||+.++.+|++|||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9976 9999998643 599999999999999999999999 999999999999999999999999999998764 3
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
+...+.+.||+-|||||++.+++|+..+|+||+||++||+++|++||.... +.+++...+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------------------i~~Lv~~I~~ 214 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------------------ITQLVKSILK 214 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------------------HHHHHHHHhc
Confidence 456677899999999999999999999999999999999999999996322 1111111111
Q ss_pred C--hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 K--EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+ ..+......+..++...|..||..|.+..+++.
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 123356678999999999999999999998874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.59 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=203.5
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
+.|.+.+.||+|+||.||++.+.++..+|+|..... ....++|.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357788999999999999999888889999987643 2234678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999987543 2589999999999999999999998 99999999999999999999999999998654333222
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .....+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~-~~i~~~~~---------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVV-EMISRGFR---------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHHCCCC---------CC
Confidence 223345678999999998899999999999999999999 89998643211 111 11111100 00
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
.+......+.+++.+||+.+|++||+++++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112245689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=339.59 Aligned_cols=264 Identities=24% Similarity=0.358 Sum_probs=216.8
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhH-HHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV-EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.....+.++||+|-||.|.+.....+..||||+++.....+. .+|.+|+++|.+|+||||++|+|.|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 345667789999999999999998889999999987655554 8899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
|++|+|.++|..+.... +.-....+|+.||+.||+||.+. .+|||||.++|+|++.++++||+|||++|.+...+.
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999998874332 45566778999999999999998 999999999999999999999999999997655444
Q ss_pred ee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh--CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 507 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 507 ~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt--g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
+. .....-+.+|||+|.+.-+++|.+||||+||++|||+++ ...||.....+. .++..-.....+.. .
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~------~ 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR------Q 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc------c
Confidence 33 344556789999999999999999999999999999876 889987554321 22222122221111 1
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
..-..+.-++..+.+++.+||..+.++||+++++...|++.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 12233456677899999999999999999999999888764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=333.50 Aligned_cols=251 Identities=26% Similarity=0.321 Sum_probs=201.0
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999995 478999999865321 2233467899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998886532 23589999999999999999999998 99999999999999999999999999998653222
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
......||..|+|||++.+..++.++||||||+++|||++|+.||....... ........... ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~----------~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKE----------DQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhc----------cc
Confidence 2234468999999999999999999999999999999999999997543211 00011111100 01
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
...+......+.+|+.+||+.||++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1122334567889999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=331.11 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=213.5
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+...+|...++||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567899999999999999999988899999999877665566789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999998643 34689999999999999999999998 99999999999999999999999999997664322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. .....++..|+|||.+....++.++||||||+++++|++ |+.||......+ . + .... ...
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~---~-~~~~---------~~~ 221 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V---Y-DQIT---------AGY 221 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H---H-HHHH---------hCC
Confidence 21 223345778999999998899999999999999999998 899996533111 1 1 1111 111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
....+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=332.73 Aligned_cols=249 Identities=34% Similarity=0.570 Sum_probs=195.9
Q ss_pred cccccCccceEEEEEEEeC-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 353 ANRILGQGGQGTVYKGMLA-----DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2568999998654 334478999999999999999999999999988889999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC-
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ- 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~- 505 (686)
+++|+|.++|... ....+++..++.|+.||++||+|||+. +|+|+||+++|||+++++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 234699999999999999999999998 99999999999999999999999999998763222
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
............|+|||.+....++.++||||||+++|||++ |+.||...... . +...+.+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~-~~~~~~~~~--------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------E-IIEKLKQGQ--------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------H-HHHHHHTTE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-ccccccccc---------
Confidence 222233457789999999999999999999999999999999 78887643211 1 111111111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
....+...+..+.+++.+||+.+|++||++++++++|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112223455688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=329.06 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=207.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
..|.+.+.||+|+||.||+|... .++.||+|..... ......+.+|+.++++++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35778899999999999999965 4889999987643 334577999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+|||+++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999997543 23589999999999999999999998 9999999999999999999999999999876433222
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ . ..... .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~-~~~~~---------~~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V-YELLE---------KGYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HHHHH---------CCCCC
Confidence 2222234668999999999999999999999999999998 999986432211 1 11111 11111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
..+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.15 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=208.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..|+..+.||+|.||.||+|... .++.||+|.+... .+...+++.+|+.+|.+++++||.+++|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34677789999999999999954 5889999987653 345578899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+.+|++.+.|.... .+.+..+.-|+++++.||.|||++ +.+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999997532 357778888999999999999999 899999999999999999999999999988765544
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
.. ..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+.. ..-++-.....
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCC
Confidence 43 66889999999999998899999999999999999999999997654311 11111111111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........|.+++..||..+|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 122255667999999999999999999999885
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=331.04 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=208.0
Q ss_pred cccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
++|.+.+.||+|+||.||+|.... ...||+|.++... ......|.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999998643 2579999876533 334467899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 422 LVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975421 13588999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHh
Q 038345 489 RAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~ 566 (686)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 22233456788999999998899999999999999999998 999987543211
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
....+... .....+...+.++.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus 235 ~~~~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111 11122334567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.07 Aligned_cols=260 Identities=28% Similarity=0.458 Sum_probs=210.6
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888999999999999999842 345689998876666666789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 423 VYEFVPNGTLYQNIHNHI----------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 123589999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+++........ ......++..|+|||++.+..++.++||||||++++||++ |+.||......+ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 999999865432211 1222335778999999998999999999999999999999 999986543211 1111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
+..+.... .+...+..+.+|+.+||+.+|.+|||+++|++.|+.+...
T Consensus 235 i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 12111111 1112345689999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.44 Aligned_cols=257 Identities=23% Similarity=0.470 Sum_probs=204.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.+|+..+.||+|+||.||+|++. ++. .||+|.++.. .....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888999999999999999854 333 4899987653 334557899999999999999999999999764 5789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 999999999999998643 3488999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceee-eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
....... ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~----- 228 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE----- 228 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCC-----
Confidence 4332221 22234678999999999999999999999999999998 999986432211 111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
....+......+.+++.+||+.+|.+||++.+++..|..+...
T Consensus 229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 0011112335688999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.33 Aligned_cols=261 Identities=25% Similarity=0.390 Sum_probs=207.4
Q ss_pred hccccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETE 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 418 (686)
..++|.+.++||+|+||.||+|+... +..||||+++... ....+.|.+|+.+++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 35678899999999999999998531 3479999986533 334567999999999996 999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCC---------------------------------------------------------
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE--------------------------------------------------------- 441 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 441 (686)
..+|||||+++|+|.++|+....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998865311
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec
Q 038345 442 ------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485 (686)
Q Consensus 442 ------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 485 (686)
...+++..++.++.|+++||+|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 12478889999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCch
Q 038345 486 DKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSL 563 (686)
Q Consensus 486 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l 563 (686)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---- 347 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---- 347 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH----
Confidence 9999999999999865432221 1222346788999999999999999999999999999997 999986532211
Q ss_pred hHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 564 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.+....... .....+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 348 --~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 111111111 001112234567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.91 Aligned_cols=253 Identities=25% Similarity=0.338 Sum_probs=204.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999976 5889999987642 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999754 2589999999999999999999999 999999999999999999999999999976532
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+....... ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~---~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWK---ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcc---ccccCCC
Confidence 2234568999999999999999999999999999999999999997543221 111100000 0000000
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
..........++.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 011112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=325.75 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=204.0
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.+.||+|+||.||+|...++..+|+|.+.... ...+.|.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3577889999999999999998777789999876432 234679999999999999999999999999899999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|+|.+++..... .+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976432 589999999999999999999998 99999999999999999999999999998654333222
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......... ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLR---------LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCC---------CC
Confidence 222345678999999998889999999999999999999 999986433211 1111111100 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.18 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=206.7
Q ss_pred cccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|...+.||+|+||.||+|.+.. ...||||..+.. .......|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999999742 457999987653 333456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++..... .+++..+++++.|++.||+|||+. +|+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999976432 589999999999999999999998 999999999999999999999999999987652
Q ss_pred CCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 504 DQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 504 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ +.......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~------- 224 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDG------- 224 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcC-------
Confidence 222 12222335678999999999999999999999999999998 999986432111 11111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.....+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111223356689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.45 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=207.0
Q ss_pred cccccccccCccceEEEEEEEeCC------CcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.|.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999998764443 4578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 422 LVYEFVPNGTLYQNIHNHI-----------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
+||||+++++|.++|.... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997542 123588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhH
Q 038345 491 KVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 491 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~ 568 (686)
||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999976533221 11223345788999999999999999999999999999999 999986543211 11
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.....+. ....+...+..+.+++.+||+.+|++||++.||+++|+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11112234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.80 Aligned_cols=265 Identities=22% Similarity=0.246 Sum_probs=201.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|.+.+.||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999976 5789999987643 22335678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++++.|..+... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9998777654432 23589999999999999999999998 99999999999999999999999999998764333
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh---------HHHhhcchh
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF---------LQAMNENRL 576 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~ 576 (686)
........|++.|+|||++.+..++.++||||||+++|||++|+.||......+........ .........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 22333456899999999999989999999999999999999999999754321110000000 000000000
Q ss_pred hhhhhhhcc------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALVL------KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+... ..........+.+|+.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0001123456999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.19 Aligned_cols=264 Identities=29% Similarity=0.446 Sum_probs=205.4
Q ss_pred cccccccccCccceEEEEEEEeC-----CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-----DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~ 421 (686)
++|.+.+.||+|+||.||++... ++..||+|++........+.|.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46888899999999999999742 478999999877666667889999999999999999999998754 34678
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999997542 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc-----
Q 038345 502 TVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN----- 574 (686)
Q Consensus 502 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----- 574 (686)
....... .....++..|+|||++.+..++.++||||||++++||++|..|+...... +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 4332211 11122345699999999889999999999999999999988775432110 11110000
Q ss_pred ---hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 575 ---RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 575 ---~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.+.+.+............+..+.+|+.+||+.+|++|||+++|++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 011111111111112233457999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=381.54 Aligned_cols=262 Identities=27% Similarity=0.439 Sum_probs=212.6
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
...|...++||+|+||.||+|.. .++..||||++...... ..+|++++++++|||||+++|++.+....++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34577788999999999999996 47899999987643321 23568899999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++|+|.++++. ++|..+.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+.....+
T Consensus 765 ~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 765 IEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 999999999962 8899999999999999999997666699999999999999999888876 6665433211
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.... ........|............++|+.+..
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12357899999999999999999999999999999999999995432 23345555555444444444555554432
Q ss_pred --hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 587 --EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 587 --~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
....+...++.+++.+||+.+|++||+|+||+++|+.+.+
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2334566788999999999999999999999999998765
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.66 Aligned_cols=260 Identities=27% Similarity=0.428 Sum_probs=211.2
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.+|.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999742 345789999876666666789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 423 VYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
||||+++++|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999975421 23489999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhh
Q 038345 490 AKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYF 567 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~ 567 (686)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 11223446788999999999999999999999999999999 999986543211 1
Q ss_pred HHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 568 LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 568 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
...+..+... ......+..+.+++.+||+.+|++||++.+|+++|+.+...
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1112211111 11223356789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=332.38 Aligned_cols=249 Identities=25% Similarity=0.345 Sum_probs=202.5
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
....++|..+++||+|+||.||+++.+ +|..+|+|+++.. ...+++..+.|-.+|....+|.||+|+-.|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 335678999999999999999999965 5999999998763 455677888999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
||||||++||++..+|.+.. .|++..+..++.+++-|++-||+. |||||||||+|+|||..|.+||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999998653 699999999999999999999999 999999999999999999999999999853
Q ss_pred ccC-----------------------CCc-----e------------------eeeeeeccccccCccccccCCCCcccc
Q 038345 501 ITV-----------------------DQT-----H------------------LTTKVQGTFGYVDPEYFQSSQFTEKSD 534 (686)
Q Consensus 501 ~~~-----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~t~ksD 534 (686)
+.. +.. . .....+|||-|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 210 000 0 011356999999999999999999999
Q ss_pred EeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038345 535 VYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT 613 (686)
Q Consensus 535 v~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 613 (686)
.|||||||||||.|.+||....+.+.-.-+......+. .........+..+||.+|+. ||++|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999987665432111111111111 11111223678899999999 9999975
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.26 Aligned_cols=261 Identities=28% Similarity=0.408 Sum_probs=204.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||++... ++..||+|..... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999965 5788999987653 23345679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997543 5889999999999999999999863 6999999999999999999999999999765322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh--------------
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM-------------- 571 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~-------------- 571 (686)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+ +...+....
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233468999999999999999999999999999999999999996433211 000000000
Q ss_pred ----------------hcchhhhhhhhhcc----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 ----------------NENRLFEVLDALVL----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ----------------~~~~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......++.+.... .........++.+|+.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000111111100 0011124567899999999999999999999984
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.93 Aligned_cols=261 Identities=29% Similarity=0.458 Sum_probs=206.0
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC-C
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLET-E 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 418 (686)
.++|.+.++||+|+||.||+|... .++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 357899999999999999999742 24789999876432 33456788999999999 899999999988654 5
Q ss_pred cceEEEEeccCCchhhhhhccCC---------------------------------------------------------
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE--------------------------------------------------------- 441 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 441 (686)
..+++|||+++++|.++|.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864221
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee-eeeeecccccc
Q 038345 442 -EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL-TTKVQGTFGYV 519 (686)
Q Consensus 442 -~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 519 (686)
..++++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 12689999999999999999999998 99999999999999999999999999998764322211 22234567899
Q ss_pred CccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHH
Q 038345 520 DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598 (686)
Q Consensus 520 aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 598 (686)
|||++.+..++.++||||||++||||++ |+.||......+ .+...+.... ....+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT---------RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC---------CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 999997533221 1111111111 11112233457899
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 599 LAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 599 l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
++.+||+.+|++||++.||++.|+++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.56 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=199.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999975 5889999987542 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997542 588999999999999999999998 9999999999999999999999999999865432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+....+
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~-------- 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGRL-------- 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCCc--------
Confidence 2 2346899999999999999999999999999999999999999643211 1 1111111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVA 618 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~ 618 (686)
..+......+.+|+.+||+.||.+||+ +++++
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 111123346789999999999999997 56665
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.78 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=196.8
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6889999987642 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 999998754 3589999999999999999999999 99999999999999999999999999987532221 2233
Q ss_pred eeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~~~~~~----------~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMEE----------IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHH-HHHHcCC----------CCCCC
Confidence 456999999999999999999999999999999999999999643211 111 1111100 11122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 591 EEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3456688999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.46 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=202.4
Q ss_pred ccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+|.+.+.||+|+||.||+|...++..+|+|...... .....|.+|+.++++++|+||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998877889999875422 2335788999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999975432 589999999999999999999998 999999999999999999999999999976543222222
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ....... .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~---------~~~~~ 222 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V----VESVSAG---------YRLYR 222 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H----HHHHHcC---------CcCCC
Confidence 22234567999999999999999999999999999999 899987533211 1 1111111 00111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 223456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.99 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=204.7
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|.+.++||+|+||.||+|...++..||+|.+..... ..+.|.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 356888999999999999999988888899998765332 3467999999999999999999999875 45689999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999997642 23589999999999999999999998 9999999999999999999999999999765433222
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... . ....+.. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~---------~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------E-VLEQVER---------GYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHc---------CCCC
Confidence 2222335678999999988899999999999999999999 89998643211 1 1111111 1111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
..+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.26 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=205.4
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|.+.++||+|+||.||+|...+...||+|++..... ..+.|.+|+.++++++|+||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356899999999999999999987777899998875322 3467899999999999999999999874 45679999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999997542 23589999999999999999999998 9999999999999999999999999999766433322
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ........ ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcC---------CCC
Confidence 2223346778999999998899999999999999999999 888886432111 01111100 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
......+..+.+++.+||+.+|++||+++++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11234456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.61 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=204.5
Q ss_pred hccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
..++|++.+.||+|+||.||+|... .+..||+|+.... ......+|.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999753 2467999987543 23345678999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE-------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875322 23468899999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999997654322211 112345778999999999999999999999999999999 788886432211 1111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
....... ..+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111111 112233456899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.88 Aligned_cols=263 Identities=28% Similarity=0.424 Sum_probs=209.7
Q ss_pred HHhhccccccccccCccceEEEEEEEeCC------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEe
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCL 415 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 415 (686)
++...++|...+.||+|+||.||++...+ ...+|+|..... ......++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 34445678889999999999999998642 367999987643 334456789999999999 8999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHI-------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
.....++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 9999999999999999999997531 234689999999999999999999998 999999999999
Q ss_pred eecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccC
Q 038345 483 LLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~ 560 (686)
|+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 9999999999999999876433221 1222335678999999998999999999999999999998 999986433211
Q ss_pred CchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.......+ .....+......+.+|+.+||..+|++|||++++++.|+.+.
T Consensus 243 ------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ------LFKLLKEG---------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111 111122233457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.60 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=206.7
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+.|.+.++||+|+||.||+|...+++.||+|.+..... ..+.|.+|+.++++++|+||+++++++ ..+..++||||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 3467889999999999999999988899999998765332 346899999999999999999999986 45678999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999999987543 34689999999999999999999998 999999999999999999999999999976643322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......++..|+|||++....++.++||||||++++||++ |+.||......+ ....+... ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERG---------YR 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcC---------CC
Confidence 22223345778999999998899999999999999999999 999997443211 11111111 11
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...+...+.++.+++.+||..+|++||++++++..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11112234569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.24 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=201.9
Q ss_pred ccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc--CCCCeeeEEeEEeeCC----cceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI--NHRNIVKLLGCCLETE----VPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~----~~~lV 423 (686)
.....++||+|.||.||||.+. ++.||||++. ..+.+.|++|-.|.+.. +|+||+++++.-.... .++||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 4455679999999999999986 5899999876 44557888888887664 8999999999876555 78999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc------CCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA------ASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
+||.+.|+|.+||..+ .++|....+|+.-+++||+|||+. .+++|+|||||++||||..+++..|+||||
T Consensus 287 t~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999876 499999999999999999999973 467899999999999999999999999999
Q ss_pred cccccCCCce-eeeeeeccccccCccccccCC-CC-----ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 498 SRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQ-FT-----EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 498 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
|..+...... .....+||.+|||||++.+.- +. .+.||||+|.|||||+++-.-+......+.. ..|...
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq---lpfe~e 439 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ---LPFEAE 439 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc---CchhHH
Confidence 9887643322 223357999999999987642 22 3789999999999999976655321111111 111111
Q ss_pred hhcch----hhhh-----hhhhccCh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 571 MNENR----LFEV-----LDALVLKE-AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 571 ~~~~~----~~~~-----~d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
+.... +.++ ..+.+.+. ..-..+..+.+.+..||..||+.|.|+.=|.+++..+....
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 11111 1111 11111100 00133567899999999999999999999999998876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.21 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=199.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999965 6889999987542 2234467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997543 589999999999999999999998 9999999999999999999999999999865422
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~-~~~i~~~~--------- 214 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GI-YEKILAGK--------- 214 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHhCC---------
Confidence 22346899999999999999999999999999999999999999753211 11 11111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVA 618 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~ 618 (686)
...+......+.+|+.+||+.||.+||+ +++++
T Consensus 215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l 252 (291)
T cd05612 215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK 252 (291)
T ss_pred -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence 0112223456889999999999999995 66665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.48 Aligned_cols=264 Identities=27% Similarity=0.424 Sum_probs=208.2
Q ss_pred cccccccccCccceEEEEEEEeCC-C--cEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-G--RIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.++||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998754 3 34788887643 344456799999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 424 YEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
|||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999975321 12588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~-------~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-------LYE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 99999998643211 11111223567999999998899999999999999999998 999996443211 111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
.. ........+......+.+|+.+||+.+|.+||++.++++.|+.+....+..+.
T Consensus 230 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~ 284 (297)
T cd05089 230 KL---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVN 284 (297)
T ss_pred HH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccccc
Confidence 11 11111111223445688999999999999999999999999998876655443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=331.83 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=196.4
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
++||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 6899999987642 2344567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 999888753 3589999999999999999999998 99999999999999999999999999987543221 1223
Q ss_pred eeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~~~~-----------~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMED-----------IKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhccCC-----------ccCCC
Confidence 4569999999999999999999999999999999999999996432111 111110000 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 591 EEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3345688999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.52 Aligned_cols=267 Identities=29% Similarity=0.424 Sum_probs=204.3
Q ss_pred cccccccCccceEEEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceE
Q 038345 351 YNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 422 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 422 (686)
|...+.||+|+||+||++.. .++..||+|..+... ......|.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988653 357889999876533 23456788999999999999999999998764 35789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999753 489999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......++..|+|||.+....++.++||||||++++||++|+.||....... ...............+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 32211 1122235667999999998899999999999999999999999986432110 00010000001111122222
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
+.......+...+..+.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222211222334567999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.77 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=204.3
Q ss_pred cccccccccCccceEEEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
+.|++.+.||+|+||.||+|.. .++..||+|.+... .......|.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999984 24678999988643 33445678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 423 VYEFVPNGTLYQNIHNHIE--------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999863321 23488999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHh
Q 038345 489 RAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~ 566 (686)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999976543221 12223345678999999988889999999999999999998 99998643211 1
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
........... ..+......+.+++.+||+.+|.+||++.+|+++|..
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111 1112234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.38 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=204.4
Q ss_pred ccccccccCccceEEEEEEEeC-C-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-D-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.|.+.+.||+|+||.||+|... + +..||+|............+.+|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999854 3 6788889776555555667889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 428 PNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 428 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++|+|.++|.... ...++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886532 334689999999999999999999998 999999999999999999999999999987643221
Q ss_pred -eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... +..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~--------- 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKY--------- 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC---------
Confidence 1233456999999999999999999999999999999999999999643211 11111100 000
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112234457899999999999999999999874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.18 Aligned_cols=243 Identities=28% Similarity=0.402 Sum_probs=206.6
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCc
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV 419 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 419 (686)
....++|...++||+|.||+|+++.++ +++.+|||.++. ....+++..+.|-.|+.... ||.++.|+.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999976 578999998775 34566788899999988885 9999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+.||++..+.+. ..+++..+.-+|..|+.||+|||++ +||+||||.+|||||.+|.+||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999996555543 2589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
..- .....+.++.||+.|||||++.+..|+.+.|.|||||+|||||.|..||.+.+.+| +
T Consensus 517 e~m-~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~ 576 (694)
T KOG0694|consen 517 EGM-GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------V 576 (694)
T ss_pred ccC-CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------H
Confidence 643 23345677899999999999999999999999999999999999999998654322 1
Q ss_pred hhhhccC--hhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 580 LDALVLK--EAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 580 ~d~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
.|..+.+ .++.-.+.+...|++++|..+|++|.-+
T Consensus 577 FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1111111 2345567788999999999999999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.94 Aligned_cols=237 Identities=25% Similarity=0.311 Sum_probs=192.8
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999965 5789999987542 334456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 9999754 2589999999999999999999998 99999999999999999999999999997543222 223345
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+....... ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~-----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP-----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC-----------CCCCCcC
Confidence 699999999999999999999999999999999999999974321 11111111110 1112234
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEV 617 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev 617 (686)
...+.+++.+||+.||++||++..+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 4568899999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.40 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=213.0
Q ss_pred hccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-----c
Q 038345 347 ATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV-----P 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~ 420 (686)
..++|++.+.||+|||+-||++. +.+++.+|+|++.....++.+..++|++..++++||||++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34689999999999999999999 67789999999887777888999999999999999999999999876544 8
Q ss_pred eEEEEeccCCchhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
||+++|...|+|.+.+.+...+ ..+++.+.++|+.+|.+||.+||+..+ ++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999875433 379999999999999999999999844 69999999999999999999999999987
Q ss_pred cccCCCceee--------eeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 500 SITVDQTHLT--------TKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 500 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
.....-.... ..-.-|..|.|||.+. +...+++.|||||||+||+|+.|..||+.... ...++.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla---- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA---- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE----
Confidence 6532211111 1123578899999874 45678999999999999999999999974322 111111
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+....+........++.+.+++++||+.||.+||+..+++..++.+.
T Consensus 253 --------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 --------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111112211222236778999999999999999999999999998764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=347.46 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=216.1
Q ss_pred HHhhccccccccccCccceEEEEEEEeCCC-cEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEe-EEee----
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLADG-RIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLG-CCLE---- 416 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~---- 416 (686)
+.....++++.++|.+|||+.||.|....+ ..+|+|++-..++...+..++|+.+|++|+ |+|||.+++ ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 444556788899999999999999997765 999999988778888999999999999997 999999999 3332
Q ss_pred --CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 417 --TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 417 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
.-..+|.|||+.+|.|.+++....... |++.++++|+.|+++|+++||.. .++|||||||-+||||..++..||+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 135689999999999999998765554 99999999999999999999997 45799999999999999999999999
Q ss_pred cCCcccccCCCcee--e------eeeeccccccCcccc---ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCch
Q 038345 495 FGTSRSITVDQTHL--T------TKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563 (686)
Q Consensus 495 fGla~~~~~~~~~~--~------~~~~gt~~y~aPE~~---~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l 563 (686)
||.+.-........ . ....-|+.|+|||++ .+...++|+|||+|||+||-|+....||+...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 99986432221100 0 011248899999986 56789999999999999999999999997431
Q ss_pred hHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 564 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
...+++....-.....+...|.+||+.||+.||++||++.+|++.+-.|...
T Consensus 263 ------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1223333333333457788999999999999999999999999999888754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=330.28 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=198.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|...++||+|+||.||+|... ++..||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46889999999999999999965 68899999876432 22345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 48988886543 2478999999999999999999998 999999999999999999999999999976532221
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc------------
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE------------ 573 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------ 573 (686)
......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+... ........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccc
Confidence 1223457899999998865 568999999999999999999999997544322111 11110000
Q ss_pred chhhhhhhhhccC----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 574 NRLFEVLDALVLK----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 574 ~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
......+.+.... ........++.+++.+||+.||.+|||++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 0001111000000 00011234678999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.63 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=203.3
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||+||+|... +++.||||+++.. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999965 6899999987642 2244567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.+. ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999865 3589999999999999999999998 9999999999999999999999999999865433
Q ss_pred C----------------------------ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 505 Q----------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 505 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
. ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 111233568999999999999999999999999999999999999997543
Q ss_pred cccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 038345 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-MKEVAF 619 (686)
Q Consensus 557 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~ev~~ 619 (686)
..+ ......... ..............+.+++.+||. +|.+||+ ++++++
T Consensus 235 ~~~------~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 235 LQE------TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHH------HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 211 111111100 000000011135668899999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.97 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=205.8
Q ss_pred ccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
+|.+.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999853 23578888876432 3445789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCC
Q 038345 423 VYEFVPNGTLYQNIHNHI---------------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 481 (686)
||||+++++|.+++.... ...++++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999886421 113588999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCccc
Q 038345 482 ILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~ 559 (686)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999765432221 1122345678999999998899999999999999999999 999986533211
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.. +.+........+......+.+++.+||+.+|++||+++++++.|+++..
T Consensus 238 -------~~---------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -------LF---------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HH---------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11 1111111111122334578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=338.20 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=197.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+|.+.+.||+|+||.||++... .++.||+|... ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999964 68899999643 24578999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. ++|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 7888888653 3589999999999999999999998 999999999999999999999999999975432222
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCC-c---hhHhhHHHhhc---------
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR-S---LVGYFLQAMNE--------- 573 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~-~---l~~~~~~~~~~--------- 573 (686)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. . ...........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2233457999999999999999999999999999999999999887543211110 0 00000000000
Q ss_pred -chhhhhh----hhhc-----c--ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 574 -NRLFEVL----DALV-----L--KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 574 -~~~~~~~----d~~~-----~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+.... .... . .......+.++.+|+.+||+.||++|||++|++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000000 0000 0 000113355788999999999999999999998
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.39 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=202.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999965 6889999987643 2234567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999998652 3589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeeeeeccccccCccccc------cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQ------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccC
Confidence 333334456899999999986 456789999999999999999999999643221 11111111111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. .........+.+|+..||+ +|++||++.+++.
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0111234568899999998 9999999999884
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=332.82 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=219.1
Q ss_pred HHhhccccccccccCccceEEEEEEEeCC---C--cEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLAD---G--RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
++...+.....++||+|-||.||+|++.+ | -.||||..+. ......+.|+.|..++++++||||++|+|.|.+
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 33344455566799999999999999543 2 3589998876 445567889999999999999999999999965
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
...++|||+.+-|.|..||+.... .|+...+..++.||..||+|||+. .+|||||.++|||+...-.+||+||||
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 466899999999999999997654 588899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+|.+..+..+......-+..|||||.+..+++|.+||||.|||.+||++. |.+||.+....+..
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI--------------- 602 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI--------------- 602 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------------
Confidence 99987776666666666889999999999999999999999999999998 99999875443211
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
..+...-+-..++.++..+..|+.+||..+|.+||.+.|+...|..++.
T Consensus 603 -~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111112234456778889999999999999999999999999988775
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=324.06 Aligned_cols=261 Identities=24% Similarity=0.403 Sum_probs=209.8
Q ss_pred ccccccccccCccceEEEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~ 420 (686)
.++|.+.++||+|+||.||+|...+ +..|++|.+... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678899999999999999999765 688999987643 34456778999999999999999999998876 5678
Q ss_pred eEEEEeccCCchhhhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEE-----FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 4689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhc
Q 038345 496 GTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 496 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MA----AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHc
Confidence 9998664333221 122345778999999998899999999999999999999 999996533211 11 11111
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
. .........+..+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus 235 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 G---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred C---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1 00011112345688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=333.64 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=202.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999976 5788999987653 33345679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++... ..+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999753 25889999999999999999999753 7999999999999999999999999999765322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH--------------------
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG-------------------- 565 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~-------------------- 565 (686)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+......
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 1233468999999999999899999999999999999999999997432211000000
Q ss_pred hhHHHhh-----cchhhhhhhhhccChh----hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 YFLQAMN-----ENRLFEVLDALVLKEA----EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 ~~~~~~~-----~~~~~~~~d~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....... ......+.+....... ......++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000000 0000111111110000 0112456899999999999999999999974
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=332.78 Aligned_cols=246 Identities=26% Similarity=0.395 Sum_probs=206.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.-|...+-||+|+-|.|-+|++. +|+.+|||.+... .......+.+|+.+|+.+.||||+++++.+.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999964 6999999986553 2233456789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|-|+++|.+++ +|++.+..+++.||+.|+.|+|.. +|+||||||+|+|||.+.++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998654 699999999999999999999999 9999999999999999999999999999764332
Q ss_pred CceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
....+.+|.+.|.|||++.+.+| +.++||||.||+|+.||||+.||+..+ + ......+..+.
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------i-r~LLlKV~~G~-------- 228 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------I-RVLLLKVQRGV-------- 228 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------H-HHHHHHHHcCc--------
Confidence 33445689999999999999988 579999999999999999999997322 1 11112222221
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
-+.+...+.+..+|+.+||..||+.|.|++||++
T Consensus 229 --f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 229 --FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --ccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1223345667899999999999999999999984
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=339.13 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=207.9
Q ss_pred HHhhccccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEe
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNIVKLLGCCL 415 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 415 (686)
.+...++|.+.++||+|+||.||+|++++ +..||||+++... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34445678888999999999999998642 4679999987543 333457899999999997 999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccCC------------------------------------------------------
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIE------------------------------------------------------ 441 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------ 441 (686)
.....++||||+++|+|.++|+....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCC
Q 038345 442 -----------------------------------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSA 480 (686)
Q Consensus 442 -----------------------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 480 (686)
...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12478888999999999999999998 9999999999
Q ss_pred CeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcc
Q 038345 481 NILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINID 558 (686)
Q Consensus 481 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~ 558 (686)
|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986532221 11122346788999999998889999999999999999998 89998643321
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
+ ........+ .....+.....++.+|+.+||+.+|.+||++++|++.|+++.
T Consensus 349 ~------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 011111111 001112223467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.12 Aligned_cols=256 Identities=23% Similarity=0.430 Sum_probs=201.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.+.||+|+||+||+|.+. +++ .+++|...... .....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35777899999999999999964 344 47788765432 233467888999999999999999999875 456789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
++||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 999999999999997643 3589999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+ ....+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~--- 230 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERL--- 230 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcC---
Confidence 3322 12233456788999999998999999999999999999998 999997543211 11111111100
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
..+......+..++.+||..+|++|||+.|+++.|..+..
T Consensus 231 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 ------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0011123457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.26 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=212.5
Q ss_pred cccccccCccceEEEEEEEeC--CCc--EEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 351 YNANRILGQGGQGTVYKGMLA--DGR--IVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
....++||+|.||.|++|.|. +|+ .||||.+...... ...+|++|+.+|.+|+|+|+++|+|...+ ...+||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 344679999999999999975 344 5899998875544 57899999999999999999999999988 77889999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+.+.|+|.+.|++ ..+..|-...+..++.|||.||+||.++ ++|||||.++|+||-....+||+||||.|.+...+
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999998 3445688899999999999999999999 99999999999999999999999999999886544
Q ss_pred cee-e-eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 506 THL-T-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 506 ~~~-~-~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... + ....-...|+|||.+....|+.+||||+|||+||||+| |+.||.+.... .+.+.+|.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~ 330 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDA 330 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccc
Confidence 332 2 22234678999999999999999999999999999999 99999865431 34445554
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.-+-..+..+++.+.+++++||..+|.+|||+..|.+.+-
T Consensus 331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 4445556778899999999999999999999999986553
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.27 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=202.4
Q ss_pred cccccccCccceEEEEEEEeCC----CcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-----
Q 038345 351 YNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV----- 419 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 419 (686)
|.+.+.||+|+||.||+|.+.. +..||+|+++.. .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999998642 367999987643 33445789999999999999999999999876554
Q ss_pred -ceEEEEeccCCchhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 420 -PLLVYEFVPNGTLYQNIHNHI---EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 420 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.++||||+++|+|..++.... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 223689999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhc
Q 038345 496 GTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 496 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+ . ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHc
Confidence 9998664332221 112235678999999998899999999999999999999 889986432211 1 111111
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
+. ....+......+.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=320.37 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=208.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||.||+|+.. +++.||||.+.. ........+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999954 689999997653 23344567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988864322 23588999999999999999999998 999999999999999999999999999886543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...... ........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-~~~~~~~~------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-QKIEQCDY------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-HHHhcCCC-------
Confidence 221 11234578899999999988899999999999999999999999864221 111111 11111100
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
...........+.+++.+||+.+|++||++.+|++.|++++
T Consensus 226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01112234567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.10 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=210.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... +++.||+|.++. ......+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 789999997653 23334578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
||+++++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987532 234589999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ..+.... .....+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~-------- 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEKCD-------- 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHH-hhhhcCC--------
Confidence 2211 223458889999999998899999999999999999999999986432 1111111 1111110
Q ss_pred ccChhh-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 584 VLKEAE-REEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 584 ~~~~~~-~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
....+ ......+.+++.+||..+|++||++.+|+++|+.+.
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111 134557889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.63 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=203.8
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.++||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999876432 23467899999999999999999999875 456899999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.++++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999997642 23589999999999999999999998 99999999999999999999999999997654332222
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+... ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERG---------YRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CCCC
Confidence 223346778999999998899999999999999999999 899987532211 11111111 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
.+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=328.17 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=209.1
Q ss_pred ccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLET 417 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 417 (686)
.++|.+.+.||+|+||.||++... +...+|+|..+.. ......++.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999752 2357999987753 234456788999999999 799999999999999
Q ss_pred CcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 484 (686)
...++||||+++|+|.+++..... ...+++.++++++.|++.||+|||+. +++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976422 23589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCc
Q 038345 485 DDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRS 562 (686)
Q Consensus 485 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~ 562 (686)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 99999999999998765422111 1112234568999999999899999999999999999998 88888643211
Q ss_pred hhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 563 LVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 563 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
.+........ ..+.+.....++.+|+.+||+.+|++||++.+|++.|+.+.+...
T Consensus 250 ---~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 250 ---ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 1111111111 111222345678899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.50 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=198.7
Q ss_pred ccccccccCccceEEEEEEEe----CCCcEEEEEEcccc----ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 350 NYNANRILGQGGQGTVYKGML----ADGRIVAVKKSKLV----DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
+|.+.+.||+|+||.||++.. .+++.||+|.+... .....+.+..|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 35789999987542 223345688999999999 599999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998753 3589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.............||+.|+|||++.+. .++.++||||||+++|||++|+.||....... ....+...+..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRILK------ 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHHHHHHHhc------
Confidence 544333333446799999999998865 47889999999999999999999996432211 11111111110
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
.++ ..+......+.+++.+||+.||++|| +++++++
T Consensus 226 ~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 11122345688999999999999999 6667763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=333.93 Aligned_cols=245 Identities=26% Similarity=0.310 Sum_probs=199.7
Q ss_pred ccccccccccCccceEEEEEEEeCC--CcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD--GRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568899999999999999998543 368999986532 23345678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997543 589999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+....
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~------- 244 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGI------- 244 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCC-------
Confidence 22 23456999999999999988999999999999999999999999753221 0 111111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+......+.+++.+||+.+|++|+ +++++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 011122334578999999999999995 7777764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.37 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=197.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||++... +++.||+|.+.. ......+.|.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999965 588999998753 22334566889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997532 3588999999999999999999999 9999999999999999999999999998765433
Q ss_pred CceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ...............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC
Confidence 3322333469999999999863 4578899999999999999999999964321 1111111111111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGK--NRPTMKEVAFE 620 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~--~RPt~~ev~~~ 620 (686)
. ......+..+.+++.+|+..+++ .||+++++++.
T Consensus 230 ~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 P------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 01112345677888887765433 37899888854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.29 Aligned_cols=255 Identities=26% Similarity=0.463 Sum_probs=199.5
Q ss_pred cccccccCccceEEEEEEEeCCC-c--EEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Cc
Q 038345 351 YNANRILGQGGQGTVYKGMLADG-R--IVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET------EV 419 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~ 419 (686)
|.+.++||+|+||.||+|...+. . .||+|..+.. .....+.|.+|+.++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34568999999999999997543 2 6899987643 345567899999999999999999999987532 25
Q ss_pred ceEEEEeccCCchhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHI---EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 223589999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 497 TSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 497 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . .......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcC
Confidence 998764332211 122235678999999999999999999999999999999 88998653221 1 11111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
... ..+......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11123345688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=317.07 Aligned_cols=246 Identities=24% Similarity=0.403 Sum_probs=208.3
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.+|.+.+.||+|.||.|-+|.. ..|+.||||.++. .++++.-.+.+|++||+.|+||||+.++..|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 5788889999999999999995 6799999996543 45666677899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||..+|.|++|+.+.. .|++....+++.||..|+.|+|.+ +++|||||.+|||||+++++||+||||+-++...
T Consensus 133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999998653 699999999999999999999999 9999999999999999999999999999876533
Q ss_pred CceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
...+.++|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||++.+.. .+.+.+..+..+
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYr------ 271 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYR------ 271 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhccccc------
Confidence 34566889999999999999888 57899999999999999999999865321 111222222111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.++.+....-||++||..+|++|.|+.+|+..
T Consensus 272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 -----EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 12334456789999999999999999999853
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=337.97 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
...++|.+.++||+|+||.||++... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999965 5889999987532 2233456789999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.+++.+. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998753 378888999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCceeeeeeeccccccCccccccC----CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
............||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ...+..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC
Confidence 43332223345699999999998653 478899999999999999999999975321 11111111111000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~ 619 (686)
.. ......+.++.+++.+||+.+|++ ||++.++++
T Consensus 267 ~~-------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 TF-------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CC-------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 011123567889999999999987 999999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=326.99 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=195.4
Q ss_pred cccccccccCccceEEEEEEEeC--CCcEEEEEEccccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEeEEee-----
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA--DGRIVAVKKSKLVD--ENNVEQFINEVVILSQI---NHRNIVKLLGCCLE----- 416 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----- 416 (686)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999875432 22334567788777766 69999999999852
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
....++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346799999996 68988887543 23589999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--- 573 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--- 573 (686)
+++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCCh
Confidence 99765432 22334568999999999998899999999999999999999999997643221 11111111000
Q ss_pred chhhh-------hhhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLFE-------VLDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~~-------~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... .+.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000 00011123456789999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=329.31 Aligned_cols=238 Identities=25% Similarity=0.360 Sum_probs=190.2
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 5789999987642 223345566777777654 899999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999887542 589999999999999999999998 99999999999999999999999999997643222 223
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~----------~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-------LFDSILND----------RPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC----------CCCCC
Confidence 34568999999999999999999999999999999999999997543211 11111110 01112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
.....++.+++.+||+.+|++||++.+
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 223456789999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.86 Aligned_cols=247 Identities=28% Similarity=0.445 Sum_probs=199.7
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchh
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 433 (686)
++||+|+||.||+|...++..+|+|...... ......|.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999998888999999876543 333457899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeee
Q 038345 434 QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513 (686)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (686)
+++.... ..+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||++...............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 9987543 3588999999999999999999998 9999999999999999999999999998754322221112223
Q ss_pred ccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 514 gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
++..|+|||++.+..++.++||||||+++|||++ |..||......+ ........ .....+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC---------CCCCCCCCC
Confidence 4677999999999999999999999999999998 999986432211 11111111 001112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
+..+.+++.+||+.+|++||++.+++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=326.75 Aligned_cols=263 Identities=25% Similarity=0.421 Sum_probs=209.6
Q ss_pred hccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLE 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 416 (686)
..++|.+.+.||+|+||.||++... ++..||+|..... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888999999999999999741 2457999987643 234457899999999999 89999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
....++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+. +|+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999976421 23588999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDR 561 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 561 (686)
+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 999999999999999876432222 1222345678999999998899999999999999999998 788886433211
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......... ....+...+..+.+++.+||+.+|++||++.+|++.|+++....
T Consensus 248 -----~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 -----LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred -----HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 111111111 01112234567889999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.29 Aligned_cols=257 Identities=28% Similarity=0.396 Sum_probs=203.5
Q ss_pred hccccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
..++|.+.+.||+|+||.||+|.+.+ +..||+|...... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678999999999999999999753 5678999876433 3334679999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---cEEE
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE----EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKV 492 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl 492 (686)
.++||||+++++|.+++..... ...+++..+++++.||+.||+|||+. +++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 13589999999999999999999998 999999999999998654 6999
Q ss_pred EecCCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-------~~~- 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VME- 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH-
Confidence 9999998663222111 112223568999999999999999999999999999997 999987533211 111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111122334567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=331.85 Aligned_cols=241 Identities=25% Similarity=0.332 Sum_probs=195.9
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999964 6899999987642 2344567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 999888754 2589999999999999999999998 99999999999999999999999999987532221 1223
Q ss_pred eeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~-----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE-----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC-----------CCCCC
Confidence 3568999999999999999999999999999999999999996432211 111111100 01122
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 591 EEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3455688999999999999998 7888774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=322.85 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=205.4
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.+|...++||+|+||.||++... ++..+|+|..........+.|.+|+.++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777899999999999999732 356899998877666667889999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 423 VYEFVPNGTLYQNIHNHIE------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999976431 13588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhH
Q 038345 491 KVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~ 568 (686)
||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence 99999999765432211 1122335678999999999999999999999999999998 999986432211 01
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
...... .....+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111 001112233456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.67 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=204.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR--IVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+.||+|+||.||+|... ++. .+|+|..+.. .......+.+|+.++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56888899999999999999965 343 4677776543 334456789999999999 899999999999999999999
Q ss_pred EEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 424 YEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
|||+++++|.++++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999975421 13588999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+|||+++.... ........++..|+|||++.+..++.++||||||++++||+| |..||......+ .+ .
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~ 234 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-E 234 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH-H
Confidence 9999999864321 111111234667999999988889999999999999999998 999996433211 11 1
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
..... .....+......+.+|+.+||+.+|++||++.++++.|.++.....
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11110 0011111234568899999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=335.14 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=201.2
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
++....++|.+.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445578999999999999999999975 578999998753 22334456889999999999999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999999998653 378899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccC----CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
+..............||+.|+|||++.+. .++.++||||||++||||++|+.||..... ...+.......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~ 263 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHK 263 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC
Confidence 87643332223345699999999998754 378899999999999999999999974321 11111111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAF 619 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~ 619 (686)
....+ .........+.+++..||..++.+ ||++.|+++
T Consensus 264 ~~~~~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 264 NSLNF-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred cccCC-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 00000 111123456788899999855543 889999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.23 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=205.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CC---cEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DG---RIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|+..+.||+|+||.||+|... ++ ..+|+|..+.. .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999965 23 37999987654 33445779999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997543 3589999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCceeee--eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 503 VDQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 503 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
........ ....+..|+|||++....++.++||||||+++|||++ |+.||...... . +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~-~~~~i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------E-VMKAINDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------H-HHHHHhcC-----
Confidence 32221111 1223457999999998889999999999999999998 99998643211 1 11111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00111122345689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.83 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=208.1
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..++|.+.++||+|+||.||+|...++..||||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456899999999999999999998888899999876432 3346799999999999999999999999988899999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999997643 23589999999999999999999998 999999999999999999999999999976643222
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ........ ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERG---------YR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CC
Confidence 21222334668999999998899999999999999999999 999986432111 11111110 00
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11112234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.77 Aligned_cols=256 Identities=24% Similarity=0.393 Sum_probs=207.0
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..++|.+.++||+|+||.||++...++..+|+|..... ....+.|.+|+.++++++|+||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34678999999999999999999877888999987643 2345689999999999999999999999887 778999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999997643 33588999999999999999999998 999999999999999999999999999976543222
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......++..|+|||++....++.++|+||||+++++|++ |+.||......+ ......... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGY---------R 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCC---------C
Confidence 22223345678999999998889999999999999999999 999986432111 111111110 0
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.......+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111123445688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=316.36 Aligned_cols=247 Identities=28% Similarity=0.412 Sum_probs=197.4
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
+.||+|+||.||+|+.. +++.||+|..... .......|.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999964 6889999986543 334456799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee-ee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-TK 511 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~ 511 (686)
.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99997532 3589999999999999999999998 999999999999999999999999999875432111110 11
Q ss_pred eeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhH
Q 038345 512 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAER 590 (686)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~ 590 (686)
...+..|+|||.+.++.++.++||||||+++|||++ |..||......+ ..... ........+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~---------~~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAI---------EQGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHH---------HcCCCCCCcc
Confidence 123457999999999999999999999999999998 888886432211 11111 1111111222
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 591 EEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 591 ~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.49 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=199.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||+||++... +++.||||++... .......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999965 5889999987642 2334466889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997542 589999999999999999999999 9999999999999999999999999998754321
Q ss_pred Cce-------------------------------------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh
Q 038345 505 QTH-------------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547 (686)
Q Consensus 505 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt 547 (686)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112458999999999999999999999999999999999
Q ss_pred CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038345 548 GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT---MKEVAF 619 (686)
Q Consensus 548 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~ev~~ 619 (686)
|+.||......+ ............... ........+.+++.+|+. +|.+|++ ++++++
T Consensus 235 G~~Pf~~~~~~~------~~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE------TYRKIINWKETLQFP-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH------HHHHHHcCCCccCCC-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999997543211 111111100000000 011224567889999996 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.30 Aligned_cols=241 Identities=27% Similarity=0.351 Sum_probs=194.4
Q ss_pred cccCccceEEEEEEEe----CCCcEEEEEEcccc----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGML----ADGRIVAVKKSKLV----DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++||+|+||.||++.. ..++.||+|.++.. .......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 35789999987642 223345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.+.. .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999987542 578899999999999999999998 99999999999999999999999999987543222
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... .+.... .
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~-~~~~~~----------~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTID-KILKGK----------L 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHH-HHHcCC----------C
Confidence 2223356899999999999988999999999999999999999999753211 1111 111110 0
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
..+......+.+++.+||+.+|++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222345688999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=323.71 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=203.3
Q ss_pred ccccccccCccceEEEEEEEeCC------CcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 350 NYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.|.+.+.||+|+||.||+|...+ +..||+|+++.... ...+.|.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 47778899999999999998532 47899999875433 234678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 423 VYEFVPNGTLYQNIHNHI-------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 123588899999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhh
Q 038345 490 AKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYF 567 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~ 567 (686)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------V 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999886543221 11223345778999999988889999999999999999998 888886432211 1
Q ss_pred HHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 568 LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 568 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...+..... ...+...+..+.+++.+||+.+|++||++++|+..|+.
T Consensus 236 ~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111111 11223445668899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=319.62 Aligned_cols=259 Identities=24% Similarity=0.340 Sum_probs=201.2
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC--------------hhhHHHHHHHHHHHHhcC
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD--------------ENNVEQFINEVVILSQIN 403 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~ 403 (686)
+...+-.+..++|.+.+.||+|.||.|-+|+. .+++.||||++.... ....+...+|+.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 34444455668899999999999999999994 468999999764421 112457889999999999
Q ss_pred CCCeeeEEeEEee--CCcceEEEEeccCCchhhhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCC
Q 038345 404 HRNIVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEFP-ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSA 480 (686)
Q Consensus 404 h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 480 (686)
|||||+|+.+..+ .+..|||+||+..|.+.+.= ...+ |++.++++++.+++.||+|||.+ +||||||||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchh
Confidence 9999999999875 46889999999988775422 2234 99999999999999999999999 9999999999
Q ss_pred CeeecCCCcEEEEecCCcccccCCC----ceeeeeeeccccccCccccccCC----CCccccEeehHHHHHHHHhCCCCC
Q 038345 481 NILLDDKYRAKVSDFGTSRSITVDQ----THLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPI 552 (686)
Q Consensus 481 NIll~~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~S~Gv~l~elltg~~p~ 552 (686)
|+||++++++||+|||.+-...... ........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999999999987652111 11122367999999999987733 356889999999999999999999
Q ss_pred ccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 553 RAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 553 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... ...+ ..++...+.-....+....+.+||+++|..||+.|.+..+|..
T Consensus 320 ~~~~~------~~l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 320 FDDFE------LELF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred ccchH------HHHH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 64221 1111 1122222222223355677899999999999999999998873
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.07 Aligned_cols=252 Identities=29% Similarity=0.395 Sum_probs=215.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-ceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV-PLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lV 423 (686)
.++|...+++|+|+||.++..+.+ +++.+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 357889999999999999998854 5789999986553 23334578899999999999999999999999888 8999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|+|++||+|.+.|.+.. ...++++.+.+|+.|++.|+.|||+. .|+|||||+.||+++.+..+||+|||+|+.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998764 45689999999999999999999988 999999999999999999999999999998876
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
+. .....+.||+.||.||.+.+.+|..|+|||||||.+|||++-+++|...+..+ ++ ..+-..
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li-------------~ki~~~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LI-------------LKINRG 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HH-------------HHHhhc
Confidence 54 23456789999999999999999999999999999999999999998654321 11 111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.....+..+..++..++..||+.+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2344556777889999999999999999999999976
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=316.37 Aligned_cols=246 Identities=29% Similarity=0.433 Sum_probs=197.2
Q ss_pred ccCccceEEEEEEEeC---CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 356 ILGQGGQGTVYKGMLA---DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
.||+|+||.||+|.++ ++..+|+|.++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999876432 334568999999999999999999999875 45679999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee-
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT- 509 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 509 (686)
+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998753 2589999999999999999999998 999999999999999999999999999987654332211
Q ss_pred -eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 510 -TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 510 -~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCC---------CCC
Confidence 12234578999999988889999999999999999998 999997532211 111111111 111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.+...+.++.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.65 Aligned_cols=263 Identities=25% Similarity=0.368 Sum_probs=195.9
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----cce
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 421 (686)
+|.+.++||+|+||.||+|... ++..||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999964 6899999987642 2234467889999999999999999999886432 479
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+. ++|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6888888653 2589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCc--eeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh--------hHH
Q 038345 502 TVDQT--HLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--------FLQ 569 (686)
Q Consensus 502 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~--------~~~ 569 (686)
..... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11234568999999999876 6789999999999999999999999975432110000000 000
Q ss_pred Hhhcchhhhhhhhh---ccChhh---HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMNENRLFEVLDAL---VLKEAE---REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~~~~~~~~~d~~---~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+........+... ...... ......+.+++.+||+.+|++|||++|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000001111000 000000 112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.43 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=196.3
Q ss_pred ccCccceEEEEEEEeC---CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCc
Q 038345 356 ILGQGGQGTVYKGMLA---DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGT 431 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gs 431 (686)
.||+|+||.||+|.+. .+..||+|...... ....+.|.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999876543 333467999999999999999999999885 457799999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee--
Q 038345 432 LYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-- 509 (686)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-- 509 (686)
|.+++.... ..+++..+++++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999987532 3589999999999999999999998 999999999999999999999999999986543322211
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +...+... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQG---------KRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCC---------CCCCC
Confidence 11223578999999988889999999999999999996 999997543211 11111111 11112
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
+.....++.+++.+||..+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 223456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.98 Aligned_cols=250 Identities=28% Similarity=0.451 Sum_probs=206.3
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.+.||+|+||.||+|... ++.||+|....... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46888899999999999999875 78999999876544 56789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++..... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999976432 3589999999999999999999998 999999999999999999999999999986532211
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....+..|+|||++....++.++||||||+++|||++ |+.||......+ .......+ ....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKG---------YRME 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcC---------CCCC
Confidence 2335678999999998899999999999999999998 999986432211 11111111 0111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.+...+..+.+++.+||..+|++||++.+++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1223356788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.32 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=205.3
Q ss_pred hhccccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
...++|.+.++||+|+||.||+|...+ +..||+|..+... ......+.+|+.++++++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356789999999999999999997532 4579999876433 233456889999999999999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEE
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE-------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 491 (686)
..++||||+++|+|.+++.+... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 23467888999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHH
Q 038345 492 VSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 492 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~ 569 (686)
|+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..||......+ ...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999999865432211 1122235678999999999999999999999999999999 788986533211 111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
....+.. ...+......+.+++.+||+.+|++|||+.++++.|+..
T Consensus 233 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111100 011122346799999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.59 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=195.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.|...+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999864 5789999987542 23445678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999997543 588999999999999999999998 99999999999999999999999999976431100
Q ss_pred c----------------------------------------------eeeeeeeccccccCccccccCCCCccccEeehH
Q 038345 506 T----------------------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 539 (686)
Q Consensus 506 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~G 539 (686)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 038345 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKR--CLNLNGKNRPTMKEV 617 (686)
Q Consensus 540 v~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--cl~~dp~~RPt~~ev 617 (686)
|++|||++|+.||......+ ........... +..........++.+++.+ |+..++..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTE------TQLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHH------HHHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999997543211 00011100000 0000011223456778877 445666679999999
Q ss_pred HH
Q 038345 618 AF 619 (686)
Q Consensus 618 ~~ 619 (686)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=346.94 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=205.3
Q ss_pred HHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE-- 418 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-- 418 (686)
.....++|.+.++||+|+||+||+|.. .+++.||||.+... .......+.+|+.++..++|+||++++..+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 334457899999999999999999985 46899999987542 3445667889999999999999999988775432
Q ss_pred ------cceEEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEE
Q 038345 419 ------VPLLVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491 (686)
Q Consensus 419 ------~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 491 (686)
..++||||+++|+|.++|.... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence 3579999999999999997532 234689999999999999999999999 999999999999999999999
Q ss_pred EEecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 492 VSDFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 492 l~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
|+|||+++.+.... ........||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+...
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~ 257 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKT 257 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence 99999998654321 12223456999999999999999999999999999999999999999643211 111111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. .+. ....+.....++.+++.+||+.+|.+||++.++++
T Consensus 258 ~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 L-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred h-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1 110 01122334567899999999999999999999975
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.07 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=209.0
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||++.. .++..+|||.+... ......++.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 47899999976542 3334568899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
||+++++|.+++.... ....+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887432 234689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......|+..|+|||.+.+..++.++||||||+++|||++|..||...... ..... ..... ...+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~-----~~~~- 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQ-----CDYP- 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhhhc-----CCCC-
Confidence 221 122345888999999999889999999999999999999999998643211 11111 01100 0000
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0111234567899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=323.85 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=206.2
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 419 (686)
.++|...+.||+|+||.||++... .+..||+|..+... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999742 24579999876543 33456789999999999 79999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+++|+|.++++.... ..+++.+++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999975432 2489999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 500 SITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 500 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .+.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~--- 260 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEG--- 260 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcC---
Confidence 65433221 1222345678999999999999999999999999999998 999986543211 111111111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.....+......+.+++.+||..+|++||++.+|++.|+++
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.08 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=193.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|...++||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999965 68999999875432 33456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++|+|.... .+.+..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 356778889999999999999998 99999999999999999999999999998654322
Q ss_pred eeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.......||..|+|||++.. ...+.++||||||+++|||++|+.||......+ ... ........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~-~~~~~~~~------- 291 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WAS-LMCAICMS------- 291 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHH-HHHHHhcc-------
Confidence 11233568999999998743 234568999999999999999999997322111 111 00000000
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........++.+|+.+||+.||++||++.|+++
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001112234557899999999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.81 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=197.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999975 68899999876432 2233567899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 67877776532 3588999999999999999999999 99999999999999999999999999987543222
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hhhh---
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RLFE--- 578 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~--- 578 (686)
.......|++.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............. ....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence 12233458899999999865 457889999999999999999999997542110 0111110000000 0000
Q ss_pred --hhhhh-cc----Chhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 --VLDAL-VL----KEAE-----REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 --~~d~~-~~----~~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..++. .. .... ......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 0000 011246789999999999999999999983
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.04 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=205.1
Q ss_pred cccccccccCccceEEEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.+|.+.+.||+|+||.||+|... .+..+|+|.++.. .....+.|.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888899999999999999863 2347999987653 233456899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997643 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeee--eeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 504 DQTHLTT--KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 504 ~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
....... ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ....+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCC-----
Confidence 3322221 1223568999999999899999999999999999887 999986543211 111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
........+..+.+++.+||+.+|++||+|.++++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=316.88 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=197.1
Q ss_pred cccCccceEEEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLAD-GR--IVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||+|.+.+ +. .+++|..+.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 43 4688887643 344556889999999999 799999999999999999999999999
Q ss_pred CchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 430 GTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 430 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
|+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 12488999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+++..... ........+..|+|||++....++.++||||||+++|||++ |..||...... ..+ ......
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~-~~~~~~- 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELY-EKLPQG- 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHH-HHHhCC-
Confidence 98632211 11111223567999999988899999999999999999997 99999643211 111 111111
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
...+.+......+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011112223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=298.79 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=205.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|++.+.||+|.||.||.|+.+ ++-.||+|++... ..+-..++.+|++|-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 356889999999999999999965 5778999986542 222346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
+||.++|.|+..|..... ..+++.....++.|+|.||.|+|.. .|+||||||+|+|++..+.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999985432 3588888999999999999999999 89999999999999999999999999986543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
........||..|++||+..+..++.+.|+|++|++.+|++.|.+||.....++ . .+.+.. .+
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---t----YkrI~k---~~----- 238 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---T----YKRIRK---VD----- 238 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---H----HHHHHH---cc-----
Confidence 233455789999999999999999999999999999999999999997533111 1 111111 11
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
-..+.......+++|.+|+..+|.+|.+..|+++
T Consensus 239 --~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 239 --LKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1222344566889999999999999999999874
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.31 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=205.8
Q ss_pred ccccccccccCccceEEEEEEEeCC------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||.||+|...+ +..||+|...... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4578889999999999999998642 3689999976432 34456789999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 421 LLVYEFVPNGTLYQNIHNHIE-------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999975322 22478999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHh
Q 038345 494 DFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 494 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 9999976543322 11223346789999999998889999999999999999998 999986433211 11111
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..... ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 1112223567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=315.31 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=201.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-----ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|...+.||+|++|.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 56889999999999999999864 58999999865321 2234678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987542 588999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCceee--eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
....... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-------- 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIAT-------- 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhc--------
Confidence 3221111 2345788999999999999999999999999999999999998643211 00111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......+......+.+++.+||..+|++|||+.++++
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 222 -QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred -cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 00111222334556889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.61 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=204.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|++|.||+|... +++.|++|.+.. ......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999965 588999998654 2345567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998642 34689999999999999999999998 999999999999999999999999999986643322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ......... ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~---------~~~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRG---------VFP 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC---------CCC
Confidence 223345889999999999999999999999999999999999999744311 011111111 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 122234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=324.53 Aligned_cols=262 Identities=25% Similarity=0.423 Sum_probs=207.2
Q ss_pred ccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLET 417 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 417 (686)
.++|.+.++||+|+||.||++... ....+|+|..+.. .......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999742 2457899987643 234456789999999999 699999999999998
Q ss_pred CcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 484 (686)
...++||||+++|+|.+++..... ...+++..+++++.|++.||+|||+. +|+||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999975321 23589999999999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCc
Q 038345 485 DDKYRAKVSDFGTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRS 562 (686)
Q Consensus 485 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~ 562 (686)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998654322111 112234567999999998899999999999999999999 889986433211
Q ss_pred hhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 563 LVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 563 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
+......... ...+.....++.+++.+||+.+|++||++.++++.|+++....
T Consensus 245 ----~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 ----LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111111111 1112233456889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=311.87 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=206.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcc--ccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee-----CC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSK--LVDENNVEQFINEVVILSQINHRNIVKLLGCCLE-----TE 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~ 418 (686)
+...|...+.||+|+||.|..+... +|+.||||++. .......++..+|+++|+.++|+||+.+++.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999954 68999999987 3456677889999999999999999999999875 34
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..|+|+|+| ..+|...|+... .|+.....-++.|+++||.|+|+. +|+||||||+|+|++.+..+||+|||||
T Consensus 100 DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 679999999 578888887542 499999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCC-CceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH--------
Q 038345 499 RSITVD-QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL-------- 568 (686)
Q Consensus 499 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~-------- 568 (686)
|..... .....+....|.+|.|||++.. ..||.+.||||.||+|.||++|++-|.+.+.-+...++....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987532 1223456678999999998754 689999999999999999999999998765444333332221
Q ss_pred HHhhcchhhhhhhhhc---cC---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNENRLFEVLDALV---LK---EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~---~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+...+....+.... .. ..-+.......+|+.+||..||.+|+|++|+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111111100 00 001122356789999999999999999999984
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.24 Aligned_cols=243 Identities=27% Similarity=0.406 Sum_probs=192.8
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 233456678899988877 799999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 9999888653 3589999999999999999999999 99999999999999999999999999997532221 122
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCccc--CCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE--DRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+....+.... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence 34568999999999999999999999999999999999999996432211 1111122222111111 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
.+......+.+++.+||+.||++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222344568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.01 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=206.1
Q ss_pred cccccccccCccceEEEEEEEeCC----CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.++||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999998643 2468999876544 4556789999999999999999999998865 557899
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 99999999999997643 2589999999999999999999998 999999999999999999999999999986644
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
..........++..|+|||.+....++.++||||||++++||++ |..||......+ . . ..+.....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~-~~~~~~~~------ 226 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---V---I-GRIENGER------ 226 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---H---H-HHHHcCCc------
Confidence 33222223335568999999988889999999999999999996 999997543211 1 1 11111100
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
...+...+..+.+++.+||..+|++|||+.++++.|+.++..
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 227 ---LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011223345789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.59 Aligned_cols=255 Identities=21% Similarity=0.298 Sum_probs=197.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||.||++... +++.+|+|.+... .......+.+|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999976 4778999987532 2233456889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997632 2589999999999999999999998 9999999999999999999999999999765433
Q ss_pred CceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~ 229 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF 229 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC
Confidence 333333456999999999986 34678999999999999999999999974321 1111111111100000
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAFE 620 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~~ 620 (686)
..........+.+++.+|+..++++ |++++++++.
T Consensus 230 ------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 ------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011123456788899988654444 6888888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.92 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=195.2
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 6889999987642 2334567788999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
+|..++... ..+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 999888753 258999999999999999999997 5 899999999999999999999999999875432221 22
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+ ....... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~-~~i~~~~----------~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF-ELILMEE----------IRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HH-HHHhcCC----------CCCC
Confidence 33569999999999999999999999999999999999999996432211 01 1111000 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
.....++.+++.+||+.||++|+ +++++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 22345688999999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.32 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=192.9
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||++... +++.||+|.++.. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 5889999987642 233446688999999998 799999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 9999888653 3599999999999999999999999 99999999999999999999999999987532211 222
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCccc--CCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE--DRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999997433222 11111122222111110 1
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCC
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPT 613 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt 613 (686)
.+......+.+++.+||+.||.+||+
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 12223456889999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=321.98 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=201.7
Q ss_pred cccccccccCccceEEEEEEEeCC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD---------------GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLG 412 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g 412 (686)
++|.+.+.||+|+||.||++...+ ...||+|..... .......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 235899987653 3334567999999999999999999999
Q ss_pred EEeeCCcceEEEEeccCCchhhhhhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIE---------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 413 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999865321 12478999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh--CCCCCccCCcccC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINIDED 560 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt--g~~p~~~~~~~~~ 560 (686)
+++++.+||+|||++......... ......++..|+|||++..+.++.++||||||++++||++ +..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999999765432221 1222345678999999998899999999999999999998 667776433211
Q ss_pred CchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
........... .........+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 241 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111110000 0000001111223457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.39 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=197.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999965 5788999987542 2333456888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997632 2588999999999999999999998 9999999999999999999999999999876544
Q ss_pred CceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.........||+.|+|||++.+ +.++.++||||||++||||++|+.||..... ...............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~ 229 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQF 229 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCcccC
Confidence 3333334569999999999875 5678899999999999999999999974322 1111111111100000
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~ 619 (686)
.......+.++.+++.+|+..++++ |++++++++
T Consensus 230 ------p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 230 ------PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ------CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0001123456888999999865544 467777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.12 Aligned_cols=251 Identities=26% Similarity=0.329 Sum_probs=200.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68899999875422 2223567889999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886542 23589999999999999999999998 99999999999999999999999999997654222
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+...+.. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~----------~~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKE----------DQ 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhh----------cc
Confidence 1 223468999999999998999999999999999999999999997532211 11111111110 01
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+......+.+|+.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 122234556789999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=313.02 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=197.9
Q ss_pred cccCccceEEEEEEEeCC----CcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLAD----GRIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|.+.. +..+|+|....... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998532 26899998765433 34567999999999999999999999875 4567999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998643 589999999999999999999998 999999999999999999999999999987643332211
Q ss_pred --eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 510 --TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 510 --~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ......... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EV----IAMLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HH----HHHHHcCCc---------C
Confidence 11223567999999999999999999999999999998 99999643221 11 111111110 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+...+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112233457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.66 Aligned_cols=269 Identities=28% Similarity=0.374 Sum_probs=202.9
Q ss_pred ccccccccCccceEEEEEEEe-----CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccce
Q 038345 350 NYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 421 (686)
.|.+.+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999974 247889999976543 34456799999999999999999999998875 5678
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 9999999999999987543 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 502 TVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 502 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... ......++..|+|||++.+..++.++||||||+++|||++++.|.......... .................
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMTVTRLVRV 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccccccHHHHHHH
Confidence 433221 122344677899999999889999999999999999999987764321100000 00000000000000011
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
+........+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111011111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=317.74 Aligned_cols=256 Identities=25% Similarity=0.454 Sum_probs=202.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|...++||+|+||+||+|.+. +++ .||+|.++.. .....+.+.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46888899999999999999853 444 4899987643 33445678999999999999999999999875 45789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
+|||+++|+|.++++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 999999999999997643 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ + ...+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~----- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---I----PDLLEKGE----- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCC-----
Confidence 332221 122235678999999998999999999999999999998 999986432111 1 11111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
....+......+.+++.+||+.||++||++.++++.|+.+..
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 011112334568899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.43 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=202.9
Q ss_pred ccccccccCccceEEEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLAD-G---RIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.|.+.+.||+|+||.||+|.... + ..||||.++.. .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 47788999999999999999653 3 36999987654 3445678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999987543 3589999999999999999999998 9999999999999999999999999998765432
Q ss_pred Ccee--eeeee--ccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 505 QTHL--TTKVQ--GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 505 ~~~~--~~~~~--gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.... ..... .+..|+|||++.+..++.++||||||+++|||++ |..||......+ +...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~----- 227 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQD----- 227 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC-----
Confidence 2111 11111 2457999999999999999999999999999887 999986432211 11111110
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.....+...+..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111123345688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=320.16 Aligned_cols=263 Identities=27% Similarity=0.417 Sum_probs=205.3
Q ss_pred ccccccccccCccceEEEEEEEeCC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeee
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-----------------GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVK 409 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 409 (686)
..+|.+.+.||+|+||.||++...+ +..||+|.+... .....+.+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999988542 246899987653 2345678999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCchhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCC
Q 038345 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIE--------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 410 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 481 (686)
+++++..+...++||||+++++|.+++.+... ...+++..++.++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976431 22589999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh--CCCCCccCCcc
Q 038345 482 ILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINID 558 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt--g~~p~~~~~~~ 558 (686)
|+++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999976543221 12223446778999999998889999999999999999998 67787543211
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.............. .......+...+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111100 00111112233467899999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=304.80 Aligned_cols=261 Identities=22% Similarity=0.253 Sum_probs=201.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhh--HHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENN--VEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 423 (686)
++|...+.|++|+||.||+|+.. +++.||+|+++...+.. .-...+|+.+|.+.+|||||.+...... -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46778899999999999999954 68999999988754322 1235799999999999999999887764 3568999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++ +|..+|.+.. .++...++.-++.|+++||+|||.. .|+|||||++|+|+...|.+||+||||||.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999975 8888888754 3688999999999999999999999 899999999999999999999999999998875
Q ss_pred CCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH--Hhhcchhhhh-
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ--AMNENRLFEV- 579 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~--~~~~~~~~~~- 579 (686)
.. ...+..+-|.+|.|||.+.+ ..|+.+.|+||+||++.||+++++-|.+...-+ .+...|.. ...+..+..+
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCcc
Confidence 53 33456678999999999877 468999999999999999999999998754322 22222211 1111100000
Q ss_pred ----h---------hhhccChhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 580 ----L---------DALVLKEAERE-EIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 580 ----~---------d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
. -..+...+... ....-.+|+...|..||.+|.|+.+.+
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 0 00011111111 235567899999999999999999988
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.01 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=196.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999854 6889999987542 2334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999754 3588999999999999999999999 9999999999999999999999999999643210
Q ss_pred Cc----------------------------------------------eeeeeeeccccccCccccccCCCCccccEeeh
Q 038345 505 QT----------------------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 538 (686)
Q Consensus 505 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~ 538 (686)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00012468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCC---CCHH
Q 038345 539 GVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNR---PTMK 615 (686)
Q Consensus 539 Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~ 615 (686)
||++|||++|+.||......+ .+...........+. .......++.+++.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p-------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYFP-------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCC-------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999996433211 111111100000000 001223567899999997 67665 5998
Q ss_pred HHHHH
Q 038345 616 EVAFE 620 (686)
Q Consensus 616 ev~~~ 620 (686)
++++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.39 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=204.1
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
|++.+++++.....||+|+||.||+|... ++..||+|..........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 35566777777889999999999999954 57889999877666666778999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRS 500 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~ 500 (686)
+|+||+++++|.+++.........++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999998643221237888999999999999999998 9999999999999976 67999999999876
Q ss_pred ccCCCceeeeeeeccccccCccccccCC--CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
...... ......|+..|+|||++.... ++.++||||||+++|||++|+.||........ . ...... .
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~-~~~~~~-----~- 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---A-MFKVGM-----F- 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---h-Hhhhhh-----h-
Confidence 532221 122335789999999986643 78899999999999999999999864321110 0 000000 0
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+.....++.+++.+||+.+|++|||+.++++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011122234456889999999999999999999974
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.50 Aligned_cols=264 Identities=25% Similarity=0.411 Sum_probs=208.5
Q ss_pred hccccccccccCccceEEEEEEEeCC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD--------GRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLE 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 416 (686)
...+|.+.+.||+|+||.||++.... ...||+|..+.. .....+++.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 33568899999999999999997421 236899987643 234467899999999999 79999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHI-------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
....++||||+++|+|.++|.... ....+++..++.++.|++.||+|||+. +|+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 999999999999999999997532 123588999999999999999999998 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDR 561 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 561 (686)
+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 244 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 244 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 999999999999999765432211 1122234567999999999999999999999999999998 888886433211
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
+...+.... ....+......+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 245 -----~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 -----LFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -----HHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111111111 111122334578899999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.53 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=203.0
Q ss_pred cccccccccCccceEEEEEEEeC-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-----------------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKL 410 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 410 (686)
++|++.++||+|+||.||++... +...||+|..... ......+|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999998532 2346899987653 33445789999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCchhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIE--------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 411 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999976421 12478899999999999999999999 999999999999
Q ss_pred eecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh--CCCCCccCCccc
Q 038345 483 LLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT--GQKPIRAINIDE 559 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt--g~~p~~~~~~~~ 559 (686)
|++.++.+||+|||+++.+...... ......++..|+|||....+.++.++||||||+++|||++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865432221 1122334678999999888899999999999999999998 778886433221
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
............. .......+...+..+.+++.+||+.||++||++.+|++.|++
T Consensus 242 ---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111000 000001112234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=326.72 Aligned_cols=239 Identities=26% Similarity=0.360 Sum_probs=190.8
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHH---HhcCCCCeeeEEeEEeeCCcceEE
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVIL---SQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
|.+.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++ ++++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999965 5889999987642 223345666776655 566799999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|..+++. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988764 2589999999999999999999998 999999999999999999999999999875332
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~-~~i~~~~-------- 217 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF-DSIVNDE-------- 217 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCC--------
Confidence 21 22234568999999999999999999999999999999999999997543211 11 1111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+......+.+++.+||+.||++||++
T Consensus 218 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 --VRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 01122334567899999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.37 Aligned_cols=251 Identities=27% Similarity=0.452 Sum_probs=202.2
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3577889999999999999998778899999876432 234678999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999987543 3588999999999999999999998 99999999999999999999999999987654322211
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....++.+|+|||.+.++.++.++||||||+++|||++ |+.||...... ........+ ....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~---------~~~~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAG---------FRLY 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCC---------CCCC
Confidence 222235678999999998899999999999999999998 99998643211 111111111 0000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
.+......+.+|+.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112345689999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=327.57 Aligned_cols=261 Identities=29% Similarity=0.424 Sum_probs=203.1
Q ss_pred ccccccccccCccceEEEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC-C
Q 038345 348 TDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLET-E 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~ 418 (686)
.++|.+.++||+|+||.||+|.. .+++.||||.++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999973 346789999986532 33456788999999999 689999999988654 4
Q ss_pred cceEEEEeccCCchhhhhhccCC---------------------------------------------------------
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE--------------------------------------------------------- 441 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 441 (686)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864311
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce-eeeeee
Q 038345 442 -------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQ 513 (686)
Q Consensus 442 -------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 513 (686)
...+++..+..++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12478889999999999999999998 9999999999999999999999999999765322211 112233
Q ss_pred ccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 514 gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .+......+... ..+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM---------RAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCC---------CCCCCC
Confidence 5678999999998999999999999999999997 999986532211 111111111100 011112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
...+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.24 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=194.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+|...++||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999964 5889999987542 23345678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998754 2588999999999999999999998 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------ceeeeeeeccccccCccccccCCCCccccEeehH
Q 038345 506 ----------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFG 539 (686)
Q Consensus 506 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~G 539 (686)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 038345 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT---MKE 616 (686)
Q Consensus 540 v~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~e 616 (686)
|+||||++|+.||......+ ......... .............++.+++.+++ .+|++|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~------~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE------TQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH------HHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999997543211 011111000 00000011122345667777765 59999997 777
Q ss_pred HHH
Q 038345 617 VAF 619 (686)
Q Consensus 617 v~~ 619 (686)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.54 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=203.3
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
..++....++|.+.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999965 578999998753 223334568899999999999999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
....++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999998653 378888999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccC----CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSS----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
+++..............||+.|+|||++... .++.++||||||+++|||++|+.||..... ...+.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence 9987653333233445699999999998754 378899999999999999999999975322 111211111
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAFE 620 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~~ 620 (686)
......+. ........+.+++.+||...+.+ ||+++++++.
T Consensus 262 ~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111 11234556889999999844433 6788888753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.31 Aligned_cols=249 Identities=27% Similarity=0.415 Sum_probs=203.7
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.+|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788899999999999999995 468899999887655555678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.+. .+++.+++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999998643 488999999999999999999999 9999999999999999999999999998765432211
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......... .....
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~--------~~~~~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG--------TPELQ 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC--------CCCCC
Confidence 223458889999999998889999999999999999999999996433211 000000000 00001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......+.+++.+||..+|++||++.++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12234456889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=316.51 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=201.8
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|.+.+.||+|+||.||+|+. .+++.||+|+...........+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999996 468899999887655555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.++++.. .++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999998753 3589999999999999999999998 999999999999999999999999999986542221
Q ss_pred eeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 508 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......|+..|+|||.+. ...++.++||||||+++|||++|+.||......+.... +....+ ..+..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~---~~~~~ 231 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSNF---QPPKL 231 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCCC---CCCCC
Confidence 122345888999999874 34578899999999999999999999864332111000 000000 00000
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.........+.+++.+||+.+|++||+++++++.
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0111234578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.65 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=198.4
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----cce
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 421 (686)
+|+..++||+|+||.||++.. .+++.||||++... .....+++.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 46899999987542 2334567899999999999999999999998766 789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5787777543 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh----
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL---- 576 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---- 576 (686)
............++..|+|||++.+. .++.++||||||+++|||++|+.||......+. .............
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence 43333333344578999999998774 578999999999999999999999975443211 1111110000000
Q ss_pred ------hhhhhhhcc--C------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 ------FEVLDALVL--K------EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ------~~~~d~~~~--~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+..... . ........++.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000000000 0 011122456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.29 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=204.7
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|...+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999853 46789999876532 33456799999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCC
Q 038345 421 LLVYEFVPNGTLYQNIHNHI-------------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 481 (686)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999997432 113578999999999999999999998 99999999999
Q ss_pred eeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCccc
Q 038345 482 ILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~ 559 (686)
||+++++.+||+|||+++....... ........+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876532221 11112234667999999998999999999999999999998 888886433211
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
........... ..+...+.++.+++.+||+.+|++|||+.||++.|++
T Consensus 241 -------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111111 1112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=312.62 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=200.3
Q ss_pred cccCccceEEEEEEEeCC--C--cEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLAD--G--RIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999999643 3 3689998776544 566789999999999999999999999988 888999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce--
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-- 507 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 507 (686)
++|.+++.+... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999986543 4689999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE---------RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC---------cC
Confidence 1122456789999999999999999999999999999999 999986432211 0111110000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111233467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=315.39 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=197.7
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+|...++||+|+||.||+|.. .+++.||+|..... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999985 46889999987543 3344567999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999996542 367888999999999999999998 9999999999999999999999999999765322
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+............... .....
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 220 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--------DPPVL 220 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------CCCCC
Confidence 1233468999999999999999999999999999999999999997533222111111111111100 00000
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......++.+++.+||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11123456889999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=323.38 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=195.1
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 233456688999999888 699999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 9999888653 2599999999999999999999998 99999999999999999999999999987532211 122
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||++||||++|+.||..................+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCC
Confidence 345699999999999999999999999999999999999999975443332222222222222111 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
......+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 22345678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=312.27 Aligned_cols=249 Identities=27% Similarity=0.447 Sum_probs=200.7
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~ 427 (686)
++|.+.+.||+|+||.||++... +..||+|..+.. ...+.|.+|+.++++++|+|++++++++. +....++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999875 778999987643 23467899999999999999999999865 456789999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999997643 23588999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... ...+..+ ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDV-VPRVEKG---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcC---------CCC
Confidence 22335668999999998899999999999999999998 9999864321 111 1111111 011
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=312.54 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=201.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----cceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 422 (686)
-.|...+++|.|+||.||+|.+. .++.||||+.....+. -.+|+++|++++|||||+|+-+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35777899999999999999965 4789999987654332 237999999999999999999987432 3468
Q ss_pred EEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCCccc
Q 038345 423 VYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRS 500 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~ 500 (686)
|||||+. +|.++++... .+..++...+.-+..||.+||+|||+. +|+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999984 8988887531 123577777888999999999999997 99999999999999976 9999999999998
Q ss_pred ccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh---
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL--- 576 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 576 (686)
+...+.. ....-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+....+...++-.+......+.+
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 7654433 44567889999999887 47999999999999999999999999875433222211111111111111
Q ss_pred ---------hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhhh
Q 038345 577 ---------FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF--ELGGIRAS 627 (686)
Q Consensus 577 ---------~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~--~L~~i~~~ 627 (686)
.++.......-.......+..+++.++|+.+|.+|.++.|++. .++.++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111111111123344567899999999999999999999985 45666544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.60 Aligned_cols=201 Identities=26% Similarity=0.391 Sum_probs=174.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|...+.||+|+||+||++... +++.||||.+... .......+.+|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 5889999987542 2233457888999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999754 3589999999999999999999998 9999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCC
Q 038345 505 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550 (686)
Q Consensus 505 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~ 550 (686)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCccC
Q 038345 551 PIRAI 555 (686)
Q Consensus 551 p~~~~ 555 (686)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.42 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=202.8
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCC------
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRN-IVKLLGCCLETE------ 418 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------ 418 (686)
..|...++||+|+||+||+|+. .+|+.||+|++....+ .-.....+|+.+|++|+|+| |++|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566778899999999999994 4789999999766433 23345689999999999999 999999999877
Q ss_pred cceEEEEeccCCchhhhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
..+||+||++ -+|..++...... ..++...+..++.||+.||+|||++ +|+||||||.||||++.+.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7899999995 6899998865432 3477789999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 574 (686)
|+........ .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+....+ ......+.+...
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCCc
Confidence 9976543332 4456789999999999876 79999999999999999999999988754321 111111111111
Q ss_pred -hhhhhh---hhh--c-----cChhhH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 575 -RLFEVL---DAL--V-----LKEAER---EEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 575 -~~~~~~---d~~--~-----~~~~~~---~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.+..+. +-. . ...... .......+++.+||+.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 110000 000 0 000011 111367899999999999999999999854
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.74 Aligned_cols=241 Identities=26% Similarity=0.371 Sum_probs=194.3
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~ 424 (686)
+|.+.+.||+|+||.||+|... +++.||||.+... .....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 4789999987642 23445678899999999976 56888999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887542 588999999999999999999998 9999999999999999999999999998753222
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~--------- 217 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHN--------- 217 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 21 2234568999999999999999999999999999999999999997533211 111111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+.....++.+++.+||+.+|.+||+.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122334568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=315.01 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=205.2
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
.+|...+.||+|+||.||+|+.. +.+.|++|.+...... ..+.+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999954 2467999987654333 4578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 422 LVYEFVPNGTLYQNIHNHIEE------FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 2589999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
|+++..............++..|+|||.+.+..++.++||||||++++||++ |..||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence 9987543332222333456788999999988889999999999999999999 888986432111 11111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.+. .......+..+.+++.+||+.+|++||++.+++..|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 110 1111233457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=348.87 Aligned_cols=262 Identities=23% Similarity=0.349 Sum_probs=205.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||.||+|... +++.||+|++... .....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 5889999987542 2233467999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 425 EFVPNGTLYQNIHNHIE--------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
||+++|+|.+++..... ...+++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 13467788999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCc-----------------eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCccc
Q 038345 497 TSRSITVDQT-----------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559 (686)
Q Consensus 497 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~ 559 (686)
+++....... .......||+.|+|||++.+..++.++||||||+++|||+||+.||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01112468999999999999999999999999999999999999997522110
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIRAS 627 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~ev~~~L~~i~~~ 627 (686)
.. ..... .++.. .......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus 239 ---i~--~~~~i--------~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ---IS--YRDVI--------LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ---hh--hhhhc--------cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00000 00000 000123345688999999999999995 677788888776543
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=316.15 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=195.0
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||.||++... +++.||+|.+.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999965 58999999875321 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 98886543 33589999999999999999999998 99999999999999999999999999987654322 22334
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...... ... +..... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~-~~~--------~~~~~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELK-RRT--------LEDEVK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHH-HHh--------hccccc-cccccC
Confidence 68999999999999889999999999999999999999996432111 100000 000 000000 001123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..++.+|+.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 556899999999999999999988775443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=316.36 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=194.1
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||+||++... +++.||+|++.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 68899999875422 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeee
Q 038345 433 YQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK 511 (686)
Q Consensus 433 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 511 (686)
..++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98885432 234689999999999999999999998 999999999999999999999999999976543322 2233
Q ss_pred eeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHH
Q 038345 512 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAERE 591 (686)
Q Consensus 512 ~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 591 (686)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....... ++... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~--------~~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQR--------ILNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHh--------hcccC--CCCccc
Confidence 5689999999999999999999999999999999999999975322110 0000000 00000 111223
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 038345 592 EIMTVATLAKRCLNLNGKNRP-----TMKEVA 618 (686)
Q Consensus 592 ~~~~l~~l~~~cl~~dp~~RP-----t~~ev~ 618 (686)
.+..+.+++.+||+.||++|| ++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l 255 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLR 255 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHh
Confidence 456788999999999999999 555665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=322.62 Aligned_cols=241 Identities=26% Similarity=0.369 Sum_probs=193.7
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999965 4789999987642 233456678899998876 799999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 9999888754 2589999999999999999999999 99999999999999999999999999987543222 223
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~-~~i~~~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LF-ESILHDDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997543211 11 11111100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRP-------TMKEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RP-------t~~ev~~ 619 (686)
.....++.+++.+||+.||++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12345688999999999999999 6777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.08 Aligned_cols=238 Identities=27% Similarity=0.340 Sum_probs=193.0
Q ss_pred cccCccceEEEEEEEe----CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 355 RILGQGGQGTVYKGML----ADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999876422 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|+|.+++.+. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 99999998753 3589999999999999999999998 99999999999999999999999999997654322 22
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+.... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~-~~i~~~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETM-TMILKAK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHH-HHHHcCC----------CCC
Confidence 33456899999999999888999999999999999999999999743211 111 1111100 011
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.03 Aligned_cols=271 Identities=27% Similarity=0.394 Sum_probs=207.4
Q ss_pred cccccccccCccceEEEEEEEeC-----CCcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-----DGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLE--TEVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 420 (686)
..|...+.||+|+||.||+|.+. .+..||||.+...... ..+.|.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999854 3678999988754443 46789999999999999999999999877 5578
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999986432 589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
........ .....++..|++||.+.+..++.++||||||++++||++|+.|+............ ..........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG-IAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc-cccccccHHHHHH
Confidence 65322211 11223456799999999889999999999999999999999998643221100000 0000000001111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.+........+...+.++.+++.+||+.+|++||++.||+++|+.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111111112233467999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.48 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=199.6
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchh
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 433 (686)
++||+|+||.||++...+++.||+|........ ....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987654333 5578999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee-eee
Q 038345 434 QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-TKV 512 (686)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 512 (686)
+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||+++.......... ...
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 9997543 2588999999999999999999998 999999999999999999999999999976532211111 112
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAERE 591 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 591 (686)
.++..|+|||.+.++.++.++||||||++++||++ |..||....... ....... ......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIES---------GYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhc---------CCCCCCCcc
Confidence 34567999999998899999999999999999999 888886443211 1111111 001111223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 592 EIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 592 ~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.+..+.+++.+||+.+|++||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=312.11 Aligned_cols=239 Identities=23% Similarity=0.384 Sum_probs=190.0
Q ss_pred cccCccceEEEEEEEeCC-------------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 355 RILGQGGQGTVYKGMLAD-------------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358899876655555668899999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc-------EEEEe
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR-------AKVSD 494 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~D 494 (686)
+||||+++|+|..++.... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999998887543 3589999999999999999999998 9999999999999986654 89999
Q ss_pred cCCcccccCCCceeeeeeeccccccCccccc-cCCCCccccEeehHHHHHHHH-hCCCCCccCCcccCCchhHhhHHHhh
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEIL-TGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~S~Gv~l~ell-tg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||......+ ......
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHh
Confidence 9998754321 2234788899999886 567899999999999999998 5888876432211 000000
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
.. ... .......+.+|+.+||+.||++||++.+|++.|
T Consensus 224 -~~-~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQ-CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cC-ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 000 011235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.37 Aligned_cols=244 Identities=28% Similarity=0.440 Sum_probs=203.7
Q ss_pred ccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhh
Q 038345 356 ILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQ 434 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 434 (686)
+||+|.||+||.|+..+ ...+|||.+...+....+-+.+|+.+.++|+|+|||+++|.+.+.+..-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999654 56789999887777777889999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEEEEecCCcccccCCCceeeee
Q 038345 435 NIHNHIEEFPI--TWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTK 511 (686)
Q Consensus 435 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~ 511 (686)
+|+..= .|+ .+.++--+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||.++.+. .-...+..
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET 735 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence 998643 245 6778888999999999999999 999999999999994 67899999999998764 22344566
Q ss_pred eeccccccCccccccC--CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 512 VQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 512 ~~gt~~y~aPE~~~~~--~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
+.||..|||||++..+ .|+.++|||||||++.||.||++||....... .. ++.+---......+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----AA---------MFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----AA---------MFKVGMYKVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----Hh---------hhhhcceecCCCCc
Confidence 7899999999999775 58899999999999999999999997543211 10 11111111223445
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+...+...++.+|+.++|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677788999999999999999999999985
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.83 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=192.5
Q ss_pred cccCccceEEEEEEEeCC---CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLAD---GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||+|...+ +..+|+|+++... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 4578999876533 233457899999999999999999999999999999999999999
Q ss_pred chhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 431 TLYQNIHNHIE--EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 431 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 23467888899999999999999998 99999999999999999999999999997543322211
Q ss_pred -eeeeeccccccCccccccC-------CCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 509 -TTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 509 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+ .... ... ......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1234567889999998642 35789999999999999996 999996543211 1000 011 111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.++.+ .......+.+++.+|| .+|++|||++||+..|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1122345788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=322.42 Aligned_cols=238 Identities=29% Similarity=0.411 Sum_probs=192.0
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|... +++.||||.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999965 5889999987542 233456778898888877 699999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999887542 589999999999999999999998 99999999999999999999999999987543222 122
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCC----------CCC
Confidence 34568999999999999999999999999999999999999997543211 1111111100 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
.....++.+++.+||+.||++||++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 123456889999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.58 Aligned_cols=251 Identities=23% Similarity=0.302 Sum_probs=195.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5889999999999999999964 5889999987532 22334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999999754 2588999999999999999999998 99999999999999999999999999975321000
Q ss_pred ------------------------------------------ceeeeeeeccccccCccccccCCCCccccEeehHHHHH
Q 038345 506 ------------------------------------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 543 (686)
Q Consensus 506 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ 543 (686)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012346999999999999999999999999999999
Q ss_pred HHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 038345 544 EILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP---TMKEVAFE 620 (686)
Q Consensus 544 elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---t~~ev~~~ 620 (686)
||++|+.||......+ .............+ .........+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 236 ell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAE------TQLKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHH------HHHHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999997543211 01111000000000 001122345677888866 5999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.06 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=189.3
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||+||+|... +++.||+|.+... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999965 6899999987542 1223345555554 56789999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 9999988753 3588999999999999999999998 99999999999999999999999999987532221 223
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... .. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~----------~~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN-KP----------LRLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-CC----------CCCC
Confidence 3456899999999999999999999999999999999999999753221 11111111 00 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
......+.+++.+||+.||.+||++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 223556889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=311.14 Aligned_cols=251 Identities=29% Similarity=0.453 Sum_probs=194.6
Q ss_pred cccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCcceEEEEecc
Q 038345 355 RILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPLLVYEFVP 428 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lV~e~~~ 428 (686)
+.||+|+||.||+|.+.+ ...||+|+.... .....+.+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 457999987543 3445678899999999999999999999876 4556899999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce-
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH- 507 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~- 507 (686)
+|+|.+++.+... .+++..++.++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976432 367888899999999999999998 9999999999999999999999999999765332111
Q ss_pred --eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhC-CCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 508 --LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 508 --~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......++..|+|||.+.+..++.++||||||+++|||++| .+||...... .+. .......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~----~~~~~~~--------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT----VYLLQGR--------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhcCC---------
Confidence 11223457789999999988999999999999999999995 5555432111 111 1111100
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
....+...+..+.+++.+||+.+|++||++.+|++.|+.+..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000111224568899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.76 Aligned_cols=249 Identities=31% Similarity=0.488 Sum_probs=203.8
Q ss_pred cccCccceEEEEEEEeCC----CcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLAD----GRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|.... +..|++|.+...... ..+.+.+|+.++++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999654 788999987764433 367899999999999999999999999999999999999999
Q ss_pred CchhhhhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 430 GTLYQNIHNHIE------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 430 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
++|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 25699999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 504 DQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 504 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+ +.......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC-------
Confidence 321 12233457889999999988899999999999999999999 699997542111 11111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.....+...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 --YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122233567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=323.58 Aligned_cols=243 Identities=26% Similarity=0.374 Sum_probs=191.5
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||++... +++.||+|.+... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999964 6899999987542 2233345566655 56778999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 9999888753 3589999999999999999999998 99999999999999999999999999987532211 123
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... ..+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc----------cCC
Confidence 3456899999999999999999999999999999999999999743211 11111111 100 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
......+.+++.+||+.+|.+||++++.++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 12345678999999999999999987544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.97 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=198.3
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 57889999876432 22335678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 8888776543 2488999999999999999999998 999999999999999999999999999976433221
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hhhhh---
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RLFEV--- 579 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--- 579 (686)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ........ ....+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSN 235 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcch
Confidence 1223457899999998865 5688999999999999999999999975443221111 11110000 00000
Q ss_pred -----hh-hhccC----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 -----LD-ALVLK----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 -----~d-~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+ +.... ........++.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 00000 001123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=319.69 Aligned_cols=264 Identities=28% Similarity=0.410 Sum_probs=202.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.++||+|+||.||++... ++..+|+|..+.. ......++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999965 5788999987643 233446788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999754 35899999999999999999999742 8999999999999999999999999998755322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc-------------
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE------------- 573 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~------------- 573 (686)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.....................
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 123346889999999998888999999999999999999999998643321110000000000000
Q ss_pred ----chhhhhhhhhccCh---h-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 574 ----NRLFEVLDALVLKE---A-EREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 574 ----~~~~~~~d~~~~~~---~-~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
....+..+...... . ......++.+++.+||+.+|++||++++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011111100000 0 01134568999999999999999999999843
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=321.34 Aligned_cols=240 Identities=25% Similarity=0.359 Sum_probs=191.6
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999975 5889999987642 123345677788888765 899999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 9999988753 3588999999999999999999998 99999999999999999999999999987532221 223
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+... . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~-~~~~~~~~------~----~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------E-LFESIRVD------T----PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhC------C----CCCC
Confidence 3456899999999999999999999999999999999999999743211 0 11111110 0 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMK-EVA 618 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~-ev~ 618 (686)
.....++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12345688999999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.44 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+|.+.++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+....++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 6889999987542 3345577889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ...+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++|+|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-A 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-c
Confidence 9999999886532 23588999999999999999999998 99999999999999999999999999997654322 1
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... . .......+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------N-LILKVCQGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------H-HHHHHhcCCC---------CC
Confidence 223356889999999999889999999999999999999999999643211 0 1111111111 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.+......+.+++.+||+.+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122334568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=322.69 Aligned_cols=241 Identities=26% Similarity=0.374 Sum_probs=194.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 424 (686)
+|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 5789999987642 223345677788888877 5899999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999887542 588999999999999999999998 9999999999999999999999999999754322
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ + ...+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~----~~~i~~~~--------- 217 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L----FQSIMEHN--------- 217 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---H----HHHHHhCC---------
Confidence 21 2234568999999999999999999999999999999999999997533211 1 11111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+.....++.+++.+||+.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122344568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=338.12 Aligned_cols=267 Identities=21% Similarity=0.317 Sum_probs=195.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-------
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET------- 417 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 417 (686)
....+|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34567999999999999999999965 58899999875321 2345799999999999999999887532
Q ss_pred -CcceEEEEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEe
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSD 494 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~D 494 (686)
...++||||+++ +|.+++... .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 235689999974 677766532 2234689999999999999999999999 999999999999998664 799999
Q ss_pred cCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
||+++.+..... .....||+.|+|||++.+ ..++.++||||||++||||++|++||.+....+ ......+....
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~~~~ 289 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRIIQVLGT 289 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Confidence 999986643222 233468999999999865 468999999999999999999999997543211 11111111100
Q ss_pred ch--hhhhhh-------------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 038345 574 NR--LFEVLD-------------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF--ELGGIR 625 (686)
Q Consensus 574 ~~--~~~~~d-------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~--~L~~i~ 625 (686)
.. ...... ..+....+...+.++.+|+.+||+.||.+|||+.|+++ .++.++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 000000 00001111223457899999999999999999999984 355544
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=314.27 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=199.6
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC-----
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLET----- 417 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----- 417 (686)
+.+++.|...+.||+|+||.||+|... +++.||+|...... .....+.+|+.++.++ +|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 345678999999999999999999965 57899999876543 3346788999999998 699999999998753
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 35789999999999999987642 23589999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
+++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.||....... .... .
T Consensus 157 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~~--~ 228 (272)
T cd06637 157 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALFL--I 228 (272)
T ss_pred Cceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHHH--H
Confidence 9976532221 223456899999999986 3457889999999999999999999986432110 0000 0
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... . .......+..+.+|+.+||+.+|.+|||+.++++
T Consensus 229 ~~~~~-----~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPA-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCC-----C---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 0 0111123456889999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=315.22 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=188.5
Q ss_pred ccCccceEEEEEEEeCC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeE
Q 038345 356 ILGQGGQGTVYKGMLAD-------------------------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKL 410 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 410 (686)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998866545555788999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC--
Q 038345 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-- 488 (686)
Q Consensus 411 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-- 488 (686)
++++.+....++||||+++|+|..++.... ..+++..++.++.|+++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999887532 3588999999999999999999998 999999999999997643
Q ss_pred -----cEEEEecCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHH-hCCCCCccCCcccCC
Q 038345 489 -----RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEIL-TGQKPIRAINIDEDR 561 (686)
Q Consensus 489 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~ell-tg~~p~~~~~~~~~~ 561 (686)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+.
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 4899999998643221 12346788999998865 56899999999999999995 69999875432210
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.. ..... . ..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 231 --~~----~~~~~---------~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ER----FYEKK---------H--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH----HHHhc---------c--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 00000 0 001112245889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=322.22 Aligned_cols=241 Identities=26% Similarity=0.365 Sum_probs=194.6
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||++... +++.||||.++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 4789999987642 233456678899999888 699999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|..++.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99999887542 589999999999999999999998 99999999999999999999999999987532222 122
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.... ...+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~----------~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDE----------VRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCC----------CCCC
Confidence 3456899999999999999999999999999999999999999743311 1 111111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTM-----KEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~-----~ev~~ 619 (686)
......+.+|+.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334568899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.38 Aligned_cols=250 Identities=27% Similarity=0.341 Sum_probs=198.9
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999965 68899999865421 22235678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886543 23589999999999999999999998 999999999999999999999999999876532221
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....... +++. ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~---------~~~~-~~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVER---------LVKE-VQE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHh---------hhhh-hhh
Confidence 123468999999999999999999999999999999999999997532111 0000000 0000 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
.........+.+|+.+||+.||++||| ++|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 112233456889999999999999999 778874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.25 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=191.6
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||+|... +++.||||.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 4789999987642 123345667788888764 899999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 9999998753 2588999999999999999999998 99999999999999999999999999987532221 122
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-------~~~~i~~~~------~----~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-------LFQSIRMDN------P----CYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------C----CCC
Confidence 34568999999999999999999999999999999999999997533211 111111100 0 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMK-EVA 618 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~-ev~ 618 (686)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12345678999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.07 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=199.5
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
|++.+.||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 677789999999999999976 4778899988766666678899999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|..++.+. ..++++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 9999888653 23689999999999999999999998 99999999999999999999999999987643221 122
Q ss_pred eeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 510 TKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
....++..|+|||++. +..++.++||||||+++|||++|+.||...... .......... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~-~~~------ 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE-PPT------ 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcC-CCC------
Confidence 3346889999999974 455788999999999999999999998643211 1111111100 000
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+.....++.+++.+||+.+|.+||++.+++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 011122345789999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.32 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=187.6
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||.||+|... +++.||+|.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5889999987532 1223344555554 67889999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|..++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 9999888643 3588899999999999999999998 99999999999999999999999999987532221 223
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .... ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~-~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMY-DNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHH-HHHhcCC----------CCCC
Confidence 345689999999999999999999999999999999999999975321 1111 1111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=312.08 Aligned_cols=252 Identities=34% Similarity=0.529 Sum_probs=199.5
Q ss_pred cccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhH--HHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNV--EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
|+..+.||+|+||+||++.... ++.||+|.......... ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678999999999999999764 66899999876544332 23456999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++... ..+++..++.++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 999999999832 3589999999999999999999999 99999999999999999999999999997542 2222
Q ss_pred eeeeeeccccccCccccc-cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++. +...+.++||||||+++|+|++|+.||......+ ....+..... .. +.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~----~~-~~~~~~- 224 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILK----RP-LPSSSQ- 224 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHH----TH-HHHHTT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhccc----cc-cccccc-
Confidence 334556899999999998 8889999999999999999999999997541111 0000000000 00 000000
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+.+++.+||+.||++||++.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011267999999999999999999999983
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.06 Aligned_cols=256 Identities=26% Similarity=0.474 Sum_probs=204.4
Q ss_pred cccccccccCccceEEEEEEEeCC-Cc----EEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GR----IVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.+|.+.+.||+|+||.||+|...+ +. .||+|...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 457788999999999999998643 32 58999876543 3445788999999999999999999999987 78899
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999986432 489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceee-eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
....... ....++..|+|||.+....++.++||||||+++|||++ |+.||......+ +...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC----
Confidence 3322211 11223568999999988899999999999999999999 999997543211 1111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
...+......+.+++.+||..+|++||++.++++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111233467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.06 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=203.7
Q ss_pred cccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|...++||+|+||.||+|...+ +..+++|.+..... .+++.+|+.++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999765 78999998765422 678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999987533 3689999999999999999999998 999999999999999999999999999986643321
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+. .. ..... ......
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~-------~~~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNK-------PPPTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccC-------CCCCCC
Confidence 22334578899999999998999999999999999999999999874322110 00 00000 000011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......+.+++.+||+.+|++|||+.+|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12233456899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.15 Aligned_cols=266 Identities=25% Similarity=0.280 Sum_probs=216.6
Q ss_pred cccccccccCccceEEEEEEEeCC-CcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|+..+.||.|.-|+||++.+.+ +..+|+|.+... .+....+...|-+||+.++||-++.|++.+..++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 467788999999999999999875 588999987542 3445567788999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||++||+|..+++++.. ..+++..+.-+|.+|+-||+|||-. |||.|||||+||||.++|.+-|+||.|+......
T Consensus 157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999988754 4699999999999999999999999 9999999999999999999999999987533110
Q ss_pred ---------------------------------Cc----------------------eeeeeeeccccccCccccccCCC
Q 038345 505 ---------------------------------QT----------------------HLTTKVQGTFGYVDPEYFQSSQF 529 (686)
Q Consensus 505 ---------------------------------~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 529 (686)
.. .....++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 01123568999999999999999
Q ss_pred CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCC
Q 038345 530 TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGK 609 (686)
Q Consensus 530 t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~ 609 (686)
+.+.|.|+|||+||||+.|+.||.+.+..+ .+..++...+.-......+....+||++.|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999999876543 23333333333222335567789999999999999
Q ss_pred CCCCHHHHHHHHHhhhhhhccccc
Q 038345 610 NRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 610 ~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
+|.-.+.=+.++++..-..+..|.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred hhhccccchHHhhcCccccCCChh
Confidence 999855555556655555555554
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.26 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=204.0
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788999999999999999995 468999999887655555677899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.+. .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999998643 488999999999999999999998 9999999999999999999999999999765433221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ...... .....
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~--------~~~~~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG--------TPELQ 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC--------CCCCC
Confidence 223457889999999999889999999999999999999999996543211100 000000 00001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......+.+++.+||+.+|++||++++|++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12233456789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.36 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=198.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|.+.+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999965 6889999987543 222346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ ++|.+++........+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68888887654445799999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh--cc------hhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN--EN------RLF 577 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~--~~------~~~ 577 (686)
.......+++.|+|||.+.+. .++.++||||||++++||++|+.||......+ .+...+..... .. .+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 112233568899999988654 57899999999999999999999997432110 01000000000 00 000
Q ss_pred h---hhhhh---ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 E---VLDAL---VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~---~~d~~---~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ..... ...........++.+++.+||+.||++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000 000001123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.12 Aligned_cols=246 Identities=25% Similarity=0.317 Sum_probs=195.6
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
|+..++||+|+||+||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999964 68899999875422 22335678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998887543 23699999999999999999999998 99999999999999999999999999997653221
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||......+. ........... ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~----------~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLET----------EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcc----------cc
Confidence 12334689999999999989999999999999999999999999975332110 00000000000 00
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
.........+.+|+.+||+.+|++||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11223345678999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=309.55 Aligned_cols=250 Identities=26% Similarity=0.476 Sum_probs=200.9
Q ss_pred ccccccccCccceEEEEEEEeCCCcEEEEEEccccC------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999865421 22345688999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.+.. ++++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997542 588999999999999999999998 999999999999999999999999999876432
Q ss_pred CC-----ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 504 DQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 504 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.. ........|+..|+|||++.+..++.++||||||++++||++|+.||......+ ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~--- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRG--- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccC---
Confidence 11 111223458899999999999889999999999999999999999996432111 0000000000
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+......+.+++.+||+.+|++||++.+++.
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001122234556889999999999999999999873
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.99 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=201.5
Q ss_pred ccccccccCccceEEEEEEEeCC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHHh-cCCCCeeeEEeEEee
Q 038345 350 NYNANRILGQGGQGTVYKGMLAD--GRIVAVKKSKLV----------DENNVEQFINEVVILSQ-INHRNIVKLLGCCLE 416 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~ 416 (686)
+|.+.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 688999976432 22334567889988875 799999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988542 22346899999999999999999999632 8999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
|++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.||...... . .........
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~-~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------S-LATKIVEAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------H-HHHHHhhcc
Confidence 9998654332 233456889999999999888999999999999999999999998643211 1 011111111
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
. ...........+.+++.+||+.||++||++.||.++|.
T Consensus 230 ~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 Y--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred C--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00011123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.60 Aligned_cols=249 Identities=26% Similarity=0.417 Sum_probs=203.7
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.+|...+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4689999999999999999985 468999999876655555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988643 489999999999999999999999 9999999999999999999999999998765433221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......+ ....... .... ...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~~-------~~~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGTP-------ELQ 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCc-------ccC
Confidence 223458889999999999889999999999999999999999996533211 1100000 0000 001
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12233456889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=306.32 Aligned_cols=250 Identities=28% Similarity=0.412 Sum_probs=204.5
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|+..+.||+|+||.||.+.. .+++.+++|++... ......++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999885 45889999986543 345567889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997643 34589999999999999999999998 999999999999999999999999999986643332
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ..+.. .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~-~~~~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI-VQGNY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH-HcCCC---------C
Confidence 223345899999999999888999999999999999999999998643211 111111 11111 1
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
........++.+++.+||+.+|++||+++++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.02 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=204.2
Q ss_pred ccChHHHHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChh---hHHHHHHHHHHHHhcCCCCeeeEEeE
Q 038345 338 LFTSKDLEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDEN---NVEQFINEVVILSQINHRNIVKLLGC 413 (686)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~ 413 (686)
+|.-++.++ .|...+.||.|+||.||-|+. .+.+.||||++....++ ...++..|+..|.+++|||++.+.||
T Consensus 18 LF~k~DPEk---lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC 94 (948)
T KOG0577|consen 18 LFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC 94 (948)
T ss_pred HHccCCHHH---HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce
Confidence 344444443 466788999999999999994 46889999998765443 34678899999999999999999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
|..+...+|||||+- |+-.|+|.-+. ++|.+..+..|..+.+.||+|||+. +.||||||+.||||++.+.|||+
T Consensus 95 yLre~TaWLVMEYCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 95 YLREHTAWLVMEYCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred eeccchHHHHHHHHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeec
Confidence 999999999999995 67777776433 3689999999999999999999999 88999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
|||.|....+ ...++||+.|||||++. .++|+.|.||||||++..||.-+++|+..++.- .+.-.
T Consensus 169 DFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-------SALYH 236 (948)
T KOG0577|consen 169 DFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH 236 (948)
T ss_pred cccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-------HHHHH
Confidence 9999976543 34578999999999974 588999999999999999999999998654321 11111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+..+. +. .-...+....|..++..||+.-|.+|||.++++.
T Consensus 237 IAQNe------sP--tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 237 IAQNE------SP--TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHhcC------CC--CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 22111 11 1113456778999999999999999999988764
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.89 Aligned_cols=238 Identities=24% Similarity=0.421 Sum_probs=190.4
Q ss_pred cccCccceEEEEEEEeCCCc-----------EEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 355 RILGQGGQGTVYKGMLADGR-----------IVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+.||+|+||.||+|.+.+.. .|++|........ ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999976433 5778876544333 5789999999999999999999999988 778999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-------cEEEEecC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-------RAKVSDFG 496 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~DfG 496 (686)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986432 589999999999999999999998 999999999999999887 79999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccC--CCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhc
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......+. .. ....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~----~~~~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER----FYQD 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH----HHhc
Confidence 9976533 1223467789999998876 78999999999999999999 5777765432110 00 0000
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
... .+......+.+++.+||..+|.+||++.+|++.|+
T Consensus 222 ~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00011157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=310.17 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=202.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|...+.||.|++|.||+|... +++.||+|...... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999965 58899999876532 34456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... ++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998753 589999999999999999999998 999999999999999999999999999987653321
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.... .+
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~-----~~---- 216 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNN-----PP---- 216 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcC-----CC----
Confidence 2233457889999999998889999999999999999999999996433111 001111110 00
Q ss_pred hhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAERE-EIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... ....+.+++.+||..+|++||+++++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 4456889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.88 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=202.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+.|++.++||+|+||.||+|... ++..|++|..........+.+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999975 48899999987766667788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|..++.+.. ..+++..++.++.|++.+|+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~ 165 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q 165 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence 9999988876533 3589999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred eeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 508 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
......++..|+|||++. ...++.++||||||+++|||++|+.||..... ........... . +
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~-----~ 233 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-P-----P 233 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-C-----c
Confidence 123345888999999985 34568899999999999999999999864321 11111111100 0 0
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+.....++.+++.+||+.+|++||++.++++
T Consensus 234 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 --TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112233456889999999999999999999974
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.91 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=196.8
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+|.+.+.||+|+||.||++... .++.||||... ...+.+|+.+|++++|+|||++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999975 47889999643 23467899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. ++|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 78888886532 3699999999999999999999998 999999999999999999999999999986543221
Q ss_pred -eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcc-cCCchhHhhHHHhhcchh--------
Q 038345 507 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINID-EDRSLVGYFLQAMNENRL-------- 576 (686)
Q Consensus 507 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~-~~~~l~~~~~~~~~~~~~-------- 576 (686)
.......||..|+|||++.+..++.++|||||||+||||++|..|+...... ........+.+.+.....
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1223456999999999999999999999999999999999988765432211 111111111111111100
Q ss_pred -----hhhhhhh----ccChhh-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 -----FEVLDAL----VLKEAE-------REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 -----~~~~d~~----~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....... ...... ......+.+|+.+||+.||.+|||+.||++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0000000 000000 012236889999999999999999999984
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.22 Aligned_cols=250 Identities=31% Similarity=0.469 Sum_probs=197.5
Q ss_pred cccCccceEEEEEEEeCC-------CcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLAD-------GRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+.||+|+||.||+|+..+ +..+|+|.+.... ......|.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2578999765432 34457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-----cEEEEecCC
Q 038345 427 VPNGTLYQNIHNHI----EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-----RAKVSDFGT 497 (686)
Q Consensus 427 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~DfGl 497 (686)
+++++|.+++.+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 123478999999999999999999998 899999999999999877 899999999
Q ss_pred cccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 498 SRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 498 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.||......+ . ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---V----LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---H----HHHHhcCC
Confidence 9765432211 1122235678999999999999999999999999999998 999986432111 1 11111110
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
....+...+..+.+++.+||..+|++||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 011122345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=321.26 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=196.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE----- 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 418 (686)
..++|.+.+.||+|+||.||++... ++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 5889999987542 3344567889999999999999999999986543
Q ss_pred -cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 419 -VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 419 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
..++||||+.+ +|.+.++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999975 56665542 378899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 574 (686)
++..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ ............
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~ 244 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSAE 244 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcHH
Confidence 9754322 22234568999999999999999999999999999999999999997543211 000000000000
Q ss_pred -------hhhhhhh---------------hhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 -------RLFEVLD---------------ALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 -------~~~~~~d---------------~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....... ... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 000 00011112356889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.13 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=201.1
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.+++|++.+.||+|.|+.||+.... .|+.+|+|.+.. ......+++.+|+.|.+.|+||||++|+....+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3467888899999999999998754 688888886433 3344678899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~~ 500 (686)
+|+|.|++|..-|-.. ...++..+-..+.||+++|.|.|.+ +|||||+||+|+||-. .--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666432 3478888999999999999999999 9999999999999943 34589999999988
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
+. .........||++|||||++...+++..+|||+-||+|+-|+.|.+||.+... ..+ .+.+..+.. + +
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rl----ye~I~~g~y-d-~ 231 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRL----YEQIKAGAY-D-Y 231 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHH----HHHHhcccc-C-C
Confidence 76 44455667899999999999999999999999999999999999999975221 111 111111100 0 0
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
++ ..-....++..+|+++||..||.+|.|+.|.+
T Consensus 232 ~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 232 PS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CC----cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11 01122345678999999999999999998876
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.43 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=201.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|...+.||+|+||.||+|... ++. .||+|.+.... ......+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45777889999999999999854 343 57888876533 23345788999999999999999999998754 4679
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 999999999999987543 2588999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC----
Confidence 32221 1122335678999999999999999999999999999998 999986432111 1111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
...+......+.+++.+||..+|++||+++++++.|+.+...
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011112334688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.61 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=201.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999976 6899999987643 344457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|..++........+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999876433346899999999999999999999632 8999999999999999999999999998765322
Q ss_pred eeeeeeeccccccCccccccC------CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~------~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ......+ ..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~---------~~~~ 223 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQL---------SAIV 223 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHH---------HHHh
Confidence 12234578899999998554 358899999999999999999999964321 1111111 0111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+. .....+.....++.+++.+||+.+|++||++.+++.
T Consensus 224 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 10 011222335667889999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.49 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=190.6
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHH-HHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEV-VILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||+||++... +++.||+|.+.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999965 57889999875421 22223444444 456788999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 9999998753 2478888999999999999999998 99999999999999999999999999997543222 123
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+..... .. ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~----------~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILN-KP----------LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHh-CC----------cCCC
Confidence 34569999999999999999999999999999999999999997433211 1111111 00 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
......+.+++.+||+.+|.+||++.+.+.++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 23345688999999999999999987655444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.39 Aligned_cols=242 Identities=26% Similarity=0.380 Sum_probs=194.0
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 424 (686)
+|+..+.||+|+||.||++... +++.||+|.+... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999965 6889999987642 2334466788999998885 577888999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987542 589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~-~~i~~~~--------- 217 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LF-QSIMEHN--------- 217 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCC---------
Confidence 2 12233568999999999999999999999999999999999999997543211 01 1111100
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
...+.....++.+++.+||+.+|.+|++..
T Consensus 218 -~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 -VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 011223345678999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.98 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=200.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 47888899999999999999864 58899999877655555567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... .+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999999987543 589999999999999999999999 99999999999999999999999999987654221 1
Q ss_pred eeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 508 LTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......|+..|+|||++. ...++.++||||||+++|||++|+.||........ . + ..... ... .+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~---~-~~~~~-~~~---~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L---F-LMTKS-NFQ---PPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H---H-hhhcc-CCC---CCcc
Confidence 223346899999999874 45688999999999999999999999864332110 0 0 00000 000 0000
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. .......+.+++.+||+.+|++||++++|++
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0122346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.39 Aligned_cols=248 Identities=28% Similarity=0.486 Sum_probs=199.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh---------hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE---------NNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
+|.+.+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999864 578999997654221 123568899999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999754 3588999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc-----eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 500 SITVDQT-----HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 500 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-~~------ 222 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA-IF------ 222 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH-HH------
Confidence 6642211 1112245788999999999989999999999999999999999999743210 00 00
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.. ......+......+.+++.+||+.+|.+||++.+|++
T Consensus 223 ---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ---KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 0111222334567889999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.87 Aligned_cols=256 Identities=28% Similarity=0.406 Sum_probs=204.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|++.+.||+|+||+||++... +++.||+|...... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999965 58899999865432 33457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... .++++..+..++.|++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999988753 35899999999999999999999743 79999999999999999999999999986543211
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCC-----chhHhhHHHhhcchhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR-----SLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~-----~l~~~~~~~~~~~~~~~~~d 581 (686)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......++. .....+......
T Consensus 159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 228 (284)
T cd06620 159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-------- 228 (284)
T ss_pred --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc--------
Confidence 22346899999999998889999999999999999999999999754432110 111111111110
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
..........+..+.+++.+||+.||++||++.||++..
T Consensus 229 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 -PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 000001112456788999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=321.93 Aligned_cols=191 Identities=23% Similarity=0.399 Sum_probs=164.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+|.+.+.||+|+||.||+|... ++..||+|.... .....|+.++++++|+||+++++++.+....++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 357999999999999999999975 467899997432 2345699999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 139 YS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred cC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 95 68888886533 3689999999999999999999998 9999999999999999999999999999753322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~ 552 (686)
.......||..|+|||++.+..++.++||||||+++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999966554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=325.70 Aligned_cols=250 Identities=25% Similarity=0.354 Sum_probs=194.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|...+.||+|+||.||++... +++.||+|.+... .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 5889999987542 2334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.+. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999999754 3589999999999999999999998 9999999999999999999999999998754211
Q ss_pred Cc----------------------------------eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCC
Q 038345 505 QT----------------------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550 (686)
Q Consensus 505 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~ 550 (686)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 00123469999999999999999999999999999999999999
Q ss_pred CCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 038345 551 PIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT---MKEVA 618 (686)
Q Consensus 551 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~ev~ 618 (686)
||......+ .............+. . ......++.+++.+++. +|.+|++ +.+++
T Consensus 235 Pf~~~~~~~------~~~~i~~~~~~~~~p-----~--~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 235 PFCSETPQE------TYRKVMNWKETLVFP-----P--EVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCHHH------HHHHHHcCCCceecC-----C--CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 997543211 111111100000000 0 01123457778888764 9999986 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.32 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=205.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|...+.||+|+||.||+|... +++.+++|..........+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999964 57889999887655556788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++....... .
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 9999999887542 3589999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred eeeeeeccccccCccccccC---CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 508 LTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~---~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. .. ......+ .. .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~-~~~~~~~----~~-~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LF-LISKSNF----PP-P 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHHhccC----CC-c
Confidence 22334678899999998776 889999999999999999999999975332110 00 0000000 00 0
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........++.+++.+||..+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01122344567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.44 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=198.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999865 57899999876432 22345678999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58988887543 3588999999999999999999998 999999999999999999999999999976432221
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh---cchhhhhhh-
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN---ENRLFEVLD- 581 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d- 581 (686)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ....+..... ...+..+++
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhcc
Confidence 1223356889999998865 457889999999999999999999997543221 1111111110 000000000
Q ss_pred --------hhccC----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 --------ALVLK----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 --------~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.... .........+.+|+.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001123456789999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=306.61 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=190.5
Q ss_pred cccCccceEEEEEEEeCC---CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLAD---GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||+|...+ ...+|+|.+... .......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 357888876543 2334567889999999999999999999999999999999999999
Q ss_pred chhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 431 TLYQNIHNHIE--EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 431 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|.+++..... ....++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 12356888899999999999999999 99999999999999999999999999987543322111
Q ss_pred -eeeeeccccccCcccccc-------CCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 509 -TTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 509 -~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ......... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccC
Confidence 122345678999998743 456889999999999999999 788886432211 111111111 1111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..+. ........+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 12233455677888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.18 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=204.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|.+.+.||+|+||.||++... ++..+|+|..........+.|.+|+.++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356899999999999999999965 5889999998776666778899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999987543 3589999999999999999999999 999999999999999999999999999876533221
Q ss_pred eeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||...... ...... .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~----- 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEP----- 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCC-----
Confidence 223356899999999975 345778999999999999999999999753211 111111 11000
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+ ....+.....++.+++.+||+.+|.+||++.+|++
T Consensus 226 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 P--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred C--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0 00112233456889999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=304.12 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=200.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lV~e 425 (686)
+|.+.+.||+|++|.||++... +++.||+|++... .....+.+.+|+.++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 5788999987542 33445678999999999999999999998764 446789999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999997642 23589999999999999999999998 99999999999999999999999999997664322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||..... ...... ...+.+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~--------- 219 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKL--------- 219 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCC---------
Confidence 2 22334588999999999999999999999999999999999999864321 111111 111111
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122334567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=306.35 Aligned_cols=247 Identities=27% Similarity=0.469 Sum_probs=199.2
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.+.||+|+||.||++.. .++.||+|...... ..+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 57889999876432 346789999999999999999999998654 5799999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999997643 23589999999999999999999998 9999999999999999999999999998754321
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+ ....
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG---------YRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCC---------CCCC
Confidence 112234567999999998899999999999999999998 999987543211 11111111 0111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
.....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122334668899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.26 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=203.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..|+..+.||+|+||.||+|... ++..||+|...... ......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999965 58899999876432 34567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999988642 488999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCC
Confidence 223345788999999999888999999999999999999999998754321100 000011112
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
......+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456678999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.39 Aligned_cols=240 Identities=24% Similarity=0.413 Sum_probs=190.5
Q ss_pred cccCccceEEEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLAD--------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+.||+|+||.||+|.... ...||+|..........+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999998542 234888887655555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc--------EEEEecCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR--------AKVSDFGTS 498 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~DfGla 498 (686)
+++|+|.+++..... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999986432 589999999999999999999998 9999999999999987665 699999998
Q ss_pred ccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCC-CCCccCCcccCCchhHhhHHHhhcchh
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQ-KPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~-~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....... . ......
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~-~~~~~~--- 220 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------K-LQFYED--- 220 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------H-HHHHHc---
Confidence 65432 122457889999999987 45799999999999999999985 5554322111 0 000000
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111122356889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.65 Aligned_cols=260 Identities=23% Similarity=0.325 Sum_probs=193.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEeEEeeC-----C
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQI---NHRNIVKLLGCCLET-----E 418 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~-----~ 418 (686)
+|.+.+.||+|+||+||+|... +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 58899999876432 22234566777777665 699999999988642 4
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 48888887543 23589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---ch
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE---NR 575 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~ 575 (686)
+...... ......||..|+|||++.+..++.++||||||+++|||++|++||......+ ........... ..
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChhh
Confidence 8654221 1233468899999999999899999999999999999999999986432211 01011110000 00
Q ss_pred hhh---h----hhh---hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFE---V----LDA---LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~---~----~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.. . ..+ .............+.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 0 000 0000111223456889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=311.33 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=200.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.|...+.||+|+||.||+|... ++..||+|...... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4667789999999999999865 57889999876432 344567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998864 2589999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+......+ ........ ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~---------~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKN---------SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcC---------CCCC
Confidence 1223457889999999999899999999999999999999999986432211 00001110 0111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+.+++.+||+.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 12234566889999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=311.61 Aligned_cols=263 Identities=22% Similarity=0.341 Sum_probs=203.7
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEe-
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCL- 415 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~- 415 (686)
+..+.+..+.++|.+.+.||+|+||.||++... +++.+|+|....... ....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344667778899999999999999999999864 578999998754322 235688899999999 6999999999884
Q ss_pred ----eCCcceEEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 416 ----ETEVPLLVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 416 ----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
.+...++||||+++++|.+++.... ....+++..+..++.|+++||.|||+. +|+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 3456899999999999999886432 234688999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~ 565 (686)
||+|||+++....... ......|++.|+|||++.. ..++.++||||||+++|||++|+.||......+
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------ 236 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ 236 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------
Confidence 9999999976543221 1223458999999998753 457889999999999999999999986432211
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.... .......... .+......+.+++.+||+.+|++|||+.||++.
T Consensus 237 ~~~~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ALFK-IPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred HHhh-ccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 0000000000 011123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=305.80 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=194.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 420 (686)
.+|...+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999964 5889999986532 123456788999999999999999999998753 567
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+++|||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997542 488999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCC--ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCC----
Confidence 53211 11112345788999999999888999999999999999999999999643211 1111110000
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+......+..++ +||..+|++||+++||++
T Consensus 226 -----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111222334566666 788899999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.31 Aligned_cols=197 Identities=24% Similarity=0.402 Sum_probs=160.8
Q ss_pred ccccCccceEEEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceEEEEecc
Q 038345 354 NRILGQGGQGTVYKGMLA---DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFVP 428 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~ 428 (686)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++.+.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999876432 23567899999999999999999999864 456789999986
Q ss_pred CCchhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee----cCCCcEEEEecCCc
Q 038345 429 NGTLYQNIHNHI------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTS 498 (686)
Q Consensus 429 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla 498 (686)
++|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877765321 123589999999999999999999999 99999999999999 45678999999999
Q ss_pred ccccCCCc--eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 499 RSITVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 499 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
+....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 12234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=304.67 Aligned_cols=251 Identities=31% Similarity=0.491 Sum_probs=202.2
Q ss_pred cccccccCccceEEEEEEEeCC-----CcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 351 YNANRILGQGGQGTVYKGMLAD-----GRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
+.+.+.||.|+||.||++...+ +..||+|.+...... ..+.+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456899999999999999654 388999998764433 5678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++...... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999764321 289999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.........++..|+|||.+.+..++.++||||||++++||++ |+.||..... ... .........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~~-~~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EEV-LEYLKKGYR------- 222 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HHH-HHHHhcCCC-------
Confidence 2222222336789999999988889999999999999999998 7888764221 111 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
...+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111122456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.78 Aligned_cols=251 Identities=28% Similarity=0.381 Sum_probs=209.2
Q ss_pred hccccccccccCccceEEEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcce
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDE---NNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 421 (686)
....|.+.+.||+|.||.||+++... |+.+|+|.+..... ...+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44678888999999999999999765 99999998654322 24468899999999998 999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC----CcEEEEecCC
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK----YRAKVSDFGT 497 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGl 497 (686)
+|||++.||.|.+.|... .+++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999865 299999999999999999999998 99999999999999533 5799999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
+..... ........||+.|+|||++....++...||||+|+++|.|++|..||.+....+. +. .+...++
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~-~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FL-AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HH-HHHcCCC-
Confidence 998765 4455667899999999999999999999999999999999999999986442211 11 1111111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+.-......+.++++.++..||..|+|+.++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222344667889999999999999999999996
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.38 Aligned_cols=265 Identities=25% Similarity=0.369 Sum_probs=202.3
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc--CCCCeeeEEeEEeeCC----cceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI--NHRNIVKLLGCCLETE----VPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~~----~~~l 422 (686)
......+.||+|.||+||+|.++ |+.||||++...++ +.+++|.+|.+.. +|+||+.+++.=..++ .++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 45677899999999999999997 88999999875443 6788888888764 9999999998765443 6799
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-----AASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-----~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
|.+|.++|+|+|||.+. .++.+..++++..+|.||++||. +..+.|.|||||+.|||+..++..-|+|+||
T Consensus 287 vTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 99999999999999874 59999999999999999999995 4578999999999999999999999999999
Q ss_pred cccccCCCce---eeeeeeccccccCccccccCC----C--CccccEeehHHHHHHHHhC----------CCCCccCCcc
Q 038345 498 SRSITVDQTH---LTTKVQGTFGYVDPEYFQSSQ----F--TEKSDVYSFGVVLVEILTG----------QKPIRAINID 558 (686)
Q Consensus 498 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--t~ksDv~S~Gv~l~elltg----------~~p~~~~~~~ 558 (686)
|.....+... .....+||.+|||||++...- + -..+||||||.++||+..+ +.||...-+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 9776544221 123456999999999986431 2 2368999999999999762 3455433222
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
+. -.+.+...+-.+++...++. .-...+....+.+|++.||..+|.-|-|+--+-+.|.++..
T Consensus 443 DP--s~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DP--SFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CC--CHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11 11111111112222222221 12234677889999999999999999999999988888764
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.45 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=205.8
Q ss_pred ccChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEe
Q 038345 338 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCL 415 (686)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 415 (686)
++...++..++++|.+.+.||+|+||.||++... +++.+|+|...... .....+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4566778888999999999999999999999964 68899999876432 2345678899999999 8999999999987
Q ss_pred eC-----CcceEEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 416 ET-----EVPLLVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 416 ~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
.. ...++||||+++++|.++++... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 54 35799999999999999886432 234689999999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCceeeeeeeccccccCccccccC-----CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh
Q 038345 490 AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~ 564 (686)
+||+|||+++........ .....|+..|+|||.+... .++.++||||||+++|||++|+.||......+
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----- 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----- 240 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----
Confidence 999999998765432211 1234578899999997643 36889999999999999999999986432111
Q ss_pred HhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 565 GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 565 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... +.......+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 241 -~~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 -TLFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0111 111100011 011223456899999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=304.96 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=205.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|++.+.||.|+||+||+|... ++..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67899999876432 23567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999998654434689999999999999999999998 999999999999999999999999999876654322
Q ss_pred e---eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 507 H---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 507 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
. ......|+..|+|||++... .++.++|+||||+++|||++|+.||......+ .+....... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence 2 22334688999999998877 78999999999999999999999997443211 111111110 00
Q ss_pred hccChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEA-EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...... .......+.+++.+||+.+|++||++++|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011110 1234567889999999999999999999984
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=324.41 Aligned_cols=260 Identities=23% Similarity=0.308 Sum_probs=198.4
Q ss_pred ccccccccccCccceEEEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA---DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999854 3578999986532 34568999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|++. ++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 688888843 23699999999999999999999998 9999999999999999999999999999765433
Q ss_pred Cc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch--------
Q 038345 505 QT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR-------- 575 (686)
Q Consensus 505 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-------- 575 (686)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.....................
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 22 122345699999999999999999999999999999999999999976543221111111111111000
Q ss_pred --hhhhhh---hhccChh--h-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 --LFEVLD---ALVLKEA--E-----REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 --~~~~~d---~~~~~~~--~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+...+. ....... + .....++.+++.+||+.||++||++.|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 0000000 0 012346788999999999999999999984
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=343.64 Aligned_cols=258 Identities=24% Similarity=0.397 Sum_probs=200.0
Q ss_pred HHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--C
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLET--E 418 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~ 418 (686)
.+...++|.+.++||+|+||+||++... .+..||+|.+.. ........|..|+.++++|+|||||++++++... .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999965 467889998654 2344567899999999999999999999988653 5
Q ss_pred cceEEEEeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeEeeCCCCCCeeecC-------
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAAS----ISIYRRDIKSANILLDD------- 486 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~----~~ivH~Dikp~NIll~~------- 486 (686)
..+|||||+++|+|.++|..... ...+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 68999999999999999976322 2469999999999999999999998521 25999999999999964
Q ss_pred ----------CCcEEEEecCCcccccCCCceeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCcc
Q 038345 487 ----------KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRA 554 (686)
Q Consensus 487 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~ 554 (686)
...+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||..
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2358999999998654322 2234568999999999854 4588999999999999999999999964
Q ss_pred CCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 555 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... .. .+...+.... .+ ........+.+|+.+||+.+|.+||++.+++.
T Consensus 246 ~~~-----~~-qli~~lk~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANN-----FS-QLISELKRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCc-----HH-HHHHHHhcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 321 11 1111111110 00 00123456889999999999999999999984
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=304.19 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=200.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-----ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+|...+.||+|++|.||+|... +++.|++|.+.... +...+.+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999865432 33557899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997542 588999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||..... .............
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~------ 220 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKEL------ 220 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccC------
Confidence 22 223455888999999987766 89999999999999999999999864321 0111111110000
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112223456789999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.68 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=189.6
Q ss_pred cccCccceEEEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 355 RILGQGGQGTVYKGMLADG---RIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.||+|+||.||+|...++ ..+++|...... ....+.|.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 356677655432 344578999999999999999999999999999999999999999
Q ss_pred chhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC-cee
Q 038345 431 TLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ-THL 508 (686)
Q Consensus 431 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-~~~ 508 (686)
+|.+++.+... ...+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 23467778889999999999999998 99999999999999999999999999986432111 111
Q ss_pred eeeeeccccccCcccccc-------CCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 509 TTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+...... ....+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 223457889999998753 345789999999999999997 5678754321 1111111111 112222
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
++.+.. .....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222221 23355778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.45 Aligned_cols=268 Identities=19% Similarity=0.229 Sum_probs=195.2
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCC------CCeeeEEeE
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINH------RNIVKLLGC 413 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~ 413 (686)
.+++...+++|.+.++||+|+||+||+|... .++.||||+++... .....+..|+.++++++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3455566789999999999999999999964 57889999886432 233456778888887765 458889998
Q ss_pred EeeC-CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----
Q 038345 414 CLET-EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---- 488 (686)
Q Consensus 414 ~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---- 488 (686)
+... ...++|||++ +++|.+++.+. ..+++..+..|+.||+.||+|||+.. +|+||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence 8764 4678999988 67888888754 35899999999999999999999732 899999999999998665
Q ss_pred ------------cEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 489 ------------RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 489 ------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999885432 12334679999999999999999999999999999999999999997644
Q ss_pred cccCCchhHhh--------HHHhhcchhhhhhh----------hh-----ccC--hhhHHHHHHHHHHHHHhcccCCCCC
Q 038345 557 IDEDRSLVGYF--------LQAMNENRLFEVLD----------AL-----VLK--EAEREEIMTVATLAKRCLNLNGKNR 611 (686)
Q Consensus 557 ~~~~~~l~~~~--------~~~~~~~~~~~~~d----------~~-----~~~--~~~~~~~~~l~~l~~~cl~~dp~~R 611 (686)
..+...+.... ..........++.+ +. ... .........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 32211111000 00000000000000 00 000 0000113457899999999999999
Q ss_pred CCHHHHHH
Q 038345 612 PTMKEVAF 619 (686)
Q Consensus 612 Pt~~ev~~ 619 (686)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999983
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.70 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=197.1
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET----- 417 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 417 (686)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999854 5889999987643 334456788999999999999999999988643
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999965 66666643 378899999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--- 573 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--- 573 (686)
+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+. ..........
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 239 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCP 239 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 99765322 222345689999999999999999999999999999999999999975432110 0000000000
Q ss_pred -------chhhhhhhh---------------hc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 -------NRLFEVLDA---------------LV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 -------~~~~~~~d~---------------~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......++. .. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000000000 00 00011122456889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=316.88 Aligned_cols=236 Identities=25% Similarity=0.304 Sum_probs=184.1
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc---CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI---NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
||+|+||+||+|... +++.||||.+... .......+..|..++.++ +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999965 5899999987532 122334556677777665 699999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++.+. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 9999988753 3589999999999999999999999 99999999999999999999999999987543222 122
Q ss_pred eeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 510 TKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
....||..|+|||++.+. .++.++||||||+++|||++|+.||......+ ....+..... . +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~-~-----~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV-R-----FP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC-C-----CC---
Confidence 345699999999998754 47999999999999999999999997532211 1111111100 0 00
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
.......+.+++.+||+.||++||++.
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 011345678999999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.73 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=196.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 420 (686)
.+|.+.++||+|+||.||+|... ++..||||.+... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999965 5889999986432 123456788999999999999999999998764 467
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++.+.. .+++...++++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987542 478899999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCc--eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
...... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~-~~~~~~~------ 223 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A-AIFKIAT------ 223 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H-HHHHHhc------
Confidence 532111 1122345888999999998888999999999999999999999998642111 0 0111100
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......+......+.+++.+|+. +|++||++++|++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 224 ---QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 001122234455668889999985 9999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.93 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=202.4
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|+..+.||+|+||.||++... +++.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999854 6889999987542 334456889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999887532 23578999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......|++.|+|||++.+..++.++||||||+++++|++|+.||..... .......... . ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~-~---------~~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG-S---------YP 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC-C---------CC
Confidence 12234578899999999999999999999999999999999999864221 1111111111 0 01
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 122334567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.82 Aligned_cols=259 Identities=20% Similarity=0.299 Sum_probs=194.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET----- 417 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 417 (686)
...++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 35578999999999999999999854 6789999987642 223346688999999999999999999987643
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 7888887753 2489999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc-
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN- 574 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~- 574 (686)
+++..... .....||..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTPS 236 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCC
Confidence 99865432 233468999999999876 568999999999999999999999996532211 011110000000
Q ss_pred ----------hhhhhhhhh--ccC----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 ----------RLFEVLDAL--VLK----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 ----------~~~~~~d~~--~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+... ... .........+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000 000011234789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.92 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=193.9
Q ss_pred cccccCcc--ceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 353 ANRILGQG--GQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 353 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+.++||+| +|++||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 78999999864 6899999987653 2334456788999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999975432 2589999999999999999999998 9999999999999999999999999875443211110
Q ss_pred ------eeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 508 ------LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 508 ------~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ... .... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~----~~~~-~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLL----EKLN-GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHH----HHhc-CCcccc
Confidence 0112246778999999876 468899999999999999999999997432211 000 0000 000000
Q ss_pred hh------------------------------------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 LD------------------------------------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~d------------------------------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++ ..............+.+++.+||+.||++|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00001112233457899999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.69 Aligned_cols=259 Identities=23% Similarity=0.376 Sum_probs=202.4
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee-
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLE- 416 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 416 (686)
+..++....+.|++.+.||+|+||.||+|... +++.+|+|...... .....+..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45556667788999999999999999999964 57899999875432 3346788999999998 69999999999863
Q ss_pred -----CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEE
Q 038345 417 -----TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491 (686)
Q Consensus 417 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 491 (686)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 456799999999999999887543 23588889999999999999999998 999999999999999999999
Q ss_pred EEecCCcccccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh
Q 038345 492 VSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~ 566 (686)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||......+..
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875532211 122345889999999875 346788999999999999999999999643221100
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+.............+..+.+++.+||+.+|.+||++.|+++
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ----------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000001111234557899999999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.98 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=196.5
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET------ 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 417 (686)
..++|...++||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999964 5889999987642 334456788999999999999999999987643
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999965 67666643 378899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc--ch
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--NR 575 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 575 (686)
++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+. .......... ..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~ 247 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 247 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 9765322 122345689999999999999999999999999999999999999975432111 0000000000 00
Q ss_pred hhh--------hhhh--------------hc----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFE--------VLDA--------------LV----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~--------~~d~--------------~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... .+.. .. ...........+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000 00 00001112346889999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.74 Aligned_cols=256 Identities=26% Similarity=0.366 Sum_probs=202.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh---hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE---NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|...+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999976 489999998764322 24567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987542 34689999999999999999999998 9999999999999999999999999998754321
Q ss_pred Cce----------------------------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 505 QTH----------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 505 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999999889999999999999999999999997543
Q ss_pred cccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 557 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
..+ .+.. +.+..............+.+++.+||+.+|++||+++..++++-.
T Consensus 237 ~~~------~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE------TFSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH------HHHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 1111 111111111111245679999999999999999995544444433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.98 Aligned_cols=255 Identities=25% Similarity=0.452 Sum_probs=199.0
Q ss_pred cccccccCccceEEEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 038345 351 YNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 418 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 418 (686)
|.+.+.||+|+||.||+|.+. .+..||||.+... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 3678999987542 3445677899999999999999999999886532
Q ss_pred cceEEEEeccCCchhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHI---EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
..++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 223588999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhc
Q 038345 496 GTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 496 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|+++........ ......++..|++||.+....++.++||||||+++|||++ |+.||......+ + ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHc
Confidence 999865433221 1122335678999999998899999999999999999999 889886432211 1 111111
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
... ...+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 100 001112345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.11 Aligned_cols=196 Identities=23% Similarity=0.408 Sum_probs=160.0
Q ss_pred ccccCccceEEEEEEEeCC---CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceEEEEecc
Q 038345 354 NRILGQGGQGTVYKGMLAD---GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFVP 428 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~ 428 (686)
.++||+|+||.||+|...+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999653 5789999876432 23567899999999999999999999854 456789999986
Q ss_pred CCchhhhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee----cCCCcEEEEecCCc
Q 038345 429 NGTLYQNIHNH------IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTS 498 (686)
Q Consensus 429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla 498 (686)
+ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 777776432 1123588999999999999999999998 99999999999999 56679999999999
Q ss_pred ccccCCCc--eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccC
Q 038345 499 RSITVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAI 555 (686)
Q Consensus 499 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~ 555 (686)
+....... .......||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87643321 12234568999999999876 45799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=286.88 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=202.6
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHhc-CCCCeeeEEeEEe
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--------NNVEQFINEVVILSQI-NHRNIVKLLGCCL 415 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 415 (686)
...+.|...+.||.|..++|-+..++ +|+.+|+|++..... .-.+.-.+|+.||+++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34457888899999999999888754 578899987654211 1134456799999998 5999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.....++|+|.|+.|.|+++|.... .++++...+|++|+.+|+.|||.. .||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999998643 599999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCcccccc------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
|.+..+... ......+||++|+|||.+.- ..|+...|+|+.||+||-|+.|.+||.... . ..+.+
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Q--mlMLR 238 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----Q--MLMLR 238 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----H--HHHHH
Confidence 999876543 33456789999999998753 457889999999999999999999986321 0 11222
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.+++. ++ ....=.+...++.+|+.+||+.||.+|.|++|+++
T Consensus 239 ~ImeGky-qF-----~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKY-QF-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhccc-cc-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2222221 00 11111244567899999999999999999999986
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=299.87 Aligned_cols=249 Identities=23% Similarity=0.373 Sum_probs=209.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+-|.+..+||+|+||.||+|.++ .|+.||||++.. ..+.+++..|+.++++.+.|++|+++|.+.....+++||||+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34778889999999999999976 599999998765 456789999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
.-|+..++++-. +.+|++..+..++...++||+|||.. .-+|||||+.||||+-+|.+||+|||.|-.+.. ...
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMA 184 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMA 184 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHH
Confidence 999999999753 45799999999999999999999998 677999999999999999999999999976642 222
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....+.||+.|||||++..-.|..++||||||+...||..|++||....+-.... .+.. .+...-.
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------MIPT-------~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------MIPT-------KPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------eccC-------CCCCCCC
Confidence 3456789999999999999999999999999999999999999997543311000 0000 1111123
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+...+.++.++++.||-..|++|-|+.++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 34566788999999999999999999988875
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=308.70 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=199.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58899999875432 2233568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|..++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99998888776543 2589999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh-----------c
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN-----------E 573 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~ 573 (686)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.. ........ .
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhccc
Confidence 1 1223457889999999876 56789999999999999999999999754322110 00000000 0
Q ss_pred chhh---hhhhhhccC---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLF---EVLDALVLK---EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~---~~~d~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... ...++.... .........+.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 000000000 001122456889999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.98 Aligned_cols=252 Identities=24% Similarity=0.445 Sum_probs=201.5
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEccccC------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 568899999876432 1235678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSI 501 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~ 501 (686)
||||+++++|.+++.+. .++++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999999754 2588999999999999999999999 999999999999998775 6999999999766
Q ss_pred cCCCc---eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 502 TVDQT---HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 502 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..... .......|+..|+|||.+.+..++.++||||||+++++|++|+.||....... ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~---------~ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIF---------K 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHH---------H
Confidence 43211 11223457889999999988889999999999999999999999986432111 111100 0
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+......+.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011112233345567889999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.21 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=202.2
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~ 424 (686)
+|.+.+.||.|+||.||++... ++..||+|.+.. ......+.+.+|+.++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 678999998754 234455678999999999999999999998764 44678999
Q ss_pred EeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 425 EFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLH-----SAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH-----~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
||+++++|.+++.... ...++++..++.++.|++.||+||| +. +|+|+||||+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997632 2346899999999999999999999 65 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
........ ......+++.|+|||.+....++.++||||||+++++|++|+.||...... .+........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~--- 226 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGK--- 226 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCC---
Confidence 87653322 123346899999999999888999999999999999999999999753311 1111111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+......+.+++.+||+.+|++||++++|++
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223344567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=310.47 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=199.9
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
.|.....||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444567999999999999864 588999998876555566789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++... .+++..++.++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99999988542 488999999999999999999998 999999999999999999999999999876533222 1
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ..+. .+. ..+...+. .
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~-~~~-----~~~~~~~~--~ 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMR-RIR-----DNLPPRVK--D 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHH-----hcCCCccc--c
Confidence 23346889999999998888999999999999999999999998643211 1111 010 00111110 1
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......+..++.+||..+|++|||++++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123446889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.78 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=198.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC----------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD----------ENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
+|...+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 68899999765311 112356888999999999999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999999765 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCc-eeeeeeeccccccCccccccCC--CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 499 RSITVDQT-HLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 499 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+....... .......|+..|+|||.+.... ++.++||||||+++|||++|+.||..... .... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~-~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAM-FKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHH-HHhhccc-
Confidence 76432211 1123345889999999987654 78999999999999999999999853221 1111 0100000
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. ...........+..+.+++.+||+.+|++||++.+|++
T Consensus 229 ~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 00111111234567899999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.96 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=200.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 6889999986543 334467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++.... ...+++..++.++.|++++|+|||+. +|+|+||||+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 23589999999999999999999998 99999999999999754 568999999998664322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~--------- 218 (256)
T cd08220 157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTF--------- 218 (256)
T ss_pred c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCC---------
Confidence 1 22345888999999999888999999999999999999999998643221 11111111 000
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1111224556889999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=308.69 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=201.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|++.++||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 5789999987642 23345778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++++.|..++... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655432 3489999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh-----------hc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM-----------NE 573 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~-----------~~ 573 (686)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ......... ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhccc
Confidence 3233345678899999999888 88999999999999999999999997432211 000000000 00
Q ss_pred c------hhhhhhhhhc-cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 N------RLFEVLDALV-LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~------~~~~~~d~~~-~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ...+..+... ....+...+.++.+++.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000000000 00111123577999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.31 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=203.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999854 67899999876555555678899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999998753 478999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......|++.|+|||.+....++.++||||||+++|||++|+.||......+.... ..... .....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~--------~~~~~ 236 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG--------TPELQ 236 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC--------CCCCC
Confidence 12234588899999999888899999999999999999999999975432211000 00000 00011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
........+.+++.+||..+|++||++.+++..
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122234568899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.43 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=206.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|++|.||++... +++.|++|+...... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888899999999999999976 489999998765433 4467899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++... .++++..++.++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 368999999999999999999999 8 99999999999999999999999999998764333
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ..+.... .
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~-~~~~~~~---------~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELM-QAICDGP---------P 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHH-HHHhcCC---------C
Confidence 22 22345888999999999999999999999999999999999999754321 111111 1111110 0
Q ss_pred ChhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAERE-EIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.. .+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111122 4567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.18 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=222.3
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCC------CcEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCC 414 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 414 (686)
+++.....+++...++-+|.||.||.|.+.+ .+.|.+|.++. .++-+...+..|.-++..+.|||+.++.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4555666788888999999999999997653 35677887654 4566677899999999999999999999999
Q ss_pred ee-CCcceEEEEeccCCchhhhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 415 LE-TEVPLLVYEFVPNGTLYQNIH-----NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 415 ~~-~~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
.+ .+.++.+|.++.-|+|..+|. +......++..+...+|.|++.|++|||++ +|||.||.++|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 76 468899999999999999998 333445688889999999999999999999 999999999999999999
Q ss_pred cEEEEecCCcccccCCCceee-eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHh
Q 038345 489 RAKVSDFGTSRSITVDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~ 566 (686)
++||+|-.|+|.+.+.+.+.. .....+..||+||.+....|+.++|||||||+||||+| |+.|+...++.|.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 999999999998765554332 22235678999999999999999999999999999999 9999976655431
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
...+.+..+-..+..++.++..++.-||...|++||++++++.-|.++..++.
T Consensus 508 ----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 508 ----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred ----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 12222222333455778889999999999999999999999999998876654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.77 Aligned_cols=198 Identities=30% Similarity=0.412 Sum_probs=171.7
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-C-----CCeeeEEeEEeeCCcceE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-H-----RNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~l 422 (686)
+|.+.++||+|+||.|-++... +++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7999999999999999999954 6999999998864 334567788999999997 4 489999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC--CcEEEEecCCccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK--YRAKVSDFGTSRS 500 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DfGla~~ 500 (686)
|+|.+. .+|+++|+.+.. ..++...+..|+.||+.||.+||+. +|||.||||+||||.+- ..+||+|||+|..
T Consensus 266 VfELL~-~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 699999987644 3699999999999999999999998 99999999999999643 4799999999976
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCc
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~ 557 (686)
.... .. ...-+..|+|||++.+.+|+.+.|||||||++.||++|.+-|.+.+.
T Consensus 341 ~~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4321 12 45568899999999999999999999999999999999887776543
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.60 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=208.5
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..-|...+.||+|.|..|-+|++ -.|..||||++.... ......+++|++.|+.++|||||+|+........+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577888999999999999984 379999999876543 334467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee-cCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL-DDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DfGla~~~~~ 503 (686)
|+-++|+|++||.++.. .+.+....+++.||+.|+.|+|+. .+|||||||+||.+ ..-|.+||.|||++-.+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999988754 499999999999999999999999 89999999999977 5668899999999977654
Q ss_pred CCceeeeeeeccccccCccccccCCCC-ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.+ ..+..+|...|-|||++.+..|. ++.|||||||+||-|++|+.||...+..| .+.-++|-
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 33 34557899999999999998885 68899999999999999999998655433 22333332
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.. ..+.....+..+||..||..||++|.+.+||+
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 22 33456677899999999999999999999987
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=300.63 Aligned_cols=251 Identities=25% Similarity=0.446 Sum_probs=200.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 688999998765433 3667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998753 2478999999999999999999998 999999999999999999999999999987643332
Q ss_pred eee---eeeeccccccCccccccCC---CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 507 HLT---TKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 507 ~~~---~~~~gt~~y~aPE~~~~~~---~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
... ....++..|+|||++.+.. .+.++||||||+++|||++|+.||...... ...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~---- 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFH-VGAGHK---- 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHH-HhcCCC----
Confidence 211 1345788999999998766 889999999999999999999999643211 000000 000000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.+ .........+.+++.+||+.+|++||++.+++.
T Consensus 225 -~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 -PPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 001122456789999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.26 Aligned_cols=251 Identities=29% Similarity=0.407 Sum_probs=202.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|...+.||+|++|.||++... +++.||+|.+.... ....+++.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999976 58899999876542 34456789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998643 468999999999999999999999 7 99999999999999999999999999987653222
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......+....... .
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~---------~- 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP---------P- 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC---------C-
Confidence 11 156888999999999999999999999999999999999999643211 111111111111110 0
Q ss_pred ChhhH-HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 586 KEAER-EEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 586 ~~~~~-~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+. .....+.+++.+||..+|++|||+.+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 01111 1456689999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.59 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=201.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 68999999876543 33456899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+ +++|.+++.... .++++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987543 4699999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh---h-----
Q 038345 507 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL---F----- 577 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~----- 577 (686)
.......|+..|+|||.+.+. .++.++||||||++++||++|++||...... ............... .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCc
Confidence 223334688999999998654 4689999999999999999998887643211 111111111110000 0
Q ss_pred ----hhhhhh----ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 ----EVLDAL----VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ----~~~d~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+..+. ............+.+++.+||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 000011123467899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=309.22 Aligned_cols=261 Identities=24% Similarity=0.349 Sum_probs=198.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|...++||+|+||.||+|... +++.||+|...... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999976 58899999865422 2234678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.++.... ..+++..++.++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999888876543 2489999999999999999999998 99999999999999999999999999997654332
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH-----------Hhhc
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ-----------AMNE 573 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~-----------~~~~ 573 (686)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||......+ ....... ....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID---QLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH---HHHHHHHHhCCCchhhHHHhcc
Confidence 22233457889999999875 457889999999999999999999986432111 0000000 0000
Q ss_pred chhh-hhhhhhccC-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLF-EVLDALVLK-----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~-~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+. .+..+.... .........+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000000000 001123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.30 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=199.4
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
|.....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344558999999999999864 6889999997655455567789999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|..++.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 174 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR 174 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence 999987754 2489999999999999999999998 999999999999999999999999999876543221 22
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....|+..|+|||++.+..++.++||||||++++||++|+.||......+ ... .+..... . .....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~~-----~--~~~~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMK-RLRDSPP-----P--KLKNA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHhccCC-----C--Ccccc
Confidence 33568999999999998889999999999999999999999996432111 111 1111000 0 00011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
......+.+++.+||+.+|++||++++|++.
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1233468899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.58 Aligned_cols=255 Identities=22% Similarity=0.267 Sum_probs=200.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|...+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999965 47899999876432 234467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999754 3589999999999999999999998 9999999999999999999999999998642110
Q ss_pred C--------------ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 505 Q--------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 505 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
. ........++..|+|||.+....++.++|+||||+++|||++|+.||.+.... . +...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~-~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------E-LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHH
Confidence 0 00111235788999999998888999999999999999999999999643211 1 1111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
...... ..+ ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~---~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI---EWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc---CCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111000 000 0011344568999999999999999997666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.99 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=193.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|.+.+.||+|+||.||++... +++.||+|+++... .....++..|+.+ ++.++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999965 68999999876432 2233456666665 566789999999999999999999999
Q ss_pred eccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 426 FVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 426 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|++ |+|.+++... .....+++..++.++.|++.||+|||++. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888877653 22346899999999999999999999853 7999999999999999999999999999865322
Q ss_pred CceeeeeeeccccccCcccccc----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~-------- 222 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVE-------- 222 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHh--------
Confidence 1 1223457889999998864 4568899999999999999999999863211 0111111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........+.++.+++.+||..+|++||++.++++
T Consensus 223 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 -EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000011123467899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=301.97 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=200.3
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
-|...+.||+|+||.||+|... ++..||+|...... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 68899999865432 334567899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998643 489999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ........ ....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKN---------NPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcC---------CCCC
Confidence 1223457889999999988889999999999999999999999986432110 00011111 0111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122344568899999999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.31 Aligned_cols=260 Identities=27% Similarity=0.310 Sum_probs=201.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 424 (686)
++|...+.||.|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 57899999876432 23457799999999999999999999998654 3679999
Q ss_pred EeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 234588999999999999999999998 999999999999999999999999999875532
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... +....... ...........+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~- 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE-PPLGPIEL-LSYIVNMPNPELKDE- 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC-CCCChHHH-HHHHhcCCchhhccC-
Confidence 21 1234578899999999999999999999999999999999999975432 11111111 111111111111100
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. .........+.+++.+||+.+|++|||+.||++
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.82 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=196.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..|...+.||+|+||.||+|... +++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999965 6889999987532 2334467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 57777765432 3589999999999999999999998 9999999999999999999999999998765322
Q ss_pred CceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
....++..|+|||++. ...++.++||||||+++|||++|+.||....... .... .....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~------ 230 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQND------ 230 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCC------
Confidence 2245788999999874 4568899999999999999999999986432111 0000 00000
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
............+.+++.+||+.+|++||++.+|+..
T Consensus 231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 --SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0011122345678999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.42 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=200.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC-----
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETE----- 418 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~----- 418 (686)
..+++|.+.+.||+|++|.||+|... +++.+++|....... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999975 578899998765433 346799999999999 6999999999997644
Q ss_pred -cceEEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 419 -VPLLVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 419 -~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999887532 234689999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
++........ ......|+..|+|||++.. ..++.++||||||++|+||++|+.||...... ......
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~- 230 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKI- 230 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHh-
Confidence 9876532221 1223458889999998753 34678999999999999999999999643211 001111
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... + ....+......+.+++.+||..||++|||+.++++
T Consensus 231 ~~~~~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPP-----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCC-----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11000 0 01112234567899999999999999999999984
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.27 Aligned_cols=261 Identities=21% Similarity=0.303 Sum_probs=195.7
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|+||.||+|... +|+.||+|.+... .......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999965 6889999987542 222335678899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ ++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 57877776432 3589999999999999999999998 999999999999999999999999999986543221
Q ss_pred eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc------hhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN------RLFEV 579 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~~ 579 (686)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.|+......+ ............. .+...
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhc
Confidence 1 2234578899999998764 46899999999999999999998864322111 0111110000000 00000
Q ss_pred hhhhcc---------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 LDALVL---------KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~d~~~~---------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.... .........++.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0111223467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.77 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=196.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|...+.||+|++|.||+|... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999965 688999998754322 2234577899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ ++|.+++.+... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 489998875432 589999999999999999999998 999999999999999999999999999875432211
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---chhhhhh--
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE---NRLFEVL-- 580 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~-- 580 (686)
. .....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..........+.. .......
T Consensus 159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 122346788999999865 55889999999999999999999999643310 0001000000000 0000000
Q ss_pred ------------hhhccChh-hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 ------------DALVLKEA-EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 ------------d~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0011256789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.27 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=196.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|+..+.||+|++|.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 68899999876432 22335788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. ++|..++.... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68888886543 34689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc-chhh----hh-
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE-NRLF----EV- 579 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~----~~- 579 (686)
. .....++..|+|||++.+.. ++.++||||||+++|||+||+.||...... ..+...+...-.. .... .+
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1 22234688999999887644 688999999999999999999999643211 1111111000000 0000 00
Q ss_pred -----hhhhcc---ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 -----LDALVL---KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 -----~d~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...... ..........+.+++.+||+.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 0001122356789999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=302.55 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=205.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..+++|...+.||+|++|.||+|... ++..|++|.+..... ..+.+.+|+.++++++|+||+++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45667888999999999999999976 688999998876444 4577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999998653 3699999999999999999999998 9999999999999999999999999998655432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. ......++..|++||.+.+..++.++||||||+++|+|++|+.||....... ...... ......
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~------ 235 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLIT-TKGIPP------ 235 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCCC------
Confidence 21 1223357889999999998889999999999999999999999986432211 011100 000000
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+.+++.+||+.+|.+||++.++++
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 -LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111123457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.32 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=204.3
Q ss_pred cccccccccCccceEEEEEEEeCCCc-EEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGR-IVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+.|.++..||.|+||.||+|..++.. ..|-|.+........++|+-|+.||....||+||+|++.|..++.+++..||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45777788999999999999977543 44667777777888899999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
.||..+.++.... .+|++.++.-++.|++.||.|||+. .|||||||+.|||++-+|.++|+|||.+..... ...
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ 185 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence 9999998887643 3699999999999999999999999 999999999999999999999999999854321 222
Q ss_pred eeeeeeccccccCcccc-----ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 508 LTTKVQGTFGYVDPEYF-----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~-----~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
....+.||+.|||||+. ...+|..++||||||++|.||..+.+|-...++ ...+. .+.......++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVll-KiaKSePPTLl-- 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLL-KIAKSEPPTLL-- 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHH-HHhhcCCCccc--
Confidence 34567899999999986 457899999999999999999999999654332 11111 11111111111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+......|.+++.+||..||..||++.++++
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 12345667999999999999999999999984
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.22 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=200.3
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+|+..+.||+|++|.||+|+.. ++..||||.++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999975 58899999876543 223467789999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++ +|.+++........+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888887655445699999999999999999999998 999999999999999999999999999976533221
Q ss_pred eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---chhhhh----
Q 038345 508 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE---NRLFEV---- 579 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~~~---- 579 (686)
......++..|++||.+.+ ..++.++||||||+++|||++|+.||......+. .......... ..+..+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ---LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhHHHHhcCc
Confidence 1223347889999998865 4568899999999999999999999975432211 1111000000 000000
Q ss_pred --hhh------hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 --LDA------LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 --~d~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... .............+.+++.+||+.+|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 0001111223467889999999999999999999973
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=301.27 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=199.1
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV-DENNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~ 424 (686)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 46899999987543 3445567889999999997 999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++... .+++..++.++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988643 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........ . ........ +.
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~-----~~ 221 (277)
T cd06917 155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKP-----PR 221 (277)
T ss_pred ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCC-----CC
Confidence 322 2334588899999998754 568899999999999999999999975432110 0 00000000 00
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.. .....++.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 101 113456889999999999999999999985
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.25 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=200.1
Q ss_pred cccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 351 YNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
|...++||+|++|.||++.. .+++.+++|+.........+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999995 46889999988765555567789999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|.+++.. ..+++..++.++.|++.||+|||+. +|+||||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999999875 2489999999999999999999998 999999999999999999999999998876543221 12
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ..... .+.. ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~-----~~~~--~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNL-----PPKL--KNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcC-----CCCC--ccc
Confidence 234588999999999988899999999999999999999999864321 111111 11100 0000 011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123457899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.21 Aligned_cols=260 Identities=27% Similarity=0.325 Sum_probs=198.2
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN-----NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+|...+.||+|+||.||+|... +++.||||++...... ....+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999965 6899999987654322 235677899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997643 3699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--------
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-------- 574 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 574 (686)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|.+||......+ ............
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhc
Confidence 3221 222346788999998854 467899999999999999999988776432211 111111100000
Q ss_pred -hhhhhhhhhc-----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 -RLFEVLDALV-----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 -~~~~~~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+........ ...........+.+++.+||+.+|++|||++||++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000 00111223467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=292.75 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=203.8
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
|...+.||+|++|.||++... ++..+++|+.........+.+.+|+.++++++|+||+++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 677889999999999999975 6889999998765555667899999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99999987643 3689999999999999999999998 999999999999999999999999999977654332 3
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....++..|++||.+.....+.++||||||+++++|++|+.||......+ ... .......... ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~-------~~~ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALF-KIATNGPPGL-------RNP 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHH-HHHhcCCCCc-------Ccc
Confidence 34568899999999998889999999999999999999999987432110 000 0000000000 001
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 112456899999999999999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=331.22 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=215.3
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCC--------CcEEEEEEccc-cChhhHHHHHHHHHHHHhc-CCCCeeeEEe
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLAD--------GRIVAVKKSKL-VDENNVEQFINEVVILSQI-NHRNIVKLLG 412 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~g 412 (686)
.++...++..+.+.||+|.||.|++|.... ...||||.++. ....+.+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 344455556667799999999999998431 35799999875 3445678899999999999 6999999999
Q ss_pred EEeeCCcceEEEEeccCCchhhhhhccC-----C------C--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCC
Q 038345 413 CCLETEVPLLVYEFVPNGTLYQNIHNHI-----E------E--FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKS 479 (686)
Q Consensus 413 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 479 (686)
+|.+....++|+||+..|+|.++|+... . . ..|+..+++.++.|||.||+||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998755 0 0 2389999999999999999999999 899999999
Q ss_pred CCeeecCCCcEEEEecCCcccccCCCceeeeeee--ccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCC
Q 038345 480 ANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ--GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 556 (686)
Q Consensus 480 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~ 556 (686)
+|||+.++..+||+|||+++.............. -+..|||||.+....|+.|+|||||||+||||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976655444333222 3557999999999999999999999999999999 999997532
Q ss_pred cccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 557 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+ .+.+.+.+..+-+.+..+..++.++++.||+.+|++||++.++.+.|+.+.
T Consensus 527 ~~~---------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTE---------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 111122222223344556778999999999999999999999999998853
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=303.35 Aligned_cols=243 Identities=27% Similarity=0.367 Sum_probs=199.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999965 5889999987542 2334567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999999764 3589999999999999999999998 9999999999999999999999999999876433
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.....|++.|+|||.+.+...+.++||||||+++++|++|+.||...... . .........
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~--------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------Q-IYEKILEGK--------- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCC---------
Confidence 23345889999999998888899999999999999999999999643311 0 111111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVA 618 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~ 618 (686)
...+......+.+++.+||..+|.+|| ++++++
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 011122345688999999999999998 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=306.23 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=197.0
Q ss_pred ccccccccCccceEEEEEEEeC---CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccce
Q 038345 350 NYNANRILGQGGQGTVYKGMLA---DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 421 (686)
+|.+.++||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999965 47899999877532 33446788999999999999999999999988 7899
Q ss_pred EEEEeccCCchhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC----CCcEEEEec
Q 038345 422 LVYEFVPNGTLYQNIHNHIE--EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD----KYRAKVSDF 495 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df 495 (686)
+||||+++ +|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 67666653322 23689999999999999999999998 9999999999999999 999999999
Q ss_pred CCcccccCCCc--eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh------Hh
Q 038345 496 GTSRSITVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV------GY 566 (686)
Q Consensus 496 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~------~~ 566 (686)
|+++....... .......++..|+|||++.+ ..++.++||||||++++||++|+.||............ ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 11233467889999998866 45789999999999999999999999765433211000 00
Q ss_pred hHHHhhc------------chhhhhhhhhccCh---------hhH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 567 FLQAMNE------------NRLFEVLDALVLKE---------AER--EEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 567 ~~~~~~~------------~~~~~~~d~~~~~~---------~~~--~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+...+.. .......+...... ... .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00000000000000 000 23356889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.44 Aligned_cols=261 Identities=21% Similarity=0.294 Sum_probs=198.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 423 (686)
++|...+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999976 588999998764332 2234677899999999999999999999877 889999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||++ ++|.+++..... .+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 589888876432 589999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---------
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--------- 573 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--------- 573 (686)
.... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+. ..........
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchHHHHHh
Confidence 3211 2234578899999998754 468999999999999999999999975432110 0000000000
Q ss_pred --------chhhhhhhhhccChhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 --------NRLFEVLDALVLKEAERE-EIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 --------~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+....+.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000011111111 3556889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.02 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=198.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----cc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~ 420 (686)
.++|.+.++||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 6899999987643 2334567889999999999999999999876543 47
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++|+||+. ++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 4777777542 589999999999999999999999 999999999999999999999999999976
Q ss_pred ccCCCce--eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---
Q 038345 501 ITVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--- 574 (686)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 574 (686)
....... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHH
Confidence 5432211 1123457899999998754 568999999999999999999999996432111 111111111100
Q ss_pred hhhhhhhhhc---------cC-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 038345 575 RLFEVLDALV---------LK-----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE--LGGIR 625 (686)
Q Consensus 575 ~~~~~~d~~~---------~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~--L~~i~ 625 (686)
.+..+.+... .. ........++.+++.+||+.+|++|||+.++++. |+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000000 00 0011234568899999999999999999999864 44443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=300.96 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=195.3
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++......++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 68899999875432 222346789999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777665432 3478888999999999999999998 9999999999999999999999999999764322
Q ss_pred CceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---------
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--------- 574 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------- 574 (686)
... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .............
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence 211 1223478899999998754 57889999999999999999999997543210 0000000000000
Q ss_pred hhhhhhhhhc----cChh-----hHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 575 RLFEVLDALV----LKEA-----EREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 575 ~~~~~~d~~~----~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.+........ .... .......+.+++.+|++.||++|||+.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000000000 0000 001135678999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=297.49 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=200.4
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|+||.||+|... ++..+|+|..... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 5788999987542 223446788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++.+... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999976432 3589999999999999999999998 999999999999998875 57999999997654322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... ...
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~--------- 219 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYF--------- 219 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccC---------
Confidence 122234588899999999888899999999999999999999999864321 111111111 110
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+.+++.+||+.+|++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1111233456889999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.09 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=202.4
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
+|.+.+.||.|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999975 5889999987542 22446789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+.+++|.+++... .++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999754 3689999999999999999999998 99999999999999999999999999987654332
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc----------cc
Confidence 223355888999999999888999999999999999999999999754321 11111111110 01
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTM--KEVA 618 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~--~ev~ 618 (686)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12222344678899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=302.01 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=198.1
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceEEEE
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVYE 425 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~e 425 (686)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999966 48899999977542 33446788999999999999999999999887 88999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888886542 3689999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---chhh---h
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE---NRLF---E 578 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---~~~~---~ 578 (686)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........... .... .
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhcccccc
Confidence 222233456788999998765 467899999999999999999999997543211 11111110000 0000 0
Q ss_pred -----------hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 -----------VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 -----------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+........+..+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000011112567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.38 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=201.8
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEcc--ccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSK--LVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 424 (686)
...|++.++||+||.+.||++...+.+.+|+|+.. ..+.+....|.+|+.+|.+|+ |.+||+|++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35689999999999999999998888899999754 456677889999999999995 999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|+- .-+|..+|...... ...| .++.+..|++.|+.++|.+ ||||.||||.|+|+-. |.+||+|||.|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 987 46899999875433 2334 6778899999999999999 9999999999999954 58999999999988776
Q ss_pred Ccee-eeeeeccccccCccccccC-----------CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 505 QTHL-TTKVQGTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 505 ~~~~-~~~~~gt~~y~aPE~~~~~-----------~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
.+.. ....+||+-||+||.+... ..+++|||||+||+||+|+-|++||.... +.+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~-------- 579 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI-------- 579 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH--------
Confidence 6543 3456799999999988532 25679999999999999999999986321 111
Q ss_pred cchhhhhhhhhccChhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 573 ENRLFEVLDALVLKEAERE-EIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.++..+.|+...-+++.- ...++.++++.||++||++||+..||++
T Consensus 580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 233444454332222221 1123899999999999999999999984
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.42 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=195.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCc-----
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEV----- 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~----- 419 (686)
++|...+.||+|+||.||+|... +++.||||...... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999965 68999999865432 223467889999999995 6999999999987665
Q ss_pred ceEEEEeccCCchhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE--EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFG 496 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfG 496 (686)
.++||||+++ +|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78888865332 24689999999999999999999998 9999999999999998 8899999999
Q ss_pred CcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+++.+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .+.. +........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCC
Confidence 99765432211 122346888999998865 457899999999999999999999997532211 0110 001000000
Q ss_pred --h----hhhhh--------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 --L----FEVLD--------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 --~----~~~~d--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ....+ +............++.+++.+||+.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 00000 00000111224566889999999999999999999873
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.39 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=204.9
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLVY 424 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV~ 424 (686)
+|...+.||+|++|.||+|... ++..|++|...... ....+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 68899999876543 24567899999999999999999999999988 8899999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998643 699999999999999999999998 9999999999999999999999999999876543
Q ss_pred Cce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......++..|++||.+.+...+.++||||||+++++|++|+.||.... ........... ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~---------~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGS---------SG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccc---------cC
Confidence 221 1233458889999999998889999999999999999999999997543 11111111110 00
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+......+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111222233567999999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=323.38 Aligned_cols=267 Identities=19% Similarity=0.256 Sum_probs=190.0
Q ss_pred hccccccccccCccceEEEEEEEeCC--CcEEEEE------------------EccccChhhHHHHHHHHHHHHhcCCCC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD--GRIVAVK------------------KSKLVDENNVEQFINEVVILSQINHRN 406 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 406 (686)
..++|.+.+.||+|+||+||++.++. +..+++| +.. ........+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11223456889999999999999
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCchhhhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee
Q 038345 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIE--EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484 (686)
Q Consensus 407 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 484 (686)
|+++++++...+..++|+|++. ++|.+++..... ........+..|+.||+.||+|||+. +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999985 577777654321 11234667788999999999999998 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCC-CccCCcccCCch
Q 038345 485 DDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP-IRAINIDEDRSL 563 (686)
Q Consensus 485 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p-~~~~~~~~~~~l 563 (686)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||+||||++|+.+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987654433333445799999999999999999999999999999999998754 432221111111
Q ss_pred hHhhHHHhh--c-------chhhhhhhhhccCh----hh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 564 VGYFLQAMN--E-------NRLFEVLDALVLKE----AE-----REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 564 ~~~~~~~~~--~-------~~~~~~~d~~~~~~----~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... .... . .++.+.++...... .+ ......+.+++.+||+.||++|||+.|+++
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1110 0000 0 01111111110000 00 011235778899999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=310.52 Aligned_cols=270 Identities=26% Similarity=0.358 Sum_probs=204.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----cce
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETE-----VPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 421 (686)
+|.+.+.||+|++|.||+|... .++.||||++.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999975 48899999876533 344578999999999999999999999988765 789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||++ ++|.+++.+.. ++++..++.++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888887533 699999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCc--eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh--------HHH
Q 038345 502 TVDQT--HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF--------LQA 570 (686)
Q Consensus 502 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~--------~~~ 570 (686)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+........ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 112334578899999999887 8899999999999999999999999765432110000000 000
Q ss_pred hhcchhhhhhhhh------ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 038345 571 MNENRLFEVLDAL------VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE--LGGIRA 626 (686)
Q Consensus 571 ~~~~~~~~~~d~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~--L~~i~~ 626 (686)
.........+... ............+.+++.+||+.+|++||+++++++. +++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000011000 0001112235678899999999999999999999963 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.00 Aligned_cols=258 Identities=17% Similarity=0.246 Sum_probs=184.4
Q ss_pred cccccccccCccceEEEEEEEeCC----CcEEEEEEccccChhh-----------HHHHHHHHHHHHhcCCCCeeeEEeE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLVDENN-----------VEQFINEVVILSQINHRNIVKLLGC 413 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~g~ 413 (686)
++|.+.++||+|+||.||+|...+ +..+|+|......... ......++..+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999654 3466777543322111 0112234445566789999999998
Q ss_pred EeeCC----cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 414 CLETE----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 414 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
+.... ..++++|++. .++.+.+... ...++..++.|+.|+++||+|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 76544 3367777664 3555555432 2357888999999999999999998 9999999999999999999
Q ss_pred EEEEecCCcccccCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCch
Q 038345 490 AKVSDFGTSRSITVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l 563 (686)
+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||++|+||++|+.||....... ..
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~ 242 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NL 242 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HH
Confidence 999999999876432211 1123469999999999999999999999999999999999999998653211 11
Q ss_pred hHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 564 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
.... ..+-+..+..... .....+..+.+++..||+.+|++||++.++.+.|+
T Consensus 243 ~~~~----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 IHAA----KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHh----HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1110 0000011111100 01123467899999999999999999999998763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.10 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=196.4
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
|+..+.||+|++|.||+|... +|..||+|++.... ....+.+.+|+.++++++|||++++++++.+....++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 68999999876432 223467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
+ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689998875432 3589999999999999999999998 9999999999999999999999999999765322211
Q ss_pred eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--------hhhh
Q 038345 508 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--------RLFE 578 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~~~ 578 (686)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .+...+....... .+.+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468899999987654 57889999999999999999999996543211 0111000000000 0000
Q ss_pred hhhh------hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDA------LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... .............+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000111123356889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.20 Aligned_cols=253 Identities=28% Similarity=0.384 Sum_probs=193.9
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556789999999999999965 58899999876432 344567889999999996 99999999999998899999999
Q ss_pred ccCCchhhh---hhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 427 VPNGTLYQN---IHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 427 ~~~gsL~~~---l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
+.. +|.++ +... ....+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 863 54443 3222 2246899999999999999999999743 899999999999999999999999999976543
Q ss_pred CCceeeeeeeccccccCccccccC---CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
... .....|+..|+|||++.+. .++.++||||||+++|||++|+.||.... .............
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~------ 227 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD------ 227 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC------
Confidence 221 1233578899999998776 68999999999999999999999996432 1111111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.+..........++.+|+.+||+.+|++|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111122235567899999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.44 Aligned_cols=248 Identities=26% Similarity=0.391 Sum_probs=196.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.|...+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++|||++++++++.+....++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3777889999999999999964 6889999987532 22344678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++ |+|.+++... ..++++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 997 5777777543 23589999999999999999999998 9999999999999999999999999998754321
Q ss_pred ceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 506 THLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
....|+..|+|||++. .+.++.++||||||+++|||++|+.||......+ .. ..+...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~---------~~~~~~ 239 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL---------YHIAQN 239 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HH---------HHHHhc
Confidence 2345788999999974 4578899999999999999999999986432110 00 001110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
.............+.+++.+||+.+|.+||++.++++.+-.
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 00011112344568899999999999999999999975543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.12 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=203.7
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|++.++||+|+||.||++... +++.+|+|..... .......+.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 6789999987643 334456788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++.+... ...+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876322 24689999999999999999999998 9999999999999999999999999999876543
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
......++..|++||.+.+..++.++|+||||+++|||++|+.||......+ +........ .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGK---------Y 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCC---------C
Confidence 2223457889999999999999999999999999999999999997543211 111111111 1
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.....++.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1222345567999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.85 Aligned_cols=259 Identities=22% Similarity=0.333 Sum_probs=197.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLET------ 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 417 (686)
..++|...+.||+|+||.||+|... +++.||+|.+.. ........+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999954 689999998753 2334456788999999999999999999998643
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34699999996 5888877532 78899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc--ch
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--NR 575 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~ 575 (686)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+..+ ........... ..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 98654322 1233457889999999999999999999999999999999999997543211 00000000000 00
Q ss_pred -----------------------hhhhhhhhc----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 -----------------------LFEVLDALV----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 -----------------------~~~~~d~~~----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.++..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 00001133556889999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=303.60 Aligned_cols=265 Identities=26% Similarity=0.339 Sum_probs=198.2
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETE---- 418 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---- 418 (686)
...++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 58899999876532 223356788999999999999999999987654
Q ss_pred ------cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 419 ------VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 419 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
..++|+||+++ +|..++... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 677777653 23589999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998764333222223346788999998865 45789999999999999999999999743211 1111111111
Q ss_pred hcch---hhhh--------hhhhc-----cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENR---LFEV--------LDALV-----LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~---~~~~--------~d~~~-----~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... ..++ .+... ........+..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 00000 00000112457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.97 Aligned_cols=241 Identities=24% Similarity=0.315 Sum_probs=186.4
Q ss_pred ccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHh---cCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 356 ILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQ---INHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999965 58899999765321 1222334455544443 479999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999988754 2599999999999999999999998 99999999999999999999999999987543221
Q ss_pred eeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....|+..|+|||.+.+ ..++.++||||||++++||++|+.||........ ........ .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhh----------cCCcC
Confidence 123458999999999864 5688999999999999999999999975432110 01111000 01112
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
.+.....++.+++.+||+.||++|| +++|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 2233456788999999999999999 5888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.86 Aligned_cols=270 Identities=20% Similarity=0.304 Sum_probs=202.2
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----Cc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 419 (686)
.++|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999954 6899999987542 233456778899999999999999999988654 34
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6888888653 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh-------
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM------- 571 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~------- 571 (686)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+ .........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH---QLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCChHH
Confidence 664332 12233457889999998765 568899999999999999999999997542211 111111100
Q ss_pred ----hcchhhhhhhhhc---c---ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhhh
Q 038345 572 ----NENRLFEVLDALV---L---KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE--LGGIRASI 628 (686)
Q Consensus 572 ----~~~~~~~~~d~~~---~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~--L~~i~~~~ 628 (686)
........+.... . .........++.+++.+||+.+|++|||++++++. +..+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000010000000 0 00112345678899999999999999999999965 66554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=310.58 Aligned_cols=241 Identities=25% Similarity=0.420 Sum_probs=193.7
Q ss_pred cccccCccceEEEEEEEeC-CCcEEE---EEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc--ceEEEE
Q 038345 353 ANRILGQGGQGTVYKGMLA-DGRIVA---VKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV--PLLVYE 425 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~-~~~~va---vK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lV~e 425 (686)
...+||+|+|-+||||... +|-.|| ||.-+. ......++|..|+.+|+.|+||||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999964 466666 343222 234456899999999999999999999999987765 789999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCcccccCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~ 504 (686)
++..|+|..|+.++. .++.+.+..|++||++||.|||++. ++|+|||||-+||+|+. .|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999999765 4888999999999999999999975 58999999999999975 489999999999876432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh---cchhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN---ENRLFEVLD 581 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d 581 (686)
....+.|||.|||||++. ..|....||||||+.|+||+|+..||.. -.+.....+.... ...+..+-
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SGiKP~sl~kV~- 269 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSGIKPAALSKVK- 269 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcCCCHHHhhccC-
Confidence 234478999999999988 7899999999999999999999999963 3333222222221 11111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..++.++|.+||.. .++|||+.|+++
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 24688999999999 999999999985
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.06 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=192.7
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC--CcceEEEE
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVYE 425 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~e 425 (686)
|.+.++||+|+||.||+|... +++.||+|+.+... ........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999954 68899999876532 222234567899999885 99999999999987 88999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888776532 3589999999999999999999998 9999999999999999 999999999998654322
Q ss_pred ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh-----------c
Q 038345 506 THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN-----------E 573 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~-----------~ 573 (686)
. .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+ .......... .
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 2 123457889999997654 567889999999999999999999997543211 1111111110 0
Q ss_pred chhhhhhhhhcc----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLFEVLDALVL----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+... .......+..+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 0011234578999999999999999999999984
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.06 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=197.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 420 (686)
.+|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999964 5889999986421 233456789999999999999999999998764 457
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++|+||+++++|.+++.... .+++..+++++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987532 488999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCC--ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..... ........++..|+|||++.+..++.++||||||++++||++|+.||...... ..+. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~---------~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIF---------K 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHH---------H
Confidence 53211 11122345889999999999888999999999999999999999999643211 1111 1
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+......+.+++.+||+ +|..||+..+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111111122334455678999999999 5799999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=291.32 Aligned_cols=250 Identities=31% Similarity=0.458 Sum_probs=205.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|+||.||++... ++..|++|+..... ....+.+.+|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999965 58899999876543 35567789999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+++++|.+++.... ....+++..++.++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997642 134699999999999999999999998 99999999999999999999999999997654432
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......|++.|+|||.+....++.++||||||+++++|++|+.||..... ........ ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCC---------C
Confidence 223334688899999999988899999999999999999999999864321 11111111 111 1
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112233456889999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.03 Aligned_cols=262 Identities=27% Similarity=0.368 Sum_probs=197.9
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC--Ccc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~ 420 (686)
..++|.+.+.||+|+||.||+|... +++.+|+|++.. ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567999999999999999999965 578999998743 2233446678899999999 999999999998653 367
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||++ ++|..++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5898888653 588999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCc----eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH-----
Q 038345 501 ITVDQT----HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA----- 570 (686)
Q Consensus 501 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~----- 570 (686)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~ 233 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGPPS 233 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence 643321 12234568899999998765 5678899999999999999999999965332211 0000000
Q ss_pred ------hhcchhhhhhhhhc------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 571 ------MNENRLFEVLDALV------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 571 ------~~~~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.......+++... ..........++.+++.+||+.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00000000111000 00011113467899999999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.51 Aligned_cols=241 Identities=27% Similarity=0.314 Sum_probs=194.2
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||.|++|.||+++.. +++.||+|..... .....+.+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 4889999987542 223456799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++.+.. .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997642 489999999999999999999998 99999999999999999999999999998765332 22234
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.++..|++||.+....++.++|+||||+++|||++|+.||..... +......... +.......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDIL---------KGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHh---------ccCCCCCCCccc
Confidence 578899999999888899999999999999999999999975432 1111111111 000111122223
Q ss_pred HHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPT-----MKEVA 618 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt-----~~ev~ 618 (686)
...+.+++.+||+.+|++||+ ++|++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~ 250 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIK 250 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHh
Confidence 567899999999999999999 55554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.24 Aligned_cols=271 Identities=26% Similarity=0.395 Sum_probs=209.3
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ccce
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLET------EVPL 421 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 421 (686)
.|...+.||+|+||.||+|+.+ .|+.||||..... .....+...+|+++|++++|+|||++++.-.+. ..+.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556689999999999999954 6999999987653 344567889999999999999999999886543 4678
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec----CCCcEEEEecCC
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD----DKYRAKVSDFGT 497 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~----~~~~~kl~DfGl 497 (686)
+||||+++|+|...|.+..+...|++...+.++..+..||.|||++ +|+||||||.||++- .....||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999999988888899999999999999999999998 999999999999992 334579999999
Q ss_pred cccccCCCceeeeeeeccccccCccccc-cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 574 (686)
||.+..+. ....+.||..|++||++. .+.|+...|.|||||++||.+||..||....... .....++......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk--~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK--NNKEIMWHIITKKPS 246 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc--ccchhhhhhhccCCC
Confidence 99775443 667789999999999998 4889999999999999999999999997654321 1111122211111
Q ss_pred hhhhhhh-----hh-------ccChhhHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhhh
Q 038345 575 RLFEVLD-----AL-------VLKEAEREEIMTVATLAKRCLNLNGKNRP--TMKEVAFELGGIRAS 627 (686)
Q Consensus 575 ~~~~~~d-----~~-------~~~~~~~~~~~~l~~l~~~cl~~dp~~RP--t~~ev~~~L~~i~~~ 627 (686)
...-..+ +. ......+.....+-.++..+|..+|++|- ..-+....+..|...
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0000000 00 01222344556677888888889999987 666666666666543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=298.04 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=197.0
Q ss_pred ccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 354 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
..+||+|+||.||++... +++.||||+...........+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 468999999999999864 6899999987655555567799999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++... .+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++........ .....
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 9987542 488999999999999999999998 999999999999999999999999999876543221 12334
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.|+..|+|||.+.+..++.++|+||||+++|||++|+.||......+ . ...... .+..... .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~----~~~~~~-----~~~~~~~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRD-----NLPPKLK--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHh-----hCCcccC--CcccC
Confidence 58899999999988889999999999999999999999987432111 0 011110 0000000 01123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 445788999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.97 Aligned_cols=244 Identities=28% Similarity=0.363 Sum_probs=195.3
Q ss_pred cCccceEEEEEEEeCC-CcEEEEEEccccCh---hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDE---NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||.||++...+ ++.+++|.+..... ...+.+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 89999998764322 4456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc------
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT------ 506 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~------ 506 (686)
.+++.+.. .+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997643 589999999999999999999998 999999999999999999999999999876533211
Q ss_pred -eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 -HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......++..|++||.+.....+.++||||||++++||++|+.||...... ..+..... ... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~--------~ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKI--------E 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCc--------C
Confidence 1223345788999999998888999999999999999999999999643311 11111111 000 0
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
..........+.+++.+||+.+|++|||+.++.+.|
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 000001256789999999999999999996665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=296.80 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=200.2
Q ss_pred ccccccccCccceEEEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 350 NYNANRILGQGGQGTVYKGML----ADGRIVAVKKSKLVD----ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
+|.+.+.||+|++|.||++.. .+++.||||.++... ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477789999999999999984 356889999875421 22345688999999999 599999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999998753 3588999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCceeeeeeeccccccCccccccCC--CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~--~~~~~~~~~~~~~~----- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE--QNSQSEISRRILKS----- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc--cchHHHHHHHHHcc-----
Confidence 5443322233356889999999987665 78899999999999999999999863221 11111111111000
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
....+......+.+++.+||+.+|++|||++++.+.|+.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011122234568899999999999999999988877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.21 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=195.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|...+.||+|++|.||+|... +++.||+|+..... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999965 68899999875432 2334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCcccccCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~ 504 (686)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+. +|+|+||+|+||+++. +..+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57877775432 23468888999999999999999998 9999999999999985 567999999999765432
Q ss_pred CceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--h------
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--R------ 575 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~------ 575 (686)
.. ......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||......+ ............ .
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhccccc
Confidence 11 1223357889999998866 457899999999999999999999997532211 110010100000 0
Q ss_pred -hhhhhh--hh----ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 -LFEVLD--AL----VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 -~~~~~d--~~----~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.+... +. ...........++.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00 000011223456889999999999999999999985
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.89 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=195.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 422 (686)
.++|.+.+.||+|+||.||+|... +++.||+|..+... ......+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999965 58999999876432 22234567899999999999999999998765 46799
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888876532 3689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc--chhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--NRLFEV 579 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~ 579 (686)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........... ......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchh
Confidence 33211 222345788999999865 557899999999999999999999997543211 11111111000 000000
Q ss_pred h-----------hhhccChh---hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 L-----------DALVLKEA---EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~-----------d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+ ........ .......+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000000 0112456789999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=288.93 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=202.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...+.||+|++|.||++... +++.|++|....... ...+.+.+|++++++++|+|++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 578999998766443 4567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998764 3689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
. .....++..|+|||.+.+...+.++||||||+++++|++|+.||..... ... ..... .. ...
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~-~~---------~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAA-LFRIV-QD---------DHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHH-HHHHh-cc---------CCC
Confidence 1 2334588899999999888889999999999999999999999864321 000 00100 00 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112233457889999999999999999999873
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=297.63 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=199.9
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
|...+.||+|++|.||++... +++.+++|.+..... .....+.+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999965 688999998765322 34567889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++ +|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887643 3689999999999999999999998 99999999999999999999999999997765433 1
Q ss_pred eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc------hhh---
Q 038345 508 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN------RLF--- 577 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~--- 577 (686)
......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+. ........... .+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhh
Confidence 12234578889999998876 789999999999999999999999965432111 10011100000 000
Q ss_pred -----hhhhh--hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 -----EVLDA--LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 -----~~~d~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+. ............++.+++.+||+.||.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000 0001122345678999999999999999999999984
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.83 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=198.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 420 (686)
.++|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999954 58999999876432 2345678889999999999999999998763 3467
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 6898888643 2489999999999999999999998 999999999999999999999999999976
Q ss_pred ccCCCce---eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH--------hhH
Q 038345 501 ITVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG--------YFL 568 (686)
Q Consensus 501 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~--------~~~ 568 (686)
....... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||............. .+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1123468889999999865 468899999999999999999999996533211000000 000
Q ss_pred HHhhcchhhhhhhhhc------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNENRLFEVLDALV------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+.+....+... ...........+.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0011111111111000 00111234567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.97 Aligned_cols=265 Identities=22% Similarity=0.334 Sum_probs=192.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc------
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEV------ 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 419 (686)
++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56899999999999999999965 58899999875432 2223456789999999999999999999876543
Q ss_pred --ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 420 --PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 420 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
.++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 499999996 47877776532 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCce---eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 498 SRSITVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 498 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9766432211 11234578889999988664 4788999999999999999999999754322111111110000000
Q ss_pred ch-----hhhhhhhhc-cCh----hh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NR-----LFEVLDALV-LKE----AE-----REEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~-----~~~~~d~~~-~~~----~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. ..+..+... ... .. ......+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 000000000 000 00 001245678999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=293.47 Aligned_cols=241 Identities=25% Similarity=0.301 Sum_probs=190.4
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||+||++... +++.||+|.+.... ......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 68899999865321 22345678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++..... ..+++..++.++.|++.||.|||+. +++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999976533 3589999999999999999999998 99999999999999999999999999987654321 12234
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.++..|+|||++.+..++.++||||||+++++|++|+.||........ ...+...... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~----------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---KEELKRRTLE----------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---HHHHHhcccc----------ccccCCccC
Confidence 578899999999888899999999999999999999999965432110 0000000000 001112233
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
...+.+++.+||+.+|++||+.++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 556889999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.39 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=194.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
+.|...+.||+|+||.||+|... ++..+|+|.... ......+++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34777789999999999999965 578899998653 22334567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+. |+|.+++.... .++++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68877775432 3589999999999999999999998 9999999999999999999999999998765422
Q ss_pred CceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
....++..|+|||.+. ...++.++||||||+++|||++|+.||......+ . .........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A-LYHIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------H-HHHHhhcCC-----
Confidence 2345788999999974 3567889999999999999999999986432111 0 000111000
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 011112345568899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=294.20 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=195.9
Q ss_pred ccccccccCccceEEEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 350 NYNANRILGQGGQGTVYKGML----ADGRIVAVKKSKLVD----ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
+|++.+.||+|+||.||++.. .+|..||+|.+.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999876422 22346788999999999 599999999999998899
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++... .++++..+..++.|+++||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999999753 3588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccC--CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.............|+..|+|||.+... .++.++||||||+++|+|++|+.||...... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC----
Confidence 644333323345688999999998753 4678999999999999999999998642211 11111111111100
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVA 618 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~ 618 (686)
...+......+.+++.+||+.+|++|| ++.+++
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 011223345688999999999999997 556654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=331.68 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=201.3
Q ss_pred hhccccccccccCccceEEEEEEE-eCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..+-+|....+||.|.||.||.|. ..+|...|+|.++.. .....+.+.+|+.+|..++|||+|+++|.-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345678888899999999999999 556889999976542 33445678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
.|||+++|+|.+.+.... -+++.....+..|++.|++|||++ |||||||||+||+|+.+|.+|++|||.|..+.
T Consensus 1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999887432 356666777889999999999999 99999999999999999999999999998876
Q ss_pred CCCce---eeeeeeccccccCccccccC---CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 503 VDQTH---LTTKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 503 ~~~~~---~~~~~~gt~~y~aPE~~~~~---~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
..... ......||+.|||||++.+. ....++||||+|||.+||+||+.||...+.+ ..+.+-..+...
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V~~gh~--- 1459 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHVAAGHK--- 1459 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHHhccCC---
Confidence 44211 12345799999999999764 3567999999999999999999999855421 111111111111
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+.....+-.+++.+||+.||++|-++.|++
T Consensus 1460 ---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qll 1492 (1509)
T KOG4645|consen 1460 ---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLL 1492 (1509)
T ss_pred ---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHH
Confidence 223334566778999999999999997776665
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=299.83 Aligned_cols=267 Identities=19% Similarity=0.288 Sum_probs=197.2
Q ss_pred cccCcc--ceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQG--GQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
..||+| +||+||++... +++.||+|..... .....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999964 6899999987643 334457889999999999999999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee-
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL- 508 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 508 (686)
++|.+++.+... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 999999886532 2589999999999999999999998 99999999999999999999999998654322111100
Q ss_pred -----eeeeeccccccCccccccC--CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH-------------
Q 038345 509 -----TTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL------------- 568 (686)
Q Consensus 509 -----~~~~~gt~~y~aPE~~~~~--~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~------------- 568 (686)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 0112245679999998763 478999999999999999999999975432110 000000
Q ss_pred ---HHhh-----------cch-----hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhhh
Q 038345 569 ---QAMN-----------ENR-----LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF--ELGGIRAS 627 (686)
Q Consensus 569 ---~~~~-----------~~~-----~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~--~L~~i~~~ 627 (686)
.... +.. ...+.+..+...........+.+|+.+||+.||++|||+.|+++ .++.++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 0000 000 00111111222223445678999999999999999999999985 35555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=295.48 Aligned_cols=260 Identities=19% Similarity=0.271 Sum_probs=193.7
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.+.+|.|+++.||++.. +++.||||+.... .....+.+.+|+.++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666655 6899999987643 4456678999999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc----
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT---- 506 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~---- 506 (686)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 99999986432 3588999999999999999999999 999999999999999999999999998875532211
Q ss_pred --eeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh----hcch---
Q 038345 507 --HLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM----NENR--- 575 (686)
Q Consensus 507 --~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~----~~~~--- 575 (686)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||....... .+........ ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 11123346788999999876 357899999999999999999999997532211 1111000000 0000
Q ss_pred ----hhh----hhhh----hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 ----LFE----VLDA----LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ----~~~----~~d~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... ..+. ............++.+++.+||+.+|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000 0000 0011122334567889999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.87 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=188.7
Q ss_pred hhcccccccccc--CccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcce
Q 038345 346 KATDNYNANRIL--GQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 346 ~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 421 (686)
...++|.+.+.+ |+|+||.||++... ++..+|+|......... .|+.....+ +||||+++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 334566676666 99999999999954 57889999875422111 123222222 6999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRS 500 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~ 500 (686)
+||||+++++|.+++.... .+++..++.++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999997643 699999999999999999999998 999999999999999988 999999999876
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.... ....++..|+|||++.+..++.++||||||++++||++|+.||...... ......+. ....
T Consensus 160 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~-------- 224 (267)
T PHA03390 160 IGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLL-KRQQ-------- 224 (267)
T ss_pred cCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHH-Hhhc--------
Confidence 5422 1235889999999999989999999999999999999999999743221 11111111 1000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-MKEVA 618 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~ev~ 618 (686)
. ...........+.+++.+||+.+|.+||+ +++++
T Consensus 225 -~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 225 -K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred -c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 0 00111234567899999999999999995 68887
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=290.67 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=195.4
Q ss_pred cccccccCccceEEEEEEEeCC-CcEEEEEEccccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEeEEeeCCc-----
Q 038345 351 YNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVD--ENNVEQFINEVVILSQI---NHRNIVKLLGCCLETEV----- 419 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~----- 419 (686)
|++.+.||+|+||.||+|.... ++.||+|.++... ......+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999764 8999999876432 22234566788877766 59999999999988776
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+++|||++ ++|.+++..... ..+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 478888875432 3589999999999999999999998 99999999999999999999999999997
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh---
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL--- 576 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 576 (686)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCChHhc
Confidence 7643321 122347889999999999999999999999999999999999987533211 11111111100000
Q ss_pred -------hhhhhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 -------FEVLDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 -------~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........ ...........+.+++.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01111234567889999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=274.13 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=195.0
Q ss_pred cccccCccceEEEEEEEeC-CCcEEEEEEccc-cChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 353 ANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL-VDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
.+..||.|+-|.|++.+.+ .|...|||.... .+.++.++++..+.++.+-+ .|.||+.+|||......++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 3567999999999999966 588999998655 45566678888888877765 8999999999999999999999984
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
..++.+|.+.. .++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++||+|||.+-.+... ...
T Consensus 175 ~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 175 TCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred HHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 45666665432 36899999999999999999999987 9999999999999999999999999999765433 334
Q ss_pred eeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 510 TKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
+...|-+.|||||.+.- ..|..++||||||+.|+||.||+.||.+-..+-+ ....+.++. . +.+.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~e-P----P~L~- 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEE-P----PLLP- 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcC-C----CCCC-
Confidence 55678999999999864 4688899999999999999999999986543210 011111100 0 1111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+..+.+++..||+.|+.+||.+.++++
T Consensus 317 -~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 -GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11226678999999999999999999999984
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.42 Aligned_cols=262 Identities=22% Similarity=0.343 Sum_probs=194.2
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 418 (686)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999964 6899999987542 2223456889999999999999999999987543
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++|+||+.. +|..++. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 6665542 2488999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH-------
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA------- 570 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~------- 570 (686)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 764321 123457889999999876 468899999999999999999999997532111 00000000
Q ss_pred ----hhcchhhhhhhh--h-ccChh---hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 038345 571 ----MNENRLFEVLDA--L-VLKEA---EREEIMTVATLAKRCLNLNGKNRPTMKEVAFE--LGGIR 625 (686)
Q Consensus 571 ----~~~~~~~~~~d~--~-~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~--L~~i~ 625 (686)
............ . ..... .......+.+++.+||+.||++||++++++.. ++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000000000000 0 00000 01123568899999999999999999999843 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.10 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=193.6
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++|.+.+.||+|+||.||+|...+ ++.||||.++... ......+..|+.++.++. |+||+++++++.+....++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999999765 8899999976432 233456777887777775 999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+. ++|.+++.... .++++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++..+...
T Consensus 94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9985 46766665432 26899999999999999999999732 8999999999999999999999999999765432
Q ss_pred CceeeeeeeccccccCccccccCC----CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ........... ...
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-- 238 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS-- 238 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC--
Confidence 22 12234788999999987553 788999999999999999999998642111 11111111110 000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
. ........++.+++.+||+.+|++||++.++++.
T Consensus 239 ---~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ---L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0011234568999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=289.17 Aligned_cols=243 Identities=26% Similarity=0.280 Sum_probs=188.7
Q ss_pred cccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||+|... +++.||+|...... ......+..|..+ ....+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999964 58899999875432 2222344555544 4455899999999999999999999999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997542 588999999999999999999998 999999999999999999999999999875432 2
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
....++..|+|||.+.+..++.++||||||+++|||++|..||......+ .+ ........ .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~------~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VF-DNILSRRI------NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhccc------CCCCccc
Confidence 23457889999999988889999999999999999999999996432211 11 11111100 0001111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 590 REEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 590 ~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
......+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23456789999999999999999876665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.64 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=196.6
Q ss_pred HHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE-- 418 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-- 418 (686)
+....++|.+.+.||+|+||.||++... ++..||||+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 4446778999999999999999999854 6899999987532 2223456889999999999999999999987654
Q ss_pred ----cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 419 ----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 419 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 348999998 6788887763 2589999999999999999999998 999999999999999999999999
Q ss_pred cCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH--------
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG-------- 565 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~-------- 565 (686)
||+++..... .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||....... ....
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~ 235 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGTP 235 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCC
Confidence 9999765322 123457889999999876 458899999999999999999999997432110 0000
Q ss_pred --hhHHHhhcchhhhhhhhh--cc----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 --YFLQAMNENRLFEVLDAL--VL----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 --~~~~~~~~~~~~~~~d~~--~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+...+........+... .. ..........+.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000000 00 0001123446889999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.40 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=192.2
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
|...+.||+|+||+||+|+.. ++..|++|++... .....+.+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999964 5889999987542 223446788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. |+|.+++.... .++++..++.++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777776432 3589999999999999999999998 999999999999999999999999999864321
Q ss_pred eeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...... ......... ..
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~------- 237 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-DS------- 237 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-CC-------
Confidence 12346888999999974 466888999999999999999999998643211 111111100 00
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........+.+++.+||+.+|.+||++.+++.
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111123345889999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.68 Aligned_cols=246 Identities=26% Similarity=0.341 Sum_probs=203.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.+.|+.-++||+||||.||-...+ +|+.+|.|++... .+....-.++|-.+|++++.+.||.|--.|...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999865 5999999976432 122234567899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
+..|.||+|.-+|.+... ..+++..++-+|.+|+-||++||.. .||.|||||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987754 4699999999999999999999999 999999999999999999999999999987764
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.+. ....+||.+|||||++....|+...|.|||||+||||+.|+.||....... + .+-+|..
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k----~eEvdrr 401 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------K----REEVDRR 401 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------h----HHHHHHH
Confidence 443 334479999999999999999999999999999999999999997432111 1 1112222
Q ss_pred c---cChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 584 V---LKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 584 ~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
+ ..+++...+++...|.+..|+.||++|.--+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2 1344556677888999999999999997443
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.49 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=198.6
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
...++..+.++|.+.+.||+|+||.||+|.. .+++.||+|+++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 46889999987642 22334678899999999999999999998864
Q ss_pred C------CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 417 T------EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 417 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
. ...+++++++ +++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3357888876 78898877542 489999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .......
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILR 232 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999998764321 223457889999999866 568889999999999999999999996432211 1000000
Q ss_pred Hhh--cchhhh---------h---hhhhccChh---hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMN--ENRLFE---------V---LDALVLKEA---EREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~--~~~~~~---------~---~d~~~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... ...+.. . +........ ......++.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000 000000 0 000000000 0012456889999999999999999999884
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=298.85 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=205.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
....|.+.+.||+|.|++|.+|++. .+..||||.+... +....+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467999999999999999999954 5899999987653 334445689999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||..+|.++++|.++.. +.+.....++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999997653 56688889999999999999999 99999999999999999999999999998765
Q ss_pred CCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.........|++.|.|||++.+..+ +++.|+||+|++||-|+.|..||++....+-+ ++
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------------------~r 266 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------------------PR 266 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------------------ch
Confidence 3344566789999999999998776 67999999999999999999999864432211 11
Q ss_pred hccCh--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKE--AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+... .+.-...+..++++++|-.+|.+|+++.++.+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11111 11122345779999999999999999999875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=288.30 Aligned_cols=241 Identities=23% Similarity=0.317 Sum_probs=185.6
Q ss_pred ccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHH---HHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 356 ILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVV---ILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
.||+|+||.||++... +++.||+|.+.... ......+..|.. +++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 58899999865321 111223444444 3444579999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999988643 3599999999999999999999998 99999999999999999999999999987553221
Q ss_pred eeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....|+..|+|||.+.++ .++.++||||||+++|||++|+.||......... ........ .. ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~------~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------MA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----HHHHHhhc------cC----CC
Confidence 1234589999999998754 6899999999999999999999999754221110 00000000 00 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
.+......+.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1122346788999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.48 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=195.1
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccCh-hhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-NNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
|.+.+.||+|++|+||+|... +++.|+||++..... .......+|+..+.+++ |+||+++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999976 478899998754322 22234567999999999 999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
+|+|.+++.... ...+++..++.++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889999887643 23589999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeeeeccccccCccccc-cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh----------HhhHHHhhcchh
Q 038345 508 LTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV----------GYFLQAMNENRL 576 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~ 576 (686)
.....++..|+|||++. ...++.++|+||||++++||++|+.||......+...-. .+.........+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 22345788999999875 456789999999999999999999999654321110000 000000000000
Q ss_pred hhhhhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.... ...........+.+++.+||+.+|++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 00000112467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=294.36 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=197.4
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee-CC
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLE-TE 418 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~ 418 (686)
++..++++|...+.||+|+||.||++... +++.||+|++.. ......+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34457789999999999999999999854 789999998643 223345678899999999999999999999875 56
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+ +++|.+++... ++++..+..++.|+++||+|||+. +|+||||+|+|||+++++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence 789999998 56888877632 478888999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh--------HhhHH
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV--------GYFLQ 569 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~--------~~~~~ 569 (686)
...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||............ ..+..
T Consensus 156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 754321 123357889999998766 56899999999999999999999999654321100000 00000
Q ss_pred Hhhcchhhhhhhhhc-cChhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 570 AMNENRLFEVLDALV-LKEAE-----REEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~-~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
........+++.... ....+ ......+.+++.+||+.+|++||++.+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000001111110000 00001 12346789999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.74 Aligned_cols=247 Identities=28% Similarity=0.396 Sum_probs=201.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 423 (686)
++|...+.||+|+||.||++... +++.||+|..... .....+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999965 6899999986542 2334467889999999998 99999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
||++++++|.+++.+.. .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997643 599999999999999999999998 999999999999999999999999999876543
Q ss_pred CCc-------------------eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh
Q 038345 504 DQT-------------------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564 (686)
Q Consensus 504 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~ 564 (686)
... .......++..|+|||.+....++.++||||||+++++|++|+.||..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------Y 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------H
Confidence 221 112234578899999999888899999999999999999999999975431 1
Q ss_pred HhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCH----HHHH
Q 038345 565 GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM----KEVA 618 (686)
Q Consensus 565 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~----~ev~ 618 (686)
..+..... .....+......+.+++.+||+.+|++||++ ++++
T Consensus 229 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 229 LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 11111110 0111222335678999999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=317.08 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=211.7
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
..++.-..++|.+.++||+|+||.|...+++ .++.+|+|++.. .......-|..|-.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4556666788999999999999999999975 588999998876 344556779999999999999999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
..++|||||||+||+|..+|.+.. +++++.+.-++..|+.||+-||+. |+|||||||+|||||..|.+||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998765 588999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
.+-.+..+..-.....+|||.|++||+++. +.|++..|.||+||++|||+.|..||... +++.-....+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHh
Confidence 998887777666667789999999999852 67899999999999999999999999743 2333333333
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT---MKEVA 618 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~ev~ 618 (686)
.....+.+.+. ...+.+..+||.+.+. +|+.|.. ++++-
T Consensus 295 ~hk~~l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 295 NHKESLSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred chhhhcCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 33222222211 2245567788888765 6777776 66554
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=297.73 Aligned_cols=263 Identities=24% Similarity=0.306 Sum_probs=193.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 418 (686)
.++|.+.++||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 58899999865432 222346789999999999999999999876543
Q ss_pred --cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 419 --VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 419 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
..++||||+.+ +|...+... ...+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 45999999964 676666643 23599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCce----------eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH
Q 038345 497 TSRSITVDQTH----------LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 497 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~ 565 (686)
+++........ ..+...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99765422211 1123457888999998765 457899999999999999999999997533211 111
Q ss_pred hhHHHhhcc---------hhhhhhh----hhccC---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 YFLQAMNEN---------RLFEVLD----ALVLK---EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 ~~~~~~~~~---------~~~~~~d----~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......... .+....+ ..... .........+.+++.+||+.+|++|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111100000 0000000 00000 000112356889999999999999999999873
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=278.16 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=206.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|...++||+|.||.|.+.+-+ .++.+|+|+++. ..+.....-+.|-++|+..+||.+..|.-.|+..+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999854 689999998765 3445556677899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||..||.|+-+|.+. ..+++....-+...|+.||.|||++ +||.||||.+|+|||.+|.+||+||||.+.--
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 9999999999988753 3588888888999999999999998 99999999999999999999999999997532
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.....+..++||+.|+|||++....|..+.|.|.+||+||||++|+.||...+. +++++++--
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh----------------~kLFeLIl~- 382 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH----------------EKLFELILM- 382 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch----------------hHHHHHHHh-
Confidence 233446678999999999999999999999999999999999999999974322 233333211
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~ 618 (686)
-.-.+++....+...|+...|..||.+|. +++||.
T Consensus 383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 01234556667788999999999999996 455554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=287.11 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=194.8
Q ss_pred ccccccccCccceEEEEEEEeCC-CcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+|.+.++||+|+||.||++.... +..+++|..+.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999998643 444555544331 223345677899999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 424 YEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887532 234699999999999999999999998 9999999999999976 469999999987654
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.... .......... .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-------- 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-------- 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C--------
Confidence 322 22233457889999999988888999999999999999999999985321 1111111110 0
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.....+.....++.+++.+||+.+|++||++.++++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011123345567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.33 Aligned_cols=259 Identities=26% Similarity=0.350 Sum_probs=198.2
Q ss_pred cccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 351 YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
|+..+.||+|++|.||+|+.. +++.||+|...... ....+.+..|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999966 48999999876542 333467889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
+ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999998643 3589999999999999999999998 999999999999999999999999999986643322
Q ss_pred eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc--chhhh------
Q 038345 508 LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--NRLFE------ 578 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~------ 578 (686)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+ ........... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccc
Confidence 12223457789999998776 88999999999999999999999996543211 01111110000 00000
Q ss_pred -------hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 -------VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 -------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.................+.+++.+||..+|++||++.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000011122457899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.52 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=193.7
Q ss_pred ccccc-ccccCccceEEEEEEEeC-CCcEEEEEEccccChhh--------------HHHHHHHHHHHHhcCCCCeeeEEe
Q 038345 349 DNYNA-NRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENN--------------VEQFINEVVILSQINHRNIVKLLG 412 (686)
Q Consensus 349 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g 412 (686)
++|.. .+.||+|+||+||+|... +++.||||+........ ...+.+|+.++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999965 68999999875432211 124778999999999999999999
Q ss_pred EEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 413 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
++...+..++||||+. |+|.+++... ..+++.....++.|++.||+|||+. +|+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 6898888643 3589999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCC-------------ceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcc
Q 038345 493 SDFGTSRSITVDQ-------------THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINID 558 (686)
Q Consensus 493 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~ 558 (686)
+|||+++...... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111223467889999998764 4689999999999999999999999754321
Q ss_pred cCCchhHhhHHHhhcchh---hhhh--------hhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 559 EDRSLVGYFLQAMNENRL---FEVL--------DALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~---~~~~--------d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
+ ....+......... .+.. .... ...........+.+++.+||+.+|++||++++++
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 1 11111111110000 0000 0000 0000112245688999999999999999999998
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.47 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=193.3
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC----------
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET---------- 417 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---------- 417 (686)
.+|...+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67999999999999999999964 5889999988766556667889999999999999999999776543
Q ss_pred ----CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEEE
Q 038345 418 ----EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKV 492 (686)
Q Consensus 418 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl 492 (686)
...++||||++ ++|.+++... .+++..++.++.||++||.|||+. +|+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 5888877532 488999999999999999999998 999999999999997 5567899
Q ss_pred EecCCcccccCCCce--eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 493 SDFGTSRSITVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 493 ~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+. ......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ---MQLILE 233 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHH
Confidence 999999765322111 1122357889999998654 5678899999999999999999999975432110 000000
Q ss_pred Hhh------cchhhhhhhhhc-----c-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMN------ENRLFEVLDALV-----L-----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~------~~~~~~~~d~~~-----~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... .......+.... . .........++.+++.+||+.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 000000000000 0 0001123456889999999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=274.01 Aligned_cols=205 Identities=24% Similarity=0.386 Sum_probs=171.4
Q ss_pred ccccccccccCccceEEEEEEEeCC-----CcEEEEEEccccChh--hHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-----GRIVAVKKSKLVDEN--NVEQFINEVVILSQINHRNIVKLLGCCLE-TEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~ 419 (686)
...|+....||+|.||.||+|.-.+ ...+|||+++..... -.....+|+.+++.++||||+.|...+.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3468889999999999999996332 237899988764222 23567899999999999999999999988 778
Q ss_pred ceEEEEeccCCchhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC----CcEEEE
Q 038345 420 PLLVYEFVPNGTLYQNIHNH--IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK----YRAKVS 493 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~ 493 (686)
.+|++||.++ +|..+|+-+ .....++...+..|+.||+.|+.|||++ =|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 8999999975 788887643 2335789999999999999999999999 78999999999999776 999999
Q ss_pred ecCCcccccCCCce--eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 494 DFGTSRSITVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 494 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
|||++|.+...-.. ....++-|.+|.|||.+.+ ..||.+.|||+.||++.||+|-++-|.+.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999988643322 3355778999999999887 468999999999999999999999887654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.43 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=188.0
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLET------ 417 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 417 (686)
+...+|...++||+||||.|||++.+ ||+.+|||++... +......+.+|+.+|++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567888999999999999999965 8999999997653 344456788999999999999999988432110
Q ss_pred --------------------------------------------------------------------------------
Q 038345 418 -------------------------------------------------------------------------------- 417 (686)
Q Consensus 418 -------------------------------------------------------------------------------- 417 (686)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHh
Q 038345 418 ---------------------------------EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464 (686)
Q Consensus 418 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL 464 (686)
...||-|||++..+|.++++++.... .....++++.+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01267788888777777776543211 3567899999999999999
Q ss_pred hhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC-----------------CCceeeeeeeccccccCccccccC
Q 038345 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV-----------------DQTHLTTKVQGTFGYVDPEYFQSS 527 (686)
Q Consensus 465 H~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~ 527 (686)
|++ +||||||||.||+|+++..+||+|||+|..... ......+...||.-|+|||++.+.
T Consensus 714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 999 999999999999999999999999999986210 011123556799999999998765
Q ss_pred ---CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhc
Q 038345 528 ---QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCL 604 (686)
Q Consensus 528 ---~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl 604 (686)
.|+.|+|+|||||+|+||+. ||.... |. ......++.+.+..- .++.......=+.+|++++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HH----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999995 554211 00 011111222221111 1223334445578999999
Q ss_pred ccCCCCCCCHHHHHH
Q 038345 605 NLNGKNRPTMKEVAF 619 (686)
Q Consensus 605 ~~dp~~RPt~~ev~~ 619 (686)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999984
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.75 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=196.2
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc----
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV---- 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---- 419 (686)
..++|...+.||+|++|.||+|... +++.||+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999975 5789999987542 23344677889999999999999999998876554
Q ss_pred --ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 420 --PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 420 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 79999998 5799888864 2589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH------
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA------ 570 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~------ 570 (686)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ........
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCH
Confidence 9765322 223457889999999865 467899999999999999999999996433211 00000000
Q ss_pred -----hhcchhhhhhhhhcc---C---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 571 -----MNENRLFEVLDALVL---K---EAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 571 -----~~~~~~~~~~d~~~~---~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
+........+..... . .........+.+++.+||+.+|++|||+.+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 000000000000000 0 00112356789999999999999999999997
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.37 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=191.2
Q ss_pred ccccccccCccceEEEEEEEeC-C--CcEEEEEEcccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeC----Cc
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-D--GRIVAVKKSKLV--DENNVEQFINEVVILSQI-NHRNIVKLLGCCLET----EV 419 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~ 419 (686)
+|.+.+.||+|+||.||++... . +..||+|++... .....+.+.+|+.++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 3 678999986542 222346788999999999 599999999876432 45
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++++||+. ++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 6898888643 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc---eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh---
Q 038345 500 SITVDQT---HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN--- 572 (686)
Q Consensus 500 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~--- 572 (686)
....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......+ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 6543221 11223468999999998765 468899999999999999999999987533111 1111110000
Q ss_pred --------cchhhhhhh---hhcc---ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 573 --------ENRLFEVLD---ALVL---KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 573 --------~~~~~~~~d---~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......... .... ..........+.+++.+||+.+|++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0000 0000112457889999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=270.55 Aligned_cols=266 Identities=24% Similarity=0.323 Sum_probs=201.7
Q ss_pred hHHHHhhccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETE 418 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 418 (686)
+.++-+.|+ ++||+|+|+.|..++ +.++..+|||++.........+..+|++++.+.+ |+||++|+.+|.++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 344555444 689999999999988 6789999999987665566678999999999995 999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---cEEEEec
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKVSDF 495 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Df 495 (686)
..|||||-|.||+|..+|+++. .+++..+.++.++|+.||.|||.+ ||.||||||+|||-.+.. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998653 589999999999999999999999 999999999999996544 3799999
Q ss_pred CCcccccCC------CceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh
Q 038345 496 GTSRSITVD------QTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564 (686)
Q Consensus 496 Gla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~ 564 (686)
.|..-+... .+.......|+..|||||+.. ...|..+.|.|||||+||-||+|.+||.+.-..+-..-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 987644211 112223456889999999863 345788999999999999999999999876432211000
Q ss_pred HhhHHHhhcchhhhhhhhhccChhhH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 565 GYFLQAMNENRLFEVLDALVLKEAER----EEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 565 ~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...-+ .-++.+++-+.... -+++. ..+.+..+++...|..++.+|.++.+++.
T Consensus 304 Ge~Cr-~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCR-VCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccH-HHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 00000 00112222222111 11222 23456778899999999999999998874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=276.84 Aligned_cols=236 Identities=30% Similarity=0.367 Sum_probs=192.3
Q ss_pred cCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 357 LGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
||+|+||.||++... +++.+|+|.+.... ......+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 48899999865432 23456889999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeee
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 512 (686)
.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99997543 589999999999999999999998 99999999999999999999999999997654322 123345
Q ss_pred eccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 513 ~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
.++..|++||.+.+...+.++|+||||+++|||++|+.||..... .. ........ ....+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~----------~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KE-IYEKILKD----------PLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHhcC----------CCCCCCCC
Confidence 578899999999888899999999999999999999999964321 00 01111110 01112222
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKE 616 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~e 616 (686)
...+.+++.+||..||++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=311.21 Aligned_cols=145 Identities=28% Similarity=0.361 Sum_probs=130.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||.||+|... +++.||||+++.. .......+.+|+.++..++||||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999976 6889999987542 2333467889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
||+.+++|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997542 488999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=246.06 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=197.1
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+|...++||+|.||+||+|+.. .++.||+|+.... ++.-.....+|+-+|+.++|+|||++++....+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666789999999999999954 5889999986553 333346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+. .+|..+..... ..++......++.|+++||.+.|++ .+.|||+||.|.||+.+|.+||+|||+++.+...-.
T Consensus 83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 46766665432 2488899999999999999999999 899999999999999999999999999998765433
Q ss_pred eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh---hhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF---EVLD 581 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~~~d 581 (686)
- .....-|.+|.+|.++.+. -|+...|+||-|+++.||.. |++-|.+.+.++....+-+......++++. .+.|
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 2334569999999998875 57889999999999999998 666666654433222222222222222221 1112
Q ss_pred hhccCh---------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 582 ALVLKE---------AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 582 ~~~~~~---------~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
-..... .-+.....=++++...+.-+|.+|.++++.+
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 111111 1112223446788888999999999998876
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=275.45 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=198.7
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCC 414 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 414 (686)
+..+..++ .+|..+.+||+|+||.|-+|.-+ ..+.+|||+++.. ...+.+--+.|-++|... +-|.+++|+.++
T Consensus 341 ~~~d~i~~-tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 341 SKRDRIKA-TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred Ccccceee-cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 33343333 35889999999999999999865 3578999987652 233344456677777766 568899999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
+.-+.+|+||||+.||+|..+|+... .+.+..+.-+|.+||-||-+||++ +|+.||||.+|||||.+|.+||+|
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence 99999999999999999999998654 377788889999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
||+++.--.+ ...+..+.||+.|+|||++..++|+...|.|||||+||||+.|++||++.+.++ ..+.+.
T Consensus 494 FGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------lF~aI~-- 563 (683)
T KOG0696|consen 494 FGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQAIM-- 563 (683)
T ss_pred cccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHH--
Confidence 9999753222 233556889999999999999999999999999999999999999998754322 111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 612 (686)
+.. -.++...+.+...+....|...|.+|.
T Consensus 564 ------ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 564 ------EHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ------Hcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111 234455667788899999999999995
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=261.60 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=197.6
Q ss_pred hccccccc-cccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee----CCc
Q 038345 347 ATDNYNAN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLE----TEV 419 (686)
Q Consensus 347 ~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~ 419 (686)
++++|.+. ++||-|-.|.|-....+ .++.+|+|.+... ...++|+++.-+. .|||||.+++.+.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45667664 58999999999988865 6889999987643 4456788875555 69999999999864 346
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEEEecC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFG 496 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfG 496 (686)
+++|||.|+||.|+..+..+. ...+++.++..|++||..|++|||+. .|.||||||+|+|.. .+-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 789999999999999998764 34799999999999999999999999 999999999999995 45679999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+|+..... ......+-|+.|.|||++...+|....|+||+||++|-||+|.+||..... ..+..-++..+..+..
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc
Confidence 99864322 223345679999999999999999999999999999999999999975321 2222223333333221
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++.+ +.=...++...++|+.+|..+|.+|.|+.+++.
T Consensus 285 -~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 -EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1111 111244667889999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=290.06 Aligned_cols=264 Identities=19% Similarity=0.241 Sum_probs=181.9
Q ss_pred hccccccccccCccceEEEEEEEe-----------------CCCcEEEEEEccccChhhHHHH--------------HHH
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-----------------ADGRIVAVKKSKLVDENNVEQF--------------INE 395 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 395 (686)
..++|.+.++||+|+||+||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999974 2356799999865443333333 346
Q ss_pred HHHHHhcCCCCe-----eeEEeEEee--------CCcceEEEEeccCCchhhhhhccCC---------------------
Q 038345 396 VVILSQINHRNI-----VKLLGCCLE--------TEVPLLVYEFVPNGTLYQNIHNHIE--------------------- 441 (686)
Q Consensus 396 ~~~l~~l~h~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 441 (686)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 677888753 3467999999999999999875321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCc
Q 038345 442 EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521 (686)
Q Consensus 442 ~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 521 (686)
...+++..+..++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788999999999999999998 999999999999999999999999999976543222112223357899999
Q ss_pred cccccCCC----------------------CccccEeehHHHHHHHHhCCC-CCccCCcccCC-chhHhhHHHhhcchhh
Q 038345 522 EYFQSSQF----------------------TEKSDVYSFGVVLVEILTGQK-PIRAINIDEDR-SLVGYFLQAMNENRLF 577 (686)
Q Consensus 522 E~~~~~~~----------------------t~ksDv~S~Gv~l~elltg~~-p~~~~~~~~~~-~l~~~~~~~~~~~~~~ 577 (686)
|.+..... ..+.||||+||+++||++|.. |+......... .........++
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r----- 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR----- 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----
Confidence 98754321 234799999999999999875 66432111000 00000000000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCC---CCCCCHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNG---KNRPTMKEVA 618 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPt~~ev~ 618 (686)
........-...........+|+.++|..+| .+|+|++|++
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 0000000001112234567899999999766 6899999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=297.87 Aligned_cols=259 Identities=19% Similarity=0.264 Sum_probs=170.3
Q ss_pred hccccccccccCccceEEEEEEEeC-C----CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeE------Ee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-D----GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC------CL 415 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~ 415 (686)
..++|...++||+|+||.||+|++. + +..||||++..... .+.+..| .+....+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999975 4 68999998754322 1222222 1122222233222221 23
Q ss_pred eCCcceEEEEeccCCchhhhhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCC
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIEE-----------------FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 478 (686)
.....+|||||+++++|.+++...... .......+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999988753211 0112344668999999999999998 99999999
Q ss_pred CCCeeecC-CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccC----------------------CCCccccE
Q 038345 479 SANILLDD-KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS----------------------QFTEKSDV 535 (686)
Q Consensus 479 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDv 535 (686)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999986654433344456789999999965322 23456799
Q ss_pred eehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc----hhhhhhhhhccChhh------HHHHHHHHHHHHHhcc
Q 038345 536 YSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN----RLFEVLDALVLKEAE------REEIMTVATLAKRCLN 605 (686)
Q Consensus 536 ~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~----~~~~~~d~~~~~~~~------~~~~~~l~~l~~~cl~ 605 (686)
|||||+||||+++..|+.. .+..........+ .+...+.+....+.. ........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 9999999999997766431 1111111110000 011111111000000 0012235589999999
Q ss_pred cCCCCCCCHHHHHH
Q 038345 606 LNGKNRPTMKEVAF 619 (686)
Q Consensus 606 ~dp~~RPt~~ev~~ 619 (686)
.||++|||++++++
T Consensus 436 ~dP~kR~ta~e~L~ 449 (566)
T PLN03225 436 FKGRQRISAKAALA 449 (566)
T ss_pred CCcccCCCHHHHhC
Confidence 99999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=274.24 Aligned_cols=255 Identities=29% Similarity=0.432 Sum_probs=196.8
Q ss_pred cccccccccCccceEEEEEEE-eCCCcEEEEEEcccc---Ch----hhHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCc
Q 038345 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLV---DE----NNVEQFINEVVILSQINHRNIVKLLGCCL-ETEV 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~ 419 (686)
++|..+.+||+|||+.||+|. +...+.||+|+.... .. ...+...+|..|.+.|.||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 568888999999999999999 446789999975431 11 12345678999999999999999999986 5667
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFG 496 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfG 496 (686)
.+-|+||++|.+|+-||..+. .++++.+..|+.||+.||.||... .++|||=||||.||||-+ -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 889999999999999998653 589999999999999999999986 458999999999999943 4789999999
Q ss_pred CcccccCCC------ceeeeeeeccccccCcccccc----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh
Q 038345 497 TSRSITVDQ------THLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 497 la~~~~~~~------~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~ 566 (686)
|++.+..+. ...+....||.+|++||.+.- ...+.|.||||.||++|..+-|++||....... +
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--d---- 692 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--D---- 692 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--H----
Confidence 999875433 234556789999999998753 356889999999999999999999996432211 1
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.+.++.+...-. +.-...+....+...+|++||+..-++|.+..+++
T Consensus 693 ---ILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ---ILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred ---HHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111100 00011123345678899999999999999988876
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=279.51 Aligned_cols=243 Identities=26% Similarity=0.357 Sum_probs=191.2
Q ss_pred ccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 354 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
.++||+|-||+||-|+++ +|+.||||.+.. .......++++|+.||++++||.||.+.-.|+..+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 479999999999999965 699999997654 234445789999999999999999999999999999999999995 5
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEEecCCcccccCCCce
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~~~~~~~~ 507 (686)
++.+.|... +...|++....-++.||+.||.|||.+ +|+|.||||+||||.+. -.+||+|||.||.+... .
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 655555443 334688888888999999999999999 99999999999999543 57999999999988643 3
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
....++||+.|+|||+++...|...-|+||.||++|--|+|..||... .+..+.+ ....++ ..+...
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQI----QNAaFM--yPp~PW-- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQI----QNAAFM--YPPNPW-- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHh----hccccc--cCCCch--
Confidence 345678999999999999999999999999999999999999999742 2221111 111110 001111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.+......+||...|+..-.+|-+...-+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12334567888888888888888766544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=270.06 Aligned_cols=222 Identities=23% Similarity=0.231 Sum_probs=177.1
Q ss_pred cceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhc
Q 038345 360 GGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN 438 (686)
Q Consensus 360 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 438 (686)
|.+|.||++... +++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68899999876432 234455556666799999999999999999999999999999999875
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccc
Q 038345 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518 (686)
Q Consensus 439 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 518 (686)
.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 42 489999999999999999999998 9999999999999999999999999987654321 1223456789
Q ss_pred cCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHH
Q 038345 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598 (686)
Q Consensus 519 ~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 598 (686)
+|||.+.+..++.++||||+|++++||++|+.|+....... ... .....+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH---------TTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc---------cccCCcccCCHHHHH
Confidence 99999988889999999999999999999998875321100 000 000111223456889
Q ss_pred HHHHhcccCCCCCCCHHHH
Q 038345 599 LAKRCLNLNGKNRPTMKEV 617 (686)
Q Consensus 599 l~~~cl~~dp~~RPt~~ev 617 (686)
++.+||+.||++||++.+.
T Consensus 208 li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 208 LLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHccCCHHHhcCCCcc
Confidence 9999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=266.99 Aligned_cols=238 Identities=28% Similarity=0.393 Sum_probs=192.7
Q ss_pred ceEEEEEEEeCC-CcEEEEEEccccChhh-HHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhc
Q 038345 361 GQGTVYKGMLAD-GRIVAVKKSKLVDENN-VEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN 438 (686)
Q Consensus 361 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 438 (686)
+||.||+|...+ ++.+|+|......... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8999999987654443 68899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccc
Q 038345 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518 (686)
Q Consensus 439 ~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 518 (686)
.. .+++..++.++.+++.+|.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 43 288999999999999999999998 99999999999999999999999999998765332 23345578899
Q ss_pred cCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHH
Q 038345 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598 (686)
Q Consensus 519 ~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 598 (686)
++||.+....++.++||||||+++++|++|..||...... .............. .........++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCC-------ccccccCCHHHHH
Confidence 9999999888999999999999999999999998642110 00111111110000 0000004467899
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 038345 599 LAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 599 l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=286.21 Aligned_cols=239 Identities=24% Similarity=0.273 Sum_probs=193.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++.|.....+|.|+|+.|-.+... +++..++|++... ..+-.+|+.++... +||||+++.+.+.+....++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999998854 5788999987653 12334677666555 7999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee-cCCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL-DDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DfGla~~~~~ 503 (686)
|.+.++-|.+.+.... .....+..|+.+|+.|+.|||++ |+|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998888776543 22267778999999999999998 99999999999999 5889999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
+ ....+-|..|.|||++....++.++|+||||++||+||+|+.||.....+ ......+..
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~---------- 528 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQM---------- 528 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcC----------
Confidence 4 22334688999999999999999999999999999999999999765433 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+....+...++|+.+||+.||.+||+|.++.
T Consensus 529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred --CccccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence 222245566788999999999999999999997
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=269.19 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=201.0
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCC--C----CeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINH--R----NIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~g~~~~~~~~ 420 (686)
+++|.+.+.||+|.||.|-....+. +..||||+++...+. .+..+-|+++|+++.+ | .+|++.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6789999999999999999998553 689999998876443 3567789999999943 2 378899999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---------------
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD--------------- 485 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--------------- 485 (686)
++|+|.+ |-++.++|..+. ..+++..++..|+.|++++++|||+. +++|-||||+|||+-
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 9999999 569999998754 34789999999999999999999999 999999999999983
Q ss_pred -----CCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccC
Q 038345 486 -----DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560 (686)
Q Consensus 486 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~ 560 (686)
.+..+||+|||.|...... ...++.|..|.|||++.+-.++..+||||+||+|.||.||..-|...+..|.
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 1345899999999765432 2456789999999999999999999999999999999999999987653331
Q ss_pred C--------chhHhhHHHh------hcchh-----------hhhhhhh--c--cChhhHHHHHHHHHHHHHhcccCCCCC
Q 038345 561 R--------SLVGYFLQAM------NENRL-----------FEVLDAL--V--LKEAEREEIMTVATLAKRCLNLNGKNR 611 (686)
Q Consensus 561 ~--------~l~~~~~~~~------~~~~~-----------~~~~d~~--~--~~~~~~~~~~~l~~l~~~cl~~dp~~R 611 (686)
. .+...+.... ..+++ ..+.+.- + .-.....+..++.+|+++||..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1 0001111111 00000 0000000 0 001122445679999999999999999
Q ss_pred CCHHHHHH
Q 038345 612 PTMKEVAF 619 (686)
Q Consensus 612 Pt~~ev~~ 619 (686)
+|+.|++.
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=265.58 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=192.9
Q ss_pred cccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 353 ANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
....||.|+||+|+|-.++ .|+..|||++.... ..+.++++.|.....+- +.||||+++|.+..+...++-||+|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 3568999999999999865 58999999977643 35667888888876555 68999999999999999999999995
Q ss_pred Cchhhhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 430 GTLYQNIHN--HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 430 gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
.+|+.+-.. ......+++..+-+|+...+.||.||.... .|+||||||+||||+..|.+||+|||.+-.+.. +.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 566544322 112345899999999999999999999875 899999999999999999999999999865432 22
Q ss_pred eeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc-
Q 038345 508 LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV- 584 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~- 584 (686)
..+.-.|-..|||||.+.. ..|..+|||||||++|+|+.||+.|+..... ..+...+.... |+.+
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g-------dpp~l 290 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG-------DPPIL 290 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-------CCCee
Confidence 2344568888999999864 3488999999999999999999999975321 12221111111 1111
Q ss_pred -cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 -LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 -~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+....|..++.-||..|-++||.+.++.+
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 12222456778999999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=287.48 Aligned_cols=259 Identities=23% Similarity=0.380 Sum_probs=211.4
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee-
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLE- 416 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~- 416 (686)
.++.+...++-|.+.+.||.|.+|.||+++ .++++.+|+|+....... .+++..|..+|+.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344455567789999999999999999999 457889999987664433 36778899999988 69999999999974
Q ss_pred ----CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 417 ----TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 417 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
++.++|||||+.+|+.-|++++.. ...+.|..+.-|+..++.||++||.. .++|||||-.||||+.++.+||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 568899999999999999998765 55799999999999999999999999 8999999999999999999999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF 567 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~ 567 (686)
.|||++..+..... ......||+.|||||++.. ..|+..+|+||||++..||.-|.+|+..+.+.
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------- 234 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------- 234 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------
Confidence 99999987653332 2345679999999999853 35677999999999999999999998654321
Q ss_pred HHHhhcchhhhhh-hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 568 LQAMNENRLFEVL-DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 568 ~~~~~~~~~~~~~-d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..++.+. .+...-..+....++|.++|..||..|-.+||++.++++
T Consensus 235 ------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 ------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1112221 122223335567788999999999999999999998874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=258.62 Aligned_cols=264 Identities=22% Similarity=0.372 Sum_probs=194.5
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--------C
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET--------E 418 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~ 418 (686)
.|....+||+|.||.||+|+.. .|+.||+|+.-.. ...-.....+|+.+|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3555678999999999999965 5788999875432 222335678999999999999999999887642 2
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..||||.++++ +|.-+|.+.. ..++..++.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 46999999975 7777776543 3488899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCce---eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 499 RSITVDQTH---LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 499 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
+.+...... ..+..+.|..|++||.+.+ +.++++.|||.-||+|.||+||.+-+.+........++...-..+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 876533221 2233456999999998876 679999999999999999999998887654332222222221111111
Q ss_pred --------hhhhhh--hhhccChhh--HHHH------HHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 --------RLFEVL--DALVLKEAE--REEI------MTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 --------~~~~~~--d~~~~~~~~--~~~~------~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.+.+ .+....... .+.. .+..+|+.+++..||.+|+++.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 122222 111111110 0111 25779999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=272.14 Aligned_cols=242 Identities=25% Similarity=0.322 Sum_probs=201.1
Q ss_pred cccccccccCccceEEEEEEEeCCCc-EEEEEEcc---ccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGR-IVAVKKSK---LVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++..+..||-||||.|-+...+... .+|+|.++ ..+..+.+....|-.+|...+.|.||+|+..|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556678999999999999876443 37776544 456667788999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|-+-||.|...|.+.. .+...+..-++..+++|++|||++ +||.|||||+|.||+.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999998654 588888888999999999999999 9999999999999999999999999999987654
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. .+-+++||+.|.|||++.......+.|.||||++++||++|++||.+.++-...++ +..-+|
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~------------ILkGid--- 636 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL------------ILKGID--- 636 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH------------HHhhhh---
Confidence 3 35568899999999999999999999999999999999999999987654221111 111111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPT 613 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 613 (686)
.-+.++.......+|+++....+|.+|.-
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 13445556667889999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=254.26 Aligned_cols=132 Identities=27% Similarity=0.353 Sum_probs=113.1
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-----C---CCeeeEEeEEee---
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-----H---RNIVKLLGCCLE--- 416 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~--- 416 (686)
.+|.+.++||.|.|++||++.. .+.+.||+|+.+.. +...+..+.|+++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5799999999999999999995 45789999998764 334567889999999984 3 469999999975
Q ss_pred -CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec
Q 038345 417 -TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485 (686)
Q Consensus 417 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 485 (686)
+.+.+||+|++ |-+|..+|....- +.++...+.+|+.||+.||.|||..+ +|||.||||+||||.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45789999999 6788888876533 35899999999999999999999998 999999999999993
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=249.68 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 422 (686)
.++|...++||+|+|.+|-.+.+. ..+.+|+|.++. .+.+++.-...|-.+..+. +||.+|-|+.+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999965 578899997664 2344455566777777776 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|.||+++|+|.-+++++. .|+++.+.-+...|..||.|||++ ||+.||||.+|+|||..+.+||+|+|+.+.-
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-
Confidence 999999999988777543 599999999999999999999999 9999999999999999999999999999753
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCccc-CCchhHhhHHHhhcchhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE-DRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d 581 (686)
......+..+.||+.|+|||.+.+..|.-..|.|+|||+|+||+.|+.||+....+. +.+..++..+.+-+.++
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi----- 476 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI----- 476 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence 233445667899999999999999999999999999999999999999998543322 23333444444333221
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCC
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 612 (686)
..++..+.....+++.-|..||.+|.
T Consensus 477 -----riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 -----RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence 12333444567888999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=280.66 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=187.3
Q ss_pred ccccccccCccceE-EEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEec
Q 038345 350 NYNANRILGQGGQG-TVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 350 ~~~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
-|...+++|.|+.| .||+|... ++.||||++-. +......+|+..|+.- .|||||++++.-.+....|+..|.+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35566789999987 47999984 88999998653 3334567999999988 5999999999988999999999999
Q ss_pred cCCchhhhhhccCCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-----CCcEEEEecCCcccc
Q 038345 428 PNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-----KYRAKVSDFGTSRSI 501 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~~ 501 (686)
. .+|.+++....... ...-...+.+..|+++||++||+. +||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 69999998741111 112144577889999999999998 9999999999999965 367999999999988
Q ss_pred cCCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 502 TVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 502 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..+.... .....||.||+|||++.....+.+.|||||||++|+.++ |+.||...-..+. +. ......+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI------l~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI------LTGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh------hcCccceee
Confidence 7655433 345679999999999999888999999999999999999 5899863221110 00 000001111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
+ .... +. +..+||.+|++.+|..||++.+|+
T Consensus 735 L------~~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 L------EPLP-DC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred e------ccCc-hH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1 0111 11 678999999999999999999998
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-31 Score=251.36 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=198.7
Q ss_pred cccccCccceEEEEEEEe-CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----CcceEEE
Q 038345 353 ANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLET-----EVPLLVY 424 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lV~ 424 (686)
..+.||-|+||.||..+. ++|+.||+|++...-. ...+.+.+|+++|..++|.|++..++..... ...|+|.
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 357899999999999985 5799999998765322 3357899999999999999999998876543 3567888
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
|+|. .+|..+|-. ..+|+.+.+.-+..||++||.|||+. +|.||||||.|.|++.+-.+||+|||+++....+
T Consensus 137 ELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 8884 577777653 23688899999999999999999999 9999999999999999999999999999987776
Q ss_pred CceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH-----h---hcch
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA-----M---NENR 575 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~-----~---~~~~ 575 (686)
+...++...-|..|.|||.+.+ +.|+.+.||||.|+++.||+.++.-|....+-+..+++...... + -++.
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 6666666678999999999887 57899999999999999999999888766555444433322211 1 1111
Q ss_pred hhhhhhhhccC---------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 576 LFEVLDALVLK---------EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 576 ~~~~~d~~~~~---------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
-..++...... ..+.....+-..+..+++..||+.|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111100 00112223456788889999999999998887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=263.02 Aligned_cols=206 Identities=25% Similarity=0.360 Sum_probs=174.6
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
-|..++.||-|+||+|.++... ....+|.|.+... .+.+....+.|-.||.....+-||+|+-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4777889999999999999844 4667899976543 34556678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc---
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT--- 502 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~--- 502 (686)
|++||++-.+|.+.. .+.+..+.-++.++.-|+++.|.. |+|||||||+|||||.+|.+||+||||..-+.
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999988653 477888888899999999999999 99999999999999999999999999975321
Q ss_pred CC-----Cce---------------------------------eeeeeeccccccCccccccCCCCccccEeehHHHHHH
Q 038345 503 VD-----QTH---------------------------------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 544 (686)
Q Consensus 503 ~~-----~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~e 544 (686)
.. ..+ .....+||+-|+|||++....++...|.||.||+|+|
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00 000 0113469999999999999999999999999999999
Q ss_pred HHhCCCCCccCCcccCC
Q 038345 545 ILTGQKPIRAINIDEDR 561 (686)
Q Consensus 545 lltg~~p~~~~~~~~~~ 561 (686)
|+.|+.||....+.+..
T Consensus 864 m~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HhhCCCCccCCCCCcce
Confidence 99999999877665543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=233.59 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=193.5
Q ss_pred ccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC--CcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV 423 (686)
.++|++.+++|+|.+++||.|. ..+.+.++||.++.... +.+.+|+.+|+.|. ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4679999999999999999999 55788999999986543 67889999999997 99999999998764 567899
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCCccccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSIT 502 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~ 502 (686)
+||+.+.+...+.. .|+...+.-.+.+++.||+|+|+. ||+|||+||.|+++|.. ..++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999877655443 367778888999999999999999 99999999999999865 569999999999886
Q ss_pred CCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch------
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR------ 575 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------ 575 (686)
+..... -...+..|--||.+.. +.|...-|+|||||+|.+|+..+.||-..... ...++..+ ..+....
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIa-kVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIA-KVLGTDELYAYLN 260 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHH-HHhChHHHHHHHH
Confidence 554432 2235667889998865 56788999999999999999999998643221 12222211 1111111
Q ss_pred ---------hhhhhhhhccC-------hhhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 ---------LFEVLDALVLK-------EAERE-EIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ---------~~~~~d~~~~~-------~~~~~-~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+++....+. ..+.. ...+..+++.+.|..|-.+|||++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11222111110 01111 1257889999999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-28 Score=235.66 Aligned_cols=210 Identities=36% Similarity=0.576 Sum_probs=183.1
Q ss_pred cCccceEEEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhh
Q 038345 357 LGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQ 434 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 434 (686)
||+|.+|.||++...+ ++.+++|........ ..+.+.+|+..++.++|++|+++++++......+++||++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 889999997764332 34679999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCcccccCCCceeeeeee
Q 038345 435 NIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVDQTHLTTKVQ 513 (686)
Q Consensus 435 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 513 (686)
++.... ..+++..++.++.+++++|++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987642 3589999999999999999999999 9999999999999999 89999999999976543321 122345
Q ss_pred ccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHH
Q 038345 514 GTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592 (686)
Q Consensus 514 gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 592 (686)
+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999998877 888999999999999999
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 593 IMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 593 ~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 347899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=229.24 Aligned_cols=207 Identities=26% Similarity=0.366 Sum_probs=166.9
Q ss_pred HHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
++...+.......||+|++|.|-+-++ .+|...|+|++... ..+..++.++|+.+..+. ..|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444445555567899999999988885 47999999987653 444556788888876665 689999999999999999
Q ss_pred eEEEEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 421 LLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
++.||.|. .+|+.+-..- .....+++..+-+||..+.+||.|||++- .++|||+||+|||++.+|++|++|||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 5776655432 23346899999999999999999999985 89999999999999999999999999987
Q ss_pred cccCCCceeeeeeeccccccCcccccc----CCCCccccEeehHHHHHHHHhCCCCCccC
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQKPIRAI 555 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDv~S~Gv~l~elltg~~p~~~~ 555 (686)
.+.++ -..+...|-..|||||.+.. ..|+.||||||||+.+.||.+++.||...
T Consensus 198 ~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 65322 11222347778999998743 47899999999999999999999999743
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=229.22 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=187.7
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeE-EeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGC-CLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lV~ 424 (686)
.+.|.+.+.||+|.||.+-++.++. .+.+++|.+... ....++|.+|...--.| .|.||+.-+.. |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3679999999999999999999874 667888876542 33457899998876666 58999987754 55667788999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee-c-CCCcEEEEecCCccccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL-D-DKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-~-~~~~~kl~DfGla~~~~ 502 (686)
||.+.|+|.+-+... .+.+....+++.|++.||.|+|+. .+||||||.+|||| + +..++||+|||+.+...
T Consensus 102 E~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998877653 377888899999999999999999 99999999999999 3 34589999999987543
Q ss_pred CCCceeeeeeeccccccCccccccC-----CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
. ......-+..|.+||..... ...+.+|||.||++++..+||+.||.... ..+...+.|....-+ ...
T Consensus 175 ~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~r--k~~ 247 (378)
T KOG1345|consen 175 T----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKR--KNP 247 (378)
T ss_pred c----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcc--cCc
Confidence 1 11122345679999987543 24568999999999999999999998433 333444444322211 111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
.+. ..-....+.+.++.++-|..+|++|--..++.++-..
T Consensus 248 ~~P------~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 248 ALP------KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cCc------hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 111 1112234557788899999999999766666655433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=235.30 Aligned_cols=199 Identities=35% Similarity=0.513 Sum_probs=173.5
Q ss_pred cccccccCccceEEEEEEEeCC-CcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 351 YNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
|...+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999875 889999998765444 56789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+++|.+++..... .+++..+..++.+++.+|.+||+. +++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999986432 178999999999999999999998 99999999999999999999999999998765432112
Q ss_pred eeeeeccccccCcccc-ccCCCCccccEeehHHHHHHHHhCCCCCcc
Q 038345 509 TTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~-~~~~~t~ksDv~S~Gv~l~elltg~~p~~~ 554 (686)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578889999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=254.48 Aligned_cols=196 Identities=24% Similarity=0.343 Sum_probs=166.2
Q ss_pred cccccccccCccceEEEEEEEeCC-CcEEEEEEccccC---hh-----hHHHHHHHHHHHHhcC---CCCeeeEEeEEee
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVD---EN-----NVEQFINEVVILSQIN---HRNIVKLLGCCLE 416 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 416 (686)
..|...+.||+|+||.|++++++. ...|+||.+.... .. ..-..-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358889999999999999999764 5678888754311 11 1122446999999997 9999999999999
Q ss_pred CCcceEEEEecc-CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 417 TEVPLLVYEFVP-NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 417 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
++..||+||... +-+|+++|..+. .+++....-|++||+.|+++||+. +|||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 999999999754 558999998654 489999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCc
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
|.+...... ....++||.+|.|||++.+..| ...-|||++|++||.++....||.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999765432 3455789999999999999877 456799999999999999988875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=249.85 Aligned_cols=271 Identities=19% Similarity=0.209 Sum_probs=208.0
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC------CCCeeeEEeE
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN------HRNIVKLLGC 413 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~ 413 (686)
..-.+..-.+|.+....|+|-|++|-+|... -|+.||||++..... -.+.=+.|+++|.+|+ .-|.++|+-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3334455678999999999999999999954 478999999865322 2244568999999995 3589999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEE
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKV 492 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl 492 (686)
|...++++||+|-+ ..+|.+.|.+.+....|....+..++.|+.-||..|... +|+|.||||.|||+++. ..+||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 99999999999998 479999999988877899999999999999999999998 99999999999999865 56899
Q ss_pred EecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH----
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL---- 568 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~---- 568 (686)
+|||.|....... .+.+..+..|.|||++.+-+|....|+||.||.||||.||+..|.+........+.....
T Consensus 579 CDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 579 CDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9999997654332 233445668999999999999999999999999999999999998765433222221111
Q ss_pred -HHhhcchh---------------------------hhhhhh------hc-----cChhhHHHHHHHHHHHHHhcccCCC
Q 038345 569 -QAMNENRL---------------------------FEVLDA------LV-----LKEAEREEIMTVATLAKRCLNLNGK 609 (686)
Q Consensus 569 -~~~~~~~~---------------------------~~~~d~------~~-----~~~~~~~~~~~l~~l~~~cl~~dp~ 609 (686)
.++..+.+ +..+.+ .+ ..+........|.+|+..||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 01111100 000000 01 1122334567899999999999999
Q ss_pred CCCCHHHHHH
Q 038345 610 NRPTMKEVAF 619 (686)
Q Consensus 610 ~RPt~~ev~~ 619 (686)
+|.|..++++
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999998873
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=236.25 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=192.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------c
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETE------V 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~ 419 (686)
.+|...+.+|.|.. .|-.+... .++.||+|+... ......++..+|+.++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999988 55555532 578999998543 33445677889999999999999999999997543 5
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.|+|||+|. .+|...++. .++-+.+..|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhc
Confidence 689999995 688888873 367788899999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCc--------hhHhhHHHh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRS--------LVGYFLQAM 571 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~--------l~~~~~~~~ 571 (686)
.-..+ ...+....|..|.|||++.+..+.+..||||+||++.||++|+--|.+...-+.-. +-..|...+
T Consensus 167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 64433 45667788999999999999889999999999999999999998886432111100 000010000
Q ss_pred hc-c--------h-----hhhhh-hhhc--cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 572 NE-N--------R-----LFEVL-DALV--LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 572 ~~-~--------~-----~~~~~-d~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.. . + ..+.+ |... ..+.++-......+++.+||..+|++|.++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 00 0 0 00000 1000 1111122334678999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-28 Score=254.08 Aligned_cols=253 Identities=27% Similarity=0.357 Sum_probs=203.3
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|.....+|.|.||.|||++. ..++..|+|.++........-..+|+.+++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35788889999999999999995 46889999999887777778888999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+.+|+|.+.-+-. .+|++.++..+.+..++||.|||+. +-+|||||-.|||+++.+.+|++|||.+-.+..--
T Consensus 94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999877743 3799999999999999999999999 77799999999999999999999999987664321
Q ss_pred eeeeeeeccccccCcccc---ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~---~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.....+.||+.|||||+. ..+.|..++|||++|+...||---++|.....+- .+.-.+.. .. .++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmTk-S~---~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMTK-SG---FQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhhc-cC---CCCC
Confidence 223457799999999986 4577999999999999999998877775322110 01111111 00 0111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+......+.|.++++.++..+|++||+++.++.
T Consensus 236 -~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 -TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11122234567899999999999999999987653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=219.03 Aligned_cols=273 Identities=16% Similarity=0.211 Sum_probs=215.2
Q ss_pred cccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
-+|.+.++||+|.||+.+.|+ +-++++||||.... +.+..++..|....+.|. .++|..++-|..++.+..||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 479999999999999999999 56799999997554 334567888999999885 59999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-----CCcEEEEecCCcccc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-----KYRAKVSDFGTSRSI 501 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~~ 501 (686)
+ |-+|+|+..-... .++.++++.||+|++.-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7788887764433 599999999999999999999999 8999999999999953 346899999999988
Q ss_pred cCCCcee------eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 502 TVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 502 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
.+..+.. .....||.+||+-..+.++..+...|+-|||-|+.+.|.|..||.+...+..+.....+-...+.-.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 6554432 3456799999999999999999999999999999999999999998765432221111111111111
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccccccCcc
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQNCG 638 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~~~~~~ 638 (686)
+ .+.-...+.+|..-++..-..+-.+-|++.-+...+..+....+....-.+.|
T Consensus 260 i---------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW 313 (449)
T KOG1165|consen 260 I---------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDW 313 (449)
T ss_pred H---------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 1 11222345667777777778999999999999999998888776655444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=233.64 Aligned_cols=267 Identities=21% Similarity=0.234 Sum_probs=203.7
Q ss_pred ccccccccCccceEEEEEEEeCCC--cEEEEEEccccChhhHHHHHHHHHHHHhcCC----CCeeeEEeEE-eeCCcceE
Q 038345 350 NYNANRILGQGGQGTVYKGMLADG--RIVAVKKSKLVDENNVEQFINEVVILSQINH----RNIVKLLGCC-LETEVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 422 (686)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4788887665433333378889999999873 6899999999 47778899
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-----CcEEEEecCC
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-----YRAKVSDFGT 497 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DfGl 497 (686)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+. |++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999776654 45699999999999999999999999 99999999999999754 4699999999
Q ss_pred cc--cccCCCce------e-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 498 SR--SITVDQTH------L-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 498 a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
++ .+...... . .....||..|+++..+.+...+++.|+||++.++.||+.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 43222211 1 1235699999999999999999999999999999999999999976543221 11111
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
...... .. .......+.++.++...+-..+..++|.+..+...|+......+..+.
T Consensus 251 ~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~ 306 (322)
T KOG1164|consen 251 KDPRKL----LT-----DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKED 306 (322)
T ss_pred HHhhhh----cc-----ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCC
Confidence 111110 00 001112234566666666669999999999999999888777655544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=231.29 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=195.6
Q ss_pred HHhhccccccccccCccceEEEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETE 418 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 418 (686)
+....+.|...++||+|.|++||++++. ..+.||+|.+...+. ...+.+|+++|..+. +.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344567889999999999999999954 367899998776443 356889999999995 899999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCC
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGT 497 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGl 497 (686)
...+|+||+++-...+++.. ++...+...+..++.||.++|.. |||||||||+|+|.+. .+.-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 99999999999888887763 67888999999999999999999 9999999999999974 46789999999
Q ss_pred cccccCCC------c-------------------------------------eeeeeeeccccccCcccccc-CCCCccc
Q 038345 498 SRSITVDQ------T-------------------------------------HLTTKVQGTFGYVDPEYFQS-SQFTEKS 533 (686)
Q Consensus 498 a~~~~~~~------~-------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ks 533 (686)
|....... . .......||+||.|||++.. ...+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87210000 0 01112459999999999865 5678999
Q ss_pred cEeehHHHHHHHHhCCCCCccCCcccCCchhHhh----HH-----Hhhcch--hh---------hh------hh-hhcc-
Q 038345 534 DVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF----LQ-----AMNENR--LF---------EV------LD-ALVL- 585 (686)
Q Consensus 534 Dv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~----~~-----~~~~~~--~~---------~~------~d-~~~~- 585 (686)
||||-||+++-+++++.||-....+- ..+...+ .. +...++ +. ++ ++ ..+.
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999996543222 1111111 00 000111 00 00 10 0000
Q ss_pred --------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 --------KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 --------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......+..+.+++.+|+..||.+|.|+++.++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111112336889999999999999999999984
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=270.94 Aligned_cols=195 Identities=18% Similarity=0.205 Sum_probs=139.6
Q ss_pred hcCC-CCeeeEEeEE-------eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 038345 401 QINH-RNIVKLLGCC-------LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472 (686)
Q Consensus 401 ~l~h-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 472 (686)
.++| +||+++++++ .+....++++|++ +++|.++|... ...+++..++.++.||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4456 6888888887 3345678889988 56999999753 24599999999999999999999998 99
Q ss_pred EeeCCCCCCeeecC-------------------CCcEEEEecCCcccccCCC---------------ceeeeeeeccccc
Q 038345 473 YRRDIKSANILLDD-------------------KYRAKVSDFGTSRSITVDQ---------------THLTTKVQGTFGY 518 (686)
Q Consensus 473 vH~Dikp~NIll~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~y 518 (686)
+||||||+||||+. ++.+||+|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666666665321100 0001123578899
Q ss_pred cCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHH
Q 038345 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598 (686)
Q Consensus 519 ~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 598 (686)
||||++.+..++.++|||||||+||||++|..|+.... ... ..+.. ..+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~~----~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLRH----RVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHHH----hhcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999988864211 000 00000 001110 0111234568
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 038345 599 LAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 599 l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++.+||+.+|.+||+|.||++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=210.01 Aligned_cols=269 Identities=18% Similarity=0.231 Sum_probs=211.1
Q ss_pred hccccccccccCccceEEEEEEE-eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~ 424 (686)
....|.++++||.|+||.+|.|. ..+|..||||..... ....++..|..+...|+| ..|..+..+..+.....|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 568999999986542 223567889999999986 78888889999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~~~ 501 (686)
+++ |-+|++++.-... .++.++++-+|-|++.-++|+|.+ +++||||||+|+|..- -..+.|+|||||+.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 7789887765433 488999999999999999999999 8999999999999954 356899999999987
Q ss_pred cCCCcee------eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 502 TVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 502 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
.+..+.. .....||.+|.+-..+.+...+...|+-|+|.+|..+..|..||.+........-.+ +
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE---------k 235 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE---------K 235 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH---------H
Confidence 5443322 234569999999999888889999999999999999999999999765433211111 1
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
+.+.--....+..-...+.++.-.+..|-..--++-|+..-+-+.++-+.....+..
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~ 292 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQY 292 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccC
Confidence 111100111112223446778889999999999999999999998888877665544
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=208.99 Aligned_cols=169 Identities=22% Similarity=0.234 Sum_probs=126.8
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
|+|.+++.... .++++..++.|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999997542 3599999999999999999999998 4 999999999999999 99997654322
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAE 589 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~ 589 (686)
..||+.|||||++.+..++.++||||||+++|||++|+.||...... .............. ++. .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~------~~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD------DPR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC------Ccc-ccccH
Confidence 25889999999999999999999999999999999999998643210 11111111111000 000 00111
Q ss_pred HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 590 REEIM--TVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 590 ~~~~~--~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
..... ++.+++.+||..+|++||++.++++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 22222 68999999999999999999999998877654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=219.87 Aligned_cols=168 Identities=18% Similarity=0.111 Sum_probs=130.1
Q ss_pred HHhhccccccccccCccceEEEEEEEeC--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA--DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
.....++|...++||+|+||+||+|.+. +++.||||+.... .....+.|.+|+++|++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999864 5778899985422 22235679999999999999999853322
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCC-CCCCeeecCCCcEEEEec
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDI-KSANILLDDKYRAKVSDF 495 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Df 495 (686)
....+|||||+++++|.. +.. .. ...++.|++++|+|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 245799999999999963 211 11 146788999999999998 9999999 999999999999999999
Q ss_pred CCcccccCCCce-------eeeeeeccccccCccccccC
Q 038345 496 GTSRSITVDQTH-------LTTKVQGTFGYVDPEYFQSS 527 (686)
Q Consensus 496 Gla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 527 (686)
|+++.+...... ......+++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999876433211 11345678889999998643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=205.33 Aligned_cols=249 Identities=19% Similarity=0.319 Sum_probs=191.1
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
...+|.+...|+.|+|+++.+. +++|+++. ......++|..|.-.|+.+.||||+.++|.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3457888999999999997554 44465443 23333478999999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 510 (686)
+|+..|+.... ..++..+..++|.++|+|++|||+...+ |.---|.+..+++|++.+++|+= +-+++.... .
T Consensus 273 slynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarism-ad~kfsfqe-----~ 344 (448)
T KOG0195|consen 273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE-----V 344 (448)
T ss_pred HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheec-ccceeeeec-----c
Confidence 99999997643 3577788999999999999999998632 33446899999999999988752 111111101 1
Q ss_pred eeeccccccCccccccCCCC---ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 511 KVQGTFGYVDPEYFQSSQFT---EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 511 ~~~gt~~y~aPE~~~~~~~t---~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
...-.+.||+||.++..+.. .++|+|||+++||||.|++.||....+-|-. +.+.-+.++-.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeglrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGLRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcccccc
Confidence 11235789999999876543 5789999999999999999999866543321 11222233445
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.++..+..+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 56677788999999999999999999999999888754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-21 Score=199.70 Aligned_cols=261 Identities=31% Similarity=0.387 Sum_probs=196.5
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccChh---hHHHHHHHHHHHHhcCCC-CeeeEEeEEeeCCcceEEEEe
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN---NVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lV~e~ 426 (686)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 78899986653322 367899999999999988 799999999777778999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~ 505 (686)
+.+++|.+++........+.......++.|++.++.|+|+. +++||||||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997666432112588899999999999999999999 899999999999999988 79999999998654333
Q ss_pred ce-----eeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 506 TH-----LTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 506 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
.. ......|+..|+|||.+.. .......|+||+|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2355679999999999987 67889999999999999999999997643321 0011111111111000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.................+.+++..++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467899999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-22 Score=223.19 Aligned_cols=253 Identities=20% Similarity=0.252 Sum_probs=187.8
Q ss_pred ccccccCccceEEEEEEEeC-CCcEEEEEEcc-----ccCh-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 352 NANRILGQGGQGTVYKGMLA-DGRIVAVKKSK-----LVDE-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
...+++|.|++|.|+..... .....+.|... .... .....+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977777633 33334444322 1111 11223667888888899999988888877776666679
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++ +|+.++... ..++...+..+++|++.|+.|||+. ||.|||||++|+++..++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988764 2477888899999999999999999 9999999999999999999999999999766433
Q ss_pred Cc---eeeeeeeccccccCccccccCCCCc-cccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 505 QT---HLTTKVQGTFGYVDPEYFQSSQFTE-KSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 505 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.. .....+.|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+... ........ .-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~---~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQ---RN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccc---cc
Confidence 22 4455678999999999999998875 6799999999999999999998665443221 00000000 00
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...-........+...+.++.++|+.+|.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000111223345667889999999999999999999983
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-21 Score=185.94 Aligned_cols=171 Identities=12% Similarity=0.134 Sum_probs=133.0
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhh---HHH------HHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENN---VEQ------FINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
..++|...++||.|+||.||+... ++..+|||.+....... ... +.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999665 57789999876432222 222 57899999999999999999886643
Q ss_pred --------CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 418 --------EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 418 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
...+|||||++|.+|.++.. ++. ....+++.+|..||.. +++||||||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999987632 222 2456999999999999 999999999999999988
Q ss_pred EEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHH
Q 038345 490 AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ell 546 (686)
++|+|||.......+... ..+.....+..++|+||||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654322111 11344455667999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=181.42 Aligned_cols=139 Identities=18% Similarity=0.157 Sum_probs=107.8
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChh--h-------HHH-----------------HHHHHHHHHhcCCCCe
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN--N-------VEQ-----------------FINEVVILSQINHRNI 407 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 407 (686)
...||+|+||.||+|...+|+.||||.++..... . ... ...|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999987643211 0 112 2349999999988876
Q ss_pred eeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEeeCCCCCCeeecC
Q 038345 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL-HSAASISIYRRDIKSANILLDD 486 (686)
Q Consensus 408 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Dikp~NIll~~ 486 (686)
.....+. ....+|||||+++++|...+.. ..++++..+..++.|++.+|.|| |+. +|+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEEC
Confidence 4433322 2234899999998877654322 23588999999999999999999 677 9999999999999984
Q ss_pred CCcEEEEecCCcccc
Q 038345 487 KYRAKVSDFGTSRSI 501 (686)
Q Consensus 487 ~~~~kl~DfGla~~~ 501 (686)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=216.23 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=181.1
Q ss_pred ccccccccCccceEEEEEEEeCCCcEEEEEEcc-ccChhhHHHHHHHHHH--HHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSK-LVDENNVEQFINEVVI--LSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++...+.||.+.|=+|.+|+.+.|. |+||.+- ....-..+.|.++++- ...++|||.+++...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5777899999999999999998887 7888743 3334444555554433 4455899999998887777788999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc--CC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT--VD 504 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~--~~ 504 (686)
+.+ +|+|.|... .-|...+.+-|+-|++.||..+|.. +|+|||||.+||||+.-.-+.|+||..-+... .+
T Consensus 103 vkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 965 888887643 2467778888999999999999999 99999999999999999999999998876543 22
Q ss_pred Cce----eeeeeeccccccCcccccc----------CC-CCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhH
Q 038345 505 QTH----LTTKVQGTFGYVDPEYFQS----------SQ-FTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 505 ~~~----~~~~~~gt~~y~aPE~~~~----------~~-~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~ 568 (686)
... ...+...-..|+|||.+.. .. .+++.||||+||++.||++ |++||... .+..|-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~ 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc
Confidence 111 1112223357999997633 22 6789999999999999999 78888522 1111111
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.. ....+.+-..+ +...+++++..|++.||++|.++++.++.-+++
T Consensus 250 ~~---~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 250 GN---ADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cC---ccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00 00011110111 112578999999999999999999999885443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=175.13 Aligned_cols=140 Identities=19% Similarity=0.182 Sum_probs=110.4
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHHhcCCCCe
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN--------------------------NVEQFINEVVILSQINHRNI 407 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 407 (686)
.+.||+|++|.||+|...+|+.||||........ ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999986643210 01234678999999999987
Q ss_pred eeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecC
Q 038345 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDD 486 (686)
Q Consensus 408 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~ 486 (686)
.....+... ..+|||||++++++...+.. ...++......++.|++.+|.+||+ . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544443332 35899999998865443221 1247788999999999999999999 7 999999999999999
Q ss_pred CCcEEEEecCCccccc
Q 038345 487 KYRAKVSDFGTSRSIT 502 (686)
Q Consensus 487 ~~~~kl~DfGla~~~~ 502 (686)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=195.16 Aligned_cols=218 Identities=23% Similarity=0.444 Sum_probs=164.3
Q ss_pred HHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-EeeCC
Q 038345 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI-YRRDI 477 (686)
Q Consensus 399 l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i-vH~Di 477 (686)
|+.+.|.|+.+++|.+.++...+.|.+|++.|+|.+.+... ...++|.....+.++|+.||+|||+. +| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 35688999999999999999999999999999999999873 34689999999999999999999987 44 99999
Q ss_pred CCCCeeecCCCcEEEEecCCcccccC-CCceeeeeeeccccccCccccccC-------CCCccccEeehHHHHHHHHhCC
Q 038345 478 KSANILLDDKYRAKVSDFGTSRSITV-DQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQ 549 (686)
Q Consensus 478 kp~NIll~~~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDv~S~Gv~l~elltg~ 549 (686)
++.|.++|..+.+||+|||+...... ..........-..-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876532 111111122234579999998763 2477899999999999999999
Q ss_pred CCCccCCcccCC-chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 550 KPIRAINIDEDR-SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 550 ~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.||......+.. .++.. ++.+ ....+.+.+... .+...++..++.+||..+|.+||++++|-..++.+....
T Consensus 156 ~~~~~~~~~~~~~eii~~----~~~~-~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILR----VKKG-GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCChHHHHHH----HHhc-CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999864433322 11111 1110 000011111111 133447899999999999999999999999888776643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=169.92 Aligned_cols=185 Identities=15% Similarity=0.047 Sum_probs=137.3
Q ss_pred ccccccCccceEEEEEEEeCCCcEEEEEEccccChh----hHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEe
Q 038345 352 NANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN----NVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.+...|++|+||+||.+.- ++.+++.+.+.....- ....|.+|+++|++|+ |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997665 5778887776654331 1225789999999995 5889999886 346999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCC-CCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDI-KSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
+.|.+|...+.. ....++.|++++|.++|+. ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 1135778999999999999 9999999 7999999999999999999998544322
Q ss_pred ce----e--------eeeeeccccccCccccccC-CCC-ccccEeehHHHHHHHHhCCCCCcc
Q 038345 506 TH----L--------TTKVQGTFGYVDPEYFQSS-QFT-EKSDVYSFGVVLVEILTGQKPIRA 554 (686)
Q Consensus 506 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDv~S~Gv~l~elltg~~p~~~ 554 (686)
.. . ......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 0112256778888753221 222 567888999999999999988653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.3e-19 Score=199.21 Aligned_cols=203 Identities=21% Similarity=0.300 Sum_probs=163.9
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC---CCCeeeEEeEEee
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN---HRNIVKLLGCCLE 416 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~ 416 (686)
...+.+.-.+.|.+.+.||+|+||.||+|...+|+.||||..+.... -+|.--.+++.+|+ -+-|..+...+.-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34556666778999999999999999999988899999998765433 22333344555555 2345555555566
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-------CCCc
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-------DKYR 489 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-------~~~~ 489 (686)
.+.-+||+||.+.|+|.+++.. .+.++|..++.++.|+++.++.||.. +|||+||||+|+||. +..-
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccc
Confidence 7778999999999999999983 34699999999999999999999999 999999999999994 3456
Q ss_pred EEEEecCCcccccC-CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCC
Q 038345 490 AKVSDFGTSRSITV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551 (686)
Q Consensus 490 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p 551 (686)
++|+|||-+..+.. .+.......++|-.+--+|+..++.++...|.|.|+.+++-||.|+..
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 89999999876542 222345567789999999999999999999999999999999999854
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=9e-19 Score=176.12 Aligned_cols=232 Identities=21% Similarity=0.281 Sum_probs=148.7
Q ss_pred cccccccCccceEEEEEEEeCC-CcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCC----------CCeeeEEeEEe-
Q 038345 351 YNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLV---DENNVEQFINEVVILSQINH----------RNIVKLLGCCL- 415 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~- 415 (686)
....+.||.|+++.||.++... ++.+|||..... .....+++++|......+.+ -.++.-++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4556899999999999999764 899999975432 23346777777766555332 12222222211
Q ss_pred --------eC---C-----cceEEEEeccCCchhhhhhc---cCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEee
Q 038345 416 --------ET---E-----VPLLVYEFVPNGTLYQNIHN---HIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRR 475 (686)
Q Consensus 416 --------~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~ 475 (686)
.. . ..+++|+-+ .++|.+++.- ... ...+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 1 225677777 4688776542 211 12345566677889999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCcccccc--------CCCCccccEeehHHHHHHHHh
Q 038345 476 DIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS--------SQFTEKSDVYSFGVVLVEILT 547 (686)
Q Consensus 476 Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDv~S~Gv~l~ellt 547 (686)
||||+|++++.+|.++|+||+....... .... ...+..|.+||.... -.++.+.|.|+||+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987764331 1111 234577999997643 257889999999999999999
Q ss_pred CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCC
Q 038345 548 GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNR 611 (686)
Q Consensus 548 g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 611 (686)
++.||........... ...... +.++.+..||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999975433221110 112333 667789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=166.76 Aligned_cols=136 Identities=16% Similarity=0.157 Sum_probs=106.1
Q ss_pred ccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-----CCCCeeeEEeEEeeCC---c-ceE
Q 038345 352 NANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-----NHRNIVKLLGCCLETE---V-PLL 422 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~-~~l 422 (686)
...++||+|+||.||. +.+....+||+.........+.+.+|+.+++++ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 443333478887654444567899999999999 5799999999998864 3 237
Q ss_pred EEEe--ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeEeeCCCCCCeeecC----CCcEEEEec
Q 038345 423 VYEF--VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL-FYLHSAASISIYRRDIKSANILLDD----KYRAKVSDF 495 (686)
Q Consensus 423 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df 495 (686)
|+|| .++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999653 25544 35677888777 999999 9999999999999963 348999995
Q ss_pred CCc
Q 038345 496 GTS 498 (686)
Q Consensus 496 Gla 498 (686)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=193.28 Aligned_cols=225 Identities=27% Similarity=0.339 Sum_probs=177.6
Q ss_pred ccCccceEEEEEEE----eCCCcEEEEEEccccCh--hhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEecc
Q 038345 356 ILGQGGQGTVYKGM----LADGRIVAVKKSKLVDE--NNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
.+|+|.||.|++.. ...+..+|+|.++.... ........|..++...+ ||.+|++.-.+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999754 33467788887654321 11125667888888887 9999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|.|...+.... .+++.........++-+++++|+. +|+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988776533 466677777888899999999999 9999999999999999999999999999876433222
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
.||..|||||++. ....++|.||||++++||+||-.||.. + ... .++. ..-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~---------~Il~--~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMK---------RILK--AELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHH---------HHhh--hccCC
Confidence 7999999999988 567799999999999999999999974 0 010 1111 11234
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
+.+.......++.+++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 56667778888999999999999755
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=164.88 Aligned_cols=141 Identities=16% Similarity=0.128 Sum_probs=111.1
Q ss_pred ccccccccCccceEEEEEEE--eCCCcEEEEEEccccChh------------------------hHHHHHHHHHHHHhcC
Q 038345 350 NYNANRILGQGGQGTVYKGM--LADGRIVAVKKSKLVDEN------------------------NVEQFINEVVILSQIN 403 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 403 (686)
-|.+.+.||+|+||.||+|. ..+|+.||+|........ ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999986543210 0123568999999997
Q ss_pred CC--CeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eEeeCCCCC
Q 038345 404 HR--NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS-IYRRDIKSA 480 (686)
Q Consensus 404 h~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-ivH~Dikp~ 480 (686)
+. .+++++++ ...++||||+++.+|...+... ..+.......++.|++.+|++||+. + |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 63 34455543 2358999999998887654322 2356667789999999999999999 8 999999999
Q ss_pred CeeecCCCcEEEEecCCcccc
Q 038345 481 NILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 481 NIll~~~~~~kl~DfGla~~~ 501 (686)
||+++ ++.++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 789999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=160.59 Aligned_cols=134 Identities=20% Similarity=0.257 Sum_probs=113.0
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccC--h------hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVD--E------NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+.||+|++|.||+|.. ++..|++|+..... . .....+.+|+.++..++|++|+....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 57788888744321 1 1124678899999999999998877777777888999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+++++|.+++.... + .+..++.+++.+|.+||+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 7889999999999999999 999999999999999 78899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=181.30 Aligned_cols=174 Identities=25% Similarity=0.368 Sum_probs=131.5
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
.+++.|+++.-.+|.++|.+.......++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999876666678899999999999999999 5 8889999999999999989999999998
Q ss_pred ccccCCC-----ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhh
Q 038345 499 RSITVDQ-----THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 499 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
....... ....+...||..||+||.+.+..|+.|+||||||++|+||+. =..++... .+...++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhh
Confidence 7654433 223455679999999999999999999999999999999997 22332210 0111112
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev 617 (686)
.+.+. ..+-.+. ..=..++.+++.+.|.+||++.++
T Consensus 474 ~g~ip--------~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIP--------PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCC--------hHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 22111 1111111 123478999999999999954443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=156.16 Aligned_cols=143 Identities=21% Similarity=0.190 Sum_probs=111.2
Q ss_pred HHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHHh
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE----------------------NNVEQFINEVVILSQ 401 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~ 401 (686)
+.+....|.+.+.||+|+||.||++...+|+.||||....... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333334777899999999999999988899999997543210 011236778999999
Q ss_pred cCCC--CeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCC
Q 038345 402 INHR--NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKS 479 (686)
Q Consensus 402 l~h~--niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp 479 (686)
+.|+ .+++.++ ....++||||+++++|..+... .....++.+++.++.++|+. +|+||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 9887 4455554 2456899999999998765431 23467889999999999998 999999999
Q ss_pred CCeeecCCCcEEEEecCCccccc
Q 038345 480 ANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 480 ~NIll~~~~~~kl~DfGla~~~~ 502 (686)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-16 Score=156.00 Aligned_cols=130 Identities=19% Similarity=0.277 Sum_probs=106.7
Q ss_pred ccCccceEEEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 356 ILGQGGQGTVYKGMLADGRIVAVKKSKLVD--------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.||+|+||.||+|.+ ++..|++|...... ....+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 57789999744311 112356788999999999987766555666677789999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++++|.+++.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 7899999999999998 999999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.9e-17 Score=181.09 Aligned_cols=138 Identities=17% Similarity=0.232 Sum_probs=112.2
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEcc-ccC------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSK-LVD------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
...|...++||+|+||+||+|.+.+...++.++.. ... ....+.+.+|++++.+++|++++....++......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 44556788999999999999987654433322221 111 11235688999999999999999888888877788
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++. ....++.|++++|.|||+. +|+||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998875 3467899999999999998 99999999999999 577999999999975
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.9e-16 Score=159.01 Aligned_cols=196 Identities=23% Similarity=0.247 Sum_probs=135.7
Q ss_pred CCCCeeeEEeEEeeC---------------------------CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHH
Q 038345 403 NHRNIVKLLGCCLET---------------------------EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV 455 (686)
Q Consensus 403 ~h~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 455 (686)
+|||||+++++|.+. ...|+||.-.+ -+|.+++..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 589999988877532 23478887664 47888886542 56677778999
Q ss_pred HHHHHHHHhhhcCCCCeEeeCCCCCCeee--cCC--CcEEEEecCCcccccC-----CCceeeeeeeccccccCcccccc
Q 038345 456 EVSGALFYLHSAASISIYRRDIKSANILL--DDK--YRAKVSDFGTSRSITV-----DQTHLTTKVQGTFGYVDPEYFQS 526 (686)
Q Consensus 456 qi~~~L~yLH~~~~~~ivH~Dikp~NIll--~~~--~~~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 526 (686)
|+++|+.|||.+ +|.|||+|++|||| |++ -.+.|+|||.+-.-.. +.....-...|...-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 333 4578999997643211 11111122346778999998764
Q ss_pred CC------CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHH
Q 038345 527 SQ------FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLA 600 (686)
Q Consensus 527 ~~------~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~ 600 (686)
.+ --.|+|.|+.|.+.||+++...||.... | -+.+ .+...+.++.. .+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--e--m~L~--~r~Yqe~qLPa---------lp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--E--MLLD--TRTYQESQLPA---------LPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--h--heec--hhhhhhhhCCC---------CcccCChHHHHHH
Confidence 32 1358999999999999999999997521 1 0000 01122222222 2233455688999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 038345 601 KRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 601 ~~cl~~dp~~RPt~~ev~~~L 621 (686)
...|+.||++||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876655544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.3e-17 Score=179.25 Aligned_cols=208 Identities=25% Similarity=0.360 Sum_probs=144.0
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+|..++.|..|++|.||..+++. .+.+|+|.-+.. .+.+- ++.....| +.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~np---------------fvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNP---------------FVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCc---------------cee---
Confidence 4578899999999999999998764 567887543321 01110 22222222 233
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC-
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ- 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~- 505 (686)
|+=...+... .+++.. ++.+++|||+. +|+|||+||+|.||+.-|.+|+.|||+++......
T Consensus 136 ---gDc~tllk~~---g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNI---GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccC---CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333333322 123322 27789999999 99999999999999999999999999987542110
Q ss_pred -------------ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 506 -------------THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 506 -------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
......+.||+.|+|||++..+.|....|+|++|+++||.+-|+.||.+..++| | |.+.+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---l---fg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L---FGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---H---Hhhhhh
Confidence 011234679999999999999999999999999999999999999998765543 1 111111
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 612 (686)
+ .....+.......+.++++.+.|+.+|..|-
T Consensus 273 d--------~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 D--------DIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--------hccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1111222334556788999999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=145.26 Aligned_cols=136 Identities=20% Similarity=0.243 Sum_probs=99.2
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChh--hHHHH----------------------HHHHHHHHhcCCCC--e
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN--NVEQF----------------------INEVVILSQINHRN--I 407 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 407 (686)
.+.||+|+||.||+|...+++.||||........ ....+ ..|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999976542211 11111 35666666665443 4
Q ss_pred eeEEeEEeeCCcceEEEEeccCCchhhh-hhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeec
Q 038345 408 VKLLGCCLETEVPLLVYEFVPNGTLYQN-IHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLD 485 (686)
Q Consensus 408 v~l~g~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~ 485 (686)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. . +|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 555543 346899999998654322 11111 11 5678899999999999999 7 999999999999999
Q ss_pred CCCcEEEEecCCccccc
Q 038345 486 DKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 486 ~~~~~kl~DfGla~~~~ 502 (686)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=5.7e-15 Score=136.86 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=114.9
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999754 7899998765333 4678899999999977 58999999888888899999999987
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||+++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566778899999999999987555799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.9e-15 Score=128.08 Aligned_cols=94 Identities=34% Similarity=0.621 Sum_probs=67.3
Q ss_pred CCccCCCCceeeecCCCC---ccccc-----cccCCCcceEEEEecccceeeeccccccCCCCCCCceeEEEEecCCCcc
Q 038345 107 NGSCIGTGCCQIEIPRGS---FKNHT-----NVSSFNPCTYAFVVDQSQFHFTSNYLAFDGIPDDFPIVLDWEITTIETC 178 (686)
Q Consensus 107 ~~~CsG~gCCq~~i~~~~---~~~~~-----~~~~~~~c~~a~~~~~~~~~f~~~~~~~~~~~~~~p~~LdW~i~~~~~c 178 (686)
+++|+|+|||||+||.+. |.... +.....+|.+|||+|+.||.++..++......+++||+|+|+|...+..
T Consensus 1 n~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n~t~p~~~~~~~y~pv~L~W~i~t~~~~ 80 (103)
T PF08488_consen 1 NSSCSGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSNITDPEDFHAMGYVPVVLDWFIDTSDSS 80 (103)
T ss_pred CCccCCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEeccccccccCCChHHhccCCeeEEEEEEEEecCCcC
Confidence 478999999999999983 33222 1234589999999999999998888877778889999999999754211
Q ss_pred ccccccCCCCCCCCCCCCccCCCCceecCC
Q 038345 179 EEAKICGPNASCDKSKDNTTTSSGYHCKCN 208 (686)
Q Consensus 179 ~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~ 208 (686)
. ....+|.+.... ....+|.|.
T Consensus 81 ----~-~~s~~C~~~~~y---~~~~~C~C~ 102 (103)
T PF08488_consen 81 ----F-SNSLACKNNTEY---SSSNRCSCS 102 (103)
T ss_pred ----c-CcCccCCCceec---cCCCcEeCC
Confidence 1 112478765441 122388885
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-14 Score=143.31 Aligned_cols=134 Identities=18% Similarity=0.256 Sum_probs=103.9
Q ss_pred cccC-ccceEEEEEEEeCCCcEEEEEEcccc-------------ChhhHHHHHHHHHHHHhcCCCCe--eeEEeEEeeCC
Q 038345 355 RILG-QGGQGTVYKGMLADGRIVAVKKSKLV-------------DENNVEQFINEVVILSQINHRNI--VKLLGCCLETE 418 (686)
Q Consensus 355 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~ 418 (686)
..|| .||.|+||+.... +..++||..... .......+.+|+.++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4677 8888999988875 678888866421 11223567889999999998885 67777754432
Q ss_pred ----cceEEEEeccC-CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 419 ----VPLLVYEFVPN-GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 419 ----~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
..++|||++++ .+|.+++... +++.. .+.+++.+|.+||+. ||+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 6888887642 34543 356899999999999 99999999999999998899999
Q ss_pred ecCCccc
Q 038345 494 DFGTSRS 500 (686)
Q Consensus 494 DfGla~~ 500 (686)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-16 Score=173.96 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=187.1
Q ss_pred cccccccccCccceEEEEEEEeCC--CcEEEEEEccccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD--GRIVAVKKSKLVD--ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 423 (686)
..|.+.+.||+|+|+.|-...... ...+|+|...... ....+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457777889999999998877533 4456777655443 233445556788877786 99999999999999999999
Q ss_pred EEeccCCchhhhh-hccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNI-HNHIEEFPITWELLLRIAVEVSGALFYLH-SAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~ 500 (686)
.+|..++++.+.+ +.... ..+....-..+.|+..++.|+| .. ++.|+||||+|.+++..+ ..|++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 9999999999988 43321 3555667778999999999999 66 899999999999999999 999999999987
Q ss_pred ccC--CCceeeeeeec-cccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 501 ITV--DQTHLTTKVQG-TFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 501 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..||....... .....|.... ...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~~ 250 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GRF 250 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---ccc
Confidence 765 23333344568 9999999999884 55678999999999999999999997654332 1111111000 000
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...... .......+++.+++..+|..|.+.+++.
T Consensus 251 ----~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 ----TQLPWN----SISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ----ccCccc----cCChhhhhcccccccCCchhcccccccc
Confidence 000011 1223456788888889999999988775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.9e-13 Score=146.31 Aligned_cols=141 Identities=18% Similarity=0.166 Sum_probs=100.5
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhH----------------------------------------HHHH
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV----------------------------------------EQFI 393 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 393 (686)
.+.||.|++|.||+|++++|+.||||+......... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999998654211100 1245
Q ss_pred HHHHHHHhcC----CCCeeeEEeEEe-eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHH-HHHHhhhc
Q 038345 394 NEVVILSQIN----HRNIVKLLGCCL-ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG-ALFYLHSA 467 (686)
Q Consensus 394 ~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~yLH~~ 467 (686)
+|+..+.+++ |.+-+.+-..+. .....+|||||++|++|.+++..... .+ .+.+++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666666653 222233222322 24567999999999999887653211 12 23456666666 46788887
Q ss_pred CCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 468 ~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|++|+|+||.||++++++.++|+|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=112.08 Aligned_cols=77 Identities=30% Similarity=0.637 Sum_probs=64.3
Q ss_pred CEEeeCCCCCCCccccccCCcEEEEeeec-cEEEEEeeccccccCCCCCccccCCCCcCCcceEeecCCCeEEEEeeee
Q 038345 1 FLITCNDTFKPPKPFLTKSSIEVVNISID-GHLNVLQYTAKDCYNAKGYSVDSNLPTITLSKFTVSNTENRFVVIGCDS 78 (686)
Q Consensus 1 F~l~C~~t~~pp~~~l~~~~~ev~~isl~-g~~~v~~~~~~~c~~~~~~~~~~~~~~~~~~pf~~S~~~N~~~~iGC~~ 78 (686)
|+|+|++++++|+|++.++++||++|+++ ++++|..++.+.|+............++.+ ||++|+++|+|+++||++
T Consensus 29 F~L~C~~~~~~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 29 FELTCNNNTSPPKLLLSSGNYEVLSISYENGTIRVSDPISSNCYSSSSSNSSNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred cEEECCCCCCCceeEecCCcEEEEEEecCCCEEEEEeccccceecCCCCcccccEEeecC-CceEccCCcEEEEECCCC
Confidence 89999999899999999999999999998 999999999999987766332111123333 899999999999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=138.68 Aligned_cols=248 Identities=21% Similarity=0.244 Sum_probs=177.3
Q ss_pred cccccccccCc--cceEEEEEEEe---CCCcEEEEEEccccCh--hhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcc
Q 038345 349 DNYNANRILGQ--GGQGTVYKGML---ADGRIVAVKKSKLVDE--NNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 420 (686)
..|...+.+|. |.+|.||.+.. .++..+|+|+.+..-. .....=.+|+....++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34666788999 99999999986 3578899998554322 2333345666666666 499999988888888999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEec
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG----ALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDF 495 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Df 495 (686)
++-.|+.. .+|.++.+.... .++...++.+..+..+ ||.++|+. .++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 99999885 788888776433 2566667777777777 99999999 99999999999999998 88999999
Q ss_pred CCcccccCCCce----eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 496 GTSRSITVDQTH----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 496 Gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
|+...+....-. ......|...|++||... +.++.++|+|++|.++++..++..+....-.. .| .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W----~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW----S 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc----c
Confidence 999887644311 112225778899999866 46688999999999999999877654321000 00 0
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+. .+..++-.....++..++.++++.+|..|++.+.+..
T Consensus 337 ~~r~~------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQG------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccc------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 0111222222334555889999999999998877663
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-12 Score=127.80 Aligned_cols=200 Identities=19% Similarity=0.257 Sum_probs=137.7
Q ss_pred HHHhcCCCCeeeEEeEEeeCC-----cceEEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 038345 398 ILSQINHRNIVKLLGCCLETE-----VPLLVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASIS 471 (686)
Q Consensus 398 ~l~~l~h~niv~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 471 (686)
-|-++-|.|||+++.|+.+.. ...++.|||+.|+|..+|++.. ....+......+|+-||+.||.|||+. .++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 455567999999999986543 4578999999999999998743 234688888899999999999999996 457
Q ss_pred eEeeCCCCCCeeecCCCcEEEEecCCcccccCC----CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh
Q 038345 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVD----QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547 (686)
Q Consensus 472 ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt 547 (686)
|+|+++.-+-|++..++-+|+.- +........ .........+-++|.|||+=.....+.++|||+||+-.+||.-
T Consensus 199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999998888742 211111100 0111122346789999999777788889999999999999987
Q ss_pred CCCCCc-cCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 548 GQKPIR-AINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 548 g~~p~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+..--. .....+..... ...+..+-++ .=+.++..|++..|..||+|++++.
T Consensus 278 lEiq~tnseS~~~~ee~i--------a~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENI--------ANVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceeehhhhh--------hhheeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 664311 11000000000 0000000000 0135678999999999999998763
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-11 Score=116.79 Aligned_cols=130 Identities=21% Similarity=0.129 Sum_probs=96.8
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCee-eEEeEEeeCCcceEEEEeccCCch
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
.+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357889999999999875 77899998654322 123567899999998765544 455443 3346899999999887
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA--SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+.. . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 1 11245678999999999983 22369999999999999 5689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-11 Score=133.89 Aligned_cols=145 Identities=17% Similarity=0.147 Sum_probs=95.4
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChh----------------------------------hH---
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDEN----------------------------------NV--- 389 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~--- 389 (686)
...|+. +.||+|++|.||+|++++ |+.||||.....-.. -.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999987 999999987532100 00
Q ss_pred ---HHHHHHHHHHHhcC----CCCeeeEEeEEee-CCcceEEEEeccCCchhhh--hhccC-CCCCCCHHHHHHHHHHHH
Q 038345 390 ---EQFINEVVILSQIN----HRNIVKLLGCCLE-TEVPLLVYEFVPNGTLYQN--IHNHI-EEFPITWELLLRIAVEVS 458 (686)
Q Consensus 390 ---~~~~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~-~~~~l~~~~~~~i~~qi~ 458 (686)
-+|.+|+..+.+++ +.+.+.+-..+.+ ....+|||||++|+.+.++ +.... ....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12445555555553 3333443333333 4567899999999999774 22211 00112223333333333
Q ss_pred HHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEecCCcccccC
Q 038345 459 GALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDFGTSRSITV 503 (686)
Q Consensus 459 ~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfGla~~~~~ 503 (686)
+.. |++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999887 999999999977643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=124.26 Aligned_cols=167 Identities=19% Similarity=0.201 Sum_probs=127.2
Q ss_pred eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHH
Q 038345 370 LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL 449 (686)
Q Consensus 370 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 449 (686)
..++.+|.|...+.......+...+-++.|+.++||||++++.....+...|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 44688888888777666555667888899999999999999999999999999999884 56666664 33455
Q ss_pred HHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCC
Q 038345 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529 (686)
Q Consensus 450 ~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 529 (686)
+.-.+.||+.||.|||+.+ +++|++|.-..|++++.|..||++|.++.....-.. ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6667899999999999766 899999999999999999999999998754321111 011111122466676544322
Q ss_pred CccccEeehHHHHHHHHhCC
Q 038345 530 TEKSDVYSFGVVLVEILTGQ 549 (686)
Q Consensus 530 t~ksDv~S~Gv~l~elltg~ 549 (686)
-..|.|.||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3459999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-10 Score=111.33 Aligned_cols=142 Identities=19% Similarity=0.229 Sum_probs=111.3
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCC--CeeeEEeEEeeCC---cceEEEEecc
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDE-NNVEQFINEVVILSQINHR--NIVKLLGCCLETE---VPLLVYEFVP 428 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~---~~~lV~e~~~ 428 (686)
+.|+.|..+.||++...+|..+++|....... .....+..|+++++.+.+. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998654322 1345788999999999764 4577887766542 5689999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA---------------------------------------- 468 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---------------------------------------- 468 (686)
+.+|.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776542 24677788888899999999998531
Q ss_pred -------------CCCeEeeCCCCCCeeecC--CCcEEEEecCCccc
Q 038345 469 -------------SISIYRRDIKSANILLDD--KYRAKVSDFGTSRS 500 (686)
Q Consensus 469 -------------~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~ 500 (686)
...++|+|+++.||+++. +..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998853
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.7e-10 Score=106.01 Aligned_cols=135 Identities=15% Similarity=0.118 Sum_probs=98.2
Q ss_pred cccCccceEEEEEEEeCC-------CcEEEEEEccccC----------------------hhhHHHHH----HHHHHHHh
Q 038345 355 RILGQGGQGTVYKGMLAD-------GRIVAVKKSKLVD----------------------ENNVEQFI----NEVVILSQ 401 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 401 (686)
..||.|--+.||.|.-.+ +..+|||..+... ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 4789999643210 01122233 79999999
Q ss_pred cCC--CCeeeEEeEEeeCCcceEEEEeccCCchhh-hhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeEeeCC
Q 038345 402 INH--RNIVKLLGCCLETEVPLLVYEFVPNGTLYQ-NIHNHIEEFPITWELLLRIAVEVSGALFYL-HSAASISIYRRDI 477 (686)
Q Consensus 402 l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~~~~ivH~Di 477 (686)
+.. -++++++++ ...+|||||+.+..+.. .|.+ ..++......+..+++.+|..| |.. +|+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 964 466677764 56789999997654422 2222 1345566778889999999999 777 9999999
Q ss_pred CCCCeeecCCCcEEEEecCCcccc
Q 038345 478 KSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 478 kp~NIll~~~~~~kl~DfGla~~~ 501 (686)
++.|||+++ +.+.|+|||.+...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 57999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.5e-11 Score=127.66 Aligned_cols=260 Identities=18% Similarity=0.205 Sum_probs=181.1
Q ss_pred cccccChHH-HHhhccccccccccCccceEEEEEEEeC--CCcEEEEEEccccChhhHHH--HHHHHHHHHhc-CCCCee
Q 038345 335 KTKLFTSKD-LEKATDNYNANRILGQGGQGTVYKGMLA--DGRIVAVKKSKLVDENNVEQ--FINEVVILSQI-NHRNIV 408 (686)
Q Consensus 335 ~~~~~~~~~-~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv 408 (686)
..++|..++ ....+.+|..+..||.|.|+.|++...+ ++..+++|.+.........+ -..|+.+...+ .|.+++
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence 344555555 4455678999999999999999987743 57889999765533222222 24566666666 588899
Q ss_pred eEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-
Q 038345 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK- 487 (686)
Q Consensus 409 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~- 487 (686)
.....+.+-...++--||+.++++...+.- ...+....++++..|++.++.++|+. .++|+|+||+||++..+
T Consensus 330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~ 403 (524)
T KOG0601|consen 330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG 403 (524)
T ss_pred CCCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence 888888888888899999999988766622 22467778899999999999999988 99999999999999876
Q ss_pred CcEEEEecCCcccccCCCceeeeeeecccccc--CccccccCCCCccccEeehHHHHHHHHhCCCC-CccCCcccCCchh
Q 038345 488 YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV--DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP-IRAINIDEDRSLV 564 (686)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p-~~~~~~~~~~~l~ 564 (686)
+..++.|||.+..+.... .......++. +++......+-.+.|+||||.-+.|.+++..- +.....
T Consensus 404 ~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------- 472 (524)
T KOG0601|consen 404 FFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------- 472 (524)
T ss_pred hhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------
Confidence 888999999986432111 1112233344 55666667788999999999999999987743 111000
Q ss_pred HhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 565 GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 565 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+..+... ........+..+.+.++..++..||.+.++....+.++
T Consensus 473 ----~~i~~~~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 473 ----LTIRSGDTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----eeeeccccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 001111000 01111245677888899999999999988876555443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-09 Score=99.12 Aligned_cols=131 Identities=21% Similarity=0.271 Sum_probs=99.3
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEc--cccChh------hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKS--KLVDEN------NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~--~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..+++|+-+.+|.+.+. |..+++|.- |..... ..++-.+|+.++.+++--.|.-..=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46789999999999775 334666642 221111 234567899999999876666555566677788899999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++|..|.++|... ...++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888754 134566666777889999 999999999999998775 99999999964
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.1e-09 Score=97.60 Aligned_cols=143 Identities=21% Similarity=0.229 Sum_probs=106.3
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEcc--cc------ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSK--LV------DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
...+|-+|+-+.|+++.+. |+...||.-. .. .+-...+.++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4568889999999999985 7777777421 11 1112356788999999997666655555667777788999
Q ss_pred EeccC-CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---cEEEEecCCccc
Q 038345 425 EFVPN-GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKVSDFGTSRS 500 (686)
Q Consensus 425 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~ 500 (686)
||+++ -++.+++....... ........++.+|-+.+.-||.. +|+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888887654332 22233367888999999999999 999999999999996543 468999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.3e-09 Score=110.58 Aligned_cols=168 Identities=23% Similarity=0.368 Sum_probs=128.0
Q ss_pred EEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcceEEEEeccC-Cchhhhh
Q 038345 363 GTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLVYEFVPN-GTLYQNI 436 (686)
Q Consensus 363 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~l 436 (686)
.+.||++. .||..|++|++.............-++.++++.|.|||++...+.. +...+|||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899984 4899999999854333333334456889999999999999998873 4567899999886 5677655
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 437 HNHI------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 437 ~~~~------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
.... ....+++..+|.++.|++.||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 122467899999999999999999999 9999999999999999999999998887655433
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCC
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p 551 (686)
.. |.+.. -.+-|.=.||.+++.|.||..-
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 31 11111 1256777899999999998643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.2e-08 Score=97.51 Aligned_cols=125 Identities=24% Similarity=0.246 Sum_probs=82.5
Q ss_pred EEEEEEeCCCcEEEEEEccccC--------------h------------hhHHHHHHHHHHHHhcCCC--CeeeEEeEEe
Q 038345 364 TVYKGMLADGRIVAVKKSKLVD--------------E------------NNVEQFINEVVILSQINHR--NIVKLLGCCL 415 (686)
Q Consensus 364 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~g~~~ 415 (686)
.||.|...+|..+|||..+... . .......+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899998889999999643310 0 0123456899999999765 566776552
Q ss_pred eCCcceEEEEecc--CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 416 ETEVPLLVYEFVP--NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY-LHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 416 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
...|||||++ +..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 5589999998 55554433221 1133456677788886666 4676 99999999999999988 9999
Q ss_pred EecCCcccc
Q 038345 493 SDFGTSRSI 501 (686)
Q Consensus 493 ~DfGla~~~ 501 (686)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.4e-10 Score=128.75 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=170.4
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
....+.+.+.+-+-+|.++.++.+.-. .|...++|.... ....+.+....+-.++-..+||-++...--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 345567788888999999999987643 243344443222 2222233333343333334456666555555567788
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+||++|..+++|...|+... .++..........+..+++|||+. .+.|+|++|.|+|...++..+++|||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred chhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 99999999999999988654 355555556667788999999998 689999999999999999999999984332
Q ss_pred ccCC------------------------------CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCC
Q 038345 501 ITVD------------------------------QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550 (686)
Q Consensus 501 ~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~ 550 (686)
...- .........||+.|.+||...+......+|.|++|+.++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2100 0011223568999999999999999999999999999999999999
Q ss_pred CCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 551 PIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 551 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
||....... .| +.+.... ......+.+...+..+++.+.+..+|.+|-.+.
T Consensus 1034 p~na~tpq~------~f-~ni~~~~-------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQ------IF-ENILNRD-------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhh------hh-hccccCC-------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 997543321 01 1110000 001122334455677888899999999997765
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.3e-09 Score=127.75 Aligned_cols=68 Identities=29% Similarity=0.746 Sum_probs=50.1
Q ss_pred ccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc--CCCcccCCCCCccc--cccccCCcceEEeCCCCccCCC
Q 038345 183 ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR--DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~--~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~ 258 (686)
.|..+ +|..+..|.....||.|+|+.||+| +.|+ +++||.. +.|. +.|.|.+|+|.|.|.+|+.+..
T Consensus 3905 pC~sn-PC~~GgtCip~~n~f~CnC~~gyTG-----~~Ce~~Gi~eCs~---n~C~~gg~C~n~~gsf~CncT~g~~gr~ 3975 (4289)
T KOG1219|consen 3905 PCASN-PCLTGGTCIPFYNGFLCNCPNGYTG-----KRCEARGISECSK---NVCGTGGQCINIPGSFHCNCTPGILGRT 3975 (4289)
T ss_pred cccCC-CCCCCCEEEecCCCeeEeCCCCccC-----ceeeccccccccc---ccccCCceeeccCCceEeccChhHhccc
Confidence 34443 6776777777777777788777777 5573 4888864 5674 5899999999999999988764
Q ss_pred C
Q 038345 259 R 259 (686)
Q Consensus 259 ~ 259 (686)
+
T Consensus 3976 c 3976 (4289)
T KOG1219|consen 3976 C 3976 (4289)
T ss_pred C
Confidence 3
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.8e-08 Score=99.05 Aligned_cols=133 Identities=14% Similarity=0.085 Sum_probs=97.5
Q ss_pred EEEEEEEeCCCcEEEEEEccccChhh-H----------HHHHHHHHHHHhcCCCCe--eeEEeEEee-----CCcceEEE
Q 038345 363 GTVYKGMLADGRIVAVKKSKLVDENN-V----------EQFINEVVILSQINHRNI--VKLLGCCLE-----TEVPLLVY 424 (686)
Q Consensus 363 g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lV~ 424 (686)
..|.+..+ +|+.+.||......... . ..+.+|...+.++...+| ++++++... ...-+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666655 57789999754322111 1 147899999999965444 455666643 23468999
Q ss_pred EeccCC-chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-------CCcEEEEecC
Q 038345 425 EFVPNG-TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-------KYRAKVSDFG 496 (686)
Q Consensus 425 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~DfG 496 (686)
|++++. +|.+++.... ..+.+......++.+++..+.-||.. ||+|+|+++.|||++. +..+.|+||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 7888875432 12456677789999999999999999 9999999999999975 5789999999
Q ss_pred Cccc
Q 038345 497 TSRS 500 (686)
Q Consensus 497 la~~ 500 (686)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8853
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-07 Score=96.12 Aligned_cols=264 Identities=18% Similarity=0.184 Sum_probs=158.0
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEE-------eeCCcceEEE
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCC-------LETEVPLLVY 424 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~-------~~~~~~~lV~ 424 (686)
..+.||+|+.+.+|.--.- +..|| |+..........+.. ..|... .||-+-.-+.+= ..+...-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~VA-KIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQVA-KIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hchhh-eeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999963311 22344 433322222222222 222222 455433211110 1122355777
Q ss_pred EeccCCch-hhhhhc---cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 425 EFVPNGTL-YQNIHN---HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 425 e~~~~gsL-~~~l~~---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
..+++..- ..++.- ...-....|..+++.+..+|.+.+-||.. |.+-+|+.++|+|+.++..+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 77766422 222211 11112478999999999999999999999 899999999999999999999998654332
Q ss_pred ccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhC-CCCCccCCccc--CCchhHhhHHHhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTG-QKPIRAINIDE--DRSLVGYFLQAMN 572 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg-~~p~~~~~~~~--~~~l~~~~~~~~~ 572 (686)
. .........+|...|.+||.-. +..-+...|.|.||+++++|+.| +.||.+..... ..-+.. .+.
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~----~Ia 240 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET----DIA 240 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----hhh
Confidence 2 2223334456888999999743 34557789999999999999985 99998753211 111110 011
Q ss_pred cchhhhhhhhhc-----cChhh-HHHHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhhhhhcc
Q 038345 573 ENRLFEVLDALV-----LKEAE-REEIMTVATLAKRCLNLN--GKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 573 ~~~~~~~~d~~~-----~~~~~-~~~~~~l~~l~~~cl~~d--p~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
.+.....-|... ....+ ...+..+..|..+|+... +.-|||++.++..|..++.+.+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 111111111000 00111 123456778888888643 56899999999999988876544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.6e-08 Score=94.42 Aligned_cols=135 Identities=20% Similarity=0.186 Sum_probs=96.1
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHHhcCCC--C
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE----------------------NNVEQFINEVVILSQINHR--N 406 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--n 406 (686)
..+..+||.|--+.||.|....|.++|||.-..... .......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445679999999999999999999999995322100 0123456899999999755 6
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC
Q 038345 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD 486 (686)
Q Consensus 407 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 486 (686)
+++.+++ +...+|||++++-.|...- ++....-.|+..|++-+.-+-.. ||||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7776654 5668999999886664322 12223333444444444444455 9999999999999999
Q ss_pred CCcEEEEecCCccc
Q 038345 487 KYRAKVSDFGTSRS 500 (686)
Q Consensus 487 ~~~~kl~DfGla~~ 500 (686)
++.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.1e-07 Score=87.91 Aligned_cols=107 Identities=18% Similarity=0.188 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHHhcCCCC--eeeEEeEEeeCC----cceEEEEeccCC-chhhhhhccCCCCCCCHHHHHHHHHHHHHHH
Q 038345 389 VEQFINEVVILSQINHRN--IVKLLGCCLETE----VPLLVYEFVPNG-TLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461 (686)
Q Consensus 389 ~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L 461 (686)
.....+|...+.+|...+ .++.+++..... ..+||+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 356788999888886443 466777766533 348999999984 78888875322 55667788999999999
Q ss_pred HHhhhcCCCCeEeeCCCCCCeeecCCC---cEEEEecCCcccc
Q 038345 462 FYLHSAASISIYRRDIKSANILLDDKY---RAKVSDFGTSRSI 501 (686)
Q Consensus 462 ~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~~ 501 (686)
+-||.. ||+|+|+++.|||++.+. .+.|+||+.++..
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 999999999999998876 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.2e-08 Score=109.23 Aligned_cols=152 Identities=23% Similarity=0.277 Sum_probs=103.5
Q ss_pred HHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee--------eeeeccccccCccccc
Q 038345 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT--------TKVQGTFGYVDPEYFQ 525 (686)
Q Consensus 454 ~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~ 525 (686)
+.+++.||.|+|... ++||++|.|++|.++.++..||..|+.+........... .-..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999876 899999999999999999999999998764432111100 1112345799999999
Q ss_pred cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcc
Q 038345 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLN 605 (686)
Q Consensus 526 ~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~ 605 (686)
...-+.++|+||+|++++-+..|..+..... ..+..+.... ..+..-........+.++.+=+.+++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~----~~~~~~~~~~--------~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN----GGLLSYSFSR--------NLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc----CCcchhhhhh--------cccccccccccccCcHHHHHHHHHHhc
Confidence 9888999999999999999996555432211 1111111110 011111112224556678888899999
Q ss_pred cCCCCCCCHHHHHH
Q 038345 606 LNGKNRPTMKEVAF 619 (686)
Q Consensus 606 ~dp~~RPt~~ev~~ 619 (686)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=8.4e-07 Score=97.45 Aligned_cols=140 Identities=16% Similarity=0.153 Sum_probs=91.7
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChhh----------------------------------------HHHHHH
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENN----------------------------------------VEQFIN 394 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 394 (686)
+.|+.++-|.||+|++++|+.||||+....-+.. .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999754321110 012344
Q ss_pred HHHHHHhcC-----CCCeeeEEeEEe-eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhhc
Q 038345 395 EVVILSQIN-----HRNIVKLLGCCL-ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL-FYLHSA 467 (686)
Q Consensus 395 E~~~l~~l~-----h~niv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~ 467 (686)
|..-+.+++ .+++ ++=..+. -.....|+|||++|-.+.+...-... .++.+. ++..++++. ..+=..
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHHHHHHHhc
Confidence 555555552 2333 2222332 35677999999999988887432221 244333 333333322 111122
Q ss_pred CCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 468 ~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.4e-06 Score=79.78 Aligned_cols=138 Identities=17% Similarity=0.132 Sum_probs=102.1
Q ss_pred cCccceEEEEEEEeCCCcEEEEEEccc-c----C-hhhHHHHHHHHHHHHhcCCCC--eeeEEeEEeeC-----CcceEE
Q 038345 357 LGQGGQGTVYKGMLADGRIVAVKKSKL-V----D-ENNVEQFINEVVILSQINHRN--IVKLLGCCLET-----EVPLLV 423 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~~~~~vavK~~~~-~----~-~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~-----~~~~lV 423 (686)
-|+||-+-|++-.+. |+.+-+|+... . . +.....|.+|+..|.+|...+ ++++. ++... ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 356888899987765 44788897542 1 1 224578999999999996433 45555 33221 235799
Q ss_pred EEeccC-CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc--EEEEecCCccc
Q 038345 424 YEFVPN-GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR--AKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DfGla~~ 500 (686)
+|-+++ -+|.+++.+.. ..+.+......+..++++.+.-||+. ++.|+|+.+.|||++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 47888876532 22467778889999999999999999 9999999999999986666 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.1e-06 Score=81.50 Aligned_cols=138 Identities=14% Similarity=0.128 Sum_probs=84.8
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeEEeeCCcceEEEEeccCCc-
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFVPNGT- 431 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e~~~~gs- 431 (686)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-+ +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24467788765422 2345688999999987544 4677888777777889999999863
Q ss_pred hhhh---------------------hhccCCCCCCCHHHHH-HHHH----------HHHH-HHHHhhhc-CCCCeEeeCC
Q 038345 432 LYQN---------------------IHNHIEEFPITWELLL-RIAV----------EVSG-ALFYLHSA-ASISIYRRDI 477 (686)
Q Consensus 432 L~~~---------------------l~~~~~~~~l~~~~~~-~i~~----------qi~~-~L~yLH~~-~~~~ivH~Di 477 (686)
+... ||.... ......... ++.. .+.+ ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 111100 001111100 0000 0111 11222211 1235789999
Q ss_pred CCCCeeecCCCcEEEEecCCcc
Q 038345 478 KSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 478 kp~NIll~~~~~~kl~DfGla~ 499 (686)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.4e-07 Score=106.77 Aligned_cols=73 Identities=30% Similarity=0.787 Sum_probs=60.5
Q ss_pred ccc-ccccCCCCCCCCCCCCcc-CCCCceecCCCCcccCCCCCCCC-cCCCcccCCCCCccc--cccccCCcceEEeCCC
Q 038345 178 CEE-AKICGPNASCDKSKDNTT-TSSGYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNNCT--HICDNTAGNYTCRCPK 252 (686)
Q Consensus 178 c~~-~~~c~~~~~C~~~~~c~~-~~~~y~C~C~~Gy~gnpy~~~gC-~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~ 252 (686)
|.- .+.|+.+ +|++++.|.. ..+||.|+|+..|.||. | +++..|.. .+|- ++|.-..++|.|.|+.
T Consensus 3860 C~l~~d~C~~n-pCqhgG~C~~~~~ggy~CkCpsqysG~~-----CEi~~epC~s---nPC~~GgtCip~~n~f~CnC~~ 3930 (4289)
T KOG1219|consen 3860 CSLLTDPCNDN-PCQHGGTCISQPKGGYKCKCPSQYSGNH-----CEIDLEPCAS---NPCLTGGTCIPFYNGFLCNCPN 3930 (4289)
T ss_pred ccccccccccC-cccCCCEecCCCCCceEEeCcccccCcc-----cccccccccC---CCCCCCCEEEecCCCeeEeCCC
Confidence 544 3678766 8999999984 56899999999999964 8 57888975 6884 6999999999999999
Q ss_pred CccCCCC
Q 038345 253 GFRGDGR 259 (686)
Q Consensus 253 g~~~~~~ 259 (686)
||+|..|
T Consensus 3931 gyTG~~C 3937 (4289)
T KOG1219|consen 3931 GYTGKRC 3937 (4289)
T ss_pred CccCcee
Confidence 9998755
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.5e-06 Score=90.70 Aligned_cols=140 Identities=19% Similarity=0.153 Sum_probs=89.6
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChh-------------------------------------hHHHHHHHH
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN-------------------------------------NVEQFINEV 396 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~ 396 (686)
.+.||.-+.|.||+|++++|+.||||..+..-+. ..-+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3689999999999999999999999975442111 011244455
Q ss_pred HHHHhc----CCCC------eeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038345 397 VILSQI----NHRN------IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466 (686)
Q Consensus 397 ~~l~~l----~h~n------iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 466 (686)
+-..+. .|-+ |++++-. -.....|+||||+|..+.+.-.- ....++...+..-+.+ +. ++.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~---~~--~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVE---AY--LEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHH---HH--HHH
Confidence 444433 3544 3333322 23567899999999877764321 1112554444333333 22 222
Q ss_pred cCCCCeEeeCCCCCCeeecC----CCcEEEEecCCccccc
Q 038345 467 AASISIYRRDIKSANILLDD----KYRAKVSDFGTSRSIT 502 (686)
Q Consensus 467 ~~~~~ivH~Dikp~NIll~~----~~~~kl~DfGla~~~~ 502 (686)
.-..|++|.|=.|.||+++. ++.+.+.|||+...+.
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 22228999999999999984 6789999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.4e-05 Score=75.64 Aligned_cols=137 Identities=17% Similarity=0.197 Sum_probs=88.7
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHH---------HHHHHHHHhcCCC---CeeeEEeEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQF---------INEVVILSQINHR---NIVKLLGCCL 415 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h~---niv~l~g~~~ 415 (686)
..+|...+++-......|.+-.. +|..+++|..........+.| .+++..+.+++.. .+..++....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45677777777766666666555 578899997655333222222 2344444444322 2223222222
Q ss_pred -----eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 416 -----ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 416 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
.....+|||||++|..|.++.. ++. .++..+++++.-||.. |++|+|..|.|+++++++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-E
Confidence 1234468999999988866432 222 3556777889999999 999999999999998664 9
Q ss_pred EEEecCCccc
Q 038345 491 KVSDFGTSRS 500 (686)
Q Consensus 491 kl~DfGla~~ 500 (686)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=8e-06 Score=78.42 Aligned_cols=104 Identities=26% Similarity=0.329 Sum_probs=82.9
Q ss_pred HHHHHHHHhcCC-CCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 038345 393 INEVVILSQINH-RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471 (686)
Q Consensus 393 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ 471 (686)
..|..+++.+++ +++++++|+| ..++|.||...+++...-.....-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 34789999987766432100001123689999999999999999999865557
Q ss_pred eEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 472 IYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 472 ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.13 E-value=3.6e-05 Score=75.16 Aligned_cols=151 Identities=21% Similarity=0.227 Sum_probs=99.2
Q ss_pred ChHHHHhhcccccccc---ccCccceEEEEEEEeCCCcEEEEEEccccChh-------------------hHH-----HH
Q 038345 340 TSKDLEKATDNYNANR---ILGQGGQGTVYKGMLADGRIVAVKKSKLVDEN-------------------NVE-----QF 392 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~---~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~ 392 (686)
+.+.+.....+..+.. .|..|--+.||+|.-.++..+|||+.+..... ..+ -.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3444555555555444 45567777899999888999999976542111 000 12
Q ss_pred HHHHHHHHhcC--CCCeeeEEeEEeeCCcceEEEEeccCCch-hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 038345 393 INEVVILSQIN--HRNIVKLLGCCLETEVPLLVYEFVPNGTL-YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469 (686)
Q Consensus 393 ~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~ 469 (686)
.+|+.-|.++. +-.+.+.+++. ...|||||+....+ .-.| ...++.......+..++++.+.-|-..+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 35777777774 44455555543 44799999965411 1111 1123444466777888888888877743
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 470 ~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
++||+||+.=|||+. ++.+.|+|||-|...
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 999999999999999 779999999988543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.4e-05 Score=77.78 Aligned_cols=139 Identities=15% Similarity=0.088 Sum_probs=85.4
Q ss_pred cCccce-EEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEeccCCchhh
Q 038345 357 LGQGGQ-GTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQ 434 (686)
Q Consensus 357 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 434 (686)
|-.|.. ..||+.... +..+.||...... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444544 788998764 4678888765432 345678999988884 4446678888776677899999999887764
Q ss_pred hh-------------------hccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHhhh----cC
Q 038345 435 NI-------------------HNHIE-EFPIT--WELLLRIAV--------------------EVSGALFYLHS----AA 468 (686)
Q Consensus 435 ~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------qi~~~L~yLH~----~~ 468 (686)
.. |.... ..++. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 00111 000010000 01111222211 12
Q ss_pred CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 469 ~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3468999999999999998778999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.8e-07 Score=97.17 Aligned_cols=186 Identities=17% Similarity=0.146 Sum_probs=133.3
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCcceEEEEeccC
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+...+-++++++++++|.+....+....+.+... ....-++++|.+++||| .+..++-+..+...++++++...
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 3444568899999999987433333334443321 44556889999999999 77777777778888999999987
Q ss_pred C-chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 430 G-TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 430 g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+ +-..... .....+...+...+...-+++|+|||+. .=+|+| |||..+ ...|..||+....+.... .
T Consensus 319 ~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~ 386 (829)
T KOG0576|consen 319 GRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K 386 (829)
T ss_pred CccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--c
Confidence 6 2211111 1112244445556667778899999987 457998 887766 578999999987664332 2
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCc
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
.....+|+.++|||+.....+..+-|+|++|+-..++.-|.+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 344568999999999999999999999999987777777777643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.3e-05 Score=78.16 Aligned_cols=143 Identities=22% Similarity=0.256 Sum_probs=84.9
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCC--CeeeEEeEEeeC---CcceEEEEecc
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHR--NIVKLLGCCLET---EVPLLVYEFVP 428 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lV~e~~~ 428 (686)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3678899999999999877 68999986543 3456788899999888543 356777654332 34689999999
Q ss_pred CCchhh----------------hh---hccC-CCCCCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 038345 429 NGTLYQ----------------NI---HNHI-EEFPITWEL---------LLRI------------AVEVSG-ALFYLHS 466 (686)
Q Consensus 429 ~gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~qi~~-~L~yLH~ 466 (686)
+..+.. .+ +... ...++.+.. .... ...+.+ .++.++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 987776 11 1110 111111100 0000 111222 3333332
Q ss_pred ----cCCCCeEeeCCCCCCeeec-CCCcEEEEecCCcc
Q 038345 467 ----AASISIYRRDIKSANILLD-DKYRAKVSDFGTSR 499 (686)
Q Consensus 467 ----~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~ 499 (686)
.....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1334799999999999999 66666899999874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures] | Back alignment and domain information |
|---|
Probab=97.98 E-value=6e-06 Score=90.39 Aligned_cols=56 Identities=39% Similarity=0.958 Sum_probs=47.7
Q ss_pred cCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 198 TTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 198 ~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
..++.|.|.|.+||.|.. ..|+|.|||.. .-|+ ..|.|++|++.|.|.+||.+|+.
T Consensus 804 hGgs~y~C~CLPGfsGDG---~~c~dvDeC~p---srChp~A~CyntpgsfsC~C~pGy~GDGf 861 (1289)
T KOG1214|consen 804 HGGSTYSCACLPGFSGDG---HQCTDVDECSP---SRCHPAATCYNTPGSFSCRCQPGYYGDGF 861 (1289)
T ss_pred cCCceEEEeecCCccCCc---cccccccccCc---cccCCCceEecCCCcceeecccCccCCCc
Confidence 346679999999999954 57999999984 4565 58999999999999999999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=87.04 Aligned_cols=79 Identities=13% Similarity=0.289 Sum_probs=57.6
Q ss_pred ccccCccceEEEEEEEeCCC---cEEEEEEccccC-hhhHHHHHHHHHHHHhcC-CCCe--eeEEeEEeeC---CcceEE
Q 038345 354 NRILGQGGQGTVYKGMLADG---RIVAVKKSKLVD-ENNVEQFINEVVILSQIN-HRNI--VKLLGCCLET---EVPLLV 423 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lV 423 (686)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+.+++.+. |.++ +++++++.+. ..+++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876653 367777654321 123356889999999995 6665 7888888664 467999
Q ss_pred EEeccCCch
Q 038345 424 YEFVPNGTL 432 (686)
Q Consensus 424 ~e~~~~gsL 432 (686)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.6e-05 Score=68.64 Aligned_cols=128 Identities=18% Similarity=0.200 Sum_probs=85.7
Q ss_pred ccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCee-eEEeEEeeCCcceEEEEeccCC
Q 038345 352 NANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV-KLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lV~e~~~~g 430 (686)
...+.|++|++|.||+|.+. |..+|+|..... .....+..|+++|..+.--++- +++.|.. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 34578999999999999987 558888876543 3346788999999999876664 4554432 24559999887
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCC-CCCeeecCCCcEEEEecCCcc
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK-SANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik-p~NIll~~~~~~kl~DfGla~ 499 (686)
.|.+.-.. .+-+++++ +++.---|... ||-|+.|. |..++|-.+..+.|+||..|.
T Consensus 98 ~L~~~~~~------~~rk~l~~----vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIG------GDRKHLLR----VLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhc------ccHHHHHH----HHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 77654432 12233333 33332223333 88899887 444444444489999999886
|
|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=97.88 E-value=5.3e-06 Score=58.29 Aligned_cols=33 Identities=39% Similarity=0.990 Sum_probs=28.7
Q ss_pred CCCcccCCCCCccc--cccccCCcceEEeCCCCccC
Q 038345 223 DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRG 256 (686)
Q Consensus 223 ~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~ 256 (686)
|||||.... +.|. +.|+|+.|+|.|.|++||..
T Consensus 1 DidEC~~~~-~~C~~~~~C~N~~Gsy~C~C~~Gy~~ 35 (42)
T PF07645_consen 1 DIDECAEGP-HNCPENGTCVNTEGSYSCSCPPGYEL 35 (42)
T ss_dssp ESSTTTTTS-SSSSTTSEEEEETTEEEEEESTTEEE
T ss_pred CccccCCCC-CcCCCCCEEEcCCCCEEeeCCCCcEE
Confidence 689998744 6785 69999999999999999984
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00023 Score=68.66 Aligned_cols=128 Identities=22% Similarity=0.271 Sum_probs=90.7
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccC----------------hhhHHHHHHHHHHHHhcC------CCCeeeEE
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVD----------------ENNVEQFINEVVILSQIN------HRNIVKLL 411 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~ 411 (686)
...||+|+.=.||. +++.....||+..... ....+++.+|+.-..++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999998885 4556667778765543 223456777777666665 78999999
Q ss_pred eEEeeCCcceEEEEeccC--C----chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec
Q 038345 412 GCCLETEVPLLVYEFVPN--G----TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485 (686)
Q Consensus 412 g~~~~~~~~~lV~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 485 (686)
|+..+...+-+|+|.+.+ | +|.+++... .++. .. ...+-+-..||-+. .|+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~---~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-EL---RQALDEFKRYLLDH---HIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HH---HHHHHHHHHHHHHc---CCeecCCCcccEEEE
Confidence 999999999999998764 2 566666432 3544 33 33334445677777 899999999999994
Q ss_pred CC---C-cEEEEe
Q 038345 486 DK---Y-RAKVSD 494 (686)
Q Consensus 486 ~~---~-~~kl~D 494 (686)
.. . .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.3e-05 Score=47.86 Aligned_cols=24 Identities=38% Similarity=0.995 Sum_probs=21.0
Q ss_pred CceecCCCCcccCCCCCCCCcCCCc
Q 038345 202 GYHCKCNKGYEGNPYLSDGCRDVNE 226 (686)
Q Consensus 202 ~y~C~C~~Gy~gnpy~~~gC~~~~~ 226 (686)
||+|.|++||+.+| ....|+||||
T Consensus 1 sy~C~C~~Gy~l~~-d~~~C~DIdE 24 (24)
T PF12662_consen 1 SYTCSCPPGYQLSP-DGRSCEDIDE 24 (24)
T ss_pred CEEeeCCCCCcCCC-CCCccccCCC
Confidence 69999999999877 4578999997
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=72.11 Aligned_cols=73 Identities=18% Similarity=0.227 Sum_probs=46.7
Q ss_pred cccCccceE-EEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCC---CeeeEEeEEeeC---CcceEEEEec
Q 038345 355 RILGQGGQG-TVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHR---NIVKLLGCCLET---EVPLLVYEFV 427 (686)
Q Consensus 355 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~---~~~~lV~e~~ 427 (686)
+.|+.|+.. .||+. +..+++|.... ......+.+|++++..+... -+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 58874 23467776543 22345788999999888532 345555544332 2458999999
Q ss_pred cCCchh
Q 038345 428 PNGTLY 433 (686)
Q Consensus 428 ~~gsL~ 433 (686)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.0006 Score=70.77 Aligned_cols=76 Identities=9% Similarity=0.039 Sum_probs=56.7
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC---CCeeeEEeEEee---CCcceEEEEec
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH---RNIVKLLGCCLE---TEVPLLVYEFV 427 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~---~~~~~lV~e~~ 427 (686)
.+.||.|..+.||+-...++ .+.+|..+.. .....|..|...|+.|.. -.++++++.+.. .+..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 56799999999999876655 4666664331 123578899999999853 468889988754 35689999999
Q ss_pred cCCch
Q 038345 428 PNGTL 432 (686)
Q Consensus 428 ~~gsL 432 (686)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00051 Score=65.79 Aligned_cols=125 Identities=30% Similarity=0.467 Sum_probs=89.7
Q ss_pred cccccccccCccce-EEEEEEEeCCCcEEEEEEccc---cCh------------------hhHHHHHHHHHHHHhcC---
Q 038345 349 DNYNANRILGQGGQ-GTVYKGMLADGRIVAVKKSKL---VDE------------------NNVEQFINEVVILSQIN--- 403 (686)
Q Consensus 349 ~~~~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 403 (686)
.+++..+.||.|.. |.||++.+. |+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 999999985 77999998221 000 12345788998888885
Q ss_pred CCCe--eeEEeEEeeCC------------------cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 038345 404 HRNI--VKLLGCCLETE------------------VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463 (686)
Q Consensus 404 h~ni--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~y 463 (686)
+.++ |+.+||..-.. ...||.||++... .++. +-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 99999974220 1246777776432 1222 334566777888
Q ss_pred hhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 464 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 8988 9999999999986 3589999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00063 Score=68.09 Aligned_cols=140 Identities=19% Similarity=0.245 Sum_probs=81.1
Q ss_pred cccCccceEEEEEEEeCC--CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEeccCCc
Q 038345 355 RILGQGGQGTVYKGMLAD--GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFVPNGT 431 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gs 431 (686)
+.|..|-...+|+....+ +..|++|........ .-...+|+.++..+...++ +++++... ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999988664 678889976542221 1223478888888854334 44544432 248999999876
Q ss_pred hhhh-----------------hhccCCCC--------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 038345 432 LYQN-----------------IHNHIEEF--------PI-TWELLLRIAV----------------------EVSGALFY 463 (686)
Q Consensus 432 L~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~----------------------qi~~~L~y 463 (686)
+... +|...... .. -+..+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 11111110 11 1222212211 11111111
Q ss_pred h----hhc-CCCCeEeeCCCCCCeeecC-CCcEEEEecCCcc
Q 038345 464 L----HSA-ASISIYRRDIKSANILLDD-KYRAKVSDFGTSR 499 (686)
Q Consensus 464 L----H~~-~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~ 499 (686)
| ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 111 2346999999999999998 5789999999874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00039 Score=70.65 Aligned_cols=137 Identities=13% Similarity=0.122 Sum_probs=77.8
Q ss_pred cCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEeccCCchhhh
Q 038345 357 LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFVPNGTLYQN 435 (686)
Q Consensus 357 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gsL~~~ 435 (686)
+..|-...+|+.. .++..+++|........-.-...+|..+++.+...++ .++++... ..+||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 4557778899887 3566788887543222111135678899998864433 34444432 4799999998765421
Q ss_pred -----------------hhccCC-CCCCCHHHH-HHHHHH---------HHHHHHHhhhc-----CCCCeEeeCCCCCCe
Q 038345 436 -----------------IHNHIE-EFPITWELL-LRIAVE---------VSGALFYLHSA-----ASISIYRRDIKSANI 482 (686)
Q Consensus 436 -----------------l~~~~~-~~~l~~~~~-~~i~~q---------i~~~L~yLH~~-----~~~~ivH~Dikp~NI 482 (686)
||.... ..+++.... .....+ +...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 121110 112222211 111111 11112222111 123689999999999
Q ss_pred eecCCCcEEEEecCCcc
Q 038345 483 LLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~ 499 (686)
++++++ +.|+||+.+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG4260 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.57 E-value=3.7e-05 Score=74.01 Aligned_cols=79 Identities=24% Similarity=0.586 Sum_probs=60.1
Q ss_pred eeEEEEecCCCccccccccCCCC-CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCcc---cccccc
Q 038345 166 IVLDWEITTIETCEEAKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNC---THICDN 241 (686)
Q Consensus 166 ~~LdW~i~~~~~c~~~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c---~~~C~~ 241 (686)
-.-.|+++ ...|.++++|..-. .|.....|+|+.++|.|.+++||++. +|+|..- ...| ...|.|
T Consensus 222 CkkGW~ld-e~gCvDvnEC~~ep~~c~~~qfCvNteGSf~C~dk~Gy~~g---------~d~C~~~-~d~~~~kn~~c~n 290 (350)
T KOG4260|consen 222 CKKGWKLD-EEGCVDVNECQNEPAPCKAHQFCVNTEGSFKCEDKEGYKKG---------VDECQFC-ADVCASKNRPCMN 290 (350)
T ss_pred hcccceec-ccccccHHHHhcCCCCCChhheeecCCCceEecccccccCC---------hHHhhhh-hhhcccCCCCccc
Confidence 34569887 45899999997755 78777899999999999999999863 4444320 1223 247999
Q ss_pred CCcceEEeCCCCcc
Q 038345 242 TAGNYTCRCPKGFR 255 (686)
Q Consensus 242 ~~g~~~C~C~~g~~ 255 (686)
++|.|+|.|..|..
T Consensus 291 i~~~~r~v~f~~~~ 304 (350)
T KOG4260|consen 291 IDGQYRCVCFSGLI 304 (350)
T ss_pred CCccEEEEecccce
Confidence 99999999988754
|
|
| >KOG4260 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00014 Score=70.18 Aligned_cols=37 Identities=35% Similarity=0.860 Sum_probs=30.4
Q ss_pred CCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 220 GCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 220 gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
||.|||||.. +..+|. +.|+|+.|+|.|.+.+||.+.
T Consensus 232 gCvDvnEC~~-ep~~c~~~qfCvNteGSf~C~dk~Gy~~g 270 (350)
T KOG4260|consen 232 GCVDVNECQN-EPAPCKAHQFCVNTEGSFKCEDKEGYKKG 270 (350)
T ss_pred ccccHHHHhc-CCCCCChhheeecCCCceEecccccccCC
Confidence 5669999986 346674 689999999999999999763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0023 Score=68.55 Aligned_cols=76 Identities=18% Similarity=0.208 Sum_probs=55.4
Q ss_pred ccccCccceEEEEEEEeCCC-cEEEEEEcccc----C---hhhHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCcceE
Q 038345 354 NRILGQGGQGTVYKGMLADG-RIVAVKKSKLV----D---ENNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 422 (686)
.+.||.|.+..||+....+| +.|+||..... . ....+++..|.+.|..+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998877 58999974321 1 124567788888888863 3467777777 4456789
Q ss_pred EEEeccCCc
Q 038345 423 VYEFVPNGT 431 (686)
Q Consensus 423 V~e~~~~gs 431 (686)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=97.34 E-value=6.4e-05 Score=52.74 Aligned_cols=35 Identities=29% Similarity=0.667 Sum_probs=29.1
Q ss_pred ccccCCCC-CCCCCCCCccCCCCceecCCCCcccCC
Q 038345 181 AKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 181 ~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
++||.... .|..++.|+++.++|.|.|++||+.++
T Consensus 2 idEC~~~~~~C~~~~~C~N~~Gsy~C~C~~Gy~~~~ 37 (42)
T PF07645_consen 2 IDECAEGPHNCPENGTCVNTEGSYSCSCPPGYELND 37 (42)
T ss_dssp SSTTTTTSSSSSTTSEEEEETTEEEEEESTTEEECT
T ss_pred ccccCCCCCcCCCCCEEEcCCCCEEeeCCCCcEECC
Confidence 56776654 798889999999999999999998443
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >PF14670 FXa_inhibition: Coagulation Factor Xa inhibitory site; PDB: 3Q3K_B 1NFY_B 1LQD_A 1G2L_B 1IQF_L 2UWP_B 2VH6_B 3KQC_L 2P93_L 2BQW_A | Back alignment and domain information |
|---|
Probab=97.32 E-value=9.6e-05 Score=49.43 Aligned_cols=26 Identities=46% Similarity=1.160 Sum_probs=22.3
Q ss_pred CCccccccccCCcceEEeCCCCccCC
Q 038345 232 LNNCTHICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 232 ~~~c~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
+..|++.|++++|+|.|.|++||..+
T Consensus 5 NGgC~h~C~~~~g~~~C~C~~Gy~L~ 30 (36)
T PF14670_consen 5 NGGCSHICVNTPGSYRCSCPPGYKLA 30 (36)
T ss_dssp GGGSSSEEEEETTSEEEE-STTEEE-
T ss_pred CCCcCCCCccCCCceEeECCCCCEEC
Confidence 47899999999999999999999875
|
... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0044 Score=65.17 Aligned_cols=141 Identities=13% Similarity=0.160 Sum_probs=77.2
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeE------EeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGC------CLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e~ 426 (686)
+.|+.|....+|+....+| .+++|+...... +....|+.++..|...+ +.+.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777788999876555 678887652222 33344556665553222 3343321 1234567899999
Q ss_pred ccCCchhh--------------hhhccCCC--------CCCCH-HHHHH------------HH-HHHHHHHHHhhhc---
Q 038345 427 VPNGTLYQ--------------NIHNHIEE--------FPITW-ELLLR------------IA-VEVSGALFYLHSA--- 467 (686)
Q Consensus 427 ~~~gsL~~--------------~l~~~~~~--------~~l~~-~~~~~------------i~-~qi~~~L~yLH~~--- 467 (686)
++|..+.. .+|..... ..+.| ..... .. ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 11211110 01112 11111 11 1111122333211
Q ss_pred -CCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 468 -ASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 468 -~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
-..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 24489999999999999977666899999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00069 Score=78.89 Aligned_cols=196 Identities=18% Similarity=0.198 Sum_probs=134.0
Q ss_pred HHHHHHHHHHhcCCCCeeeEEeEEeeCCcc----eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 038345 391 QFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466 (686)
Q Consensus 391 ~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 466 (686)
...-|+..+.++.|+|++.++.|..+.... .+..++++.-++...+... ..++..+.+.+..++.+||+|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHH
Confidence 334577788888999999999998765433 3444677777777766643 358889999999999999999999
Q ss_pred cCCCCeEeeCCCCC---CeeecCCCcEEEE--ecCCcccccCCCceeeeeeeccccccCccccccCCCC--ccccEeehH
Q 038345 467 AASISIYRRDIKSA---NILLDDKYRAKVS--DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT--EKSDVYSFG 539 (686)
Q Consensus 467 ~~~~~ivH~Dikp~---NIll~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t--~ksDv~S~G 539 (686)
. ...|.-+..+ +...+..+.+.++ ||+.++......... ...-+..+.+||......+. ...|+|.+|
T Consensus 305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHH
Confidence 8 4445555444 5555667777777 999887665333221 12234567888887665544 457999999
Q ss_pred HHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 540 v~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.++..+..|..+-.... ....+++... ...+......|+..++++|++..+++.
T Consensus 380 ll~~~~~~~~~i~~~~~------------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA------------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCccccccc------------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhh
Confidence 99999998776532110 0111111110 114667888999999999999999985
Q ss_pred H
Q 038345 620 E 620 (686)
Q Consensus 620 ~ 620 (686)
.
T Consensus 434 ~ 434 (1351)
T KOG1035|consen 434 H 434 (1351)
T ss_pred c
Confidence 4
|
|
| >KOG1214 consensus Nidogen and related basement membrane protein proteins [Cell wall/membrane/envelope biogenesis; Extracellular structures] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00031 Score=77.42 Aligned_cols=91 Identities=29% Similarity=0.672 Sum_probs=65.2
Q ss_pred CCccccccccCCCC-CCCCCCCCccCCCCceecCCCCcccCCCCCCCCc------CCCcccCCCCCccc----cccccCC
Q 038345 175 IETCEEAKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR------DVNEFEDPSLNNCT----HICDNTA 243 (686)
Q Consensus 175 ~~~c~~~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~------~~~~c~~~~~~~c~----~~C~~~~ 243 (686)
..+|.+.++|.... .|..++.|++..+.|+|.|..||+-.- ....|. .++.|.+ ..+.|. ..|..+-
T Consensus 728 gr~c~d~~eca~~~~~CGp~s~Cin~pg~~rceC~~gy~F~d-d~~tCV~i~~pap~n~Ce~-g~h~C~i~g~a~c~~hG 805 (1289)
T KOG1214|consen 728 GRNCVDENECATGFHRCGPNSVCINLPGSYRCECRSGYEFAD-DRHTCVLITPPAPANPCED-GSHTCAIAGQARCVHHG 805 (1289)
T ss_pred CCCCCChhhhccCCCCCCCCceeecCCCceeEEEeecceecc-CCcceEEecCCCCCCcccc-CccccCcCCceEEEecC
Confidence 34788888887754 799999999999999999999987211 224674 3456765 345663 3676664
Q ss_pred -cceEEeCCCCccCCCCC--CCCCccC
Q 038345 244 -GNYTCRCPKGFRGDGRR--DGGGCIP 267 (686)
Q Consensus 244 -g~~~C~C~~g~~~~~~~--~~~~C~~ 267 (686)
+.|.|.|.+||++|+.. +...|.+
T Consensus 806 gs~y~C~CLPGfsGDG~~c~dvDeC~p 832 (1289)
T KOG1214|consen 806 GSTYSCACLPGFSGDGHQCTDVDECSP 832 (1289)
T ss_pred CceEEEeecCCccCCccccccccccCc
Confidence 46899999999999763 4445543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0023 Score=66.79 Aligned_cols=140 Identities=24% Similarity=0.361 Sum_probs=82.9
Q ss_pred cccCccceEEEEEEEeCC-------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLAD-------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 426 (686)
+.|..|-...+|+....+ ++.+++|...... ....+..+|..++..+...++ .++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 445556667899888654 4788899865432 222345688888888854333 45555553 2468999
Q ss_pred ccCCchhhh-----------------hhccCCCC--------CCCHHHHHH--------------------------HHH
Q 038345 427 VPNGTLYQN-----------------IHNHIEEF--------PITWELLLR--------------------------IAV 455 (686)
Q Consensus 427 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~ 455 (686)
++|..+... ||...... +.-|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 12111110 011111111 111
Q ss_pred HHHHHHHHhhh------cCCCCeEeeCCCCCCeeecCC----CcEEEEecCCcc
Q 038345 456 EVSGALFYLHS------AASISIYRRDIKSANILLDDK----YRAKVSDFGTSR 499 (686)
Q Consensus 456 qi~~~L~yLH~------~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~ 499 (686)
.+...+..|.. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 234578999999999999874 789999999884
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0057 Score=63.51 Aligned_cols=142 Identities=15% Similarity=0.134 Sum_probs=85.3
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeE------EeeCCcceEEEE
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGC------CLETEVPLLVYE 425 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~------~~~~~~~~lV~e 425 (686)
.+.|..|....+|+....+ ..+++|.... ........|+.++..+.+.+ +++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999887544 4688887654 22355667888888885433 4454432 123445689999
Q ss_pred eccCCchhh--------------hhhccCCC--------CCCCHHHHH----------HHHHHHHHHHHHhhh----cCC
Q 038345 426 FVPNGTLYQ--------------NIHNHIEE--------FPITWELLL----------RIAVEVSGALFYLHS----AAS 469 (686)
Q Consensus 426 ~~~~gsL~~--------------~l~~~~~~--------~~l~~~~~~----------~i~~qi~~~L~yLH~----~~~ 469 (686)
|++|..+.. .||..... ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11111100 111222211 011223334445443 123
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 470 ~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+++|+|+.|.|||++++....|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0061 Score=63.72 Aligned_cols=143 Identities=17% Similarity=0.186 Sum_probs=82.5
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeEE------eeCCcceEEEE
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGCC------LETEVPLLVYE 425 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lV~e 425 (686)
.+.++.|....+|+....++ .+++|...... ..+....|++++..|...+ +++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789998876545 57778754321 1234556777777774322 34444321 12345689999
Q ss_pred eccCCchhh--------------hhhccCCCC---------CCCHHHHH------------HHHHHHHHHHHHhhh----
Q 038345 426 FVPNGTLYQ--------------NIHNHIEEF---------PITWELLL------------RIAVEVSGALFYLHS---- 466 (686)
Q Consensus 426 ~~~~gsL~~--------------~l~~~~~~~---------~l~~~~~~------------~i~~qi~~~L~yLH~---- 466 (686)
|++|..+.. .+|...... .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998855421 122211110 01121110 011223344555542
Q ss_pred cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 467 ~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
....+++|+|+.+.||+++++....|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 234589999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG4289 consensus Cadherin EGF LAG seven-pass G-type receptor [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.00034 Score=81.03 Aligned_cols=54 Identities=30% Similarity=0.847 Sum_probs=45.5
Q ss_pred cCCCCceecCCCCcccCCCCCCCC-cCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 198 TTSSGYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 198 ~~~~~y~C~C~~Gy~gnpy~~~gC-~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
+...|.+|.|++||+|. -| +.||+|-. .+|. +.|....|+|+|.|.+||.|..+
T Consensus 1217 ~pvnglrCrCPpGFTgd-----~CeTeiDlCYs---~pC~nng~C~srEggYtCeCrpg~tGehC 1273 (2531)
T KOG4289|consen 1217 HPVNGLRCRCPPGFTGD-----YCETEIDLCYS---GPCGNNGRCRSREGGYTCECRPGFTGEHC 1273 (2531)
T ss_pred cccCceeEeCCCCCCcc-----cccchhHhhhc---CCCCCCCceEEecCceeEEecCCccccce
Confidence 35679999999999984 58 57899975 6774 69999999999999999998744
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.011 Score=60.55 Aligned_cols=71 Identities=14% Similarity=0.087 Sum_probs=41.8
Q ss_pred ccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC--C-CeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 356 ILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH--R-NIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
..++|-...|+.....+|..+++|.... ........+|+++|+.+.. + -+.+++.. ....++|++++|..+
T Consensus 18 ~~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~ 91 (276)
T cd05152 18 LNESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA 91 (276)
T ss_pred ecCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence 3445555566665555688899998753 2234567899999999853 1 11222211 223567777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.013 Score=62.24 Aligned_cols=139 Identities=19% Similarity=0.214 Sum_probs=80.6
Q ss_pred ccCccceEEEEEEEeCC-----CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEeccC
Q 038345 356 ILGQGGQGTVYKGMLAD-----GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~ 429 (686)
.|-.|-.-.+|+....+ ++.|++|........... -.+|..++..+...++ .++++++..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 44446667888876532 367889976553322222 2678889888865444 3566665332 58999987
Q ss_pred Cchhhh-----------------hhccCC---CCCCCHHHHHHHHHHH-----------------HHHHHHh----hh-c
Q 038345 430 GTLYQN-----------------IHNHIE---EFPITWELLLRIAVEV-----------------SGALFYL----HS-A 467 (686)
Q Consensus 430 gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~qi-----------------~~~L~yL----H~-~ 467 (686)
.+|... +|.... ..+..|..+.++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 121110 0112233333333222 1112222 21 2
Q ss_pred CCCCeEeeCCCCCCeeecC-CCcEEEEecCCcc
Q 038345 468 ASISIYRRDIKSANILLDD-KYRAKVSDFGTSR 499 (686)
Q Consensus 468 ~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~ 499 (686)
....++|+|+++.|||+++ +..+.|+||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2347899999999999976 4689999999875
|
|
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.00041 Score=46.54 Aligned_cols=28 Identities=36% Similarity=0.930 Sum_probs=22.5
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPY 216 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy 216 (686)
.|..++.|.++.++|.|.|++||.|+.+
T Consensus 7 ~C~~nA~C~~~~~~~~C~C~~Gy~GdG~ 34 (36)
T PF12947_consen 7 GCHPNATCTNTGGSYTCTCKPGYEGDGF 34 (36)
T ss_dssp GS-TTCEEEE-TTSEEEEE-CEEECCST
T ss_pred CCCCCcEeecCCCCEEeECCCCCccCCc
Confidence 7888899998899999999999999764
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.02 Score=59.23 Aligned_cols=136 Identities=14% Similarity=0.194 Sum_probs=78.0
Q ss_pred EEEEEEeCCCcEEEEEEcc-ccChhhHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCC--cceEEEEeccCCchhhhhhc
Q 038345 364 TVYKGMLADGRIVAVKKSK-LVDENNVEQFINEVVILSQINH--RNIVKLLGCCLETE--VPLLVYEFVPNGTLYQNIHN 438 (686)
Q Consensus 364 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~--~~~lV~e~~~~gsL~~~l~~ 438 (686)
.+|..... ++.+++++.. ...........+|+.+++.+.- --+...++.|.++. .++.||+|++|..+...+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 34444333 6777777331 2233445667788888888753 33456677777766 77999999988433222211
Q ss_pred cCCC----------------------------------CC-CCHHHHHHHH--------HHHHHHHHHhhhcC-----CC
Q 038345 439 HIEE----------------------------------FP-ITWELLLRIA--------VEVSGALFYLHSAA-----SI 470 (686)
Q Consensus 439 ~~~~----------------------------------~~-l~~~~~~~i~--------~qi~~~L~yLH~~~-----~~ 470 (686)
.... .+ -.|...++.+ -....-..+|+... .+
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 0000 00 0111111000 01112223343322 34
Q ss_pred CeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 471 ~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
.++|+|+.+.||++++..-+=|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 799999999999999988899999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0029 Score=64.14 Aligned_cols=134 Identities=19% Similarity=0.224 Sum_probs=89.3
Q ss_pred cccccccCccceEEEEEEEeCCCcEEEEEEccccC---------h---------h----hHHHHHHHHHHHHhcCCC--C
Q 038345 351 YNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD---------E---------N----NVEQFINEVVILSQINHR--N 406 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~---------~----~~~~~~~E~~~l~~l~h~--n 406 (686)
+.+.++||-|--+-+|.+-..+|++.++|...... + . ..-...+|...|+.|... -
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56778999999999999999999999999422100 0 0 011245688888888532 2
Q ss_pred eeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC
Q 038345 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD 486 (686)
Q Consensus 407 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~ 486 (686)
+++.+++ +..++|||++.+-.|...-+- .+..++.. .+..-+--|-.+ |+||+|..-=||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~---~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYD---DLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHH---HHHHHHHHHHHc---CceecccchheeEEec
Confidence 4444444 456899999988777654321 11222222 222222334444 9999999999999999
Q ss_pred CCcEEEEecCCccc
Q 038345 487 KYRAKVSDFGTSRS 500 (686)
Q Consensus 487 ~~~~kl~DfGla~~ 500 (686)
+..++++||--...
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999975543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.00024 Score=84.24 Aligned_cols=161 Identities=14% Similarity=0.017 Sum_probs=116.5
Q ss_pred HHHHHHHHHhcCCCCeeeEEeEEee--CCcceEEEEeccCCchhhhhhccCCCC-CCCHHHHHHHHHHHHHHHHHhhhcC
Q 038345 392 FINEVVILSQINHRNIVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFYLHSAA 468 (686)
Q Consensus 392 ~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~ 468 (686)
...|...++...|+++.....-... ....+.+++++..|.+...|.+..++. ++...-+...-.+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445555666789888766554432 345688999999999999987654433 3444444444444466666666543
Q ss_pred CC--CeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHH
Q 038345 469 SI--SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546 (686)
Q Consensus 469 ~~--~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ell 546 (686)
.. -.+|+++|+-|.+|..+.++|+.++|+.+.... .........+++.|++|+....-.++.++|+|..+..++++-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 22 367999999999999999999999999983322 222333445788899999988888999999999999999998
Q ss_pred hCCCCCc
Q 038345 547 TGQKPIR 553 (686)
Q Consensus 547 tg~~p~~ 553 (686)
.|..+|.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8887763
|
|
| >KOG4289 consensus Cadherin EGF LAG seven-pass G-type receptor [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.002 Score=74.99 Aligned_cols=64 Identities=27% Similarity=0.790 Sum_probs=47.9
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC---CCcccCCCCCcc--ccccccC-CcceEEeCCCC
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD---VNEFEDPSLNNC--THICDNT-AGNYTCRCPKG 253 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~---~~~c~~~~~~~c--~~~C~~~-~g~~~C~C~~g 253 (686)
.+.|-.+ .|.+++.|..-.+||.|.|.+||+| +.|.- -..|.. .-| .++|.|. .|++.|.||.|
T Consensus 1239 iDlCYs~-pC~nng~C~srEggYtCeCrpg~tG-----ehCEvs~~agrCvp---GvC~nggtC~~~~nggf~c~Cp~g 1308 (2531)
T KOG4289|consen 1239 IDLCYSG-PCGNNGRCRSREGGYTCECRPGFTG-----EHCEVSARAGRCVP---GVCKNGGTCVNLLNGGFCCHCPYG 1308 (2531)
T ss_pred hHhhhcC-CCCCCCceEEecCceeEEecCCccc-----cceeeecccCcccc---ceecCCCEEeecCCCceeccCCCc
Confidence 4566554 8999999998899999999999998 56742 123432 334 3588776 67889999998
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.016 Score=59.50 Aligned_cols=137 Identities=20% Similarity=0.226 Sum_probs=73.9
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
.+.++.|....+|+.. .+++.+.||... ......|..|..-|+.|. --.+++++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578888889999877 568889999765 223356788888888883 456788999988888889999999876
Q ss_pred ch-----------hhhhhc-cCCCC------------------CCCHHHH-----HHHH--------------HHHHHHH
Q 038345 431 TL-----------YQNIHN-HIEEF------------------PITWELL-----LRIA--------------VEVSGAL 461 (686)
Q Consensus 431 sL-----------~~~l~~-~~~~~------------------~l~~~~~-----~~i~--------------~qi~~~L 461 (686)
.. ...||. ..... .-+|... +... .++.+.+
T Consensus 98 ~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~ 177 (288)
T PF03881_consen 98 SPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERL 177 (288)
T ss_dssp ---CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHH
Confidence 11 122343 11110 1233321 1111 1112222
Q ss_pred -HHhhhc-CCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 462 -FYLHSA-ASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 462 -~yLH~~-~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
..|+.. ..+.++|+||-+.|++.+.++.+.|.|
T Consensus 178 ~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~D 212 (288)
T PF03881_consen 178 PSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFD 212 (288)
T ss_dssp HHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S
T ss_pred HHHhcCCCCCceeeEcCccccceeecCCCCceeec
Confidence 123321 245799999999999999998898887
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0007 Score=44.26 Aligned_cols=25 Identities=32% Similarity=0.902 Sum_probs=22.7
Q ss_pred CCCCCCCCccCC-CCceecCCCCccc
Q 038345 189 SCDKSKDNTTTS-SGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~~~~-~~y~C~C~~Gy~g 213 (686)
.|.+++.|+... .+|.|.|++||+|
T Consensus 5 ~C~n~g~C~~~~~~~y~C~C~~G~~G 30 (32)
T PF00008_consen 5 PCQNGGTCIDLPGGGYTCECPPGYTG 30 (32)
T ss_dssp SSTTTEEEEEESTSEEEEEEBTTEES
T ss_pred cCCCCeEEEeCCCCCEEeECCCCCcc
Confidence 799889998766 9999999999998
|
The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.033 Score=58.58 Aligned_cols=73 Identities=18% Similarity=0.177 Sum_probs=48.7
Q ss_pred ccCccceEEEEEEEeCCC-cEEEEEEccc-------cChhhHHHHHHHHHHHHhcC--CC-CeeeEEeEEeeCCcceEEE
Q 038345 356 ILGQGGQGTVYKGMLADG-RIVAVKKSKL-------VDENNVEQFINEVVILSQIN--HR-NIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~lV~ 424 (686)
.||-|...-||++...++ +.|+||.... .-+-..++..-|...|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478999999999997654 6899996322 11233456667788887663 24 45555543 555667999
Q ss_pred EeccCC
Q 038345 425 EFVPNG 430 (686)
Q Consensus 425 e~~~~g 430 (686)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 686 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-46 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-45 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-20 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 9e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 9e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-05 | ||
| 1lmj_A | 86 | Nmr Study Of The Fibrillin-1 Cbegf12-13 Pair Of Ca2 | 1e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1LMJ|A Chain A, Nmr Study Of The Fibrillin-1 Cbegf12-13 Pair Of Ca2+ Binding Epidermal Growth Factor-like Domains Length = 86 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-110
Identities = 111/298 (37%), Positives = 178/298 (59%), Gaps = 5/298 (1%)
Query: 326 LSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD 385
LSS+ ++ DLE+AT+N++ ++G G G VYKG+L DG VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 386 ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH-NHIEEFP 444
+E+F E+ LS H ++V L+G C E +L+Y+++ NG L ++++ + +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV- 503
++WE L I + + L YLH+ A I I+R D+KS NILLD+ + K++DFG S+ T
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA-I-IHR-DVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
DQTHL+T V+GT GY+DPEYF + TEKSDVYSFGVVL E+L + I E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ +++ N +L +++D + + E + A +CL L+ ++RP+M +V ++L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-105
Identities = 105/286 (36%), Positives = 167/286 (58%), Gaps = 4/286 (1%)
Query: 336 TKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVE-QFIN 394
K F+ ++L+ A+DN++ ILG+GG G VYKG LADG +VAVK+ K E QF
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIE-EFPITWELLLRI 453
EV ++S HRN+++L G C+ LLVY ++ NG++ + E + P+ W RI
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
A+ + L YLH I RD+K+ANILLD+++ A V DFG ++ + TH+TT V+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI--RAINIDEDRSLVGYFLQAM 571
GT G++ PEY + + +EK+DV+ +GV+L+E++TGQ+ + D+D L+ + +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E +L ++D + + EE+ + +A C + RP M EV
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-101
Identities = 99/315 (31%), Positives = 168/315 (53%), Gaps = 20/315 (6%)
Query: 325 ELSSNKSSVEKTKLFTSKDLEKATDN------YNANRILGQGGQGTVYKGMLADGRIVAV 378
E S + S + F+ +L+ T+N +G+GG G VYKG + + VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 379 KKSKLVDENNVEQ----FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQ 434
KK + + E+ F E+ ++++ H N+V+LLG + + LVY ++PNG+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 435 NIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494
+ P++W + +IA + + +LH I+ RDIKSANILLD+ + AK+SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIH-RDIKSANILLDEAFTAKISD 176
Query: 495 FGTSRSITV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553
FG +R+ QT +T+++ GT Y+ PE + T KSD+YSFGVVL+EI+TG +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 554 AINIDEDRSLVGYFLQAMNENR-LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612
E + L+ + +E + + + +D + +A+ + + ++A +CL+ RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 613 TMKEVAFELGGIRAS 627
+K+V L + AS
Sbjct: 293 DIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-73
Identities = 65/327 (19%), Positives = 124/327 (37%), Gaps = 41/327 (12%)
Query: 322 LQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKS 381
+ + S V+ +++L + + +G G V+K L VAVK
Sbjct: 1 MGHHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55
Query: 382 KLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFVPNGTLYQNIH 437
+ D+ + Q EV L + H NI++ +G L+ F G+L +
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 438 NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR-------RDIKSANILLDDKYRA 490
+ ++W L IA ++ L YLH RDIKS N+LL + A
Sbjct: 115 AN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 491 KVSDFGTSRSITVDQTHLTTKVQ-GTFGYVDPEYFQSS-----QFTEKSDVYSFGVVLVE 544
++DFG + ++ T Q GT Y+ PE + + + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 545 ILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEI----------M 594
+ + + F + + ++ E + +V+ + +R +
Sbjct: 231 LASRCTAADGPV----DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286
Query: 595 TVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ + C + + + R + V +
Sbjct: 287 MLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 6e-69
Identities = 81/274 (29%), Positives = 123/274 (44%), Gaps = 30/274 (10%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLG 412
+G G GTV++ G VAVK D V +F+ EV I+ ++ H NIV +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
+ +V E++ G+LY+ +H + L +A +V+ + YLH+ + I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
R++KS N+L+D KY KV DFG SR + GT ++ PE + EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEK 219
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
SDVYSFGV+L E+ T Q+P +N Q + A V + +R E
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLN----------PAQVV----------AAVGFKCKRLE 259
Query: 593 I-----MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
I VA + + C RP+ + L
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-68
Identities = 80/284 (28%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
++G+G G V K + VA+K+ + E+ + FI E+ LS++NH NIVKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 415 LETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
L P+ LV E+ G+LY +H T + ++ S + YLHS ++
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 474 RRDIKSANILLDDKYR-AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
RD+K N+LL K+ DFGT+ I QTH+T G+ ++ PE F+ S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREE 592
DV+S+G++L E++T +KP I F + + R
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIG-----------------GPAFRI--MWAVHNGTRPP 224
Query: 593 IMT-----VATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631
++ + +L RC + + RP+M+E+ + + +
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-66
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENN----VEQFINEVVILSQINHRNIVKL 410
I+G GG G VY+ G VAVK ++ + + +E E + + + H NI+ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
G CL+ LV EF G L + + I ++L+ AV+++ + YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 471 SIYRRDIKSANILLDDKYR--------AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
I RD+KS+NIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPE 184
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582
++S F++ SDV+S+GV+L E+LTG+ P R I+ L
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----------GLAVA----------Y 224
Query: 583 LVLKEAEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
V I A L + C N + +RP+ + +L I
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 3e-64
Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 47/287 (16%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENN-------VEQFINEVVILSQINHRN 406
+ +G+GG G V+KG + D +VA+K L D ++F EV I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IVKL G P +V EFVP G LY + + PI W + LR+ ++++ + Y+ +
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 467 AASISIYRRDIKSANILLDDK-----YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
+ I RD++S NI L AKV+DFG S+ H + + G F ++ P
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 522 EYF--QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
E + +TEK+D YSF ++L ILTG+ P + + +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS----------YGKIK-------- 237
Query: 580 LDALVLKEAEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
++ +E R I + + + C + + K RP + EL
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-63
Identities = 57/279 (20%), Positives = 107/279 (38%), Gaps = 41/279 (14%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLG 412
L + G ++KG G + VK K+ F E L +H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 413 CCLETEVPLL--VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
C P + ++P G+LY +H F + ++ A++++ + +LH+ +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 528
I R + S ++++D+ A++S S + +V PE Q
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 529 -FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587
+D++SF V+L E++T + P ++ ++ V E
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLS----------NMEIG----------MKVALE 226
Query: 588 AEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
R I V+ L K C+N + RP + L
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-58
Identities = 64/297 (21%), Positives = 119/297 (40%), Gaps = 43/297 (14%)
Query: 355 RILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
+LG+G G K G ++ +K+ DE F+ EV ++ + H N++K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+ + + E++ GTL I + + W + A +++ + YLH S++I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNII 130
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-------------TKVQGTFGYVD 520
RD+ S N L+ + V+DFG +R + ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580
PE + EK DV+SFG+VL EI+ D D +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------DPD-------YLPRTMDF----- 232
Query: 581 DALVLKEAEREEI-----MTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632
L ++ + + RC +L+ + RP+ ++ L +R + +
Sbjct: 233 -GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-57
Identities = 71/327 (21%), Positives = 125/327 (38%), Gaps = 48/327 (14%)
Query: 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVI 398
+ + DN ++G+G G VYKG L D R VAVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 399 --LSQINHRNIVKLLGCCLETEVP-----LLVYEFVPNGTLYQNIHNHIEEFPITWELLL 451
+ + H NI + + LLV E+ PNG+L + + H W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 452 RIAVEVSGALFYLHSAASISIYR------RDIKSANILLDDKYRAKVSDFGTSR------ 499
R+A V+ L YLH+ + RD+ S N+L+ + +SDFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 500 -SITVDQTHLTTKVQGTFGYVDPEYFQSS-------QFTEKSDVYSFGVVLVEILTGQKP 551
++ + GT Y+ PE + + ++ D+Y+ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 552 IRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEI-----------MTVATLA 600
+ + + F + + FE + LV +E +R + ++
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 601 KRCLNLNGKNRPTMKEVAFELGGIRAS 627
+ C + + + R T + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 5e-56
Identities = 56/282 (19%), Positives = 109/282 (38%), Gaps = 38/282 (13%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLG 412
++G+G G VY G G VA++ + +E+ ++ F EV+ Q H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C+ ++ TLY + + + + +IA E+ + YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITV----DQTHLTTKVQGTFGYVDPEYFQSSQ 528
+D+KS N+ D+ + ++DFG V + G ++ PE +
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 529 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
F++ SDV++ G + E+ + P + + + M +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTGMKPNL 263
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ KE ++ + C + RPT ++ L
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-55
Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 43/282 (15%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLG 412
+ +G G GTVYKG G VAVK + ++ F NEV +L + H NI+ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 413 CCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS 471
T L +V ++ +LY ++H E + L+ IA + + + YLH+ S
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ-THLTTKVQGTFGYVDPE---YFQSS 527
I RD+KS NI L + K+ DFG + + +H ++ G+ ++ PE S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587
++ +SDVY+FG+VL E++TGQ P IN + Q + +V +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---------QII----------EMVGRG 241
Query: 588 AEREEIMT--------VATLAKRCLNLNGKNRPTMKEVAFEL 621
+ ++ + L CL RP+ + E+
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-52
Identities = 63/298 (21%), Positives = 111/298 (37%), Gaps = 45/298 (15%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVI--LSQINHRNIVKLLG 412
+G+G G V++G G VAVK DE + E + + H NI+ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 413 CCLETEVP----LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+ + L+ + G+LY + + LRI + ++ L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 469 SISIYR-----RDIKSANILLDDKYRAKVSDFGTSR----SITVDQTHLTTKVQGTFGYV 519
+ + RD+KS NIL+ + ++D G + S +V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 520 DPE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573
PE ++ D+++FG+VL E+ R ++ F +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-----RMVSNGIVEDYKPPFYDVVPN 239
Query: 574 NRLFEVLDALVLKEAEREEI----------MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ FE + +V + +R I ++A L K C N R T + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-51
Identities = 61/306 (19%), Positives = 111/306 (36%), Gaps = 49/306 (16%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINE--VVILSQINHRNIVKLLG 412
+ +G+G G V+ G G VAVK +E + E + + H NI+ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 413 CCLETEVP----LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
++ L+ ++ NG+LY + + + + +L++A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 469 SISIYR-----RDIKSANILLDDKYRAKVSDFGTSR---SITVDQTHLTTKVQGTFGYVD 520
+ + RD+KS NIL+ ++D G + S T + GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 521 PE------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY---FLQAM 571
PE Q +D+YSFG++L E+ + Y + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE--------EYQLPYHDLV 266
Query: 572 NENRLFEVLDALVLKEAEREEI----------MTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ +E + +V + R + L C N +R T V L
Sbjct: 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326
Query: 622 GGIRAS 627
+ S
Sbjct: 327 AKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 8e-50
Identities = 64/307 (20%), Positives = 118/307 (38%), Gaps = 43/307 (14%)
Query: 356 ILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINE--VVILSQINHRNIVKLLGC 413
+G+G G V++G G VAVK + E + + H NI+ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 414 CLETEVP----LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
+ LV ++ +G+L+ ++ + +T E ++++A+ + L +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 470 ISIYR-----RDIKSANILLDDKYRAKVSDFGTSR---SITVDQTHLTTKVQGTFGYVDP 521
+ + RD+KS NIL+ ++D G + S T GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 522 E------YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
E + + +++D+Y+ G+V EI I ED L Y L + +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI---GGIHEDYQLPYYDLVPSDPS- 276
Query: 576 LFEVLDALVLKEAEREEI----------MTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
E + +V ++ R I +A + + C NG R T + L +
Sbjct: 277 -VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 626 ASIGASI 632
G +
Sbjct: 336 QQEGIKM 342
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-46
Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 39/284 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
++Y +G G G K +DG+I+ K+ + E + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 406 NIVKLLGCCLETEVPLL--VYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALF 462
NIV+ ++ L V E+ G L I +E + E +LR+ +++ AL
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 463 YLHS--AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
H ++ RD+K AN+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580
PE + EKSD++S G +L E+ P A + E
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------------------- 223
Query: 581 DALVLK--EAEREEIMT-----VATLAKRCLNLNGKNRPTMKEV 617
L K E + I + + R LNL +RP+++E+
Sbjct: 224 --LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK---SKLVDENNVEQFINEVVILSQINH 404
N+ + +G+G VY+ L DG VA+KK L+D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALFY 463
N++K +E +V E G L + I + ++ I + + V++ AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
+HS + RDIK AN+ + K+ D G R + T + V GT Y+ PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+ + KSD++S G +L E+ Q P ++ MN L +L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--------------FYGDKMN-------LYSL 246
Query: 584 VLK--EAEREEIMT------VATLAKRCLNLNGKNRPTMKEV 617
K + + + + + L C+N + + RP + V
Sbjct: 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 60/276 (21%), Positives = 112/276 (40%), Gaps = 32/276 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
+ Y + +G+G G DGR +K+ + + E+ EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNI----HNHIEEFPITWELLLRIAVEVSGAL 461
NIV+ E +V ++ G L++ I +E + +L V++ AL
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-----DQILDWFVQICLAL 138
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
++H I RDIKS NI L ++ DFG +R + + GT Y+ P
Sbjct: 139 KHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSP 194
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
E ++ + KSD+++ G VL E+ T + A ++ L + F +
Sbjct: 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFPPVS 246
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ + +L + N ++RP++ +
Sbjct: 247 LHYSYD--------LRSLVSQLFKRNPRDRPSVNSI 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLV-DENNVEQFINEVVILSQINHRN 406
Y LG GG TVY VA+K E +++F EV SQ++H+N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IV ++ E + LV E++ TL + I P++ + + ++ + + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIK NIL+D K+ DFG +++++ T V GT Y PE +
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKP 551
E +D+YS G+VL E+L G+ P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 65/302 (21%), Positives = 121/302 (40%), Gaps = 57/302 (18%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
++ +LGQG G V K D R A+KK + E + ++EV++L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 407 IVKLLGCCLETEVPL-------------LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI 453
+V+ LE + + E+ NGTLY IH+ + R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYWRL 121
Query: 454 AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT----------- 502
++ AL Y+HS I RD+K NI +D+ K+ DFG ++++
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 503 ---VDQTHLTTKVQGTFGYVDPEYFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINID 558
+LT+ + GT YV E + + EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------- 227
Query: 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIM---TVATLAKRCLNLNGKNRPTMK 615
F M + + L ++ ++ + + + ++ + RP +
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279
Query: 616 EV 617
+
Sbjct: 280 TL 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-40
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 48/286 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
++ ++G GG G V+K DG+ +K+ K +E EV L++++H NI
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK----AEREVKALAKLDHVNI 66
Query: 408 VKLLGCCLETEVPL----------------LVYEFVPNGTLYQNIHNHIEEFPITWELLL 451
V GC + + EF GTL Q I E + L L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK 511
+ +++ + Y+HS + RD+K +NI L D + K+ DFG S+ D +K
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 512 VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571
GT Y+ PE S + ++ D+Y+ G++L E+L A
Sbjct: 183 --GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AF 222
Query: 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
++ F L ++ + ++ TL ++ L+ ++RP E+
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKE---KTLLQKLLSKKPEDRPNTSEI 265
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 76/295 (25%), Positives = 116/295 (39%), Gaps = 42/295 (14%)
Query: 355 RILGQGGQGTVYKGML-----ADGRIVAVKKSK-LVDENNVEQFINEVVILSQINHRNIV 408
R LG+G G V G +VAVK K + + E+ IL + H +I+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 409 KLLGCCLETEVP--LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
K GCC + LV E+VP G+L + H I LL A ++ + YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYF 524
I RD+ + N+LLD+ K+ DFG ++++ + + G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 525 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
+ +F SDV+SFGV L E+LT + + M RL E
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTE----- 262
Query: 584 VLKEAEREE-----------IMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
+L+ ER +M K C RPT + + L +
Sbjct: 263 LLERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKTVHEK 311
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 8/228 (3%)
Query: 328 SNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDE 386
S +S+ E + + D +LG+G G VY G L++ +A+K+ D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 387 NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPIT 446
+ E+ + + H+NIV+ LG E + E VP G+L + +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQ 505
+ + ++ L YLH I RDIK N+L++ K+SDFGTS+ +
Sbjct: 121 EQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 506 THLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 551
T GT Y+ PE + + +D++S G ++E+ TG+ P
Sbjct: 178 PCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-39
Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 35/280 (12%)
Query: 355 RILGQGGQGTVYKGMLADGRI-VAVKKSK-LVDENNVEQFINEVVILSQINHRNIVKLLG 412
+G+G G V+ G L VAVK + + + +F+ E IL Q +H NIV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C + + +V E V G + + + LL++ + + + YL S I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI-- 235
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 530
RD+ + N L+ +K K+SDFG SR D + + PE +++
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 531 EKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVL 585
+SDV+SFG++L E + G P ++ + R V G L + +F
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF-------- 345
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
+M +C RP+ + EL IR
Sbjct: 346 ------RLME------QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 59/294 (20%), Positives = 111/294 (37%), Gaps = 46/294 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRN 406
++ + LG+GG G V++ D A+K+ +L + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 407 IVKLLGCCLE---------TEVPLLVY---EFVPNGTLYQNIHNHIEEFPITWELLLRIA 454
IV+ LE + + +Y + L ++ + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ- 513
++++ A+ +LHS + RD+K +NI KV DFG ++ D+ T
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 514 ----------GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
GT Y+ PE + ++ K D++S G++L E+L
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------------- 225
Query: 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
F M R + L ++ + + L+ + RP +
Sbjct: 226 --PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 39/288 (13%)
Query: 355 RILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK 409
LG+G G+V G +VAVK+ + + F E+ IL ++ IVK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 410 LLGCCLET-EVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
G L LV E++P+G L + H + LL + ++ + YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSR 146
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQ 525
+ RD+ + NIL++ + K++DFG ++ + +D+ + + G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+ F+ +SDV+SFGVVL E+ T K E ++G +RL E +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLE-----L 256
Query: 585 LKEAER---------E--EIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
L+E +R E E+M K C + ++RP+ + +L
Sbjct: 257 LEEGQRLPAPPACPAEVHELM------KLCWAPSPQDRPSFSALGPQL 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 36/294 (12%)
Query: 355 RILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK 409
+ LG+G G+V G +VAVKK + E ++ F E+ IL + H NIVK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 410 LLGCCLET-EVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
G C L L+ E++P G+L + H E LL+ ++ + YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 164
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQ 525
I RD+ + NIL++++ R K+ DFG ++ + D+ + K G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
S+F+ SDV+SFGVVL E+ T + ++ + R + M L E +L
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LL 276
Query: 586 KEAER-----------EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628
K R IM C N N RP+ +++A + IR +
Sbjct: 277 KNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 36/296 (12%)
Query: 355 RILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK 409
+ LG+G G+V G +VAVKK + E ++ F E+ IL + H NIVK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 410 LLGCCLET-EVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
G C L L+ E++P G+L + H E LL+ ++ + YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 133
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQ 525
I RD+ + NIL++++ R K+ DFG ++ + D+ K G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
S+F+ SDV+SFGVVL E+ T + ++ + R + M L E +L
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE-----LL 245
Query: 586 KEAER-----------EEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630
K R IM C N N RP+ +++A + IR ++
Sbjct: 246 KNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQIRDNMAG 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 74/323 (22%), Positives = 138/323 (42%), Gaps = 52/323 (16%)
Query: 354 NRILGQGGQGTVYKGMLADG----RIVAVK--KSKLVDENNVEQFINEVVILSQINHRNI 407
R+LG+G G+V + L VAVK K+ ++ +++E+F+ E + + +H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 408 VKLLGCCLETE------VPLLVYEFVPNGTL--Y-QNIHNHIEEFPITWELLLRIAVEVS 458
KL+G L + +P+++ F+ +G L + F + + L+R V+++
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
+ YL +S + RD+ + N +L + V+DFG SR I + QG
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 519 V-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQA 570
+ E + +T SDV++FGV + EI+T GQ P I E + + G L+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 571 MNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628
E ++ ++M +C + + K RP+ + EL I +
Sbjct: 261 PPECMEEVY--------------DLM------YQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 629 GASILQQNCGVIDCVNGDISEHY 651
Q+ I+ H+
Sbjct: 301 SVLSTSQDPLYINIERAHHHHHH 323
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 63/288 (21%), Positives = 125/288 (43%), Gaps = 56/288 (19%)
Query: 355 RILGQGGQGTVYKGMLADGR-----IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIV 408
++LG G GTVYKG+ VA+K+ + ++ ++E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG CL + V L+ + +P G L + H + + LL V+++ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---FGYVDPEYFQ 525
+ RD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+T +SDV+S+GV + E++T G KP Y + E+
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP--------------Y--DGIP-AS--EISSI-- 231
Query: 585 LKEAEREE-----------IMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
L++ ER IM +C ++ +RP +E+ E
Sbjct: 232 LEKGERLPQPPICTIDVYMIMR------KCWMIDADSRPKFRELIIEF 273
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 60/274 (21%), Positives = 115/274 (41%), Gaps = 36/274 (13%)
Query: 354 NRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKL 410
+ +G+G TVYKG+ VA + + ++ ++F E +L + H NIV+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 411 LGCCLETEVP----LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
T +LV E + +GTL + + ++L ++ L +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 467 AASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
I+ RD+K NI + K+ D G + T+ + V GT ++ PE ++
Sbjct: 148 RTPPIIH-RDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE 203
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR---LFEVLDA 582
++ E DVY+FG+ ++E+ T + P E ++ + + + + +V
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
V +E I C+ N R ++K+
Sbjct: 258 EV-----KEIIE-------GCIRQNKDERYSIKD 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 355 RILGQGGQGTVYKGMLA-----DGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIV 408
R LG+G G V G VAVK K N++ E+ IL + H NIV
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 409 KLLGCCLETEV-PL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
K G C E + L+ EF+P+G+L + + + + + L+ AV++ + YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ--QLKYAVQICKGMDYLGS 144
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYF 524
+ RD+ + N+L++ +++ K+ DFG +++I D+ + T K + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 525 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
S+F SDV+SFGV L E+LT + + + M RL
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVN----- 254
Query: 584 VLKEAEREE-----------IMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
LKE +R +M ++C NR + + +
Sbjct: 255 TLKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGF 297
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 351 YNANRILGQGGQGTVYKGMLAD---GRIVAVK--KSKLV-DENNVEQFINEVVILSQINH 404
Y ILG GG V+ D R VAVK ++ L D + +F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 405 RNIVKLL--GC--CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
IV + G +P +V E+V TL +H E P+T + + + + A
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQA 128
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT--KVQGTFGY 518
L + H I RD+K ANI++ KV DFG +R+I +T V GT Y
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ PE + +SDVYS G VL E+LTG+ P
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 18/209 (8%)
Query: 351 YNANRILGQGGQGTVYKGMLAD---GRIVAVK--KSKLV-DENNVEQFINEVVILSQINH 404
Y R++G+GG G VY+ D RIVA+K L D + E ++
Sbjct: 36 YRLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
++V + + + L + + P+ + I ++ AL
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAA 150
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT--KVQGTFGYVDPE 522
H+A RD+K NIL+ A + DFG + + LT GT Y+ PE
Sbjct: 151 HAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPE 205
Query: 523 YFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
F S T ++D+Y+ VL E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-37
Identities = 75/273 (27%), Positives = 126/273 (46%), Gaps = 31/273 (11%)
Query: 355 RILGQGGQGTVYKGMLADGRI-VAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
C ++ EF+ G L + ++ +LL +A ++S A+ YL I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 340
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
R++ + N L+ + + KV+DFG SR +T D + + PE ++F+ KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 534 DVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLKEA 588
DV++FGV+L EI T G P I++ + L+ Y ++ +++
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY----------- 449
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
E+M + C N +RP+ E+
Sbjct: 450 ---ELM------RACWQWNPSDRPSFAEIHQAF 473
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ LG G G V G VAVK K + ++F E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ +V E++ NG L + +H + + LL + +V + +L S I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ--LLEMCYDVCEGMAFLESHQFI---H 127
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 532
RD+ + N L+D KVSDFG +R + DQ + V F PE F +++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 533 SDVYSFGVVLVEILT-GQKP 551
SDV++FG+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVKKSK-LVDENNVEQFINEVVILSQINHRNIVK 409
++G+G G VY G L D AVK + D V QF+ E +I+ +H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 410 LLGCCLETEVPLL-VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
LLG CL +E L V ++ +G L I N T + L+ ++V+ + +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL---A 209
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD---PEYFQ 525
S RD+ + N +LD+K+ KV+DFG +R + + G V E Q
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ +FT KSDV+SFGV+L E++T G P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 354 NRILGQGGQGTVYKGMLADGR----IVAVK--KSKLVDENNVEQFINEVVILSQINHRNI 407
+ILG+G G+V +G L VAVK K + +E+F++E + +H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 408 VKLLGCCLETE-----VPLLVYEFVPNGTL--Y-QNIHNHIEEFPITWELLLRIAVEVSG 459
++LLG C+E P+++ F+ G L Y I + LL+ V+++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
+ YL ++ + RD+ + N +L D V+DFG S+ I + QG +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 520 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
E +T KSDV++FGV + EI T G P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVKKSK-LVDENNVEQFINEVVILSQINHRNIVK 409
++G+G G VY G L D AVK + D V QF+ E +I+ +H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 410 LLGCCLETEVPLL-VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
LLG CL +E L V ++ +G L I N T + L+ ++V+ + YL A
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKYL---A 145
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD---PEYFQ 525
S RD+ + N +LD+K+ KV+DFG +R + + + G V E Q
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ +FT KSDV+SFGV+L E++T G P
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 75/291 (25%), Positives = 120/291 (41%), Gaps = 59/291 (20%)
Query: 355 RILGQGGQGTVYKGML--ADGRI--VAVKKSK---LVDENNVEQFINEVVILSQINHRNI 407
LG G G V +G G+ VAVK K L ++ FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 408 VKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
++L G L P+ +V E P G+L + H F + L R AV+V+ + YL S
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYF 524
I RD+ + N+LL + K+ DFG R++ + H + + PE
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 525 QSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
++ F+ SD + FGV L E+ T GQ+P + +N ++L +
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP--------------W--IGLN-GS--QILHKI 237
Query: 584 VLKEAERE-------------EIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ E E +M +C ++RPT + L
Sbjct: 238 ---DKEGERLPRPEDCPQDIYNVM------VQCWAHKPEDRPTFVALRDFL 279
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-37
Identities = 60/206 (29%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 354 NRILGQGGQGTVYKGMLADGRI---VAVK--KSKLVDENNVEQFINEVVILSQINHRNIV 408
++ LG G GTV KG ++ VAVK K++ D ++ + E ++ Q+++ IV
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+++G C E +LV E G L + + + + + ++ + +VS + YL +
Sbjct: 82 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQS 526
+ RD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKP 551
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 67/317 (21%), Positives = 122/317 (38%), Gaps = 34/317 (10%)
Query: 328 SNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDE 386
+ SS + F + +Y + LG+GG V L DG A+K+ ++
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ 67
Query: 387 NNVEQFINEVVILSQINHRNIVKLLGCCLETEVP----LLVYEFVPNGTLYQNIHNHIEE 442
+ E+ E + NH NI++L+ CL L+ F GTL+ I ++
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 443 -FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-- 499
+T + +L + + + L +H+ RD+K NILL D+ + + D G+
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184
Query: 500 SITVDQTHLTTKVQ------GTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQK 550
I V+ + +Q T Y PE F E++DV+S G VL ++ G+
Sbjct: 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 551 PIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKN 610
P + G + +N+L + L + ++
Sbjct: 245 PY------DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ--------LLNSMMTVDPHQ 290
Query: 611 RPTMKEVAFELGGIRAS 627
RP + + +L ++
Sbjct: 291 RPHIPLLLSQLEALQPP 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 50/207 (24%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 355 RILGQGGQGTVYKGMLADGR-----IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIV 408
++LG G GTVYKG+ VA+K+ + ++ ++E +++ +++ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG CL L+ + +P G L + H + + LL V+++ + YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---FGYVDPEYFQ 525
+ RD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESIL 192
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+T +SDV+S+GV + E++T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
LE LV EF+ +G L + F LL + ++V + YL A I
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET--LLGMCLDVCEGMAYLEEACVI---H 127
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 532
RD+ + N L+ + KVSDFG +R + DQ T+ F PE F S+++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 533 SDVYSFGVVLVEILT-GQKP 551
SDV+SFGV++ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 355 RILGQGGQGTVYKGMLADGR-----IVAVKKSK-LVDENNVEQFINEVVILSQINHRNIV 408
++LG G GTV+KG+ V +K + + + + ++ + ++H +IV
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+LLG C LV +++P G+L ++ H +LLL V+++ ++YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG 135
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---FGYVDPEYFQ 525
+ R++ + N+LL + +V+DFG + + D ++ E
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ--LLYSEAKTPIKWMALESIH 190
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
++T +SDV+S+GV + E++T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVKKSK-LVDENNVEQFINEVVILSQINHRNIVK 409
R++G+G G VY G D A+K + + VE F+ E +++ +NH N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 410 LLGCCLETE-VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
L+G L E +P ++ ++ +G L Q I + + L+ ++V+ + YL A
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYL---A 141
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD---PEYFQ 525
RD+ + N +LD+ + KV+DFG +R I + + + + V E Q
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVL 580
+ +FT KSDV+SFGV+L E+LT G P R I+ + + G L + L+
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY--- 258
Query: 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
++M +C + RPT + + E+
Sbjct: 259 -----------QVMQ------QCWEADPAVRPTFRVLVGEV 282
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 415 LETEVPLL-VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
T+ P+ + E++ NG+L + +T LL +A +++ + ++ I
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYI--- 131
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 531
RD+++ANIL+ D K++DFG +R I ++ T + F PE FT
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTI 189
Query: 532 KSDVYSFGVVLVEILT-GQKP 551
KSDV+SFG++L EI+T G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-36
Identities = 71/316 (22%), Positives = 135/316 (42%), Gaps = 33/316 (10%)
Query: 312 KFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA 371
++ ++ L + + +S +T+ E ++ LGQG G V+ G
Sbjct: 147 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 206
Query: 372 DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNG 430
VA+K K + E F+ E ++ ++ H +V+L +E P+ +V E++ G
Sbjct: 207 GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 263
Query: 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490
+L + ++ + L+ +A +++ + Y+ + RD+++ANIL+ +
Sbjct: 264 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 319
Query: 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 549
KV+DFG +R I ++ + + PE +FT KSDV+SFG++L E+ T G+
Sbjct: 320 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379
Query: 550 KPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLN 605
P + E V GY + E L ++M +C
Sbjct: 380 VPYPGMVNREVLDQVERGYRMPCPPECPESLH--------------DLM------CQCWR 419
Query: 606 LNGKNRPTMKEVAFEL 621
+ RPT + + L
Sbjct: 420 KEPEERPTFEYLQAFL 435
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ LG G G V G VA+K K + ++FI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYR 474
+ ++ E++ NG L + F LL + +V A+ YL S +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ--LLEMCKDVCEAMEYLESKQFL---H 143
Query: 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTEK 532
RD+ + N L++D+ KVSDFG SR + D+ T+ V F PE S+F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 533 SDVYSFGVVLVEILT-GQKP 551
SD+++FGV++ EI + G+ P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-36
Identities = 71/316 (22%), Positives = 135/316 (42%), Gaps = 33/316 (10%)
Query: 312 KFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA 371
++ ++ L + + +S +T+ E ++ LGQG G V+ G
Sbjct: 230 AYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWN 289
Query: 372 DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNG 430
VA+K K + E F+ E ++ ++ H +V+L +E P+ +V E++ G
Sbjct: 290 GTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKG 346
Query: 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490
+L + ++ + L+ +A +++ + Y+ + RD+++ANIL+ +
Sbjct: 347 SLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVGENLVC 402
Query: 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQ 549
KV+DFG +R I ++ + + PE +FT KSDV+SFG++L E+ T G+
Sbjct: 403 KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462
Query: 550 KPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLN 605
P + E V GY + E L ++M +C
Sbjct: 463 VPYPGMVNREVLDQVERGYRMPCPPECPESLH--------------DLM------CQCWR 502
Query: 606 LNGKNRPTMKEVAFEL 621
+ RPT + + L
Sbjct: 503 KEPEERPTFEYLQAFL 518
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 17/225 (7%)
Query: 331 SSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVE 390
SV F + +G+G G V G G VAVK K ++ +
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQ 59
Query: 391 QFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWEL 449
F+ E +++Q+ H N+V+LLG +E + L +V E++ G+L + + + +
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDC 118
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
LL+ +++V A+ YL + RD+ + N+L+ + AKVSDFG ++ + +
Sbjct: 119 LLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------S 169
Query: 510 TKVQGTFGY--VDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
T+ G PE + +F+ KSDV+SFG++L EI + G+ P
Sbjct: 170 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 60/302 (19%), Positives = 103/302 (34%), Gaps = 40/302 (13%)
Query: 325 ELSSNKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSK 382
S ++ + E ++ LG G G V+K DGR+ AVK+S
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSM 91
Query: 383 L--VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH 439
+ + + EV ++ H V+L E + L E +L Q+
Sbjct: 92 SPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW 150
Query: 440 IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499
P + + AL +LHS + D+K ANI L + R K+ DFG
Sbjct: 151 GASLPE--AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV 205
Query: 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ + G Y+ PE Q + +DV+S G+ ++E+ +
Sbjct: 206 ELGTAGAGEVQE--GDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL-------- 254
Query: 560 DRSLVGYF----LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615
Q + + L A + E ++ L + K R T +
Sbjct: 255 ------PHGGEGWQQLRQGYLPPEFTAGLSSELR--------SVLVMMLEPDPKLRATAE 300
Query: 616 EV 617
+
Sbjct: 301 AL 302
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 355 RILGQGGQGTVYKGMLADGRI-VAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGC 413
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
C ++ EF+ G L + ++ +LL +A ++S A+ YL I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 133
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 531
RD+ + N L+ + + KV+DFG SR +T D T F PE ++F+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 532 KSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLK 586
KSDV++FGV+L EI T G P I++ + L+ Y ++ +++
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY--------- 242
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
E+M C N +RP+ E+
Sbjct: 243 -----ELMR------ACWQWNPSDRPSFAEIHQAF 266
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-36
Identities = 55/290 (18%), Positives = 106/290 (36%), Gaps = 49/290 (16%)
Query: 351 YNANRILGQGGQGTVYKG--MLADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNI 407
Y + GG G +Y +GR V +K D + E L+++ H +I
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 408 VKLL-----GCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
V++ V +V E+V +L ++ + + +E+ AL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALS 196
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
YLH + + +Y D+K NI+L ++ + K+ D G I + GT G+ PE
Sbjct: 197 YLH-SIGL-VYN-DLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPE 247
Query: 523 YFQ-SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
+ T +D+Y+ G L + +D + ++
Sbjct: 248 --IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVL-------KTYDSYG 298
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIRASIGA 630
L+ R ++ + + R T +E++ +L G+ + A
Sbjct: 299 RLLR----------------RAIDPDPRQRFTTAEEMSAQLTGVLREVVA 332
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-36
Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 357 LGQGGQGTVYKGML--ADGRI-VAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLG 412
LG G G+V +G+ +I VA+K K ++ + E+ + E I+ Q+++ IV+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C + +LV E G L++ + EE + + +VS + YL +
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 132
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF--GYVDPEYFQSSQFT 530
RD+ + N+LL +++ AK+SDFG S+++ D ++ T + G + + PE +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 531 EKSDVYSFGVVLVEILT-GQKP 551
+SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-36
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ +G+G G V G G VAVK K ++ + F+ E +++Q+ H N+V+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 415 LETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+E + L +V E++ G+L + + + + LL+ +++V A+ YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV--- 311
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 531
RD+ + N+L+ + AKVSDFG ++ + +T+ G PE + +F+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 365
Query: 532 KSDVYSFGVVLVEILT-GQKP 551
KSDV+SFG++L EI + G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-36
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 20/238 (8%)
Query: 322 LQQELSSNKSSVEKTKLF-TSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK 379
L E N+ + KL + + +G+G G V++ G AVK
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 380 KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH 439
K V E+V + ++ IV L G E + E + G+ +
Sbjct: 90 K---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS----LGQL 140
Query: 440 IEEF-PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGT 497
I++ + + L + L YLH+ I D+K+ N+LL RA + DFG
Sbjct: 141 IKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197
Query: 498 SRSITVDQTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ + D + + GT ++ PE K D++S +++ +L G P
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 64/205 (31%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 355 RILGQGGQGTVYKGML---ADGRI-VAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
+I+G G G V G L + VA+K K E F++E I+ Q +H NI++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L G + ++V E++ NG+L + H +F T L+ + V + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSS 527
+ RD+ + N+L+D KVSDFG SR + D T G PE
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKP 551
F+ SDV+SFGVV+ E+L G++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 51/292 (17%)
Query: 354 NRILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQINHRN 406
+R LGQG G VY+G+ VA+K +F+NE ++ + N +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQ-------NIHNHIEEFPITWELLLRIAVEVSG 459
+V+LLG + + L++ E + G L + N+ P + ++++A E++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
+ YL + RD+ + N ++ + + K+ DFG +R I + +G G +
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 520 -----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAM 571
PE + FT SDV+SFGVVL EI T ++P + ++ ++ V G L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 572 NE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ + LF E+M + C N K RP+ E+ +
Sbjct: 263 DNCPDMLF--------------ELM------RMCWQYNPKMRPSFLEIISSI 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 61/312 (19%), Positives = 118/312 (37%), Gaps = 42/312 (13%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVK--- 379
SS + F S ++ Y+ + +G GG V++ + +I A+K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 380 KSKLVDENNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYEFVPNGTLYQNIH 437
+ D ++ + NE+ L+++ + I++L + + +V E N L +
Sbjct: 62 LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK 119
Query: 438 NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497
+ + A+ +H I D+K AN L+ D K+ DFG
Sbjct: 120 KK-KSIDP--WERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 498 SRSITVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLVEI 545
+ + D T + Q GT Y+ PE + + + KSDV+S G +L +
Sbjct: 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
Query: 546 LTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLN 605
G+ P + + + ++ N E + K+ + + K CL
Sbjct: 233 TYGKTP-----FQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQD--------VLKCCLK 278
Query: 606 LNGKNRPTMKEV 617
+ K R ++ E+
Sbjct: 279 RDPKQRISIPEL 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
R LG+G G V+ + +VAVK K + F E +L+ + H +IV
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 409 KLLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITWELLLRIAV 455
K G C + + ++V+E++ +G L + + + +L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
+++ + YL AS RD+ + N L+ K+ DFG SR + + +V G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 516 FGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ PE +FT +SDV+SFGV+L EI T G++P
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 355 RILGQGGQGTVYKGMLADGRI----VAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
RILG+G G VY+G+ + + VAVK K +N E+F++E VI+ ++H +IVK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L+G E E ++ E P G L + + + L+ ++++ A+ YL S
Sbjct: 78 LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINC 134
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT---FGYVDPEYFQS 526
+ RDI NIL+ K+ DFG SR I + K T ++ PE
Sbjct: 135 V---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINF 188
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+ F V + EIL+ G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 16/207 (7%)
Query: 355 RILGQGGQGTVYKGMLADGRI-----VAVK--KSKLVDENNVEQFINEVVILSQINHRNI 407
+++G G G VYKGML VA+K K+ ++ V+ F+ E I+ Q +H NI
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
++L G + + +++ E++ NG L + + EF + L+ + ++ + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLVGMLRGIAAGMKYLANM 166
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQ 525
+ RD+ + NIL++ KVSDFG SR + D T G PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 526 SSQFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+SFG+V+ E++T G++P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 61/314 (19%), Positives = 118/314 (37%), Gaps = 41/314 (13%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDN---YNANRILGQGGQGTVYKGMLADGRIVAVK 379
+Q + S + +S E + Y+ + +G GG V++ + +I A+K
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 380 KSKL--VDENNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFVPNGTLYQN 435
L D ++ + NE+ L+++ I++L + + +V E N L
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSW 145
Query: 436 IHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495
+ + + A+ +H I D+K AN L+ D K+ DF
Sbjct: 146 LKKK-KSIDP--WERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDF 198
Query: 496 GTSRSITVDQTHLTTKVQ-GTFGYVDPEYFQSS-----------QFTEKSDVYSFGVVLV 543
G + + D T + Q G Y+ PE + + + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258
Query: 544 EILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRC 603
+ G+ P + + + ++ N E + K+ + + K C
Sbjct: 259 YMTYGKTP-----FQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQD--------VLKCC 304
Query: 604 LNLNGKNRPTMKEV 617
L + K R ++ E+
Sbjct: 305 LKRDPKQRISIPEL 318
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 14/225 (6%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEV 396
+ + + +++ +LG+G VY+ + G VA+K K + V++ NEV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 397 VILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLR-IA 454
I Q+ H +I++L E + LV E NG + + + N ++ F E R
Sbjct: 63 KIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFM 118
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG 514
++ + YLHS I RD+ +N+LL K++DFG + + + T + G
Sbjct: 119 HQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCG 174
Query: 515 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
T Y+ PE S +SDV+S G + +L G+ P +
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/230 (24%), Positives = 97/230 (42%), Gaps = 25/230 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 405 RNIVKLLGC--CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
+NIVKL T +L+ EF P G+LY + + + L + +V G +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 463 YLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
+L I R+IK NI+ D + K++DFG +R + D + GT Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 519 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
+ P+ ++ + ++ D++S GV TG P R
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR 231
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-34
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 355 RILGQGGQGTVYKGML----ADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
+++G G G V G L VA+K K+ E F+ E I+ Q +H NI++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L G +++ ++V E++ NG+L + H +F T L+ + ++ + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGY 168
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSS 527
+ RD+ + NIL++ KVSDFG R + D T G PE
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKP 551
+FT SDV+S+G+VL E+++ G++P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
LG+G G V+ + +VAVK K E+ + F E +L+ + H++IV
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 409 KLLGCCLETEVPLLVYEFVPNGTL------------YQNIHNHIEEFPITWELLLRIAVE 456
+ G C E L+V+E++ +G L + P+ LL +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
V+ + YL A + RD+ + N L+ K+ DFG SR I +V G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219
Query: 517 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ PE +FT +SDV+SFGVVL EI T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 64/218 (29%), Positives = 96/218 (44%), Gaps = 19/218 (8%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVSGAL 461
NI++L G + L+ E+ P GT+Y+ + + +E + E++ AL
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITELANAL 122
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
Y H S + RDIK N+LL K++DFG S GT Y+ P
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL--CGTLDYLPP 176
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
E + EK D++S GV+ E L G+ P A E
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 70/275 (25%), Positives = 118/275 (42%), Gaps = 37/275 (13%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+ LG G G V+ VAVK K +VE F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 415 LETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
T+ P+ ++ EF+ G+L + + E L+ + +++ + ++ I
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306
Query: 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFTE 531
RD+++ANIL+ K++DFG +R I ++ T + F PE FT
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 532 KSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLK 586
KSDV+SFG++L+EI+T G+ P ++ E + GY + L+
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY--------- 415
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
IM RC + RPT + + L
Sbjct: 416 -----NIM------MRCWKNRPEERPTFEYIQSVL 439
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-34
Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 357 LGQGGQGTVYKGML--ADGRI-VAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLG 412
LG G G+V +G+ +I VA+K K ++ + E+ + E I+ Q+++ IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISI 472
C + +LV E G L++ + EE P + + +VS + YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY--VDPEYFQSSQFT 530
R++ + N+LL +++ AK+SDFG S+++ D ++ T + G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 531 EKSDVYSFGVVLVEILT-GQKP 551
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 72/320 (22%), Positives = 128/320 (40%), Gaps = 89/320 (27%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQINHRNI 407
+ LG+G G V K + VAVK K + + ++E +L Q+NH ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTL---------------------YQNIHNHIEEFPIT 446
+KL G C + LL+ E+ G+L + +H +E +T
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506
L+ A ++S + YL A + + RD+ + NIL+ + + K+SDFG SR +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV----- 200
Query: 507 HLTTKVQGTFGYVDPEYFQSSQ-----------------FTEKSDVYSFGVVLVEILT-G 548
Y + Y + SQ +T +SDV+SFGV+L EI+T G
Sbjct: 201 -----------YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 549 QKPIRAINIDEDRSLV--GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCL 604
P I + +L+ G+ ++ + ++ +M +C
Sbjct: 250 GNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY--------------RLM------LQCW 289
Query: 605 NLNGKNRPTMKEVAFELGGI 624
RP +++ +L +
Sbjct: 290 KQEPDKRPVFADISKDLEKM 309
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 12/203 (5%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVK 409
R +G+G G V++G+ VA+K K ++ E+F+ E + + Q +H +IVK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
L+G E ++ E G L + + L+ A ++S AL YL S
Sbjct: 81 LIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKRF 137
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF 529
+ RDI + N+L+ K+ DFG SR + + +K + ++ PE +F
Sbjct: 138 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 530 TEKSDVYSFGVVLVEILT-GQKP 551
T SDV+ FGV + EIL G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 81/309 (26%), Positives = 121/309 (39%), Gaps = 72/309 (23%)
Query: 355 RILGQGGQGTVYKGMLAD------GRIVAVKKSK-LVDENNVEQFINEVVILSQI-NHRN 406
+ LG+G G V + R VAVK K + ++E+ IL I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 407 IVKLLGCCLETEVPLLV-YEFVPNGTL-------------YQNIHNHIEEFPITWELLLR 452
+V LLG C + PL+V EF G L Y+ + + +T E L+
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
+ +V+ + +L AS RD+ + NILL +K K+ DFG +R I D + V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205
Query: 513 QGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGY 566
+ + PE +T +SDV+SFGV+L EI + G P Y
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--------------Y 251
Query: 567 FLQAMNENRLFEVLDALVLKEAER-----------EEIMTVATLAKRCLNLNGKNRPTMK 615
+ + E LKE R + M C + RPT
Sbjct: 252 --PGVKIDE--EFCRR--LKEGTRMRAPDYTTPEMYQTM------LDCWHGEPSQRPTFS 299
Query: 616 EVAFELGGI 624
E+ LG +
Sbjct: 300 ELVEHLGNL 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 60/305 (19%), Positives = 111/305 (36%), Gaps = 74/305 (24%)
Query: 355 RILGQGGQGTVYKGMLADGRI--------VAVKKSKLVDENNVEQFINEVVILSQINHRN 406
LGQG ++KG+ + V +K N E F ++S+++H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+V G C+ + +LV EFV G+L + + I W L +A +++ A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEE 131
Query: 467 AASISIYRRDIKSANILLDDKYR--------AKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
I ++ + NILL + K+SD G S ++
Sbjct: 132 NTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 519 VDP---------EYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFL 568
+ E + +D +SFG L EI + G KP L
Sbjct: 178 QERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP----------------L 219
Query: 569 QAMNENRLFEVLDALVLKEAEREEIM------TVATLAKRCLNLNGKNRPTMKEVAFELG 622
A++ ++ L E + +A L C++ +RP+ + + +L
Sbjct: 220 SALD-SQ--RKLQFY-----EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271
Query: 623 GIRAS 627
+
Sbjct: 272 SLFTP 276
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-34
Identities = 81/367 (22%), Positives = 142/367 (38%), Gaps = 68/367 (18%)
Query: 299 KFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATD--------N 350
+ +R+ S + N L + + S+ + L + E D
Sbjct: 23 RIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDK 82
Query: 351 YNANRILGQGGQGTVYKGMLADGR--------IVAVKKSK-LVDENNVEQFINEVVILSQ 401
+ LG+G G V VAVK K E ++ ++E+ ++
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 142
Query: 402 I-NHRNIVKLLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITW 447
I H+NI+ LLG C + ++ E+ G L Y N + E +T+
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 448 ELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507
+ L+ +++ + YL AS RD+ + N+L+ + K++DFG +R I +
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 508 LTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDR 561
+ T G + PE +T +SDV+SFGV++ EI T G P I ++E
Sbjct: 260 ----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315
Query: 562 SLV--GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L+ G+ + N L+ +M + C + RPT K++
Sbjct: 316 KLLKEGHRMDKPANCTNELY--------------MMM------RDCWHAVPSQRPTFKQL 355
Query: 618 AFELGGI 624
+L I
Sbjct: 356 VEDLDRI 362
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINH--R 405
Y+ + +G GG V++ + +I A+K L D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
I++L + + +V E N L + + + A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK-KSIDP--WERKSYWKNMLEAVHTIH 125
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ-GTFGYVDPEYF 524
I D+K AN L+ D K+ DFG + + D T + Q GT Y+ PE
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 525 Q-----------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573
+ S+ + KSDV+S G +L + G+ P + + + ++
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDP 236
Query: 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
N E + K+ + + K CL + K R ++ E+
Sbjct: 237 NHEIE-FPDIPEKDLQD--------VLKCCLKRDPKQRISIPEL 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 7e-34
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 18/224 (8%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNVEQFINEVVILSQI 402
+ + LG GG G V + + G VA+K+ + + N E++ E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 403 NHRNIVKLLGCCLETE-------VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAV 455
NH N+V + +PLL E+ G L + ++ + + +
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSITVDQTHLTTKV 512
++S AL YLH I RD+K NI+L + K+ D G ++ + T V
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV 184
Query: 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556
GT Y+ PE + ++T D +SFG + E +TG +P
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 25/221 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 405 RNIVKLLGC--CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
+NIVKL T +L+ EF P G+LY + + + L + +V G +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 463 YLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
+L I R+IK NI+ D + K++DFG +R + D + GT Y
Sbjct: 127 HLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 519 VDPEYFQSS--------QFTEKSDVYSFGVVLVEILTGQKP 551
+ P+ ++ + ++ D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 73/303 (24%), Positives = 125/303 (41%), Gaps = 60/303 (19%)
Query: 355 RILGQGGQGTVYKGMLADGR--------IVAVKKSK-LVDENNVEQFINEVVILSQI-NH 404
+ LG+G G V VAVK K E ++ ++E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITWELLL 451
+NI+ LLG C + ++ E+ G L Y N + E +T++ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK 511
+++ + YL AS RD+ + N+L+ + K++DFG +R I +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 512 VQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV- 564
+ T G + PE +T +SDV+SFGV++ EI T G P I ++E L+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273
Query: 565 -GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
G+ + N L+ +M + C + RPT K++ +L
Sbjct: 274 EGHRMDKPANCTNELY--------------MMM------RDCWHAVPSQRPTFKQLVEDL 313
Query: 622 GGI 624
I
Sbjct: 314 DRI 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-33
Identities = 33/329 (10%), Positives = 75/329 (22%), Gaps = 52/329 (15%)
Query: 325 ELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---K 380
E + + + L + L G + V+ + A+K
Sbjct: 38 EAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTM 97
Query: 381 SKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP-------------------- 420
+ +E+ +++ + +
Sbjct: 98 GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157
Query: 421 ------LLVYEFVPNGTLYQNI----HNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
LL+ + L ++ L + ++ L S
Sbjct: 158 YAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS--Q 528
+ N+ + R + D + Y E+ +S
Sbjct: 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTAT 269
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
FT + + G+ + + P + S L+ + L +
Sbjct: 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV 329
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ L R LN + + R E
Sbjct: 330 KT--------LIGRFLNFDRRRRLLPLEA 350
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 60/305 (19%), Positives = 119/305 (39%), Gaps = 37/305 (12%)
Query: 326 LSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD 385
+ S+ S + + + ++ +LG G +GT+ + D R VAVK+ +
Sbjct: 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---IL 57
Query: 386 ENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP 444
EV +L + + H N+++ + + + E TL + + +F
Sbjct: 58 PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFA 114
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-----YRAKVSDFGTSR 499
+ + + + L +LH S++I RD+K NIL+ +A +SDFG +
Sbjct: 115 HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 500 SITVDQTHLT--TKVQGTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRA 554
+ V + + + V GT G++ PE T D++S G V +++
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--- 228
Query: 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT--LAKRCLNLNGKNRP 612
+ + +L A L E+ V L ++ + ++ + RP
Sbjct: 229 ------------PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276
Query: 613 TMKEV 617
+ K V
Sbjct: 277 SAKHV 281
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 17/218 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
Y R LG+GG ++ + A K KS L+ + E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVSGAL 461
+++V G E + +V E +L + + E P L +I
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 154
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLH + RD+K N+ L++ K+ DFG + + D + GT Y+ P
Sbjct: 155 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 210
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
E + + DV+S G ++ +L G+ P + E
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 51/218 (23%), Positives = 87/218 (39%), Gaps = 17/218 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
Y R LG+GG ++ + A K KS L+ + E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVSGAL 461
+++V G E + +V E +L + + E P L +I
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTE-PEARYYLRQIV----LGC 128
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YLH + RD+K N+ L++ K+ DFG + + D + GT Y+ P
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
E + + DV+S G ++ +L G+ P + E
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 51/291 (17%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQINHRNI 407
R LG G G VY+G ++ VAVK + E + F+ E +I+S+ NH+NI
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTL--Y--QNIHNHIEEFPITWELLLRIAVEVSGALFY 463
V+ +G L++ ++ E + G L + + + + LL +A +++ Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 464 LHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV- 519
L RDI + N LL AK+ DFG +R I + +G +
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----RKGGCAMLP 208
Query: 520 ----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV--GYFLQAMN 572
PE F FT K+D +SFGV+L EI + G P + + E V G +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 268
Query: 573 E--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
++ IMT +C ++RP + +
Sbjct: 269 NCPGPVY--------------RIMT------QCWQHQPEDRPNFAIILERI 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
D+++ R LG+G G VY LA + I+A+K KS+L E Q E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVS 458
+ H NI+++ + L+ EF P G LY+ + H +E + E++
Sbjct: 71 LRHPNILRMYN-YFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRSATFMEELA 124
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
AL Y H + RDIK N+L+ K K++DFG S+ T + GT Y
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT-MCGTLDY 178
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ PE + EK D++ GV+ E L G P + + E
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-33
Identities = 75/365 (20%), Positives = 131/365 (35%), Gaps = 66/365 (18%)
Query: 302 KKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNAN------- 354
+I + + + + Q S + + + T + ++
Sbjct: 9 HHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEV 68
Query: 355 --------RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVIL 399
R LG G G VY+G ++ VAVK + E + F+ E +I+
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128
Query: 400 SQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL--Y--QNIHNHIEEFPITWELLLRIAV 455
S+ NH+NIV+ +G L++ ++ E + G L + + + + LL +A
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSITVDQTHLTTKV 512
+++ YL RDI + N LL AK+ DFG +R I +
Sbjct: 189 DIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----R 241
Query: 513 QGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV-- 564
+G + PE F FT K+D +SFGV+L EI + G P + + E V
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 565 GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
G + ++ IMT +C ++RP + +
Sbjct: 302 GGRMDPPKNCPGPVY--------------RIMT------QCWQHQPEDRPNFAIILERIE 341
Query: 623 GIRAS 627
Sbjct: 342 YCTQD 346
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 355 RILGQGGQGTVYKGMLADG---RIVAVKKSK-LVDENNVEQFINEVVILSQI-NHRNIVK 409
++G+G G V K + A+K+ K +++ F E+ +L ++ +H NI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 410 LLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITWELLLRIAVE 456
LLG C L E+ P+G L + ++ + LL A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
V+ + YL + RD+ + NIL+ + Y AK++DFG SR V V+ T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 200
Query: 517 GYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
G + E S +T SDV+S+GV+L EI++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 69/297 (23%)
Query: 293 GIWGLYKFTKKRR-EIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNY 351
G+ YK+ +K + +++ K +++ ++ + ++ T+L ++ E +N
Sbjct: 1 GVD--YKYKQKPKYQVRWK----------IIESYEGNSYTFIDPTQLPYNEKWEFPRNNL 48
Query: 352 NANRILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQI-N 403
+ LG G G V + VAVK K + E ++E+ I+S +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTL-----------YQNIHNHIEEFPITWELLLR 452
H NIV LLG C L++ E+ G L + I + LL
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
+ +V+ + +L AS + RD+ + N+LL + + AK+ DFG +R I
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----------- 214
Query: 513 QGTFGYVDPEYFQSSQ-----------------FTEKSDVYSFGVVLVEILT-GQKP 551
D Y +T +SDV+S+G++L EI + G P
Sbjct: 215 -----MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 51/226 (22%), Positives = 96/226 (42%), Gaps = 39/226 (17%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQINHRNI 407
LG+ G VYKG L VA+K K + E+F +E ++ +++ H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITWELLLRIA 454
V LLG + + +++ + +G L + + + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG 514
+++ + YL +S + +D+ + N+L+ DK K+SD G R + K+ G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLG 188
Query: 515 --------TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-32
Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 45/312 (14%)
Query: 318 GGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIV 376
G + L + + + D Y R+LG+G G V G+
Sbjct: 1 GPGSMMDHLHATPGMFVQHS---TAIFS---DRYKGQRVLGKGSFGEVILCKDKITGQEC 54
Query: 377 AVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433
AVK K ++ + + E + EV +L Q++H NI+KL + LV E G L+
Sbjct: 55 AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELF 114
Query: 434 QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRA 490
I I + RI +V + Y+H I RD+K N+LL+ K
Sbjct: 115 DEI---ISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANI 168
Query: 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550
++ DFG S + + K+ GT Y+ PE + + EK DV+S GV+L +L+G
Sbjct: 169 RIIDFGLSTHFEASKK-MKDKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCP 225
Query: 551 PIRAINIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLN 605
P F NE + + V E + V+ AK + L
Sbjct: 226 P---------------F-NGANEYDILKKVEKGKY--TFELPQWKKVSESAKDLIRKMLT 267
Query: 606 LNGKNRPTMKEV 617
R + ++
Sbjct: 268 YVPSMRISARDA 279
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 355 RILGQGGQGTVYKGMLADGR----IVAVK--KSKLVDENNVEQFINEVVILSQINHRNIV 408
R +G+G G V++G+ VA+K K+ D + F+ E + + Q +H +IV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
KL+G E V ++ E G L + + L+ A ++S AL YL S
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKR 511
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
+ RDI + N+L+ K+ DFG SR + + +K + ++ PE +
Sbjct: 512 FV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 529 FTEKSDVYSFGVVLVEILT-GQKP 551
FT SDV+ FGV + EIL G KP
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKP 592
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
Y +GQG GTVY M +A G+ VA+++ L + E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLH 465
IV L L + +V E++ G+L + ++E I + E AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
S I RDIKS NILL K++DFG IT +Q+ +T V GT ++ PE
Sbjct: 134 SNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKP 551
+ K D++S G++ +E++ G+ P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
++ +G+G G V GR VAVK L + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+V++ L E ++ EF+ G L +I + + + E + + V AL YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDI---VSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RDIKS +ILL R K+SDFG I+ D + V GT ++ PE
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 527 SQFTEKSDVYSFGVVLVEILTGQ------KPIRAI 555
S + + D++S G++++E++ G+ P++A+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-32
Identities = 67/307 (21%), Positives = 113/307 (36%), Gaps = 40/307 (13%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK-- 379
++ L +F + ++ Y + LG G G V A+K
Sbjct: 11 RENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKII 70
Query: 380 -KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN 438
K+ + + + + EV +L ++H NI+KL + LV E G L+ I
Sbjct: 71 RKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-- 127
Query: 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDF 495
I I +V + YLH +I RD+K N+LL+ K K+ DF
Sbjct: 128 -IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI 555
G S + + ++ GT Y+ PE + + EK DV+S GV+L +L G P
Sbjct: 184 GLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPF--- 237
Query: 556 NIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKN 610
+ + V + E V+ AK + L + +
Sbjct: 238 -------------GGQTDQEILRKVEKGKY--TFDSPEWKNVSEGAKDLIKQMLQFDSQR 282
Query: 611 RPTMKEV 617
R + ++
Sbjct: 283 RISAQQA 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 48/234 (20%), Positives = 91/234 (38%), Gaps = 33/234 (14%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQI-N 403
T ++ +G G G+V+K + DG I A+K+SK + + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALF 462
H ++V+ E + L+ E+ G+L I + L + ++V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 463 YLHSAASISIYRRDIKSANILLD-------------------DKYRAKVSDFGTSRSITV 503
Y+HS S+ DIK +NI + +K K+ D G I+
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 504 DQTHLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAIN 556
Q +G ++ E Q + K+D+++ + +V + R +
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 41/231 (17%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQINHRNI 407
R +G+G G V++ +VAVK K + F E ++++ ++ NI
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTL---------------------YQNIHNHIEEFPIT 446
VKLLG C + L++E++ G L + + P++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506
L IA +V+ + YL + RD+ + N L+ + K++DFG SR+I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 507 HLTTKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKP 551
+ + PE +++T +SDV+++GVVL EI + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-32
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 60/304 (19%)
Query: 354 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSK-LVDENNVEQFINEVVILSQI-N 403
+ LG+G G V VAVK K E ++ I+E+ ++ I
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTL-------------YQNIHNHIEEFPITWELL 450
H+NI+ LLG C + ++ E+ G L Y +H E ++ + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510
+ A +V+ + YL AS RD+ + N+L+ + K++DFG +R I +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 511 KVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLV 564
+ T G + PE +T +SDV+SFGV+L EI T G P + ++E L+
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 565 --GYFLQAMNE--NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620
G+ + + N L+ +M + C + RPT K++ +
Sbjct: 307 KEGHRMDKPSNCTNELY--------------MMM------RDCWHAVPSQRPTFKQLVED 346
Query: 621 LGGI 624
L I
Sbjct: 347 LDRI 350
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 74/313 (23%), Positives = 116/313 (37%), Gaps = 73/313 (23%)
Query: 355 RILGQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQI-NHRN 406
+ LG G G V + VAVK K E ++E+ +LS + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTL---------------YQNIHNHIEEFPITWELLL 451
IV LLG C L++ E+ G L +E + E LL
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK 511
+ +V+ + +L AS + RD+ + NILL K+ DFG +R I D ++
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 512 -----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVG 565
V+ PE + +T +SDV+S+G+ L E+ + G P
Sbjct: 206 NARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSP-------------- 247
Query: 566 YFLQAMNENRLFEVLDALVLKEAEREE-----------IMTVATLAKRCLNLNGKNRPTM 614
Y M + + +KE R IM K C + + RPT
Sbjct: 248 Y--PGMPVDS--KFYKM--IKEGFRMLSPEHAPAEMYDIM------KTCWDADPLKRPTF 295
Query: 615 KEVAFELGGIRAS 627
K++ + +
Sbjct: 296 KQIVQLIEKQISE 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 75/372 (20%), Positives = 137/372 (36%), Gaps = 85/372 (22%)
Query: 298 YKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRIL 357
+K+ K+ R +S+ + + + + V+ + E +N ++L
Sbjct: 1 HKYKKQFR-YESQLQMVQ------VTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVL 53
Query: 358 GQGGQGTVYKGMLADGR------IVAVKKSK-LVDENNVEQFINEVVILSQI-NHRNIVK 409
G G G V VAVK K D + E ++E+ +++Q+ +H NIV
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 410 LLGCCLETEVPLLVYEFVPNGTL--------------------YQNIHNHIEEFPITWEL 449
LLG C + L++E+ G L + + + +T+E
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
LL A +V+ + +L S RD+ + N+L+ K+ DFG +R I D +
Sbjct: 174 LLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-- 228
Query: 510 TKVQGTFGYV-----DPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSL 563
V + PE +T KSDV+S+G++L EI + G P
Sbjct: 229 --VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------------ 274
Query: 564 VGYFLQAMNENRLFEVLDALVLKEAEREE-----------IMTVATLAKRCLNLNGKNRP 612
Y + + +++ + + IM + C + + RP
Sbjct: 275 --Y--PGIPVDA--NFYK--LIQNGFKMDQPFYATEEIYIIM------QSCWAFDSRKRP 320
Query: 613 TMKEVAFELGGI 624
+ + LG
Sbjct: 321 SFPNLTSFLGCQ 332
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 24/244 (9%)
Query: 322 LQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK 380
+Q + + + +K E + ++ LG+G G+VYK + G+IVA+K+
Sbjct: 5 VQLRNPPRRQLKKLDEDSLTKQPE---EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 381 SKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGT---LYQNIH 437
+ E+++++ I E+ I+ Q + ++VK G + +V E+ G+ + + +
Sbjct: 62 VPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119
Query: 438 NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497
+ E I I L YLH I RDIK+ NILL+ + AK++DFG
Sbjct: 120 KTLTEDEIA-----TILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGV 171
Query: 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ------KP 551
+ +T T + GT ++ PE Q + +D++S G+ +E+ G+ P
Sbjct: 172 AGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
Query: 552 IRAI 555
+RAI
Sbjct: 231 MRAI 234
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 66/299 (22%), Positives = 117/299 (39%), Gaps = 50/299 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNI 407
+ + +ILG G GTV GR VAVK+ + + + + E+ +L++ +H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71
Query: 408 VKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEV----SGALF 462
++ C T+ L + E N L + + + + + +
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 463 YLHSAASISIYRRDIKSANILLDDK-------------YRAKVSDFGTSRSITVDQTHLT 509
+LH S+ I RD+K NIL+ R +SDFG + + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 510 TKVQ---GTFGYVDPEYFQSSQF-------TEKSDVYSFGVVLVEILT-GQKPIRAINID 558
T + GT G+ PE + S T D++S G V IL+ G+ P
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E + G F + + + + D ++ EA L + ++ + RPT +V
Sbjct: 247 ESNIIRGIF----SLDEMKCLHDRSLIAEAT--------DLISQMIDHDPLKRPTAMKV 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 77/317 (24%), Positives = 123/317 (38%), Gaps = 50/317 (15%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK-- 379
++ L ++ ++ K K ++Y R LG G G V A+K
Sbjct: 11 RENLYFQGIAINPG-MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVI 69
Query: 380 -KSKLVD----------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428
KS+ E E+ NE+ +L ++H NI+KL + + LV EF
Sbjct: 70 KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129
Query: 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK- 487
G L++ I I I ++ + YLH +I RDIK NILL++K
Sbjct: 130 GGELFEQI---INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN 183
Query: 488 --YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 545
K+ DFG S + D L ++ GT Y+ PE + + EK DV+S GV++ +
Sbjct: 184 SLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYIL 240
Query: 546 LTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK--- 601
L G P F N+ + + V + + ++ AK
Sbjct: 241 LCGYPP---------------F-GGQNDQDIIKKVEKGKY--YFDFNDWKNISDEAKELI 282
Query: 602 -RCLNLNGKNRPTMKEV 617
L + R T +E
Sbjct: 283 KLMLTYDYNKRCTAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 45/304 (14%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK---KSK 382
+ S + L+ + YN +LG+G G V K + AVK K+
Sbjct: 3 HHHHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 383 LVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIE 441
+++ + EV +L +++H NI+KL E +V E G L+ I I+
Sbjct: 60 AKNKD-TSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEI---IK 114
Query: 442 EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTS 498
+ RI +V + Y+H +I RD+K NILL+ K K+ DFG S
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINID 558
+ + ++ GT Y+ PE + + + EK DV+S GV+L +L+G P
Sbjct: 172 TCFQQNTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP------- 221
Query: 559 EDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPT 613
F NE + + V + + T++ AK + L + R T
Sbjct: 222 --------F-YGKNEYDILKRVETGKY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 614 MKEV 617
+
Sbjct: 271 ATQC 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 37/235 (15%), Positives = 77/235 (32%), Gaps = 23/235 (9%)
Query: 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGM------LADGRIVAVKKSKLVDENNVE 390
+ + + + + +LG+G VY+ + + +K K +
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 391 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQ--NIHNHIEEFPITWE 448
+ L +K L +LV E GTL N++ + E +
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA-----------KVSDFGT 497
L++ A+ + + +H I DIK N +L + + + D G
Sbjct: 173 LVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229
Query: 498 SRSITV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
S + + + + T T G+ E + + + D + + +L G
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
+ + LG G G VYK G + A K + E +E +I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGT---LYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
IVKLLG ++ EF P G + + + E I + ++ AL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-----VCRQMLEALNF 132
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY----- 518
LHS I RD+K+ N+L+ + +++DFG S + + GT Y
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT-PYWMAPE 187
Query: 519 -VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
V E + + + K+D++S G+ L+E+ + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHR 405
+ + +G+G G V+KG+ ++VA+K L E+ +E E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYL 464
+ K G L+ ++ E++ G+ + ++E I I E+ L YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-----ILREILKGLDYL 135
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS I RDIK+AN+LL + K++DFG + +T Q T V GT ++ PE
Sbjct: 136 HSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ S + K+D++S G+ +E+ G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 53/248 (21%), Positives = 98/248 (39%), Gaps = 24/248 (9%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD 385
S +S F + +E R+L +GG VY+ + GR A+K+ +
Sbjct: 6 SLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 386 ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP-------LLVYEFVPNGTLYQNIH 437
E I EV + ++ H NIV+ + L+ + G L + +
Sbjct: 66 EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK 125
Query: 438 NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497
P++ + +L+I + A+ ++H I RD+K N+LL ++ K+ DFG+
Sbjct: 126 KMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184
Query: 498 SRSITVDQTHLTTKVQ-----------GTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLV 543
+ +I+ + + + T Y PE EK D+++ G +L
Sbjct: 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244
Query: 544 EILTGQKP 551
+ Q P
Sbjct: 245 LLCFRQHP 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 40/252 (15%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA--DGRIVAVK---KS 381
SN + K K+ +K ++Y R L QG + L D + A+K KS
Sbjct: 13 YSNLIYLNKYV----KEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKS 65
Query: 382 KLV--------------DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEF 426
L ++ + F NE+ I++ I + + G + + ++YE+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEY 124
Query: 427 VPNGTLYQNIHNH-----IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481
+ N ++ + I +++ I V + Y+H+ +I +R D+K +N
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI-CHR-DVKPSN 182
Query: 482 ILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT--EKSDVYSFG 539
IL+D R K+SDFG S + + GT+ ++ PE+F + K D++S G
Sbjct: 183 ILMDKNGRVKLSDFGESE--YMVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 540 VVLVEILTGQKP 551
+ L + P
Sbjct: 240 ICLYVMFYNVVP 251
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 47/221 (21%), Positives = 77/221 (34%), Gaps = 25/221 (11%)
Query: 348 TDNYNANRILGQGGQ--GTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQI 402
Y ++G+G + TV G V V++ L V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEE-FPITWELLLRIAV---EVS 458
NH NIV + +V F+ G+ I H + IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
AL Y+H + R +K+++IL+ + +S ++ S+
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 519 VD------PEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKP 551
V PE Q + + KSD+YS G+ E+ G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 60/339 (17%), Positives = 112/339 (33%), Gaps = 91/339 (26%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRN 406
++ + +G+GG G V++ D A+K+ +L + E E+ + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 407 IVKLLGCCLETEVPLL-------------------------------------------- 422
IV+ LET
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 423 -VYEFVPNGTLY------------QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAAS 469
+ P LY ++ + L I ++++ A+ +LHS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ-----------GTFGY 518
+ RD+K +NI KV DFG ++ D+ T GT Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
+ PE + ++ K D++S G++L E+L F M R+
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYS------------------FSTQMERVRIIT 284
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ L ++ + + L+ + RP ++
Sbjct: 285 DVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRN 406
D+Y ++G G V VA+K+ L + ++++ + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLR---IAV---EVSGA 460
IV + + LV + + G++ +I HI +L IA EV
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF-G-- 517
L YLH I RD+K+ NILL + +++DFG S + KV+ TF G
Sbjct: 134 LEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 518 -YVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKP 551
++ PE Q + K+D++SFG+ +E+ TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 81/346 (23%), Positives = 136/346 (39%), Gaps = 57/346 (16%)
Query: 302 KKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGG 361
KK E++ ++ KR L Q++ K D EK LG G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ---------KVGELKDDDFEKI-------SELGAGN 45
Query: 362 QGTVYKGML-ADGRIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419
G V+K G ++A K L + Q I E+ +L + N IV G
Sbjct: 46 GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105
Query: 420 PLLVYEFVPNGTLYQ--NIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDI 477
+ E + G+L Q I E ++L ++++ V L YL I RD+
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLRE--KHKIMHRDV 158
Query: 478 KSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYS 537
K +NIL++ + K+ DFG S + + + V GT Y+ PE Q + ++ +SD++S
Sbjct: 159 KPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYSVQSDIWS 215
Query: 538 FGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR---------------------- 575
G+ LVE+ G+ PI + E + G ++
Sbjct: 216 MGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275
Query: 576 -LFEVLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKE 616
+FE+LD +V + + + + +CL N R +K+
Sbjct: 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 36/303 (11%), Positives = 80/303 (26%), Gaps = 65/303 (21%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQ--------- 401
+LGQ + G V ++ N ++Q EV+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 402 -------------INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF----- 443
+ K++ L+ ++ F + N+ E
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 444 ---PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+ L++ ++V L LH + ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQ-----FTEKSDVYSFGVVLVEILTGQKPIRAI 555
+ Q T D ++ G+ + I P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 556 NIDEDRSLVGYFLQAMNENRLF-EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614
+ D + +G + + + AL+ + L ++R
Sbjct: 317 --NTDDAALGGSEWIFRSCKNIPQPVRALL----------------EGFLRYPKEDRLLP 358
Query: 615 KEV 617
+
Sbjct: 359 LQA 361
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 40/338 (11%), Positives = 88/338 (26%), Gaps = 74/338 (21%)
Query: 325 ELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---K 380
L S +L + +LGQ + G V
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 381 SKLVDENNVEQFINEVVILSQI-------------------------NHRNIVKLLGCCL 415
++ N ++Q EV+ L + + ++++
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 416 ETEVP--LLVYEFV--PNGTLYQNIHNHIEE-FPITWELLLRIAVEVSGALFYLHSAASI 470
+ V +Y + T + + +H + L++ ++V L LH
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ-- 528
+ ++ +I+LD + ++ F + G+ PE
Sbjct: 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPPELEARRATI 280
Query: 529 ---------FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
T D ++ G+V+ I PI + + + + V
Sbjct: 281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQ----PV 336
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L + L ++R +
Sbjct: 337 RA-----------------LLEGFLRYPKEDRLLPLQA 357
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 55/244 (22%), Positives = 95/244 (38%), Gaps = 28/244 (11%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD 385
S++ + + ++ R +G G G VY + + +VA+KK
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91
Query: 386 EN---NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG--TLYQNIHNHI 440
+ + I EV L ++ H N ++ GC L LV E+ L + +
Sbjct: 92 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPL 151
Query: 441 EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+E I + L YLHS I RD+K+ NILL + K+ DFG++
Sbjct: 152 QEVEIAA-----VTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 501 ITVDQTHLTTKVQGTFGYVDPE---YFQSSQFTEKSDVYSFGVVLVEILTGQ------KP 551
+ + GT ++ PE Q+ K DV+S G+ +E+ +
Sbjct: 204 MAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
Query: 552 IRAI 555
+ A+
Sbjct: 259 MSAL 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 37/286 (12%)
Query: 340 TSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINE 395
+ D + NY + +G+G V + GR VA+K K++L + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFRE 64
Query: 396 VVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLR 452
V I+ +NH NIVKL +ETE L L+ E+ G ++ + H ++E +
Sbjct: 65 VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKE-----KEARS 118
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
++ A+ Y H I RD+K+ N+LLD K++DFG S TV L
Sbjct: 119 KFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC 174
Query: 513 QGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571
G Y PE FQ ++ + DV+S GV+L +++G P N+ E L+
Sbjct: 175 -GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRER 225
Query: 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ + + + E L KR L LN R T++++
Sbjct: 226 VLRGKYRIPFYMS-TDCEN--------LLKRFLVLNPIKRGTLEQI 262
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 65/292 (22%), Positives = 111/292 (38%), Gaps = 50/292 (17%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLV-----DENNVEQFINEVVI 398
D Y ++ LG G G V + VA++ K K + + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVE 456
L ++NH I+K+ + E +V E + G L+ + + ++E ++
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-ATCKLYFYQML-- 249
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRSITVDQTHLTTKVQ 513
A+ YLH I RD+K N+LL + K++DFG S+ + + + + T
Sbjct: 250 --LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC- 302
Query: 514 GTFGYVDPEYFQSSQF---TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570
GT Y+ PE S D +S GV+L L+G P F +
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSEH 347
Query: 571 MNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ L + + E V+ A + L ++ K R T +E
Sbjct: 348 RTQVSLKDQITSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 74/306 (24%), Positives = 128/306 (41%), Gaps = 50/306 (16%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSK 382
+ + + TKL K+ E Y +LG GG G+VY G+ ++D VA+K K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 383 LVDENNVEQFIN---EVVILSQINHR--NIVKLLGCCLETEVPL-LVYEFV-PNGTLYQN 435
+ D + EVV+L +++ +++LL E L+ E P L+
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDF 139
Query: 436 IHNH--IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKV 492
I ++E EL +V A+ + H+ + RDIK NIL+D ++ K+
Sbjct: 140 ITERGALQE-----ELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191
Query: 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
DFG+ + T T GT Y PE+ + ++ + V+S G++L +++ G P
Sbjct: 192 IDFGSGA--LLKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
Query: 552 IRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNR 611
++ + G V E + L + CL L +R
Sbjct: 249 FE----HDEEIIRGQV-----------FFRQRVSSECQH--------LIRWCLALRPSDR 285
Query: 612 PTMKEV 617
PT +E+
Sbjct: 286 PTFEEI 291
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 74/305 (24%), Positives = 124/305 (40%), Gaps = 51/305 (16%)
Query: 329 NKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK---KSKLV 384
+ S + L+ + YN +LG+G G V K + AVK K+
Sbjct: 5 HHHSSGRENLYFQGTFA---ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 385 DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP 444
+++ + EV +L +++H NI+KL ++ +V E G L+ I I+
Sbjct: 62 NKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKR 117
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGTSRSI 501
+ RI +V + Y+H +I RD+K NILL+ K + K+ DFG S
Sbjct: 118 FSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR 561
+ + ++ GT Y+ PE + + + EK DV+S GV+L IL
Sbjct: 175 QQNTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILY-IL--------------- 215
Query: 562 SLVGY--FLQAMNENRLFEVLDALVLK---EAEREEIMTVATLAK----RCLNLNGKNRP 612
L G F NE + + V + + T++ AK + L + R
Sbjct: 216 -LSGTPPF-YGKNEYDILK----RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI 269
Query: 613 TMKEV 617
T +
Sbjct: 270 TATQC 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 45/307 (14%)
Query: 327 SSNKSSVEKTKLFTS-KDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL- 383
SS S + L + + ++ +G G G V+K G ++AVK+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 384 VDENNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFVPNGT--LYQNIHNH 439
++ ++ + ++ V+L + IV+ G + T+V + E + L + +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGP 120
Query: 440 IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499
I E +L ++ V + AL+YL + I+R D+K +NILLD++ + K+ DFG S
Sbjct: 121 IPE-----RILGKMTVAIVKALYYLKEKHGV-IHR-DVKPSNILLDERGQIKLCDFGISG 173
Query: 500 SITVDQTHLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRA 554
+ VD G Y+ PE + ++DV+S G+ LVE+ TGQ P +
Sbjct: 174 RL-VDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLA-----KRCLNLNGK 609
D FEVL ++ +E + K CL + +
Sbjct: 232 CKTD------------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 610 NRPTMKE 616
RP +
Sbjct: 274 KRPKYNK 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 67/291 (23%), Positives = 116/291 (39%), Gaps = 56/291 (19%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN 403
T+ Y LG+G V + + + G+ A KL + ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68
Query: 404 HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVE---- 456
H NIV+L E L+++ V G L+++I + E A
Sbjct: 69 HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE---------ADASHCIQQ 118
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGTSRSITVDQTHLTTKVQ 513
+ A+ + H + + R++K N+LL K + K++DFG + + +Q
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA- 174
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--FLQAM 571
GT GY+ PE + + + D+++ GV+L IL LVGY F
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILY-IL----------------LVGYPPF-WDE 216
Query: 572 NENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+++RL++ + + E TV AK + L +N R T E
Sbjct: 217 DQHRLYQQIKAGAY--DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 72/293 (24%), Positives = 114/293 (38%), Gaps = 64/293 (21%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN 403
+ +LG G V+ G++ A+K KS ++++E NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 404 HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVE---- 456
H NIV L E+ LV + V G L+ I E + A
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTE---------KDASLVIQQ 114
Query: 457 VSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
V A+ YLH I RD+K N+L ++ + ++DFG S+ ++T
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTAC- 168
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--FLQAM 571
GT GYV PE +++ D +S GV+ IL L GY F
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITY-IL----------------LCGYPPF-YEE 210
Query: 572 NENRLFEVLDALVLK---EAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
E++LFE + + E E ++ AK L + R T ++
Sbjct: 211 TESKLFE----KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 74/312 (23%), Positives = 122/312 (39%), Gaps = 57/312 (18%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSK 382
+ + + F K +DNY+ LG+G V + + G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 383 LVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNH 439
L + ++ E I ++ H NIV+L + E LV++ V G L+++I
Sbjct: 67 LSARD-FQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 440 IEEFPITWELLLRIAVE----VSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KV 492
E A + ++ Y HS I R++K N+LL K + K+
Sbjct: 125 YSE---------ADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKL 172
Query: 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+DFG + + D GT GY+ PE + +++ D+++ GV+L IL
Sbjct: 173 ADFGLAIEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILY-IL------ 223
Query: 553 RAINIDEDRSLVGY--FLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLN 605
LVGY F +++RL+ + + E TV AK L
Sbjct: 224 ----------LVGYPPF-WDEDQHRLYAQIKAGAY--DYPSPEWDTVTPEAKSLIDSMLT 270
Query: 606 LNGKNRPTMKEV 617
+N K R T +
Sbjct: 271 VNPKKRITADQA 282
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 64/274 (23%), Positives = 120/274 (43%), Gaps = 39/274 (14%)
Query: 357 LGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEV-VILSQINHRNIVKLLGC 413
LG+G G V K + G+I+AVK+ + V+ ++ + ++ + + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 414 CL-ETEVPLLVYEFVPNGT--LYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
E +V + E + Y+ + + + P L +IAV + AL +LHS S+
Sbjct: 75 LFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDI--LGKIAVSIVKALEHLHSKLSV 131
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE----YFQS 526
I+R D+K +N+L++ + K+ DFG S + VD G Y+ PE
Sbjct: 132 -IHR-DVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA-GCKPYMAPERINPELNQ 187
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
++ KSD++S G+ ++E+ + P + F+ L +V +
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTP------------------FQQLKQVVEE 229
Query: 587 EAER--EEIMTVATLA--KRCLNLNGKNRPTMKE 616
+ + + + + +CL N K RPT E
Sbjct: 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 75/349 (21%), Positives = 122/349 (34%), Gaps = 82/349 (23%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSK 382
+ SS + F L + Y+ +GQG G V + I A+K K+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 383 L--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHI 440
+ ++ +VE+ EV ++ +++H NI +L + + LV E G L ++ I
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 441 EEFPITWELLL-------------------------------------RIAVEVSGALFY 463
++ + + I ++ AL Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 464 LHSAASISIYRRDIKSANILLDDK--YRAKVSDFGTSRSITV----DQTHLTTKVQGTFG 517
LH + I RDIK N L + K+ DFG S+ + +TTK GT
Sbjct: 184 LH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPY 239
Query: 518 YVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
+V PE ++ + K D +S GV+L +L G P F +N+
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---------------F-PGVNDAD 283
Query: 576 LFEVLDALVLK---EAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
VL E ++ LA+ LN N R
Sbjct: 284 TISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 73/314 (23%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSK 382
S S L + D D Y ++G+G V + + G+ AVK +K
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 383 LVDEN--NVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNH 439
+ E E I + H +IV+LL ++ L +V+EF+ L I
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKR 120
Query: 440 IEEFPITWE----LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KV 492
+ + E +R +E AL Y H +I RD+K +LL K + K+
Sbjct: 121 ADAGFVYSEAVASHYMRQILE---ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKL 174
Query: 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
FG + + +V GT ++ PE + + + DV+ GV+L IL
Sbjct: 175 GGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILF-IL------ 226
Query: 553 RAINIDEDRSLVGY--FLQAMNENRLFEVLDALVLK---EAEREEIMTVATLAK----RC 603
L G F + RLFE ++K + + ++ AK R
Sbjct: 227 ----------LSGCLPFYG--TKERLFE----GIIKGKYKMNPRQWSHISESAKDLVRRM 270
Query: 604 LNLNGKNRPTMKEV 617
L L+ R T+ E
Sbjct: 271 LMLDPAERITVYEA 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 72/291 (24%), Positives = 117/291 (40%), Gaps = 57/291 (19%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN 403
+DNY+ LG+G V + + G A K KL + ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQ 63
Query: 404 HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVE---- 456
H NIV+L + E LV++ V G L+++I E A
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSE---------ADASHCIQQ 113
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGTSRSITVDQTHLTTKVQ 513
+ ++ Y HS I R++K N+LL K + K++DFG + + D
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA- 168
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--FLQAM 571
GT GY+ PE + +++ D+++ GV+L IL LVGY F
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILY-IL----------------LVGYPPFW-DE 210
Query: 572 NENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+++RL+ + + E TV AK L +N K R T +
Sbjct: 211 DQHRLYAQIKAGAY--DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 69/338 (20%), Positives = 129/338 (38%), Gaps = 54/338 (15%)
Query: 296 GLYKFTKKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANR 355
G + +++ K K N + + + K D Y+
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKIND----YDKFYEDIWKKYVPQPVEVKQ-GSVYDYYDILE 57
Query: 356 ILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLL 411
LG G G V++ + A GR+ K +D+ V+ NE+ I++Q++H ++ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLH 114
Query: 412 GCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE----LLLRIAVEVSGALFYLHS 466
E + + L+ EF+ G L+ I E++ ++ E +R A E L ++H
Sbjct: 115 DAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMS-EAEVINYMRQACE---GLKHMH- 166
Query: 467 AASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
SI DIK NI+ + K + K+ DFG + + D+ + T + PE
Sbjct: 167 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTT-ATAEFAAPEIV 222
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE-VLDAL 583
+D+++ GV+ +L+G P F ++ + V
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP---------------FA-GEDDLETLQNVKRCD 266
Query: 584 VLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
E + + +V+ AK L + R T+ +
Sbjct: 267 W--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 8e-26
Identities = 69/250 (27%), Positives = 111/250 (44%), Gaps = 14/250 (5%)
Query: 321 LLQQELSSNKSSVEKTKLFTSKDLEKAT---DNYNANRILGQGGQGTVYKGMLAD-GRIV 376
L Q S+ + K LE D + R+LG+GG G V+ + G++
Sbjct: 154 LGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLY 213
Query: 377 AVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTL 432
A K K +L + + E IL++++ R IV L ET+ L LV + G +
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272
Query: 433 YQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491
+I+N E+ P E ++ L +LH +I IYR D+K N+LLDD +
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NI-IYR-DLKPENVLLDDDGNVR 329
Query: 492 VSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+SD G + + QT GT G++ PE ++ D ++ GV L E++ + P
Sbjct: 330 ISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
Query: 552 IRAINIDEDR 561
RA +
Sbjct: 389 FRARGEKVEN 398
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 63/238 (26%), Positives = 113/238 (47%), Gaps = 16/238 (6%)
Query: 329 NKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDE 386
+ S K K+ + + ++ +G+G G+V K + G+I+AVK+ + VDE
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61
Query: 387 NNVEQFINEV-VILSQINHRNIVKLLGCCL-ETEVPLLVYEFVPNG--TLYQNIHNHIEE 442
+Q + ++ V++ + IV+ G E + + E + Y+ +++ +++
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDD 120
Query: 443 FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502
I E+L +I + AL +L ++ I RDIK +NILLD K+ DFG S +
Sbjct: 121 -VIPEEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 503 VDQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAIN 556
+ T+ G Y+ PE S + +SDV+S G+ L E+ TG+ P N
Sbjct: 178 --DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 22/238 (9%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVD 385
S S+++ L +D + ++G G G VYKG + G++ A+K +
Sbjct: 5 DSPARSLDEIDLSALRDPA---GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-T 60
Query: 386 ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL------LVYEFVPNGTLYQNIHN 438
+ E+ E+ +L + +HRNI G ++ P LV EF G++ ++
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIK 119
Query: 439 HIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
+ + + E + I E+ L +LH I RDIK N+LL + K+ DFG S
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE-----KSDVYSFGVVLVEILTGQKP 551
+ T + GT ++ PE + + KSD++S G+ +E+ G P
Sbjct: 177 AQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 71/304 (23%), Positives = 115/304 (37%), Gaps = 45/304 (14%)
Query: 328 SNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK---KSKL 383
+ S + L+ ++ D + R LG G G V+ + G +K K +
Sbjct: 4 HHHHSSGRENLYFQGTID---DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 384 VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEE 442
+ +EQ E+ +L ++H NI+K+ E + +V E G L + I +
Sbjct: 61 --QVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERI---VSA 114
Query: 443 FPITWELLLRIAVE----VSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDF 495
L E + AL Y HS + +D+K NIL D K+ DF
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAI 555
G + D+ T GT Y+ PE F+ T K D++S GVV+ +LTG P
Sbjct: 172 GLAELFKSDEH-STNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP---- 224
Query: 556 NIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVA-TLAKRCLNLNGKNRPT 613
F + + + E + A L K+ L + + RP+
Sbjct: 225 -----------F-TGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
Query: 614 MKEV 617
+V
Sbjct: 273 AAQV 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 52/294 (17%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFIN-- 394
KD E Y +LG+GG GTV+ G L D VA+K +++++ + + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 395 -EVVILSQIN----HRNIVKLLGCCLETEVPL-LVYEF-VPNGTLYQNIHNH--IEEFPI 445
EV +L ++ H +++LL ET+ LV E +P L+ I + E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGPLGE--- 138
Query: 446 TWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVD 504
+V A+ + HS + RDIK NIL+D + AK+ DFG+ +
Sbjct: 139 --GPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLH 191
Query: 505 QTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
T GT Y PE+ Q+ + V+S G++L +++ G P + L
Sbjct: 192 DEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE----RDQEIL 246
Query: 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
A V + L +RCL +RP+++E+
Sbjct: 247 EAEL-----------HFPAHVSPDCCA--------LIRRCLAPKPSSRPSLEEI 281
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 355 RILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNI 407
+ILG+G TV +LA R A+K K ++ EN V E ++S+++H
Sbjct: 36 KILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 408 VKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLH 465
VKL + + L + NG L + I I F E R E+ AL YLH
Sbjct: 93 VKLYFTF-QDDEKLYFGLSYAKNGELLKYI-RKIGSFD---ETCTRFYTAEIVSALEYLH 147
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK-VQGTFGYVDPEYF 524
I I+R D+K NILL++ +++DFGT++ ++ + GT YV PE
Sbjct: 148 GK-GI-IHR-DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ SD+++ G ++ +++ G P RA N
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 67/301 (22%), Positives = 112/301 (37%), Gaps = 62/301 (20%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLV-----DENNVEQFINE 395
+ D Y ++ LG G G V + VA+K K K + + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 396 VVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNI--HNHIEEFPITWELLLRI 453
+ IL ++NH I+K+ + E +V E + G L+ + + ++E
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE---------AT 115
Query: 454 AVE----VSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRSITVDQT 506
+ A+ YLH I RD+K N+LL + K++DFG S+ + + +
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETS 171
Query: 507 HLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
+ T GT Y+ PE S + D +S GV+L I L
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-IC----------------L 213
Query: 564 VGY--FLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKE 616
GY F + + L + + E V+ A + L ++ K R T +E
Sbjct: 214 SGYPPFSEHRTQVSLKDQITSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 271
Query: 617 V 617
Sbjct: 272 A 272
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 52/290 (17%)
Query: 345 EKATDNYNANRILGQGGQGTVYKG-MLADGRIVAVK---KSKLVDENNVEQFINEVVILS 400
Y +G+G G V A K K + D + + E+ I+
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMK 61
Query: 401 QINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEV 457
++H NI++L E + LV E G L++ + E RI +V
Sbjct: 62 SLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDV 115
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRSITVDQTHLTTKVQG 514
A+ Y H +++ RD+K N L K+ DFG + + + TKV G
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-G 170
Query: 515 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--FLQAMN 572
T YV P+ + + + D +S GV++ +L L GY F A
Sbjct: 171 TPYYVSPQVLEGL-YGPECDEWSAGVMMY-VL----------------LCGYPPF-SAPT 211
Query: 573 ENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
++ + + + ++ + V+ A+ R L + K R T +
Sbjct: 212 DSEVMLKIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 56/310 (18%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLV 384
+ +S+ + + +D + LG+G VY+ + A+K K V
Sbjct: 31 APGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV 90
Query: 385 DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIE 441
D+ V E+ +L +++H NI+KL ET + LV E V G L+ I +
Sbjct: 91 DKKIVR---TEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYS 146
Query: 442 EFPITWELLLRIAVE----VSGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSD 494
E R A + + A+ YLH I RD+K N+L K++D
Sbjct: 147 E---------RDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194
Query: 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
FG S+ + Q + T GT GY PE + + + D++S G++ IL
Sbjct: 195 FGLSKIVE-HQVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITY-IL-------- 243
Query: 555 INIDEDRSLVGY--FLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLN 607
L G+ F + +F +L+ V+ AK + + L+
Sbjct: 244 --------LCGFEPFYDERGDQFMFRRILNCEY--YFISPWWDEVSLNAKDLVRKLIVLD 293
Query: 608 GKNRPTMKEV 617
K R T +
Sbjct: 294 PKKRLTTFQA 303
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 72/292 (24%), Positives = 108/292 (36%), Gaps = 48/292 (16%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENN---VEQFINEVV 397
E D Y+ LG G V K + G A K K + E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIA 454
IL +I H N++ L E + + L+ E V G L+ + + E T L+
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQI 123
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA----KVSDFGTSRSITVDQTHLTT 510
+ ++YLH S+ I D+K NI+L D+ K+ DFG + I
Sbjct: 124 LN---GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKN 176
Query: 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570
GT +V PE ++D++S GV+ +L+G P FL
Sbjct: 177 IF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL-G 219
Query: 571 MNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ V E E E + LAK R L + K R T+++
Sbjct: 220 DTKQETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 19/251 (7%)
Query: 321 LLQQELSSNKSSVEKTKLFTSKDLEKAT---DNYNANRILGQGGQGTVYKGMLAD-GRIV 376
L + S+ + K LE+ + + R+LG+GG G V + G++
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212
Query: 377 AVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTL 432
A K K ++ +NE IL ++N R +V L ET+ L LV + G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 271
Query: 433 YQNIHNHIEE-FPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490
+I++ + FP E A E+ L LH I +YR D+K NILLDD
Sbjct: 272 KFHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRE-RI-VYR-DLKPENILLDDHGHI 325
Query: 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550
++SD G + + QT GT GY+ PE ++ ++T D ++ G +L E++ GQ
Sbjct: 326 RISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
Query: 551 PIRAINIDEDR 561
P + R
Sbjct: 384 PFQQRKKKIKR 394
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 42/269 (15%)
Query: 320 LLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANR-------------ILGQGGQGTVY 366
L + QEL +++ + +K + L+ A + ++G+G V
Sbjct: 22 LGVHQELGASELAQDKY---VADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEV- 77
Query: 367 KGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419
+ G++ A+K K ++ V F E +L + R I +L + E
Sbjct: 78 --AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDEN 134
Query: 420 PL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDI 477
L LV E+ G L + E P + R E+ A+ +H + RDI
Sbjct: 135 YLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRDI 188
Query: 478 KSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVY- 536
K NILLD +++DFG+ + D T + GT Y+ PE Q+ + Y
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248
Query: 537 ------SFGVVLVEILTGQKPIRAINIDE 559
+ GV E+ GQ P A + E
Sbjct: 249 PECDWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 25/209 (11%), Positives = 67/209 (32%), Gaps = 44/209 (21%)
Query: 357 LGQGGQGTVYKGMLAD---GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
G ++ + D R VA+ ++ ++ +++ ++ + LS+I+ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 411 LGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASI 470
L L+V E++ G+L + + + +R ++ A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG-- 149
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT 530
+ + + + ++ T +P+
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATMPD------------------ANPQ-------- 182
Query: 531 EKSDVYSFGVVLVEILTGQKPIRAINIDE 559
D+ G L +L + P+ +
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 60/331 (18%), Positives = 118/331 (35%), Gaps = 47/331 (14%)
Query: 302 KKRREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGG 361
++ ++ + K + G + + + + D+Y+ + LG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 362 QGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET 417
G V++ A G A K D+ V E+ +S + H +V L E
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAF-ED 225
Query: 418 EVPL-LVYEFVPNGTLYQNI---HNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIY 473
+ + ++YEF+ G L++ + HN + E +R + L ++H +
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV--EYMRQVCK---GLCHMH---ENNYV 277
Query: 474 RRDIKSANILLDDK--YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTE 531
D+K NI+ K K+ DFG + + Q+ + GT + PE +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT-GTAEFAAPEVAEGKPVGY 335
Query: 532 KSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAER 590
+D++S GV+ +L+G P F N++ V +
Sbjct: 336 YTDMWSVGVLSYILLSGLSP---------------FG-GENDDETLRNVKSCDW--NMDD 377
Query: 591 EEIMTVATLAK----RCLNLNGKNRPTMKEV 617
++ K + L + R T+ +
Sbjct: 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 65/294 (22%), Positives = 108/294 (36%), Gaps = 52/294 (17%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENN---VEQFINEVV 397
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE----LLLR 452
IL Q+ H N++ L E + L+ E V G L+ + ++ ++ E ++
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSRSITVDQTHL 508
++ + YLH + I D+K NI+L K+ DFG + I D
Sbjct: 123 QILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568
GT +V PE ++D++S GV+ +L+G P FL
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 569 QAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ + + + E + LAK + L + R T++E
Sbjct: 220 -GDTKQETLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 71/289 (24%), Positives = 107/289 (37%), Gaps = 48/289 (16%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENN---VEQFINEVVILS 400
D+Y LG G V K G+ A K K +L E+ EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 401 QINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEV 457
+I H NI+ L E + + L+ E V G L+ + + E T L+ ++
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT--QFLKQILD- 119
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRA----KVSDFGTSRSITVDQTHLTTKVQ 513
+ YLH S I D+K NI+L DK K+ DFG + I
Sbjct: 120 --GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF- 172
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573
GT +V PE ++D++S GV+ +L+G P FL +
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL-GETK 216
Query: 574 NRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ + + E + LAK R L + K R T+ +
Sbjct: 217 QETLTNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 68/294 (23%), Positives = 110/294 (37%), Gaps = 52/294 (17%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENN---VEQFINEVV 397
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE----LLLR 452
IL Q+ H NI+ L E + L+ E V G L+ + ++ ++ E ++
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLS-EEEATSFIK 122
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDK----YRAKVSDFGTSRSITVDQTHL 508
++ + YLH + I D+K NI+L DK K+ DFG + I D
Sbjct: 123 QILD---GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175
Query: 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568
GT +V PE ++D++S GV+ +L+G P FL
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FL 219
Query: 569 QAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ + + + E + LAK + L + R T++E
Sbjct: 220 -GDTKQETLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 63/248 (25%), Positives = 110/248 (44%), Gaps = 23/248 (9%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGRIVA 377
+ S+ S E+ ++ +K + T + + ++LG+G G V +L GR A
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYA 177
Query: 378 VK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLY 433
+K K +V ++ V + E +L H + L +T L V E+ G L+
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELF 236
Query: 434 QNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492
++ F E R E+ AL YLHS ++ +YR D+K N++LD K+
Sbjct: 237 FHLSRE-RVFS---EDRARFYGAEIVSALDYLHSEKNV-VYR-DLKLENLMLDKDGHIKI 290
Query: 493 SDFGTSR-SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+DFG + I T GT Y+ PE + + + D + GVV+ E++ G+ P
Sbjct: 291 TDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
Query: 552 IRAINIDE 559
+ ++
Sbjct: 349 FYNQDHEK 356
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHR 405
+Y LG G G V G G VAVK + K+ + V + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 406 NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVSGALF 462
+I+KL + T +V E+V G L+ I H +EE R+ ++ A+
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEARRLFQQILSAVD 125
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
Y H + RD+K N+LLD AK++DFG S ++ D L T G+ Y PE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPE 180
Query: 523 YFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
+ + D++S GV+L +L G P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
++++ + LG+G G V + VAVK + VD E E+ I +NH
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNH--IEE------FPITWELLLRIAV 455
N+VK G L E+ G L+ I + E F +L+ V
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT--HLTTKVQ 513
YLH I I RDIK N+LLD++ K+SDFG + + L
Sbjct: 119 V------YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 514 GTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
GT YV PE + +F E DV+S G+VL +L G+ P
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-23
Identities = 70/298 (23%), Positives = 122/298 (40%), Gaps = 53/298 (17%)
Query: 339 FTSKDLEKATDNYNANR--ILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQF 392
+ Y ++ ILG G G V+K A G +A K + D E+
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133
Query: 393 INEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEE-FPITWE-- 448
NE+ +++Q++H N+++L E++ + LV E+V G L+ I I+E + +T E
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRI---IDESYNLT-ELD 188
Query: 449 --LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSITVD 504
L ++ E + ++H + I D+K NIL ++ K+ DFG +R
Sbjct: 189 TILFMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242
Query: 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564
+ L GT ++ PE + +D++S GV+ +L+G P
Sbjct: 243 EK-LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP------------- 287
Query: 565 GYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
FL N+ +L + E EE ++ AK + L R + E
Sbjct: 288 --FL-GDNDAETLNNILACRW--DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 64/288 (22%), Positives = 116/288 (40%), Gaps = 48/288 (16%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQFINEVVILSQ 401
++ + Y LG+G G V++ + + + K K K D+ V+ E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWE----LLLRIAVE 456
HRNI+ L E+ L +++EF+ +++ I+ F + E + E
Sbjct: 58 ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINT--SAFELN-EREIVSYVHQVCE 113
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSITVDQTHLTTKVQG 514
AL +LH S +I DI+ NI+ + + K+ +FG +R +
Sbjct: 114 ---ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-T 165
Query: 515 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574
Y PE Q + +D++S G ++ +L+G P FL A
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP---------------FL-AETNQ 209
Query: 575 RLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
++ E +++A + E ++ A R L K+R T E
Sbjct: 210 QIIENIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/219 (29%), Positives = 93/219 (42%), Gaps = 34/219 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
++++ + LG+G G V + VAVK + VD E E+ I +NH
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 64
Query: 405 RNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNH--IEE------FPITWELLLRIAV 455
N+VK G L E+ G L+ I + E F +L+ V
Sbjct: 65 ENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFF---HQLM--AGV 118
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT--HLTTKVQ 513
YLH I I RDIK N+LLD++ K+SDFG + + L
Sbjct: 119 V------YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC- 168
Query: 514 GTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
GT YV PE + +F E DV+S G+VL +L G+ P
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 21/244 (8%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVK-- 379
Q+ + S+K + ++ ++++ +RI+G+GG G VY AD G++ A+K
Sbjct: 163 QKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222
Query: 380 -KSKLVDENNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQ 434
K ++ + +NE ++LS ++ IV + T L + + + G L+
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHY 281
Query: 435 NIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493
++ H F E +R A E+ L ++H+ + +YR D+K ANILLD+ ++S
Sbjct: 282 HLSQH-GVFS---EADMRFYAAEIILGLEHMHNR-FV-VYR-DLKPANILLDEHGHVRIS 334
Query: 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 552
D G + + + H V GT GY+ PE Q + S D +S G +L ++L G P
Sbjct: 335 DLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391
Query: 553 RAIN 556
R
Sbjct: 392 RQHK 395
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKL-----VDENNVEQFINEVVILS 400
Y+ LG G G V+ + + V VK K K+ +++ + + E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 401 QINHRNIVKLLGCCLETEVPL-LVYEFVPNGT-LYQNI--HNHIEEFPITWELLLRIAVE 456
++ H NI+K+L E + LV E +G L+ I H ++E L I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLASYIFRQ 138
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
+ A+ YL I RDIK NI++ + + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTI 193
Query: 517 GYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
Y PE + + + +++S GV L ++ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 17/219 (7%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFIN-EVVILSQINH 404
Y +LG+G G V + + AVK K KL N E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 405 RNIVKLLG-CCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
+N+++L+ E + + +V E+ G Q + + + E ++ L
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR--SITVDQTHLTTKVQGTFGYVD 520
YLHS I +DIK N+LL K+S G + T QG+ +
Sbjct: 124 YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQP 179
Query: 521 PEYFQSSQFTE--KSDVYSFGVVLVEILTGQKPIRAINI 557
PE K D++S GV L I TG P NI
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 51/248 (20%)
Query: 327 SSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE 386
+ + V K K E+ Y +++G G G V++ L + VA+KK D
Sbjct: 18 LDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-D- 75
Query: 387 NNVEQFIN-EVVILSQINHRNIVKLLGCCLET-----EVPL-LVYEFVPNGTLYQNIHNH 439
++F N E+ I+ + H N+V L EV L LV E+VP T+Y+ ++
Sbjct: 76 ---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY 131
Query: 440 IEEF-PITWEL-------LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRA 490
+ + L LLR +L Y+HS I RDIK N+LLD
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLR-------SLAYIHSI---GICHRDIKPQNLLLDPPSGVL 181
Query: 491 KVSDFGTSRSITVDQ--THLTTKVQGTFGYV------DPE-YFQSSQFTEKSDVYSFGVV 541
K+ DFG+++ + + Y+ PE F ++ +T D++S G V
Sbjct: 182 KLIDFGSAKILIAGEPNVS----------YICSRYYRAPELIFGATNYTTNIDIWSTGCV 231
Query: 542 LVEILTGQ 549
+ E++ GQ
Sbjct: 232 MAELMQGQ 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 64/295 (21%), Positives = 105/295 (35%), Gaps = 47/295 (15%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEV 396
+ D ++ LG+G K + + AVK K E+
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEI 56
Query: 397 VILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNI--HNHIEEFPITWELLLRI 453
L H NIVKL + LV E + G L++ I H E
Sbjct: 57 TALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE---------TE 107
Query: 454 AVEV----SGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGTSRSITVDQT 506
A + A+ ++H + + RD+K N+L D+ K+ DFG +R D
Sbjct: 108 ASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566
L T T Y PE + + E D++S GV+L +L+GQ P ++ + +
Sbjct: 165 PLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
++ + + E E V+ AK L ++ R M +
Sbjct: 224 IMKKIKKGDF----------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHR 405
+Y LG G G V G G VAVK + K+ + V + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 406 NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEE------FPITWELLLRIAVE 456
+I+KL + T + +V E+V G L+ I + ++E F ++L V+
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF---QQILS--GVD 130
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
Y H + RD+K N+LLD AK++DFG S ++ D L T G+
Sbjct: 131 ------YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSP 179
Query: 517 GYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
Y PE + + D++S GV+L +L G P
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 69/340 (20%), Positives = 127/340 (37%), Gaps = 65/340 (19%)
Query: 308 KSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK 367
+ K N E +S + +L ++ Y+ ++G+G V +
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 368 GM-LADGRIVAVK---KSKL-----VDENNVEQFINEVVILSQI-NHRNIVKLLGCCLET 417
+ A G AVK + E E E IL Q+ H +I+ L+ E+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ES 171
Query: 418 EVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEV----SGALFYLHSAASI 470
+ LV++ + G L+ + + E + + A+ +LH+
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSE---------KETRSIMRSLLEAVSFLHA---N 219
Query: 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF- 529
+I RD+K NILLDD + ++SDFG S + + L GT GY+ PE + S
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDE 277
Query: 530 -----TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY--FLQAMNENRLFE-VLD 581
++ D+++ GV+L L L G F + + +++
Sbjct: 278 THPGYGKEVDLWACGVILF-TL----------------LAGSPPFW-HRRQILMLRMIME 319
Query: 582 ALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ E ++ K R L ++ + R T ++
Sbjct: 320 GQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
+++ +++G+G G V + ++ A+K K +++ F E +L
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSG 459
+ + I L + + L LV ++ G L + + P E + R E+
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVI 186
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
A+ +H + RDIK NIL+D +++DFG+ + D T ++ GT Y+
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 520 DPEYFQSSQFTEKS-----DVYSFGVVLVEILTGQKPIRAINIDE 559
PE Q+ + + D +S GV + E+L G+ P A ++ E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 66/301 (21%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNV------EQFINEVV 397
+NY ILG+G V + + + AVK + + E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 398 ILSQIN-HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRI 453
IL +++ H NI++L ET LV++ + G L+ + + E +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSE---------KE 125
Query: 454 AVEV----SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
++ + LH ++I RD+K NILLDD K++DFG S + + L
Sbjct: 126 TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LR 181
Query: 510 TKVQGTFGYVDPEYFQSSQF------TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563
GT Y+ PE + S ++ D++S GV++ L L
Sbjct: 182 EVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY-TL----------------L 223
Query: 564 VGY--FLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKE 616
G F + + ++ + E + K R L + + R T +E
Sbjct: 224 AGSPPFW-HRKQMLMLRMIMSGNY--QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 617 V 617
Sbjct: 281 A 281
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 53/231 (22%)
Query: 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFIN-EVVILSQINHR 405
+Y +++G G G VY+ L D G +VA+KK ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 406 NIVKLLGCCLET-----EVPL-LVYEFVPNGTLYQNIHNHIEEF-PITWEL-------LL 451
NIV+L + EV L LV ++VP T+Y+ ++ + L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQ--THL 508
R +L Y+HS I RDIK N+LLD D K+ DFG+++ + +
Sbjct: 167 R-------SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215
Query: 509 TTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Y+ PE F ++ +T DV+S G VL E+L GQ PI
Sbjct: 216 ---------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 51/302 (16%)
Query: 348 TDNYNANR-ILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQI 402
D Y +LG+G V + L + AVK K + V EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67
Query: 403 -NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIH--NHIEEFPITWELLLRIAVEV-- 457
HRN+++L+ E + LV+E + G++ +IH H E A V
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE---------LEASVVVQ 118
Query: 458 --SGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGTSRSI-------TVDQ 505
+ AL +LH+ I RD+K NIL + + K+ DF I +
Sbjct: 119 DVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 506 THLTTKVQGTFGYVDPE-----YFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
L T G+ Y+ PE ++S + ++ D++S GV+L +L+G P D
Sbjct: 176 PELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC-GSD 233
Query: 561 RSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMK 615
+N LFE + + E ++ ++ AK + L + K R +
Sbjct: 234 CGWDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291
Query: 616 EV 617
+V
Sbjct: 292 QV 293
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 64/290 (22%), Positives = 104/290 (35%), Gaps = 55/290 (18%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQ-I 402
TD Y +G G + + A AVK KSK + + E+ IL +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTE---EIEILLRYG 73
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEV--- 457
H NI+ L + + +V E + G L I E R A V
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---------REASAVLFT 124
Query: 458 -SGALFYLHSAASISIYRRDIKSANILLDDKYRA----KVSDFGTSRSITVDQTHLTTKV 512
+ + YLH+ + RD+K +NIL D+ ++ DFG ++ + + L T
Sbjct: 125 ITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181
Query: 513 QGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572
T +V PE + + D++S GV+L +LTG P D
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-------------T 227
Query: 573 ENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMKEV 617
+ + +V+ AK + L+++ R T V
Sbjct: 228 PEEILARIGSGKF--SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQF----INEVVILSQINH 404
+ Y +G+G G VYK + GRIVA+K+ +L + E I E+ +L +++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHH 78
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVS 458
NIV L+ LV+EF+ L + + + ++LL
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR------- 130
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
+ + H I RD+K N+L++ K++DFG +R+ + T +V T Y
Sbjct: 131 -GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWY 185
Query: 519 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
P+ S +++ D++S G + E++TG KP+
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPL 219
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-22
Identities = 63/249 (25%), Positives = 110/249 (44%), Gaps = 19/249 (7%)
Query: 321 LLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYK-GMLADGRIVAVK 379
L + + N S K + +DL ++Y +++G+G G V + ++ A+K
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 380 ---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQN 435
K +++ ++ F E I++ N +V+L + + L +V E++P G L
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLV-- 157
Query: 436 IHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494
N + + + E R EV AL +HS + RD+K N+LLD K++D
Sbjct: 158 --NLMSNYDVP-EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS----SQFTEKSDVYSFGVVLVEILTGQK 550
FGT + + GT Y+ PE +S + + D +S GV L E+L G
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 551 PIRAINIDE 559
P A ++
Sbjct: 272 PFYADSLVG 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 58/241 (24%), Positives = 94/241 (39%), Gaps = 42/241 (17%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLV--------------------- 384
Y +G+G G V D A+K K KL+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 385 --DENNVEQFINEVVILSQINHRNIVKL---LGCCLETEVPLLVYEFVPNGTLYQNIHNH 439
+EQ E+ IL +++H N+VKL L E + +V+E V G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132
Query: 440 IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499
P++ + ++ + YLH I RDIK +N+L+ + K++DFG S
Sbjct: 133 ----PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFT---EKSDVYSFGVVLVEILTGQKPIRAIN 556
L+ V GT ++ PE ++ + DV++ GV L + GQ P
Sbjct: 186 EFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244
Query: 557 I 557
I
Sbjct: 245 I 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQIN 403
Y +G+G GTV+K IVA+K+ +L +++ E + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALREICLLKELK 59
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEV 457
H+NIV+L + LV+EF L + + + ++LL
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLK------ 112
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
L + HS ++ RD+K N+L++ K+++FG +R+ + + +V T
Sbjct: 113 --GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 518 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Y P+ F + ++ D++S G + E+ +P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN--EVVILSQINHR 405
+ Y +G+G G V+K G+IVA+KK +++ V + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVSG 459
N+V LL LV+E+ + T+ + + P ITW+ L
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQ-------- 113
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
A+ + H + RD+K NIL+ K+ DFG +R +T + +V T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 520 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 549
PE +Q+ DV++ G V E+L+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEV 396
+ +D Y+ + +G G G +VAVK + +DEN V++ E+
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQR---EI 67
Query: 397 VILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEE------FPITW 447
+ + H NIV+ + T L ++ E+ G LY+ I E F
Sbjct: 68 INHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFF---Q 123
Query: 448 ELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY--RAKVSDFGTSRSITVDQ 505
+LL V Y HS + I RD+K N LLD R K+ DFG S+S +
Sbjct: 124 QLL--SGVS------YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172
Query: 506 THLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
+ V GT Y+ PE ++ + +DV+S GV L +L G P
Sbjct: 173 -QPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINHR 405
Y LG+G G V + VA+K + L + + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 406 NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI--HNHIEEFPITWELLLRIAVEVSGALF 462
+I+KL + T + +V E+ G L+ I + E + R ++ A+
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-----DEGRRFFQQIICAIE 122
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPE 522
Y H I RD+K N+LLDD K++DFG S +I D L T G+ Y PE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPE 177
Query: 523 YFQSSQFT-EKSDVYSFGVVLVEILTGQKP 551
+ + DV+S G+VL +L G+ P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 49/302 (16%)
Query: 335 KTKLFTSKDLEKATDNYN-ANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNV 389
T+ + +E + Y ++ LG+G V + + + G+ A K K + +
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-R 72
Query: 390 EQFINEVVILSQINHR-NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI----HNHIEEF 443
+ ++E+ +L ++ L E + L+ E+ G ++ + E
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSEN 131
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKVSDFGTSRS 500
+ L++ +E ++YLH +I D+K NILL Y K+ DFG SR
Sbjct: 132 DVI--RLIKQILE---GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183
Query: 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
I L + GT Y+ PE T +D+++ G++ +LT P
Sbjct: 184 IG-HACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP--------- 232
Query: 561 RSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTMK 615
F+ + + + V + E +V+ LA L N + RPT +
Sbjct: 233 ------FV-GEDNQETYLNISQVNV--DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 616 EV 617
Sbjct: 284 IC 285
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 27/215 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQF----INEVVILSQINH 404
+ Y+ +G+G G VYK G A+KK +L E E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL--EKEDEGIPSTTIREISILKELKH 59
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVS 458
NIVKL + +LV+E + L + + +LL
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLN------- 111
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
+ Y H + RD+K N+L++ + K++DFG +R+ + T ++ T Y
Sbjct: 112 -GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 519 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
P+ S +++ D++S G + E++ G P+
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPL 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN--EVVILSQINHR 405
+ Y ++G+G G V K GRIVA+KK D++ + + I E+ +L Q+ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEVSG 459
N+V LL C + + LV+EFV + T+ ++ ++++
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIIN-------- 135
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
+ + HS +I RDIK NIL+ K+ DFG +R++ +V T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 520 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQ 549
PE ++ + DV++ G ++ E+ G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-21
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 355 RILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKL 410
R +G+G G V D ++ A+K K K V+ N V E+ I+ + H +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 411 LGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEE---FPITWELLLRI-AVEVSGALFYLH 465
+ E + +V + + G L H+++ F E +++ E+ AL YL
Sbjct: 81 W-YSFQDEEDMFMVVDLLLGGDLR----YHLQQNVHFK---EETVKLFICELVMALDYLQ 132
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+ I I+R D+K NILLD+ ++DF + + + T + GT Y+ PE F
Sbjct: 133 NQ-RI-IHR-DMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 526 SSQFTEKS---DVYSFGVVLVEILTGQKP 551
S + S D +S GV E+L G++P
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQIN 403
+ Y LG+G TVYKG +VA+K+ +L E E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWELLLRIAVEV 457
H NIV L + LV+E++ L Q + + ++LL
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL------- 110
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
L Y H + RD+K N+L++++ K++DFG +R+ ++ +V T
Sbjct: 111 -RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLW 165
Query: 518 YVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Y P+ S+ ++ + D++ G + E+ TG +P+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPL 200
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 25/233 (10%)
Query: 329 NKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---K 380
K+ + K + + A D ++ + LG G G V ML G A+K K
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDK 76
Query: 381 SKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNH 439
K+V +E +NE IL +N +VKL + L +V E+V G ++ ++
Sbjct: 77 QKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRR- 134
Query: 440 IEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
I F E R A ++ YLHS + IY RD+K N+L+D + +V+DFG +
Sbjct: 135 IGRFS---EPHARFYAAQIVLTFEYLHS-LDL-IY-RDLKPENLLIDQQGYIQVTDFGFA 188
Query: 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
+ + T + GT + PE S + + D ++ GV++ E+ G P
Sbjct: 189 KRV----KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 47/234 (20%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQF--INEVVILSQ 401
K D + R+ GQG GTV G G VA+KK V ++ + + + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAV 75
Query: 402 INHRNIVKLL------GCCLETEVPL-LVYEFVPNGTLYQNI-HNHIEEFPITWEL---- 449
++H NIV+L G ++ L +V E+VP+ TL++ + + + L
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 450 ---LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQ 505
L+R ++ LH S+++ RDIK N+L++ K+ DFG+++ ++ +
Sbjct: 135 LFQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 506 THLTTKVQGTFGYV------DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
++ Y+ PE F + +T D++S G + E++ G+ PI
Sbjct: 187 PNV--------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 67/323 (20%), Positives = 111/323 (34%), Gaps = 70/323 (21%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANR-ILGQGGQGTVYKGM-LADGRIVAVK- 379
SS + + + TD+Y ++ +LG G G V + G+ A+K
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAV---TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL 61
Query: 380 --KSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP----LLVYEFVPNGTL 432
S + EV Q +IV +L L++ E + G L
Sbjct: 62 LYDSPKARQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGEL 113
Query: 433 YQNI----HNHIEEFPITWELLLRIAVEV----SGALFYLHSAASISIYRRDIKSANILL 484
+ I E R A E+ A+ +LHS +I RD+K N+L
Sbjct: 114 FSRIQERGDQAFTE---------REAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLY 161
Query: 485 DDKYRA---KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVV 541
K + K++DFG ++ Q L T T YV PE ++ + D++S GV+
Sbjct: 162 TSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
Query: 542 LVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK---EAEREEIMTVAT 598
+ +L G P F + + + + E V+
Sbjct: 219 MYILLCGFPP---------------F-YSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262
Query: 599 LAK----RCLNLNGKNRPTMKEV 617
AK L + R T+ +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQF 285
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHR 405
D+Y R LG+G V++ + + + V VK K V + ++ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 406 NIVKLLGCCL--ETEVPLLVYEFVPNGTLYQNIH----NHIEEFPITWELLLRIAVEVSG 459
NI+ L + P LV+E V N Q I + +E+L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--MYEILK-------- 141
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRA-KVSDFGTSRSITVDQTHLTTKVQGTFGY 518
AL Y HS I RD+K N+++D ++R ++ D+G + Q +V + +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYF 196
Query: 519 VDPEYFQSSQFTEKS-DVYSFGVVLVEILTGQKPI 552
PE Q + S D++S G +L ++ ++P
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 38/227 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQIN 403
Y +GQG G V+K G+ VA+KK + EN E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKILQLLK 74
Query: 404 HRNIVKLLGCCLETEVPL--------LVYEFVPN--GTLYQNIHNHIEEFPI---TWELL 450
H N+V L+ C P LV++F + L N+ I LL
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV----DQT 506
L+Y+H I RD+K+AN+L+ K++DFG +R+ ++
Sbjct: 135 --------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 507 HLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
T +V T Y PE + D++ G ++ E+ T PI
Sbjct: 184 RYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPI 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
++++ ++LG+G G V +L GR A+K K ++ ++ V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSG 459
H + L +T L V E+ G L+ ++ F E R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFGY 518
AL YLHS + +YR DIK N++LD K++DFG + I+ T GT Y
Sbjct: 117 ALEYLHSR-DV-VYR-DIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ PE + + + D + GVV+ E++ G+ P + +
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 347 ATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQ 401
++ + LG G TVYKG+ G VA+K+ KL E E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPN--GTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
+ H NIV+L LV+EF+ N + + L+ ++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
L + H I RD+K N+L++ + + K+ DFG +R+ + +++V T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 520 DPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
P+ S ++ D++S G +L E++TG KP+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL 208
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 73/245 (29%), Positives = 117/245 (47%), Gaps = 23/245 (9%)
Query: 326 LSSNKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVY----KGMLADGRIVAVK- 379
+ + + T EKA + ++LGQG G V+ ++ A+K
Sbjct: 1 MEGSIKEIAITHHVKEGH-EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKV 59
Query: 380 --KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI 436
K+ L + V E IL ++NH IVKL +TE L L+ +F+ G L+
Sbjct: 60 LKKATLKVRDRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLF--- 114
Query: 437 HNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495
+ + + E ++ E++ AL +LHS I IYR D+K NILLD++ K++DF
Sbjct: 115 -TRLSKEVMFTEEDVKFYLAELALALDHLHSL-GI-IYR-DLKPENILLDEEGHIKLTDF 170
Query: 496 GTSR-SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
G S+ SI ++ GT Y+ PE T+ +D +SFGV++ E+LTG P +
Sbjct: 171 GLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG 228
Query: 555 INIDE 559
+ E
Sbjct: 229 KDRKE 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 355 RILGQGGQGTVYKGMLA-------DGRIVAVK---KSKLV-DENNVEQFINEVVILSQIN 403
R+LG+GG G V G+I A+K K+ +V + + E IL ++
Sbjct: 23 RVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 404 HRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVSGAL 461
H IV L+ +T L L+ E++ G L+ +E I E E+S AL
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELF----MQLEREGIFMEDTACFYLAEISMAL 134
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFGYVD 520
+LH I IYR D+K NI+L+ + K++DFG + SI T GT Y+
Sbjct: 135 GHLHQK-GI-IYR-DLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIEYMA 189
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
PE S D +S G ++ ++LTG P N +
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 56/265 (21%), Positives = 104/265 (39%), Gaps = 81/265 (30%)
Query: 344 LEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFIN-EVVILSQ 401
LE ++ Y+ + LG G G V + + G+ A+KK ++ N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKV 56
Query: 402 INHRNIVKLLGC-------------------------------------CLETEVPL-LV 423
++H NI+KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 424 YEFVPNGTLYQNIHNHIEEF-PITWEL-------LLRIAVEVSGALFYLHSAASISIYRR 475
E+VP+ TL++ + + I I L L R A+ ++HS I R
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSL---GICHR 165
Query: 476 DIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV------DPE-YFQSS 527
DIK N+L++ K+ DFG+++ + + + Y+ PE ++
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV--------AYICSRFYRAPELMLGAT 217
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPI 552
++T D++S G V E++ G+ P+
Sbjct: 218 EYTPSIDLWSIGCVFGELILGK-PL 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 27/225 (12%)
Query: 341 SKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN----- 394
+ D++ Y LG+G TVYK +IVA+KK KL + + IN
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP------ITWE 448
E+ +L +++H NI+ LL LV++F+ L I ++
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLM 120
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
L L YLH I RD+K N+LLD+ K++DFG ++S
Sbjct: 121 TLQ--------GLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 509 TTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
T +V T Y PE F + + D+++ G +L E+L P
Sbjct: 170 THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPF 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 28/250 (11%)
Query: 330 KSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVY---KGMLAD-GRIVAVK---KS 381
E + EK +N+ ++LG G G V+ K D G++ A+K K+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 382 KLVDENN-VEQFINEVVILSQINHRN-IVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHN 438
+V + E E +L I +V L +TE L L+ +++ G L+
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELF----T 148
Query: 439 HIEE---FPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494
H+ + F E ++I E+ AL +LH I IYR DIK NILLD ++D
Sbjct: 149 HLSQRERFT---EHEVQIYVGEIVLALEHLHKL-GI-IYR-DIKLENILLDSNGHVVLTD 202
Query: 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPI 552
FG S+ D+T GT Y+ P+ + + D +S GV++ E+LTG P
Sbjct: 203 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262
Query: 553 RAINIDEDRS 562
++
Sbjct: 263 TVDGEKNSQA 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 68/241 (28%), Positives = 114/241 (47%), Gaps = 25/241 (10%)
Query: 331 SSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSK 382
++ +K + + ++ ++N +LG+G G V ML+ + AVK K
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDV 57
Query: 383 LVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHI 440
++ +++VE + E +L+ + +L C +T L V E+V G L HI
Sbjct: 58 VIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM----YHI 112
Query: 441 EEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499
++ E A E++ LF+L S I IYR D+K N++LD + K++DFG +
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSK-GI-IYR-DLKLDNVMLDSEGHIKIADFGMCK 169
Query: 500 -SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINID 558
+I T T GT Y+ PE + + D ++FGV+L E+L GQ P + D
Sbjct: 170 ENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227
Query: 559 E 559
E
Sbjct: 228 E 228
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 25/245 (10%)
Query: 327 SSNKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK-- 379
+ + + A +++ +++G+G G V +LA + AVK
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKV---LLARHKAEEVFYAVKVL 71
Query: 380 -KSKLVDENNVEQFINEVVILSQ-INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNI 436
K ++ + + ++E +L + + H +V L +T L V +++ G L+ ++
Sbjct: 72 QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL 130
Query: 437 HNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495
F E R A E++ AL YLHS +I +YR D+K NILLD + ++DF
Sbjct: 131 QRE-RCFL---EPRARFYAAEIASALGYLHSL-NI-VYR-DLKPENILLDSQGHIVLTDF 183
Query: 496 GTS-RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554
G +I + T T+ GT Y+ PE + D + G VL E+L G P +
Sbjct: 184 GLCKENIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241
Query: 555 INIDE 559
N E
Sbjct: 242 RNTAE 246
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVILSQIN 403
D Y LG+G G VYK + VA+K+ +L E+ E I EV +L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQ 91
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
HRNI++L L++E+ N L + + + ++ ++ ++ + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNF 147
Query: 464 LHSAASISIYRRDIKSANILLDDKYRA-----KVSDFGTSRSITVDQTHLTTKVQGTFGY 518
HS RD+K N+LL + K+ DFG +R+ + T ++ T Y
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 519 VDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
PE S ++ D++S + E+L P+
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPL 237
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 38/227 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
++ R LG G G V L +GR A+K K +V VE +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 402 INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEE---FPITWELLLRI-AVE 456
+ H I+++ G + + ++ +++ G L+ + + + FP + + A E
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELF----SLLRKSQRFP---NPVAKFYAAE 114
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
V AL YLHS I IY RD+K NILLD K++DFG ++ + D T+ T
Sbjct: 115 VCLALEYLHS-KDI-IY-RDLKPENILLDKNGHIKITDFGFAKYVP-DVTY-------TL 163
Query: 517 -G---YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
G Y+ PE + + + D +SFG+++ E+L G P N +
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 77/222 (34%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
DN+ R+LG+G G V MLA G + AVK K ++ +++VE + E ILS
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 402 I-NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVS 458
NH + +L CC +T L V EFV G L +I F E R A E+
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFD---EARARFYAAEII 134
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFG 517
AL +LH I RD+K N+LLD + K++DFG + I T T GT
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPD 189
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
Y+ PE Q + D ++ GV+L E+L G P A N D+
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 44/232 (18%)
Query: 346 KATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN-----EVVIL 399
AT Y +G G GTVYK G VA+K ++ + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 400 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFVPNGTLYQNIHNHIEEFP------- 444
++ H N+V+L+ C + LV+E + Q++ ++++ P
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAE 120
Query: 445 ----ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+ + L L +LH+ I RD+K NIL+ K++DFG +R
Sbjct: 121 TIKDLMRQFLR--------GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARI 169
Query: 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ LT V T Y PE S + D++S G + E+ KP+
Sbjct: 170 YSYQMA-LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPL 218
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-18
Identities = 24/89 (26%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 178 CEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTH 237
C + C T + CKC++GYE + C D++E + L
Sbjct: 6 CRISPDLCGRGQC------VNTPGDFECKCDEGYESGFMMMKNCMDIDECQRDPLLCRGG 59
Query: 238 ICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
+C NT G+Y C CP G + + CI
Sbjct: 60 VCHNTEGSYRCECPPGHQLSP--NISACI 86
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 Length = 86 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-07
Identities = 10/44 (22%), Positives = 18/44 (40%), Gaps = 1/44 (2%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
D++E C NT G++ C+C +G+ C+
Sbjct: 2 DIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGF-MMMKNCM 44
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
+++ R++G+G V +L RI A+K K + D+ +++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 402 I-NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVS 458
NH +V L C +TE L V E+V G L ++ + P E R + E+S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 120
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFG 517
AL YLH I IYR D+K N+LLD + K++D+G + + T T+ GT
Sbjct: 121 LALNYLHER-GI-IYR-DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 175
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
Y+ PE + + D ++ GV++ E++ G+ P
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 42/230 (18%)
Query: 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKK--SKLVDENNVEQFIN---------EV 396
Y R + G G V G+ ++G VA+K+ + + D V + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 397 VILSQINHRNIVKLLGCCLETEVPL-----LVYEFVPNGTLYQNIH--------NHIEEF 443
+L+ +H NI+ L + E P LV E + L Q IH HI+ F
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503
+ +LL L LH A + RD+ NILL D + DF +R T
Sbjct: 140 --MYHILL--------GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 504 DQTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
D + T V Y PE Q FT+ D++S G V+ E+ K +
Sbjct: 187 DA-NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
+++ R++G+G V +L RI A++ K + D+ +++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 402 I-NHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVS 458
NH +V L C +TE L V E+V G L ++ + P E R + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEIS 163
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFG 517
AL YLH I IYR D+K N+LLD + K++D+G + + T T+ GT
Sbjct: 164 LALNYLHER-GI-IYR-DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKP 551
Y+ PE + + D ++ GV++ E++ G+ P
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINH 404
Y + +G G QG V R VA+KK +N + E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 405 RNIVKLLGCCLETEVPL------LVYEFVPNGTLYQNIHNHIEEFPITWEL--LLRIAVE 456
+NI+ LL + +V E + L Q I ++ +++ L +L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 138
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
+ +LHSA I RD+K +NI++ K+ DFG +R+ + + T T
Sbjct: 139 ---GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTR 190
Query: 517 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
Y PE + E D++S G ++ E++ G +
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 2e-17
Identities = 69/249 (27%), Positives = 116/249 (46%), Gaps = 25/249 (10%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGRIVA 377
+ K++ +K + + ++ ++N +LG+G G V ML+ + A
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKV---MLSERKGTDELYA 370
Query: 378 VK---KSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPL-LVYEFVPNGTL 432
VK K ++ +++VE + E +L+ + +L C +T L V E+V G L
Sbjct: 371 VKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL 429
Query: 433 YQNIHNHIEEFPITWELLLRI-AVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491
HI++ E A E++ LF+L S I IYR D+K N++LD + K
Sbjct: 430 M----YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK-GI-IYR-DLKLDNVMLDSEGHIK 482
Query: 492 VSDFGTSR-SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQK 550
++DFG + +I T T GT Y+ PE + + D ++FGV+L E+L GQ
Sbjct: 483 IADFGMCKENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
Query: 551 PIRAINIDE 559
P + DE
Sbjct: 541 PFEGEDEDE 549
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 66/264 (25%), Positives = 114/264 (43%), Gaps = 31/264 (11%)
Query: 304 RREIKSKQKFFKRNGGLLLQQELSSNKSSVEKTKLFTSKDLEKAT----DNYNANRILGQ 359
+I Q F K+ + + + +KS V+ F S ++ +T Y + +G
Sbjct: 15 DVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQ--FYSVEVGDSTFTVLKRYQNLKPIGS 72
Query: 360 GGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINHRNIVKLL----- 411
G QG V R VA+KK +N + E+V++ +NH+NI+ LL
Sbjct: 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132
Query: 412 GCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWEL--LLRIAVEVSGALFYLHSAA 468
LE + LV E + L Q I ++ +++ L +L + +LHSA
Sbjct: 133 QKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC-------GIKHLHSA- 183
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
I RD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 184 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 529 FTEKSDVYSFGVVLVEILTGQKPI 552
+ E D++S G ++ E++ K +
Sbjct: 240 YKENVDIWSVGCIMGEMVRH-KIL 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 65/324 (20%), Positives = 108/324 (33%), Gaps = 66/324 (20%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDN---YNANRILGQGGQGTVYKGM-LADGRIVAV 378
Q + + + ++K +++LG G G V + A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 379 K---KSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVP-----LLVYEFVPN 429
K EV + + +IV+++ E L+V E +
Sbjct: 93 KMLQDCPKARR--------EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDG 143
Query: 430 GTLYQNI----HNHIEEFPITWELLLRIAVEV----SGALFYLHSAASISIYRRDIKSAN 481
G L+ I E R A E+ A+ YLHS I+I RD+K N
Sbjct: 144 GELFSRIQDRGDQAFTE---------REASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191
Query: 482 ILLDDKYRA---KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSF 538
+L K K++DFG ++ T + LTT T YV PE ++ + D++S
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 539 GVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVA 597
GV++ +L G P + + + + E E V+
Sbjct: 250 GVIMYILLCGYPPFYSNHGLAI------------SPGMKTRIRMGQY--EFPNPEWSEVS 295
Query: 598 TLAK----RCLNLNGKNRPTMKEV 617
K L R T+ E
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEF 319
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 64/222 (28%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
+++ +++LG+G G V LA + A+K K ++ +++VE + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 402 -INHRNIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI-AVEVS 458
H + + C +T+ L V E++ G L +I + +F A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD---LSRATFYAAEII 128
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR-SITVDQTHLTTKVQGTFG 517
L +LHS I +YR D+K NILLD K++DFG + ++ D T GT
Sbjct: 129 LGLQFLHSK-GI-VYR-DLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPD 183
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
Y+ PE ++ D +SFGV+L E+L GQ P + +E
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 46/232 (19%)
Query: 346 KATDNYNANRILGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNVEQF----INEVVIL 399
+A Y +G+G G V+K + GR VA+K+ ++ + E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVL 65
Query: 400 SQIN---HRNIVKLLGCCLETEVPL-----LVYEFVPNGTLYQNIHNHIEEFP------- 444
+ H N+V+L C + LV+E + Q++ ++++ P
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTE 120
Query: 445 ----ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500
+ ++LL L +LHS + RD+K NIL+ + K++DFG +R
Sbjct: 121 TIKDMMFQLLR--------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ LT+ V T Y PE S + D++S G + E+ KP+
Sbjct: 170 YSFQMA-LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPL 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 28/233 (12%)
Query: 340 TSKDLEKATDNYN-ANRILGQGGQGTVYKGMLAD---GRIVAVKKSKLVDENNVEQFINE 395
S + E+ D + +G+G G VYK D + A+K+ + E
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACRE 68
Query: 396 VVILSQINHRNIVKLLGCCLE-TEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRI 453
+ +L ++ H N++ L L + + L++++ + L+ I H + L
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPR 127
Query: 454 AVEVS------GALFYLHSAASISIYRRDIKSANILLDDKYRA----KVSDFGTSRSITV 503
+ S + YLH+ + RD+K ANIL+ + K++D G +R
Sbjct: 128 GMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 504 ---DQTHLTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
L V TF Y PE + +T+ D+++ G + E+LT +PI
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 40/223 (17%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINH 404
Y + +G G G+V + G VA+KK ++ + + E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 405 RNIVKLLGCCLETEVPL------LVYEFVPNGTLYQNIHNHIEEFPITWEL--LLRIAVE 456
N++ LL LV F+ L + + E I + + +L+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK---- 137
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTF 516
L Y+HSA + RD+K N+ +++ K+ DFG +R + T
Sbjct: 138 ---GLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT---------- 181
Query: 517 GYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
GYV PE + + D++S G ++ E+LTG K +
Sbjct: 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 13/134 (9%)
Query: 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492
+ + + +T E L+ + +V+ + +L AS RD+ + NILL +K K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234
Query: 493 SDFGTSRSITVDQTHLTTKVQGTFGYVD-----PEYFQSSQFTEKSDVYSFGVVLVEILT 547
DFG +R I D + V+ + PE +T +SDV+SFGV+L EI +
Sbjct: 235 CDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 548 -GQKPIRAINIDED 560
G P + IDE+
Sbjct: 291 LGASPYPGVKIDEE 304
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 32/102 (31%), Positives = 45/102 (44%), Gaps = 9/102 (8%)
Query: 355 RILGQGGQGTVYKGML------ADGRIVAVKKSK-LVDENNVEQFINEVVILSQI-NHRN 406
+ LG+G G V + A R VAVK K + ++E+ IL I +H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 407 IVKLLGCCLETEVPLLV-YEFVPNGTLYQNIHNHIEEFPITW 447
+V LLG C + PL+V EF G L + + EF
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 47/227 (20%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINH 404
Y + +G G G V + G VA+KK ++ + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 405 RNIVKLLGCCLETEVPL------LVYEFVPNGTLYQNIHN------HIEEFPITWELLLR 452
N++ LL E LV F+ L + + + I+ +++L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLK- 139
Query: 453 IAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKV 512
L Y+H+A I RD+K N+ +++ K+ DFG +R + T
Sbjct: 140 -------GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------ 183
Query: 513 QGTFGYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
GYV PE ++T+ D++S G ++ E++TG K +
Sbjct: 184 ----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN---------EVV 397
Y +G+G G V + VA+KK + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-----LVYEFVPNGT-LYQNIH-NHIEEFPITWEL- 449
IL + H NI+ + + +V + + T LY+ + H+ I + L
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLY 135
Query: 450 -LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH- 507
+LR L Y+HSA ++ RD+K +N+LL+ K+ DFG +R D H
Sbjct: 136 QILR-------GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185
Query: 508 --LTTKVQGTFGYVDPEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
LT V T Y PE S +T+ D++S G +L E+L+ +PI
Sbjct: 186 GFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPI 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN---------EVV 397
+ ++ +LG+G G V G IVA+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 398 ILSQINHRNIVKLLGCCLETEVPL-----LVYEFVPNGT-LYQNIH-NHIEEFPITWEL- 449
IL H NI+ + ++ E + T L++ I + + I + +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIY 119
Query: 450 -LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508
LR A+ LH + ++ RD+K +N+L++ KV DFG +R I
Sbjct: 120 QTLR-------AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 509 TTKVQGTF---GYVD------PEY-FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+ +V PE S++++ DV+S G +L E+ +PI
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINH 404
+ Y +G G G+V G VAVKK ++ + + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 405 RNIVKLLGCCLETEVPL------LVYEFVPNGTLYQNIH-NHIEEFPITWEL--LLRIAV 455
N++ LL LV + L + + + + + + +LR
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR--- 143
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
L Y+HSA I RD+K +N+ +++ K+ DFG +R + T
Sbjct: 144 ----GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--------- 187
Query: 516 FGYVD------PE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
GYV PE + + D++S G ++ E+LTG + +
Sbjct: 188 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 60/229 (26%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
Y + LG GG G V+ + + VA+KK L D +V+ + E+ I+ +++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 407 IVKLL------GCCLETEVPL--------LVYEFVPNGT-LYQNIH-NHIEEFPITWEL- 449
IVK+ G L +V +V E++ T L + + E +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMY 127
Query: 450 -LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSITVDQTH 507
LLR L Y+HSA ++ RD+K AN+ ++ + K+ DFG +R + +H
Sbjct: 128 QLLR-------GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 508 ---LTTKVQGTFGYVDPE-YFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
L+ + T Y P + +T+ D+++ G + E+LTG K +
Sbjct: 178 KGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 47/233 (20%), Positives = 88/233 (37%), Gaps = 55/233 (23%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQFINEVVILSQIN---- 403
Y R LG G TV+ + + VA+K + + E +E+ +L ++N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADN 77
Query: 404 -------HRNIVKLLGC-----------CLETEVPLL---VYEFVPNGTLYQNIHNHIEE 442
+I+KLL + E +L + + + H
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLAL-----IKKYEHR---- 126
Query: 443 FPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA------KVSDFG 496
I + +I+ ++ L Y+H I I+ DIK N+L++ K++D G
Sbjct: 127 -GIPLIYVKQISKQLLLGLDYMHRRCGI-IHT-DIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
+ H T +Q Y PE + + +D++S ++ E++TG
Sbjct: 184 NACWYD---EHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 49/246 (19%), Positives = 91/246 (36%), Gaps = 47/246 (19%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQINH 404
DNY ++G+G G VY + VA+KK + E+ ++ + + E+ IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 405 RNIVKLLGCCLETEVPL-----LVYEFVPNGT-LYQNIH--NHIEEFPITWEL--LLRIA 454
I++L + ++ +V E + L + + E I L LL
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNLLL-- 140
Query: 455 VEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQG 514
++H + I RD+K AN LL+ KV DFG +R+I ++
Sbjct: 141 -----GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 515 TFGYVDP----------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
P + +T+ D++S G + E+L +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 553 RAINID 558
+
Sbjct: 253 INDPTN 258
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-15
Identities = 24/92 (26%), Positives = 36/92 (39%), Gaps = 17/92 (18%)
Query: 177 TCEEAKICGP-NASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG--CRDVNEFEDPSLN 233
C+ A CD ++ C+C +GY L DG C D++E E+
Sbjct: 41 RCQMFCNQTACPADCD-------PNTQASCECPEGYI----LDDGFICTDIDECENG--G 87
Query: 234 NCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
C+ +C N G + C C G + G C
Sbjct: 88 FCSGVCHNLPGTFECICGPDSALAG-QIGTDC 118
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A Length = 118 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-11
Identities = 20/80 (25%), Positives = 30/80 (37%), Gaps = 10/80 (12%)
Query: 187 NASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNY 246
A+C+ +S Y C C +G+ P+ C+ C CD
Sbjct: 9 RANCEYQCQPLDQTS-YLCVCAEGFAPIPHEPHRCQMFCN-----QTACPADCDPN-TQA 61
Query: 247 TCRCPKGFRGDGRRDGGGCI 266
+C CP+G+ D DG C
Sbjct: 62 SCECPEGYILD---DGFICT 78
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 19/88 (21%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 178 CEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTH 237
C + T+ C +G+ NP + D++E ++
Sbjct: 83 KAWGTPCEMCPAV------NTSEYKILCPGGEGFRPNPI-TVILEDIDECQELPGLCQGG 135
Query: 238 ICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
C NT G++ CRCP G+ + D C
Sbjct: 136 KCINTFGSFQCRCPTGYYLNE--DTRVC 161
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-12
Identities = 8/82 (9%), Positives = 16/82 (19%), Gaps = 11/82 (13%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243
C + + C G + C + + +
Sbjct: 49 CYLDIRP------RGDNGDTACSNEIGVGVS---KASCCCSLGKAWGTPCEMCPAVNTSE 99
Query: 244 GNYTCRCPKGFRGDGRRDGGGC 265
C +GFR +
Sbjct: 100 YKILCPGGEGFRPNP--ITVIL 119
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 19/91 (20%), Positives = 24/91 (26%), Gaps = 14/91 (15%)
Query: 178 CEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTH 237
C + C + +C NT S Y C C +E NP GC D
Sbjct: 6 CLDPTTCI-SGNCV----NTPGS--YICDCPPDFELNPT-RVGCVDTRS----GNCYLDI 53
Query: 238 ICDNTAGNYTCRCPKGFRGDGRRDGGGCIPN 268
G+ C G C
Sbjct: 54 RPRGDNGDTACSNEIGVGVSK--ASCCCSLG 82
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A Length = 162 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 17/44 (38%), Positives = 22/44 (50%), Gaps = 3/44 (6%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
DVNE DP+ + C NT G+Y C CP F + GC+
Sbjct: 2 DVNECLDPT-TCISGNCVNTPGSYICDCPPDFELNP--TRVGCV 42
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-14
Identities = 20/82 (24%), Positives = 27/82 (32%), Gaps = 13/82 (15%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243
+ C NT S Y C+C GY + C D +E + C N
Sbjct: 13 VCKHGQCI----NTDGS--YRCECPFGYILA---GNECVDTDECSVGN-PCGNGTCKNVI 62
Query: 244 GNYTCRCPKGFRGDGRRDGGGC 265
G + C C +GF C
Sbjct: 63 GGFECTCEEGFEPG---PMMTC 81
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A Length = 82 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-08
Identities = 13/39 (33%), Positives = 19/39 (48%), Gaps = 1/39 (2%)
Query: 221 CRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGR 259
D++E ++P C NT G+Y C CP G+ G
Sbjct: 2 AVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAGN 39
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 48/226 (21%), Positives = 92/226 (40%), Gaps = 34/226 (15%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKS 381
+++ S+K + + + + D Y ++G G G V + + R+VA+KK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 382 KLVDENNVE--QFINEVVILSQINHRNIVKLLGCCLETEVPL-----LVYEFVPNGT-LY 433
V E+ ++ + + E+ IL+++NH ++VK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFK 144
Query: 434 QNIH-------NHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD 486
+ HI+ + LL+ + Y+HSA I RD+K AN L++
Sbjct: 145 KLFRTPVYLTELHIKTL--LYNLLV--------GVKYVHSA---GILHRDLKPANCLVNQ 191
Query: 487 KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEK 532
KV DFG +R++ + + K
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 8e-14
Identities = 23/98 (23%), Positives = 34/98 (34%), Gaps = 21/98 (21%)
Query: 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG----CRDVNEFEDPSLNNC- 235
A+ C ++SC + C+CN G+ + C D+NE S +C
Sbjct: 6 ARWCPQDSSCVNA---------TACRCNPGFSSFSEIITTPMETCDDINECATLSKVSCG 56
Query: 236 -THICDNTAGNYTCRCPKGFRGDGRR------DGGGCI 266
C NT G+Y C C G+ C
Sbjct: 57 KFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQ 94
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A Length = 143 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-12
Identities = 25/93 (26%), Positives = 37/93 (39%), Gaps = 16/93 (17%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG-------CRDVNE-FEDPSLNNC 235
CG + C NT S Y C C+ GYE C+DV+E +
Sbjct: 55 CGKFSDCW----NTEGS--YDCVCSPGYEPVSGAKTFKNESENTCQDVDECSSGQHQCDS 108
Query: 236 THICDNTAGNYTCRCPKGFRGDGRRDGGGCIPN 268
+ +C NT G+Y+CRC G++ +
Sbjct: 109 STVCFNTVGSYSCRCRPGWKPRH--GIPNNQKD 139
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQFINEVVILSQINHR-- 405
Y +++G+G G V K + VA+K +++ + Q E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDK 155
Query: 406 ----NIVKLLGC-------CLETEVPLL---VYEFVPNGTLYQNIHNHIEEFPITWELLL 451
N++ +L C+ E LL +YE + N + F + L+
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKK--------NKFQGFSLP--LVR 203
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSITVDQTHLT 509
+ A + L LH I D+K NILL + R+ KV DFG+S + +
Sbjct: 204 KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVY 257
Query: 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
T +Q F Y PE +++ D++S G +L E+LTG
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 45/228 (19%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQF----INEVVIL 399
EK D Y + ++G+G G V K + VA+K K N + F EV +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-----NKKAFLNQAQIEVRLL 104
Query: 400 SQINHR------NIVKLLGC-------CLETEVPLL---VYEFVPNGTLYQNIHNHIEEF 443
+N IV L CL E +L +Y+ + N +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRN--------TNFRGV 154
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA--KVSDFGTSRSI 501
+ L + A ++ AL +L + +SI D+K NILL + R+ K+ DFG+S
Sbjct: 155 SLN--LTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--- 208
Query: 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
+ +Q F Y PE + D++S G +LVE+ TG+
Sbjct: 209 CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-13
Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 8/68 (11%)
Query: 199 TSSGYHCKCNKGYEGNPYLSDG-CRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257
GY C C G++ C D++E +DP + C+ +C N G Y C+C +GF+ D
Sbjct: 46 LKIGYECLCPDGFQLVA---QRRCEDIDECQDP--DTCSQLCVNLEGGYKCQCEEGFQLD 100
Query: 258 GRRDGGGC 265
C
Sbjct: 101 P--HTKAC 106
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A Length = 107 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-11
Identities = 17/76 (22%), Positives = 26/76 (34%), Gaps = 15/76 (19%)
Query: 199 TSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR--G 256
S Y + G NE D + C+++C++ Y C CP GF+
Sbjct: 9 PMSDYDIPTTENLYF-----QGAMGTNECLDNN-GGCSYVCNDLKIGYECLCPDGFQLVA 62
Query: 257 DGR-------RDGGGC 265
R +D C
Sbjct: 63 QRRCEDIDECQDPDTC 78
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 56/242 (23%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVE--QFINEVVILSQIN- 403
Y + LG+G G V+K + G +VAVKK +N+ + + E++IL++++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 404 HRNIVKLLGCCLETEVPL--------LVYEFVPNGT-LYQNIH-NHIEEFPITWEL--LL 451
H NIV LL V LV++++ T L+ I N +E + + L+
Sbjct: 68 HENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLI 119
Query: 452 RIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK 511
+ + YLHS + RD+K +NILL+ + KV+DFG SRS +
Sbjct: 120 K-------VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 512 VQGTFGYVDP---------EY------------FQSSQFTEKSDVYSFGVVLVEILTGQK 550
+ +Y S+++T+ D++S G +L EIL G K
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-K 228
Query: 551 PI 552
PI
Sbjct: 229 PI 230
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 7e-12
Identities = 26/93 (27%), Positives = 34/93 (36%), Gaps = 18/93 (19%)
Query: 178 CEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG--CRDVNEFEDPSLNNC 235
C A C N + C+C +GY N C D++E + N C
Sbjct: 6 CSLKPSICGTAVCK----NIPGD--FECECPEGYRYNL---KSKSCEDIDECSE---NMC 53
Query: 236 THICDNTAGNYTCRC--PKGFRGDGRRDGGGCI 266
+C N G YTC C KGF+ D C
Sbjct: 54 AQLCVNYPGGYTCYCDGKKGFKLAQ--DQKSCE 84
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} Length = 87 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-07
Identities = 13/45 (28%), Positives = 21/45 (46%), Gaps = 2/45 (4%)
Query: 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
+DV+E T +C N G++ C CP+G+R + C
Sbjct: 1 KDVDECSLKPSICGTAVCKNIPGDFECECPEGYRYNL--KSKSCE 43
|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 21/78 (26%), Positives = 30/78 (38%), Gaps = 4/78 (5%)
Query: 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTC 248
S + + T C KGY C D++E E +C NT G++ C
Sbjct: 74 SLGAAWGSPCTLCQVDPICGKGYSRIKGTQ--CEDIDECEVFPGVCKNGLCVNTRGSFKC 131
Query: 249 RCPKGFRGDGRRDGGGCI 266
+CP G D G C+
Sbjct: 132 QCPSGMTLDA--TGRICL 147
|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 9e-06
Identities = 9/67 (13%), Positives = 17/67 (25%), Gaps = 14/67 (20%)
Query: 202 GYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRR- 260
+ C+C+ +P C + + T C T + C +
Sbjct: 23 SFICECSSESTLDPT-KTICIETIK--------GT--CWQTVIDGRCEININGATLKSQC 71
Query: 261 --DGGGC 265
G
Sbjct: 72 CSSLGAA 78
|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} Length = 147 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-05
Identities = 11/45 (24%), Positives = 17/45 (37%), Gaps = 4/45 (8%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267
D++E E +C N+ G++ C C D CI
Sbjct: 3 DIDECESS--PCINGVCKNSPGSFICECSSESTLDP--TKTICIE 43
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 74/377 (19%), Positives = 116/377 (30%), Gaps = 130/377 (34%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQFINEVVILSQI-- 402
Y+ R LG G TV+ + + VA+K KS E+ E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92
Query: 403 ------NHRNIVKLLGCCLETEVPLLVYEFV---PNGT--------LYQNIHNHIEEFP- 444
N +V+LL F NGT L ++ I +
Sbjct: 93 SDPNDPNREMVVQLLDD------------FKISGVNGTHICMVFEVLGHHLLKWIIKSNY 140
Query: 445 --ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL------------------ 484
+ + +I +V L YLH+ I I+ DIK NILL
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCRI-IHT-DIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 485 -------------------------------DDKYRAKVSDFGTSRSITVDQTHLTTKVQ 513
+K + K++D G + H T +Q
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ 255
Query: 514 GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRS----------L 563
T Y E S + +D++S + E+ TG + +E L
Sbjct: 256 -TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 564 VG---------------YF--------LQAMNENRLFEVLDALVLKEAEREEIMTVATLA 600
+G +F + + LFEVL E +EE
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFL 372
Query: 601 KRCLNLNGKNRPTMKEV 617
L L + R T E
Sbjct: 373 LPMLELIPEKRATAAEC 389
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* Length = 114 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-10
Identities = 24/96 (25%), Positives = 33/96 (34%), Gaps = 15/96 (15%)
Query: 178 CEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNN-C 235
A +C + +C + C C G+EG C R+V+ N C
Sbjct: 16 HPCASLCCGHGTC------IDGIGSFSCDCRSGWEG-----RFCQREVSFLNCSLDNGGC 64
Query: 236 THICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKN 271
TH C G C C G++ D C P K
Sbjct: 65 THYCLEEVGWRRCSCAPGYKLG--DDLLQCHPAVKF 98
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 61/244 (25%), Positives = 91/244 (37%), Gaps = 69/244 (28%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFIN----EVVILSQINHR 405
+ R +G G G V + + + AVK + N++++ E IL +I +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQND 91
Query: 406 -----NIVKLLGC-------CLETEVPLL---VYEFVPNGTLYQNIHNHIEEFPITWELL 450
NIVK G CL E L +YE + N+ F I E +
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR--------NNYNGFHI--EDI 139
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA-------------------- 490
+E+ AL YL S+ D+K NILLDD Y
Sbjct: 140 KLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 491 -----KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEI 545
K+ DFG + T + + + Y PE + + SD++SFG VL E+
Sbjct: 197 KSTGIKLIDFGCA---TFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 546 LTGQ 549
TG
Sbjct: 253 YTGS 256
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 58/305 (19%), Positives = 92/305 (30%), Gaps = 84/305 (27%)
Query: 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFIN 394
K D +++LG G G V + A+K
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-------- 59
Query: 395 EVVILSQI-NHRNIVKLLGCCLETEVP-----LLVYEFVPNGTLYQNI----HNHIEEFP 444
EV + + +IV+++ E L+V E + G L+ I E
Sbjct: 60 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-- 116
Query: 445 ITWELLLRIAVEV----SGALFYLHSAASISIYRRDIKSANILLDDKYRA---KVSDFGT 497
R A E+ A+ YLHS I+I RD+K N+L K K++DFG
Sbjct: 117 -------REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG- 165
Query: 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557
+ G Y + D++S GV++ +L G P + +
Sbjct: 166 ----------FAKETTGE-KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHG 203
Query: 558 DEDRSLVGYFLQAMNENRLFE-VLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRP 612
+ + E E V+ K L R
Sbjct: 204 LAI------------SPGMKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRM 249
Query: 613 TMKEV 617
T+ E
Sbjct: 250 TITEF 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 53/243 (21%), Positives = 89/243 (36%), Gaps = 65/243 (26%)
Query: 348 TDNYNANRILGQGGQGTVYKGM--LADGRIVAVKKSKLVDENNVEQFIN----EVVILSQ 401
+ Y LG+G G V + + VA+K + NV ++ E+ +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKK 72
Query: 402 INHR------NIVKLLGC-------CLETEVPLL---VYEFVPNGTLYQNIHNHIEEFPI 445
I + V + C+ E LL +EF+ N+ + +P+
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKE--------NNFQPYPL 122
Query: 446 TWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA--------------- 490
+ +A ++ AL +LH + D+K NIL +
Sbjct: 123 --PHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 491 ----KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEIL 546
+V+DFG++ T D H TT V Y PE + + DV+S G +L E
Sbjct: 178 NTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 547 TGQ 549
G
Sbjct: 234 RGF 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-09
Identities = 67/482 (13%), Positives = 129/482 (26%), Gaps = 170/482 (35%)
Query: 215 PYLSD-GCRDVNEFEDPSLNN--CTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKN 271
++ + C+DV + L+ HI + + +
Sbjct: 28 AFVDNFDCKDVQDMPKSILSKEEIDHIIMS-------------------------KDAVS 62
Query: 272 LIKVALGAGCSGGLGLLFLIVGIWGLYKFTKKRREIKSKQKFF----KRNGGLLLQQELS 327
G L L W K+ E+ QKF + N L+ +
Sbjct: 63 --------------GTLRL---FW---TLLSKQEEM--VQKFVEEVLRINYKFLMSPIKT 100
Query: 328 SNKSSVEKTKLFTSKDLEKATDN-----YNANRI-----LGQG------GQGTVYKGMLA 371
+ T+++ + DN YN +R+ L Q + + G+L
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 372 DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL----- 421
G K+ + + ++ L+ L C E L
Sbjct: 161 SG------KTWVALDVCLSYKVQCKMDFKIFWLN----------LKNCNSPETVLEMLQK 204
Query: 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481
L+Y+ PN + + +H + + L L + + ++
Sbjct: 205 LLYQIDPN---WTSRSDHSSNIKLRIH-------SIQAELRRL-------LKSKPYENCL 247
Query: 482 ILLDDKYRAKVS---DFG-----TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKS 533
++L + AK + T+R V T + S T
Sbjct: 248 LVLLNVQNAKAWNAFNLSCKILLTTRFKQV-----TDFLSAATTTHISLDHHSMTLTPDE 302
Query: 534 DVYSFGVVL--------VEILTG-------------QKPIRA-----INIDEDRSLVGYF 567
L E+LT +N D+ +++
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS 362
Query: 568 LQAMNEN---RLFEVL-----DAL----VLK----EAEREEIMTVAT-LAKRCL-NLNGK 609
L + ++F+ L A +L + + ++M V L K L K
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422
Query: 610 NR 611
Sbjct: 423 ES 424
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Length = 186 | Back alignment and structure |
|---|
Score = 56.6 bits (135), Expect = 2e-09
Identities = 22/95 (23%), Positives = 31/95 (32%), Gaps = 5/95 (5%)
Query: 173 TTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSL 232
T + + CG + C + S C C G NP C E
Sbjct: 88 TCVLDVCQYXNCGESGECIVEYLSEIQS--AGCSCAIGXVPNPEDEXXCTXTGETACQLX 145
Query: 233 N-NCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
+C N G Y C+C +GF D + C+
Sbjct: 146 CNTDNEVCXNVEGVYXCQCMEGFTFD--XEXNVCL 178
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Length = 186 | Back alignment and structure |
|---|
Score = 51.2 bits (121), Expect = 2e-07
Identities = 13/75 (17%), Positives = 20/75 (26%), Gaps = 2/75 (2%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243
CG C ++ D + Y C C +GY C +
Sbjct: 56 CGEFGQCIENPDPAQVNM-YXCGCIEGYTLXEDTCV-LDVCQYXNCGESGECIVEYLSEI 113
Query: 244 GNYTCRCPKGFRGDG 258
+ C C G +
Sbjct: 114 QSAGCSCAIGXVPNP 128
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A Length = 186 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 7e-07
Identities = 17/118 (14%), Positives = 30/118 (25%), Gaps = 24/118 (20%)
Query: 178 CEEAKI----CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLN 233
E + + N S+ + C CN+G + C + NE +L
Sbjct: 2 AEASAVTVDTICXNGQL------VQMSNHFXCMCNEGLVHLS--ENTCEEXNECXXETLG 53
Query: 234 N--------CTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSG 283
+ Y C C +G+ C+ + C
Sbjct: 54 XACGEFGQCIENPDPAQVNMYXCGCIEGYTL----XEDTCVLDVCQYXNCGESGECIV 107
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 1e-08
Identities = 36/254 (14%), Positives = 75/254 (29%), Gaps = 71/254 (27%)
Query: 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNV--------EQFINEVVI 398
T+ +G+G G V++ + AD VA+K + + V E+ + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 399 LSQI---------NHRNIVKLLGCCL----------------------ETEVPL------ 421
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 422 --LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKS 479
+V EF G + + + + I +++ +L + S+ RD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL----SSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 480 ANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG---------------YVDPEYF 524
N+LL K+ +S T+ L + + +D + F
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI-IDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 525 QSSQFTEKSDVYSF 538
+ D+Y
Sbjct: 250 T-GDGDYQFDIYRL 262
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 65/240 (27%)
Query: 351 YNANRILGQGGQGTVYKG--MLADGRIVAVKKSKLVDENNVEQFIN----EVVILSQINH 404
Y LG+G G V + A GR VAVK K NV+++ E+ +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNT 70
Query: 405 R------NIVKLLGC-------CLETEVPLL---VYEFVPNGTLYQNIHNHIEEFPITWE 448
V++L C+ E LL Y+F+ N F + +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKE--------NGFLPFRL--D 118
Query: 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL-DDKYRA----------------- 490
+ ++A ++ ++ +LHS + D+K NIL Y
Sbjct: 119 HIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 491 -KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ 549
KV DFG++ T D H +T V Y PE + +++ DV+S G +L+E G
Sbjct: 176 IKVVDFGSA---TYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 50/239 (20%), Positives = 93/239 (38%), Gaps = 38/239 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRN 406
+ + R +G G G +Y G + VA+K + + Q + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 407 IVKLLGCCLETEVPLLVYEFV-PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
I + +E + +LV + + P+ L + + + + +L +A ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 466 SAASISIYRRDIKSANILLDDKYRAK---VSDFGTSRSITVDQTHL------TTKVQGTF 516
S + + RDIK N L+ RA + DFG ++ TH + GT
Sbjct: 121 SKSFLH---RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 517 GYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINIDEDRSLVG 565
Y +S E+S D+ S G VL+ L G P ++A + +
Sbjct: 178 RY-------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 22/87 (25%), Positives = 32/87 (36%), Gaps = 16/87 (18%)
Query: 184 CGPNASCDKSKDNTTTSSGYHC-KCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT-----H 237
C P A C ++ + C C G+ GN C D++E + C
Sbjct: 11 CFPGAQC-----SSFPDGSWSCGFCPVGFLGNGT---HCEDLDECAL-VPDICFSTSKVP 61
Query: 238 ICDNTAGNYTC-RCPKGFRGDGRRDGG 263
C NT + C CP +RG+ G
Sbjct: 62 RCVNTQPGFHCLPCPPRYRGNQPVGVG 88
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* Length = 634 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 16/88 (18%), Positives = 31/88 (35%), Gaps = 4/88 (4%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243
C +A C + Y C+C GY G+ + D++ + + +L T+ +
Sbjct: 112 CHKHAEC--IYLGHFSDPMYKCECQTGYAGDGLICGEDSDLDGWPNLNLVCATNATYHCI 169
Query: 244 GNYTCRCPKGFRGDGRRDGGGCIPNQKN 271
+ P + D D G +
Sbjct: 170 KDNCPHLPNSGQEDF--DKDGIGDACDD 195
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L Length = 400 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 1e-07
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 12/86 (13%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243
G + C GY C C G++ C D++E +DP C+ +C N
Sbjct: 8 GGCSHVC------NDLKIGYECLCPDGFQLVAQRR--CEDIDECQDPD--TCSQLCVNLE 57
Query: 244 GNYTCRCPKGFRGDGRRDGGGCIPNQ 269
G Y C+C +GF+ D C
Sbjct: 58 GGYKCQCEEGFQLDP--HTKACKAVG 81
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 53/239 (22%), Positives = 92/239 (38%), Gaps = 38/239 (15%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINH-RN 406
+ Y R +G G G +Y G +A G VA+K + + Q E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 407 IVKLLGCCLETEVPLLVYEFV-PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
I + C E + ++V E + P+ L + +F + + +L +A ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 466 SAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSITVDQTHL------TTKVQGTF 516
S I RD+K N L+ + DFG ++ +TH + GT
Sbjct: 123 SKNFIH---RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 517 GYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINIDEDRSLVG 565
Y +S E+S D+ S G VL+ G P ++A + +
Sbjct: 180 RY-------ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... Length = 134 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 14/58 (24%), Positives = 23/58 (39%), Gaps = 8/58 (13%)
Query: 202 GYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257
Y C C +G+EG C ++ + SL+N C + C C +G+
Sbjct: 62 EYTCTCLEGFEG-----KNC-ELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLA 113
|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... Length = 142 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 14/60 (23%), Positives = 21/60 (35%), Gaps = 9/60 (15%)
Query: 202 GYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNN--CTHICDNTAGN-YTCRCPKGFRGD 257
Y C C +EG C ++ N C C + G +CRC +G+
Sbjct: 67 SYICFCLPAFEGR-----NCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHEGYSLL 121
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 16/76 (21%), Positives = 25/76 (32%), Gaps = 14/76 (18%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDN 241
C C Y C C +G+EG C ++ + SL+N C
Sbjct: 50 CQNQGKC------KDGLGEYTCTCLEGFEG-----KNC-ELFTRKLCSLDNGDCDQFCHE 97
Query: 242 TAGNYTCRCPKGFRGD 257
+ C C +G+
Sbjct: 98 EQNSVVCSCARGYTLA 113
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 11/91 (12%), Positives = 17/91 (18%), Gaps = 16/91 (17%)
Query: 171 EITTIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNE-FE 228
E+ T + C + C + C C +GY +
Sbjct: 77 ELFTRKLCSL-DNGDCDQFC------HEEQNSVVCSCARGYTLAD-----NGKACIPTGP 124
Query: 229 DPSLNNCTHICDNTAGNYTCRCPKGFRGDGR 259
P G D
Sbjct: 125 YPCGKQTL--ERRKRSVAQATSSSGEAPDSI 153
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* Length = 195 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 18/80 (22%), Positives = 28/80 (35%), Gaps = 7/80 (8%)
Query: 179 EEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNE-FEDPSLNNCTH 237
EE K C + + + +K E + +D ++ P N
Sbjct: 1 EEMKKGHLERECMEETCSYEEAREVFEDSDKTNEF----WNKYKDGDQCETSPCQNQ--G 54
Query: 238 ICDNTAGNYTCRCPKGFRGD 257
C + G YTC C +GF G
Sbjct: 55 KCKDGLGEYTCTCLEGFEGK 74
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 8e-07
Identities = 20/77 (25%), Positives = 27/77 (35%), Gaps = 13/77 (16%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDG--CRDVNEFEDPSLNNCTHICDN 241
G C C C+ GY DG C+DVNE + C+ C N
Sbjct: 11 GGCAQKC------QMIRGAVQCTCHTGYR---LTEDGRTCQDVNECAEEG--YCSQGCTN 59
Query: 242 TAGNYTCRCPKGFRGDG 258
+ G + C C G+
Sbjct: 60 SEGAFQCWCEAGYELRP 76
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 45/241 (18%), Positives = 86/241 (35%), Gaps = 40/241 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRN 406
+Y R +G+G G +++G L + + VA+K ++ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 407 IVKLLGCCLETEVPLLVYEFV-PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
I + E +LV + + P+ ++ +F + + + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSV--KTVAMAAKQMLARVQSIH 123
Query: 466 SAASISIYRRDIKSANILLDDKYRAK-----VSDFGTSRSITVDQTHL------TTKVQG 514
+ + RDIK N L+ V DFG + T + G
Sbjct: 124 EKSLVY---RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 515 TFGYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINIDEDRSLV 564
T Y S E+S D+ + G V + L G P ++A + +
Sbjct: 181 TARY-------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233
Query: 565 G 565
G
Sbjct: 234 G 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/183 (20%), Positives = 60/183 (32%), Gaps = 36/183 (19%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSK--------LVDENNVEQFINEVVILS 400
+ + +G GG G +Y A K L E Q + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 401 QINHRNIVKLLGCCLETEVPLLVY--EFVPNGTLY------------QNIHNHIEEFPIT 446
+ R + LG +PL G Y Q I F
Sbjct: 98 KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV--SDFGTSRSITVD 504
+L++ + + L Y+H + DIK+AN+LL K +V +D+G S +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 505 QTH 507
H
Sbjct: 207 GNH 209
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 Length = 53 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 6e-06
Identities = 13/46 (28%), Positives = 18/46 (39%), Gaps = 9/46 (19%)
Query: 223 DVNE-------FEDPSLNNCTHICDNTAGNYTCRCPKGFR--GDGR 259
D++E E+ C H+C N G Y C C G+ D
Sbjct: 3 DLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQEDRH 48
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* Length = 146 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 12/57 (21%), Positives = 14/57 (24%), Gaps = 7/57 (12%)
Query: 202 GYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257
Y C C G+EG C D C C G+R
Sbjct: 68 SYECWCQVGFEG-----KNCELDATCNIKNGRCKQFC-KTGADSKVLCSCTTGYRLA 118
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} Length = 143 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-06
Identities = 24/77 (31%), Positives = 34/77 (44%), Gaps = 10/77 (12%)
Query: 184 CGPNASCDKSKDNTT-TSSGYHCKCNKGYEGNPYLSDGC-RDVNE-FEDPSLNNCTHICD 240
C +C+ S+ T GY CKC +G+ G C ++NE +P N C
Sbjct: 60 CHNGGTCEISEAYRGDTFIGYVCKCPRGFNG-----IHCQHNINECEVEPCKNGGI--CT 112
Query: 241 NTAGNYTCRCPKGFRGD 257
+ NY+C CP F G
Sbjct: 113 DLVANYSCECPGEFMGR 129
|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A Length = 169 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 18/86 (20%)
Query: 176 ETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNEFEDPS--L 232
C++ C P+ C + + + C C + G C +D+N L
Sbjct: 94 LYCDK---CIPHPGCV----HGICNEPWQCLCETNWGG-----QLCDKDLNYCGTHQPCL 141
Query: 233 NNCTHICDNTA-GNYTCRCPKGFRGD 257
N T C NT Y C CP+G+ G
Sbjct: 142 NGGT--CSNTGPDKYQCSCPEGYSGP 165
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 25/102 (24%), Positives = 34/102 (33%), Gaps = 12/102 (11%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNEFEDPSLNNCTHICDNT 242
C N SC +D+ GY C C+ GYEG C NE + C H C
Sbjct: 13 CLHNGSC---QDS---IWGYTCTCSPGYEG-----SNCELAKNECHPERTDGCQHFCLPG 61
Query: 243 AGNYTCRCPKGFRGDGRRDGGGCIPNQKNLIKVALGAGCSGG 284
+YTC C +G+R + +
Sbjct: 62 QESYTCSCAQGYRLGEDHKQCVPHDQCACGVLTSEKRAPDLQ 103
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-05
Identities = 22/76 (28%), Positives = 30/76 (39%), Gaps = 15/76 (19%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNE-FEDPSLNNCTHICDN 241
C C T + C+C +GY G C DVNE +P N+ T C +
Sbjct: 15 CEHAGKC------INTLGSFECQCLQGYTG-----PRCEIDVNECVSNPCQNDAT--CLD 61
Query: 242 TAGNYTCRCPKGFRGD 257
G + C C G+ G
Sbjct: 62 QIGEFQCICMPGYEGV 77
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* Length = 135 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 21/76 (27%), Positives = 29/76 (38%), Gaps = 15/76 (19%)
Query: 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGC-RDVNE-FEDPSLNNCTHICDN 241
C +A+C + C C GYEG C + +E P L+N C +
Sbjct: 53 CQNDATC------LDQIGEFQCICMPGYEG-----VHCEVNTDECASSPCLHNGR--CLD 99
Query: 242 TAGNYTCRCPKGFRGD 257
+ C CP GF G
Sbjct: 100 KINEFQCECPTGFTGH 115
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 46/240 (19%), Positives = 88/240 (36%), Gaps = 40/240 (16%)
Query: 350 NYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNI 407
N+ + +G G G + G L VA+K + ++ Q E Q+ + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 408 VKLLGCCLETEVPLLVYEFV-PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
++ + +V E + P+ ++ + F + + +L IA+++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDR--TFSL--KTVLMIAIQLISRMEYVHS 123
Query: 467 AASISIYRRDIKSANILLDDKYRAKVS-----DFGTSRSITVDQTHL------TTKVQGT 515
I RD+K N L+ DF ++ +T + GT
Sbjct: 124 KNLIY---RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 516 FGYVDPEYFQSS----QFTEKS---DVYSFGVVLVEILTGQKP---IRAINIDEDRSLVG 565
Y S E+S D+ + G + + L G P ++A + E +G
Sbjct: 181 ARY-------MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 Length = 51 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-05
Identities = 10/44 (22%), Positives = 16/44 (36%), Gaps = 8/44 (18%)
Query: 231 SLNN--CTHICDNTAGNYTCRCPKGFR--GDGRRDGGGCIPNQK 270
SL+N C C C C G+ D + C+ ++
Sbjct: 2 SLDNGGCDQFCREERSEVRCSCAHGYVLGDDSKS----CVSTER 41
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 28/180 (15%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 350 NYNANRILGQGGQGTVYKGM---------LADGRIVAVK----KSKLVDENNVEQF---- 392
+ + QG +Y+ + ++K +L +E N Q
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 393 --INEVVILSQINHRNIVKLLGC-CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL 449
+N+ L I +G + + LV + G Q+ + + ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERS 160
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV--SDFGTSRSITVDQTH 507
+L++A + AL +LH + ++ + NI +D + +++V + +G + H
Sbjct: 161 VLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 36/186 (19%), Positives = 63/186 (33%), Gaps = 39/186 (20%)
Query: 350 NYNANRILGQGGQGTVYKGM------LADGRIVAVKKSK-----LVDENNVEQFINEVVI 398
+ +GQGG G +Y + VK L E Q +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVY--EFVPNGTLY---------QNIHNHIEE----F 443
+ + +K LG VP NG Y ++ E F
Sbjct: 96 IQKWIRTRKLKYLG------VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 444 PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV--SDFGTSRSI 501
+ +L++++ + L Y+H + DIK++N+LL+ K +V D+G +
Sbjct: 150 SR--KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
Query: 502 TVDQTH 507
+ H
Sbjct: 205 CPEGVH 210
|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A Length = 91 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 1e-04
Identities = 14/56 (25%), Positives = 19/56 (33%), Gaps = 6/56 (10%)
Query: 203 YHCKCNKGYEGNPYLSDGCRDVNE-FEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257
+C CN G V E N T ++ C+CP+GF G
Sbjct: 32 EYCWCNSGRAQC-----HSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGK 82
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... Length = 55 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 1e-04
Identities = 12/41 (29%), Positives = 18/41 (43%), Gaps = 8/41 (19%)
Query: 231 SLNN--CTHICDNTAGNYTCRCPKGFR--GDGRRDGGGCIP 267
SL+N C C + C C +G+ +G+ CIP
Sbjct: 5 SLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKA----CIP 41
|
| >4aqt_A Laminin subunit gamma-1; cell adhesion; HET: NAG BMA; 3.20A {Mus musculus} Length = 375 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 34/187 (18%), Positives = 49/187 (26%), Gaps = 31/187 (16%)
Query: 107 NGSCIGTGCCQIEIPRGSFKNHTNVSSFNPCTYAFVVDQSQFHFTSNYL-AFDGIPDDFP 165
G + + +F N + + T V F + +
Sbjct: 185 TGGNVAFSTLEGRPSAYNFDNSPVLQEWVTATDIRVTLNRLNTFGDEVFNEPKVLKSYYY 244
Query: 166 IVLDWEITTIETCEE-AKICGPNAS---CDKSKDNTTTSSGYHC-KCNKGYEGNPYLSDG 220
+ D+ + C A C N K NT G C KC + P+
Sbjct: 245 AISDFAVGGRCKCNGHASECVKNEFDKLMCNCKHNTY---GVDCEKCLPFFNDRPWRRAT 301
Query: 221 CRDVNEFE-------------DPSLNNCTH---ICDNTAGNYT---C-RCPKGFRGDGRR 260
+E DP L T C N N C RC + F G
Sbjct: 302 AESASECLPCDCNGRSQECYFDPELYRSTGHGGHCTNCRDNTDGAKCERCRENFFRLGNT 361
Query: 261 DGGGCIP 267
+ C P
Sbjct: 362 E--ACSP 366
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 99.17 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 99.07 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 99.04 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 99.03 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 98.9 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 98.87 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 98.84 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 98.8 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 98.76 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 98.66 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 98.66 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 98.59 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 98.59 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 98.59 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 98.56 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 98.51 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 98.37 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 98.23 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 98.21 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 98.16 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 98.13 | |
| 1uzk_A | 162 | Fibrillin-1; glycoprotein, extra-cellular matrix, | 98.12 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 97.97 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 97.86 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.46 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 97.46 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 97.35 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 97.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.24 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 97.21 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.13 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.1 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 97.09 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.09 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.06 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 97.04 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.86 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.82 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 96.82 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 96.8 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 96.79 | |
| 1kig_L | 51 | Factor XA; glycoprotein, serine protease, plasma, | 96.72 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 96.71 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 96.65 | |
| 1kli_L | 69 | Factor VIIA; extrinsic coagulation pathway, serine | 96.55 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 96.52 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.49 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 96.42 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 96.37 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 96.36 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 96.28 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 96.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.24 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 96.22 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 96.21 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 96.18 | |
| 2wph_E | 59 | Coagulation factor IXA light chain; serine proteas | 96.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.09 | |
| 1n7d_A | 699 | LDL receptor, low-density lipoprotein receptor; fa | 96.04 | |
| 4fbr_A | 267 | Lectin, myxobacterial hemagglutinin; beta-barrel, | 95.91 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 95.9 | |
| 2bz6_L | 53 | Blood coagulation factor VIIA; serine protease, en | 95.86 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 95.85 | |
| 1nzi_A | 159 | Complement C1S component; calcium, innate immunity | 95.74 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 95.69 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 95.67 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 95.61 | |
| 3m0c_C | 791 | LDL receptor, low-density lipoprotein receptor; pr | 95.61 | |
| 2kl7_A | 71 | Fibulin-4; secreted, calcium, disease mutation, di | 95.59 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 95.51 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 95.37 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 95.32 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 95.2 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 95.06 | |
| 3f1s_B | 283 | Vitamin K-dependent protein Z; PZ, ZPI, complex, s | 94.84 | |
| 3v64_C | 349 | Agrin; beta propeller, laminin-G, signaling, prote | 94.78 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 94.72 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 94.56 | |
| 2w86_A | 147 | Fibrillin-1, fibrillin1; phosphoprotein, EGF-like | 94.51 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 94.46 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 94.37 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 94.33 | |
| 2wg3_C | 463 | Hedgehog-interacting protein; lipoprotein, develop | 94.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.08 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 94.07 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 94.02 | |
| 2c4f_L | 142 | Coagulation factor VII precursor; blood coagulatio | 94.01 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 93.94 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 93.8 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 93.62 | |
| 3fcs_B | 690 | Integrin beta-3; beta propeller, rossmann fold, EG | 93.5 | |
| 2vh0_B | 134 | Activated factor XA light chain; serine protease, | 93.49 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 93.42 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 92.5 | |
| 1ijq_A | 316 | LDL receptor, low-density lipoprotein receptor; be | 92.11 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 91.98 | |
| 2ygq_A | 324 | WIF-1, WNT inhibitory factor 1; signaling protein, | 91.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.75 | |
| 4a0p_A | 628 | LRP6, LRP-6, low-density lipoprotein receptor-rela | 91.37 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 90.77 | |
| 3cfw_A | 164 | L-selectin; EGF, cell adhesion, EGF-like domain, g | 90.56 | |
| 2gy5_A | 423 | Angiopoietin-1 receptor; ligand-binding domain, tr | 90.29 | |
| 3k6s_B | 687 | Integrin beta-2; cell receptor, adhesion molecule, | 90.08 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 89.35 | |
| 1q4g_A | 553 | Prostaglandin G/H synthase 1; cyclooxygenase, non- | 89.09 | |
| 3s94_A | 619 | LRP-6, low-density lipoprotein receptor-related pr | 88.96 | |
| 1g1s_A | 162 | P-selectin; selectin, lectin, EGF, sulphated, SLEX | 88.83 | |
| 1szb_A | 170 | Mannose binding lectin-associated serine protease- | 88.79 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.62 | |
| 3e50_C | 50 | Protransforming growth factor alpha; IDE, TGF-alph | 88.5 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 88.24 | |
| 3nt1_A | 587 | Prostaglandin-endoperoxide synthase 2; prostagland | 88.03 | |
| 3f1s_B | 283 | Vitamin K-dependent protein Z; PZ, ZPI, complex, s | 87.81 | |
| 3v64_C | 349 | Agrin; beta propeller, laminin-G, signaling, prote | 87.46 | |
| 3sov_A | 318 | LRP-6, low-density lipoprotein receptor-related pr | 87.28 | |
| 2vj2_A | 169 | Jagged-1; signalling, polymorphism, glycoprotein, | 86.19 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 85.9 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 85.77 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.41 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.92 | |
| 1xdt_R | 79 | Hbegf, heparin-binding epidermal growth factor; co | 82.06 | |
| 4aqs_A | 525 | Laminin subunit beta-1; cell adhesion; HET: NAG BM | 81.02 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.57 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=452.28 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=217.6
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999864 467899999987777777899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 423 VYEFVPNGTLYQNIHNHI----------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
||||+++|+|.++|+... ....++|.++++|+.|||+||+|||++ +|+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 234699999999999999999999998 9999999999999999999999
Q ss_pred EecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 999999876543332 2334569999999999999999999999999999999999 999997643221 1112
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
+..+.. ...+...+.++.+|+.+||+.||++||||++|++.|+++.+.
T Consensus 243 i~~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 221111 122334556789999999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=454.14 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=211.4
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.++||+|+||+||+|+++ +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777899999999999999864 478899999988777777899999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 423 VYEFVPNGTLYQNIHNHIE------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
||||+++|+|.++|+.... ..+++|.++++|+.|||+||+|||+. +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999986432 24699999999999999999999998 99999999999999999999
Q ss_pred EEEecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhH
Q 038345 491 KVSDFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 491 kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~ 568 (686)
||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 999999998764333 223345679999999999999999999999999999999999 999997543221 11
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..+..+. ....+...+.++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 271 ~~i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1111111 1122334456789999999999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=447.88 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=212.3
Q ss_pred cccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
.++++.++||+|+||+||+|.+. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 4678999998653 3334578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 422 LVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
|||||+++|+|.++|+.... ...++|..+++|+.|||+||+|||+. +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999975321 23699999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHh
Q 038345 489 RAKVSDFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~ 566 (686)
++||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||.+....+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 99999999998765333 223345679999999999999999999999999999999999 899997643221
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
+...+..+. ....+...+..+.+|+.+||+.||++||||+||++.|+.+
T Consensus 256 ~~~~i~~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQ---------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222221 1122334566789999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=441.24 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=206.9
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..+++.+.++||+|+||+||+|++.+ .||||.++.. .....+.|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34567888999999999999999754 5999987653 34556789999999999999999999999865 5689999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.++|+... .+++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999998643 3599999999999999999999998 9999999999999999999999999999876432
Q ss_pred C-ceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 505 Q-THLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 505 ~-~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
. ........||+.|||||++.+ +.++.++|||||||+||||+||+.||......+ .+...+..+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~---- 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA---- 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----
Confidence 2 233445679999999999864 468999999999999999999999997543211 11111111100
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.+. ....+...+..+.+|+.+||+.||++||||.||++.|+.|+..
T Consensus 256 ~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 010 0122234456789999999999999999999999999988644
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=440.21 Aligned_cols=271 Identities=28% Similarity=0.411 Sum_probs=222.1
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEeCC------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCC-CCeeeE
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLV-DENNVEQFINEVVILSQINH-RNIVKL 410 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l 410 (686)
+..++++...++|.+.+.||+|+||+||+|.+.. ++.||||+++.. .....+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556677778899999999999999999998642 368999998654 33456789999999999965 999999
Q ss_pred EeEEeeC-CcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeC
Q 038345 411 LGCCLET-EVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476 (686)
Q Consensus 411 ~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~D 476 (686)
+|+|.+. ...+|||||+++|+|.++|+.... ...++|..++.|+.|||+||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999765 568999999999999999976422 24589999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCcc
Q 038345 477 IKSANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 554 (686)
Q Consensus 477 ikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~ 554 (686)
|||+||||++++.+||+|||+|+....+.. .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654433 33445679999999999999999999999999999999998 9999976
Q ss_pred CCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 555 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
....+ .+...+..+. ....+...+.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 291 ~~~~~------~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 54321 1222222211 1122233456789999999999999999999999999988654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=432.89 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=203.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++|.+.+.||+|+||+||+|+.. +|+.||||++... .....+.|.+|+.+|++|+|||||++++++.+.+..||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999964 6899999987542 4455678999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999997543 33589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. .......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ...+..... +..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~-~~~-------- 242 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIIS-GSF-------- 242 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH-TCC--------
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHc-CCC--------
Confidence 1 223446799999999999999999999999999999999999999975432 111111111 111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112234567889999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=428.32 Aligned_cols=270 Identities=21% Similarity=0.282 Sum_probs=203.5
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----cceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE----VPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lV~ 424 (686)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++|++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3577889999999999999998 589999999864322 1122334666667889999999999998764 468999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA-----ASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
||+++|+|.++|++. +++|..+++|+.|+++||+|||++ +.++|+||||||+||||+.++++||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999864 499999999999999999999976 24589999999999999999999999999998
Q ss_pred cccCCCcee---eeeeeccccccCccccccC------CCCccccEeehHHHHHHHHhCCCCCccCCcccCC--------c
Q 038345 500 SITVDQTHL---TTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR--------S 562 (686)
Q Consensus 500 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~--------~ 562 (686)
......... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+......+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433222 2345799999999998764 4678999999999999999999887543321110 0
Q ss_pred hhHhhHHHhhcchhhhhhhhhccC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 563 LVGYFLQAMNENRLFEVLDALVLK-EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 563 l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
............. +++.+.. ....+.+..+.+|+.+||+.||++||||.||++.|+.|....
T Consensus 237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 0111111111111 1111111 112345678999999999999999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=426.41 Aligned_cols=256 Identities=22% Similarity=0.234 Sum_probs=208.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.+.|...++||+|+||+||+|+.. +|+.||||+++... .+.+|+.++++++|||||++++++.+.+..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888899999999999999965 58999999986422 234799999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccccCCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~ 505 (686)
+++|+|.++|.+.. .+++..++.++.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998643 599999999999999999999999 999999999999999887 69999999998765432
Q ss_pred ce----eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 506 TH----LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 506 ~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.. ....+.||+.|||||++.+..++.++|||||||+||||++|+.||......+ +.. ........
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~~~----- 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIASEPPP----- 274 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHHHSCCG-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHcCCCC-----
Confidence 21 1233579999999999999999999999999999999999999997644322 111 11111100
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
..+.+...+..+.+++.+||+.||++|||+.|+++.|.......
T Consensus 275 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 275 ---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp ---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 01222344567889999999999999999999999988776543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=428.38 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=208.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
..|...++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46899999999999999999975 68999999987655555677899999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.+. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999999753 499999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+ ..+.... .+. ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~~-----~~~--~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAM-KMIRDNL-----PPR--LK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSS-----CCC--CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcCC-----CCC--CC
Confidence 344568999999999999999999999999999999999999999753321 111 1111110 000 11
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.....+.++.+|+.+||+.||++|||++|++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 1223456788999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=414.89 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=196.4
Q ss_pred ccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcceEEE
Q 038345 352 NANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLVY 424 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 424 (686)
.+.++||+|+||+||+|... ++..||+|++.. ......+.|.+|+.+|++++|||||++++++.+ ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999965 588999998754 344556789999999999999999999999875 34579999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~ 503 (686)
||+++|+|.++|.+.. .+++..+..|+.||+.||+|||++.. +|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998643 69999999999999999999999811 399999999999997 478999999999986432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ......||+.|||||++.+ .++.++|||||||+||||+||+.||..... .. .+...+..+...
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~-~~~~~i~~~~~~------ 248 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AA-QIYRRVTSGVKP------ 248 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HH-HHHHHHTTTCCC------
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HH-HHHHHHHcCCCC------
Confidence 2 2345679999999998865 699999999999999999999999964321 11 111112111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+...+.++.+|+.+||+.||++|||++|++
T Consensus 249 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 011112234688999999999999999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=427.51 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=209.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
..|...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 68999999987666666678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999999753 499999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...... .. ...+.... .+. ..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~-~~~i~~~~-----~~~--~~ 368 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KA-MKMIRDNL-----PPR--LK 368 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH-HHHHHHSC-----CCC--CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HH-HHHHHcCC-----CCC--Cc
Confidence 344568999999999999999999999999999999999999999753321 11 11111110 000 01
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.....+.++.+|+.+||+.||++|||+.|++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell 399 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELL 399 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 1123345688999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=415.82 Aligned_cols=247 Identities=25% Similarity=0.362 Sum_probs=207.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.++||+|+||+||+|+.. +++.||||.+... .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999964 6899999987542 2344578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.++|.+.. .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998643 599999999999999999999999 9999999999999999999999999999977543
Q ss_pred C-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 Q-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ........||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+ ..+...++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~~~------- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIF-AKIIKLEY------- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHTCC-------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHcCCC-------
Confidence 3 23345578999999999999999999999999999999999999999753321 111 11111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+.....++.+|+.+||+.||++|||++|++
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11223345688999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=402.17 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=190.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||+||+|... +++.||||.+... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999964 6899999987542 2333567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+ +|+|.++|.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 68999999764 3599999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ......||+.|||||++.+..+ +.++|||||||+||||++|+.||..... ...+ ..+....
T Consensus 166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~-~~i~~~~-------- 228 (275)
T 3hyh_A 166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLF-KNISNGV-------- 228 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHTC--------
T ss_pred C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHH-HHHHcCC--------
Confidence 2 2345679999999999998876 5799999999999999999999974321 1111 1111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 229 --~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 --YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0112223456889999999999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=404.33 Aligned_cols=250 Identities=23% Similarity=0.360 Sum_probs=190.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-------
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEV------- 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------- 419 (686)
++|++.+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999965 68999999876543 3445779999999999999999999999976543
Q ss_pred -----ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 420 -----PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 420 -----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
.|+||||+++|+|.+++..........+..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 689999999999999998765444567888999999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCce-----------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCch
Q 038345 495 FGTSRSITVDQTH-----------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563 (686)
Q Consensus 495 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l 563 (686)
||+|+........ ..+...||+.|||||++.+..++.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 9999876543221 1234579999999999999999999999999999999996 774210 00
Q ss_pred hHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 564 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... ......... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-~~~~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT-LTDVRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHHhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 001111110 1112233445678999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=408.60 Aligned_cols=242 Identities=27% Similarity=0.336 Sum_probs=193.8
Q ss_pred cccccccccCccceEEEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|++.+.||+|+||+||+|+.. .++.||||.++.. .......+.+|+.+|++++|||||++++++.+.+..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999852 4689999987542 22234568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.++|.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998643 599999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... .......||+.|||||++.+..++.++|||||||+||||+||+.||.+....+ .+ ..+....
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~-~~i~~~~------- 242 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TM-TMILKAK------- 242 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC-------
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HH-HHHHcCC-------
Confidence 322 22345679999999999999999999999999999999999999997543211 11 1111111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+...+.++.+|+.+||+.||++|||+
T Consensus 243 ---~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 ---LGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ---CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 01122345568899999999999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=395.42 Aligned_cols=288 Identities=36% Similarity=0.604 Sum_probs=249.9
Q ss_pred cccChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
..++..++..++++|...+.||+|+||.||+|.+.+++.||||+.........+.+.+|+.++++++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34566778888999999999999999999999988899999999877666667889999999999999999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976432 23699999999999999999999998 9999999999999999999999999
Q ss_pred CCcccccCC-CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 496 GTSRSITVD-QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 496 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
|+++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+........
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 999865422 2222344568999999999999999999999999999999999999998777666666776666666666
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.+..++++..........+..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 66666776666667778889999999999999999999999999999988754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=390.08 Aligned_cols=291 Identities=36% Similarity=0.612 Sum_probs=248.5
Q ss_pred ccccccChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccCh-hhHHHHHHHHHHHHhcCCCCeeeEEe
Q 038345 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE-NNVEQFINEVVILSQINHRNIVKLLG 412 (686)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g 412 (686)
...+.|+..++..+.++|...++||+|+||.||+|...+++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567899999999999999999999999999999988899999999765332 22346899999999999999999999
Q ss_pred EEeeCCcceEEEEeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEE
Q 038345 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAK 491 (686)
Q Consensus 413 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 491 (686)
++......++||||+++|+|.+++..... ..++++..++.++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987543 34599999999999999999999998777899999999999999999999
Q ss_pred EEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC--cccCCchhHhhHH
Q 038345 492 VSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN--IDEDRSLVGYFLQ 569 (686)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~--~~~~~~l~~~~~~ 569 (686)
|+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999998776555555556679999999999999999999999999999999999999996322 2233444555555
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
......+..+.+...........+..+.+++.+||+.||++|||++||++.|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 5555566666666666677788889999999999999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=398.57 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee------CC
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE------TE 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~ 418 (686)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.+|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999965 6999999997643 33445778999999999999999999999764 35
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..||||||++ |+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999995 7899999754 3699999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC---ceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 499 RSITVDQ---THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 499 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+ ....+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCC
Confidence 8764321 2233456899999999998875 56999999999999999999999997643221 111111110000
Q ss_pred -----------hhhhhhhhhc-c-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 575 -----------RLFEVLDALV-L-----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 575 -----------~~~~~~d~~~-~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.....+.... . .........++.+|+.+||+.||++|||++|++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 343 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000000 0 000011235688999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=387.07 Aligned_cols=201 Identities=17% Similarity=0.335 Sum_probs=171.9
Q ss_pred HHhhccccccccccCccceEEEEEEEeC----CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 418 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 418 (686)
+....++|.+.++||+|+||+||+|+.+ .++.||||++... ....++.+|+++|.++ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3445678999999999999999999853 4678999987543 2346788999999998 6999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCC
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGT 497 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGl 497 (686)
..+|||||+++|+|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 9999999999999999884 388999999999999999999999 99999999999999876 7999999999
Q ss_pred cccccCCCc---------------------------eeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCC
Q 038345 498 SRSITVDQT---------------------------HLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQ 549 (686)
Q Consensus 498 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~ 549 (686)
|+....... .......||+.|+|||++.+. .++.++||||+||+++||++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 986532211 112345699999999999875 5899999999999999999999
Q ss_pred CCCccC
Q 038345 550 KPIRAI 555 (686)
Q Consensus 550 ~p~~~~ 555 (686)
.||...
T Consensus 245 ~Pf~~~ 250 (361)
T 4f9c_A 245 YPFYKA 250 (361)
T ss_dssp SSSSCC
T ss_pred CCCCCC
Confidence 999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=406.30 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=210.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|.+.+.||+|+||+||+|... +|+.||+|.+........+.+.+|+.+|++++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999965 6899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC--CcEEEEecCCcccccCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK--YRAKVSDFGTSRSITVD 504 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~ 504 (686)
+++|+|.++|.+.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999997532 3599999999999999999999999 99999999999999754 89999999999977543
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. ......||+.|||||++.+..++.++|||||||+||||++|+.||.+....+ .+ ..+.... ...
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~-~~i~~~~------~~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TL-RNVKSCD------WNM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTC------CCC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HH-HHHHhCC------CCC
Confidence 3 2345679999999999999999999999999999999999999997543211 11 1111110 001
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+.++.+|+.+||+.||++|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111233456889999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=365.57 Aligned_cols=284 Identities=33% Similarity=0.558 Sum_probs=231.4
Q ss_pred cccccChHHHHhhccccccc------cccCccceEEEEEEEeCCCcEEEEEEcccc----ChhhHHHHHHHHHHHHhcCC
Q 038345 335 KTKLFTSKDLEKATDNYNAN------RILGQGGQGTVYKGMLADGRIVAVKKSKLV----DENNVEQFINEVVILSQINH 404 (686)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 404 (686)
....|+..++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999887 8999999999999987 5889999987542 23345789999999999999
Q ss_pred CCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee
Q 038345 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484 (686)
Q Consensus 405 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 484 (686)
|||+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999998655555799999999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCch
Q 038345 485 DDKYRAKVSDFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563 (686)
Q Consensus 485 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l 563 (686)
+.++.+||+|||+++...... ........||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+ .+
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 999999999999998664322 222334568999999998865 57899999999999999999999997644322 11
Q ss_pred hHhhHHHhh-cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 564 VGYFLQAMN-ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 564 ~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
......... ...+.+.++..+ ..........+.+++.+||+.+|.+|||+.+|++.|+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111111 122333333333 33455677889999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=372.54 Aligned_cols=264 Identities=24% Similarity=0.388 Sum_probs=217.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|...++||+|+||+||+|... +++.||+|++........+.|.+|+.++++++||||+++++++.+....++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999975 58999999987777777889999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999999998643 3599999999999999999999999 9999999999999999999999999999876433221
Q ss_pred e-------------eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 508 L-------------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 508 ~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~---------- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL---------- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh----------
Confidence 1 11456999999999999999999999999999999999999998754332211100
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccc
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~ 631 (686)
.....++... +...+..+.+++.+||+.||++|||++++++.|+.++......
T Consensus 235 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 235 NVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp CHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHC
T ss_pred hhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCc
Confidence 0111111111 1223345889999999999999999999999999998765443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=399.02 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=199.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHH---HHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQF---INEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~---~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.++||+|+||+||+|+.. +|+.||||++... .......+ ..++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 478999999999999999999965 5899999987532 11122233 3446677778999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
||||||++||+|.++|.+.. .+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998643 599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
+.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||......+ ..... .......
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~-~~i~~~~---- 410 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEID-RMTLTMA---- 410 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHH-HHHHHCC----
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH-HhhcCCC----
Confidence 65332 334679999999999975 579999999999999999999999997543221 11111 1111100
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||.+|++ ++||++
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122234566889999999999999998 566653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=373.40 Aligned_cols=269 Identities=29% Similarity=0.400 Sum_probs=208.7
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
...++....++|.+.+.||+|+||+||+|.. +++.||||++... .....+.|.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344555567899999999999999999987 5889999987643 344567899999999999999999999999999
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeeCCCCCCeeecCCCcEEEEec
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS--IYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
...++||||+++|+|.+++........+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCC
Confidence 99999999999999999998654334599999999999999999999998 7 999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
|+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 184 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~-- 254 (309)
T 3p86_A 184 GLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFK-- 254 (309)
T ss_dssp C------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHS--
T ss_pred CCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc--
Confidence 9997543322 22334569999999999999999999999999999999999999997543211 11000000
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......+......+.+|+.+||+.||++|||+++|++.|+.+.+..
T Consensus 255 -------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 255 -------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0011222334456899999999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=376.48 Aligned_cols=263 Identities=25% Similarity=0.422 Sum_probs=215.5
Q ss_pred hccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLE 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 416 (686)
..++|.+.+.||+|+||.||+|... ++..||||.++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3468999999999999999999852 3467999998754 344567899999999999 89999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999986431 23589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDR 561 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 561 (686)
++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-- 313 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999986643322 12233457889999999999999999999999999999999 999997543221
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....+..+ .....+......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 314 -----~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -----LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -----HHHHHHTT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 111222334567899999999999999999999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.62 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=215.5
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
..++|.+.+.||+|+||.||+|...++..||+|.++.... ..+++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4567999999999999999999998888999999865432 346799999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999997643 2589999999999999999999999 999999999999999999999999999987655544
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ....... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~-~~~~~~~---------~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VV-LKVSQGH---------R 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH-HHHHTTC---------C
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HH-HHHHcCC---------C
Confidence 44444557788999999999899999999999999999999 999997543211 11 1111110 0
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+++..+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 11111224568899999999999999999999999999876544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=368.84 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=212.1
Q ss_pred ccccccccccCccceEEEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.+.||+|+||.||+|.+. .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999974 3456999998754 44456789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999997543 3599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 503 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 503 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~------ 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEE------ 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHT------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHc------
Confidence 43221 2233346788999999999999999999999999999999 999996543211 1111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 270 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 270 ---GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1111222334567899999999999999999999999999987653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=370.27 Aligned_cols=268 Identities=27% Similarity=0.441 Sum_probs=211.7
Q ss_pred ccccccccccCccceEEEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccc
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 420 (686)
.++|.+.++||+|+||.||+|.+ .+++.||||++........+.|.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36799999999999999999984 25889999998877777778899999999999999999999998654 458
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999998653 2589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc----
Q 038345 501 ITVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---- 574 (686)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---- 574 (686)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH--------HHHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH--------HHHhhhcCccccc
Confidence 6433221 12233477789999999999999999999999999999999999864211 011111110
Q ss_pred ----hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 575 ----RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 575 ----~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.+.+.+........+...+..+.+|+.+||+.||++|||++||++.|+.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111111111122223345567999999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=390.73 Aligned_cols=268 Identities=23% Similarity=0.374 Sum_probs=219.4
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
+...+++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34455666778899999999999999999999888999999987543 34678999999999999999999999986 66
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+++|+|.++|.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 7899999999999999998542 22588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
+..............+|+.|+|||++....++.++||||||++||||++ |+.||......+ ....+..
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~---- 400 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALER---- 400 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHH----
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc----
Confidence 8764332222233446789999999999999999999999999999999 999997543211 1111111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......+...+..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 401 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 401 -----GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1111122334567899999999999999999999999999986543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=379.90 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=214.5
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
....++|.+.+.||+|+||.||+|.+. +++.||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 344567899999999999999999976 6899999997653 23345678999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999998643 2589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceee-eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHLT-TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
....... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~------- 330 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEK------- 330 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHT-------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc-------
Confidence 3221111 12246788999999999999999999999999999998 999997543211 1111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
......+...+..+.+|+.+||+.||++|||+++|++.|+.+++.
T Consensus 331 --~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 --GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111112223455788999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=370.32 Aligned_cols=276 Identities=22% Similarity=0.288 Sum_probs=211.5
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc----ceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV----PLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~l 422 (686)
..++|.+.++||+|+||+||+|... ++.||||++.... .....+.+|+.++++++||||+++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4468999999999999999999876 7899999986543 333556679999999999999999999987553 599
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------CCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA-------ASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-------~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +..+|+||||||+|||++.++.+||+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999999753 499999999999999999999986 2338999999999999999999999999
Q ss_pred CCcccccCCCce-eeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 496 GTSRSITVDQTH-LTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 496 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
|+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.................
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 2233568999999999886 3567789999999999999999999986543322211111000
Q ss_pred Hhhcchhhhhh-----hhhccCh-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 570 AMNENRLFEVL-----DALVLKE-AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 570 ~~~~~~~~~~~-----d~~~~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......+...+ .+.+... ........+.+|+.+||+.||++|||+.||++.|+.|.+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000000 0001000 11244567999999999999999999999999999998653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=361.82 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=208.5
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|...+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999995 46899999998765555567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999754 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......... ....
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~--------~~~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG--------TPEL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC--------SCCC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC--------CCCC
Confidence 2334569999999999999999999999999999999999999996433211 111111100 0001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 112234556889999999999999999999983
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=359.81 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=214.2
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|.+.+.||+|+||.||+|...+++.||+|++..... ..+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357899999999999999999998899999999875432 3467999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999999997643 3589999999999999999999999 9999999999999999999999999999866443333
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+... ...
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTG---------FRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT---------CCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhcC---------ccC
Confidence 3334456788999999999999999999999999999999 999997533211 11111111 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..+......+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 11222345688999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=373.44 Aligned_cols=274 Identities=28% Similarity=0.402 Sum_probs=220.7
Q ss_pred cccChHHHHhhccccccccccCccceEEEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCee
Q 038345 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIV 408 (686)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv 408 (686)
..+...+++...++|.+.+.||+|+||.||+|.+ .+++.||||+++.. .....+.+.+|+.++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455667777889999999999999999999984 24578999998653 344457799999999999 799999
Q ss_pred eEEeEEeeCC-cceEEEEeccCCchhhhhhccCC----------------------------------------------
Q 038345 409 KLLGCCLETE-VPLLVYEFVPNGTLYQNIHNHIE---------------------------------------------- 441 (686)
Q Consensus 409 ~l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------- 441 (686)
++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999998755 48999999999999999986532
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 442 -----------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 442 -----------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 11289999999999999999999999 9999999999999999999999999999866433
Q ss_pred C-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 505 Q-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 505 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
. ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+ .+...+...
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~-------- 312 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEG-------- 312 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHT--------
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcC--------
Confidence 2 223345568999999999999999999999999999999998 999997543221 111111111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.....+......+.+++.+||+.||.+|||++||++.|+.+....
T Consensus 313 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 -TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111112223456889999999999999999999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=375.07 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=203.2
Q ss_pred ccccccccccCccceEEEEEEEeC----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+|+||.||+|++. ++..||||.++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999865 4678999998754 34456789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999998643 3599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 503 VDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 503 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ . ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~---------~~~ 262 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------V---------IKA 262 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------H---------HHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------H---------HHH
Confidence 432221 122345778999999999999999999999999999998 999996543211 1 111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
+........+...+..+.+|+.+||+.||++||++.+|++.|+.+.....
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 11111112222345678999999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=362.75 Aligned_cols=268 Identities=16% Similarity=0.209 Sum_probs=215.2
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36799999999999999999996 568999999876432 235688999999999 99999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc-----EEEEecCCccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR-----AKVSDFGTSRS 500 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DfGla~~ 500 (686)
|+ +++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999864 23699999999999999999999999 9999999999999998887 99999999987
Q ss_pred ccCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 501 ITVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 501 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~---~~~~~~~i-~~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKI-GDT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS---HHHHHHHH-HHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc---HHHHHHHH-Hhh
Confidence 6433221 1235679999999999999999999999999999999999999998654322 11111111 110
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
.... ..... ....+ ++.+++.+||+.+|.+||++.+|++.|+.+....+....
T Consensus 236 ~~~~-~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 236 KRAT-PIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp HHHS-CHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred hccC-CHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 0000 00000 01122 789999999999999999999999999999887766544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=361.33 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=201.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 68999999875432 2234678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999753 3599999999999999999999998 99999999999999999999999999998654322
Q ss_pred -ceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 506 -THLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 506 -~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..+.........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~------- 227 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY------- 227 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-----HHHHHHHTTCTT-------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-----HHHHHHhccccc-------
Confidence 222334679999999999988775 789999999999999999999997543211 011111111100
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..........+.+|+.+||+.||++|||++|++
T Consensus 228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --CCccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 011122345678999999999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=383.96 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=211.2
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
..++...++|.+.++||+|+||.||+|.+.++..||||.++... ...+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 34445567899999999999999999999888889999987543 235789999999999999999999999876 6789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.++|.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999999999999997532 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
............++..|+|||.+....++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~------ 397 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG------ 397 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT------
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC------
Confidence 5433333334457889999999999999999999999999999999 999997543211 11111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.....+...+..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus 398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 111122344567899999999999999999999999999886543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=357.60 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=202.5
Q ss_pred HhhccccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
+...++|.+.+.||+|+||.||+|.... +..||+|..... .....+.+.+|+.++++++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3445689999999999999999999643 457999987653 3444578999999999999999999999984 567
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 899999999999999997542 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ...+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~----~~~i~~~~--- 234 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGE--- 234 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTC---
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---H----HHHHHcCC---
Confidence 765443333334457889999999999999999999999999999997 999997543221 1 11111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
....+...+..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 011222345678899999999999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=357.44 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=212.0
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
...++|.+.+.||+|+||.||+|...++..||||+++.... ..+++.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34568999999999999999999998888999999875432 34679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999998643 3599999999999999999999999 99999999999999999999999999998664333
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.. ..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~---------~~ 238 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQ---------GL 238 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHT---------TC
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhc---------cc
Confidence 222333456788999999999999999999999999999998 999997543211 1111111 11
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
....+......+.+++.+||+.+|++|||++++++.|+.+...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111122345688999999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=387.58 Aligned_cols=260 Identities=29% Similarity=0.451 Sum_probs=216.9
Q ss_pred HhhccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+....+|.+.++||+|+||.||+|.+.. +..||||.++... ...+.|.+|+.++++++||||+++++++.+....+||
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3445678999999999999999999765 7899999987543 3457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.++|.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999998643 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
..........+++.|+|||++....++.++||||||++||||++ |+.||......+ +. +.+..
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-------~~---------~~~~~ 434 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY---------ELLEK 434 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------HH---------HHHHT
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-------HH---------HHHHc
Confidence 43333334456789999999999999999999999999999999 999997644221 11 11111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 435 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1112223344567899999999999999999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=371.48 Aligned_cols=270 Identities=26% Similarity=0.399 Sum_probs=219.6
Q ss_pred HHhhccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGC 413 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~ 413 (686)
.+...++|.+.++||+|+||.||+|... .+..||||+++.. .....+.+.+|+.+++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3445678999999999999999999852 2357999997653 344567899999999999 99999999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCC
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSA 480 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 480 (686)
+.+.+..++||||+++|+|.+++..... ...+++..++.|+.||+.||+|||+. +|+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 9999999999999999999999986432 23599999999999999999999999 9999999999
Q ss_pred CeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcc
Q 038345 481 NILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINID 558 (686)
Q Consensus 481 NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~ 558 (686)
|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986643222 22334457889999999999999999999999999999999 99999754321
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
+ ....+... .....+.....++.+|+.+||+.||++|||++||++.|+.+........
T Consensus 301 ~-------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 E-------LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H-------HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H-------HHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1 11111111 1111222345578999999999999999999999999999987654443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.94 Aligned_cols=268 Identities=26% Similarity=0.394 Sum_probs=218.6
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeE
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGC 413 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 413 (686)
..++....++|.+.+.||+|+||.||+|.. .++..||||.+... .....+.+.+|+.++++++||||++++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 334445567899999999999999999985 23578999998653 34556789999999999999999999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASISI 472 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~i 472 (686)
+.+....++||||+++++|.+++..... ...+++..++.++.||++||+|||+. +|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i 171 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL 171 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence 9999999999999999999999986432 23489999999999999999999999 99
Q ss_pred EeeCCCCCCeeecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCC
Q 038345 473 YRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQK 550 (686)
Q Consensus 473 vH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~ 550 (686)
+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.
T Consensus 172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876543322 2233457889999999999999999999999999999999 999
Q ss_pred CCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 551 PIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 551 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
||......+ ....+... .....+...+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 252 p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPER-------LFNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGG-------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHH-------HHHHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 997543321 11111111 11112223456789999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=358.46 Aligned_cols=261 Identities=26% Similarity=0.369 Sum_probs=213.9
Q ss_pred cccChHHHHhhccc----------cccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCC
Q 038345 337 KLFTSKDLEKATDN----------YNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHR 405 (686)
Q Consensus 337 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 405 (686)
..++.++++.+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777777653 777789999999999999976 6999999998766666677899999999999999
Q ss_pred CeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec
Q 038345 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485 (686)
Q Consensus 406 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 485 (686)
||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 9999999999999999999999999999988643 599999999999999999999998 999999999999999
Q ss_pred CCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH
Q 038345 486 DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 486 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~ 565 (686)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~ 248 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------Q 248 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 999999999999987654322 233457999999999999999999999999999999999999999743221 1
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. ..+... ..+.. .........+.+++.+||+.||++|||+.++++
T Consensus 249 ~~-~~~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 AM-KRLRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HH-HHHHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HH-HHHhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111110 00000 111223456889999999999999999999984
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.18 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=208.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999964 6889999986432 334457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997643 599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~---- 232 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV---- 232 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH----
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc----
Confidence 4333344567999999999999999999999999999999999999999754321 1111111111 0000
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIRAS 627 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~ev~~~L~~i~~~ 627 (686)
........+..+.+++.+||+.||++|| +++++.+.|+.+...
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0111123346789999999999999998 999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=358.07 Aligned_cols=268 Identities=25% Similarity=0.392 Sum_probs=218.0
Q ss_pred HHhhccccccccccCccceEEEEEEEe------CCCcEEEEEEccccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEe
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLVD-ENNVEQFINEVVILSQI-NHRNIVKLLGCCL 415 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 415 (686)
++...++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 344557899999999999999999985 246789999986543 34457899999999999 9999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCC
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIE---------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSA 480 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~ 480 (686)
+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 99999999999999999999986532 12589999999999999999999999 9999999999
Q ss_pred CeeecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcc
Q 038345 481 NILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINID 558 (686)
Q Consensus 481 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~ 558 (686)
|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 999999999999999999876544322 2334557889999999999999999999999999999999 99999754321
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
+ .+..... .......+...+..+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 255 ~------~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 S------KFYKMIK---------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp H------HHHHHHH---------HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred h------HHHHHhc---------cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1 1111111 111111122334678999999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.72 Aligned_cols=269 Identities=16% Similarity=0.175 Sum_probs=216.6
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999995 568999999875432 335688999999999 79999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc-----EEEEecCCccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR-----AKVSDFGTSRS 500 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DfGla~~ 500 (686)
|+ +++|.+++.... .++++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999998643 3599999999999999999999998 9999999999999987765 99999999987
Q ss_pred ccCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 501 ITVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 501 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 2344569999999999999999999999999999999999999998654322111111111111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
.. .......+..+.+++.+||+.||++||++++|++.|+.+....+....
T Consensus 241 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~ 290 (298)
T 1csn_A 241 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 290 (298)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred cH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCC
Confidence 10 011112346789999999999999999999999999999887665544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=354.31 Aligned_cols=266 Identities=24% Similarity=0.392 Sum_probs=215.9
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
+.+...++|.+.+.||+|+||.||+|...++..||||.+.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445567899999999999999999998888899999886543 23578999999999999999999999986 456899
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 999999999999997532 12589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~------- 226 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERG------- 226 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT-------
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcc-------
Confidence 443333334457889999999998899999999999999999999 999997543211 11111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred --cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 11111223345789999999999999999999999999998765443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=355.48 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=204.7
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--cCCCCeeeEEeEEeeC----Ccc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ--INHRNIVKLLGCCLET----EVP 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~----~~~ 420 (686)
..++|.+.+.||+|+||+||+|.. +++.||||++.. .....+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346899999999999999999998 688999998764 334566777777777 7999999999997653 457
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH--------SAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999643 5999999999999999999999 66 9999999999999999999999
Q ss_pred EecCCcccccCCCcee---eeeeeccccccCccccccC------CCCccccEeehHHHHHHHHhC----------CCCCc
Q 038345 493 SDFGTSRSITVDQTHL---TTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTG----------QKPIR 553 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDv~S~Gv~l~elltg----------~~p~~ 553 (686)
+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998665433322 2234699999999999876 556799999999999999999 78876
Q ss_pred cCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 554 AINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 554 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
........ ................+ ............+.+|+.+||+.||++|||+.+|++.|++|
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRPNI---PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCCCC---ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54322211 11111111111000000 01112335677899999999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.06 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=212.4
Q ss_pred ccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467999999999999999999953 3668999998653 344556799999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---cEEEE
Q 038345 421 LLVYEFVPNGTLYQNIHNHIE----EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKVS 493 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 493 (686)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 23589999999999999999999999 999999999999998544 59999
Q ss_pred ecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHh
Q 038345 494 DFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 494 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH
Confidence 999997653221 122233457899999999999999999999999999999998 999997543211 11111
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
... .....+...+..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 300 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 300 TSG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HcC---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111 1111122334568899999999999999999999999998876543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=362.14 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=206.8
Q ss_pred hhccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
...++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++......++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3456899999999999999999997 57899999987543 44556788999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999997643 589999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCceeeeeeeccccccCccccccCCCC-ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
... ......||+.|+|||++.+..+. .++||||||+++|||++|+.||...... . ....+..+.
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~------ 230 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGK------ 230 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCC------
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCC------
Confidence 332 23445799999999999888765 7999999999999999999999754321 1 111111110
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+|+.+||+.||.+|||++|+++
T Consensus 231 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 ----YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111223456889999999999999999999983
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=377.42 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=211.4
Q ss_pred HhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-cceEE
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE-VPLLV 423 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lV 423 (686)
+...++|.+.+.||+|+||.||+|.+. ++.||||.++... ..+.|.+|+.++++++||||+++++++.+.. ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 344578999999999999999999985 7799999987543 4578999999999999999999999987765 78999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998653 23479999999999999999999999 999999999999999999999999999985432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
. .....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+ .. ..+..+
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~-------- 402 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKG-------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTT--------
T ss_pred c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcC--------
Confidence 1 122357889999999999999999999999999999998 999997654321 11 111111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 403 -~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 -YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11122233456789999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.37 Aligned_cols=265 Identities=29% Similarity=0.449 Sum_probs=221.5
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
+++...++|.+.+.||+|+||.||+|.... +..||+|.+... ....+.+.+|+.++++++||||+++++++.+....+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 344456789999999999999999999764 788999998653 345578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999998643 34699999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+ . .+.+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------~---------~~~~ 225 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------V---------YELL 225 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------H---------HHHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H---------HHHH
Confidence 6555444555668889999999999999999999999999999999 999997543221 1 1111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111222334567899999999999999999999999999887654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=362.42 Aligned_cols=257 Identities=23% Similarity=0.463 Sum_probs=203.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|...++||+|+||+||+|.+. +++ .||+|.+... .....+.|.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56899999999999999999964 344 4688876543 3345578999999999999999999999998754 789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|+||+++|+|.+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 999999999999998643 3599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ . ...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~---------~~~~ 232 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------I---------SSIL 232 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------H---------HHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------H---------HHHH
Confidence 43322 2233457889999999999999999999999999999999 999997543321 1 1111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
........+......+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11111112223445688999999999999999999999999988654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=365.39 Aligned_cols=267 Identities=24% Similarity=0.388 Sum_probs=216.0
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCL 415 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 415 (686)
.+....++|.+.+.||+|+||.||+|... +++.||||.++.. .....+.|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455688999999999999999999974 3478999998754 3344578999999999999999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASISIYR 474 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 474 (686)
+.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+. +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999999999999999999976421 14699999999999999999999999 9999
Q ss_pred eCCCCCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCC
Q 038345 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPI 552 (686)
Q Consensus 475 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~ 552 (686)
|||||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986543221 22234568899999999999999999999999999999999 99999
Q ss_pred ccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 553 RAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 553 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
......+ ....+..+.. ...+...+..+.+|+.+||+.||++|||+.+|++.|+++....
T Consensus 278 ~~~~~~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 278 YGMAHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTSCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCCChHH-------HHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7543211 1111111111 1112234457899999999999999999999999999987544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=362.89 Aligned_cols=269 Identities=26% Similarity=0.429 Sum_probs=214.0
Q ss_pred HHHhhccccccccccCccceEEEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCC 414 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 414 (686)
+++...++|.+.+.||+|+||.||+|.. .++..||||.+... .....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445568899999999999999999996 23568999997643 233457899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEe
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEE--------------------FPITWELLLRIAVEVSGALFYLHSAASISIYR 474 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH 474 (686)
...+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+. +|+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 9999999999999999999999865321 2489999999999999999999999 9999
Q ss_pred eCCCCCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCC
Q 038345 475 RDIKSANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPI 552 (686)
Q Consensus 475 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~ 552 (686)
|||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999999987654332 22334567889999999999999999999999999999998 99999
Q ss_pred ccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 553 RAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 553 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
......+ .+....... .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+...
T Consensus 276 ~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDA------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSH------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 7543221 111111111 1111222335678999999999999999999999999998876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=353.93 Aligned_cols=271 Identities=24% Similarity=0.368 Sum_probs=215.0
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--cceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 423 (686)
.++|.+.++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 367999999999999999999976 48999999976532 334577889999999999999999999998765 67999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee----cCCCcEEEEecCCcc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSR 499 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla~ 499 (686)
|||+++++|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999998765555699999999999999999999999 99999999999999 888889999999998
Q ss_pred cccCCCceeeeeeeccccccCccccc--------cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQ--------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... ...+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHh
Confidence 7654332 23456999999999986 578899999999999999999999999754332211 11111111
Q ss_pred hcch---hhh----------hh-hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 572 NENR---LFE----------VL-DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 572 ~~~~---~~~----------~~-d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
.... +.. +. +..............+.+++.+||+.||++|||++|+++...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1110 000 00 001112344677788999999999999999999999999887643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=361.99 Aligned_cols=269 Identities=25% Similarity=0.383 Sum_probs=216.7
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCC------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeE
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGC 413 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~ 413 (686)
++++...++|.+.+.||+|+||.||+|.... ...||+|.+... .....+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3455566889999999999999999999642 247999987654 334567799999999999 89999999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIE-----------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceE
Confidence 9999999999999999999999975421 23589999999999999999999999 999999999999
Q ss_pred eecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccC
Q 038345 483 LLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~ 560 (686)
|++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 274 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS- 274 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence 999999999999999986643332 22334557889999999999999999999999999999999 999997543211
Q ss_pred CchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.+...... ......+...+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus 275 -----~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 -----KFYKLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -----HHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 11111111 1111112223456889999999999999999999999999887543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.33 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=203.0
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.+.||+|+||.||+|... ++.||||++.. ....+.|.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56888999999999999999975 78899999864 344578999999999999999999999886 45899999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc-EEEEecCCcccccCCCce
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR-AKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DfGla~~~~~~~~~ 507 (686)
+|+|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999987554445889999999999999999999943338999999999999988876 799999999755322
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...... ...... ...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~-~~~~~~---------~~~ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMW-AVHNGT---------RPP 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHH-HHHTTC---------CCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHH-HHhcCC---------CCC
Confidence 22345899999999999999999999999999999999999999743221 111111 111110 011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
.....+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 266 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP 266 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence 112234568899999999999999999999999999876544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=361.22 Aligned_cols=267 Identities=25% Similarity=0.418 Sum_probs=200.6
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCCC----cEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLADG----RIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
++....++|.+.+.||+|+||.||+|..... ..||||.++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3445567899999999999999999996543 27999987653 44556889999999999999999999999987
Q ss_pred CCcc------eEEEEeccCCchhhhhhccCC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC
Q 038345 417 TEVP------LLVYEFVPNGTLYQNIHNHIE---EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK 487 (686)
Q Consensus 417 ~~~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 487 (686)
.... ++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 999999999999999965321 22589999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhH
Q 038345 488 YRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~ 565 (686)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~-- 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---I-- 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H--
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---H--
Confidence 9999999999987643322 12233456789999999999999999999999999999999 999997543221 1
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....... .....+...+..+.+|+.+||+.||++|||+.++++.|+++....
T Consensus 249 --~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 --YNYLIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --HHHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --HHHHhcC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 011112234457899999999999999999999999999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=350.23 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=213.2
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|.+.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357889999999999999999998889999999875433 3468999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 9999999997643 3589999999999999999999999 9999999999999999999999999999865433222
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~i~~~---------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------E-VVEDISTG---------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTT---------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------H-HHHHHhcC---------CcC
Confidence 2233457788999999998999999999999999999999 89998753221 1 11111111 001
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..+......+.+++.+||+.||++|||++++++.|+.+.+.
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11122345688999999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.76 Aligned_cols=276 Identities=16% Similarity=0.199 Sum_probs=212.5
Q ss_pred hccccccccccCccceEEEEEEEeCC------CcEEEEEEccccChhh-----------HHHHHHHHHHHHhcCCCCeee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD------GRIVAVKKSKLVDENN-----------VEQFINEVVILSQINHRNIVK 409 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 409 (686)
..++|.+.++||+|+||.||+|.+.. ++.||||.+....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999764 4789999876533211 123445666777788999999
Q ss_pred EEeEEeeC----CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec
Q 038345 410 LLGCCLET----EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485 (686)
Q Consensus 410 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~ 485 (686)
+++++... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 99999875 4579999999 999999998642 3699999999999999999999999 999999999999998
Q ss_pred --CCCcEEEEecCCcccccCCCcee------eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCc
Q 038345 486 --DKYRAKVSDFGTSRSITVDQTHL------TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557 (686)
Q Consensus 486 --~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~ 557 (686)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||++||||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764332211 1334599999999999999999999999999999999999999985332
Q ss_pred ccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccccc
Q 038345 558 DEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQ 634 (686)
Q Consensus 558 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~~ 634 (686)
.. ......... ....+.++++..+.. ...+.++.+++.+||+.+|++||++.+|++.|+.+....+.....
T Consensus 267 ~~--~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 267 DP--KYVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp CH--HHHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CH--HHHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 11 111111111 112233333332211 123457899999999999999999999999999998877666543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=377.96 Aligned_cols=264 Identities=21% Similarity=0.292 Sum_probs=212.7
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEeCC-CcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCC 414 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 414 (686)
+..+++....++|.+.++||+|+||+||+|+... ++.||+|++.... ....+.+.+|+.++.+++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3456677778999999999999999999999764 7899999876421 22234588999999999999999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
.+.+..+|||||+++|+|.++|.+.. ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999998632 3599999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .+..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHh
Confidence 9999877655554455567999999999987 5678999999999999999999999997543211 1111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAF 619 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~ 619 (686)
.+.......+ ..........+.+|+.+||..+|++ ||+++|+++
T Consensus 293 i~~~~~~~~~------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 293 IMNHKERFQF------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHTHHHHCCC------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhccccccC------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111000000 0001123456889999999888888 999999885
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=349.67 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=196.7
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccCh----hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE----NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|...++||+|+||.||+|... ++.||||....... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 467999999999999999999975 88999998765322 2346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC--------CCcEEEEec
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--------KYRAKVSDF 495 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~Df 495 (686)
|||+++++|.+++... .+++..++.++.|++.||+|||+....+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998642 5899999999999999999999983223999999999999986 678999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .......
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~--- 228 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAM--- 228 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHT---
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhc---
Confidence 9997654322 223468999999999999999999999999999999999999997543211 1111111
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.......+...+..+.+++.+||+.||++|||+.|+++.|+.|
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111112223446789999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=355.72 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=202.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEV------ 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------ 419 (686)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999976 78999999976433 3455789999999999999999999999866432
Q ss_pred ---------------------------------------------------ceEEEEeccCCchhhhhhccCCCCCCCHH
Q 038345 420 ---------------------------------------------------PLLVYEFVPNGTLYQNIHNHIEEFPITWE 448 (686)
Q Consensus 420 ---------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 448 (686)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 78999999999999999886655567888
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc-----------eeeeeeecccc
Q 038345 449 LLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT-----------HLTTKVQGTFG 517 (686)
Q Consensus 449 ~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~ 517 (686)
.++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999999 999999999999999999999999999987654321 11233469999
Q ss_pred ccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHH
Q 038345 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVA 597 (686)
Q Consensus 518 y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 597 (686)
|+|||++.+..++.++||||||+++|||++|..|+.... ....... ..............+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------~~~~~~~---------~~~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------RIITDVR---------NLKFPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------HHHHHHH---------TTCCCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------HHHHHhh---------ccCCCcccccCChhHH
Confidence 999999999999999999999999999999887743100 0000011 1111122234456678
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 038345 598 TLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 598 ~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+++.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999984
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.39 Aligned_cols=267 Identities=25% Similarity=0.414 Sum_probs=215.9
Q ss_pred HhhccccccccccCccceEEEEEEEeC--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA--------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCC 414 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 414 (686)
....++|.+.+.||+|+||.||+|... ++..||||++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 334578999999999999999999863 4678999998653 344567899999999999 899999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCC
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 481 (686)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence 999999999999999999999986532 23489999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCccc
Q 038345 482 ILLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~ 559 (686)
||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999876543322 2233457889999999998899999999999999999999 999997543211
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
....+... .....+......+.+++.+||+.+|.+|||+.++++.|+.+......
T Consensus 268 -------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 -------LFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -------HHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11111111 11112223445689999999999999999999999999999875443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=387.18 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=215.6
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
..++...++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 44555667899999999999999999999888889999987543 235789999999999999999999999876 6789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
|||||+++|+|.++|.... ...+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 9999999999999997532 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
............++..|+|||++....++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~------ 480 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG------ 480 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTT------
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC------
Confidence 4322222223446789999999999999999999999999999999 999997543211 11111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.....+......+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11112223456789999999999999999999999999987644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.67 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=204.0
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++|.+.++||+|+||+||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4457899999999999999999999889999999876432 23346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||++ ++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99997 58888887543 3599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh---hhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL---FEV 579 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~ 579 (686)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .............. ...
T Consensus 172 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGG
T ss_pred Ccc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhh
Confidence 322 2334568999999999876 568999999999999999999999997654322 12111111111000 000
Q ss_pred -------------hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 580 -------------LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 580 -------------~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...............++.+|+.+||+.||++|||++|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 000000011112345688999999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=347.23 Aligned_cols=272 Identities=19% Similarity=0.239 Sum_probs=213.2
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEE-eeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC-LETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~ 424 (686)
..++|.+.+.||+|+||.||+|.. .+++.||||...... ..+.+.+|+.++++++|++++..++.+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 568899999755422 224688999999999988777666655 5677889999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~ 501 (686)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999997533 3599999999999999999999999 99999999999999 78899999999999876
Q ss_pred cCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 502 TVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 502 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22345689999999999999999999999999999999999999987654443333322211111110
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccccc
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQQ 635 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~~~ 635 (686)
.. ......+..+.+++.+||+.||++|||+.+|++.|+.+....+..+..+
T Consensus 239 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 4hgt_A 239 IE---------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp HH---------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred hh---------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence 00 0011224578999999999999999999999999999998887766543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.71 Aligned_cols=273 Identities=27% Similarity=0.385 Sum_probs=214.0
Q ss_pred cccccccCccceEEEEEEEeC-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceE
Q 038345 351 YNANRILGQGGQGTVYKGMLA-----DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLL 422 (686)
Q Consensus 351 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 422 (686)
|.+.+.||+|+||+||++.+. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998743 5789999998754 334567799999999999999999999999874 56799
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999754 389999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... ...............+.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHHH
Confidence 43322 2233457888999999999999999999999999999999999986421100 00000000011111222223
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccc
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~ 631 (686)
........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.....
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 322223333445677999999999999999999999999999998766543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=353.86 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=206.8
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||.||++... +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3568999999999999999999975 5889999987653 3345678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC--CCcEEEEecCCcccccC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--KYRAKVSDFGTSRSITV 503 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~ 503 (686)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999997532 3599999999999999999999999 9999999999999987 78999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+......
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~-~~i~~~~~~------ 221 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QII-ENIMNAEYT------ 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHTCCC------
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHH-HHHHcCCCC------
Confidence 32 234457999999999999988999999999999999999999999753321 111 111111000
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........+.++.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000011123456889999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=358.76 Aligned_cols=271 Identities=25% Similarity=0.415 Sum_probs=219.6
Q ss_pred cccChHHHHhhccccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeee
Q 038345 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVK 409 (686)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 409 (686)
..+..++++...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34556677778889999999999999999999854 36789999986533 344567999999999999999999
Q ss_pred EEeEEeeCCcceEEEEeccCCchhhhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 410 LLGCCLETEVPLLVYEFVPNGTLYQNIHNHIE-------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 410 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
+++++.+....++||||+++|+|.+++..... ..++++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 99999999999999999999999999975321 13579999999999999999999999 999999999999
Q ss_pred eecCCCcEEEEecCCcccccCCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccC
Q 038345 483 LLDDKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDED 560 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~ 560 (686)
|++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 248 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-
Confidence 9999999999999999865433221 1223457889999999999999999999999999999999 899987543211
Q ss_pred CchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
....+..... ...+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 249 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ------VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111111 11122344568899999999999999999999999988754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=361.38 Aligned_cols=272 Identities=25% Similarity=0.334 Sum_probs=214.3
Q ss_pred cccccccccCccceEEEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe--eCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL--ETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~ 421 (686)
++|.+.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5789999999999999999984 357899999988776777788999999999999999999999987 455688
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999999999998643 2589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh---hcchh
Q 038345 502 TVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM---NENRL 576 (686)
Q Consensus 502 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~---~~~~~ 576 (686)
...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ....+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF----LRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHCC----CCHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh----hhhcccccccccHHHH
Confidence 543322 2233457888999999999999999999999999999999999986422110 00000000 00111
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
.+.+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 22222222223334456679999999999999999999999999999865443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=353.18 Aligned_cols=273 Identities=28% Similarity=0.412 Sum_probs=219.2
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEe------CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeE
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKL 410 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 410 (686)
+...++....++|.+.+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44556666678999999999999999999984 24688999997653 334456799999999999 79999999
Q ss_pred EeEEeeCC-cceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeC
Q 038345 411 LGCCLETE-VPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRD 476 (686)
Q Consensus 411 ~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~D 476 (686)
++++...+ ..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 58999999999999999986542 12388999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCcc
Q 038345 477 IKSANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRA 554 (686)
Q Consensus 477 ikp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~ 554 (686)
|||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644332 23334568899999999999999999999999999999998 9999975
Q ss_pred CCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 555 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
....+ .+...+.... ....+......+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 254 ~~~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhH------HHHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 43221 1111111111 011122234568899999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=359.20 Aligned_cols=258 Identities=24% Similarity=0.450 Sum_probs=204.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.++||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46888999999999999999964 344 3788876432 2333467889999999999999999999986 566889
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999998642 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......||..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~------ 233 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKG------ 233 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTT------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC------
Confidence 43322 2344567889999999999999999999999999999999 999997643221 11111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.....+......+.+++.+||+.||++||+++++++.|+.+....
T Consensus 234 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 234 ---ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011111123345789999999999999999999999999886543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.73 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=207.8
Q ss_pred hccccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
..++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.|.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45679999999999999999998543 346999987654 34456789999999999999999999999865 4568
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999997643 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ..+....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~----~~~~~~~----- 231 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VI----GVLEKGD----- 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HH----HHHHHTC-----
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HH----HHHhcCC-----
Confidence 5443333344557889999999999999999999999999999998 999997543221 11 1111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....+......+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 01111223456889999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=348.80 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=214.1
Q ss_pred cccccccc-ccCccceEEEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANR-ILGQGGQGTVYKGMLA---DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.+ .||+|+||.||+|... ++..||||.++.. .....+.+.+|+.++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999854 5778999998764 344567899999999999999999999999 5667899
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999999753 23599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 503 VDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 503 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTT-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcC-----
Confidence 433322 123346889999999998899999999999999999999 999997543211 11111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+..+.+...
T Consensus 230 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 230 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 1111223345678999999999999999999999999999987766554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.14 Aligned_cols=271 Identities=20% Similarity=0.249 Sum_probs=215.2
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEE-eeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC-LETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lV~ 424 (686)
..++|.+.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.++++++|++++..+..+ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 346899999999999999999996 5789999998765332 24688999999999988866666555 5667789999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~ 501 (686)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 999999997533 3599999999999999999999999 99999999999999 48889999999999876
Q ss_pred cCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 502 TVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 502 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12345699999999999999999999999999999999999999987554433333322221111110
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccccc
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQ 634 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~~ 634 (686)
. .......+..+.+++.+||+.||++|||+.+|++.|+.+....+.....
T Consensus 239 ~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~ 288 (296)
T 3uzp_A 239 I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 288 (296)
T ss_dssp H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSC
T ss_pred h---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccc
Confidence 0 0011123456899999999999999999999999999998877665443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.66 Aligned_cols=245 Identities=22% Similarity=0.255 Sum_probs=194.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|...++||+|+||+||+|... +++.||||++... .......+..|+..+.++ +||||+++++++.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999976 6899999986542 233344566666666665 899999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 679999887653 3599999999999999999999998 999999999999999999999999999976543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... ....+....
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~-------- 268 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGY-------- 268 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTC--------
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccC--------
Confidence 22 2334569999999999875 78999999999999999999977654211 011111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
............+.+++.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 269 LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111112233567899999999999999999999983
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.29 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=205.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367999999999999999999975 6899999987642 233456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999997542 589999999999999999999999 999999999999999999999999999986432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+....
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~-------- 221 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLF-ELILMEE-------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC--------
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHH-HHHHcCC--------
Confidence 22 2234567999999999999999999999999999999999999999743211 111 1111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+.....++.+|+.+||+.||++|| +++|+++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 011223445688999999999999999 8888875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.46 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=210.3
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
..++....++|.+.++||+|+||+||+|... +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556667789999999999999999999976 5889999987542 12223458899999999999999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
....+|||||+++|+|.+++.+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999999753 489999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCC----CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ----FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
+++..............||+.|+|||++.+.. ++.++||||||++||||++|+.||...... ..+.....
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~ 287 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMN 287 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHh
Confidence 99877655444445667999999999998765 789999999999999999999999753321 11111111
Q ss_pred cchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038345 573 ENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKN--RPTMKEVAF 619 (686)
Q Consensus 573 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~ev~~ 619 (686)
.... +.-........++.+|+.+||+.+|.+ ||+++||++
T Consensus 288 ~~~~-------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 288 HKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHH-------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccc-------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1000 000001123456889999999999988 999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=345.71 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=206.9
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--CcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... ++.||||.++.. .....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357899999999999999999985 889999987653 344567899999999999999999999999877 788999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS--IYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
|||+++|+|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+|||++.++.++|.|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999998643 23689999999999999999999998 7 999999999999999999999999987643
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCc---cccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTE---KSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||......+ ........
T Consensus 164 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~----- 226 (271)
T 3kmu_A 164 QS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALE----- 226 (271)
T ss_dssp SC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHS-----
T ss_pred cc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhc-----
Confidence 22 2235899999999998765544 8999999999999999999997543211 11111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
......+...+..+.+++.+||+.||++|||++++++.|+.+.+
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ----GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112222345568999999999999999999999999998764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=355.51 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=208.7
Q ss_pred cccccccccCccceEEEEEEEe-----CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC--Ccc
Q 038345 349 DNYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLET--EVP 420 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~ 420 (686)
++|...+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999984 35889999997643 333457899999999999999999999999876 667
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 99999999999999996543 3599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh-------
Q 038345 501 ITVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM------- 571 (686)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~------- 571 (686)
....... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM--------ALFLKMIGPTHGQM 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--------HHHHHHHCSCCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh--------hHHhhccCCccccc
Confidence 6544322 2233457888999999999999999999999999999999999864211 0000000
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
....+...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 001111111111122223344567999999999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.02 Aligned_cols=268 Identities=27% Similarity=0.429 Sum_probs=214.8
Q ss_pred ccccccccccCccceEEEEEEEe-----CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--cc
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-----ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETE--VP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~ 420 (686)
.++|.+.+.||+|+||.||++.+ .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999984 358899999988766667788999999999999999999999987654 78
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999998643 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc-----
Q 038345 501 ITVDQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE----- 573 (686)
Q Consensus 501 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 573 (686)
........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--------~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--------AEFMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--------HHHHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--------HHHHHhhccccchh
Confidence 65443221 223456788999999999899999999999999999999999975321 001111100
Q ss_pred ---chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 574 ---NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 574 ---~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
..+.+.+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0111122111111222344567999999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=356.57 Aligned_cols=252 Identities=25% Similarity=0.305 Sum_probs=205.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChh------hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN------NVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
..++|.+.+.||+|+||.||++... +|+.||+|.++..... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999975 5899999987653221 34679999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEec
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDF 495 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Df 495 (686)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999753 3699999999999999999999999 999999999999998776 7999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ .+ ..+....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~-~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITAVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcC
Confidence 9998765332 2334569999999999999999999999999999999999999997533211 11 1111110
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. . .+ ..........+.+|+.+||..||++|||+.|+++
T Consensus 235 ~-~-~~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y-D-FD----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C-C-CC----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C-C-CC----chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0 00 0111123456889999999999999999999984
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.46 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=199.6
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEe----
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCL---- 415 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~---- 415 (686)
+.++....+|.+.++||+|+||.||+|... +++.||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 344445568999999999999999999964 68999999887666666788999999999996 999999999994
Q ss_pred ----eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeeCCCCCCeeecCCCc
Q 038345 416 ----ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS--IYRRDIKSANILLDDKYR 489 (686)
Q Consensus 416 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~ 489 (686)
.....++||||+. |+|.+++.......++++..++.++.||+.||+|||+. + |+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSC
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCC
Confidence 2345789999995 79999987654455799999999999999999999998 7 999999999999999999
Q ss_pred EEEEecCCcccccCCCcee-----------eeeeeccccccCcccc---ccCCCCccccEeehHHHHHHHHhCCCCCccC
Q 038345 490 AKVSDFGTSRSITVDQTHL-----------TTKVQGTFGYVDPEYF---QSSQFTEKSDVYSFGVVLVEILTGQKPIRAI 555 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~ 555 (686)
+||+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998764332211 1134589999999998 5677899999999999999999999999643
Q ss_pred CcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 556 NIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 556 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
.... ++...............+.+|+.+||+.||++|||+.|+++.|+.+.........
T Consensus 257 ~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 257 AKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp ----------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred hHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 2111 0000000011111223478899999999999999999999999999876555443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=346.16 Aligned_cols=253 Identities=31% Similarity=0.555 Sum_probs=202.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhh-------HHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENN-------VEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|... +++.||+|.+....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367999999999999999999974 68999999875432211 167899999999999999999999986544
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeeCCCCCCeeecCCCc-----EEE
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS--IYRRDIKSANILLDDKYR-----AKV 492 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~-----~kl 492 (686)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999999887643 3699999999999999999999998 7 999999999999987776 999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCcccc--ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF--QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......+ .... ..
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~-~~ 241 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFI-NM 241 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHH-HH
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHH-HH
Confidence 99999975432 23345689999999998 44567899999999999999999999997543221 1111 11
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
... .......+...+..+.+++.+||+.||++|||+++|++.|++|
T Consensus 242 ~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 IRE--------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH--------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred Hhc--------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 1111122233456789999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=348.52 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=196.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHH
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--------------------------NNVEQFINEVVILS 400 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 400 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999964 688999998754321 12356899999999
Q ss_pred hcCCCCeeeEEeEEee--CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCC
Q 038345 401 QINHRNIVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478 (686)
Q Consensus 401 ~l~h~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 478 (686)
+++||||+++++++.+ ....++||||+++++|.+++.. .++++..++.++.|++.||+|||+. +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999986 5678999999999999886543 3699999999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCC---CCccccEeehHHHHHHHHhCCCCCccC
Q 038345 479 SANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAI 555 (686)
Q Consensus 479 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDv~S~Gv~l~elltg~~p~~~~ 555 (686)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654332 233457999999999997765 378899999999999999999999643
Q ss_pred CcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 556 NIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 556 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. .. ....+.... ............+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~------~~-~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI------MC-LHSKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH------HH-HHHHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH------HH-HHHHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 11 111111110 000111123456889999999999999999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=352.33 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=204.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE------NNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357999999999999999999975 589999998764322 1357799999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEecC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDFG 496 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 496 (686)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999753 3699999999999999999999999 999999999999998877 89999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~-~~~~~~~- 233 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVN- 233 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHTC-
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HH-HHHHhcC-
Confidence 998764332 2234569999999999999999999999999999999999999997532211 11 1111000
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........+..+.+|+.+||+.||++|||+.++++
T Consensus 234 -----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 -----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000111123456889999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=354.12 Aligned_cols=258 Identities=23% Similarity=0.452 Sum_probs=202.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
++|.+.++||+|+||.||+|... +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57999999999999999999964 344 3577776432 3445678999999999999999999999998755 789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999998643 3599999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~-------- 233 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILE-------- 233 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHH--------
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHH--------
Confidence 3322 22233456889999999999999999999999999999999 999997644322 111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.......+......+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus 234 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 234 -KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11111122234456889999999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=366.25 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=211.4
Q ss_pred ccChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeE
Q 038345 338 LFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGC 413 (686)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~ 413 (686)
.+..+++....++|.+.++||+|+||.||++... +++.||||++... .....+.+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3455667777899999999999999999999975 6899999987642 22334568899999999999999999999
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
+.+.+..+|||||+++|+|.++|.+.. ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999998643 2589999999999999999999998 99999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccc-------cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ-------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~ 566 (686)
|||+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+ .
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~ 278 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------T 278 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------H
Confidence 99999877654443444567999999999987 4578999999999999999999999997543211 1
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNR---PTMKEVAF 619 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~ev~~ 619 (686)
+........ ...........+.++.+|+.+||. +|.+| |+++|+++
T Consensus 279 ~~~i~~~~~------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKE------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHH------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhccc------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111000 000011112345678999999999 99998 58888864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=357.71 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=198.7
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~l 422 (686)
..++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999888999999987543 34456789999999999986 999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||| +.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5688999999864 3589999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCce-eeeeeeccccccCcccccc-----------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 503 VDQTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 503 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~---- 229 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK---- 229 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHH----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHH----
Confidence 43322 2334579999999999865 6789999999999999999999999964321 1111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+..++++......+......+.+|+.+||+.||++|||+.|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp -----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11122222222222223456889999999999999999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=381.94 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=208.1
Q ss_pred ccccccc-ccCccceEEEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANR-ILGQGGQGTVYKGMLA---DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+++.+.+ .||+|+||.||+|.+. ++..||||.++.. .....+.|.+|+.+|++++||||+++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444444 7999999999999864 4567999998764 33456889999999999999999999999976 568999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.++|... ...+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999999754 33599999999999999999999999 999999999999999999999999999987653
Q ss_pred CCceee--eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 504 DQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 504 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... ....+|+.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~------ 555 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG------ 555 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTT------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcC------
Confidence 332222 22345689999999999999999999999999999998 999997644321 11111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccc
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~ 631 (686)
.....+...+..+.+|+.+||+.+|++||++.+|++.|+.+.......
T Consensus 556 ---~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 556 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 111222344567899999999999999999999999999987765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.98 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=200.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+|+||+||+++.. +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 5789999987643 233345688999999887 89999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|..++.+.. .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998643 599999999999999999999999 99999999999999999999999999998633
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccC--CchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED--RSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~ 580 (686)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........+....
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 22 2234456799999999999999999999999999999999999999975432221 111111111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+.....++.+|+.+||+.||++||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11222345568899999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=358.33 Aligned_cols=266 Identities=20% Similarity=0.279 Sum_probs=204.0
Q ss_pred ccccccccccCcc--ceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQG--GQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+| +||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 6899999987643 34455778899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999997653 23599999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCce------eeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh--
Q 038345 503 VDQTH------LTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN-- 572 (686)
Q Consensus 503 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~-- 572 (686)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .+.........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcc
Confidence 22111 1122368899999999987 678999999999999999999999997543221 11100000000
Q ss_pred -------cc-------------hhhhhhh---------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 573 -------EN-------------RLFEVLD---------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 573 -------~~-------------~~~~~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. .+.+.+. ..............+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 0000000 00000112233467899999999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=346.59 Aligned_cols=262 Identities=27% Similarity=0.456 Sum_probs=198.8
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++|.+.++||+|+||.||+|.... .||||.++.. .....+.|.+|+.++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 345689999999999999999998643 5999987653 344567899999999999999999999965 55668999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999997543 3599999999999999999999999 999999999999999999999999999976542
Q ss_pred C-CceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 504 D-QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 504 ~-~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
. .........||+.|+|||.+. ...++.++||||||+++|||++|+.||......+ ..............
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcc
Confidence 2 122233456899999999986 6678899999999999999999999997543211 11111111111110
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
+ .......+..+.+|+.+||+.+|++|||+.++++.|+.+.+
T Consensus 247 ~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 L-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp T-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred h-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 11122345678999999999999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.07 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=207.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999975 6889999998766555667899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC--CCcEEEEecCCcccccCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--KYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~ 504 (686)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++. .+.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999997542 3589999999999999999999999 9999999999999974 477999999999876543
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+..... ..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~i~~~~~------~~ 269 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETL-QNVKRCDW------EF 269 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHH-HHHHHCCC------CC
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCC------CC
Confidence 32 33456999999999999999999999999999999999999999753211 111 11111000 00
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........++.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01111233456889999999999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=354.00 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=203.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-----ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357999999999999999999965 68999999875321 123578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc---EEEEecCC
Q 038345 422 LVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR---AKVSDFGT 497 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGl 497 (686)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886532 234589999999999999999999999 9999999999999976654 99999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .....+......
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RLFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HHHHHHHHTCCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HHHHHHHcCCCC
Confidence 987654322 23345699999999999999999999999999999999999999975210 011111111000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+ ......+..+.+|+.+||+.||++|||+.++++
T Consensus 251 --~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNP----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000123456889999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.02 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=207.7
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcce
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPL 421 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 421 (686)
..++|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999996 5789999998876666677889999999999999999999999973 34778
Q ss_pred EEEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 422 LVYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997632 234699999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCce--------eeeeeeccccccCccccccCC---CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 501 ITVDQTH--------LTTKVQGTFGYVDPEYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 501 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
....... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||....... .... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~ 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVA----L 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHH----H
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhh----H
Confidence 4321110 011234799999999987554 6889999999999999999999996321111 0010 0
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.... .............+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0000 000111123345689999999999999999999999999987643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.87 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=204.9
Q ss_pred ccccccccccCccceEEEEEEEeCC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
..+|...++||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3568888999999999999998643 236999997653 3344567999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999997642 3599999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 502 TVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 502 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~---- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDG---- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTT----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCC----
Confidence 433221 1222346788999999999999999999999999999999 999996543211 11111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.....+...+..+.+++.+||+.+|++||++.+|++.|+.+....
T Consensus 267 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 267 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011112234456899999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=347.62 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=199.9
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|+||.||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999999889999999876533 22346788999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 9998887543 3589999999999999999999999 999999999999999999999999999986543221
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hhhh----
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RLFE---- 578 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~---- 578 (686)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............ ....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcc
Confidence 2233468999999999876 458999999999999999999999997543211 111111111000 0000
Q ss_pred -hhhhhc-------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 -VLDALV-------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 -~~d~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..++.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00111223456889999999999999999999973
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=358.77 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=199.3
Q ss_pred cccccccccCccceEEEEEEEeC--CC--cEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee-CCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA--DG--RIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLE-TEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~l 422 (686)
..|...++||+|+||.||+|.+. ++ ..||||.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35777899999999999999864 22 36899987653 34556789999999999999999999998765 567899
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999997643 3588999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCce---eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 503 VDQTH---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 503 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ ... ....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~~~~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----HHHTTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----HHHcCC---
Confidence 32211 1233457889999999999999999999999999999999 677776543221 111 111110
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 001112234568899999999999999999999999999886544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=344.62 Aligned_cols=261 Identities=26% Similarity=0.388 Sum_probs=209.8
Q ss_pred hcccccccc-ccCccceEEEEEEEeC---CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 347 ATDNYNANR-ILGQGGQGTVYKGMLA---DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 347 ~~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
..++|.+.+ .||+|+||.||+|.+. +++.||||.++... ....+.+.+|+.++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345788877 9999999999999642 46789999876532 33357899999999999999999999999 66778
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999864 2589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCceee--eeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 501 ITVDQTHLT--TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 501 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
......... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~--- 236 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG--- 236 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcC---
Confidence 654433222 22346788999999998889999999999999999999 999997543211 11111111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
.....+...+..+.+++.+||+.||++||++.+|++.|+.+......
T Consensus 237 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 237 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 11112233456789999999999999999999999999998766443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=349.32 Aligned_cols=268 Identities=25% Similarity=0.425 Sum_probs=204.7
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeC----CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCL 415 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 415 (686)
+++....++|.+.+.||+|+||.||+|... .+..||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344445678999999999999999999854 2458999987643 3445678999999999999999999999998
Q ss_pred eCC-----cceEEEEeccCCchhhhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC
Q 038345 416 ETE-----VPLLVYEFVPNGTLYQNIHNH---IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK 487 (686)
Q Consensus 416 ~~~-----~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 487 (686)
+.. ..++||||+++++|.+++... .....+++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 755 349999999999999998542 1234699999999999999999999999 99999999999999999
Q ss_pred CcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhH
Q 038345 488 YRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 488 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~ 565 (686)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-- 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M-- 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H--
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H--
Confidence 9999999999986643322 12233457889999999999999999999999999999999 889987543221 1
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....... .....+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 259 --~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 259 --YDYLLHG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --HHHHHTT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --HHHHHcC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111 011112234457899999999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.37 Aligned_cols=273 Identities=23% Similarity=0.356 Sum_probs=216.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC--cceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETE--VPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lV 423 (686)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999976 48999999976532 234577889999999999999999999998765 67999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee----cCCCcEEEEecCCcc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRAKVSDFGTSR 499 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla~ 499 (686)
|||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999998765555699999999999999999999999 99999999999999 788889999999998
Q ss_pred cccCCCceeeeeeeccccccCcccccc--------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQS--------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||........ ....+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHh
Confidence 7643322 234569999999999865 5678899999999999999999999975433221 111121211
Q ss_pred hcchh---h---h-------hh-hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 572 NENRL---F---E-------VL-DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 572 ~~~~~---~---~-------~~-d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..... . . +. +..............+.+++.+||+.||++||++.++++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11100 0 0 00 00011233466778899999999999999999999999999888764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=347.85 Aligned_cols=273 Identities=22% Similarity=0.328 Sum_probs=207.4
Q ss_pred HHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc--CCCCeeeEEeEEeeC---
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI--NHRNIVKLLGCCLET--- 417 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~g~~~~~--- 417 (686)
.-....++|.+.+.||+|+||.||+|... ++.||||++... ....+.+|.+++..+ +||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 34445678999999999999999999986 899999987542 234555666666555 899999999999887
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeEeeCCCCCCeeecCCCcEE
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA-----SISIYRRDIKSANILLDDKYRAK 491 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~k 491 (686)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 6789999999999999999753 4899999999999999999999761 33899999999999999999999
Q ss_pred EEecCCcccccCCCcee---eeeeeccccccCccccccCCCCcc------ccEeehHHHHHHHHhC----------CCCC
Q 038345 492 VSDFGTSRSITVDQTHL---TTKVQGTFGYVDPEYFQSSQFTEK------SDVYSFGVVLVEILTG----------QKPI 552 (686)
Q Consensus 492 l~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDv~S~Gv~l~elltg----------~~p~ 552 (686)
|+|||+++......... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997664332221 123469999999999987766655 9999999999999999 5666
Q ss_pred ccCCcccCCchhHhhHHHhhcchhhhhhhhhcc-ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 553 RAINIDEDRSLVGYFLQAMNENRLFEVLDALVL-KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 553 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
........ .............. .+... .......+..+.+|+.+||+.||++|||+.+|++.|+.+.+...
T Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 263 HDLVPSDP--SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hhhcCCCC--chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 54322211 11111111111111 11111 11123567789999999999999999999999999999987643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.09 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=207.3
Q ss_pred ccccccccCccceEEEEEEEeCC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc-eEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLAD-G---RIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP-LLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lV 423 (686)
.|...++||+|+||.||+|.+.+ + ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998532 2 37999987653 334567899999999999999999999999876655 999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997633 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCc---eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCC-ccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 504 DQT---HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI-RAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 504 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~-~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+ ......+ ........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~----- 244 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQG----- 244 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTT-----
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcC-----
Confidence 221 1223345789999999999999999999999999999999966554 3222111 11111111
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccc
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGAS 631 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~ 631 (686)
.....+...+..+.+++.+||+.||.+|||++++++.|+.+.......
T Consensus 245 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 245 ----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 111112223456889999999999999999999999999998765443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=344.14 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=205.3
Q ss_pred ccccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe-eCCcce
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCL-ETEVPL 421 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~ 421 (686)
..+|.+.++||+|+||.||+|...+ ...||+|.+... .....+.+.+|+.++++++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568889999999999999999643 236899987653 3445678999999999999999999999865 456789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999997633 3589999999999999999999999 9999999999999999999999999999866
Q ss_pred cCCCc---eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 502 TVDQT---HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 502 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+ ... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~~-- 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGR-- 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTTC--
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcCC--
Confidence 43321 12233457889999999999999999999999999999999 556665432211 111 111110
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....+...+..+.+++.+||+.+|++|||++++++.|+.+....
T Consensus 250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 01111223456889999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=347.87 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=204.8
Q ss_pred ccccccccccCccceEEEEEEEeCC-C-------cEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-G-------RIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578999999999999999998653 3 4799999877666677889999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc--------EE
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR--------AK 491 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~k 491 (686)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999998643 2489999999999999999999999 9999999999999988877 99
Q ss_pred EEecCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCC-CCccCCcccCCchhHhhHH
Q 038345 492 VSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQK-PIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 492 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~-p~~~~~~~~~~~l~~~~~~ 569 (686)
|+|||++...... ....||+.|+|||.+.+ ..++.++||||||+++|||++|.. ||...... .. ..
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~-~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RK-LQ 229 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HH-HH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HH-HH
Confidence 9999999754321 23458899999999987 778999999999999999999554 44322111 00 00
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
..... ...+......+.+|+.+||+.||++|||+.++++.|+.+......
T Consensus 230 ~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 230 FYEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HHHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred Hhhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00000 001111234588999999999999999999999999998764433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.29 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=180.9
Q ss_pred ccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEeccCCc
Q 038345 354 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVPNGT 431 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gs 431 (686)
.++||+|+||.||++... +++.||||++.. .....+.+|+.++.++. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 589999998753 33467889999999997 9999999999999999999999999999
Q ss_pred hhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---cEEEEecCCcccccCCCcee
Q 038345 432 LYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY---RAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 432 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~ 508 (686)
|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 99999864 3699999999999999999999999 999999999999997665 899999999986543322 2
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+.. ......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence 33456899999999999999999999999999999999999999764432211111111222221110 011111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
....+.++.+|+.+||+.||++|||+++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 223456789999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=355.09 Aligned_cols=248 Identities=29% Similarity=0.388 Sum_probs=200.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999965 5899999987642 233456788999999998 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997643 599999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+ ..+....
T Consensus 176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~------- 240 (353)
T 3txo_A 176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDE------- 240 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCC-------
T ss_pred cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HH-HHHHcCC-------
Confidence 22 223345679999999999999999999999999999999999999997543211 11 1111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTM------KEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~ev~~ 619 (686)
...+......+.+|+.+||+.||++||++ +++++
T Consensus 241 ---~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ---VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01122234568899999999999999998 66654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=356.61 Aligned_cols=212 Identities=27% Similarity=0.317 Sum_probs=185.1
Q ss_pred cccccChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-----CCCee
Q 038345 335 KTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-----HRNIV 408 (686)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv 408 (686)
....++.++.....++|.+.++||+|+||.||+|... +++.||||.++.. ....+.+..|+.++++++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 3455677777778899999999999999999999974 6889999998642 344567888999999996 99999
Q ss_pred eEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC--
Q 038345 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-- 486 (686)
Q Consensus 409 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-- 486 (686)
++++++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence 9999999999999999999 9999999986532 3589999999999999999999999 9999999999999975
Q ss_pred -----------------------CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHH
Q 038345 487 -----------------------KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 543 (686)
Q Consensus 487 -----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ 543 (686)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999864322 23456899999999999999999999999999999
Q ss_pred HHHhCCCCCccCC
Q 038345 544 EILTGQKPIRAIN 556 (686)
Q Consensus 544 elltg~~p~~~~~ 556 (686)
||++|+.||....
T Consensus 251 ell~g~~pf~~~~ 263 (360)
T 3llt_A 251 ELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHSSCSCCCSS
T ss_pred HHHHCCCCCCCCc
Confidence 9999999997543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=347.73 Aligned_cols=272 Identities=23% Similarity=0.341 Sum_probs=213.5
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHh--cCCCCeeeEEeEEeeCC
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQ--INHRNIVKLLGCCLETE 418 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~ 418 (686)
...-....++|.+.+.||+|+||.||+|.. +++.||||.+.. .....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999998 489999998763 334678889999988 78999999999998776
Q ss_pred ----cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeEeeCCCCCCeeecC
Q 038345 419 ----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH--------SAASISIYRRDIKSANILLDD 486 (686)
Q Consensus 419 ----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH--------~~~~~~ivH~Dikp~NIll~~ 486 (686)
..++||||+++|+|.+++.+. .+++..++.++.|++.||+||| +. +|+||||||+|||++.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 789999999999999999753 4899999999999999999999 66 9999999999999999
Q ss_pred CCcEEEEecCCcccccCCCce---eeeeeeccccccCccccccC------CCCccccEeehHHHHHHHHhC---------
Q 038345 487 KYRAKVSDFGTSRSITVDQTH---LTTKVQGTFGYVDPEYFQSS------QFTEKSDVYSFGVVLVEILTG--------- 548 (686)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDv~S~Gv~l~elltg--------- 548 (686)
++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999876543322 12344689999999998765 344789999999999999999
Q ss_pred -CCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 549 -QKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK-EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 549 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
+.||......+. . ...+........+ .+.+.. .........+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus 263 ~~~p~~~~~~~~~-~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-S-VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCCTTTTTSCSSC-C-HHHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCccccCcCcc-c-HHHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 778765432211 1 1111111111111 111111 1123566789999999999999999999999999999987
Q ss_pred hhc
Q 038345 627 SIG 629 (686)
Q Consensus 627 ~~~ 629 (686)
..+
T Consensus 337 ~~~ 339 (342)
T 1b6c_B 337 QEG 339 (342)
T ss_dssp TTC
T ss_pred Hhc
Confidence 654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=354.65 Aligned_cols=265 Identities=18% Similarity=0.214 Sum_probs=200.1
Q ss_pred ccccccccccCccceEEEEEEEeC----CCcEEEEEEccccChh-----------hHHHHHHHHHHHHhcCCCCeeeEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLVDEN-----------NVEQFINEVVILSQINHRNIVKLLG 412 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g 412 (686)
.++|.+.+.||+|+||.||+|... ++..||||........ ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 5788999987653321 1234678889999999999999999
Q ss_pred EEee----CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 413 CCLE----TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 413 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999998643 699999999999999999999999 999999999999998877
Q ss_pred --cEEEEecCCcccccCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccC
Q 038345 489 --RAKVSDFGTSRSITVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560 (686)
Q Consensus 489 --~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~ 560 (686)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876432211 1134568999999999999999999999999999999999999996422111
Q ss_pred CchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
............ .+...+..... ....+.++.+++.+||+.||++||++++|++.|+.+.
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 -VAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp -HHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred -HHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 001111111100 01111100000 0023457899999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.80 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=201.8
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999996 468999999875321 12235789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+ +|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999887543 599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......+.... +...
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~-------- 223 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSC-------- 223 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSS--------
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcC--------
Confidence 32 2234569999999999988776 6899999999999999999999975432211100 0000
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00111223456889999999999999999999984
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=362.06 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=204.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4568999999999999999999864 6889999987543 234456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~ 500 (686)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 9999999999999764 3599999999999999999999999 999999999999998 567899999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... . ....+..+.. ...
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~-~~~ 233 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------R-LYQQIKAGAY-DFP 233 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCC-CCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------H-HHHHHHhCCC-CCC
Confidence 654332 233457999999999999999999999999999999999999999643211 1 1111111110 000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0011123456889999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=353.91 Aligned_cols=261 Identities=26% Similarity=0.342 Sum_probs=202.7
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-----DENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
++....++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35566788999999999999999999964 6889999986532 34456789999999999999999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC-------------------------------------CCCCCHHHHHHHHHHHHH
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE-------------------------------------EFPITWELLLRIAVEVSG 459 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~qi~~ 459 (686)
....++||||+++|+|.+++..... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999863110 112467788999999999
Q ss_pred HHHHhhhcCCCCeEeeCCCCCCeeecCCC--cEEEEecCCcccccCCC---ceeeeeeeccccccCcccccc--CCCCcc
Q 038345 460 ALFYLHSAASISIYRRDIKSANILLDDKY--RAKVSDFGTSRSITVDQ---THLTTKVQGTFGYVDPEYFQS--SQFTEK 532 (686)
Q Consensus 460 ~L~yLH~~~~~~ivH~Dikp~NIll~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~t~k 532 (686)
||+|||+. +|+||||||+|||++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998766 89999999998654321 112344569999999999875 678999
Q ss_pred ccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC
Q 038345 533 SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612 (686)
Q Consensus 533 sDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 612 (686)
+||||||+++|||++|+.||......+ ............ ...........+.+|+.+||+.||++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999997543211 111111111000 0111112345688999999999999999
Q ss_pred CHHHHHH
Q 038345 613 TMKEVAF 619 (686)
Q Consensus 613 t~~ev~~ 619 (686)
++.++++
T Consensus 324 s~~~~l~ 330 (345)
T 3hko_A 324 DAMRALQ 330 (345)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 9999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.96 Aligned_cols=253 Identities=23% Similarity=0.278 Sum_probs=201.1
Q ss_pred ccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 352 NANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
...++||+|+||.||+|... +++.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33578999999999999964 68999999988766666788999999999999999999999999999999999999999
Q ss_pred chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee--cCCCcEEEEecCCcccccCCCcee
Q 038345 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL--DDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 431 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll--~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9999887532 3589999999999999999999999 99999999999999 6778999999999987653322
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~ 588 (686)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+....... . . .....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~-~-~-----~~~~~ 311 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACR-W-D-----LEDEE 311 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C-C-----SCSGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcc-C-C-----CChhh
Confidence 233469999999999999999999999999999999999999997543211 111111100 0 0 00111
Q ss_pred hHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 038345 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAF--ELGGI 624 (686)
Q Consensus 589 ~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~--~L~~i 624 (686)
......++.+|+.+||+.||++|||+.|+++ .+...
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1223457899999999999999999999996 45544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=356.34 Aligned_cols=253 Identities=23% Similarity=0.345 Sum_probs=205.7
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
...++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34578999999999999999999975 5899999987543 34456789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEEecCCcc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSR 499 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~ 499 (686)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999998754 3589999999999999999999999 99999999999999765 459999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+..+.. ..
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~-~~~~i~~~~~-~~ 249 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAY-DY 249 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCC-CC
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCC-CC
Confidence 765322 233457999999999999999999999999999999999999999753211 1 1111111110 00
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........++.+|+.+||+.||++||++.++++
T Consensus 250 -----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 -----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111123456889999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.68 Aligned_cols=269 Identities=25% Similarity=0.366 Sum_probs=204.5
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccc---cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKL---VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..++|.+.+.||+|+||.||+|.. .+++.||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999996 4689999998764 234456789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 423 VYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999987532 234689999999999999999999999 9999999999999999999999999999765
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...+......
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~~~---- 256 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEQCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHH-HHHHHTTCSC----
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHH-HHHhhcccCC----
Confidence 43222 22345689999999999999999999999999999999999999964321 11111 1111111110
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
..........+.+|+.+||+.||++|||+.+|++.|+++++....+.
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 00112234568899999999999999999999999999998766554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.52 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=198.7
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhcC--CCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQIN--HRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lV 423 (686)
..+|.+.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++.+++ ||||+++++++...+..+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 356999999999999999999988899999998754 33455678999999999996 59999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|| +.+++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999998643 589999999999999999999999 999999999999996 57899999999987653
Q ss_pred CCce-eeeeeeccccccCcccccc-----------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 504 DQTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 504 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~----- 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISK----- 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHH-----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHH-----
Confidence 3322 2334569999999999865 4688999999999999999999999964321 1111
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+..+++.......+......+.+|+.+||+.||++|||+.||++
T Consensus 277 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11222222111122222456889999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=361.99 Aligned_cols=269 Identities=19% Similarity=0.275 Sum_probs=213.7
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.++||+|+||.||+|.. .+++.||||+...... .+++.+|+.+++.++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 4689999998654322 2468899999999987 666677777778888999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCccccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 502 (686)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999997543 3599999999999999999999999 99999999999999 688999999999998765
Q ss_pred CCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 503 VDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 503 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||.............. +....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----ISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH----HHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH----Hhhccc
Confidence 43321 12246799999999999999999999999999999999999999986543221111111 111111
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
...+. ......+.++.+|+.+||+.+|++||++.+|++.|+.+....+....
T Consensus 234 ~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~ 285 (483)
T 3sv0_A 234 ATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFD 285 (483)
T ss_dssp HSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred cccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCcc
Confidence 11111 11122346789999999999999999999999999999876665543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=344.43 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=202.4
Q ss_pred hccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-CcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e 425 (686)
..++|.+.+.||+|+||.||+|... ++.||||.++.. ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3467999999999999999999875 889999998653 3457899999999999999999999997654 47899999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 999999999997542 22488999999999999999999999 9999999999999999999999999999754322
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+... .
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~ 231 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKG---------Y 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------HHHHHTTT---------C
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcC---------C
Confidence 122357889999999999999999999999999999998 999997543211 11111111 1
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
....+...+..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1112223456789999999999999999999999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=349.53 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=201.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999975 5889999987642 344556788999999998 899999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997643 599999999999999999999999 999999999999999999999999999986432
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCC--chhHhhHHHhhcchhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR--SLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~~d 581 (686)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .........+....
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 22 2234567999999999999999999999999999999999999999753221110 11111111111110
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+......+.+|+.+||+.||++||++
T Consensus 236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11222345568899999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.91 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=198.7
Q ss_pred ccccccc-cccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNAN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.+.|.+. ++||+|+||.||+|... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999954 6899999998765555567899999999995 7999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc---EEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR---AKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGla~~~ 501 (686)
||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998642 589999999999999999999999 9999999999999988766 999999999765
Q ss_pred cCCCc------eeeeeeeccccccCcccccc-----CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh------
Q 038345 502 TVDQT------HLTTKVQGTFGYVDPEYFQS-----SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV------ 564 (686)
Q Consensus 502 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~------ 564 (686)
..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999875 56889999999999999999999999765432211100
Q ss_pred --HhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 565 --GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 565 --~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+..... .. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~-~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EF-----PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC-CC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc-cc-----CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 000111111100 00 00000123457899999999999999999999984
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.77 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=207.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcE--EEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRI--VAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+.||+|+||.||+|... ++.. ||+|.++.. .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999964 4554 489987643 334456789999999999 899999999999999999999
Q ss_pred EEeccCCchhhhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 424 YEFVPNGTLYQNIHNHI-------------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997642 234699999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence 99999999743211 11223457889999999998889999999999999999998 999997543211 111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
.+... .....+......+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus 253 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 253 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 11111 11111223345689999999999999999999999999998875443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.30 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=203.8
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357999999999999999999975 6899999987642 123456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998643 589999999999999999999998 999999999999999999999999999986542
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+...... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~---------~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA---------E 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC---------C
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---------C
Confidence 2 23457999999999999999999999999999999999999999753211 111111111 0
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
. ..+.....++.+++.+||+.||++|| +++++++
T Consensus 220 ~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 L--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp C--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 11223345688999999999999999 8888873
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.27 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=194.2
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||+||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3467999999999999999999976 689999998765332 23678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc--EEEEecCCcccccC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR--AKVSDFGTSRSITV 503 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DfGla~~~~~ 503 (686)
|+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999997543 599999999999999999999998 9999999999999987765 99999999975432
Q ss_pred CCceeeeeeeccccccCccccccCCCCcc-ccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEK-SDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||......+ ........... .
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~---------~ 237 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS---------V 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT---------T
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc---------C
Confidence 21 2234569999999999988887655 899999999999999999997543211 11111111111 1
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.............+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000111123456889999999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.25 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=203.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999965 5889999987542 233457789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999999854 3599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
. .......||+.|+|||++.. ..++.++||||||+++|||++|+.||....... ... ....+...
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~-~~~~~~~~------ 235 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKE-IVHTFETT------ 235 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHH-HHHHHHHC------
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHH-HHHHHhhc------
Confidence 3 22345679999999999864 458999999999999999999999997543221 111 11111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-HHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-MKEVA 618 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~ev~ 618 (686)
....+......+.+|+.+||+.||.+||+ +++|.
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 01122234467899999999999999998 66655
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.85 Aligned_cols=271 Identities=14% Similarity=0.181 Sum_probs=210.6
Q ss_pred ccccccccccCccceEEEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeee---------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD---------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK--------- 409 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 409 (686)
.++|.+.+.||+|+||.||+|.... ++.||||..... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999763 789999987643 46889999999999999987
Q ss_pred ------EEeEEee-CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 410 ------LLGCCLE-TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 410 ------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 6777776 67889999999 999999998642 24699999999999999999999999 999999999999
Q ss_pred eecCCC--cEEEEecCCcccccCCCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCcc
Q 038345 483 LLDDKY--RAKVSDFGTSRSITVDQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRA 554 (686)
Q Consensus 483 ll~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~ 554 (686)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876433221 11334689999999999999999999999999999999999999975
Q ss_pred CCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccccc
Q 038345 555 INIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASILQ 634 (686)
Q Consensus 555 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~~ 634 (686)
..... ............ ....+.+... .....+..+.+|+.+||+.||++|||+++|++.|+.+....+.....
T Consensus 271 ~~~~~--~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 271 CLPNT--EDIMKQKQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD 344 (352)
T ss_dssp GTTCH--HHHHHHHHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred CCcCH--HHHHHHHHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence 43211 001011110000 0000100000 00112456899999999999999999999999999998877655443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.55 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=201.2
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999965 6889999997653 223347789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999998642 589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+........ .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~-~------ 252 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI-P------ 252 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC-C------
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC-C------
Confidence 4333334556899999999999999999999999999999999999999743211 1111111110 0
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhhhcc
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIRASIGA 630 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~ev~~~L~~i~~~~~~ 630 (686)
.........+..+.+++.+||+.||++|| +++++++.|+.+......
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 00111223345688999999999999999 999999999887655443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=352.35 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=199.8
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4688899999999999999996 578999999876432 234467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+. |+|.+++.... .++++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 68888886432 3699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...... .......... .
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~-~----- 270 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-S----- 270 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC-C-----
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC-C-----
Confidence 2356999999999984 567899999999999999999999999643311 1111111110 0
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+ ..........+.+++.+||+.||++|||++++++
T Consensus 271 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0011123456889999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.59 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=191.5
Q ss_pred HHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.....++|.+.+.||+|+||.||+|... +++.||||.++... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 3456678999999999999999999976 57899999986532 34678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCCcc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGTSR 499 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~ 499 (686)
||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999999754 3589999999999999999999999 9999999999999975 8899999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .....+..... .
T Consensus 200 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~- 269 (349)
T 2w4o_A 200 IVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-Y- 269 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-C-
T ss_pred ccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-c-
Confidence 65432 22334569999999999999999999999999999999999999996433211 01111111100 0
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
............+.+|+.+||+.||++|||+.++++
T Consensus 270 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 ----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111233456889999999999999999999984
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.81 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=199.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|.+.++||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 5899999987643 33345778999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 6666555432 3599999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hh---hh
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RL---FE 578 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~---~~ 578 (686)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .............. .. ..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcc
Confidence 2 233456899999999998765 799999999999999999988886432211 11111111111100 00 00
Q ss_pred hhh---------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 579 VLD---------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 579 ~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+ ..............+.+|+.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 000 0000111123446688999999999999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.10 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=189.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457899999999999999999965 58999999876533 3334678899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 426 FVPNGTLYQNIHNHI---EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|++ |+|.+++.... ....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886532 123589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--h----
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--R---- 575 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~---- 575 (686)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence 3222 2234468999999999876 468999999999999999999999997543221 111111110000 0
Q ss_pred ------------------hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 576 ------------------LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 576 ------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
+.+.+.+.. .......+.+++.+||+.||++|||++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000011100 112345689999999999999999999987
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.14 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=204.9
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999976 477899999876555567889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCccccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 502 (686)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999887543 589999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ....+......
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~----- 225 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFT----- 225 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC-----
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCC-----
Confidence 332 22345689999999998654 8999999999999999999999997543211 11111111000
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
............+.+++.+||+.||++|||+.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 -FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000123457889999999999999999999984
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.64 Aligned_cols=264 Identities=24% Similarity=0.307 Sum_probs=198.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999975 58999999865432 233567889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999888743 3589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh--------HHHhhcch
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF--------LQAMNENR 575 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 575 (686)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+........ ........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2234568999999999876 67899999999999999999999999754332211100000 00000000
Q ss_pred hhhh---hhhhccCh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 576 LFEV---LDALVLKE---AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 576 ~~~~---~d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.... .++..... ........+.+|+.+||+.||++|||++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 0000 00000000 0012345688999999999999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=378.25 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=201.5
Q ss_pred cccCccceEEEEEEEeC---CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLA---DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
+.||+|+||.||+|.+. .++.||||+++.. .....++|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999753 4678999998753 2334678999999999999999999999986 4567899999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce--
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH-- 507 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 507 (686)
|+|.++|... ..+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999754 3589999999999999999999999 9999999999999999999999999999876543321
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+.. ....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~---------~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK---------GERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT---------TCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc---------CCCC
Confidence 2233457889999999999999999999999999999998 999997543221 1111111 1112
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..+...+.++.+|+.+||+.||++||++.+|+++|+.+...
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 22334456789999999999999999999999999988654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.07 Aligned_cols=259 Identities=28% Similarity=0.357 Sum_probs=198.6
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc---
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP--- 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 420 (686)
.++|.+.+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999996 56899999997653 233456789999999999999999999999876544
Q ss_pred -eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 421 -LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 421 -~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
++||||+++++|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999997543 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 500 SITVDQT--HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 500 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence 7643322 1223456899999999999999999999999999999999999999754321 1111111111110
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA-FELGGIR 625 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~-~~L~~i~ 625 (686)
. .......+..+.+|+.+||+.||++||+..+++ +.|..+.
T Consensus 239 ~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 001112345688999999999999999766554 4555543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=348.99 Aligned_cols=263 Identities=26% Similarity=0.375 Sum_probs=208.2
Q ss_pred hccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
..++|.+.+.||+|+||.||+|.+. ++..||||.+... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3468999999999999999999842 4678999998643 34556789999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEE
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIE----EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKV 492 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl 492 (686)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +|+||||||+|||++ .+..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 13589999999999999999999999 999999999999998 4456999
Q ss_pred EecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHH
Q 038345 493 SDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 493 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHHH
Confidence 99999976533221 12233457889999999999999999999999999999998 999986432211 1111
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
+.... ....+......+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 258 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 258 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11110 11112233456889999999999999999999999999887643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.27 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=205.9
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee---------
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--------- 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 416 (686)
...+|.+.+.||+|+||.||+|... +++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999976 78999999886533 357789999999999999999999864
Q ss_pred -------CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc
Q 038345 417 -------TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR 489 (686)
Q Consensus 417 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 489 (686)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 445799999999999999997642 23699999999999999999999999 9999999999999999999
Q ss_pred EEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 490 AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ....
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHH
Confidence 99999999987654322 233468999999999999999999999999999999999998864210 0111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
.... ..+ +......+.+++.+||+.||++|||+.|+++.|..++....
T Consensus 230 ~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 DLRD--------GII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHT--------TCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred Hhhc--------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111 111 11223457899999999999999999999999998875543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=348.20 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999975 6899999987542 223456789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998643 589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .. ...+..+.
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~-~~~i~~~~-------- 254 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QI-YEKIVSGK-------- 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCC--------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HH-HHHHHcCC--------
Confidence 2 23457999999999999999999999999999999999999999753221 11 11111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
...+......+.+|+.+||+.||.+||+ +++|++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0112233456889999999999999998 777764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=345.39 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=194.0
Q ss_pred ccccccccccCccceEEEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGML----ADGRIVAVKKSKLVD----ENNVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
.++|.+.++||+|+||.||++.. .+++.||+|.++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999996 468999999876532 2344668899999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997543 589999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ .
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~----- 236 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-C----- 236 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-T-----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-C-----
Confidence 543222 2233456999999999999999999999999999999999999999753321 11111111 0
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
. ...+......+.+++.+||+.||++|| ++.|+++
T Consensus 237 ---~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 ---K--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---C--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---C--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 011223345688999999999999999 6677764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.58 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=204.2
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999975 6899999987643 23345789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999998753 3589999999999999999999999 99999999999999999999999999998654322
Q ss_pred c-eeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 506 T-HLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 506 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... . .+.........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~---~~~~~~~~~~~------- 227 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q---EYSDWKEKKTY------- 227 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--H---HHHHHHTTCTT-------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--H---HHHHhhhcccc-------
Confidence 1 22334568999999999987765 789999999999999999999997543211 0 01111111000
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+.+++.+||+.||++|||++++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0011123456889999999999999999999973
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.05 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=203.7
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCc
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEV 419 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 419 (686)
....++|.+.+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344578999999999999999999975 5889999987642 123456788999999987 89999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999997642 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+....
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN---- 234 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC----
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCC----
Confidence 643222 22345679999999999999999999999999999999999999997533211 111111110
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK-EVA 618 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-ev~ 618 (686)
...+......+.+|+.+||+.||++||++. +++
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011222345688999999999999999997 554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=353.25 Aligned_cols=261 Identities=16% Similarity=0.198 Sum_probs=211.1
Q ss_pred hHHHHhhccccccccccCccceEEEEEEE------eCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC---CCCeeeEE
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGM------LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN---HRNIVKLL 411 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~ 411 (686)
..+++...++|.+.++||+|+||+||+|. ..+++.||||++... ...++..|+.++.+++ |+||++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 34455567889999999999999999994 446889999998654 3456788888888886 99999999
Q ss_pred eEEeeCCcceEEEEeccCCchhhhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---
Q 038345 412 GCCLETEVPLLVYEFVPNGTLYQNIHNHI--EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--- 486 (686)
Q Consensus 412 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--- 486 (686)
+++...+..+|||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+. +|+||||||+||||+.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 99999999999999999999999997532 234699999999999999999999998 9999999999999998
Q ss_pred --------CCcEEEEecCCcccccC-CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCc
Q 038345 487 --------KYRAKVSDFGTSRSITV-DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557 (686)
Q Consensus 487 --------~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~ 557 (686)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976542 223344556799999999999999999999999999999999999999864322
Q ss_pred ccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhhhh
Q 038345 558 DEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNR-PTMKEVAFELGGIRASI 628 (686)
Q Consensus 558 ~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Pt~~ev~~~L~~i~~~~ 628 (686)
... .+...+. .. .....+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 291 ~~~--------------~~~~~~~----~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 291 GEC--------------KPEGLFR----RL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp TEE--------------EECSCCT----TC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred Cce--------------eechhcc----cc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 110 0000000 00 113457789999999999998 68899999998876653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.45 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=192.2
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCC--cc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETE--VP 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~ 420 (686)
..++|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 689999998754 23455677889999999997 999999999997544 67
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999997 6899988753 589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCC--------------------CceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCccc
Q 038345 501 ITVD--------------------QTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559 (686)
Q Consensus 501 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~ 559 (686)
+... .....+...||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5321 1112334579999999999876 678999999999999999999999997643221
Q ss_pred CCchhHhhHHHhhcchhh-----------hhhh----------hhccChh------------hHHHHHHHHHHHHHhccc
Q 038345 560 DRSLVGYFLQAMNENRLF-----------EVLD----------ALVLKEA------------EREEIMTVATLAKRCLNL 606 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~-----------~~~d----------~~~~~~~------------~~~~~~~l~~l~~~cl~~ 606 (686)
. .............. ..+. ......+ .......+.+|+.+||+.
T Consensus 239 ~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 239 Q---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp H---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred H---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 1 11111110000000 0000 0000000 002235688999999999
Q ss_pred CCCCCCCHHHHHH
Q 038345 607 NGKNRPTMKEVAF 619 (686)
Q Consensus 607 dp~~RPt~~ev~~ 619 (686)
||++|||++|+++
T Consensus 316 dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 316 NPNKRISANDALK 328 (388)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHhC
Confidence 9999999999983
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=339.57 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=201.0
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
+|....+||+|+||.||+|... ++..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555669999999999999964 688999999877666666889999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecCCcccccCCCce
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~ 507 (686)
+++|.+++........+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999998765455678999999999999999999999 9999999999999987 8999999999998654322 1
Q ss_pred eeeeeeccccccCccccccCC--CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... ........ ....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~----------~~~~ 244 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGM----------FKVH 244 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHH----------HCCC
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhcc----------cccc
Confidence 223456899999999987654 7899999999999999999999996432111 00000000 0011
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.||++||++.++++
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122234456889999999999999999999983
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.07 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=183.5
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999996 468999999875422 12246789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... .++++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999998643 3689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ...... +
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~------~-- 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLA------D-- 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------C--
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhc------c--
Confidence 222 123356899999999999989999999999999999999999999754322110 000000 0
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+.....++.+++.+||+.||++|||+++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 011122345688999999999999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=364.70 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=195.7
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..++|.+.++||+|+||.||+|... +++.||||.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999964 6899999987642 33445678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999997543 58999999999999999999998 7 8999999999999999999999999999864
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+ ..+....
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~------ 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMEE------ 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHHhCC------
Confidence 3322 2234467999999999999999999999999999999999999999753321 111 1111110
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+......+.+|+.+||+.||++|| +++|+++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011223345688999999999999999 9999885
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=340.53 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=199.2
Q ss_pred ccccccccccCccceEEEEEEEeC--CCc--EEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA--DGR--IVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||.||+|.+. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999853 233 6899987643 3345678999999999999999999999998765 8
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997643 3589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 501 ITVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
....... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~--- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG--- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccC---
Confidence 6543322 1233457889999999998889999999999999999999 999997543211 111111111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 242 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0011122345678999999999999999999999999988764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=337.50 Aligned_cols=247 Identities=29% Similarity=0.404 Sum_probs=200.8
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
+.++|.+.+.||+|+||.||+|... ++..||||.+.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567999999999999999999965 57799999875421 2224678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999997643 589999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+...
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~-------- 222 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRV-------- 222 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHT--------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HH-HHHHhC--------
Confidence 22 2234568999999999999999999999999999999999999997432211 11 111100
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+......+.+|+.+||+.||++|||++|+++
T Consensus 223 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 01112223456889999999999999999999985
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=347.02 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=200.6
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+|+||.||+|.... ++.||||.++.. .....+.+..|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999999764 789999987642 223456788999999988 79999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999998643 589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+....
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~-~~i~~~~------- 237 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF-QSIMEHN------- 237 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC-------
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHH-HHHHhCC-------
Confidence 222 2234567999999999999999999999999999999999999999753321 111 1111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+.....++.+|+.+||+.||.+||++
T Consensus 238 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 ---VAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 01122344678899999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=344.84 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=198.3
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC-----hhhHHHHHHHHHHHHhcC---CCCeeeEEeEEeeC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD-----ENNVEQFINEVVILSQIN---HRNIVKLLGCCLET 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~ 417 (686)
..++|.+.++||+|+||+||+|.. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999995 468999999876422 112346677887777765 99999999999876
Q ss_pred C-----cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 418 E-----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 418 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
. ..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 699999986532 3499999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ..........
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC
Confidence 9999998654322 2344568999999999999999999999999999999999999997543211 1111111110
Q ss_pred cchhhhh------hhhhc-------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 573 ENRLFEV------LDALV-------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 573 ~~~~~~~------~d~~~-------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
......+ ..... ...........+.+|+.+||+.||++|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 0000000 00000 0001112345788999999999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.44 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=205.0
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999965 5889999987542 344567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc---EEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR---AKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGla~~ 500 (686)
|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999999988754 3589999999999999999999999 9999999999999976655 99999999976
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ....+..... ..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~-~~- 226 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY-DY- 226 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-CC-
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccc-cC-
Confidence 543322 234568999999999999999999999999999999999999996432211 1111111100 00
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........+.+++.+||+.||++|||+.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00111123456889999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.49 Aligned_cols=274 Identities=25% Similarity=0.385 Sum_probs=200.8
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHH--HHhcCCCCeeeEEeEEee-----CCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVI--LSQINHRNIVKLLGCCLE-----TEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~-----~~~~ 420 (686)
.++|.+.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 58999999986432 3445555555 445899999999986543 2356
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA------SISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
++||||+++|+|.+++... .+++..++.++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999754 3589999999999999999999862 23899999999999999999999999
Q ss_pred cCCcccccCCCc-------eeeeeeeccccccCcccccc-------CCCCccccEeehHHHHHHHHhCCCCCccCCcccC
Q 038345 495 FGTSRSITVDQT-------HLTTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560 (686)
Q Consensus 495 fGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~ 560 (686)
||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643221 11223469999999999876 4567899999999999999999877654322111
Q ss_pred CchhHhhHHHhhcchhh----hhhh-hhccC------hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 561 RSLVGYFLQAMNENRLF----EVLD-ALVLK------EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 561 ~~l~~~~~~~~~~~~~~----~~~d-~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
... .+.......... ..+. ..... ......+..+.+|+.+||+.||++|||++||++.|+.+.....
T Consensus 244 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQM--AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCC--TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHH--hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 110 001000000000 0000 00000 1122356679999999999999999999999999999986544
Q ss_pred cc
Q 038345 630 AS 631 (686)
Q Consensus 630 ~~ 631 (686)
..
T Consensus 322 ~~ 323 (336)
T 3g2f_A 322 RN 323 (336)
T ss_dssp C-
T ss_pred hc
Confidence 43
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.83 Aligned_cols=252 Identities=24% Similarity=0.285 Sum_probs=205.1
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChh------hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN------NVEQFINEVVILSQINHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 419 (686)
..++|.+.+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999975 5899999987653221 35779999999999999999999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEec
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDF 495 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Df 495 (686)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999753 3589999999999999999999999 999999999999999887 7999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITSVS 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhcc
Confidence 9998765332 2234568999999999999999999999999999999999999997532211 11 1111100
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000111123456889999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=336.95 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=199.7
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 422 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999976 6899999987652 334557788999999999 99999999999999999999
Q ss_pred EEEeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---------------
Q 038345 423 VYEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--------------- 486 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--------------- 486 (686)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976422 24689999999999999999999999 9999999999999984
Q ss_pred ----CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCC
Q 038345 487 ----KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDR 561 (686)
Q Consensus 487 ----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~ 561 (686)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4579999999998764332 23489999999999876 66789999999999999999998764211
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
. ...+..... ...+......+.+++.+||+.||++|||+.+++
T Consensus 236 -~----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 236 -Q----WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp -H----HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -H----HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 0 111111111 111222345688999999999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=338.61 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=197.0
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.++||+|+||.||++... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57999999999999999999965 5889999987653 233457899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCccccc
Q 038345 427 VPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 502 (686)
+++|+|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986532 234699999999999999999999999 99999999999999 456889999999998654
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+ ...........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~------ 243 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPN------ 243 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC------
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcc------
Confidence 322 233456899999999876 568999999999999999999999997543211 11100000000
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
. ..........+.+|+.+||+.||++|||+.||+
T Consensus 244 -~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 244 -Y-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp -C-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred -c-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 000011245688999999999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=347.43 Aligned_cols=261 Identities=22% Similarity=0.341 Sum_probs=195.4
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChh-hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN-NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|+||.||+|... +++.||||++...... ....+.+|+.++++++||||+++++++......++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 6899999987653322 122466899999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 69999887643 3589999999999999999999999 999999999999999999999999999976543222
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hhhhhhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RLFEVLDA 582 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~ 582 (686)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............ .+......
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence 2234468999999999876 568999999999999999999999997644322 111111111100 00000000
Q ss_pred ---------hcc----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 ---------LVL----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ---------~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... ..........+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000 0001123456889999999999999999999984
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.92 Aligned_cols=258 Identities=21% Similarity=0.311 Sum_probs=203.4
Q ss_pred HHHHhhccccccc-cccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEee
Q 038345 342 KDLEKATDNYNAN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQIN-HRNIVKLLGCCLE 416 (686)
Q Consensus 342 ~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 416 (686)
...+...++|.+. +.||+|+||.||+|... +++.||||.+... .......+.+|+.++.++. ||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3344556678877 89999999999999965 5899999987643 2334578999999999995 6999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEE
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVS 493 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 493 (686)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEe
Confidence 999999999999999999986542 24699999999999999999999999 9999999999999987 7899999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhc
Confidence 999998764322 2234569999999999999999999999999999999999999997543211 11110000
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...............+.+++.+||+.||++|||+++++
T Consensus 249 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 249 -------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp -------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred -------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00011111123445688999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=363.76 Aligned_cols=254 Identities=26% Similarity=0.332 Sum_probs=207.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..++|...++||+|+||.||+|... +++.||+|++... .......+.+|+.+|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567999999999999999999975 6899999987542 22334678899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999998643 23599999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ......+...
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~-~~i~~~i~~~-------- 404 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KR-EEVERLVKEV-------- 404 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CH-HHHHHHHHHC--------
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hH-HHHHHHhhcc--------
Confidence 3322 334579999999999999999999999999999999999999997543211 11 1111111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
....+......+.+|+.+||+.||.+|| +++||++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1112223456789999999999999999 6788774
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.96 Aligned_cols=252 Identities=15% Similarity=0.161 Sum_probs=195.9
Q ss_pred hhccccccccccCccceEEEEEEEe-CCCcEEEEEEccc---cChhhHHHHHHHH---HHHHhcCCCCeeeEE-------
Q 038345 346 KATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKL---VDENNVEQFINEV---VILSQINHRNIVKLL------- 411 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~------- 411 (686)
...++|.+.+.||+|+||.||+|+. .+++.||||++.. ......+.|.+|+ .++++++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999999996 4689999999763 3344567899999 555556899999998
Q ss_pred eEEeeCC-----------------cceEEEEeccCCchhhhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 038345 412 GCCLETE-----------------VPLLVYEFVPNGTLYQNIHNHIE----EFPITWELLLRIAVEVSGALFYLHSAASI 470 (686)
Q Consensus 412 g~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~~~ 470 (686)
+++...+ ..+|||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--- 225 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--- 225 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---
Confidence 5554443 278999999 6899999986321 12355688999999999999999999
Q ss_pred CeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccC-----------CCCccccEeehH
Q 038345 471 SIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-----------QFTEKSDVYSFG 539 (686)
Q Consensus 471 ~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDv~S~G 539 (686)
+|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 999999999999999999999999999985322 2344567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 540 VVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 540 v~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
++||||++|+.||......+... .+.. . ....+..+.+|+.+||+.||++|||+.++++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~---------------~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSE---------------WIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CCSG---------------GGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccchh---------------hhhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999997543221110 0000 0 0122356889999999999999999999996
Q ss_pred --HHHhhhhh
Q 038345 620 --ELGGIRAS 627 (686)
Q Consensus 620 --~L~~i~~~ 627 (686)
.++.++..
T Consensus 360 hp~f~~~~~~ 369 (377)
T 3byv_A 360 TPEYEQLRTE 369 (377)
T ss_dssp SHHHHHHHHH
T ss_pred ChHHHHHHHH
Confidence 55555543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=339.91 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=203.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 422 (686)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467999999999999999999975 6899999987643 34456789999999999999999999998854 567899
Q ss_pred EEEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eEeeCCCCCCeeecCCCcEEEEecC
Q 038345 423 VYEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAASIS-----IYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~-----ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997643 234599999999999999999999998 6 9999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..+..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~~~~ 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKF 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-------HHHHHHhhccc
Confidence 9976543221 122346899999999999999999999999999999999999999754311 11111111111
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L 621 (686)
...+...+..+.+++.+||+.||++||++.||++.+
T Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 234 ---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 111223446789999999999999999999999644
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=358.91 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE----- 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 418 (686)
..++|.+.++||+|+||+||+|... +++.||||++... .....+++.+|+.++++++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3568999999999999999999965 5889999987643 4455678999999999999999999999997653
Q ss_pred -cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 419 -VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 419 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
..+|||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 45999999975 56666643 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--- 574 (686)
++..... .......||+.|+|||++.+..++.++||||||++||||++|+.||.+....+ ............
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPE 285 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHH
Confidence 9865432 22345679999999999999999999999999999999999999997643211 000000000000
Q ss_pred -------h---------------hhhhhhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 -------R---------------LFEVLDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 -------~---------------~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. +.......+ ..+.......++.+|+.+||+.||++|||++|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 000000000 01112233567899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=372.92 Aligned_cols=266 Identities=26% Similarity=0.415 Sum_probs=211.6
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCL 415 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 415 (686)
..+.+...++|.+.+.||+|+||.||+|.+.. +..||||..+.. .....+.|.+|+.++++++||||+++++++.
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34455556789999999999999999999642 457999987653 3344578999999999999999999999985
Q ss_pred eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCC
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEec
Confidence 456899999999999999997542 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
|+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ....+..+
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~ 608 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENG 608 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHT
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcC
Confidence 9998765443333344557889999999999999999999999999999997 999997543211 11111111
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
. ....+...+..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 609 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 609 E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0 11122234567889999999999999999999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=345.70 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=201.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--------ENNVEQFINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3568999999999999999999954 68899999876532 11334678899999999999999999999999
Q ss_pred CcceEEEEeccCC-chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 EVPLLVYEFVPNG-TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++||||+.+| +|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999997543 599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 9987654322 334569999999999988876 88999999999999999999999642110
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... ..+......+.+|+.+||+.||++|||+.++++
T Consensus 237 ----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 001113456889999999999999999999984
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.24 Aligned_cols=257 Identities=26% Similarity=0.308 Sum_probs=204.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE------NNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 689999998754321 1357899999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEecC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDFG 496 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 496 (686)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999753 3589999999999999999999999 999999999999998876 89999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
++....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~- 227 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TL-TNISAVN- 227 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTC-
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HH-HHhHhcc-
Confidence 998654322 2234568999999999999999999999999999999999999997533211 11 1111100
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF--ELGGIR 625 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~--~L~~i~ 625 (686)
..............+.+++.+||+.||++|||+.++++ .++.++
T Consensus 228 -----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 228 -----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00000111123456889999999999999999999996 455554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.57 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=205.5
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
+.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56889999999999999999964 68899999876532 34567899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 999999999864 2589999999999999999999999 999999999999999999999999999987643322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+... ...
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 237 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKN---------NPP 237 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHS---------CCC
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcC---------CCC
Confidence 2234568999999999999999999999999999999999999997433211 01111111 011
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.........+.+|+.+||+.||++|||+.++++.
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1112234568899999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=349.22 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=203.5
Q ss_pred ccccccccccCccceEEEEEEEe----CCCcEEEEEEccccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 038345 348 TDNYNANRILGQGGQGTVYKGML----ADGRIVAVKKSKLVD----ENNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 418 (686)
.++|.+.++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 368999999876421 23345678899999999 6999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..+|||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999997643 589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+..............||+.|+|||++.+ ..++.++||||||++||||++|+.||....... ............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc---
Confidence 8765444333445679999999999985 357899999999999999999999997543221 111111111110
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAFE 620 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~~ 620 (686)
....+......+.+|+.+||+.||++|| +++|+++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0111223345688999999999999999 88888753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.95 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=192.4
Q ss_pred ccccccc-cccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHh-cCCCCeeeEEeEEee----CCcc
Q 038345 348 TDNYNAN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQ-INHRNIVKLLGCCLE----TEVP 420 (686)
Q Consensus 348 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~ 420 (686)
.++|.+. ++||+|+||+||++... +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 78999999999999965 588999999853 2457788888754 489999999999875 5678
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGT 497 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 497 (686)
+|||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999998643 23599999999999999999999998 9999999999999987 78999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
++...... ......||+.|+|||++.+..++.++||||||++||||++|+.||......+.... ....+..+..
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~- 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY- 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCC-
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCcc-
Confidence 98654322 23345689999999999999999999999999999999999999975443221100 1111111100
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~ 620 (686)
.. ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 EF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 000011234568899999999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.93 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=191.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--------ENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999965 57899999865421 112235889999999999999999999975
Q ss_pred CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEE
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVS 493 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~ 493 (686)
.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 45579999999999999988754 3599999999999999999999999 99999999999999654 459999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~ 570 (686)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+. ..
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~----~~ 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLK----DQ 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHH----HH
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHH----HH
Confidence 99999876432 22345679999999999853 67889999999999999999999999754321 1111 11
Q ss_pred hhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 571 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+...... .. ..........+.+|+.+||+.||++|||++|+++
T Consensus 357 i~~~~~~-~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYN-FI-----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCC-CC-----HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCC-CC-----chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1111100 00 0011123456889999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.00 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=197.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~ 421 (686)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999965 5789999987542 44556789999999999999999999999875 35679
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eEeeCCCCCCeeec-CCCcEEEEecCCc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASIS--IYRRDIKSANILLD-DKYRAKVSDFGTS 498 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DfGla 498 (686)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. + |+||||||+|||++ +++.+||+|||++
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999764 3589999999999999999999998 7 99999999999997 7899999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
....... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||..... ..... .........
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~-~~~~~~~~~- 248 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIY-RRVTSGVKP- 248 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHH-HHHTTTCCC-
T ss_pred ccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHH-HHHhccCCc-
Confidence 7544322 23456899999999876 4589999999999999999999999964322 11111 111111000
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+......+.+++.+||+.||++|||+++++
T Consensus 249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 111112234688999999999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=355.72 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=204.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999975 68999999875422 22346789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999999753 3599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ..+ ..+..+.
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~------- 232 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF-KKICDGI------- 232 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH-HHHHTTC-------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHhcCC-------
Confidence 32 2334569999999999988765 78999999999999999999999743221 111 1111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ..+......+.+|+.+||+.||++|||++++++
T Consensus 233 -~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 -F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 111123356889999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=341.42 Aligned_cols=248 Identities=21% Similarity=0.347 Sum_probs=205.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999976 4789999986542 334567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988754 2589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..... +....
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-~~~~~-------- 257 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNE-------- 257 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTC--------
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHH-HhcCC--------
Confidence 322 233456899999999999999999999999999999999999999743211 11111 11110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+|+.+||+.||++|||+.|+++
T Consensus 258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111123356889999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=334.94 Aligned_cols=248 Identities=21% Similarity=0.348 Sum_probs=204.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367999999999999999999976 4789999986542 334567889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887542 589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... .....
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~-------- 231 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLR-IKKNE-------- 231 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHTTC--------
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-Hhhcc--------
Confidence 322 223456899999999999999999999999999999999999999753321 11111 11110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.||++|||++++++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0111223456889999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.59 Aligned_cols=252 Identities=22% Similarity=0.323 Sum_probs=196.0
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHH-HHhcCCCCeeeEEeEEeeCCcceE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVI-LSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
.++|.+.++||+|+||.||+++.. +++.||||.++... ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 57899999875432 2334566777776 567899999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997643 589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... .
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~---------~ 254 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN---------K 254 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHH---------S
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh---------c
Confidence 222 2234567999999999999999999999999999999999999999753221 11111111 1
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGG 623 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~ 623 (686)
.+ ..+......+.+|+.+||+.||.+||++.+.++.+..
T Consensus 255 ~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~ 293 (373)
T 2r5t_A 255 PL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS 293 (373)
T ss_dssp CC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred cc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence 00 1112234568899999999999999998765555543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.64 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=195.8
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC-----
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETE----- 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----- 418 (686)
..++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3468999999999999999999974 6899999997542 3344578899999999999999999999998653
Q ss_pred -cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 419 -VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 419 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999998752 489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh-----
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM----- 571 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~----- 571 (686)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||.+....+ .........
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD---QLKEIMKVTGTPPA 247 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 9875432 234568999999999887 689999999999999999999999997543211 111110000
Q ss_pred ------hcchhhhhhhhh------ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 ------NENRLFEVLDAL------VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ------~~~~~~~~~d~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+... ............+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000000000000 000111223456889999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.05 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=202.5
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 689999999876554455678999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCccccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 502 (686)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987543 589999999999999999999999 99999999999999 788999999999997543
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..... .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~-~---- 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------K-LFEKIKEGYY-E---- 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHCCC-C----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCC-C----
Confidence 22 122345899999999999999999999999999999999999999753211 1 1111111100 0
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........+..+.+++.+||+.||++|||++++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001111233456889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=348.80 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=205.0
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999976 6899999987654 34456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999997643 5899999999999999999999842 7999999999999999999999999999755321
Q ss_pred ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH--------------------
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG-------------------- 565 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~-------------------- 565 (686)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+......
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 2234568999999999999999999999999999999999999997543221100000
Q ss_pred ---hhHHHhhcchhhhhhhhhcc----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 ---YFLQAMNENRLFEVLDALVL----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 ---~~~~~~~~~~~~~~~d~~~~----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+...........+.++.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000011111111110 0111123456899999999999999999999984
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.60 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=200.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..++|.+.+.||+|+||.||++... +++.||||.+..... .+.+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999975 588999999764322 345788888888 7999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC----CcEEEEecCCccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK----YRAKVSDFGTSRS 500 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~~ 500 (686)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+.+. +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999754 3599999999999999999999999 99999999999998433 3599999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... .....+..+...
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~-~~~~~i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPE-EILARIGSGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHH-HHHHHHHHCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHH-HHHHHHccCCcc---
Confidence 654332 233456899999999999888999999999999999999999999753211 111 111111111110
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
............+.+|+.+||+.||++||++.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001111234456889999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.95 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=201.1
Q ss_pred cccChHHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEE
Q 038345 337 KLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCC 414 (686)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 414 (686)
..++..++....++|.+.+.||+|+||.||+|... +++.||||.+.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 34455566677889999999999999999999974 68999999876533 3347889999999999 799999999999
Q ss_pred ee------CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 415 LE------TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 415 ~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
.. ....++||||+++++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 87 467899999999999999998643 23689999999999999999999999 999999999999999999
Q ss_pred cEEEEecCCcccccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCch
Q 038345 489 RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSL 563 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l 563 (686)
.+||+|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---- 241 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---- 241 (326)
T ss_dssp CEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH----
T ss_pred CEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----
Confidence 999999999976543221 223456899999999987 5678999999999999999999999996433211
Q ss_pred hHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 564 VGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 564 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... ...... ...........+.+++.+||+.||.+||++.++++
T Consensus 242 --~~~~-~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 242 --ALFL-IPRNPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HHHH-HHHSCC--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HHHH-hhcCcc--------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 111000 00011123456889999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.20 Aligned_cols=262 Identities=20% Similarity=0.277 Sum_probs=192.7
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
...++|.+.++||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999954 688999999765332 234568899999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee-----cCCCcEEEEecCC
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL-----DDKYRAKVSDFGT 497 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll-----~~~~~~kl~DfGl 497 (686)
||||++ |+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999997643 589999999999999999999999 99999999999999 4556699999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 574 (686)
++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ............
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCT
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCch
Confidence 987643322 23344689999999999874 58999999999999999999999997543211 110111100000
Q ss_pred -hhhh-------------hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 575 -RLFE-------------VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 575 -~~~~-------------~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.... .....+..........++.+|+.+||+.||++|||++|++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0000 0000000001111345688999999999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=353.96 Aligned_cols=195 Identities=27% Similarity=0.425 Sum_probs=155.6
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----C
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLET-----E 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 418 (686)
..++|.+.++||+|+||+||+|... +++.||||++.. ......+.+.+|+.+|++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3478999999999999999999965 689999998754 2344567899999999999999999999999543 4
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 679999998 57999988753 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--------------------------eeeeeeeccccccCcccc-ccCCCCccccEeehHHHHHHHHhC
Q 038345 499 RSITVDQT--------------------------HLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTG 548 (686)
Q Consensus 499 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDv~S~Gv~l~elltg 548 (686)
+....... ...+...||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87642211 123445689999999986 566799999999999999999993
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=337.41 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=199.9
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEee--CCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLE--TEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lV~ 424 (686)
++|.+.++||+|+||.||+|.. .+++.||||.++.. ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999985 46899999998643 3467899999999997 9999999999987 56789999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~ 503 (686)
||+++++|.+++.. +++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999998852 88999999999999999999999 999999999999999766 899999999986643
Q ss_pred CCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..............+.+.++.
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHH
Confidence 322 234468999999999877 678999999999999999999999995432111 111111111111111111111
Q ss_pred h-----------------------ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 L-----------------------VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~-----------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ............+.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 011111224567899999999999999999999983
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.78 Aligned_cols=262 Identities=22% Similarity=0.344 Sum_probs=198.8
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-------
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLET------- 417 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 417 (686)
.++|.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999997 468999999875432 23346788999999999999999999999874
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++||||++ ++|.+.+.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccC-CCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 46799999997 47777776543 3599999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCC---ceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 497 TSRSITVDQ---THLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 497 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ..........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Confidence 998764221 122234568999999999876 568999999999999999999999997543221 1111111100
Q ss_pred c--chhhhhhhh---------h--ccChhhH-----HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 573 E--NRLFEVLDA---------L--VLKEAER-----EEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 573 ~--~~~~~~~d~---------~--~~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
. .......+. . ....... .....+.+|+.+||+.||++|||++|++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 000000000 0 0000000 0134588999999999999999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=357.50 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=204.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|...++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999975 58999999875421 23356789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 424 YEFVPNGTLYQNIHNHIE-EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...... ...+...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~-~~~i~~~-------- 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKEL-KQRVLEQ-------- 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHH-HHHHHHC--------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHH-HHHHhhc--------
Confidence 3322 233457999999999999999999999999999999999999999754321 111111 1111111
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMK 615 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 615 (686)
. ...+...+..+.+|+.+||+.||++||++.
T Consensus 409 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 409 A--VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred c--cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 0 112223456788999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.84 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=204.7
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh--------hhHHHHHHHHHHHHhc-CCCCeeeEEe
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE--------NNVEQFINEVVILSQI-NHRNIVKLLG 412 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~g 412 (686)
......++|.+.+.||+|+||.||+|.+. +|+.||||.+..... ...+.+.+|+.++.++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34455678999999999999999999975 699999998754321 1245688999999999 7999999999
Q ss_pred EEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 413 CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 413 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
++......++||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999754 3599999999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCcccccc------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~ 566 (686)
+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~- 312 (365)
T 2y7j_A 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L- 312 (365)
T ss_dssp CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H-
T ss_pred EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H-
Confidence 9999998765332 2334579999999999863 35888999999999999999999999643211 0
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+...... ...+ ........+.+++.+||+.||++|||+.++++
T Consensus 313 ~~~~i~~~~~~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 MLRMIMEGQYQ-FSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHTCCC-CCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhCCCC-CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111000 0000 00122456889999999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=331.81 Aligned_cols=245 Identities=27% Similarity=0.367 Sum_probs=202.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... ++..||||.+.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999975 57889999875421 223467899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999997643 589999999999999999999998 9999999999999999999999999999765432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+... +
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~~~~~------~--- 228 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH-RRIVNV------D--- 228 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTT------C---
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH-HHHhcc------c---
Confidence 2 234568999999999999999999999999999999999999997432111 11 111110 0
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.||.+||++.++++
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0112223456889999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=344.59 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=199.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999975 4899999986543 2333566889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998876643 2599999999999999999999999 9999999999999999999999999999765432
Q ss_pred CceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH-----------hh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA-----------MN 572 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~-----------~~ 572 (686)
.. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+. ....... ..
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHhh
Confidence 22 22345689999999999875 789999999999999999999999975432210 0000000 00
Q ss_pred cchhh-hhhhhhccC-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 573 ENRLF-EVLDALVLK-----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 573 ~~~~~-~~~d~~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... ....+.... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000000 011123567999999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.45 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=186.8
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999954 68899999876432 33456788999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 424 YEFVPNGTLYQNIHNH-----IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
|||+++++|.+++... .....+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998742 1234589999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCc----eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 499 RSITVDQT----HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 499 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhcc
Confidence 76543211 11234568999999999876 568999999999999999999999997543221 11111111
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ....................+.+++.+||+.||.+|||+.++++
T Consensus 243 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 D-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp S-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred C-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00000000000111123456889999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.06 Aligned_cols=199 Identities=26% Similarity=0.387 Sum_probs=167.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----Cc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 419 (686)
.++|.+.++||+|+||.||+|... +++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468999999999999999999965 5789999998653 344567899999999999999999999999876 56
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+. ++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 6999999753 3599999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc---------------------eeeeeeeccccccCcccc-ccCCCCccccEeehHHHHHHHHhCCCCCc
Q 038345 500 SITVDQT---------------------HLTTKVQGTFGYVDPEYF-QSSQFTEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 500 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
....... ...+...||+.|+|||++ ....++.++||||||+++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7643321 123456799999999986 55679999999999999999998655553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=342.13 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=196.7
Q ss_pred HhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN-----NVEQFINEVVILSQINHRNIVKLLGCCLETE 418 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 418 (686)
....++|.+.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999965 5899999987643221 1246889999999999999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+++ +|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999985 8888887543 3588899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch--
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR-- 575 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 575 (686)
+...... .......||+.|+|||++.+. .++.++||||||+++|||++|..||......+ .............
T Consensus 160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEE 235 (346)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChh
Confidence 8764332 223345689999999998764 58999999999999999999999987543211 1111111111000
Q ss_pred -hhh---hhhhhcc---C-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 -LFE---VLDALVL---K-----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 -~~~---~~d~~~~---~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+ ..+.... . .........+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 0000000 0 001223467899999999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=343.21 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=202.0
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----C
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLET-----E 418 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 418 (686)
...++|.+.++||+|+||.||+|... ++..||||++... .....+.+.+|+.++.+++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34568999999999999999999965 6889999997643 334457899999999999999999999999765 3
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+. |+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 6799999997 6999988753 499999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcee--eeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 499 RSITVDQTHL--TTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 499 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .............
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPS 252 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCC
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence 8764332211 234579999999998754 458999999999999999999999997644322 1111111111000
Q ss_pred h-----------hhhhhhhc-c-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 L-----------FEVLDALV-L-----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~-----------~~~~d~~~-~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ........ . ..........+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00000000 0 0001123456889999999999999999999983
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=337.86 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=201.0
Q ss_pred cChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccc--cChhhHHHHHHHHHHHHhcC--CCCeeeEEeEE
Q 038345 339 FTSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQIN--HRNIVKLLGCC 414 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~ 414 (686)
+....+....++|.+.+.||+|+||.||++...+++.||||.+.. ......+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 444445556678999999999999999999988899999998754 33455678999999999997 59999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
......++||| +.+++|.+++.... .+++..++.++.|+++||.|||+. +|+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 56889999998643 589999999999999999999999 9999999999999965 7999999
Q ss_pred cCCcccccCCCce-eeeeeeccccccCcccccc-----------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCc
Q 038345 495 FGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQS-----------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRS 562 (686)
Q Consensus 495 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~ 562 (686)
||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 244 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence 9999876433221 2234568999999999875 4788899999999999999999999964321
Q ss_pred hhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 563 LVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 563 l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+ ..+++.......+......+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 245 QISKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHH---------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11111 1111111111122222456889999999999999999999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=334.32 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=200.0
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
...++|.+.+.||+|+||.||+|... +++.||||.+... ...+.+.+|+.++.+++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34567999999999999999999976 5899999987653 23477899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999987432 3589999999999999999999999 9999999999999999999999999999766433
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .... ...... +
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~-----~-- 243 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFM-IPTNPP-----P-- 243 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSCC-----C--
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHH-HhcCCC-----c--
Confidence 22 2234568999999999999999999999999999999999999997433211 0100 000000 0
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
....+......+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111223456889999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.69 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=200.6
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccC-----------hhhHHHHHHHHHHHHhcCCCCee
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD-----------ENNVEQFINEVVILSQINHRNIV 408 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv 408 (686)
...++....++|.+.+.||+|+||.||+|...++..||||++.... ....+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4567888899999999999999999999998889999999875421 22247899999999999999999
Q ss_pred eEEeEEeeC-----CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 409 KLLGCCLET-----EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 409 ~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
++++++... ...++||||+. |+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 999998543 35699999997 6888888753 23699999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCc
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRS 562 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~ 562 (686)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 241 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--- 241 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---
Confidence 9999999999999997543322 2334568999999999877 678999999999999999999999997543211
Q ss_pred hhHhhHHHhhcchh-----------hhhhhhhcc-------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 563 LVGYFLQAMNENRL-----------FEVLDALVL-------KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 563 l~~~~~~~~~~~~~-----------~~~~d~~~~-------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.............. .+.+..... ..........+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111100 000000000 0111122456889999999999999999999983
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.22 Aligned_cols=253 Identities=24% Similarity=0.346 Sum_probs=199.8
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467999999999999999999976 588999999876666667889999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999987533 3599999999999999999999999 99999999999999999999999999875432111
Q ss_pred ceeeeeeeccccccCcccc-----ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 506 THLTTKVQGTFGYVDPEYF-----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
.......||+.|+|||++ ....++.++||||||+++|||++|+.||...... ........... ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~-~~-- 241 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP-PT-- 241 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-CC--
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC-cc--
Confidence 112334689999999998 3677899999999999999999999999754321 11111111110 00
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+..+.+++.+||+.||++|||+.++++
T Consensus 242 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 -----LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0112233456889999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=344.36 Aligned_cols=268 Identities=20% Similarity=0.344 Sum_probs=204.7
Q ss_pred ChHHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 340 TSKDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 340 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
..++.+...++|.+.+.||+|+||.||+|...+ .||+|.++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345555667889999999999999999999754 4999987643 233346688999999999999999999999999
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999997643 3589999999999999999999999 999999999999998 67999999999
Q ss_pred cccccCCC----ceeeeeeeccccccCcccccc---------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh
Q 038345 498 SRSITVDQ----THLTTKVQGTFGYVDPEYFQS---------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564 (686)
Q Consensus 498 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~ 564 (686)
++...... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----- 250 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 87653211 111223458999999999864 457899999999999999999999997543211
Q ss_pred HhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcc
Q 038345 565 GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGA 630 (686)
Q Consensus 565 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~ 630 (686)
....+..... +.. .....+..+.+++.+||+.||++|||+.+|++.|+.+......
T Consensus 251 --~~~~~~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 251 --IIWQMGTGMK-----PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp --HHHHHHTTCC-----CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred --HHHHhccCCC-----CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111111100 000 0112234588999999999999999999999999998876544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.65 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=188.3
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEccccC-h-hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD-E-NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999996 468999999876532 2 2233455566668888999999999999999999999
Q ss_pred EEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 424 YEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
|||++ |+|.+++... .....+++..++.++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99997 5888877642 22346999999999999999999999853 79999999999999999999999999998654
Q ss_pred CCCceeeeeeeccccccCcccc----ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 503 VDQTHLTTKVQGTFGYVDPEYF----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 503 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
.... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||..... ............
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---- 230 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEP---- 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSC----
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccC----
Confidence 3322 2334689999999996 566789999999999999999999999964321 111111111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........+..+.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111233456899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=328.22 Aligned_cols=247 Identities=26% Similarity=0.351 Sum_probs=195.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999976 68999999875422 22356789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997643 589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
.. ......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... . ....+....
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~------- 227 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------T-LFKKIRGGV------- 227 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCC-------
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H-HHHHhhcCc-------
Confidence 22 2234468999999999988765 68999999999999999999999643211 1 111111110
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.||++|||+.++++
T Consensus 228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0011223456889999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.60 Aligned_cols=254 Identities=12% Similarity=0.039 Sum_probs=183.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhc--CCCCeeeEE-------eEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQI--NHRNIVKLL-------GCC 414 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~ 414 (686)
..+|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +.+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456899999999999999999965 68999999977643 23456778886555555 599988755 343
Q ss_pred eeC-----------------CcceEEEEeccCCchhhhhhccCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCC
Q 038345 415 LET-----------------EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELL------LRIAVEVSGALFYLHSAASIS 471 (686)
Q Consensus 415 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~yLH~~~~~~ 471 (686)
... ...+|||||++ |+|.+++..... .+.+..+ +.++.||+.||+|||+. +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 322 23799999998 899999986422 3455555 78889999999999999 9
Q ss_pred eEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCC
Q 038345 472 IYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQ 549 (686)
Q Consensus 472 ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~ 549 (686)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 1223457799999999987 78999999999999999999999
Q ss_pred CCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 550 KPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 550 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.||............ ....................+..+.+|+.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999865432211100 00000000000101111233457889999999999999999999984
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=366.52 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=202.7
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcce
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 421 (686)
..++|.+.++||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +||+|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999965 5889999987642 233456788999999988 7999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
|||||+++|+|.++|.... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998643 599999999999999999999999 9999999999999999999999999999864
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+ ..+....
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~-~~i~~~~------ 558 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF-QSIMEHN------ 558 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHSSC------
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHH-HHHHhCC------
Confidence 3322 2344567999999999999999999999999999999999999999754321 111 1111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTM 614 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 614 (686)
...+.....++.+|+.+||+.||++||++
T Consensus 559 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11222345678999999999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.60 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=193.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 418 (686)
.++|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 688999998764 23445577899999999999999999999997654
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999997 578888753 388999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc-----
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE----- 573 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~----- 573 (686)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+......
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID------QWNKVIEQLGTPC 246 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHC-CCCCC
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCC
Confidence 865422 22334578999999999999999999999999999999999999997543211 01000000
Q ss_pred -----------------c------hhhhhhhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 -----------------N------RLFEVLDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 -----------------~------~~~~~~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. .+........ ...........+.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0000000000 01122334677999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=339.97 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=203.6
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhh-----------------HHHHHHHHHHHHhcCCCCeeeE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENN-----------------VEQFINEVVILSQINHRNIVKL 410 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 410 (686)
.++|.+.+.||+|+||.||+|.. +++.||||.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999875422111 1789999999999999999999
Q ss_pred EeEEeeCCcceEEEEeccCCchhhh------hhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCee
Q 038345 411 LGCCLETEVPLLVYEFVPNGTLYQN------IHNHIEEFPITWELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANIL 483 (686)
Q Consensus 411 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIl 483 (686)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ . +|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 5432 13579999999999999999999999 7 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccC-CCCc-cccEeehHHHHHHHHhCCCCCccCCcccCC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTE-KSDVYSFGVVLVEILTGQKPIRAINIDEDR 561 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDv~S~Gv~l~elltg~~p~~~~~~~~~~ 561 (686)
++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 999999999999999875433 23445689999999999887 6666 999999999999999999999754321
Q ss_pred chhHhhHHHhhcchhhh------hhhh---hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 562 SLVGYFLQAMNENRLFE------VLDA---LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~------~~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.. ....+....... .... .............+.+|+.+||+.||.+|||+.|+++
T Consensus 259 --~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 --VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111111111000 0000 0000011234567899999999999999999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=343.21 Aligned_cols=261 Identities=24% Similarity=0.256 Sum_probs=202.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC--------CCCeeeEEeEEe---
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN--------HRNIVKLLGCCL--- 415 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~--- 415 (686)
.++|.+.++||+|+||+||+|... +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999854 6889999998643 344578899999999996 788999999987
Q ss_pred -eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC------
Q 038345 416 -ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY------ 488 (686)
Q Consensus 416 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~------ 488 (686)
.....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 556789999999 566666665432 235999999999999999999999964 799999999999998775
Q ss_pred -------------------------------------------cEEEEecCCcccccCCCceeeeeeeccccccCccccc
Q 038345 489 -------------------------------------------RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525 (686)
Q Consensus 489 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 525 (686)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865432 23346899999999999
Q ss_pred cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHH---hhcch---------------------------
Q 038345 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA---MNENR--------------------------- 575 (686)
Q Consensus 526 ~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~---~~~~~--------------------------- 575 (686)
+..++.++||||||++||||++|+.||......+........... .....
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999865443322111111111 00000
Q ss_pred ---hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 ---LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ---~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.+.+.. ....+......+.+|+.+||+.||++|||++|+++
T Consensus 347 ~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVE--KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHH--TSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhh--hcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000 01224566778999999999999999999999983
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=347.10 Aligned_cols=204 Identities=23% Similarity=0.394 Sum_probs=157.3
Q ss_pred hcccccc-ccccCccceEEEEEEEeC---CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcc
Q 038345 347 ATDNYNA-NRILGQGGQGTVYKGMLA---DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVP 420 (686)
Q Consensus 347 ~~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~ 420 (686)
..+.|.+ .++||+|+||+||+|... +++.||||++.... ....+.+|+.+|++++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3345665 458999999999999965 47899999986532 23578899999999999999999999964 6688
Q ss_pred eEEEEeccCCchhhhhhccC------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee----cCCCcE
Q 038345 421 LLVYEFVPNGTLYQNIHNHI------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL----DDKYRA 490 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~ 490 (686)
++||||+. ++|.+++.... ....+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 58888775321 123599999999999999999999999 99999999999999 778999
Q ss_pred EEEecCCcccccCCCc--eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 491 KVSDFGTSRSITVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 491 kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
||+|||+++....... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999987643221 22344678999999999987 458999999999999999999999997543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.23 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=199.0
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|.+.++||+|+||+||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999975 68899999876432 33457789999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~ 500 (686)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887543 589999999999999999999999 99999999999999764 5599999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ....+...... .
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-~- 256 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT-F- 256 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C-
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-C-
Confidence 65332 233456999999999886 568999999999999999999999997543211 11111111100 0
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 ----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111123456889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.37 Aligned_cols=252 Identities=28% Similarity=0.375 Sum_probs=201.3
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh-------------hhHHHHHHHHHHHHhcCCCCeeeEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-------------NNVEQFINEVVILSQINHRNIVKLL 411 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~ 411 (686)
...++|.+.++||+|+||+||+|... +++.||||.+..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999975 578999998764321 2346789999999999999999999
Q ss_pred eEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC---
Q 038345 412 GCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY--- 488 (686)
Q Consensus 412 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~--- 488 (686)
+++.+....++||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999987542 599999999999999999999999 999999999999998775
Q ss_pred cEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 489 RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||......+ ..
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HH
Confidence 69999999998765332 233456999999999987 568999999999999999999999997543211 11
Q ss_pred HHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+....... + .......+..+.+|+.+||+.||.+|||++|+++
T Consensus 257 ~~i~~~~~~~--~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYF--D----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCC--C----HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCC--C----ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111100 0 0000123456889999999999999999999984
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=337.51 Aligned_cols=261 Identities=24% Similarity=0.348 Sum_probs=194.6
Q ss_pred ccccccccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe-----------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCL----------- 415 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----------- 415 (686)
.++|.+.+.||+|+||.||+|.... ++.||||++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999764 8999999987776777788999999999999999999999874
Q ss_pred ---eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEE
Q 038345 416 ---ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAK 491 (686)
Q Consensus 416 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~k 491 (686)
+....++||||++ |+|.+++.. .++++..++.++.|++.||+|||+. +|+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467799999997 699998864 3589999999999999999999999 999999999999997 567999
Q ss_pred EEecCCcccccCCCc--eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 492 VSDFGTSRSITVDQT--HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 492 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
|+|||+++....... .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||......+ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 999999987643211 11223457889999998865 678999999999999999999999997543211 011110
Q ss_pred HHhhc---c---hhhhh----hhhhcc------ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNE---N---RLFEV----LDALVL------KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~---~---~~~~~----~d~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..... . .+... +..... ..........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000 0 00000 000000 0011123567899999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=345.27 Aligned_cols=258 Identities=21% Similarity=0.305 Sum_probs=183.9
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET------ 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------ 417 (686)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999954 6889999997642 344567889999999999999999999998754
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
...++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5579999999 7899988864 2599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc---
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE--- 573 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~--- 573 (686)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+....+ ...........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 9865422 334578999999999887 678999999999999999999999997543211 11111111100
Q ss_pred --------chhhhhhhhhc---cC---hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 --------NRLFEVLDALV---LK---EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 --------~~~~~~~d~~~---~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+.... .. .........+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000000 00 000112356889999999999999999999984
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.19 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=196.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC--------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD--------ENNVEQFINEVVILSQINHRNIVKLLGCCLET 417 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 417 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999965 57899999875421 12234688999999999999999999998765
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc---EEEEe
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR---AKVSD 494 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~D 494 (686)
. .++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 79999999999999988753 3589999999999999999999999 9999999999999987654 99999
Q ss_pred cCCcccccCCCceeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+... +
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~----~ 232 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----I 232 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----H
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----H
Confidence 99998654321 123346899999999974 5678999999999999999999999997543221 11111 1
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...... . ...........+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~-~-----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN-F-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC-C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc-c-----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 0 00111123456889999999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=354.55 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=201.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
.++|.+.++||+|+||+||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999975 6899999987532 2334578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~ 501 (686)
||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887543 599999999999999999999999 999999999999995 4567999999999866
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+.......
T Consensus 175 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--- 241 (486)
T 3mwu_A 175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF--- 241 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCS---
T ss_pred CCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC---
Confidence 4332 2334569999999999875 58999999999999999999999997543211 111111111000
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+..+.+|+.+||+.||++|||+.++++
T Consensus 242 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 ---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00111223456889999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.21 Aligned_cols=200 Identities=25% Similarity=0.316 Sum_probs=173.7
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhc------CCCCeeeEEeEEeeCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQI------NHRNIVKLLGCCLETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~ 419 (686)
...+|.+.++||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999865 5889999998653 33446788899998888 56799999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc--EEEEecCC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR--AKVSDFGT 497 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DfGl 497 (686)
.++||||+. ++|.+++..... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 689998876432 3589999999999999999999999 9999999999999999887 99999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
++..... .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9764322 233568999999999999999999999999999999999999997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.22 Aligned_cols=260 Identities=23% Similarity=0.299 Sum_probs=194.1
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc------ce
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV------PL 421 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~ 421 (686)
..+|...++||+|+||.||+|....+..||+|++..... ...+|+.++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 457999999999999999999988777799998654221 23479999999999999999999965433 78
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEEEEecCCccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRS 500 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~ 500 (686)
+||||++++.+............+++..++.++.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999998654444333222334699999999999999999999999 999999999999998 799999999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh--h
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL--F 577 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~--~ 577 (686)
...... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.+....+ .+. ........... .
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~-~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLV-EIIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH-HHHHHHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHHHhCCCCHHHH
Confidence 643322 2345689999999998764 58999999999999999999999997543211 111 11111100000 0
Q ss_pred hhhhhhc-------------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALV-------------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~-------------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...++.. ..........++.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000 00011123457899999999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=337.10 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=201.1
Q ss_pred hhccccccccccCccceEEEEEEEe--CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhc---CCCCeeeEEeEEe---
Q 038345 346 KATDNYNANRILGQGGQGTVYKGML--ADGRIVAVKKSKLVD--ENNVEQFINEVVILSQI---NHRNIVKLLGCCL--- 415 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~--- 415 (686)
.+.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4557899999999999999999997 367899999875432 22234567788877776 8999999999987
Q ss_pred --eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 416 --ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 416 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 699999976532 3589999999999999999999999 99999999999999999999999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ...........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 999998654322 2234568999999999999999999999999999999999999997543211 11111111100
Q ss_pred chhhhh----------h---hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 574 NRLFEV----------L---DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 574 ~~~~~~----------~---d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.....+ . ...............+.+|+.+||+.||++|||+.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 000000 0 00000111123345688999999999999999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.30 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=203.4
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---------hhhHHHHHHHHHHHHhcC-CCCeeeEEeEEe
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---------ENNVEQFINEVVILSQIN-HRNIVKLLGCCL 415 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~ 415 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999999999999975 58899999876432 123467889999999996 999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEec
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDF 495 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 495 (686)
.....++||||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 999999999999999999999764 3589999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCCceeeeeeeccccccCccccc------cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 496 GTSRSITVDQTHLTTKVQGTFGYVDPEYFQ------SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 496 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
|++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||......+ ...
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 239 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHH
Confidence 9998764332 223456899999999985 4568899999999999999999999996432111 111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+..... . .........+..+.+++.+||+.||++|||+.++++
T Consensus 240 ~~~~~~~-~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNY-Q-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCC-C-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCc-c-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111100 0 001111234557899999999999999999999973
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=327.97 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=197.3
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC----hhhHHHHHHHHHHHHhcCCCCeeeEEeEEe--eCCc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD----ENNVEQFINEVVILSQINHRNIVKLLGCCL--ETEV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~ 419 (686)
..++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3468999999999999999999964 68899999876432 234578999999999999999999999984 4557
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||++++ |.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 777776543 34699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCC-ceeeeeeeccccccCccccccCC--CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 500 SITVDQ-THLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 500 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
...... ........||+.|+|||++.+.. .+.++||||||+++|||++|+.||..... .. ....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-~~~~i~~~~- 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YK-LFENIGKGS- 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HH-HHHHHHHCC-
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HH-HHHHHhcCC-
Confidence 764322 22233456899999999987644 37799999999999999999999974321 11 111111110
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+......+.+++.+||+.||++|||++++++
T Consensus 230 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 ---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111223456889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=341.96 Aligned_cols=268 Identities=22% Similarity=0.291 Sum_probs=190.4
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEV- 419 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~- 419 (686)
.......++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445666789999999999999999999975 6899999987543 2233567788899999999999999999976443
Q ss_pred ------ceEEEEeccCCchhhhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeEeeCCCCCCeeecC-CCc
Q 038345 420 ------PLLVYEFVPNGTLYQNIHN-HIEEFPITWELLLRIAVEVSGALFYLH--SAASISIYRRDIKSANILLDD-KYR 489 (686)
Q Consensus 420 ------~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~yLH--~~~~~~ivH~Dikp~NIll~~-~~~ 489 (686)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999986 44444432 223446899999999999999999999 77 9999999999999996 899
Q ss_pred EEEEecCCcccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhH
Q 038345 490 AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL 568 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~ 568 (686)
+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ......
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEIV 245 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHHH
Confidence 99999999987653332 2345689999999998665 48999999999999999999999997543221 111111
Q ss_pred HHhhcc--hhhhhhhhh----------------ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 569 QAMNEN--RLFEVLDAL----------------VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 569 ~~~~~~--~~~~~~d~~----------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...... .....+++. ............+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111000 000000000 001111124567999999999999999999999983
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=355.67 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=204.2
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..++|.+.++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999975 6899999987542 23456789999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---cCCCcEEEEecCCcc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL---DDKYRAKVSDFGTSR 499 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~ 499 (686)
||||+.+|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999998754 3599999999999999999999999 99999999999999 567899999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+......
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-- 245 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYT-- 245 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC--
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 664332 2233469999999999876 68999999999999999999999997543211 11111111100
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........+..+.+|+.+||+.+|++|||+.|+++
T Consensus 246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000111233456889999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=346.06 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=198.9
Q ss_pred HHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET----- 417 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----- 417 (686)
++...++|.+.+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345567899999999999999999996 468999999875432 2234799999999999999999998543
Q ss_pred ---------------------------------CcceEEEEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 038345 418 ---------------------------------EVPLLVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFY 463 (686)
Q Consensus 418 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~y 463 (686)
...++||||++ |+|.+.+... .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34789999998 5888777642 123469999999999999999999
Q ss_pred hhhcCCCCeEeeCCCCCCeeec-CCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHH
Q 038345 464 LHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVV 541 (686)
Q Consensus 464 LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~ 541 (686)
||+. +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 999999999999997 688999999999987643322 2345689999999998764 58999999999999
Q ss_pred HHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh--h-------------hhccChhhHHHHHHHHHHHHHhccc
Q 038345 542 LVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL--D-------------ALVLKEAEREEIMTVATLAKRCLNL 606 (686)
Q Consensus 542 l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--d-------------~~~~~~~~~~~~~~l~~l~~~cl~~ 606 (686)
+|||++|+.||......+ ................+. + .......+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999997543221 111111111110000000 0 0000011122345689999999999
Q ss_pred CCCCCCCHHHHHH--HHHhhhh
Q 038345 607 NGKNRPTMKEVAF--ELGGIRA 626 (686)
Q Consensus 607 dp~~RPt~~ev~~--~L~~i~~ 626 (686)
||++|||+.|+++ .++.++.
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHHH
T ss_pred ChhhCCCHHHHhcCHHHHHHHh
Confidence 9999999999985 3444443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.28 Aligned_cols=262 Identities=22% Similarity=0.311 Sum_probs=199.7
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----Cc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLET-----EV 419 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~ 419 (686)
..++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4568999999999999999999975 68899999986533 34456788999999999999999999998764 57
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+. ++|.+++... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999997 6999988753 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCce---------eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 500 SITVDQTH---------LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 500 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 76432211 1123468999999998764 7789999999999999999999999975432110 000000
Q ss_pred Hhhc------------chhhhhhhhhc------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMNE------------NRLFEVLDALV------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~~------------~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... ....+.+.... ...........+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 00000000000 00011123457889999999999999999999984
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.98 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=202.8
Q ss_pred ccccccccccCccceEEEEEEEe--CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC------eeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGML--ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN------IVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|.. .+++.||||.++.. ....+.+.+|+.++++++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 36889999998643 344577899999999997664 9999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-------------
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD------------- 486 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~------------- 486 (686)
.++||||+ +++|.+++.... ..++++..++.++.|++.||+|||+. +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 899999997653 23689999999999999999999999 9999999999999987
Q ss_pred ------CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccC
Q 038345 487 ------KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560 (686)
Q Consensus 487 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~ 560 (686)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999864322 2335689999999999999999999999999999999999999975433221
Q ss_pred CchhHhhHHHhhc-----------chhh--------------hhhhhh-----ccChhhHHHHHHHHHHHHHhcccCCCC
Q 038345 561 RSLVGYFLQAMNE-----------NRLF--------------EVLDAL-----VLKEAEREEIMTVATLAKRCLNLNGKN 610 (686)
Q Consensus 561 ~~l~~~~~~~~~~-----------~~~~--------------~~~d~~-----~~~~~~~~~~~~l~~l~~~cl~~dp~~ 610 (686)
...+...... .... ..+... ............+.+|+.+||+.||.+
T Consensus 243 ---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 ---LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp ---HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred ---HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 1111110000 0000 000000 000112244677999999999999999
Q ss_pred CCCHHHHHH
Q 038345 611 RPTMKEVAF 619 (686)
Q Consensus 611 RPt~~ev~~ 619 (686)
|||+.|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999983
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=327.61 Aligned_cols=252 Identities=26% Similarity=0.452 Sum_probs=193.1
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee---------
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE--------- 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------- 416 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3467999999999999999999964 6899999988542 3455789999999999999999999999865
Q ss_pred ----CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEE
Q 038345 417 ----TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492 (686)
Q Consensus 417 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 492 (686)
....++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356799999999999999998643 3588899999999999999999999 9999999999999999999999
Q ss_pred EecCCcccccCCC-------------ceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcc
Q 038345 493 SDFGTSRSITVDQ-------------THLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINID 558 (686)
Q Consensus 493 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~ 558 (686)
+|||+++...... ........||+.|+|||++.+. .++.++||||||+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998654221 1122345689999999999764 78999999999999999998 543210
Q ss_pred cCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 559 EDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 559 ~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... ....+... ...............+.+++.+||+.||.+|||+.++++
T Consensus 233 ---~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---ERVN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hHHH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000 01111110 011112222334456889999999999999999999984
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.68 Aligned_cols=258 Identities=26% Similarity=0.344 Sum_probs=192.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------Ccce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET------EVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 421 (686)
.+|...++||+|+||.||+|++. +++.||||++.... ..+.+|++++++++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46899999999999999999975 58999999875432 2344799999999999999999998642 2357
Q ss_pred EEEEeccCCchhhhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCCcc
Q 038345 422 LVYEFVPNGTLYQNIHNH-IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSR 499 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~ 499 (686)
+||||+++ +|.+.+... .....+++..++.++.||++||+|||+. +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 666665432 2234699999999999999999999998 99999999999999955 678999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---h
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---R 575 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 575 (686)
....... .....||+.|+|||++.+. .++.++||||||++||||++|+.||.+....+ .+.. ........ .
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~-i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHH
Confidence 7643322 2345689999999998764 78999999999999999999999997543211 1111 11111000 0
Q ss_pred hhhh-------hhhhcc-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEV-------LDALVL-----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~-------~d~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+..+ ..+.+. .........++.+|+.+||+.||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000 000000 0011123467899999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.69 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=199.5
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEeEEee
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-----------HRNIVKLLGCCLE 416 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~ 416 (686)
++|.+.+.||+|+||.||+|.. .+++.||||.+.. .....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999996 4688999999864 2334567889999999886 8999999999986
Q ss_pred CC----cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec------C
Q 038345 417 TE----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD------D 486 (686)
Q Consensus 417 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~------~ 486 (686)
.. ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++. +|+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 54 789999999 8999999986432 35999999999999999999999953 799999999999994 4
Q ss_pred CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHh
Q 038345 487 KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566 (686)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~ 566 (686)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999865432 2334689999999999999999999999999999999999999975442221111111
Q ss_pred hHHHhh---cc--------h----------------------hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC
Q 038345 567 FLQAMN---EN--------R----------------------LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT 613 (686)
Q Consensus 567 ~~~~~~---~~--------~----------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 613 (686)
...... .. + +..++.. ....+......+.+|+.+||+.||++|||
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111100 00 0 0000000 11234566788999999999999999999
Q ss_pred HHHHHH
Q 038345 614 MKEVAF 619 (686)
Q Consensus 614 ~~ev~~ 619 (686)
++||++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999983
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=331.94 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=196.3
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc---
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP--- 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 420 (686)
..++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3468999999999999999999965 6899999987653 334457889999999999999999999999877655
Q ss_pred ---eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 421 ---LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 421 ---~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 688887743 389999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-- 574 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 574 (686)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCcH
Confidence 9865322 234568999999999887 788999999999999999999999997543211 111110000000
Q ss_pred h---------hhhhhhh---hccCh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 575 R---------LFEVLDA---LVLKE---AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 575 ~---------~~~~~d~---~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
. ....... ..... ........+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0000000 00000 01123467899999999999999999999983
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=336.04 Aligned_cols=207 Identities=29% Similarity=0.370 Sum_probs=175.0
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CC-----CeeeEEeEE
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HR-----NIVKLLGCC 414 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~ 414 (686)
...+...++|.+.++||+|+||+||+|... +++.||||+++.. .....++..|+.+++.++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 334455689999999999999999999965 5789999998643 334567888999999885 45 499999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec--CCCcEEE
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD--DKYRAKV 492 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl 492 (686)
......++||||++ ++|.+++..... ..+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||
T Consensus 126 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 126 MFRNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EETTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred ccCCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999996 599999986532 3589999999999999999999952 12899999999999994 5788999
Q ss_pred EecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCC
Q 038345 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN 556 (686)
Q Consensus 493 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~ 556 (686)
+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876422 234568999999999999999999999999999999999999998543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=322.50 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=201.9
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999975 6899999987542 234567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC---CcEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK---YRAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~ 500 (686)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999999887543 589999999999999999999999 99999999999999754 4799999999986
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
...... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... . ....+.......
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~-- 241 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAF-- 241 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC--
T ss_pred ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCC--
Confidence 543221 223458999999999875 4899999999999999999999999754321 1 111111111000
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+..+.+++.+||+.||++|||+.++++
T Consensus 242 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 ----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00011123456889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.41 Aligned_cols=256 Identities=22% Similarity=0.327 Sum_probs=196.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-----
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV----- 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 419 (686)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999965 6899999987543 33445788999999999999999999999987654
Q ss_pred -ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 420 -PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 420 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 688887753 389999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhc----
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNE---- 573 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~---- 573 (686)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ...........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 765322 234568999999999877 678999999999999999999999997543211 11111110000
Q ss_pred -------chhhhhhhhhc------cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 -------NRLFEVLDALV------LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 -------~~~~~~~d~~~------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......+.... ...........+.+|+.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000 01111234567899999999999999999999983
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.54 Aligned_cols=253 Identities=21% Similarity=0.251 Sum_probs=173.5
Q ss_pred hcccccccc-ccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcc
Q 038345 347 ATDNYNANR-ILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVP 420 (686)
Q Consensus 347 ~~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~ 420 (686)
..++|.+.+ +||+|+||.||+|... +++.||||++... . ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999976 6899999987542 1 122233344667799999999999976 4457
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGT 497 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 497 (686)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999986532 3699999999999999999999999 9999999999999976 45599999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...........
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~-- 249 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQ-- 249 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhccc--
Confidence 9865422 223456899999999999889999999999999999999999999754322110 00000000000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..............+.+|+.+||+.||++|||++|+++
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001111233456889999999999999999999996
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=343.00 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=187.3
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+.|...++||+|+||+||.+...+|+.||||++.. ...+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34555788999999999877667899999998754 2345678999999987 8999999999999999999999999
Q ss_pred cCCchhhhhhccCCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-------------CCcE
Q 038345 428 PNGTLYQNIHNHIEEF----PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-------------KYRA 490 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-------------~~~~ 490 (686)
. |+|.+++....... ..++..++.++.||+.||+|||+. +|+||||||+|||++. ++.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 79999998643211 123345678999999999999999 9999999999999965 3589
Q ss_pred EEEecCCcccccCCCce---eeeeeeccccccCcccccc-------CCCCccccEeehHHHHHHHHh-CCCCCccCCccc
Q 038345 491 KVSDFGTSRSITVDQTH---LTTKVQGTFGYVDPEYFQS-------SQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~ 559 (686)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234569999999999875 678999999999999999999 999996432111
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........ .. +............++.+|+.+||+.||++|||+.+|++
T Consensus 248 -----~~i~~~~~--~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----SNIIRGIF--SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----HHHHHTCC--CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHhcCCC--Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00000000 00 00011123455678999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.82 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=199.3
Q ss_pred ccChHHHHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHHhcC--CCCee
Q 038345 338 LFTSKDLEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE------NNVEQFINEVVILSQIN--HRNIV 408 (686)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv 408 (686)
....++.+...++|.+.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++++++ |+||+
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 344455566678899999999999999999985 4688999998764321 12356778999999996 59999
Q ss_pred eEEeEEeeCCcceEEEEeccC-CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-C
Q 038345 409 KLLGCCLETEVPLLVYEFVPN-GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-D 486 (686)
Q Consensus 409 ~l~g~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~ 486 (686)
++++++...+..++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++ +
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 999999999999999999976 8999999764 3589999999999999999999999 999999999999999 7
Q ss_pred CCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhH
Q 038345 487 KYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565 (686)
Q Consensus 487 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~ 565 (686)
++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------- 253 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 253 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence 8999999999998765322 233568999999999987765 788999999999999999999996321
Q ss_pred hhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 566 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...... . ..+......+.+|+.+||+.||++|||+++|++
T Consensus 254 ---~~~~~~-~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ---EIIRGQ-V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHHCC-C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhhccc-c----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0 011123456889999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=326.60 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=191.1
Q ss_pred HHHHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccCh------hhHHHHHHHHHHHHhc----CCCCeeeE
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE------NNVEQFINEVVILSQI----NHRNIVKL 410 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l 410 (686)
++.+...++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34455668899999999999999999986 4688999999765322 1234566899999999 89999999
Q ss_pred EeEEeeCCcceEEEEe-ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCC
Q 038345 411 LGCCLETEVPLLVYEF-VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKY 488 (686)
Q Consensus 411 ~g~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~ 488 (686)
++++...+..++|||+ +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 9999999999999999 78999999998643 589999999999999999999999 999999999999999 889
Q ss_pred cEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCC-ccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh
Q 038345 489 RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFT-EKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF 567 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~ 567 (686)
.+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 99999999998765332 2345689999999998877664 58999999999999999999986321
Q ss_pred HHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 568 LQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 568 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.... .. ...+......+.+++.+||+.||++|||++|+++
T Consensus 244 -~~~~---------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 -EILE---------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -HHHH---------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -HHhh---------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 0111223456889999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.13 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=199.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CC-cEEEEEEccccChhhHHHHHHHHHHHHhcCCCC------eeeEEeEEeeCCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DG-RIVAVKKSKLVDENNVEQFINEVVILSQINHRN------IVKLLGCCLETEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~ 419 (686)
.++|.+.+.||+|+||.||+|... ++ ..||||.++.. ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 68999998643 344577889999999998766 8999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee---------------
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL--------------- 484 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll--------------- 484 (686)
.++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 667777776542 23699999999999999999999998 99999999999999
Q ss_pred ----cCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccC
Q 038345 485 ----DDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560 (686)
Q Consensus 485 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~ 560 (686)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 56789999999999864322 234568999999999999999999999999999999999999997543221
Q ss_pred CchhHhhHHHhhc-----------chhh--------------hhhhhh-----ccChhhHHHHHHHHHHHHHhcccCCCC
Q 038345 561 RSLVGYFLQAMNE-----------NRLF--------------EVLDAL-----VLKEAEREEIMTVATLAKRCLNLNGKN 610 (686)
Q Consensus 561 ~~l~~~~~~~~~~-----------~~~~--------------~~~d~~-----~~~~~~~~~~~~l~~l~~~cl~~dp~~ 610 (686)
....+...... .... ..+... ............+.+|+.+||+.||++
T Consensus 247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 11111110000 0000 000000 000111233567899999999999999
Q ss_pred CCCHHHHH
Q 038345 611 RPTMKEVA 618 (686)
Q Consensus 611 RPt~~ev~ 618 (686)
|||+.|++
T Consensus 325 Rpt~~e~l 332 (355)
T 2eu9_A 325 RITLAEAL 332 (355)
T ss_dssp SCCHHHHT
T ss_pred CcCHHHHh
Confidence 99999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=329.46 Aligned_cols=257 Identities=26% Similarity=0.358 Sum_probs=179.5
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHH-HHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVV-ILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
..++|...+.||+|+||.||+|... +++.||||++... ......++..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3468999999999999999999975 6899999987653 2334455666666 77778999999999999999999999
Q ss_pred EEeccCCchhhhhhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 424 YEFVPNGTLYQNIHNH--IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 999974 887777531 12346899999999999999999999953 7999999999999999999999999999866
Q ss_pred cCCCceeeeeeeccccccCcccc----ccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYF----QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ .... .....
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~-- 246 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQ-VVKGD-- 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSC--
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHH-HhcCC--
Confidence 4322 22334689999999998 456789999999999999999999999975321100 0000 00000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.+.+...........+.+|+.+||+.||++|||+.+|++
T Consensus 247 ---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ---PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111111223456899999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=341.61 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=188.1
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV~ 424 (686)
....+|...++||+|+||+||.....+++.||||++.... ...+.+|+.+|+++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445799999999999999665555679999999875432 23467899999999 7999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-----CCCcEEEEecCCcc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-----DKYRAKVSDFGTSR 499 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-----~~~~~kl~DfGla~ 499 (686)
||+. |+|.+++..... .+.+..++.++.||+.||+|||+. +|+||||||+|||++ ....+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 699999986532 344556678999999999999999 999999999999994 33468899999998
Q ss_pred cccCCCc--eeeeeeeccccccCccccc---cCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhc
Q 038345 500 SITVDQT--HLTTKVQGTFGYVDPEYFQ---SSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573 (686)
Q Consensus 500 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~ 573 (686)
....... .......||+.|+|||++. ...++.++||||||+++|||++ |+.||...... ........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhcc
Confidence 7653321 2234456999999999997 4667889999999999999999 99998532211 01111111
Q ss_pred chhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 574 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... .. ..........+.+|+.+||+.||++|||+++|++
T Consensus 245 ~~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 00 0111233455789999999999999999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.18 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=181.3
Q ss_pred HHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh-hh-HHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-NN-VEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.....++|...+.||+|+||.||+|... +++.||||.+..... .. .+.+.++..+++.++||||+++++++.+.+..
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV 99 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence 3444578999999999999999999975 689999998765322 22 23445555678888999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+ ++.+..++... ...+++..++.++.|+++||+|||+.. +|+||||||+|||++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 45555544432 235899999999999999999999832 899999999999999999999999999976
Q ss_pred ccCCCceeeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
..... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ............
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~ 247 (318)
T 2dyl_A 175 LVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC
T ss_pred ccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC
Confidence 54322 223456899999999984 567889999999999999999999999743211 111111111100
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
+.. .........+.+++.+||+.||.+||++.++++
T Consensus 248 ------~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ------PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000 001123456889999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=351.84 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=196.2
Q ss_pred ccccccccccCccceEEEEEEEeC--CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCc-----
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA--DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEV----- 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----- 419 (686)
.++|.+.++||+|+||.||+|... +++.||||.+... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367999999999999999999975 5899999987643 34455678999999999999999999999987665
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+|||||+++++|.+++.. .+++..++.|+.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 589999999999999999999999 99999999999999986 89999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
..... ....||+.|+|||++.+.. +.++||||||++||||++|..||........ .
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~-- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P-- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c--
Confidence 76432 3456999999999987654 8999999999999999999988764221100 0
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIRA 626 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~ev~~~L~~i~~ 626 (686)
...........+.+|+.+||+.||++|| +++++.+.|..+..
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0011112335688999999999999999 56777777776653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.29 Aligned_cols=270 Identities=23% Similarity=0.350 Sum_probs=205.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee------CCc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLE------TEV 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~ 419 (686)
.++|.+.++||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999964 5899999987653 44556789999999999999999999999765 677
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCc---EEEEecC
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYR---AKVSDFG 496 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfG 496 (686)
.++||||+++|+|.+++........+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998765555699999999999999999999998 9999999999999986654 9999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-- 574 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-- 574 (686)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..+........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccch
Confidence 998764332 234457999999999999999999999999999999999999999643110 00000000000
Q ss_pred --hhhhhhhh--------hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhhhh
Q 038345 575 --RLFEVLDA--------LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE-----VAFELGGIRAS 627 (686)
Q Consensus 575 --~~~~~~d~--------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e-----v~~~L~~i~~~ 627 (686)
...+.... ..........+..+.+++.+||+.||++|||+++ +.+.++.+...
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000000 0011233345678999999999999999999988 45666665543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.19 Aligned_cols=234 Identities=12% Similarity=0.124 Sum_probs=185.6
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 48999999986532 33457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++... .....+.+|+.|++.||+|||+. +|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998542 35567889999999999999999 99999999999999999999997543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
|++ .++.++||||||+++|||++|+.||......+...... ...... ..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~-~~------ 223 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ-PI------ 223 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC-BC------
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC-CC------
Confidence 333 36889999999999999999999998654322110000 000000 00
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.........+..+.+|+.+||+.||++| |+.|+++.|+.+....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0001112234568999999999999999 9999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.13 Aligned_cols=253 Identities=15% Similarity=0.171 Sum_probs=185.9
Q ss_pred HHhhccccccccccCccceEEEEEEEe-CCCcEEEEEEccccCh---hhHHHHHHHHHHHHhcCC-CCeee---------
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE---NNVEQFINEVVILSQINH-RNIVK--------- 409 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~--------- 409 (686)
+.....+|...++||+|+||+||+|.. .+++.||||++..... ...+.|.+|+.++..++| +|...
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 334456688889999999999999995 4689999998774322 235789999999999987 32211
Q ss_pred ------------EEeEEee-----CCcceEEEEeccCCchhhhhhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 038345 410 ------------LLGCCLE-----TEVPLLVYEFVPNGTLYQNIHNH----IEEFPITWELLLRIAVEVSGALFYLHSAA 468 (686)
Q Consensus 410 ------------l~g~~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 468 (686)
+..++.. ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 1111111 12345666655 68999888521 1234588999999999999999999999
Q ss_pred CCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeeeccccccCcccc----------ccCCCCccccEeeh
Q 038345 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF----------QSSQFTEKSDVYSF 538 (686)
Q Consensus 469 ~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDv~S~ 538 (686)
+|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999999999999999999999999764322 344567 999999999 55668889999999
Q ss_pred HHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 539 GVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 539 Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
|+++|||++|+.||......+... .++... . ..+..+.+|+.+||+.||++||++.+++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~---------------~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSE---------------WIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSG---------------GGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHCCCCCCCcchhhhHH---------------HHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999997543221110 001000 0 1235689999999999999999998887
Q ss_pred HH--HHhhhh
Q 038345 619 FE--LGGIRA 626 (686)
Q Consensus 619 ~~--L~~i~~ 626 (686)
+. ++.+..
T Consensus 363 ~~~~~~~~~~ 372 (413)
T 3dzo_A 363 ETPEYEQLRT 372 (413)
T ss_dssp TSHHHHHHHH
T ss_pred hCHHHHHHHH
Confidence 53 444443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.03 Aligned_cols=231 Identities=22% Similarity=0.286 Sum_probs=178.4
Q ss_pred ccccccc-cccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHH-HhcCCCCeeeEEeEEee----CCcc
Q 038345 348 TDNYNAN-RILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVIL-SQINHRNIVKLLGCCLE----TEVP 420 (686)
Q Consensus 348 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~ 420 (686)
.++|.+. +.||+|+||.||++... +++.||+|.++. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3557766 78999999999999964 689999999753 24677888888 55689999999999987 6778
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGT 497 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 497 (686)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999998753 23699999999999999999999999 9999999999999998 78999999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
++... +..++.++||||||+++|||++|+.||......+.... .........
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~-- 218 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQ-- 218 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTC--
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhcc--
Confidence 86432 24467899999999999999999999965432110000 000000000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..............+.+++.+||+.||++|||+.|+++
T Consensus 219 ----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 219 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ----CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000001123467899999999999999999999985
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=314.93 Aligned_cols=242 Identities=16% Similarity=0.208 Sum_probs=184.9
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccC--------hhhHHHHHHHHHHHHhcC---------CCCeeeE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--------ENNVEQFINEVVILSQIN---------HRNIVKL 410 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 410 (686)
.++|.+.++||+|+||+||+|+. +++.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45789999999999999999998 68999999876532 223478899999999986 7777777
Q ss_pred EeEEe-----------------e-------------CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHH
Q 038345 411 LGCCL-----------------E-------------TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460 (686)
Q Consensus 411 ~g~~~-----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~ 460 (686)
++.+. + ....+|||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 66542 2 6788999999999987777753 358999999999999999
Q ss_pred HHHhh-hcCCCCeEeeCCCCCCeeecCCC--------------------cEEEEecCCcccccCCCceeeeeeecccccc
Q 038345 461 LFYLH-SAASISIYRRDIKSANILLDDKY--------------------RAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519 (686)
Q Consensus 461 L~yLH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 519 (686)
|+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 88 999999999999999886 8999999999865422 346999999
Q ss_pred CccccccCCCCccccEeehHHH-HHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHH
Q 038345 520 DPEYFQSSQFTEKSDVYSFGVV-LVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT 598 (686)
Q Consensus 520 aPE~~~~~~~t~ksDv~S~Gv~-l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 598 (686)
|||++.+.. +.++|||||+.+ .+++++|..||.... ........+.... ................++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL------WLHYLTDKMLKQM---TFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH------HHHHHHHHHHHTC---CCSSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh------hhhHHHHhhhhhh---ccCcccchhhhhhcCHHHHH
Confidence 999998766 899999998777 777888999985210 0000000000000 00011112234467788999
Q ss_pred HHHHhcccCCCCCCCHHHHH
Q 038345 599 LAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 599 l~~~cl~~dp~~RPt~~ev~ 618 (686)
|+.+||+.| |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=285.57 Aligned_cols=186 Identities=18% Similarity=0.113 Sum_probs=131.1
Q ss_pred ccCccceEEEEEEE-eCCCcEEEEEEcccc----------ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 356 ILGQGGQGTVYKGM-LADGRIVAVKKSKLV----------DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 356 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
..+.|++|.+..+. ...|+.+|+|.+... .+...++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666554 335888999986532 123346799999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||++|++|.++|.+.. +++.. +|+.||+.||+|||++ +||||||||+||||++++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999998643 46654 5889999999999999 999999999999999999999999999987654
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCC
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~ 552 (686)
+.. ......||++|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 332 2344679999999999875 4677899999999998887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=258.81 Aligned_cols=185 Identities=14% Similarity=0.176 Sum_probs=146.4
Q ss_pred ccccccCccceEEEEEEEeCCCcEEEEEEccccC--h------hhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 352 NANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--E------NNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++||+|+||.||+|.. .+..+++|+..... . ...++|.+|+.++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 47788888743211 1 1235689999999999999999777777788888999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++++|.+++.. ++.++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 458999999999999999 9999999999999999 999999999987754
Q ss_pred CCcee------eeeeeccccccCcccccc--CCCCccccEeehHHHHHHHHhCCCCCc
Q 038345 504 DQTHL------TTKVQGTFGYVDPEYFQS--SQFTEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 504 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
..... .....||+.|||||++.. ..|+.+.|+||..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 235679999999999987 668889999999999998888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.3e-23 Score=210.90 Aligned_cols=152 Identities=15% Similarity=0.131 Sum_probs=122.3
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccCh------------------hhHHHHHHHHHHHHhcC
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDE------------------NNVEQFINEVVILSQIN 403 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 403 (686)
..+......|.+.+.||+|+||.||+|...+|+.||||.+..... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344445566777899999999999999997799999998754221 13467899999999999
Q ss_pred CCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 404 h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
| +++.+++ +.+..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||
T Consensus 163 --~-~~v~~~~-~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVY-AWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEE-EEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEE-eccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 6666654 3466799999999999988 421 12447999999999999999 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccc
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 525 (686)
++ ++.+||+|||+++. +..++|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99 99999999999963 34578899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-19 Score=181.61 Aligned_cols=137 Identities=18% Similarity=0.160 Sum_probs=106.6
Q ss_pred ccccccccCccceEEEEEEEe-CCCcE--EEEEEccccCh------------------------hhHHHHHHHHHHHHhc
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRI--VAVKKSKLVDE------------------------NNVEQFINEVVILSQI 402 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l 402 (686)
-|.+.+.||+|+||.||+|.. .+|+. ||||..+.... .....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367788999999999999997 67888 99997543211 1113678999999999
Q ss_pred CCCCe--eeEEeEEeeCCcceEEEEeccC-C----chhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeEe
Q 038345 403 NHRNI--VKLLGCCLETEVPLLVYEFVPN-G----TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH-SAASISIYR 474 (686)
Q Consensus 403 ~h~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~~~~ivH 474 (686)
+|+++ +.++++ ...+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +. +|+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 98864 444442 467899999942 4 55554332 224467789999999999999 87 9999
Q ss_pred eCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 475 RDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 475 ~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
|||||+|||+++ .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=8.2e-17 Score=169.35 Aligned_cols=136 Identities=14% Similarity=0.170 Sum_probs=99.7
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccC--------------hhhHHH--------HHHHHHHHHhcCCCC
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--------------ENNVEQ--------FINEVVILSQINHRN 406 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~E~~~l~~l~h~n 406 (686)
.-|.+.+.||+|+||.||+|...+|+.||||.++... ...... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3488999999999999999999899999999754310 000111 234566666665444
Q ss_pred ee--eEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeee
Q 038345 407 IV--KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILL 484 (686)
Q Consensus 407 iv--~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll 484 (686)
+. ..+++ ...+|||||+++++|.++... .....++.|++.+|.|||+. +||||||||.|||+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEE
Confidence 32 22221 234799999999888765431 12356889999999999998 99999999999999
Q ss_pred cCCC----------cEEEEecCCccc
Q 038345 485 DDKY----------RAKVSDFGTSRS 500 (686)
Q Consensus 485 ~~~~----------~~kl~DfGla~~ 500 (686)
++++ .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8776 489999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=7.1e-12 Score=126.58 Aligned_cols=146 Identities=14% Similarity=0.084 Sum_probs=114.5
Q ss_pred HhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEE
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV 423 (686)
....+.|.....++.|+.+.||+.... +..+++|............+.+|+.+++.+. |..+++++++....+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888998999999998754 6889999876422223356889999999995 67788999999888899999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA----------------------------------- 468 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----------------------------------- 468 (686)
|||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 1123478889999999999811
Q ss_pred ---------------------CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 469 ---------------------SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 469 ---------------------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1359999999999999876666799999874
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=99.27 E-value=1.8e-12 Score=106.62 Aligned_cols=82 Identities=28% Similarity=0.735 Sum_probs=65.2
Q ss_pred cccccCCC-CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc-cccccCCcceEEeCCCCccCC
Q 038345 180 EAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 180 ~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~ 257 (686)
++++|... ..|.+ +.|+++.++|+|.|++||+++++....|+|+|||.. ....|. ++|.|+.|+|.|.|++||.++
T Consensus 2 dideC~~~~~~C~~-g~C~n~~g~y~C~C~~Gy~~~~~~g~~C~dideC~~-~~~~C~~~~C~n~~g~y~C~C~~G~~~~ 79 (86)
T 1lmj_A 2 DIDECRISPDLCGR-GQCVNTPGDFECKCDEGYESGFMMMKNCMDIDECQR-DPLLCRGGVCHNTEGSYRCECPPGHQLS 79 (86)
T ss_dssp CCCTTTTCSSTTTT-SCEEEETTEEEECCCSSEEECTTTSSSEEECCHHHH-CSSTTTTSEEEEETTEEEEESCTTSCCC
T ss_pred ccccccCCCCCCCC-CEEECCCCCEEeeCCCCcCccCCCCCccCCcccccC-CCCcCCCCEeEcCCCCEEEECcCCcccC
Confidence 35667654 25864 489999999999999999998877789999999975 223475 699999999999999999876
Q ss_pred CCCCCCCc
Q 038345 258 GRRDGGGC 265 (686)
Q Consensus 258 ~~~~~~~C 265 (686)
.++..|
T Consensus 80 --~~~~~C 85 (86)
T 1lmj_A 80 --PNISAC 85 (86)
T ss_dssp --SSSCCC
T ss_pred --CCCCcc
Confidence 344444
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=5.1e-11 Score=119.81 Aligned_cols=138 Identities=15% Similarity=0.139 Sum_probs=102.8
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lV~e 425 (686)
...+....+.+.|..+.||+....+|..+++|..... ....+.+|+.+++.+.+.+ +++++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445544444456669999998777888999986543 2356788999999996545 5668888887778899999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA------------------------------------- 468 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------- 468 (686)
|++|.+|. ... .. ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 221 11 2356778888888888742
Q ss_pred ------------------CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 469 ------------------SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 469 ------------------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
...++|+|++|.|||++++..+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999874
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=99.17 E-value=1.7e-11 Score=99.68 Aligned_cols=75 Identities=27% Similarity=0.647 Sum_probs=62.8
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc-cccccCCcceEEeCCCCcc
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFR 255 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~ 255 (686)
+|.++++|.....|.+ +.|+++.++|+|.|++||+++ ...|+++|||.. ..+|. ++|.|+.|+|.|.|++||.
T Consensus 1 sC~dideC~~~~~C~~-g~C~n~~g~y~C~C~~Gy~~~---g~~C~dideC~~--~~~C~~~~C~n~~g~y~C~C~~G~~ 74 (82)
T 1emn_A 1 SAVDMDECKEPDVCKH-GQCINTDGSYRCECPFGYILA---GNECVDTDECSV--GNPCGNGTCKNVIGGFECTCEEGFE 74 (82)
T ss_dssp CCCCCCSSSSTTSCSS-SEECCCSSCCCEECCTTEEEE---TTEEEECCGGGT--CCTTSSSCEEECSSSEEECCSSSSC
T ss_pred CCCccccCCCCCCcCC-CEEEecCCCEEEECCCCeECC---CCccCCcccccC--CCCCCCCEeECCCCCEEeECCCCeE
Confidence 4677888976448974 789999999999999999852 257999999974 25775 7999999999999999999
Q ss_pred CC
Q 038345 256 GD 257 (686)
Q Consensus 256 ~~ 257 (686)
++
T Consensus 75 g~ 76 (82)
T 1emn_A 75 PG 76 (82)
T ss_dssp CC
T ss_pred eC
Confidence 87
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=6.2e-11 Score=97.54 Aligned_cols=79 Identities=32% Similarity=0.759 Sum_probs=61.9
Q ss_pred ccccCCCC-CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCC--CCccCC
Q 038345 181 AKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCP--KGFRGD 257 (686)
Q Consensus 181 ~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~--~g~~~~ 257 (686)
+++|..+. .| +++.|.+..++|+|.|++||+++++ ...|+++|||.. .+|.++|.|++|+|.|.|+ .||...
T Consensus 3 ideC~~~~~~C-~~~~C~n~~g~y~C~C~~G~~~~~~-g~~C~dideC~~---~~C~~~C~n~~g~y~C~C~g~~G~~~~ 77 (87)
T 1z6c_A 3 VDECSLKPSIC-GTAVCKNIPGDFECECPEGYRYNLK-SKSCEDIDECSE---NMCAQLCVNYPGGYTCYCDGKKGFKLA 77 (87)
T ss_dssp SCSSSSSSSSB-TTSSCCCBTTBCCCSSSTTCEEETT-TTEEECCCHHHH---SCCSSEECCCSSSCCEECCSSSCCBCC
T ss_pred cccccCCCCCC-CCCEeECCCCCEEEECCCCceECCC-CCcCCCcCeeCC---CCCCCEEEccCCCEEEECCCCcCCccc
Confidence 56676553 48 6788999999999999999998774 368999999964 6899999999999999995 555433
Q ss_pred CCCCCCCcc
Q 038345 258 GRRDGGGCI 266 (686)
Q Consensus 258 ~~~~~~~C~ 266 (686)
.++..|.
T Consensus 78 --~~~~~C~ 84 (87)
T 1z6c_A 78 --QDQKSCE 84 (87)
T ss_dssp --TTSSSCB
T ss_pred --CCCCcce
Confidence 3444554
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.7e-11 Score=103.64 Aligned_cols=74 Identities=30% Similarity=0.756 Sum_probs=32.5
Q ss_pred ccccccccCCC-CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCcc
Q 038345 177 TCEEAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR 255 (686)
Q Consensus 177 ~c~~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~ 255 (686)
.| +.++|..+ ..|. +.|.+..++|+|.|++||+|++ ...|+|||||.. ..+|.++|.|+.|+|.|.|++||.
T Consensus 26 ~C-d~neC~~~~~~C~--~~C~n~~g~y~C~C~~Gy~g~~--g~~C~dideC~~--~~~C~~~C~n~~gsy~C~C~~Gy~ 98 (107)
T 2w2n_E 26 AM-GTNECLDNNGGCS--YVCNDLKIGYECLCPDGFQLVA--QRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGFQ 98 (107)
T ss_dssp CB-SCCGGGTGGGGCS--SEEECCSBSCEEECCTTCEEET--TTEEEC--------------------------------
T ss_pred CC-cCccCcCCCCCCC--CEeEeCCCCeEEECCCCccccC--CCccccccccCC--CCCcCCeeecCCCCEEEECCCCce
Confidence 46 46777654 3674 5788889999999999999853 367999999974 367999999999999999999998
Q ss_pred CC
Q 038345 256 GD 257 (686)
Q Consensus 256 ~~ 257 (686)
++
T Consensus 99 ~~ 100 (107)
T 2w2n_E 99 LD 100 (107)
T ss_dssp --
T ss_pred EC
Confidence 76
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=99.03 E-value=7.3e-11 Score=107.17 Aligned_cols=82 Identities=24% Similarity=0.611 Sum_probs=63.7
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCcccccc-ccCCcceEEeCCCCcc
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHIC-DNTAGNYTCRCPKGFR 255 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C-~~~~g~~~C~C~~g~~ 255 (686)
.|.+.++|..+ +|.+++.|++..++|.|.|++||+| ..|+++|+|.. ...+|.++| .|+.|+|.|.|++||.
T Consensus 44 ~c~dideC~~~-pC~n~g~C~~~~~~y~C~C~~G~~G-----~~C~~~deC~~-~~~~C~~~C~~n~~g~y~C~C~~Gy~ 116 (146)
T 1x7a_L 44 QYVDGDQCEPN-PCLNGGLCKDDINSYECWCQVGFEG-----KNCELDATCNI-KNGRCKQFCKTGADSKVLCSCTTGYR 116 (146)
T ss_dssp ------CCSSC-SSCTTCEEEECSSCEEEECCSSEES-----TTTCEECCTTS-GGGSCSSBCCCCSSSCCCCBCCTTEE
T ss_pred cCCCcCcCCCC-CCCCCCEeECCCCCEEEecCCCCcC-----CcCCCCccccC-CCCCCcCCCCCCCCCCEEeEcCCCcE
Confidence 46778888765 8999899999999999999999997 46999999975 346788899 9999999999999998
Q ss_pred CCCCCCCCCccC
Q 038345 256 GDGRRDGGGCIP 267 (686)
Q Consensus 256 ~~~~~~~~~C~~ 267 (686)
+. .++..|..
T Consensus 117 l~--~dG~~C~~ 126 (146)
T 1x7a_L 117 LA--PDQKSCKP 126 (146)
T ss_dssp EC--TTSSSEEE
T ss_pred eC--CCCCcCCC
Confidence 54 24445543
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=99.02 E-value=1.2e-10 Score=105.97 Aligned_cols=91 Identities=32% Similarity=0.708 Sum_probs=72.4
Q ss_pred CCccccccccCCCC--CCCCCCCCccCCCCceecCCCCcccCCCC-------CCCCcCCCcccCCCCCccc--cccccCC
Q 038345 175 IETCEEAKICGPNA--SCDKSKDNTTTSSGYHCKCNKGYEGNPYL-------SDGCRDVNEFEDPSLNNCT--HICDNTA 243 (686)
Q Consensus 175 ~~~c~~~~~c~~~~--~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~-------~~gC~~~~~c~~~~~~~c~--~~C~~~~ 243 (686)
...|+++++|.... .|.+++.|+++.++|+|.|++||+|++.. ...|+|+|||.. ...+|. ++|+|+.
T Consensus 38 ~~~C~dideC~~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~g~~~~~~~~~~~~~~C~dideC~~-~~~~C~~~~~C~n~~ 116 (143)
T 2bou_A 38 METCDDINECATLSKVSCGKFSDCWNTEGSYDCVCSPGYEPVSGAKTFKNESENTCQDVDECSS-GQHQCDSSTVCFNTV 116 (143)
T ss_dssp TCCCEECCGGGC----CCCTTEEEEECSSCEEEEECTTEEETTCCSCBSSGGGCCEEECCHHHH-TCCCCCTTSEEEECS
T ss_pred CCcCCccccccCCCCCCCCCCCEEEcCCCCeEeECCCCcccCcCccccccCCCCCcCCccCccC-cCCCCCCCCEEECCC
Confidence 35677788887652 79888899999999999999999997643 347999999985 246786 7999999
Q ss_pred cceEEeCCCCccCCCCCCCCCccCC
Q 038345 244 GNYTCRCPKGFRGDGRRDGGGCIPN 268 (686)
Q Consensus 244 g~~~C~C~~g~~~~~~~~~~~C~~~ 268 (686)
|+|.|.|++||.++ .+...|.+.
T Consensus 117 g~y~C~C~~Gy~g~--~~~~~C~~~ 139 (143)
T 2bou_A 117 GSYSCRCRPGWKPR--HGIPNNQKD 139 (143)
T ss_dssp SCEEEECCSSSCBC--TTCCSSBTT
T ss_pred CCEEeeCCCCcccC--CCCccCccC
Confidence 99999999999987 345556543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.4e-10 Score=116.39 Aligned_cols=142 Identities=13% Similarity=0.172 Sum_probs=107.0
Q ss_pred cccccCccceEEEEEEEeCCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHHhcC--CCCeeeEEeEEeeC---CcceEEE
Q 038345 353 ANRILGQGGQGTVYKGMLADGRIVAVKKSK--LVD-ENNVEQFINEVVILSQIN--HRNIVKLLGCCLET---EVPLLVY 424 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lV~ 424 (686)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..++++++++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 578888765 221 122357889999999997 45678899988776 3489999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA------------------------------------ 468 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~------------------------------------ 468 (686)
||++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988754221 13678888999999999999999731
Q ss_pred -------------------CCCeEeeCCCCCCeeecCCCc--EEEEecCCccc
Q 038345 469 -------------------SISIYRRDIKSANILLDDKYR--AKVSDFGTSRS 500 (686)
Q Consensus 469 -------------------~~~ivH~Dikp~NIll~~~~~--~kl~DfGla~~ 500 (686)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987653 68999998864
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-10 Score=109.00 Aligned_cols=82 Identities=22% Similarity=0.672 Sum_probs=31.6
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC-C-CcccCCCCCccccccccCCcceEEeCCCCc
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD-V-NEFEDPSLNNCTHICDNTAGNYTCRCPKGF 254 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~-~-~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~ 254 (686)
.|.+.++|..+ +|.+++.|.+..++|.|.|++||+| ..|++ + ++|.. ...+|.++|.|+.|+|.|.|++||
T Consensus 38 ~c~dideC~~~-pC~ngg~C~n~~g~y~C~C~~Gf~G-----~~Ce~~i~deC~~-~~~~C~~~C~n~~gsy~C~C~~Gy 110 (195)
T 1nfu_B 38 KYKDGDQCETS-PCQNQGKCKDGLGEYTCTCLEGFEG-----KNCELFTRKLCSL-DNGDCDQFCHEEQNSVVCSCARGY 110 (195)
T ss_dssp -------------------------------------------------CCGGGT-GGGGCSSEEEEETTEEEEECCTTE
T ss_pred cCCCCcccCCC-CCCCCCEeECCCCCeeEeCCCCcee-----ccccccccccccC-CCCCCCCEeECCCCCeEEECCCCc
Confidence 47778889765 8999899999999999999999997 45987 6 89975 346798999999999999999999
Q ss_pred cCCCCCCCCCccC
Q 038345 255 RGDGRRDGGGCIP 267 (686)
Q Consensus 255 ~~~~~~~~~~C~~ 267 (686)
... .++..|..
T Consensus 111 ~l~--~dG~~C~~ 121 (195)
T 1nfu_B 111 TLA--DNGKACIP 121 (195)
T ss_dssp EEC--TTSSCEEE
T ss_pred eeC--CCCCcccc
Confidence 854 24455654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=5.1e-10 Score=115.52 Aligned_cols=187 Identities=21% Similarity=0.228 Sum_probs=123.8
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCC--eeeEEeEEeeCC---cceEEEEec
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRN--IVKLLGCCLETE---VPLLVYEFV 427 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~---~~~lV~e~~ 427 (686)
.+.++.|....||+.. ..+++|.... ......+.+|+.+|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999853 4588887543 234567899999999884 333 455655544333 458999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA--------------------------------------- 468 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------- 468 (686)
+|.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888754331 3677788888999999999888611
Q ss_pred ----------------CCCeEeeCCCCCCeeecC--CCcEEEEecCCcccccCCCce--eee-----------eeecccc
Q 038345 469 ----------------SISIYRRDIKSANILLDD--KYRAKVSDFGTSRSITVDQTH--LTT-----------KVQGTFG 517 (686)
Q Consensus 469 ----------------~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~--~~~-----------~~~gt~~ 517 (686)
.+.++|+|++|.||++++ ...+.|+||+.+......... ... .+....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 135899999999999988 556899999988643211000 000 0000111
Q ss_pred ccC-ccccccCCCCccccEeehHHHHHHHHhCCCCCc
Q 038345 518 YVD-PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 518 y~a-PE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
... |+..... ....+.|+++.++|++.+|..+|.
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHHH
Confidence 112 2221111 123578999999999999998763
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=98.90 E-value=5.3e-10 Score=97.10 Aligned_cols=70 Identities=26% Similarity=0.579 Sum_probs=56.5
Q ss_pred CCCCCCCccCCCCceecCCCCcccCCCCCCCCcCC---CcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 190 CDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV---NEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 190 C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~---~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
|.+++.|++..++|+|.|++||+|+ .|+++ ++|.. ....|.++|.|+.|+|.|.|++||.+. .++..|.
T Consensus 22 C~~~g~C~~~~~~y~C~C~~G~~G~-----~C~~~~~~~~C~~-~~~~C~~~C~n~~g~y~C~C~~G~~~~--~~g~~C~ 93 (114)
T 1aut_L 22 CCGHGTCIDGIGSFSCDCRSGWEGR-----FCQREVSFLNCSL-DNGGCTHYCLEEVGWRRCSCAPGYKLG--DDLLQCH 93 (114)
T ss_dssp TTTSEEECCCSSCCCEEECTTEEST-----TSCEECCSSSSSS-GGGGCSSEEEECSSSEEEECCTTEEEC--TTSSCEE
T ss_pred CCCcCCCCCCCCCcEeeCCCCCcCC-----CcCcCCcCCcCcC-CCCCCCCEeECCCCCEEeECCCCeeEC--CCCCccC
Confidence 8778889988999999999999984 49765 46864 346788899999999999999999865 3444554
Q ss_pred C
Q 038345 267 P 267 (686)
Q Consensus 267 ~ 267 (686)
.
T Consensus 94 ~ 94 (114)
T 1aut_L 94 P 94 (114)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
Probab=98.87 E-value=4e-10 Score=100.89 Aligned_cols=81 Identities=21% Similarity=0.649 Sum_probs=30.4
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC-C-CcccCCCCCccccccccCCcceEEeCCCCc
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD-V-NEFEDPSLNNCTHICDNTAGNYTCRCPKGF 254 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~-~-~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~ 254 (686)
.|.+.++|..+ +|.+++.|++..++|+|.|++||+| ..|++ + |+|.. ...+|.++|.++.|+|.|.|++||
T Consensus 38 ~c~d~d~C~~~-pC~n~g~C~~~~~~y~C~C~~G~~G-----~~C~~~i~d~C~~-~~~~C~~~C~~~~g~y~C~C~~Gy 110 (134)
T 2vh0_B 38 KYKDGDQCETS-PCQNQGKCKDGLGEYTCTCLEGFEG-----KNCELFTRKLCSL-DNGDCDQFCHEEQNSVVCSCARGY 110 (134)
T ss_dssp -------------------------------------------------CCGGGT-GGGGCSSEEEEETTEEEEECCTTE
T ss_pred cCCCcCcCCCC-CCCCcCCcccCCCCEEeeCCCCccC-----CccccCCCCcccc-CCCCCCCEeECCCCCEEEECCCCc
Confidence 46778888765 7998899999899999999999997 46987 6 89975 346788899999999999999999
Q ss_pred cCCCCCCCCCcc
Q 038345 255 RGDGRRDGGGCI 266 (686)
Q Consensus 255 ~~~~~~~~~~C~ 266 (686)
.+. .++..|.
T Consensus 111 ~l~--~~g~~C~ 120 (134)
T 2vh0_B 111 TLA--DNGKACI 120 (134)
T ss_dssp EEC--TTSSCEE
T ss_pred EEC--CCCCccC
Confidence 854 2344454
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=2.6e-09 Score=110.96 Aligned_cols=80 Identities=31% Similarity=0.763 Sum_probs=64.2
Q ss_pred cccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc-CCCcccCCCCCccccccccCCcceEEeCCCCccCCC
Q 038345 180 EAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 180 ~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~ 258 (686)
+.++|..+ +|.+++.|.+..++|+|.|++||+| ..|+ |+|||......+|.+.|.|+.|+|.|.|++||.++
T Consensus 4 d~~~C~~~-pC~~~g~C~~~~~~~~C~C~~g~~g-----~~C~~~~~eC~~~~~~~C~~~C~~~~g~~~C~C~~g~~~~- 76 (317)
T 3h5c_B 4 GGSPCISQ-PCLHNGSCQDSIWGYTCTCSPGYEG-----SNCELAKNECHPERTDGCQHFCLPGQESYTCSCAQGYRLG- 76 (317)
T ss_dssp --CCTTSC-CCTTTCCCCCCSSSCCCCCSSSCCS-----SSSCCCSSSCCTTCTTSCSSEEECCSSSCEEECCTTEECC-
T ss_pred cCCcCCCC-CCCCCCEeECCCCCeEEECCCCCcC-----CccccCcccCCCCCCCCCcCccccCCCeeEEecccccccc-
Confidence 35567665 7998899998889999999999998 4698 99999863347899999999999999999999875
Q ss_pred CCCCCCccC
Q 038345 259 RRDGGGCIP 267 (686)
Q Consensus 259 ~~~~~~C~~ 267 (686)
.+...|.+
T Consensus 77 -~~~~~C~~ 84 (317)
T 3h5c_B 77 -EDHKQCVP 84 (317)
T ss_dssp -TTSSCCEE
T ss_pred -cccccccc
Confidence 33444543
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=98.80 E-value=2e-09 Score=115.53 Aligned_cols=78 Identities=31% Similarity=0.733 Sum_probs=62.2
Q ss_pred ccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCC
Q 038345 183 ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDG 262 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~ 262 (686)
+|..+ .|...+.|.++.++|.|.|++||++. ....|+|+|||..+ .+|.+.|.|+.|+|.|.|++||.++ .++
T Consensus 2 eC~~~-~~~c~~~C~~~~~~y~C~C~~G~~~~--~~~~C~dideC~~~--~~C~~~C~n~~g~~~C~C~~g~~~~--~~~ 74 (400)
T 3p5b_L 2 ECLDN-NGGCSHVCNDLKIGYECLCPDGFQLV--AQRRCEDIDECQDP--DTCSQLCVNLEGGYKCQCEEGFQLD--PHT 74 (400)
T ss_dssp CTTTT-GGGCSSEEEECSSSEEEECCTTEEEC--SSSCEEECCCCSTT--SSCSSCCBCCSSSCBCCCCTTCCCC--TTT
T ss_pred cccCC-CCCCCCEeECCCCCeEEECCCCCCcC--CCCcccCchhhhcc--CCCCCccCCCccceeeecccccccc--ccc
Confidence 45443 23335689999999999999999972 34689999999853 6899999999999999999999876 455
Q ss_pred CCccC
Q 038345 263 GGCIP 267 (686)
Q Consensus 263 ~~C~~ 267 (686)
..|..
T Consensus 75 ~~C~~ 79 (400)
T 3p5b_L 75 KACKA 79 (400)
T ss_dssp SSCCC
T ss_pred cceee
Confidence 66754
|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
Probab=98.76 E-value=2.1e-09 Score=97.22 Aligned_cols=83 Identities=23% Similarity=0.634 Sum_probs=63.7
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC-CCcccC--CCCCccccccccCCc-ceEEeCCC
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD-VNEFED--PSLNNCTHICDNTAG-NYTCRCPK 252 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~-~~~c~~--~~~~~c~~~C~~~~g-~~~C~C~~ 252 (686)
.|.+.++|..+ .|.+++.|++..++|+|.|++||+| ..|++ +++|.. .....|.++|.++.| +|.|.|++
T Consensus 43 ~c~did~C~~~-pC~n~g~C~~~~g~y~C~C~~G~~G-----~~C~~~~~~c~~c~~~~~~C~~~C~~~~g~~y~C~C~~ 116 (142)
T 2c4f_L 43 SYSDGDQCASS-PCQNGGSCKDQLQSYICFCLPAFEG-----RNCETHKDDQLICVNENGGCEQYCSDHTGTKRSCRCHE 116 (142)
T ss_dssp HHTTCCGGGGC-CCCTTCEEEEETTEEEEECCTTEES-----TTSCEEGGGCCSTTTGGGGCSSEEECCTTSCCEEECCT
T ss_pred cCCccCcCcCC-CcCCCCEEeCCCCCEEeeCCCCccC-----CccccCccccccccCCCCCccCEeECCCCCCEEEECCC
Confidence 35567788754 8998899999899999999999998 45986 677521 134568889999999 99999999
Q ss_pred CccCCCCCCCCCccC
Q 038345 253 GFRGDGRRDGGGCIP 267 (686)
Q Consensus 253 g~~~~~~~~~~~C~~ 267 (686)
||.+. .++..|..
T Consensus 117 Gy~l~--~dG~~C~~ 129 (142)
T 2c4f_L 117 GYSLL--ADGVSCTP 129 (142)
T ss_dssp TEEEC--TTSSCEEE
T ss_pred CceEC--CCCCCCCC
Confidence 99854 23445543
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=2e-08 Score=90.06 Aligned_cols=81 Identities=27% Similarity=0.724 Sum_probs=63.6
Q ss_pred cccccccCCC-CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc-CCCcccCCCCCccc--cccccCCcceEEeCCCC
Q 038345 178 CEEAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKG 253 (686)
Q Consensus 178 c~~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g 253 (686)
|.++++|... ..|.+++.|++..++|+|.|++||+|+ .|+ ++++|.. .+|. ++|.++.|+|.|.|++|
T Consensus 2 c~dideC~~~~~~C~~~g~C~~~~g~~~C~C~~Gy~G~-----~C~~~~~~C~~---~~C~~~~~C~~~~g~~~C~C~~G 73 (135)
T 2vj3_A 2 AQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGP-----RCEIDVNECVS---NPCQNDATCLDQIGEFQCICMPG 73 (135)
T ss_dssp -CCCCTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST-----TSCEECCTTTT---CCCCSSCEEEECSSCEEEECCTT
T ss_pred CcccccccCCCCCCCCCCEeECCCCCEEEECCCCCcCC-----cccccCccCCC---CCCCCCCEEeCCCCCceeeCCCC
Confidence 5678888753 389988999988899999999999984 584 8999974 4674 68999999999999999
Q ss_pred ccCCCCC-CCCCcc
Q 038345 254 FRGDGRR-DGGGCI 266 (686)
Q Consensus 254 ~~~~~~~-~~~~C~ 266 (686)
|.+.... +...|.
T Consensus 74 ~~G~~C~~~~~~C~ 87 (135)
T 2vj3_A 74 YEGVHCEVNTDECA 87 (135)
T ss_dssp EESSSSCEECCTTT
T ss_pred CcCCcceecCCccc
Confidence 9876442 333443
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.66 E-value=3.7e-09 Score=112.97 Aligned_cols=81 Identities=26% Similarity=0.641 Sum_probs=22.4
Q ss_pred ccccCCCC-CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccCCCC
Q 038345 181 AKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 181 ~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
.++|..+. .|. ..|.+..++|+|.|++||+.++. ...|+|+|||.. ..+|.+.|.|+.|+|.|.|++||...
T Consensus 3 ~~~C~~~~~~c~--~~C~~~~g~~~C~C~~G~~l~~~-~~~C~d~~eC~~--~~~C~~~C~~~~g~~~C~C~~g~~l~-- 75 (386)
T 3v65_B 3 EENCNVNNGGCA--QKCQMIRGAVQCTCHTGYRLTED-GRTCQDVNECAE--EGYCSQGCTNSEGAFQCWCEAGYELR-- 75 (386)
T ss_dssp ------------------------------------------------------CCTTEEC-----CCEECCTTEEEC--
T ss_pred cCcccCCCCCCC--CCCcCCCCCcEeECCCCceECCC-CCccCccceeCC--cCcccCcCCCCCCCCeEEECCCceEc--
Confidence 45665542 564 47877788899999999997764 468999999973 46899999999999999999999864
Q ss_pred CCCCCccCC
Q 038345 260 RDGGGCIPN 268 (686)
Q Consensus 260 ~~~~~C~~~ 268 (686)
.++..|...
T Consensus 76 ~d~~~C~~~ 84 (386)
T 3v65_B 76 PDRRSCKAL 84 (386)
T ss_dssp TTSSCEEEC
T ss_pred CCCCeECCc
Confidence 455667543
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=2.2e-08 Score=111.05 Aligned_cols=82 Identities=30% Similarity=0.700 Sum_probs=68.4
Q ss_pred CccccccccCCCC-CCCCCC---CCccCCCCceec-CCCCcccCCCC----------CCCCcCCCcccCCCCCccc--cc
Q 038345 176 ETCEEAKICGPNA-SCDKSK---DNTTTSSGYHCK-CNKGYEGNPYL----------SDGCRDVNEFEDPSLNNCT--HI 238 (686)
Q Consensus 176 ~~c~~~~~c~~~~-~C~~~~---~c~~~~~~y~C~-C~~Gy~gnpy~----------~~gC~~~~~c~~~~~~~c~--~~ 238 (686)
..|+++++|.... .|.+++ .|.++.++|+|. |++||+|+.+. ...|++++||.. ...+|. ++
T Consensus 39 ~~CeDiDEC~~~p~~C~~gg~~~~CvNt~gsY~C~~C~~Gy~G~~c~g~g~~~~~~dg~~C~dideC~~-~~~pC~~~~~ 117 (634)
T 1yo8_A 39 THCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGNQPVGVGLEAAKTEKQVCEPENPCKD-KTHNCHKHAE 117 (634)
T ss_dssp SSCCBCCTTTTSCCCSCCCSSSCCEEECSSSEEECCCCTTEEECCCEESSSHHHHSCCCCEEECCTTTT-TCCCCCTTEE
T ss_pred CCccccccccCCCCcccCCccccceeeccCceecccCCCCcccCccccccccccccCCCcccccccccC-CCcccccCcc
Confidence 4688889997653 499887 899999999999 99999998753 345999999985 246896 69
Q ss_pred cccCC----cceEEeCCCCccCCC
Q 038345 239 CDNTA----GNYTCRCPKGFRGDG 258 (686)
Q Consensus 239 C~~~~----g~~~C~C~~g~~~~~ 258 (686)
|+++. |+|.|.|++||.+++
T Consensus 118 Cvnt~~~~~GsY~C~C~~Gy~GdG 141 (634)
T 1yo8_A 118 CIYLGHFSDPMYKCECQTGYAGDG 141 (634)
T ss_dssp EEECCTTCSSSEEEEECTTEEESS
T ss_pred ccccccccccceeeeccCCccccC
Confidence 99999 999999999998853
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
Probab=98.59 E-value=7.4e-09 Score=90.37 Aligned_cols=62 Identities=26% Similarity=0.622 Sum_probs=52.3
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.|. +.|.+ .++|+|.|++||++++ ...|+|+|||... .+|.++|+|+.|+|.|.|++||.++
T Consensus 50 ~C~--~~C~~-~~~y~C~C~~Gy~~~~--g~~C~dideC~~~--~~C~~~C~n~~g~y~C~C~~G~~g~ 111 (118)
T 1dx5_I 50 ACP--ADCDP-NTQASCECPEGYILDD--GFICTDIDECENG--GFCSGVCHNLPGTFECICGPDSALA 111 (118)
T ss_dssp EEE--CEECT-TSTTCEECCTTEEEET--TTEEEECCHHHHC--SSCSSEEEECSSSEEEEECSSSSCE
T ss_pred CCC--CcccC-CCCeEeECCCCccCCC--CCccccccccCCC--CCCcCeEEeCCCCEEEECCCCCccC
Confidence 454 56766 4889999999999765 4689999999862 6788899999999999999999875
|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.59 E-value=1e-08 Score=93.46 Aligned_cols=38 Identities=37% Similarity=0.859 Sum_probs=31.0
Q ss_pred CCCcCCCcccCCCCCccc-cccccCCcceEEeCCCCccCC
Q 038345 219 DGCRDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 219 ~gC~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~ 257 (686)
..|+|||||.. ....|. ++|+|+.|+|+|.|++||.++
T Consensus 102 ~~C~dideC~~-~~~~C~~g~C~n~~g~y~C~C~~Gy~g~ 140 (147)
T 2w86_A 102 TQCEDIDECEV-FPGVCKNGLCVNTRGSFKCQCPSGMTLD 140 (147)
T ss_dssp TEEEECCHHHH-STTCSSSSEEEEETTEEEEECCTTCCBC
T ss_pred CccCccccccC-CCCCCCCCEEECCCCCEEeeCCCCCccC
Confidence 45778899974 234586 599999999999999999987
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.56 E-value=4.7e-08 Score=88.62 Aligned_cols=72 Identities=38% Similarity=0.864 Sum_probs=59.5
Q ss_pred ccccccccCCCCCCCCCCCCc-------cCCCCceecCCCCcccCCCCCCCCc-CCCcccCCCCCccc--cccccCCcce
Q 038345 177 TCEEAKICGPNASCDKSKDNT-------TTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCT--HICDNTAGNY 246 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~-------~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~--~~C~~~~g~~ 246 (686)
.|.+.++|... .|.+++.|. +..++|+|.|++||.| ..|+ ++++|.. .+|. ++|.++.|+|
T Consensus 48 ~c~~~~~C~~~-~C~~~g~C~~~~~~~~~~~~~~~C~C~~G~~G-----~~C~~~i~~C~~---~~C~~~~~C~~~~g~~ 118 (143)
T 4d90_A 48 EPTSAGPCTPN-PCHNGGTCEISEAYRGDTFIGYVCKCPRGFNG-----IHCQHNINECEV---EPCKNGGICTDLVANY 118 (143)
T ss_dssp SCCCCCTTSSC-CCCTTCEEEECCCEETTEECCEEEECCTTEES-----TTSCEECCTTTT---CCSCTTCEEEEETTEE
T ss_pred ccccCCcCCCC-CCCCCCEecCCCccccCCCCCeEeECcCCCcC-----CCcccCCCcCCC---CCCCCCCEeECCCCCe
Confidence 45556777654 798888888 5668999999999987 5697 9999974 4674 6999999999
Q ss_pred EEeCCCCccCC
Q 038345 247 TCRCPKGFRGD 257 (686)
Q Consensus 247 ~C~C~~g~~~~ 257 (686)
.|.|++||.++
T Consensus 119 ~C~C~~G~~G~ 129 (143)
T 4d90_A 119 SCECPGEFMGR 129 (143)
T ss_dssp EEECCTTCBST
T ss_pred EeECCCCCccC
Confidence 99999999987
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=5.7e-08 Score=107.69 Aligned_cols=73 Identities=29% Similarity=0.658 Sum_probs=59.4
Q ss_pred ccccCCCCCCCCCCCCccCCCC-cee-cCCCCcccCCCCCCCCcCCCcccCCCCCcccc-----ccccCCcceEEe-CCC
Q 038345 181 AKICGPNASCDKSKDNTTTSSG-YHC-KCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTH-----ICDNTAGNYTCR-CPK 252 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~-y~C-~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~-----~C~~~~g~~~C~-C~~ 252 (686)
+++|..+ +|.+++.|+++.++ |+| .|++||+|+. ..|++++||.. ....|.. +|+|+.++|.|. |++
T Consensus 3 IDeC~~n-PC~~gg~C~n~~~Gsy~C~~C~~GytGdg---~~CeDiDEC~~-~p~~C~~gg~~~~CvNt~gsY~C~~C~~ 77 (634)
T 1yo8_A 3 PDGCLSN-PCFPGAQCSSFPDGSWSCGFCPVGFLGNG---THCEDLDECAL-VPDICFSTSKVPRCVNTQPGFHCLPCPP 77 (634)
T ss_dssp -CGGGGC-CSCTTCCEEECTTSCEEECCCCTTBCSCS---SSCCBCCTTTT-SCCCSCCCSSSCCEEECSSSEEECCCCT
T ss_pred ccccCCC-CCCCCCEEecCCCCCeECCcCCCccCCCC---CCccccccccC-CCCcccCCccccceeeccCceecccCCC
Confidence 4667544 89988999987755 999 9999999975 46999999975 3344864 899999999999 999
Q ss_pred CccCCC
Q 038345 253 GFRGDG 258 (686)
Q Consensus 253 g~~~~~ 258 (686)
||.++.
T Consensus 78 Gy~G~~ 83 (634)
T 1yo8_A 78 RYRGNQ 83 (634)
T ss_dssp TEEECC
T ss_pred CcccCc
Confidence 998775
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=8.4e-08 Score=85.93 Aligned_cols=79 Identities=25% Similarity=0.645 Sum_probs=60.8
Q ss_pred cccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc-CCCcccCCCCCccc--cccccCCcceEEeCCCCccC
Q 038345 180 EAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRG 256 (686)
Q Consensus 180 ~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~ 256 (686)
+.++|... .|.+++.|++..++|+|.|++||+| ..|+ ++++|.. .+|. ++|.++.|+|.|.|++||.+
T Consensus 44 ~~~~C~~~-~C~~~~~C~~~~g~~~C~C~~G~~G-----~~C~~~~~~C~~---~~C~~~g~C~~~~g~~~C~C~~G~~G 114 (135)
T 2vj3_A 44 DVNECVSN-PCQNDATCLDQIGEFQCICMPGYEG-----VHCEVNTDECAS---SPCLHNGRCLDKINEFQCECPTGFTG 114 (135)
T ss_dssp ECCTTTTC-CCCSSCEEEECSSCEEEECCTTEES-----SSSCEECCTTTT---CCSTTTCEEEECSSCEEEECCTTEES
T ss_pred cCccCCCC-CCCCCCEEeCCCCCceeeCCCCCcC-----CcceecCCcccC---CCcCCCCEeECCCCCeEEECCCCCcC
Confidence 45667654 7988889998889999999999998 4585 7899974 4675 69999999999999999998
Q ss_pred CCCC-CCCCccC
Q 038345 257 DGRR-DGGGCIP 267 (686)
Q Consensus 257 ~~~~-~~~~C~~ 267 (686)
.... +...|..
T Consensus 115 ~~C~~~i~~C~~ 126 (135)
T 2vj3_A 115 HLCQVDLHHILD 126 (135)
T ss_dssp SSSCEECC----
T ss_pred CccCccCccccC
Confidence 7442 4445543
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=98.44 E-value=6e-08 Score=87.87 Aligned_cols=66 Identities=29% Similarity=0.658 Sum_probs=52.3
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCC----CCCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYL----SDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~----~~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.|.+++.|++ .|+|.|++||+|++++ ...|+++|||......+|. ++|+|+.|+|.|.|++||.++
T Consensus 8 ~C~~~~~C~~---~~~C~C~~G~~g~~~~~~~~~~~C~dideC~~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~g~ 79 (143)
T 2bou_A 8 WCPQDSSCVN---ATACRCNPGFSSFSEIITTPMETCDDINECATLSKVSCGKFSDCWNTEGSYDCVCSPGYEPV 79 (143)
T ss_dssp TCCTTEEESS---SSCEEECTTEECSSSSBCSTTCCCEECCGGGC----CCCTTEEEEECSSCEEEEECTTEEET
T ss_pred cCCCCCEEcC---CCEEeCCCCCcCccccccCCCCcCCccccccCCCCCCCCCCCEEEcCCCCeEeECCCCcccC
Confidence 5777777776 3999999999997532 3689999999874445786 699999999999999999876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.6e-06 Score=89.21 Aligned_cols=135 Identities=15% Similarity=0.144 Sum_probs=95.4
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCC---CeeeEEeEEe-eCCcceEEEEeccC
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHR---NIVKLLGCCL-ETEVPLLVYEFVPN 429 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lV~e~~~~ 429 (686)
.+.++.|....||+. +..+++|... .......+.+|+.+|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5667888743 233456789999999999753 3667777764 44567899999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA------------------------------------------ 467 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~------------------------------------------ 467 (686)
.+|.+.... .++......++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763221 134455555666666666666542
Q ss_pred ---------------CCCCeEeeCCCCCCeeecC---CCc-EEEEecCCcc
Q 038345 468 ---------------ASISIYRRDIKSANILLDD---KYR-AKVSDFGTSR 499 (686)
Q Consensus 468 ---------------~~~~ivH~Dikp~NIll~~---~~~-~kl~DfGla~ 499 (686)
....++|+|+++.|||++. ++. ..|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2235799999999999987 345 5899999875
|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
Probab=98.37 E-value=3.1e-07 Score=105.52 Aligned_cols=68 Identities=31% Similarity=0.812 Sum_probs=57.0
Q ss_pred CCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 194 KDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 194 ~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
+.|.++.++|+|.|++||++. ....|+++|||..+ .+|.+.|.|+.|+|.|.|++||.++ .++..|..
T Consensus 306 ~~C~~~~~~~~C~C~~G~~~~--~~~~C~dideC~~~--~~C~~~C~n~~g~y~C~C~~G~~~~--~~~~~C~~ 373 (699)
T 1n7d_A 306 HVCNDLKIGYECLCPDGFQLV--AQRRCEDIDECQDP--DTCSQLCVNLEGGYKCQCEEGFQLD--PHTKACKA 373 (699)
T ss_dssp TTCCCCTTCCCCCCCSSSCCC--SSSCCCCCCCCSSS--SSCTTTCCBCSSCBCCCCCSSCBCC--SSCCCCBC
T ss_pred CCcccCCCCcEEeCCCCeEcC--CCCcccCccccCCC--CccccccccCCCCeeeeeecccccC--CCCCcccc
Confidence 478888999999999999972 34689999999743 6799999999999999999999876 44555654
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
Probab=98.34 E-value=4.6e-08 Score=92.95 Aligned_cols=72 Identities=26% Similarity=0.624 Sum_probs=60.4
Q ss_pred ccccCCCCCCCCCCCCc----cCCCCceecCCCCcccCCCCCCCCcCC--CcccCCCCCcc---ccccccCCcceEEeCC
Q 038345 181 AKICGPNASCDKSKDNT----TTSSGYHCKCNKGYEGNPYLSDGCRDV--NEFEDPSLNNC---THICDNTAGNYTCRCP 251 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~----~~~~~y~C~C~~Gy~gnpy~~~gC~~~--~~c~~~~~~~c---~~~C~~~~g~~~C~C~ 251 (686)
.++|... .|.+++.|. +..++|+|.|++||+|++.....|+++ ++|.. +| .++|+|+.|+|.|.|+
T Consensus 91 ~d~C~~~-~C~~~g~C~~~~~~~~g~~~C~C~~Gy~g~~~~~~~C~~~~~~~C~~----~C~~~~~~C~n~~g~y~C~C~ 165 (186)
T 1z1y_A 91 LDVCQYX-NCGESGECIVEYLSEIQSAGCSCAIGXVPNPEDEXXCTXTGETACQL----XCNTDNEVCXNVEGVYXCQCM 165 (186)
T ss_dssp EGGGTTC-CCCTTEEEEEEEETTEEEEEEEECTEEEEETTTTTEEEEEECCCCCC----CCCTTTEEEEEETTEEEEEEC
T ss_pred CCcCcCC-CCCCCCEEeeCCcCCCCCceEECCCCCcccCCCCCcceEcCCCcccc----cccccCcceecCCCCeeeECC
Confidence 5667655 688888887 777899999999999977656789876 78973 68 4699999999999999
Q ss_pred CCccCC
Q 038345 252 KGFRGD 257 (686)
Q Consensus 252 ~g~~~~ 257 (686)
+||.++
T Consensus 166 ~G~~g~ 171 (186)
T 1z1y_A 166 EGFTFD 171 (186)
T ss_dssp TTCEEE
T ss_pred CCCccC
Confidence 999886
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.6e-06 Score=84.78 Aligned_cols=133 Identities=17% Similarity=0.167 Sum_probs=95.1
Q ss_pred cCccceE-EEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcceEEEEeccCCchh
Q 038345 357 LGQGGQG-TVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVPLLVYEFVPNGTLY 433 (686)
Q Consensus 357 lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 433 (686)
+..|..+ .||+.... ++..+++|.... .....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 3334443 68987754 466788897543 34467888999999884 334778899999999999999999998887
Q ss_pred hhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 038345 434 QNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA--------------------------------------------- 468 (686)
Q Consensus 434 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--------------------------------------------- 468 (686)
+...... .....++.++++.|+-||+..
T Consensus 109 ~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 6543221 123345566666666666421
Q ss_pred ----------CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 469 ----------SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 469 ----------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+.++|+|+.+.|||++++..+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1247999999999999988777899999874
|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.27 E-value=2.9e-07 Score=106.53 Aligned_cols=68 Identities=29% Similarity=0.769 Sum_probs=56.7
Q ss_pred CCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 194 KDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 194 ~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
+.|.++.+||.|.|++||++ +....|+|+|||.. ...|.+.|.|+.|+|.|.|++||..+ .++..|..
T Consensus 324 ~~C~~~~~~y~C~C~~Gy~l--~~g~~C~dideC~~--~~~C~~~C~n~~gsy~C~C~~Gy~l~--~~~~~C~~ 391 (791)
T 3m0c_C 324 HVCNDLKIGYECLCPDGFQL--VAQRRCEDIDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLD--PHTKACKA 391 (791)
T ss_dssp SEEEECSBSEEEECCTTCEE--ETTTEEECCCCCSS--SSSCTTTCCBCSSCBCCCCCSSEECC--SSCCCCEE
T ss_pred ccccCCCCCcccCCCCCCcc--CCCCccccCcccCC--CCCCCCeeecCCCCceeecCCCCEeC--CCCceeee
Confidence 36888889999999999986 23468999999984 36899999999999999999999875 45556754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=2.4e-06 Score=89.88 Aligned_cols=81 Identities=4% Similarity=-0.005 Sum_probs=57.1
Q ss_pred cccc-CccceEEEEEEEeC-------CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCC---CCeeeEEeEEeeC--
Q 038345 354 NRIL-GQGGQGTVYKGMLA-------DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINH---RNIVKLLGCCLET-- 417 (686)
Q Consensus 354 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~-- 417 (686)
.+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+.. -.+.+++++..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988754 26678888754322 0012457789999888853 3577888887665
Q ss_pred -CcceEEEEeccCCchhh
Q 038345 418 -EVPLLVYEFVPNGTLYQ 434 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~ 434 (686)
...++|||+++|.++.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35789999999877654
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
Probab=98.23 E-value=1.5e-07 Score=89.45 Aligned_cols=68 Identities=22% Similarity=0.548 Sum_probs=56.3
Q ss_pred CCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCC-CCccc--cccccCC-----cceEEeCCCCccCC
Q 038345 187 NASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPS-LNNCT--HICDNTA-----GNYTCRCPKGFRGD 257 (686)
Q Consensus 187 ~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~-~~~c~--~~C~~~~-----g~~~C~C~~g~~~~ 257 (686)
..+|.++ .|++..++|+|.|++||+|+. ...|+++|+|.... ..+|. ++|+++. |+|.|.|++||.++
T Consensus 10 ~~pC~ng-~C~~~~g~~~C~C~~G~~g~~--~~~C~~id~C~~~~~~~~C~~~~~C~~~~~~~~~g~y~C~C~~G~~g~ 85 (186)
T 1z1y_A 10 DTICXNG-QLVQMSNHFXCMCNEGLVHLS--ENTCEEXNECXXETLGXACGEFGQCIENPDPAQVNMYXCGCIEGYTLX 85 (186)
T ss_dssp TCCCBTE-EEEECSSCEEEEECTTEEEEE--TTEEEECCCCSGGGTTSEEETTEEEEECSSTTSSCSEEEEECTTEEEE
T ss_pred CCCCCCC-EeECCCCCeEeECCCCCccCC--CCccCCCCcccCCCCCCCCCCCCEeecCCCCcCCCCEECCCCCCCccC
Confidence 3478854 899888999999999999863 24799999998421 46786 6999999 89999999999876
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.1e-06 Score=79.38 Aligned_cols=80 Identities=25% Similarity=0.647 Sum_probs=54.7
Q ss_pred ccCCCCCCCCCCCCccCC--CCceecCCCCcccCCCC--------CCCCcCCCcccCCCCCccc--cccc-------cCC
Q 038345 183 ICGPNASCDKSKDNTTTS--SGYHCKCNKGYEGNPYL--------SDGCRDVNEFEDPSLNNCT--HICD-------NTA 243 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~--~~y~C~C~~Gy~gnpy~--------~~gC~~~~~c~~~~~~~c~--~~C~-------~~~ 243 (686)
+|..+ +|.+++.|++.. ++|+|.|++||+|..-. ...|.++++|.. .+|. ++|. ++.
T Consensus 2 ~C~~~-pC~~~g~C~~~~~~g~~~C~C~~G~~G~~C~~~~~~~~~~~~c~~~~~C~~---~~C~~~g~C~~~~~~~~~~~ 77 (143)
T 4d90_A 2 ICDPN-PCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTP---NPCHNGGTCEISEAYRGDTF 77 (143)
T ss_dssp -CCSC-CCGGGCEEEC-----CCEEECCTTCCTTTTCSCCCCTTTTTSCCCCCTTSS---CCCCTTCEEEECCCEETTEE
T ss_pred cCCCC-cCCCCCEeeCCCCCCCEEeECCCCCCCCCCccCccccccccccccCCcCCC---CCCCCCCEecCCCccccCCC
Confidence 45444 788888888644 68999999999985311 123445666753 4574 5898 788
Q ss_pred cceEEeCCCCccCCCCC-CCCCcc
Q 038345 244 GNYTCRCPKGFRGDGRR-DGGGCI 266 (686)
Q Consensus 244 g~~~C~C~~g~~~~~~~-~~~~C~ 266 (686)
++|.|.|++||.+.... +...|.
T Consensus 78 ~~~~C~C~~G~~G~~C~~~i~~C~ 101 (143)
T 4d90_A 78 IGYVCKCPRGFNGIHCQHNINECE 101 (143)
T ss_dssp CCEEEECCTTEESTTSCEECCTTT
T ss_pred CCeEeECcCCCcCCCcccCCCcCC
Confidence 99999999999887554 555564
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
Probab=98.16 E-value=3.8e-07 Score=84.40 Aligned_cols=63 Identities=32% Similarity=0.683 Sum_probs=50.0
Q ss_pred CCCCceecCCC--CcccCCCCCCCCcCCCcccCCCCCccc-cccccCCcceEEeCCCCccCCCCCCCCCc
Q 038345 199 TSSGYHCKCNK--GYEGNPYLSDGCRDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 199 ~~~~y~C~C~~--Gy~gnpy~~~gC~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
..++|+|.|+. ||+|++. ...|+|||||.. ...+|. ++|+|+.|+|+|.|++||.++ .++..|
T Consensus 96 ~~~~y~C~C~~g~G~~~~~~-~~~c~dideC~~-~~~~C~~g~C~n~~gsy~C~C~~Gy~g~--~d~~~C 161 (162)
T 1uzk_A 96 NTSEYKILCPGGEGFRPNPI-TVILEDIDECQE-LPGLCQGGKCINTFGSFQCRCPTGYYLN--EDTRVC 161 (162)
T ss_dssp TSHHHHHHCTTCTTEEECTT-TCCEEECCHHHH-CGGGGBTSEEEECSSCEEEECCTTCCBC--TTTCBB
T ss_pred CCCCceeECCCCCCcccCCC-CCccCccccccC-CCCCcCCCEeEcCCCCEEeeCCCCccCC--CCCCcc
Confidence 45689999988 9998874 356899999975 235686 599999999999999999986 444444
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
Probab=98.13 E-value=1.9e-07 Score=81.33 Aligned_cols=68 Identities=24% Similarity=0.578 Sum_probs=51.3
Q ss_pred cccccCCCCCCCCCCCCccC-CCCceecCCCCcccCCCCCCCCcCCCcccCC-CCCccccccccCCcceEEeCCCCccCC
Q 038345 180 EAKICGPNASCDKSKDNTTT-SSGYHCKCNKGYEGNPYLSDGCRDVNEFEDP-SLNNCTHICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 180 ~~~~c~~~~~C~~~~~c~~~-~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~-~~~~c~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
++++|.. .+|.+ .|++. .++|+|.|++||+|++. ++++|..+ ...+|.+.|.+ .++|.|.|++||.++
T Consensus 3 dideC~~-~pC~~--~C~~~~~g~y~C~C~~Gy~g~~~------~~~~C~~~C~~~~C~~~C~~-~~~y~C~C~~Gy~~~ 72 (118)
T 1dx5_I 3 PVDPCFR-ANCEY--QCQPLDQTSYLCVCAEGFAPIPH------EPHRCQMFCNQTACPADCDP-NTQASCECPEGYILD 72 (118)
T ss_dssp CCCGGGG-CCCSS--EEEECSSSCEEEECCTTEEEETT------EEEEEEECCCSSEEECEECT-TSTTCEECCTTEEEE
T ss_pred ccccCCC-CCCCC--CCCCCCCCCEEeECCCCccccCC------CCCccccccCCCCCCCcccC-CCCeEeECCCCccCC
Confidence 3566643 37863 89888 89999999999999752 45555432 23678899999 599999999999854
|
| >1uzk_A Fibrillin-1; glycoprotein, extra-cellular matrix, calcium, TB domain, disease mutation, extracellular matrix, polymorphism, cbegf domain; 1.35A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.23.1.1 PDB: 1uzj_A 1uzp_A 1uzq_A | Back alignment and structure |
|---|
Probab=98.12 E-value=2.6e-07 Score=85.56 Aligned_cols=73 Identities=26% Similarity=0.532 Sum_probs=54.4
Q ss_pred cccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCc--ccCCCCCcc----ccccccCCc----ceEEe
Q 038345 180 EAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNE--FEDPSLNNC----THICDNTAG----NYTCR 249 (686)
Q Consensus 180 ~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~--c~~~~~~~c----~~~C~~~~g----~~~C~ 249 (686)
++++|.....|. ++.|+++.++|+|.|++||++++ ....|+++++ |... ..+| .++|.++.+ +|.|.
T Consensus 2 dideC~~~~~C~-~~~C~n~~gsy~C~C~~Gy~~~~-~g~~C~d~~~~~C~~~-~~~c~~~~~~~C~~~~~~~~~~~~C~ 78 (162)
T 1uzk_A 2 DVNECLDPTTCI-SGNCVNTPGSYICDCPPDFELNP-TRVGCVDTRSGNCYLD-IRPRGDNGDTACSNEIGVGVSKASCC 78 (162)
T ss_dssp CCCGGGSTTSSB-TSEEEEETTEEEEECCTTCEECT-TSSBEECCCCEEEEEE-C----------CEEEEEEEECHHHHH
T ss_pred ccccCCCCCCCC-CCEeECCCCCEEEeCCCCCeECC-CCCcccCCCCCcccCC-CcccCCCCCCcccCCcCCcccCceee
Confidence 456776444786 68999999999999999999876 3467999987 8642 2233 568999988 89999
Q ss_pred CCCCcc
Q 038345 250 CPKGFR 255 (686)
Q Consensus 250 C~~g~~ 255 (686)
|++||.
T Consensus 79 C~~G~~ 84 (162)
T 1uzk_A 79 CSLGKA 84 (162)
T ss_dssp TTTCCE
T ss_pred CCCCCC
Confidence 999997
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=97.97 E-value=3.2e-06 Score=61.93 Aligned_cols=43 Identities=33% Similarity=0.767 Sum_probs=34.1
Q ss_pred cCCCcccCCC-------CCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 222 RDVNEFEDPS-------LNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 222 ~~~~~c~~~~-------~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
+|||||.... ..+|.+.|.|++|+|.|.|++||.+. .++..|.
T Consensus 2 ~DidEC~~~~~~~~~~~~~~C~~~C~n~~Gsy~C~C~~Gy~~~--~d~~~C~ 51 (53)
T 1apq_A 2 VDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQ--EDRHSCQ 51 (53)
T ss_dssp CSCCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTCEEC--TTSSCEE
T ss_pred CccccccCcccccccccCCCCCCEeECCCCCeEEECCCCCeEC--CCCCccC
Confidence 5789997632 36899999999999999999999875 3445554
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=3.2e-05 Score=82.55 Aligned_cols=75 Identities=15% Similarity=0.156 Sum_probs=50.4
Q ss_pred ccccCccceEEEEEEEeC-CCcEEEEEEccccCh-------hhHHHHHHHHHHHHhcCC--C-CeeeEEeEEeeCCcceE
Q 038345 354 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE-------NNVEQFINEVVILSQINH--R-NIVKLLGCCLETEVPLL 422 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~l 422 (686)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. + .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899997542111 123456789999988743 3 34456644 4456789
Q ss_pred EEEeccCC
Q 038345 423 VYEFVPNG 430 (686)
Q Consensus 423 V~e~~~~g 430 (686)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=4.9e-05 Score=79.01 Aligned_cols=140 Identities=15% Similarity=0.156 Sum_probs=80.6
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC--CCeeeEEe------EEeeCCcceEEEEe
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH--RNIVKLLG------CCLETEVPLLVYEF 426 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g------~~~~~~~~~lV~e~ 426 (686)
+.|+.|..+.||+....++ .+++|+... .. ..+..|+.+++.|.. -.+++++. +....+..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566667889999887655 588888764 22 334455566655532 12344443 11245667899999
Q ss_pred ccCCchh--------------hhhhccCCC-----------CCCCHHHH-------------------------------
Q 038345 427 VPNGTLY--------------QNIHNHIEE-----------FPITWELL------------------------------- 450 (686)
Q Consensus 427 ~~~gsL~--------------~~l~~~~~~-----------~~l~~~~~------------------------------- 450 (686)
++|..+. ..||..... ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 122221110 01123221
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 451 LRIAVEVSGALFYLHS----------AASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 451 ~~i~~qi~~~L~yLH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
..+..++..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224446667763 124589999999999999878889999999874
|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
Probab=97.86 E-value=6.2e-06 Score=67.95 Aligned_cols=52 Identities=27% Similarity=0.742 Sum_probs=43.5
Q ss_pred CccCCCCceecCCCCcccCCCCCCCCc--CCCcccCCCCCccc--cccccCC--cceEEeCCCCccCC
Q 038345 196 NTTTSSGYHCKCNKGYEGNPYLSDGCR--DVNEFEDPSLNNCT--HICDNTA--GNYTCRCPKGFRGD 257 (686)
Q Consensus 196 c~~~~~~y~C~C~~Gy~gnpy~~~gC~--~~~~c~~~~~~~c~--~~C~~~~--g~~~C~C~~g~~~~ 257 (686)
|.+..++|+|.|++||+ .|+ ++++|.. .+|. ++|+++. ++|.|.|++||.+.
T Consensus 25 C~n~~~~y~C~C~~G~~-------~C~~~~~~~C~~---~pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 82 (91)
T 1tpg_A 25 VLRSNRVEYCWCNSGRA-------QCHSVPVKSCSE---PRCFNGGTCQQALYFSDFVCQCPEGFAGK 82 (91)
T ss_dssp CSSSSCEEEEECSSSCC-------BCCEECEEECSS---CCSCTTCEEEEESSSSCEEEECCTTCBSS
T ss_pred cccCCCCcEeECCCCCc-------ccccCcCCcccC---CCCCCCCEeecCCCCCCeEeECCCCCcCC
Confidence 34567899999999996 586 7899974 5785 5899988 99999999999876
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00016 Score=74.22 Aligned_cols=138 Identities=16% Similarity=0.128 Sum_probs=92.6
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC---CCCeeeEEeEEeeCCcceEEEEeccCC
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN---HRNIVKLLGCCLETEVPLLVYEFVPNG 430 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lV~e~~~~g 430 (686)
.+.|+.|....+|+... ++..+++|..... ....|..|+..|+.|. ...+++++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 4678888876532 3467889999999884 356888999888788899999999987
Q ss_pred chh-----------hhhhccCC--CC-----------------CCCHHHHH---HHHH----------------HHHHHH
Q 038345 431 TLY-----------QNIHNHIE--EF-----------------PITWELLL---RIAV----------------EVSGAL 461 (686)
Q Consensus 431 sL~-----------~~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------qi~~~L 461 (686)
.+. ..||.... .. .-+|.... ++.. ++++.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 652 12333221 00 12454332 1111 111111
Q ss_pred -HHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 462 -FYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 462 -~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2246899999999999999887 8888873
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00022 Score=72.30 Aligned_cols=79 Identities=20% Similarity=0.148 Sum_probs=58.0
Q ss_pred ccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC---CCeeeEEeEEeeCCcceEEEEe
Q 038345 350 NYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH---RNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.....+.+|.|..+.||+.++.||+.|.+|+...........|..|+..|+.|.. --++++++. +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3445678999999999999999999999998654333333467889999998842 234556654 245899999
Q ss_pred ccCCch
Q 038345 427 VPNGTL 432 (686)
Q Consensus 427 ~~~gsL 432 (686)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00048 Score=73.94 Aligned_cols=78 Identities=6% Similarity=0.003 Sum_probs=46.6
Q ss_pred CCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceeeeeee--ccccccCccccccC---CCCccccEeehHHHHH
Q 038345 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQ--GTFGYVDPEYFQSS---QFTEKSDVYSFGVVLV 543 (686)
Q Consensus 469 ~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~t~ksDv~S~Gv~l~ 543 (686)
...++|+|+++.|||++.+. ++|+||+.+..-..... ..... -...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999998876 99999998864321100 00000 11345666554311 1122344556777777
Q ss_pred HHHhCC
Q 038345 544 EILTGQ 549 (686)
Q Consensus 544 elltg~ 549 (686)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776643
|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
Probab=97.46 E-value=4.4e-05 Score=58.82 Aligned_cols=44 Identities=27% Similarity=0.626 Sum_probs=35.2
Q ss_pred CcCCCcccCCCCCccccccccCCc-ceEEeCCCCccCCCCCCCCCccC
Q 038345 221 CRDVNEFEDPSLNNCTHICDNTAG-NYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 221 C~~~~~c~~~~~~~c~~~C~~~~g-~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
..|+|||.. ....|++.|.|++| +|.|.|+.||... .++..|..
T Consensus 2 ~~d~~eC~~-~nggC~h~C~n~~g~s~~C~C~~Gy~L~--~D~~tC~d 46 (69)
T 1kli_L 2 KDDQLICVN-ENGGCEQYCSDHTGTKRSCRCHEGYSLL--ADGVSCTP 46 (69)
T ss_dssp CSCCCCTTS-GGGGCSSEEEEETTTEEEEECCTTEEEC--TTSSCEEE
T ss_pred CcccccccC-CCCCcCCEeEcCCCCCEEEeCCCCCeEC--CCCCcccC
Confidence 468999975 45789999999999 8999999999765 45556654
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=97.41 E-value=4.6e-05 Score=55.99 Aligned_cols=40 Identities=23% Similarity=0.696 Sum_probs=30.8
Q ss_pred CcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 225 NEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 225 ~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
|||.. ....|.+.|.|++|+|.|.|++||... .++..|..
T Consensus 2 dEC~~-~~~~C~~~C~nt~Gsy~C~C~~Gy~L~--~d~~~C~d 41 (55)
T 2jkh_L 2 KLCSL-DNGDCDQFCHEEQNSVVCSCARGYTLA--DNGKACIP 41 (55)
T ss_dssp CCTTT-GGGGCSSEEEEETTEEEEECCTTEEEC--TTSSCEEE
T ss_pred ccccC-CCCCcCcEeEcCCCCeEEeCCCCCEEC--CCCCeecc
Confidence 67765 356799999999999999999999754 34445543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00058 Score=70.29 Aligned_cols=157 Identities=13% Similarity=0.150 Sum_probs=86.8
Q ss_pred ChHHHHhhcccccc-----ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEe
Q 038345 340 TSKDLEKATDNYNA-----NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLG 412 (686)
Q Consensus 340 ~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g 412 (686)
+.+++......|.. .+.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34444444444543 34577788889999887655 5778876542 12234566788877774322 334432
Q ss_pred E------EeeCCcceEEEEeccCCchhh--------------hhhccCCCC------CC---CHHHHHHH----------
Q 038345 413 C------CLETEVPLLVYEFVPNGTLYQ--------------NIHNHIEEF------PI---TWELLLRI---------- 453 (686)
Q Consensus 413 ~------~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~~~------~l---~~~~~~~i---------- 453 (686)
. ....+..+++|+|++|..+.. .+|...... .. .|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 112356789999999865421 122211100 01 13221110
Q ss_pred --HHHHHHHHHHhhhc----CCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 454 --AVEVSGALFYLHSA----ASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 454 --~~qi~~~L~yLH~~----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
...+.+.++.|+.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11234455555532 23479999999999999987666899999874
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=97.35 E-value=2.2e-05 Score=58.70 Aligned_cols=46 Identities=28% Similarity=0.541 Sum_probs=36.7
Q ss_pred cccccccCCCCCCCCC--CCCccCCCCceecCCCCcc-cCCCCCCCCcCCCcccC
Q 038345 178 CEEAKICGPNASCDKS--KDNTTTSSGYHCKCNKGYE-GNPYLSDGCRDVNEFED 229 (686)
Q Consensus 178 c~~~~~c~~~~~C~~~--~~c~~~~~~y~C~C~~Gy~-gnpy~~~gC~~~~~c~~ 229 (686)
|...++|.++ +|.++ +.|.+..++|+|.|++||. | ..|++.++|..
T Consensus 8 ~~~~d~C~sn-PC~nga~gtC~~~~g~y~C~C~~Gy~~G-----~~C~~~~~C~~ 56 (61)
T 2k2s_B 8 SETPAACSSN-PCGPEAAGTCKETNSGYICRCNQGYRIS-----LDGTGNVTCIV 56 (61)
T ss_dssp TTSCCHHHHC-SSCSSSCCEEEECSSEEEEECCTTEEEE-----ECSSSCEEEEE
T ss_pred cCCCCcCcCC-CCcCCCccccccCCCceEeECCCCCccC-----CCCCCCCEecc
Confidence 4556778654 89988 7999999999999999999 8 34877777754
|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00011 Score=68.03 Aligned_cols=63 Identities=30% Similarity=0.810 Sum_probs=48.4
Q ss_pred cCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc-CCCcccCCCCCccc--cccccC-CcceEEeCCCCccCC
Q 038345 184 CGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCT--HICDNT-AGNYTCRCPKGFRGD 257 (686)
Q Consensus 184 c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~--~~C~~~-~g~~~C~C~~g~~~~ 257 (686)
|.....|.++ .|. ++|+|.|.+||+| ..|+ ++++|.. ..+|. ++|.++ .++|.|.|++||.++
T Consensus 99 C~~~~~C~~g-~C~---~~~~C~C~~G~~G-----~~C~~~~~~C~~--~~~C~~~g~C~~~~~~~~~C~C~~G~~G~ 165 (169)
T 2vj2_A 99 CIPHPGCVHG-ICN---EPWQCLCETNWGG-----QLCDKDLNYCGT--HQPCLNGGTCSNTGPDKYQCSCPEGYSGP 165 (169)
T ss_dssp ECCCTTCSSE-ECS---STTCCEECTTEET-----TTTCEESCHHHH--TCCCCTTCEEEECSTTCEEEECCTTCCST
T ss_pred CCCCCCCCCC-CcC---CCCEEeCCCCCCC-----CcccCCCCCCCC--CCCCCCCCEEcCCCCCCcEeECCCCCcCc
Confidence 4333246544 665 5799999999998 4597 8999974 25675 589997 899999999999986
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00054 Score=73.71 Aligned_cols=73 Identities=18% Similarity=0.249 Sum_probs=50.7
Q ss_pred ccccCccceEEEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEE
Q 038345 354 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVY 424 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ 424 (686)
.+.|+.|....+|+....+ +..+++|+..... ..+.+.+|+.+++.|...++ +++++.+.. .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998753 4789999874311 11456689999998854444 567776542 3899
Q ss_pred EeccCCch
Q 038345 425 EFVPNGTL 432 (686)
Q Consensus 425 e~~~~gsL 432 (686)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986554
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=97.21 E-value=6.6e-05 Score=56.09 Aligned_cols=45 Identities=27% Similarity=0.599 Sum_probs=34.3
Q ss_pred CCCcCCCcccCCCCCccc----cccccCCcceEEeCCCCcc-CCCCCCCCCcc
Q 038345 219 DGCRDVNEFEDPSLNNCT----HICDNTAGNYTCRCPKGFR-GDGRRDGGGCI 266 (686)
Q Consensus 219 ~gC~~~~~c~~~~~~~c~----~~C~~~~g~~~C~C~~g~~-~~~~~~~~~C~ 266 (686)
.-|.++|+|.. .+|. ++|.++.++|.|.|++||. +..+.+...|.
T Consensus 6 ~~~~~~d~C~s---nPC~nga~gtC~~~~g~y~C~C~~Gy~~G~~C~~~~~C~ 55 (61)
T 2k2s_B 6 QLSETPAACSS---NPCGPEAAGTCKETNSGYICRCNQGYRISLDGTGNVTCI 55 (61)
T ss_dssp -CTTSCCHHHH---CSSCSSSCCEEEECSSEEEEECCTTEEEEECSSSCEEEE
T ss_pred hhcCCCCcCcC---CCCcCCCccccccCCCceEeECCCCCccCCCCCCCCEec
Confidence 34788999974 6785 5899999999999999999 76444444453
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00014 Score=61.67 Aligned_cols=42 Identities=31% Similarity=0.706 Sum_probs=33.9
Q ss_pred cCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccC
Q 038345 213 GNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRG 256 (686)
Q Consensus 213 gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~ 256 (686)
.|.|..+.| ++|||.. ....|.++|.|+.++|.|.|++||.+
T Consensus 19 ~~~~~~~~C-d~neC~~-~~~~C~~~C~n~~g~y~C~C~~Gy~g 60 (107)
T 2w2n_E 19 ENLYFQGAM-GTNECLD-NNGGCSYVCNDLKIGYECLCPDGFQL 60 (107)
T ss_dssp -CCCCSCCB-SCCGGGT-GGGGCSSEEECCSBSCEEECCTTCEE
T ss_pred CCCcCCCCC-cCccCcC-CCCCCCCEeEeCCCCeEEECCCCccc
Confidence 344555668 7999986 33578899999999999999999987
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0013 Score=69.20 Aligned_cols=140 Identities=19% Similarity=0.238 Sum_probs=83.8
Q ss_pred cccCccceEEEEEEEeC--------CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCcceEEEE
Q 038345 355 RILGQGGQGTVYKGMLA--------DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~e 425 (686)
+.|..|-...+|+.... ++..+++|+.... ........+|..+++.|...+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777788988864 2478999986432 123456678999998885323 3567776643 29999
Q ss_pred eccCCchhhh-----------------hhccCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHhh
Q 038345 426 FVPNGTLYQN-----------------IHNHIE--EFPI--TWELLLRIAVEVSG-------------------ALFYLH 465 (686)
Q Consensus 426 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~qi~~-------------------~L~yLH 465 (686)
|++|.+|..- ||.... .... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 121100 1112 24555555544422 223332
Q ss_pred ----h-cCCCCeEeeCCCCCCeeecCC----CcEEEEecCCcc
Q 038345 466 ----S-AASISIYRRDIKSANILLDDK----YRAKVSDFGTSR 499 (686)
Q Consensus 466 ----~-~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~ 499 (686)
. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 123478999999999999876 789999999884
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0014 Score=66.67 Aligned_cols=71 Identities=13% Similarity=0.123 Sum_probs=45.1
Q ss_pred ccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEec-cCCc
Q 038345 354 NRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFV-PNGT 431 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~-~~gs 431 (686)
.+.|+.|....+|+. ..+++|........ .-...+|+.+++.+...++ .+++++ ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578888999999998 45888876532111 1123568888887753333 456654 344457999999 6655
Q ss_pred h
Q 038345 432 L 432 (686)
Q Consensus 432 L 432 (686)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00011 Score=54.05 Aligned_cols=44 Identities=20% Similarity=0.560 Sum_probs=33.0
Q ss_pred cccCCC-CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCccc
Q 038345 182 KICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 182 ~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
++|... ..|. ..|.++.++|+|.|++||+..+ ....|++++||.
T Consensus 2 dEC~~~~~~C~--~~C~nt~Gsy~C~C~~Gy~L~~-d~~~C~didec~ 46 (55)
T 2jkh_L 2 KLCSLDNGDCD--QFCHEEQNSVVCSCARGYTLAD-NGKACIPTGPYP 46 (55)
T ss_dssp CCTTTGGGGCS--SEEEEETTEEEEECCTTEEECT-TSSCEEESSSSC
T ss_pred ccccCCCCCcC--cEeEcCCCCeEEeCCCCCEECC-CCCeeccCcccc
Confidence 345432 3684 4789999999999999998654 246799999975
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.09 E-value=0.002 Score=69.69 Aligned_cols=75 Identities=15% Similarity=0.032 Sum_probs=48.7
Q ss_pred ccccCccceEEEEEEEeCC-CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEeccCCc
Q 038345 354 NRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEFVPNGT 431 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~~~~gs 431 (686)
.+.|+.|-...+|+....+ +..+++|+....... .-.-.+|+.++..|...++ +++++.+. ..+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT----NGRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET----TEEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEeeCCcc
Confidence 4568888889999998765 477888875432111 1112579999999875555 56777763 236999999765
Q ss_pred hh
Q 038345 432 LY 433 (686)
Q Consensus 432 L~ 433 (686)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0025 Score=65.89 Aligned_cols=141 Identities=13% Similarity=0.060 Sum_probs=72.7
Q ss_pred cccCccceEE-EEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCcceEEEEeccCCc
Q 038345 355 RILGQGGQGT-VYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFVPNGT 431 (686)
Q Consensus 355 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gs 431 (686)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+.. -.+.+++.+..+ .-++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 4565555444 6676654467777776443211 234456777776642 235567766332 3378999997766
Q ss_pred hhhhhhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHhhh--
Q 038345 432 LYQNIHNH---------------------IEE--FPITWELLL-------R-------------IAVEVSGALFYLHS-- 466 (686)
Q Consensus 432 L~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~qi~~~L~yLH~-- 466 (686)
+.+.+... ... ..++..... . ....+...++.|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 64433211 000 011111100 0 00111122222211
Q ss_pred -cCCCCeEeeCCCCCCeeecCC----CcEEEEecCCccc
Q 038345 467 -AASISIYRRDIKSANILLDDK----YRAKVSDFGTSRS 500 (686)
Q Consensus 467 -~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~~ 500 (686)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999874 6899999998854
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00024 Score=48.01 Aligned_cols=33 Identities=27% Similarity=0.672 Sum_probs=27.7
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCcccC
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGN 214 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gn 214 (686)
.++|..+ +|.+++.|.+..++|+|.|++||.|.
T Consensus 3 ~d~C~~~-pC~ngg~C~~~~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 3 GDQCESN-PCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCTTTTC-CCCTTCEEEEETTEEEEECCTTCCST
T ss_pred cccCCCC-CCCCCCEeEcCCCceEeECCCCCcCC
Confidence 4566654 89988999988899999999999983
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0069 Score=62.24 Aligned_cols=142 Identities=14% Similarity=0.107 Sum_probs=81.6
Q ss_pred cccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC--eeeEEeE-----EeeCCcceEEEEec
Q 038345 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN--IVKLLGC-----CLETEVPLLVYEFV 427 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lV~e~~ 427 (686)
+.|+ |....||+....+|+.+++|...... .....+..|..++..+.... +++++.. ....+..++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77789998877677789999875321 12356677888888875322 4445443 11234557899999
Q ss_pred cCCchhh--------------hhhccCC------CCCCCHHHH----HHH---------------HHHHHHHHHHhhhc-
Q 038345 428 PNGTLYQ--------------NIHNHIE------EFPITWELL----LRI---------------AVEVSGALFYLHSA- 467 (686)
Q Consensus 428 ~~gsL~~--------------~l~~~~~------~~~l~~~~~----~~i---------------~~qi~~~L~yLH~~- 467 (686)
+|..+.. .+|.... ...+++... ..+ ...+.+.++.+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865431 1221110 111222211 001 11111222333221
Q ss_pred ---CCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 468 ---ASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 468 ---~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234688999999999999 4 899999998753
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00072 Score=45.56 Aligned_cols=32 Identities=38% Similarity=0.913 Sum_probs=27.2
Q ss_pred CCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|+|+|.. .+|. ++|.++.++|.|.|++||.+.
T Consensus 2 d~d~C~~---~pC~ngg~C~~~~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 2 DGDQCES---NPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTTT---CCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred ccccCCC---CCCCCCCEeEcCCCceEeECCCCCcCC
Confidence 6788864 5785 589999999999999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0027 Score=66.72 Aligned_cols=74 Identities=12% Similarity=0.080 Sum_probs=45.0
Q ss_pred ccccCccceEEEEEEEeCC---------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCcceEE
Q 038345 354 NRILGQGGQGTVYKGMLAD---------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLV 423 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV 423 (686)
.+.|+.|..-.+|+....+ +..+++|....... .......|..+++.+...+ ..++++.. .-++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence 3467777778899988654 26888887653211 1112457888888885444 44666554 24789
Q ss_pred EEeccCCch
Q 038345 424 YEFVPNGTL 432 (686)
Q Consensus 424 ~e~~~~gsL 432 (686)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987654
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.00011 Score=72.62 Aligned_cols=46 Identities=22% Similarity=0.588 Sum_probs=36.0
Q ss_pred cccccCCC-CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCccc
Q 038345 180 EAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 180 ~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
+.++|... ..|..++.|.|+.++|.|.|++||.||. ..|.|+|+..
T Consensus 4 DiDEC~~~~~~C~~~a~C~Nt~Gsy~C~C~~Gy~GnG---~~C~d~d~Pq 50 (285)
T 1gl4_A 4 AQQTCANNRHQCSVHAECRDYATGFCCRCVANYTGNG---RQCVAEGSPQ 50 (285)
T ss_dssp ---CHHHHGGGSCTTEEEEECSSCEEEEECTTEEECS---SSEEETTCEE
T ss_pred cchhccCCCCCCCCCCEeEcCCCCeEEEcCCCCCCCC---CcCCCCCCCc
Confidence 45667543 3798888999999999999999999976 4699998854
|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00068 Score=55.53 Aligned_cols=41 Identities=12% Similarity=0.089 Sum_probs=33.2
Q ss_pred CceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCcc
Q 038345 202 GYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR 255 (686)
Q Consensus 202 ~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~ 255 (686)
+|+|.|.+||+|. .| ++++|.. ..|.|..++|.|.|++||.
T Consensus 1 sy~C~C~~g~~g~-----~c-~~~~c~~-------~pC~n~~~~y~C~C~~G~~ 41 (91)
T 1tpg_A 1 SYQVICRDEKTQM-----IY-QQHQSWL-------RPVLRSNRVEYCWCNSGRA 41 (91)
T ss_dssp CCCCCCBCSSSCC-----BC-CSSCEEE-------EECSSSSCEEEEECSSSCC
T ss_pred CeeeECCCCCcCC-----eE-CCCcccC-------CccccCCCCcEeECCCCCc
Confidence 6999999999982 35 5777642 3478899999999999996
|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.00036 Score=50.23 Aligned_cols=34 Identities=21% Similarity=0.697 Sum_probs=26.8
Q ss_pred CCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 232 LNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 232 ~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
...|.+.|.|++|+|.|.|++||... .++..|..
T Consensus 5 ng~C~~~C~n~~gs~~C~C~~Gy~L~--~d~~tC~d 38 (51)
T 1kig_L 5 NGGCDQFCREERSEVRCSCAHGYVLG--DDSKSCVS 38 (51)
T ss_dssp TTSSSSCCCEETTEECCCCCTTEEEC--TTSSCEEE
T ss_pred CCCcCCEeEcCCCCeEEeCCCCcEEC--CCCCcccc
Confidence 45788899999999999999999754 34455644
|
| >1kig_L Factor XA; glycoprotein, serine protease, plasma, blood coagulation, complex (protease/inhibitor); 3.00A {Bos taurus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=96.72 E-value=0.00055 Score=49.23 Aligned_cols=37 Identities=27% Similarity=0.543 Sum_probs=29.4
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCccc
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
.|. +.|.++.++|+|.|++||+..+ ....|+|+|||.
T Consensus 7 ~C~--~~C~n~~gs~~C~C~~Gy~L~~-d~~tC~dide~p 43 (51)
T 1kig_L 7 GCD--QFCREERSEVRCSCAHGYVLGD-DSKSCVSTERFP 43 (51)
T ss_dssp SSS--SCCCEETTEECCCCCTTEEECT-TSSCEEECSSSC
T ss_pred CcC--CEeEcCCCCeEEeCCCCcEECC-CCCccccCCccc
Confidence 574 4688889999999999998544 246799999873
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00071 Score=49.29 Aligned_cols=32 Identities=22% Similarity=0.476 Sum_probs=26.4
Q ss_pred ccccCCCCCCCCCCCC-----ccCCCCceecCCCCccc
Q 038345 181 AKICGPNASCDKSKDN-----TTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c-----~~~~~~y~C~C~~Gy~g 213 (686)
.++|.++ +|.+++.| ++...+|+|.|++||+|
T Consensus 8 ~~eC~s~-pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G 44 (55)
T 3u7u_G 8 CAEKEKT-FCVNGGECFMVKDLSNPSRYLCKCPNEFTG 44 (55)
T ss_dssp CCSTTTT-TSCTTCEEEEECCC--CCCEEEEECTTEES
T ss_pred CCCCcCC-CCCCCCCcCCCCccCCCCCEeEeCCCCCcC
Confidence 6788766 89999999 45678999999999998
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.001 Score=53.25 Aligned_cols=41 Identities=22% Similarity=0.692 Sum_probs=33.7
Q ss_pred CCccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCC
Q 038345 175 IETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPY 216 (686)
Q Consensus 175 ~~~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy 216 (686)
...|.++++|.....|.+ +.|.+..++|+|.|++||.|++.
T Consensus 38 g~~C~dideC~~~~~C~~-~~C~n~~g~y~C~C~~G~~g~~~ 78 (82)
T 1emn_A 38 GNECVDTDECSVGNPCGN-GTCKNVIGGFECTCEEGFEPGPM 78 (82)
T ss_dssp TTEEEECCGGGTCCTTSS-SCEEECSSSEEECCSSSSCCCSS
T ss_pred CCccCCcccccCCCCCCC-CEeECCCCCEEeECCCCeEeCCC
Confidence 346878888975458975 58999999999999999999874
|
| >1kli_L Factor VIIA; extrinsic coagulation pathway, serine protease activation, R drug design, substrate-assisted catalysis, hydrolase; 1.69A {Homo sapiens} SCOP: g.3.11.1 PDB: 1klj_L 1jbu_L 1ygc_L* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.00053 Score=52.70 Aligned_cols=46 Identities=20% Similarity=0.513 Sum_probs=34.1
Q ss_pred cccccCCC-CCCCCCCCCccCCC-CceecCCCCcccCCCCCCCCcCCCccc
Q 038345 180 EAKICGPN-ASCDKSKDNTTTSS-GYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 180 ~~~~c~~~-~~C~~~~~c~~~~~-~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
+.++|... +.|. ..|.++.+ +|+|.|.+||...+ ....|.+++||.
T Consensus 4 d~~eC~~~nggC~--h~C~n~~g~s~~C~C~~Gy~L~~-D~~tC~d~dec~ 51 (69)
T 1kli_L 4 DQLICVNENGGCE--QYCSDHTGTKRSCRCHEGYSLLA-DGVSCTPTVEYP 51 (69)
T ss_dssp CCCCTTSGGGGCS--SEEEEETTTEEEEECCTTEEECT-TSSCEEECSSSC
T ss_pred ccccccCCCCCcC--CEeEcCCCCCEEEeCCCCCeECC-CCCcccCccccc
Confidence 45666543 3673 56888777 79999999998655 346899999975
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0017 Score=47.13 Aligned_cols=33 Identities=24% Similarity=0.538 Sum_probs=27.4
Q ss_pred ccccCCC--CCCCCCCCCc--cCCCCceecCCCCccc
Q 038345 181 AKICGPN--ASCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~--~~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
+++|.+. .+|.+++.|. +..++|.|.|++||+|
T Consensus 3 i~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G 39 (53)
T 1egf_A 3 YPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp ECCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred cccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcC
Confidence 4566654 3799989998 7888999999999998
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=96.42 E-value=0.00066 Score=51.32 Aligned_cols=40 Identities=25% Similarity=0.481 Sum_probs=30.6
Q ss_pred ccCCCCCCCCCCCCcc-----CCCCceecCCCCcccCCCCCCCCc-CCCccc
Q 038345 183 ICGPNASCDKSKDNTT-----TSSGYHCKCNKGYEGNPYLSDGCR-DVNEFE 228 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~-----~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~ 228 (686)
+|..+ +|.+++.|.+ ..++|.|.|++||.| ..|+ ++++|.
T Consensus 8 ~C~~~-pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G-----~~Ce~~i~~~~ 53 (63)
T 1hae_A 8 EKEKT-FCVNGGECFMVKDLSNPSRYLCKCQPGFTG-----ARCTENVPMKV 53 (63)
T ss_dssp HHHHT-TSCTTCEEEEEESSSSSCCEEEECCTTEES-----TTSCEECCSSC
T ss_pred CCCCC-cCCCCcEEecCCccCCCCCEEEECCCCCcC-----CccCcCcCccc
Confidence 45433 7988888975 568999999999998 4585 677764
|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0014 Score=48.65 Aligned_cols=46 Identities=15% Similarity=0.429 Sum_probs=34.1
Q ss_pred CCCCCCCCccCC-CCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCC
Q 038345 189 SCDKSKDNTTTS-SGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTA 243 (686)
Q Consensus 189 ~C~~~~~c~~~~-~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~ 243 (686)
.|. ..|.++. ++|.|.|.+||...+ ....|.|+++ .+|.+.|.|..
T Consensus 8 gC~--~~C~n~~~gs~~C~C~~Gy~L~~-D~~tC~d~~~------~pC~~~c~n~~ 54 (59)
T 2wph_E 8 RCE--QFCKNSADNKVVCSCTEGYRLAE-NQKSCEPAVP------FPCGRVSVSQT 54 (59)
T ss_dssp GCS--SEEEECSTTCEEEECCTTEEECT-TSSCEEESSS------SCTTCCCSCCC
T ss_pred CcC--CEeEeCCCCCEEeeCCCCcEECC-CCCcccCCCC------CCCCCcccccc
Confidence 563 4677777 699999999998655 2457887654 67888888863
|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0017 Score=50.25 Aligned_cols=35 Identities=31% Similarity=0.470 Sum_probs=26.1
Q ss_pred cCCCcccCCCCCccc--cccccCCcceEEe-CCCCccCC
Q 038345 222 RDVNEFEDPSLNNCT--HICDNTAGNYTCR-CPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~--~~C~~~~g~~~C~-C~~g~~~~ 257 (686)
+|||||.. ...+|. ++|+|++|+|.|. |..||.++
T Consensus 1 ~DidEC~~-~~~~C~~~~~C~Nt~Gsy~C~~~~~g~~~~ 38 (71)
T 2kl7_A 1 SDVNECLT-IPEACKGEMKCINHYGGYLCLPRSAAVIND 38 (71)
T ss_dssp CCSCCTTC-CCCSCTTEEEEEETTCCEEEEETTSCCCSC
T ss_pred CccccccC-CCCCCCCCCEeECCCCCeEecccCCccccc
Confidence 47999975 346785 5899999999998 34466554
|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=6.4e-05 Score=73.78 Aligned_cols=76 Identities=14% Similarity=0.195 Sum_probs=55.0
Q ss_pred CccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc-CCCcccC-------------------------
Q 038345 176 ETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR-DVNEFED------------------------- 229 (686)
Q Consensus 176 ~~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~-~~~~c~~------------------------- 229 (686)
..|+...+|.+. +|.++..|.+...+|+|.|+.||+|.. |. ++++|..
T Consensus 94 ~~c~~~~eC~s~-pC~ngG~C~~~~~sy~C~C~~Gf~G~~-----Ce~~~d~C~n~~~c~s~pC~ngg~c~~G~~c~~~i 167 (267)
T 4fbr_A 94 ARDKQNIVAVSI-KSNDGGKTLTGTTTYNGEGPIGFKSEV-----TDGDTYSVENQWGGSAAPWHSGGVWVLGTRGKQNV 167 (267)
T ss_dssp CCSSCCEEEEEE-ECSSTTSEEEEEEEETTSCCEEEEEEE-----CCCCEEEEEEECSSTTSCCEEEEEEECCSSTTSCE
T ss_pred CccccccccCCC-CCCCCCEEecCCccEEeeCCCCccccC-----CCCCcccccccCCcCCccccCCcceeccccccccc
Confidence 356666778765 899999999888999999999999733 42 2333210
Q ss_pred -CCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 230 -PSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 230 -~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
....+|. ++|.+..++|+|.||+||++.
T Consensus 168 ~c~~~~c~ngg~C~dg~~~y~C~Cp~Gf~G~ 198 (267)
T 4fbr_A 168 INVDAKSNDGGKTLSGTMTYNGEGPIGFRGT 198 (267)
T ss_dssp EEEEEECSSTTSEEEEEEEETTSCCEEEEEE
T ss_pred ccCCCCCCCCCEeeCCCCCeEEeCCCCcccc
Confidence 0012342 589999999999999999875
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0032 Score=45.61 Aligned_cols=35 Identities=26% Similarity=0.624 Sum_probs=28.4
Q ss_pred CCCcccCCCCCccc--cccc--cCCcceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCT--HICD--NTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~--~~C~--~~~g~~~C~C~~g~~~~ 257 (686)
++++|......+|. ++|. +..++|.|.|++||.+.
T Consensus 2 ~i~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 40 (53)
T 1egf_A 2 SYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGD 40 (53)
T ss_dssp EECCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCSS
T ss_pred CcccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcCC
Confidence 57888754345785 5899 89999999999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.011 Score=61.08 Aligned_cols=31 Identities=16% Similarity=0.308 Sum_probs=27.4
Q ss_pred CCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 470 ISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 470 ~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987753
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=96.22 E-value=0.00084 Score=66.28 Aligned_cols=37 Identities=24% Similarity=0.692 Sum_probs=28.1
Q ss_pred cCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 222 RDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
.|+|||.. ..++|. +.|.|+.|+|.|.|++||.+|+.
T Consensus 3 ~DiDEC~~-~~~~C~~~a~C~Nt~Gsy~C~C~~Gy~GnG~ 41 (285)
T 1gl4_A 3 LAQQTCAN-NRHQCSVHAECRDYATGFCCRCVANYTGNGR 41 (285)
T ss_dssp ----CHHH-HGGGSCTTEEEEECSSCEEEEECTTEEECSS
T ss_pred ccchhccC-CCCCCCCCCEeEcCCCCeEEEcCCCCCCCCC
Confidence 47999986 357896 58999999999999999998743
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0015 Score=47.40 Aligned_cols=32 Identities=28% Similarity=0.699 Sum_probs=24.6
Q ss_pred CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc
Q 038345 188 ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR 222 (686)
Q Consensus 188 ~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~ 222 (686)
..|. ..|.++.++|+|.|.+||.+++. ...|+
T Consensus 20 ~~C~--~~C~n~~Gsy~C~C~~Gy~~~~d-~~~C~ 51 (53)
T 1apq_A 20 PQCQ--HLCHNYVGGYFCSCRPGYELQED-RHSCQ 51 (53)
T ss_dssp CTTS--SEEEEETTEEEEECSTTCEECTT-SSCEE
T ss_pred CCCC--CEeECCCCCeEEECCCCCeECCC-CCccC
Confidence 4685 48999999999999999998652 23453
|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
Probab=96.18 E-value=0.0017 Score=47.07 Aligned_cols=34 Identities=32% Similarity=0.867 Sum_probs=26.7
Q ss_pred CCccccccccCCc-ceEEeCCCCccCCCCCCCCCccC
Q 038345 232 LNNCTHICDNTAG-NYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 232 ~~~c~~~C~~~~g-~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
...|++.|.|++| +|.|.|++||... .++..|..
T Consensus 6 nggC~~~C~n~~ggs~~C~C~~Gy~L~--~Dg~tC~d 40 (53)
T 2bz6_L 6 NGGCEQYCSDHTGTKRSCRCHEGYSLL--ADGVSCTP 40 (53)
T ss_dssp GGGCSSEEEEETTTEEEEECCTTEEEC--TTSSCEEE
T ss_pred CCCcCCEeEcCCCCCEEeeCCCCCEEC--CCCCcccC
Confidence 4578999999999 7999999999764 34455654
|
| >2wph_E Coagulation factor IXA light chain; serine protease, zymogen, hydrolase, glycoprotein, hydroxylation, phosphoprotein, sulfation, hemostasis; HET: DPN 1PE; 1.50A {Homo sapiens} PDB: 2wpi_E* 2wpj_E* 2wpk_E* 2wpl_E* 2wpm_E 3kcg_L* 3lc3_B* 1rfn_B* 3lc5_B* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.002 Score=47.75 Aligned_cols=34 Identities=29% Similarity=0.825 Sum_probs=26.9
Q ss_pred CCccccccccCC-cceEEeCCCCccCCCCCCCCCccC
Q 038345 232 LNNCTHICDNTA-GNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 232 ~~~c~~~C~~~~-g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
...|++.|.|++ |+|.|.|++||... .|+..|..
T Consensus 6 nggC~~~C~n~~~gs~~C~C~~Gy~L~--~D~~tC~d 40 (59)
T 2wph_E 6 NGRCEQFCKNSADNKVVCSCTEGYRLA--ENQKSCEP 40 (59)
T ss_dssp GGGCSSEEEECSTTCEEEECCTTEEEC--TTSSCEEE
T ss_pred CCCcCCEeEeCCCCCEEeeCCCCcEEC--CCCCcccC
Confidence 467999999999 69999999999765 45555654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.09 E-value=0.013 Score=55.53 Aligned_cols=99 Identities=17% Similarity=0.088 Sum_probs=64.3
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCceee
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 509 (686)
-+|.++|.... .++++++++.++.|.+.+|.-+-...... .+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~~--~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQPR--HRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCC--CCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccCC--ceecCCcceEEecCCceeccc-cccc----------
Confidence 47889888654 47999999999999999987762211111 223456889999998887764 1110
Q ss_pred eeeeccccccCccccccCCCCccccEeehHHHHHHHHh
Q 038345 510 TKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT 547 (686)
Q Consensus 510 ~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt 547 (686)
.....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456888764 345678899999999999886
|
| >1n7d_A LDL receptor, low-density lipoprotein receptor; familial hypercholesterolemia, cholestero metabolism, lipid transport; HET: NAG BMA MAN KEG; 3.70A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 g.3.11.1 g.3.11.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 g.12.1.1 PDB: 2lgp_A 1xfe_A 1f5y_A 1ldl_A 1ldr_A 1d2j_A 1f8z_A | Back alignment and structure |
|---|
Probab=96.04 E-value=0.0092 Score=68.28 Aligned_cols=72 Identities=25% Similarity=0.547 Sum_probs=48.6
Q ss_pred CCCCCCCCccC--CCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCccC---CCCCCCC
Q 038345 189 SCDKSKDNTTT--SSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRG---DGRRDGG 263 (686)
Q Consensus 189 ~C~~~~~c~~~--~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~---~~~~~~~ 263 (686)
.|.+ ..|+.. .-.+.|.|..|+.+.. ..| +++||.. ....|.+.|.|++|+|.|.|++||.+ ..+.+..
T Consensus 262 ~C~~-g~Ci~~~~~Cd~~~dC~dgsDe~~---~~C-~~~eC~~-~~~~C~~~C~~~~~~~~C~C~~G~~~~~~~~C~did 335 (699)
T 1n7d_A 262 KCHS-GECITLDKVCNMARDCRDWSDEPI---KEC-GTNECLD-NNGGCSHVCNDLKIGYECLCPDGFQLVAQRRCEDID 335 (699)
T ss_dssp CCTT-SCCCCSSCCSCSSCCSSSSCSCCC---SSC-CCCCTTS-STTTSCTTCCCCTTCCCCCCCSSSCCCSSSCCCCCC
T ss_pred ecCC-CcEeCCcccccccceecCcccccc---ccc-ccccccc-cccCcCCCcccCCCCcEEeCCCCeEcCCCCcccCcc
Confidence 4543 345432 2235688888876532 346 6899986 34679999999999999999999984 2334445
Q ss_pred Ccc
Q 038345 264 GCI 266 (686)
Q Consensus 264 ~C~ 266 (686)
.|.
T Consensus 336 eC~ 338 (699)
T 1n7d_A 336 ECQ 338 (699)
T ss_dssp CCS
T ss_pred ccC
Confidence 553
|
| >4fbr_A Lectin, myxobacterial hemagglutinin; beta-barrel, HIV-inactivating, carbohydrate binding protein; 1.60A {Myxococcus xanthus} PDB: 4fbv_A* | Back alignment and structure |
|---|
Probab=95.91 E-value=0.00025 Score=69.60 Aligned_cols=66 Identities=14% Similarity=0.173 Sum_probs=49.5
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCC-------------------------CCCCCCcCCCcccCCCCCccc--ccccc
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNP-------------------------YLSDGCRDVNEFEDPSLNNCT--HICDN 241 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnp-------------------------y~~~gC~~~~~c~~~~~~~c~--~~C~~ 241 (686)
.|.++..|++...+|.|.|+.||+|.- +....|+.++||.. .+|. ++|++
T Consensus 39 ~c~ngG~C~~g~~~y~C~Cp~Gf~G~~Ce~ni~ec~~~~~c~s~pC~nggtc~~G~~c~~~~eC~s---~pC~ngG~C~~ 115 (267)
T 4fbr_A 39 KSDDGGKTLKGTMTYNGEGPIGFRGTLSSANNYTVENQWGGTSAPWQPGGVWVLGARDKQNIVAVS---IKSNDGGKTLT 115 (267)
T ss_dssp ECSSTTSEEEEEEEETTSCCEEEEEEECSTTEEEEEEESSSTTSCEEEEEEEECCCCSSCCEEEEE---EECSSTTSEEE
T ss_pred CcCCCCeecCCCCCeEEeCCCCcccccccccccccccccCcCCCcccCCCeeeccCccccccccCC---CCCCCCCEEec
Confidence 577888999888999999999998621 01223444445543 4564 58999
Q ss_pred CCcceEEeCCCCccCC
Q 038345 242 TAGNYTCRCPKGFRGD 257 (686)
Q Consensus 242 ~~g~~~C~C~~g~~~~ 257 (686)
..++|+|.|+.||.+.
T Consensus 116 ~~~sy~C~C~~Gf~G~ 131 (267)
T 4fbr_A 116 GTTTYNGEGPIGFKSE 131 (267)
T ss_dssp EEEEETTSCCEEEEEE
T ss_pred CCccEEeeCCCCcccc
Confidence 9999999999999886
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=95.90 E-value=0.0041 Score=43.28 Aligned_cols=25 Identities=28% Similarity=0.671 Sum_probs=22.4
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
+|.+++.|. +..++|+|.|++||+|
T Consensus 10 pC~ngg~C~~~~~~~~~~C~C~~G~~G 36 (45)
T 1a3p_A 10 YCLNGGVXMHIESLDSYTCNCVIGYSG 36 (45)
T ss_dssp CCSSSCEEEECTTTSSEEEECCTTEET
T ss_pred CCCCCCEEEeecCCCCEEEEcCCCCcC
Confidence 799888997 6778999999999998
|
| >2bz6_L Blood coagulation factor VIIA; serine protease, enzyme complex, hydrolase; HET: 346; 1.6A {Homo sapiens} SCOP: g.3.11.1 PDB: 1w8b_L* 1w7x_L* 1cvw_L* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0017 Score=46.97 Aligned_cols=37 Identities=19% Similarity=0.520 Sum_probs=28.5
Q ss_pred CCCCCCCCccCCC-CceecCCCCcccCCCCCCCCcCCCccc
Q 038345 189 SCDKSKDNTTTSS-GYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 189 ~C~~~~~c~~~~~-~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
.|. +.|.++.+ +|+|.|.+||+..+ ....|+|+|||.
T Consensus 8 gC~--~~C~n~~ggs~~C~C~~Gy~L~~-Dg~tC~d~dec~ 45 (53)
T 2bz6_L 8 GCE--QYCSDHTGTKRSCRCHEGYSLLA-DGVSCTPTVEYP 45 (53)
T ss_dssp GCS--SEEEEETTTEEEEECCTTEEECT-TSSCEEECSSSC
T ss_pred CcC--CEeEcCCCCCEEeeCCCCCEECC-CCCcccCCcccc
Confidence 563 46887777 69999999998655 346799999974
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0022 Score=51.81 Aligned_cols=35 Identities=31% Similarity=0.792 Sum_probs=28.2
Q ss_pred cCCCcccCCCCCccc-cccccCCcceEEeCCCCccCC
Q 038345 222 RDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~ 257 (686)
+|||||.. ...+|. ++|+|++|+|.|.|++||.++
T Consensus 1 ~dideC~~-~~~~C~~g~C~n~~g~y~C~C~~Gy~~~ 36 (86)
T 1lmj_A 1 TDIDECRI-SPDLCGRGQCVNTPGDFECKCDEGYESG 36 (86)
T ss_dssp CCCCTTTT-CSSTTTTSCEEEETTEEEECCCSSEEEC
T ss_pred CccccccC-CCCCCCCCEEECCCCCEEeeCCCCcCcc
Confidence 47899975 234575 489999999999999999853
|
| >1nzi_A Complement C1S component; calcium, innate immunity, modular structure, CUB, EGF, hydrolase; 1.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0033 Score=57.35 Aligned_cols=45 Identities=33% Similarity=0.632 Sum_probs=35.1
Q ss_pred CCcCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 220 GCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 220 gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
.|.+++||..+....|.+.|.|+.|+|.|.|.+||... .++..|.
T Consensus 113 ~~~d~~eC~~~~~~~C~~~C~n~~g~~~C~C~~Gy~l~--~~~~~C~ 157 (159)
T 1nzi_A 113 VATDINECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLH--DDMKNCG 157 (159)
T ss_dssp EEEECCTTTC-CCCCSSSEEEEETTEEEEECCTTCEEC--TTSSCEE
T ss_pred ecccCcccCCCCCCCCCCcccCcCCCEEEecCCCcEEC--CCCCccc
Confidence 36788999875556799999999999999999999865 2444563
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0029 Score=51.28 Aligned_cols=35 Identities=37% Similarity=0.948 Sum_probs=28.1
Q ss_pred cCCCcccCCCCCcc-ccccccCCcceEEeCCCCccCC
Q 038345 222 RDVNEFEDPSLNNC-THICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c-~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
+|+|||... ...| .++|.|+.|+|.|.|++||.++
T Consensus 1 ~dideC~~~-~~~C~~~~C~n~~g~y~C~C~~G~~~~ 36 (87)
T 1z6c_A 1 KDVDECSLK-PSICGTAVCKNIPGDFECECPEGYRYN 36 (87)
T ss_dssp CCSCSSSSS-SSSBTTSSCCCBTTBCCCSSSTTCEEE
T ss_pred CccccccCC-CCCCCCCEeECCCCCEEEECCCCceEC
Confidence 478999752 2347 5699999999999999999854
|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=95.67 E-value=0.0035 Score=57.90 Aligned_cols=52 Identities=27% Similarity=0.636 Sum_probs=38.3
Q ss_pred CCcccCCCCCCCCcCCCcccCCCC--CccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 209 KGYEGNPYLSDGCRDVNEFEDPSL--NNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 209 ~Gy~gnpy~~~gC~~~~~c~~~~~--~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
.||.+. ..|.+++||..+.. ..|.+.|.|+.|+|.|.|++||... .++..|.
T Consensus 113 ~Gf~~~----~~~~di~eC~~~~~~~~~C~~~C~n~~g~~~C~C~~Gy~l~--~d~~~C~ 166 (170)
T 1szb_A 113 TGFEAF----YAAEDIDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLH--RNKRTCS 166 (170)
T ss_dssp CEEEEE----EEEEECCTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEEC--TTSSCEE
T ss_pred cCceee----eeccccCcccCCCCCCCccCCccccCCCCEEEeCCCCcEEC--CCCCccc
Confidence 566652 24778999986431 2499999999999999999999865 2455564
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
Probab=95.61 E-value=0.0021 Score=58.89 Aligned_cols=42 Identities=31% Similarity=0.667 Sum_probs=32.1
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccC
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFED 229 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~ 229 (686)
+.|.+. +|.+++.|.+..++|.|.|++||+| ..|+++++|..
T Consensus 120 ~~c~~~-~C~~~g~C~~~~~~~~c~C~~g~~G-----~~Ce~~~~c~~ 161 (162)
T 1g1s_A 120 ASCQDM-SCSKQGECLETIGNYTCSCYPGFYG-----PECEYVRDDDD 161 (162)
T ss_dssp CCCCTT-GGGGSEEEEECSSSEEEEECTTEES-----TTSCEECC---
T ss_pred CCCcCC-CCCCCCEEecCCCCceEeCCCCCcC-----cccccCcccCC
Confidence 345544 7887788998899999999999998 35999889864
|
| >3m0c_C LDL receptor, low-density lipoprotein receptor; protein complex, beta propeller, cholesterol clearance, PCSK autocatalytic cleavage; 7.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.61 E-value=0.011 Score=68.32 Aligned_cols=61 Identities=26% Similarity=0.645 Sum_probs=43.8
Q ss_pred CCCCCCCCccCC--CCceecCCCCcccCCCCCCCCcCCCcccCCCCCccccccccCCcceEEeCCCCcc
Q 038345 189 SCDKSKDNTTTS--SGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR 255 (686)
Q Consensus 189 ~C~~~~~c~~~~--~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~ 255 (686)
.|.+ +.|+... -.+.|.|..|+.+.. ..| +++||.. ....|.+.|.|++|+|.|.|++||.
T Consensus 280 ~C~~-G~Ci~~~~~Cd~~~dC~dgsDe~~---~~C-~~~~C~~-~~~~C~~~C~~~~~~y~C~C~~Gy~ 342 (791)
T 3m0c_C 280 KCHS-GECITLDKVCNMARDCRDWSDEPI---KEC-GTNECLD-NNGGCSHVCNDLKIGYECLCPDGFQ 342 (791)
T ss_dssp CCTT-SCCCCSSCCSCSSCCSSSSCSCCC---TTB-SCCSTTT-GGGGCSSEEEECSBSEEEECCTTCE
T ss_pred ccCC-CcccccccccCCccccccccCccc---ccc-ccccccc-cccCccccccCCCCCcccCCCCCCc
Confidence 5654 4565322 235678888876532 346 5788875 3467999999999999999999996
|
| >2kl7_A Fibulin-4; secreted, calcium, disease mutation, disulfide bond, EGF- like domain, glycoprotein, polymorphism, structural genomics, PSI-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0041 Score=48.07 Aligned_cols=37 Identities=14% Similarity=0.253 Sum_probs=28.3
Q ss_pred cccccCCC-CCCCCCCCCccCCCCceec-CCCCcccCCC
Q 038345 180 EAKICGPN-ASCDKSKDNTTTSSGYHCK-CNKGYEGNPY 216 (686)
Q Consensus 180 ~~~~c~~~-~~C~~~~~c~~~~~~y~C~-C~~Gy~gnpy 216 (686)
++++|... ..|..+..|+++.++|+|. |..||.++..
T Consensus 2 DidEC~~~~~~C~~~~~C~Nt~Gsy~C~~~~~g~~~~~~ 40 (71)
T 2kl7_A 2 DVNECLTIPEACKGEMKCINHYGGYLCLPRSAAVINDLH 40 (71)
T ss_dssp CSCCTTCCCCSCTTEEEEEETTCCEEEEETTSCCCSCCS
T ss_pred ccccccCCCCCCCCCCEeECCCCCeEecccCCccccccc
Confidence 35677653 3798778899999999998 5678887764
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.0055 Score=54.95 Aligned_cols=46 Identities=26% Similarity=0.596 Sum_probs=31.2
Q ss_pred CCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 219 DGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 219 ~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
..|.|+|+|.. .+|. ++|+++.|+|.|.|++||.+..+.+...|..
T Consensus 43 ~~c~dideC~~---~pC~n~g~C~~~~~~y~C~C~~G~~G~~C~~~deC~~ 90 (146)
T 1x7a_L 43 KQYVDGDQCEP---NPCLNGGLCKDDINSYECWCQVGFEGKNCELDATCNI 90 (146)
T ss_dssp -------CCSS---CSSCTTCEEEECSSCEEEECCSSEESTTTCEECCTTS
T ss_pred ccCCCcCcCCC---CCCCCCCEeECCCCCEEEecCCCCcCCcCCCCccccC
Confidence 46999999974 6786 5999999999999999999876555555643
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=95.37 E-value=0.0083 Score=41.87 Aligned_cols=35 Identities=20% Similarity=0.473 Sum_probs=26.2
Q ss_pred CCCcccCCCCCccc-cccccCC--cceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCT-HICDNTA--GNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~-~~C~~~~--g~~~C~C~~g~~~~ 257 (686)
++++|......+|. ++|.+.. ++|.|.|++||.|.
T Consensus 2 ~i~~C~~~~~~pC~nG~C~~~~~~~~~~C~C~~GytG~ 39 (46)
T 1k36_A 2 SITKCSSDMNGYCLHGQCIYLVDMSQNYCRCEVGYTGV 39 (46)
T ss_dssp CEECCCTTCCSSCSSEEEEEETTTTEEEEEECTTCSST
T ss_pred ccccCCCCCCCCCCCCEeeccCCCCCEEEECCCCCccC
Confidence 46677654446774 6898754 68999999999986
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.32 E-value=0.0081 Score=43.65 Aligned_cols=33 Identities=33% Similarity=0.760 Sum_probs=25.9
Q ss_pred cCCCcccCCCCCccc--ccc-----ccCCcceEEeCCCCccCC
Q 038345 222 RDVNEFEDPSLNNCT--HIC-----DNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~--~~C-----~~~~g~~~C~C~~g~~~~ 257 (686)
.++|||.. .+|. ++| .+..++|.|.|++||.|.
T Consensus 6 ~~~~eC~s---~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~ 45 (55)
T 3u7u_G 6 VKCAEKEK---TFCVNGGECFMVKDLSNPSRYLCKCPNEFTGD 45 (55)
T ss_dssp EECCSTTT---TTSCTTCEEEEECCC--CCCEEEEECTTEEST
T ss_pred ccCCCCcC---CCCCCCCCcCCCCccCCCCCEeEeCCCCCcCC
Confidence 47899974 6885 599 567889999999999987
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=95.20 E-value=0.017 Score=61.23 Aligned_cols=49 Identities=24% Similarity=0.746 Sum_probs=38.6
Q ss_pred CCCccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCC
Q 038345 174 TIETCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225 (686)
Q Consensus 174 ~~~~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~ 225 (686)
+..+|++.++|.....|.. .|.++.++|.|.|.+||.+.+. ...|+.++
T Consensus 33 ~~~~C~dideC~~~~~C~~--~C~n~~g~~~C~C~~g~~~~~~-~~~C~~~~ 81 (400)
T 3p5b_L 33 AQRRCEDIDECQDPDTCSQ--LCVNLEGGYKCQCEEGFQLDPH-TKACKAVG 81 (400)
T ss_dssp SSSCEEECCCCSTTSSCSS--CCBCCSSSCBCCCCTTCCCCTT-TSSCCCST
T ss_pred CCCcccCchhhhccCCCCC--ccCCCccceeeecccccccccc-ccceeecc
Confidence 3467988999986568954 8999999999999999998763 35676654
|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
Probab=95.06 E-value=0.0041 Score=44.82 Aligned_cols=38 Identities=26% Similarity=0.633 Sum_probs=27.6
Q ss_pred ceecCCCCcccCCCCCCCCcCCCcccCCCCCcccccccc----CCcceEEeCCCCccCC
Q 038345 203 YHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCTHICDN----TAGNYTCRCPKGFRGD 257 (686)
Q Consensus 203 y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~~~C~~----~~g~~~C~C~~g~~~~ 257 (686)
+.|.|++||..|| |+ . .++|.+ ..++|.|.|+.||.+.
T Consensus 3 ~~C~C~~g~~~~p-----C~------N------GGtC~~~~~~~~~~y~C~C~~Gf~G~ 44 (52)
T 3ca7_A 3 PTYKCPETFDAWY-----CL------N------DAHCFAVKIADLPVYSCECAIGFMGQ 44 (52)
T ss_dssp CCBCCCHHHHHHT-----SC------T------TCEEEEEEETTEEEEEEECCTTEEST
T ss_pred eeeECCCCCcCCc-----CC------C------CCEEecCccCCCCCEEEECCCCCcCC
Confidence 4699999998554 21 1 235665 4578999999999986
|
| >3f1s_B Vitamin K-dependent protein Z; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.84 E-value=0.0087 Score=60.29 Aligned_cols=43 Identities=33% Similarity=0.772 Sum_probs=32.8
Q ss_pred CCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 223 ~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
++|||.......|.+.|.|+.|+|.|.|++||... .+...|.+
T Consensus 1 ~~~eC~~~~~~~C~~~C~~~~~~~~C~C~~G~~l~--~d~~sC~p 43 (283)
T 3f1s_B 1 AKNECHPERTDGCQHFCLPGQESYTCSCAQGYRLG--EDHKQCVP 43 (283)
T ss_dssp --CCCCSSCSSSCSSBCCCCTTSCCCBCCTTEEEC--TTSSCEEE
T ss_pred CCCccCCCCCCCCCCEeeCCCCCeEecCCCCcccC--CCCCcccc
Confidence 46899864468999999999999999999999764 34445554
|
| >3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.0074 Score=62.82 Aligned_cols=41 Identities=29% Similarity=0.660 Sum_probs=25.1
Q ss_pred CCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccCC
Q 038345 224 VNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPN 268 (686)
Q Consensus 224 ~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~~ 268 (686)
+|||. ....|.+.|.|++|+|.|.|++||... .++..|...
T Consensus 1 i~ec~--~~~~C~~~C~n~~g~~~C~C~~g~~l~--~d~~~C~~~ 41 (349)
T 3v64_C 1 VNECA--EEGYCSQGCTNSEGAFQCWCEAGYELR--PDRRSCKAL 41 (349)
T ss_dssp ----------CCSSEECCC---CCEECCTTEEEC--TTSSCEEES
T ss_pred CcccC--CCCCCcCeeecCCCCeEEECCCCccCC--CCCCccccc
Confidence 57887 347899999999999999999999865 456678643
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=94.72 E-value=0.0092 Score=41.66 Aligned_cols=32 Identities=25% Similarity=0.583 Sum_probs=23.6
Q ss_pred ccccCCC--CCCCCCCCCcc--CCCCceecCCCCccc
Q 038345 181 AKICGPN--ASCDKSKDNTT--TSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~--~~C~~~~~c~~--~~~~y~C~C~~Gy~g 213 (686)
.++|... .+|.+ +.|.. ..++|.|.|++||+|
T Consensus 3 i~~C~~~~~~pC~n-G~C~~~~~~~~~~C~C~~GytG 38 (46)
T 1k36_A 3 ITKCSSDMNGYCLH-GQCIYLVDMSQNYCRCEVGYTG 38 (46)
T ss_dssp EECCCTTCCSSCSS-EEEEEETTTTEEEEEECTTCSS
T ss_pred cccCCCCCCCCCCC-CEeeccCCCCCEEEECCCCCcc
Confidence 3456552 38988 68874 346899999999998
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=94.56 E-value=0.0087 Score=43.20 Aligned_cols=25 Identities=28% Similarity=0.578 Sum_probs=22.2
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
+|.+++.|. ...++|.|.|++||+|
T Consensus 13 pC~nGG~C~~~~~~~~~~C~C~~GytG 39 (53)
T 1nql_B 13 YCLHDGVCMYIEALDKYACNCVVGYIG 39 (53)
T ss_dssp EECTTCEEEEETTTTEEEEEECTTEES
T ss_pred CCCCCeEEeeecCCCCEEEecCCCCcC
Confidence 798888997 6677899999999998
|
| >2w86_A Fibrillin-1, fibrillin1; phosphoprotein, EGF-like domain, disease mutation, craniosynostosis, extracellular matrix, fibrillin calcium cbegf hybrid; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.0081 Score=53.96 Aligned_cols=41 Identities=20% Similarity=0.480 Sum_probs=33.3
Q ss_pred CCCccccccccCCC-CCCCCCCCCccCCCCceecCCCCcccCC
Q 038345 174 TIETCEEAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 174 ~~~~c~~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
+...|+++++|... ..|.+ +.|+++.++|+|.|++||.|++
T Consensus 100 ~g~~C~dideC~~~~~~C~~-g~C~n~~g~y~C~C~~Gy~g~~ 141 (147)
T 2w86_A 100 KGTQCEDIDECEVFPGVCKN-GLCVNTRGSFKCQCPSGMTLDA 141 (147)
T ss_dssp ETTEEEECCHHHHSTTCSSS-SEEEEETTEEEEECCTTCCBCT
T ss_pred CCCccCccccccCCCCCCCC-CEEECCCCCEEeeCCCCCccCC
Confidence 34578888899753 36985 4899999999999999999876
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
Probab=94.46 E-value=0.0074 Score=56.70 Aligned_cols=40 Identities=30% Similarity=0.721 Sum_probs=0.0
Q ss_pred CCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCCCC
Q 038345 219 DGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGRRD 261 (686)
Q Consensus 219 ~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~ 261 (686)
..|.|+|+|.. .+|. ++|.++.|+|.|.|++||.+..+.+
T Consensus 37 ~~c~dideC~~---~pC~ngg~C~n~~g~y~C~C~~Gf~G~~Ce~ 78 (195)
T 1nfu_B 37 NKYKDGDQCET---SPCQNQGKCKDGLGEYTCTCLEGFEGKNCEL 78 (195)
T ss_dssp ---------------------------------------------
T ss_pred ccCCCCcccCC---CCCCCCCEeECCCCCeeEeCCCCceeccccc
Confidence 57999999984 6786 4999999999999999999875543
|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
Probab=94.37 E-value=0.027 Score=63.39 Aligned_cols=72 Identities=21% Similarity=0.455 Sum_probs=49.6
Q ss_pred cccc-ccccCCC--CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCc---CCCcccCCCCCccc--cccccCCcceEE
Q 038345 177 TCEE-AKICGPN--ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCR---DVNEFEDPSLNNCT--HICDNTAGNYTC 248 (686)
Q Consensus 177 ~c~~-~~~c~~~--~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~---~~~~c~~~~~~~c~--~~C~~~~g~~~C 248 (686)
.|++ ...|..+ ..|.+++.|.. |.|.|.+||.| ..|+ ++++|......+|. ++|.+. .|
T Consensus 520 ~Ce~~~~~C~~~~~~~C~~~G~C~~----g~C~C~~Gy~G-----~~CeC~~~~~~C~~~~g~~C~~~G~C~~g----~C 586 (690)
T 3fcs_B 520 YCECDDFSCVRYKGEMCSGHGQCSC----GDCLCDSDWTG-----YYCNCTTRTDTCMSSNGLLCSGRGKCECG----SC 586 (690)
T ss_dssp TSCBCSSCCCBSSSSBGGGSEEEET----TEEEECTTEES-----SSSCEECCCTTTBCTTSSBTSSSCEEETT----EE
T ss_pred CcCcccCcCcCCCCCCCCCCCEecC----CeeECcCCCcC-----CCCccCCCCCcccCCCCCCCCCCCEEeCC----EE
Confidence 4543 4456532 25766667754 89999999998 4575 67888754445675 588762 89
Q ss_pred eC-CCCccCCCCCC
Q 038345 249 RC-PKGFRGDGRRD 261 (686)
Q Consensus 249 ~C-~~g~~~~~~~~ 261 (686)
.| ++||.|..+..
T Consensus 587 ~C~~~Gy~G~~Ce~ 600 (690)
T 3fcs_B 587 VCIQPGSYGDTCEK 600 (690)
T ss_dssp ECCSTTCBSTTSCB
T ss_pred ECCCCCccCCCcCc
Confidence 99 99999875543
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.33 E-value=0.021 Score=58.42 Aligned_cols=50 Identities=22% Similarity=0.571 Sum_probs=39.3
Q ss_pred Cccc-cccccCC--CCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCccc
Q 038345 176 ETCE-EAKICGP--NASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 176 ~~c~-~~~~c~~--~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
..|+ +.++|.. ...|.+ .|.+..++|.|.|.+||.|.+. ...|.++++|.
T Consensus 37 ~~C~~~~~eC~~~~~~~C~~--~C~~~~g~~~C~C~~g~~~~~~-~~~C~~~~~c~ 89 (317)
T 3h5c_B 37 SNCELAKNECHPERTDGCQH--FCLPGQESYTCSCAQGYRLGED-HKQCVPHDQCA 89 (317)
T ss_dssp SSSCCCSSSCCTTCTTSCSS--EEECCSSSCEEECCTTEECCTT-SSCCEECSSCC
T ss_pred CccccCcccCCCCCCCCCcC--ccccCCCeeEEecccccccccc-ccccccccccc
Confidence 3576 6888876 248976 8999999999999999998763 45788887764
|
| >2wg3_C Hedgehog-interacting protein; lipoprotein, development, membrane, secreted, protease, PALM hydrolase, developmental protein, autocatalytic cleavage; HET: NAG; 2.60A {Homo sapiens} PDB: 2wg4_B 2wfx_B 2wft_A 3ho3_A 3ho4_A 3ho5_A | Back alignment and structure |
|---|
Probab=94.31 E-value=0.017 Score=62.38 Aligned_cols=51 Identities=33% Similarity=0.792 Sum_probs=19.9
Q ss_pred CCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 190 CDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 190 C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|.+ ..|.. .+.|.|.+||+|. .|+ +++|.. +|. ++|.+. +.|.|++||.+.
T Consensus 399 C~n-G~C~~---~~~C~C~~G~~G~-----~C~-~~~C~~----~C~~~g~C~~~---~~C~C~~G~~G~ 451 (463)
T 2wg3_C 399 CRN-GYCTP---TGKCCCSPGWEGD-----FCR-TAKCEP----ACRHGGVCVRP---NKCLCKKGYLGP 451 (463)
T ss_dssp CCS-EEECT---TSCEEECTTEEST-----TSC-EECC--------------------------------
T ss_pred CCC-CccCC---CCeECCCCCcCCC-----cCC-cCcCCC----CCCCCCEECCC---CEEECCCCcccC
Confidence 554 46654 3589999999984 584 567863 675 489875 689999999886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.19 Score=53.46 Aligned_cols=140 Identities=13% Similarity=0.127 Sum_probs=84.0
Q ss_pred ccccCccceEEEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCC-eeeEEeEEeeCCcceEEE
Q 038345 354 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRN-IVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lV~ 424 (686)
.+.|..|-...+|+....+ +..+++|+...... ..-+-.+|..+++.+...+ ..++++.+ ..++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 4567667778899988653 57899998643221 1112357888888885333 35566543 237899
Q ss_pred EeccCCchhh-----------------hhhccC----------CCCCCCHHHHHHHHHHHH-------------------
Q 038345 425 EFVPNGTLYQ-----------------NIHNHI----------EEFPITWELLLRIAVEVS------------------- 458 (686)
Q Consensus 425 e~~~~gsL~~-----------------~l~~~~----------~~~~l~~~~~~~i~~qi~------------------- 458 (686)
||++|.+|.. -||... ...+.-|.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876531 011100 111222444444443321
Q ss_pred HHHHHhhh---------------------cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 459 GALFYLHS---------------------AASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 459 ~~L~yLH~---------------------~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
..+..|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22233321 12346899999999999 778899999999885
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=94.07 E-value=0.032 Score=38.60 Aligned_cols=25 Identities=32% Similarity=0.832 Sum_probs=20.9
Q ss_pred Cccc--cccc--cCCcceEEeCCCCccCC
Q 038345 233 NNCT--HICD--NTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 233 ~~c~--~~C~--~~~g~~~C~C~~g~~~~ 257 (686)
.+|. ++|. +..++|.|.|++||.+.
T Consensus 9 ~pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 37 (45)
T 1a3p_A 9 GYCLNGGVXMHIESLDSYTCNCVIGYSGD 37 (45)
T ss_dssp SCCSSSCEEEECTTTSSEEEECCTTEETT
T ss_pred CCCCCCCEEEeecCCCCEEEEcCCCCcCC
Confidence 3674 5897 78899999999999876
|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
Probab=94.02 E-value=0.032 Score=45.53 Aligned_cols=64 Identities=14% Similarity=0.318 Sum_probs=49.2
Q ss_pred CCCCCCCCcc-CCCCceecCCCCcccCCCCCCCCcCCCc-ccCCCCCccc--cccccCC-cceEEeCCCCccC
Q 038345 189 SCDKSKDNTT-TSSGYHCKCNKGYEGNPYLSDGCRDVNE-FEDPSLNNCT--HICDNTA-GNYTCRCPKGFRG 256 (686)
Q Consensus 189 ~C~~~~~c~~-~~~~y~C~C~~Gy~gnpy~~~gC~~~~~-c~~~~~~~c~--~~C~~~~-g~~~C~C~~g~~~ 256 (686)
.|..++.|.. ..+...|.|..||.+. ...|..++. |.. +...|. +.|..+. ..-.|.|..+|.-
T Consensus 17 ~Cp~NA~C~r~~~G~e~CrCl~gY~~d---g~~Cv~~Np~C~~-nNGGCd~nAeC~~~~~~ki~C~C~~~~~~ 85 (105)
T 1n1i_A 17 NVPENAACYRYLDGTEEWRCLLGFKEV---GGKCVPASITCEE-NNGGCAPEAECTMDDKKEVECKCTKEGSE 85 (105)
T ss_dssp CCCTTEEEEECTTSCEEEEECTTEEEC---SSSEEECCCCTTS-GGGGSCTTSEEEECTTSCEEEECCSTTCC
T ss_pred CCCCCCCeEECCCCCEeEEEECCeecc---CCEEEECCcchhh-cCCCcCCCcEeEECCCCEEEeECCCCCCc
Confidence 5666777774 6677789999999984 468987787 654 567785 6899885 7889999988643
|
| >2c4f_L Coagulation factor VII precursor; blood coagulation, serine protease, EGF, EGF-like domain, GLA, receptor enzyme, glycoprotein, hydrolase, protease; HET: CGU GLC FUC NAG GIL; 1.72A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.32.1.1 PDB: 1w2k_L* 1w0y_L* 1z6j_L* 2b8o_L* 2aer_L* 2ec9_L* 2fir_L* 2a2q_L* 1fak_L* 1o5d_L* 1wqv_L* 1wss_L* 1wtg_L* 1wun_L* 1wv7_L* 1dan_L* 2aei_L* 2b7d_L* 2f9b_L* 2flb_L* ... | Back alignment and structure |
|---|
Probab=94.01 E-value=0.019 Score=51.21 Aligned_cols=37 Identities=22% Similarity=0.563 Sum_probs=31.5
Q ss_pred CCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 220 GCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 220 gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
.|.|+|+|.. .+|. ++|+++.|+|.|.|++||.+..+
T Consensus 43 ~c~did~C~~---~pC~n~g~C~~~~g~y~C~C~~G~~G~~C 81 (142)
T 2c4f_L 43 SYSDGDQCAS---SPCQNGGSCKDQLQSYICFCLPAFEGRNC 81 (142)
T ss_dssp HHTTCCGGGG---CCCCTTCEEEEETTEEEEECCTTEESTTS
T ss_pred cCCccCcCcC---CCcCCCCEEeCCCCCEEeeCCCCccCCcc
Confidence 5789999974 6786 49999999999999999987644
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.01 Score=62.76 Aligned_cols=44 Identities=23% Similarity=0.573 Sum_probs=0.0
Q ss_pred cCCCcccCCCCCccccccccCCcceEEeCCCCcc----CCCCCCCCCcc
Q 038345 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR----GDGRRDGGGCI 266 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~----~~~~~~~~~C~ 266 (686)
+|+|||.. +...|.+.|.++.|+|.|.|++||. +..+.+...|.
T Consensus 1 ~~~~~C~~-~~~~c~~~C~~~~g~~~C~C~~G~~l~~~~~~C~d~~eC~ 48 (386)
T 3v65_B 1 TGEENCNV-NNGGCAQKCQMIRGAVQCTCHTGYRLTEDGRTCQDVNECA 48 (386)
T ss_dssp -------------------------------------------------
T ss_pred CCcCcccC-CCCCCCCCCcCCCCCcEeECCCCceECCCCCccCccceeC
Confidence 36889975 3467999999999999999999998 33344444553
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=93.80 E-value=0.02 Score=48.90 Aligned_cols=41 Identities=20% Similarity=0.440 Sum_probs=25.9
Q ss_pred CcCCCcccCCC-----CCccc--cccccCCcceEEeCCCCccCCCCCC
Q 038345 221 CRDVNEFEDPS-----LNNCT--HICDNTAGNYTCRCPKGFRGDGRRD 261 (686)
Q Consensus 221 C~~~~~c~~~~-----~~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~ 261 (686)
|.|+|+|.... ...|. ++|+++.++|.|.|++||.++...+
T Consensus 3 ~~d~d~C~~~p~~~~C~~~C~~~g~C~~~~~~y~C~C~~G~~G~~C~~ 50 (114)
T 1aut_L 3 HVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRFCQR 50 (114)
T ss_dssp -----CCCCCSSCCSSSSTTTTSEEECCCSSCCCEEECTTEESTTSCE
T ss_pred ceecccccCCCccccccccCCCcCCCCCCCCCcEeeCCCCCcCCCcCc
Confidence 55777776421 01153 5899999999999999999875443
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
Probab=93.62 E-value=0.028 Score=45.63 Aligned_cols=64 Identities=20% Similarity=0.454 Sum_probs=46.7
Q ss_pred CCCCCCCCcc-CCCCceecCCCCcccCCCCCCCCcCC--CcccCCCCCccc--cccccCC-----cceEEeCCCCccC
Q 038345 189 SCDKSKDNTT-TSSGYHCKCNKGYEGNPYLSDGCRDV--NEFEDPSLNNCT--HICDNTA-----GNYTCRCPKGFRG 256 (686)
Q Consensus 189 ~C~~~~~c~~-~~~~y~C~C~~Gy~gnpy~~~gC~~~--~~c~~~~~~~c~--~~C~~~~-----g~~~C~C~~g~~~ 256 (686)
.|..++.|.. ..+-+.|.|..||.|+. ..|..+ +.|.. +...|. ++|..+. +...|.|..|+..
T Consensus 11 ~C~~NA~C~r~~~g~e~C~C~~gy~gdg---~~Cv~~~~~sC~~-nNGGCd~nA~C~~~~~~~~~~ki~C~C~~g~~~ 84 (99)
T 1ob1_C 11 QCPQNSGCFRHLDEREECKCLLNYKQEG---DKCVENPNPTCNE-NNGGCDADAKCTEEDSGSNGKKITCECTKPDSY 84 (99)
T ss_dssp CCCTTEEEECCTTSCCEEEECTTEEEET---TEEEECSCCCSTT-GGGGCCTTEEEECCSCSSSSCCCEEEECSTTCC
T ss_pred CCCCCCCeEEcCCCCEEEEecCCeecCC---CeEeeCCCCChhh-cCCCcCCCceeEecCCcccCCceEeEeCCCCcc
Confidence 4555666654 56788999999999854 468766 46875 346774 6898875 6789999988653
|
| >3fcs_B Integrin beta-3; beta propeller, rossmann fold, EGF domain, cell adhesion, DI mutation, glycoprotein, HOST-virus interaction, M phosphoprotein; HET: NAG MAN; 2.55A {Homo sapiens} PDB: 4g1e_B* 3ije_B* 4g1m_B* 1jv2_B* 1l5g_B* 1m1x_B* 1u8c_B* | Back alignment and structure |
|---|
Probab=93.50 E-value=0.061 Score=60.55 Aligned_cols=74 Identities=20% Similarity=0.496 Sum_probs=50.1
Q ss_pred ccCCCCCCCCCCCCccCCCCce---ecCCCCcccCCCCCCCCc-CC--------CcccCC-CCCccc--cccccCCcceE
Q 038345 183 ICGPNASCDKSKDNTTTSSGYH---CKCNKGYEGNPYLSDGCR-DV--------NEFEDP-SLNNCT--HICDNTAGNYT 247 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~~~y~---C~C~~Gy~gnpy~~~gC~-~~--------~~c~~~-~~~~c~--~~C~~~~g~~~ 247 (686)
+|... +|.++..|.+..+.|. |.|.+||.|. .|+ ++ ++|... ....|. ++|.+ +.
T Consensus 436 ~C~~~-pc~n~~~C~~g~G~~~~G~C~C~~Gy~G~-----~Ce~~~~~~~~~~~~~C~~~~~~~~Cs~~G~C~~----g~ 505 (690)
T 3fcs_B 436 ACQAQ-AEPNSHRCNNGNGTFECGVCRCGPGWLGS-----QCECSEEDYRPSQQDECSPREGQPVCSQRGECLC----GQ 505 (690)
T ss_dssp GGGTT-CCTTCTTTTTTSEEEETTEEEECTTCCSS-----SSCCSCC------CCCCSSSSSSCGGGGSEEECS----SS
T ss_pred CCcCC-CCCCCCcccCCCCeEeCCceEeCCCccCC-----ceeeccCccCCccCCcCCCCCCCCCCCCCCEEEC----Ce
Confidence 45443 6877788886777888 9999999984 463 22 567642 123575 58874 57
Q ss_pred EeCC----CCccCCCCC-CCCCcc
Q 038345 248 CRCP----KGFRGDGRR-DGGGCI 266 (686)
Q Consensus 248 C~C~----~g~~~~~~~-~~~~C~ 266 (686)
|.|+ +||.|..+. +...|.
T Consensus 506 C~C~~~~~~Gy~G~~Ce~~~~~C~ 529 (690)
T 3fcs_B 506 CVCHSSDFGKITGKYCECDDFSCV 529 (690)
T ss_dssp EEECCCSSCCCBSTTSCBCSSCCC
T ss_pred eEeecCCCCCeeCCCcCcccCcCc
Confidence 9999 999987553 334454
|
| >2vh0_B Activated factor XA light chain; serine protease, EGF-like domain, blood coagulation, polymorphism, glycoprotein, hydroxylation; HET: GSI; 1.7A {Homo sapiens} PDB: 1ezq_B* 1f0s_B* 1ksn_B* 1f0r_B* 1lpk_A* 1lpz_A* 1lqd_A* 1nfw_B* 1nfx_B* 1nfy_B* 2boh_A* 2cji_B* 1lpg_A* 2j34_B* 2j38_B* 2j2u_B* 2j94_B* 2j95_B* 2uwl_B* 2j4i_B* ... | Back alignment and structure |
|---|
Probab=93.49 E-value=0.015 Score=51.31 Aligned_cols=40 Identities=30% Similarity=0.721 Sum_probs=0.0
Q ss_pred CCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCCCC
Q 038345 219 DGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGRRD 261 (686)
Q Consensus 219 ~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~ 261 (686)
..|.++|+|.. .+|. ++|+++.++|.|.|++||.+..+.+
T Consensus 37 ~~c~d~d~C~~---~pC~n~g~C~~~~~~y~C~C~~G~~G~~C~~ 78 (134)
T 2vh0_B 37 NKYKDGDQCET---SPCQNQGKCKDGLGEYTCTCLEGFEGKNCEL 78 (134)
T ss_dssp ---------------------------------------------
T ss_pred ccCCCcCcCCC---CCCCCcCCcccCCCCEEeeCCCCccCCcccc
Confidence 46999999974 5786 4999999999999999999764443
|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
Probab=93.42 E-value=0.035 Score=59.07 Aligned_cols=61 Identities=21% Similarity=0.620 Sum_probs=38.9
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC-CCc------ccCC--CCCccc--cccccCCcceEEeCCCCccCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD-VNE------FEDP--SLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~-~~~------c~~~--~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.|.+++.|.. ..|.|.|++||.|. .|+. .++ |..+ ....|. +.| ..++|.|.|++||.+.
T Consensus 204 ~C~~~G~C~~--~~g~C~C~~G~~G~-----~Ce~~C~~g~~g~~C~~~C~~~~~C~~~g~C--~~~~~~C~C~~G~~G~ 274 (423)
T 2gy5_A 204 ACMNNGVCHE--DTGECICPPGFMGR-----TCEKACELHTFGRTCKERCSGQEGCKSYVFC--LPDPYGCSCATGWKGL 274 (423)
T ss_dssp CCCTTCEECT--TTCCEECCTTEEST-----TSCEECCTTEESTTSCEECCSTTTTTTCCEE--ETTTTEEECCBTCBSG
T ss_pred CCCCCCEEEC--CCCcEeCCCCccCC-----CcccccCCCCCCCCcCccCCCCCCCCCCCEE--CCCCCeEEeCCCcccc
Confidence 5877788865 46899999999984 4653 221 2210 112232 234 3678999999999876
Q ss_pred C
Q 038345 258 G 258 (686)
Q Consensus 258 ~ 258 (686)
.
T Consensus 275 ~ 275 (423)
T 2gy5_A 275 Q 275 (423)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.50 E-value=0.053 Score=55.50 Aligned_cols=54 Identities=28% Similarity=0.702 Sum_probs=18.7
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~ 258 (686)
.|.+++.|.. .+.|.|.+||.|. .|+ +++|. .+|. ++|.+ .+.|.|++||.++.
T Consensus 218 ~C~~~G~C~~---~~~C~C~~G~~G~-----~C~-~~~C~----~~C~~~g~C~~---~~~C~C~~G~~G~~ 273 (324)
T 2ygq_A 218 TCFNGGTCFY---PGKCICPPGLEGE-----QCE-ISKCP----QPCRNGGKCIG---KSKCKCSKGYQGDL 273 (324)
T ss_dssp CCCSSCCBSC---SSCBCCCTTCCTT-----TTC--------------------------------------
T ss_pred CCCCCCeeCC---CCeeeCCCCccCC-----CCC-cCcCC----CcCCCCCEECC---CCEEECCCCCcCCC
Confidence 5766677765 3689999999873 475 45664 3453 47764 47899999988763
|
| >1ijq_A LDL receptor, low-density lipoprotein receptor; beta-propeller, lipid transport; 1.50A {Homo sapiens} SCOP: b.68.5.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=92.11 E-value=0.065 Score=54.63 Aligned_cols=42 Identities=33% Similarity=0.662 Sum_probs=31.4
Q ss_pred CCCcccCC--CCCccccccccCC------cceEEeCCCCccCCCCCCCCCcc
Q 038345 223 DVNEFEDP--SLNNCTHICDNTA------GNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 223 ~~~~c~~~--~~~~c~~~C~~~~------g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
+.|+|... ....|++.|.+++ ++|.|.|+.|+... .++..|.
T Consensus 266 ~~n~C~~~~~~ng~Cs~~C~~~p~~~~~~~~~~C~C~~g~~l~--~d~~~C~ 315 (316)
T 1ijq_A 266 GVNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLA--RDMRSCL 315 (316)
T ss_dssp CCCTTSSSSSGGGGCSSEEEECCCCSTTCCSEEEECCTTCEEC--TTSSCEE
T ss_pred ccccccccccCCCCcCcccCCCccccCCCCCeEeeCCCCCEEC--CCCCccC
Confidence 56778642 1467999999886 68999999999765 4566674
|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
Probab=91.98 E-value=0.032 Score=40.02 Aligned_cols=25 Identities=24% Similarity=0.590 Sum_probs=21.4
Q ss_pred CCCCCCCCcc----CCCCceecCCCCccc
Q 038345 189 SCDKSKDNTT----TSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~~----~~~~y~C~C~~Gy~g 213 (686)
+|.+++.|.. ..++|.|.|++||+|
T Consensus 15 pC~NGGtC~~~~~~~~~~y~C~C~~Gf~G 43 (52)
T 3ca7_A 15 YCLNDAHCFAVKIADLPVYSCECAIGFMG 43 (52)
T ss_dssp TSCTTCEEEEEEETTEEEEEEECCTTEES
T ss_pred cCCCCCEEecCccCCCCCEEEECCCCCcC
Confidence 7888888975 356899999999998
|
| >2ygq_A WIF-1, WNT inhibitory factor 1; signaling protein, WNT signaling pathway, WNT antagonist, MO cancer, glycosaminoglycan; HET: PCF NAG FUC SCR; 3.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.92 E-value=0.078 Score=54.21 Aligned_cols=55 Identities=25% Similarity=0.635 Sum_probs=38.2
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
.|.+++.|.. .|.|.|.+||.| ..|+. ++|.. +|. ++|.+ .+.|.|++||.+..+
T Consensus 154 ~C~~~G~C~~---~~~C~C~~G~~G-----~~C~~-~~C~~----~C~~~G~C~~---~~~C~C~~G~~G~~C 210 (324)
T 2ygq_A 154 GCRNGGFCNE---RRICECPDGFHG-----PHCEK-ALCTP----RCMNGGLCVT---PGFCICPPGFYGVNC 210 (324)
T ss_dssp CCCSSCEECT---TSCEECCTTEES-----SSSCE-ESSSS----CCCTTCEECS---SCCEECCTTCBTTTT
T ss_pred CCCCCCEECC---CCeEECCCCCcC-----CCCCC-CCCCC----CCCCCCEEcC---CCEEeCCCCccCCCc
Confidence 5777777764 588999999988 35754 34542 453 57765 367999999887643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.75 E-value=0.88 Score=47.91 Aligned_cols=29 Identities=31% Similarity=0.436 Sum_probs=24.7
Q ss_pred CeEeeCCCCCCeee------cCCCcEEEEecCCcc
Q 038345 471 SIYRRDIKSANILL------DDKYRAKVSDFGTSR 499 (686)
Q Consensus 471 ~ivH~Dikp~NIll------~~~~~~kl~DfGla~ 499 (686)
.++|+|+.+.|||+ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999999884
|
| >4a0p_A LRP6, LRP-6, low-density lipoprotein receptor-related protein; signaling, WNT signalling, WNT3A, DKK1, MESD; HET: NAG; 1.90A {Homo sapiens} PDB: 3s2k_A* 3s8z_A* 3s8v_A* | Back alignment and structure |
|---|
Probab=91.37 E-value=0.071 Score=60.02 Aligned_cols=43 Identities=28% Similarity=0.689 Sum_probs=35.0
Q ss_pred CCCcccCCCCCccccccccCC-cceEEeCCCCccCCCCCCCCCccCC
Q 038345 223 DVNEFEDPSLNNCTHICDNTA-GNYTCRCPKGFRGDGRRDGGGCIPN 268 (686)
Q Consensus 223 ~~~~c~~~~~~~c~~~C~~~~-g~~~C~C~~g~~~~~~~~~~~C~~~ 268 (686)
++|+|.. +...|++.|.+++ |+|.|.|++||... .++..|.+.
T Consensus 264 ~~n~C~~-~ng~C~~~C~~~~~~~~~C~C~~g~~l~--~d~~~C~~~ 307 (628)
T 4a0p_A 264 GWNECAS-SNGHCSHLCLAVPVGGFVCGCPAHYSLN--ADNRTCSAP 307 (628)
T ss_dssp CCCTTTT-TGGGCSSEEEEETTTEEEEECSTTCEEC--TTSSCEECC
T ss_pred cceEecc-CCCCcchhhhcCCCCCeeEEcCCCcEec--ccCCcCccc
Confidence 5788975 4578999999999 99999999999765 466678653
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=90.77 E-value=0.11 Score=37.25 Aligned_cols=31 Identities=23% Similarity=0.627 Sum_probs=23.3
Q ss_pred ccCCCCCccc--cccc--cCCcceEEeCCCCccCC
Q 038345 227 FEDPSLNNCT--HICD--NTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 227 c~~~~~~~c~--~~C~--~~~g~~~C~C~~g~~~~ 257 (686)
|......+|. ++|. +..++|.|.|++||.|.
T Consensus 6 C~~~~~~pC~nGG~C~~~~~~~~~~C~C~~GytG~ 40 (53)
T 1nql_B 6 CPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGE 40 (53)
T ss_dssp CCSTTCCEECTTCEEEEETTTTEEEEEECTTEEST
T ss_pred cCCCCCCCCCCCeEEeeecCCCCEEEecCCCCcCC
Confidence 4333345674 5897 77889999999999986
|
| >2gy5_A Angiopoietin-1 receptor; ligand-binding domain, transferase; HET: NAG NDG; 2.90A {Homo sapiens} PDB: 2gy7_B* | Back alignment and structure |
|---|
Probab=90.29 E-value=0.22 Score=52.78 Aligned_cols=59 Identities=25% Similarity=0.693 Sum_probs=37.0
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCC-------CcccCCCCCccc--cccccCCcceEEeCCCCccCCCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV-------NEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~-------~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~ 259 (686)
.|.++..|. .++|.|.|++||.|. .|+.. +.|..+ .+|. ++|.+..+ |.|++||.+..+
T Consensus 251 ~C~~~g~C~--~~~~~C~C~~G~~G~-----~C~~~C~~G~~G~~C~~~--C~C~ngg~C~~~~~---C~C~~G~~G~~C 318 (423)
T 2gy5_A 251 GCKSYVFCL--PDPYGCSCATGWKGL-----QCNEACHPGFYGPDCKLR--CSCNNGEMCDRFQG---CLCSPGWQGLQC 318 (423)
T ss_dssp TTTTCCEEE--TTTTEEECCBTCBSG-----GGCBCCCTTBCSBTTCCB--CCCTTCCEEETTTE---EECCTTCBSTTS
T ss_pred CCCCCCEEC--CCCCeEEeCCCcccc-----cccCccCCCCcCCccccc--ccCCCCCEecCCCc---eECCCCCcCCCC
Confidence 455545553 468999999999983 35430 123211 1353 47877654 999999998743
|
| >3k6s_B Integrin beta-2; cell receptor, adhesion molecule, cell adhesion, pyrrolidone carboxylic acid; HET: NAG MAN; 3.50A {Homo sapiens} PDB: 3k71_B* 3k72_B* | Back alignment and structure |
|---|
Probab=90.08 E-value=0.13 Score=57.77 Aligned_cols=60 Identities=22% Similarity=0.594 Sum_probs=41.9
Q ss_pred CCCC--CCCCccCCCCceecCCCCcccCCCCCCCCc---CCCcccCCCCCccc--cccccCCcceEEeCCCCccCCCCCC
Q 038345 189 SCDK--SKDNTTTSSGYHCKCNKGYEGNPYLSDGCR---DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGDGRRD 261 (686)
Q Consensus 189 ~C~~--~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~---~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~ 261 (686)
.|.+ ++.|.. ..|.|.+||+|. .|+ +++.|.......|. ++|.+ ..|.|.+||.|..+..
T Consensus 526 ~C~~~~~G~C~~----g~C~C~~G~~G~-----~Cec~~~~~~C~~~~g~~Cs~~G~C~~----g~C~C~~Gy~G~~Ce~ 592 (687)
T 3k6s_B 526 VCGGPGRGLCFC----GKCRCHPGFEGS-----ACQCERTTEGCLNPRRVECSGRGRCRC----NVCECHSGYQLPLCQE 592 (687)
T ss_dssp ETSHHHHEEEET----TEEEECTTCCST-----TSCSCCSSCTTBCTTCSBTSSSCCBCS----SCBCCSTTCCTTTTCC
T ss_pred CcCCCCCCeEEC----CEEEcCCCCcCC-----CCccCCCCCCCCCCCCCCCCCCCcCCC----CEEECCCCCcCCCCCC
Confidence 4655 556653 289999999984 465 45678754445674 57877 4699999999875543
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=89.35 E-value=0.13 Score=38.43 Aligned_cols=32 Identities=31% Similarity=0.658 Sum_probs=23.9
Q ss_pred CcccCCCCCccc--ccccc-----CCcceEEeCCCCccCCCC
Q 038345 225 NEFEDPSLNNCT--HICDN-----TAGNYTCRCPKGFRGDGR 259 (686)
Q Consensus 225 ~~c~~~~~~~c~--~~C~~-----~~g~~~C~C~~g~~~~~~ 259 (686)
|+|.. .+|. ++|.+ ..++|.|.|++||.|..+
T Consensus 7 ~~C~~---~pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G~~C 45 (63)
T 1hae_A 7 AEKEK---TFCVNGGECFMVKDLSNPSRYLCKCQPGFTGARC 45 (63)
T ss_dssp CHHHH---TTSCTTCEEEEEESSSSSCCEEEECCTTEESTTS
T ss_pred CCCCC---CcCCCCcEEecCCccCCCCCEEEECCCCCcCCcc
Confidence 45543 4674 58986 678999999999998743
|
| >1q4g_A Prostaglandin G/H synthase 1; cyclooxygenase, non-steroidal anti-inflammatory drug, peroxi prostaglandin synthase, EGF-like domain; HET: BOG NAG NDG BMA MAN BFL HEM; 2.00A {Ovis aries} SCOP: a.93.1.2 g.3.11.1 PDB: 1diy_A* 2ayl_A* 3kk6_A* 3n8v_A* 3n8w_A* 3n8x_A* 3n8y_A* 3n8z_A* 2oyu_P* 2oye_P* 1eqg_A* 1cqe_A* 1eqh_A* 1igz_A* 1igx_A* 1fe2_A* 1pge_A* 1pgf_A* 1pgg_A* 3n8w_B* ... | Back alignment and structure |
|---|
Probab=89.09 E-value=0.11 Score=57.18 Aligned_cols=35 Identities=26% Similarity=0.681 Sum_probs=29.5
Q ss_pred cccCCCCCCCCCCCCcc-CCCCceecCC-CCcccCCCCCCCCc
Q 038345 182 KICGPNASCDKSKDNTT-TSSGYHCKCN-KGYEGNPYLSDGCR 222 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~-~~~~y~C~C~-~Gy~gnpy~~~gC~ 222 (686)
++|.++ +|.+++.|.+ ..++|.|.|. .||+| ..|+
T Consensus 3 d~C~~~-PC~ngG~C~~~~~~~y~C~C~~~G~~G-----~~Ce 39 (553)
T 1q4g_A 3 NPCCYY-PCQHQGICVRFGLDRYQCDCTRTGYSG-----PNCT 39 (553)
T ss_dssp CGGGGC-CCCTTCEEEEETTTEEEEECTTSSEET-----TTTC
T ss_pred CcCCCC-CCCCCCCcCCCCCCceEeeCCCCCcCC-----CCCC
Confidence 456655 8999999998 8889999999 99998 4585
|
| >3s94_A LRP-6, low-density lipoprotein receptor-related protein; WNT, LDL receptor-like protein, dickko YWTD B-propeller, signaling protein; HET: NAG; 2.80A {Homo sapiens} PDB: 4dg6_A* | Back alignment and structure |
|---|
Probab=88.96 E-value=0.16 Score=57.11 Aligned_cols=42 Identities=29% Similarity=0.601 Sum_probs=33.7
Q ss_pred CCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCccC
Q 038345 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 223 ~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
..|+|.. ....|.+.|.+++++|.|.|+.||... .++..|.+
T Consensus 577 ~~~~C~~-~ng~C~~~C~~~~~~~~C~C~~g~~l~--~d~~~C~~ 618 (619)
T 3s94_A 577 GSNPCAE-ENGGCSHLCLYRPQGLRCACPIGFELI--SDMKTCIV 618 (619)
T ss_dssp CCCGGGS-GGGGCSSEEEEETTEEEEECCTTCEEC--SSTTCEEC
T ss_pred ccccCCC-CCCChhHhhccCCCCeEEECCCCCEEC--CCCCcCCC
Confidence 4678875 357899999999999999999999765 45666754
|
| >1g1s_A P-selectin; selectin, lectin, EGF, sulphated, SLEX, immune system, membr protein; HET: TYS SIA GAL NAG FUC NGA; 1.90A {Homo sapiens} SCOP: d.169.1.1 g.3.11.1 PDB: 1g1r_A* 1g1q_A* 1fsb_A | Back alignment and structure |
|---|
Probab=88.83 E-value=0.16 Score=46.11 Aligned_cols=34 Identities=35% Similarity=0.575 Sum_probs=25.7
Q ss_pred Cccc--cccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 233 NNCT--HICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 233 ~~c~--~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
.+|. ++|.++.++|.|.|++||.|+.+.+...|.
T Consensus 125 ~~C~~~g~C~~~~~~~~c~C~~g~~G~~Ce~~~~c~ 160 (162)
T 1g1s_A 125 MSCSKQGECLETIGNYTCSCYPGFYGPECEYVRDDD 160 (162)
T ss_dssp TGGGGSEEEEECSSSEEEEECTTEESTTSCEECC--
T ss_pred CCCCCCCEEecCCCCceEeCCCCCcCcccccCcccC
Confidence 4564 589999999999999999998655544554
|
| >1szb_A Mannose binding lectin-associated serine protease-2 related protein, MAP19 (19KDA)...; calcium, complement, innate immunity, CUB, EGF; 2.50A {Homo sapiens} SCOP: b.23.1.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=88.79 E-value=0.11 Score=47.62 Aligned_cols=31 Identities=26% Similarity=0.708 Sum_probs=23.2
Q ss_pred CCCCCCCccCCCCceecCCCCcccCCCCCCCCcC
Q 038345 190 CDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD 223 (686)
Q Consensus 190 C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~ 223 (686)
|.. .|.++.++|.|.|.+||+..+. ...|++
T Consensus 137 C~~--~C~n~~g~~~C~C~~Gy~l~~d-~~~C~~ 167 (170)
T 1szb_A 137 CDH--HCHNHLGGFYCSCRAGYVLHRN-KRTCSE 167 (170)
T ss_dssp SSS--EEEEETTEEEEECCTTEEECTT-SSCEEE
T ss_pred cCC--ccccCCCCEEEeCCCCcEECCC-CCcccc
Confidence 754 6888899999999999986442 345554
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.62 E-value=0.046 Score=37.26 Aligned_cols=23 Identities=30% Similarity=0.492 Sum_probs=11.0
Q ss_pred hcccccchhhHHHHHHhheeeEE
Q 038345 277 LGAGCSGGLGLLFLIVGIWGLYK 299 (686)
Q Consensus 277 i~igi~~~~~~l~llv~i~~l~~ 299 (686)
|..++.+|+.++++++++++++.
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~ 35 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFM 35 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeehhHHHHHHHHHHHHHHHHh
Confidence 44444444555555555544443
|
| >3e50_C Protransforming growth factor alpha; IDE, TGF-alpha, cytoplasm, hydrolase, metal-binding, metalloprotease, polymorphism, protease, zinc; 2.30A {Homo sapiens} SCOP: g.3.11.1 PDB: 1yuf_A 1yug_A 2tgf_A 1mox_C 3tgf_A 4tgf_A | Back alignment and structure |
|---|
Probab=88.50 E-value=0.2 Score=35.38 Aligned_cols=31 Identities=23% Similarity=0.557 Sum_probs=23.5
Q ss_pred CCCCCCCCcc--CCCCceecCCCCcccCCCCCCCCcCCC
Q 038345 189 SCDKSKDNTT--TSSGYHCKCNKGYEGNPYLSDGCRDVN 225 (686)
Q Consensus 189 ~C~~~~~c~~--~~~~y~C~C~~Gy~gnpy~~~gC~~~~ 225 (686)
.|.++ .|.. ....+.|.|.+||.| ..|+-.+
T Consensus 15 yC~nG-~C~~~~~~~~~~C~C~~gy~G-----~RCe~~d 47 (50)
T 3e50_C 15 FCFHG-TCRFLVQEDKPACVCHSGYVG-----ARCEHAD 47 (50)
T ss_pred cccCC-EEeeccCCCCeEEECCCCCcc-----cCCCcee
Confidence 78877 8863 456899999999998 4576443
|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=88.24 E-value=0.083 Score=38.77 Aligned_cols=25 Identities=24% Similarity=0.583 Sum_probs=20.6
Q ss_pred CCCCCCCCc--c--CCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--T--TSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~--~~~~y~C~C~~Gy~g 213 (686)
.|.+++.|. . ...+|.|.|.+||.|
T Consensus 15 pC~NGGtC~~~~~~~~~~~~C~C~~Gf~G 43 (58)
T 3ltf_D 15 YCLNDAHCFAVKIADLPVYSCECAIGFMG 43 (58)
T ss_dssp TSCSSCEEEEEEETTEEEEEEEECTTEES
T ss_pred cCCCCCEEeCCccCCCCCEEeECCCCCcc
Confidence 588888887 2 456799999999998
|
| >3nt1_A Prostaglandin-endoperoxide synthase 2; prostaglandin H2 synthase, cyclooxygenase-2, naproxen, oxido; HET: NAG BOG NPS HEM; 1.73A {Mus musculus} PDB: 3ln1_A* 3mqe_A* 3ln0_A* 3ntb_A* 3q7d_A* 4fm5_A* 1pxx_A* 3pgh_A* 1cx2_A* 4cox_A* 5cox_A* 6cox_A* 3qh0_A* 3qmo_A* 4e1g_A* 3olu_A* 3olt_A* 3hs5_A* 3hs6_A* 3hs7_A* ... | Back alignment and structure |
|---|
Probab=88.03 E-value=0.13 Score=56.70 Aligned_cols=35 Identities=26% Similarity=0.801 Sum_probs=28.4
Q ss_pred cccCCCCCCCCCCCCcc-CCCCceecCC-CCcccCCCCCCCCc
Q 038345 182 KICGPNASCDKSKDNTT-TSSGYHCKCN-KGYEGNPYLSDGCR 222 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~-~~~~y~C~C~-~Gy~gnpy~~~gC~ 222 (686)
++|.++ +|.+++.|.+ ..++|.|.|. +||.| ..|+
T Consensus 2 d~C~s~-PC~ngG~C~~~~~~~y~C~C~~~G~~G-----~~Ce 38 (587)
T 3nt1_A 2 NPCCSN-PCQNRGECMSTGFDQYKCDCTRTGFYG-----ENCT 38 (587)
T ss_dssp CTTTTC-CCCTTCEEEEEETTEEEEECTTSSEET-----TTTC
T ss_pred CCCCCC-CCCCCCEeeCCCCCCeEEecCCCCccC-----CCCC
Confidence 467665 8999999985 4479999999 99998 4575
|
| >3f1s_B Vitamin K-dependent protein Z; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.81 E-value=0.27 Score=49.20 Aligned_cols=44 Identities=20% Similarity=0.520 Sum_probs=32.3
Q ss_pred cccCCC--CCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCccc
Q 038345 182 KICGPN--ASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEFE 228 (686)
Q Consensus 182 ~~c~~~--~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c~ 228 (686)
++|... +.| ...|.++.++|+|.|.+||..++ ....|...++|.
T Consensus 3 ~eC~~~~~~~C--~~~C~~~~~~~~C~C~~G~~l~~-d~~sC~p~~~c~ 48 (283)
T 3f1s_B 3 NECHPERTDGC--QHFCLPGQESYTCSCAQGYRLGE-DHKQCVPHDQCA 48 (283)
T ss_dssp CCCCSSCSSSC--SSBCCCCTTSCCCBCCTTEEECT-TSSCEEECSTTC
T ss_pred CccCCCCCCCC--CCEeeCCCCCeEecCCCCcccCC-CCCccccccccc
Confidence 566544 478 46788889999999999998765 235677776653
|
| >3v64_C Agrin; beta propeller, laminin-G, signaling, protein binding; HET: NAG; 2.85A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=87.46 E-value=0.17 Score=52.33 Aligned_cols=41 Identities=24% Similarity=0.702 Sum_probs=23.2
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCC
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVN 225 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~ 225 (686)
++|..+..|. +.|.++.++|+|.|.+||...| ....|+..+
T Consensus 2 ~ec~~~~~C~--~~C~n~~g~~~C~C~~g~~l~~-d~~~C~~~~ 42 (349)
T 3v64_C 2 NECAEEGYCS--QGCTNSEGAFQCWCEAGYELRP-DRRSCKALG 42 (349)
T ss_dssp -------CCS--SEECCC---CCEECCTTEEECT-TSSCEEESS
T ss_pred cccCCCCCCc--CeeecCCCCeEEECCCCccCCC-CCCcccccc
Confidence 4565445784 5788999999999999998655 235676544
|
| >3sov_A LRP-6, low-density lipoprotein receptor-related protein; beta propeller, protein binding-antagonist complex; HET: NAG FUC; 1.27A {Homo sapiens} PDB: 3soq_A* 3sob_B | Back alignment and structure |
|---|
Probab=87.28 E-value=0.31 Score=49.62 Aligned_cols=41 Identities=27% Similarity=0.596 Sum_probs=30.7
Q ss_pred CCcccCCCCCccccccccCCc--ceEEeCCCCccCCCCCCCCCccC
Q 038345 224 VNEFEDPSLNNCTHICDNTAG--NYTCRCPKGFRGDGRRDGGGCIP 267 (686)
Q Consensus 224 ~~~c~~~~~~~c~~~C~~~~g--~~~C~C~~g~~~~~~~~~~~C~~ 267 (686)
.++|.. +...|++.|...++ +|.|.|+.||... .++..|..
T Consensus 267 ~n~C~~-~ng~Cs~~C~~~~~~~~~~C~C~~g~~l~--~d~~~c~~ 309 (318)
T 3sov_A 267 TNPCGI-DNGGCSHLCLMSPVKPFYQCACPTGVKLL--ENGKTCKD 309 (318)
T ss_dssp CCTTTT-TGGGCSSEEEECSSTTSEEEECSTTCCBC--TTSSCBCC
T ss_pred cccccc-CCCCcceEEecCCCCCCeEEECCCCCEEC--CCCCCCCC
Confidence 466754 34689999999876 7999999999765 45566653
|
| >2vj2_A Jagged-1; signalling, polymorphism, glycoprotein, extracellular, developmental protein, notch signaling pathway, EGF, DSL, notch, calcium, membrane; 2.50A {Homo sapiens} PDB: 2kb9_A | Back alignment and structure |
|---|
Probab=86.19 E-value=0.19 Score=45.97 Aligned_cols=39 Identities=28% Similarity=0.842 Sum_probs=30.5
Q ss_pred Cccc-cccccCCCCCCCCCCCCccC-CCCceecCCCCcccC
Q 038345 176 ETCE-EAKICGPNASCDKSKDNTTT-SSGYHCKCNKGYEGN 214 (686)
Q Consensus 176 ~~c~-~~~~c~~~~~C~~~~~c~~~-~~~y~C~C~~Gy~gn 214 (686)
..|+ +.++|.....|.+++.|+++ .++|+|.|++||.|.
T Consensus 125 ~~C~~~~~~C~~~~~C~~~g~C~~~~~~~~~C~C~~G~~G~ 165 (169)
T 2vj2_A 125 QLCDKDLNYCGTHQPCLNGGTCSNTGPDKYQCSCPEGYSGP 165 (169)
T ss_dssp TTTCEESCHHHHTCCCCTTCEEEECSTTCEEEECCTTCCST
T ss_pred CcccCCCCCCCCCCCCCCCCEEcCCCCCCcEeECCCCCcCc
Confidence 3565 56777653489888999875 788999999999983
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.90 E-value=0.083 Score=35.92 Aligned_cols=23 Identities=30% Similarity=0.566 Sum_probs=12.0
Q ss_pred hcccccchhhHHHHHHhheeeEE
Q 038345 277 LGAGCSGGLGLLFLIVGIWGLYK 299 (686)
Q Consensus 277 i~igi~~~~~~l~llv~i~~l~~ 299 (686)
|..|+.+|+.++++++++++++.
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~ 34 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYV 34 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHHHHHHHHh
Confidence 44455555555555555555444
|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
Probab=85.77 E-value=0.49 Score=40.61 Aligned_cols=60 Identities=22% Similarity=0.529 Sum_probs=37.4
Q ss_pred CCCCCCCCccCC--CCc-eecCCCCcccCCCCCCCCc-CCCcccCCCCCccccccccC-CcceEEeCCCCccCCCCCCCC
Q 038345 189 SCDKSKDNTTTS--SGY-HCKCNKGYEGNPYLSDGCR-DVNEFEDPSLNNCTHICDNT-AGNYTCRCPKGFRGDGRRDGG 263 (686)
Q Consensus 189 ~C~~~~~c~~~~--~~y-~C~C~~Gy~gnpy~~~gC~-~~~~c~~~~~~~c~~~C~~~-~g~~~C~C~~g~~~~~~~~~~ 263 (686)
+|.+++.|.+.. .+| +|.|++||.| ..|+ +++ .. |.+. ...|.|.|..++.+ .
T Consensus 2 pC~nggtC~~~~~~~~~~~C~Cp~g~~G-----~~Ce~~~~-------~~----C~~g~G~~YrG~~~~t~sG------~ 59 (122)
T 2fd6_A 2 DCLNGGTCVSNKYFSNIHWCNCPKKFGG-----QHCEIDKS-------KT----CYEGNGHFYRGKASTDTMG------R 59 (122)
T ss_dssp CCCSSCEEEECTTTTTCEEEECCTTEES-----TTSCEESS-------CC----SBCSSCTTCCSCCCBBTTS------C
T ss_pred CCCCcCCcCCCcccCCCCCccCCCCCCC-----ccccccCc-------CC----CcccccccceeeccccccC------C
Confidence 477778887552 566 9999999998 4575 222 12 2222 23577777665544 3
Q ss_pred CccCCcc
Q 038345 264 GCIPNQK 270 (686)
Q Consensus 264 ~C~~~~~ 270 (686)
.|..|..
T Consensus 60 ~Cq~W~s 66 (122)
T 2fd6_A 60 PCLPWNS 66 (122)
T ss_dssp BBCCTTS
T ss_pred cccCccC
Confidence 6877754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.41 E-value=1.8 Score=40.81 Aligned_cols=116 Identities=11% Similarity=0.127 Sum_probs=74.8
Q ss_pred CCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCe
Q 038345 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANI 482 (686)
Q Consensus 403 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NI 482 (686)
.||+++.. ..-.+++...+.|+.-+++.=...+. .++...+++++.+|+....++++. +|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 57888866 34445555555555444332222233 377889999999999988777653 5888999999
Q ss_pred eecCCCcEEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCc
Q 038345 483 LLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIR 553 (686)
Q Consensus 483 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~ 553 (686)
+++.++.+++.-.|+-..+ +|.- .+...=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999877764322 1210 0111111135567888889988875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.92 E-value=3 Score=39.53 Aligned_cols=84 Identities=10% Similarity=0.015 Sum_probs=59.9
Q ss_pred CCCCeeeEEeEEeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeEeeCCCCCC
Q 038345 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF-YLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 403 ~h~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~~~~ivH~Dikp~N 481 (686)
.||++ -...-.+++...+.|+.-+++.-...+. .++...+++++.+|+.... ++++. +|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCce
Confidence 57887 2333355666666666654443333443 3778899999999988777 66643 578899999
Q ss_pred eeecCCCcEEEEecCCcc
Q 038345 482 ILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~ 499 (686)
|+++.++.+++.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998777643
|
| >1xdt_R Hbegf, heparin-binding epidermal growth factor; complex (toxin-growth factor), diphtheria toxin, receptor, H binding epidermal growth factor; 2.65A {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=82.06 E-value=0.41 Score=37.20 Aligned_cols=24 Identities=25% Similarity=0.621 Sum_probs=19.5
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
.|.++ .|. ...+.|.|.|.+||.|
T Consensus 47 yClnG-~C~~i~~~~~~~C~C~~GYtG 72 (79)
T 1xdt_R 47 FCIHG-ECKYVKELRAPSCICHPGYHG 72 (79)
T ss_dssp CCSSE-EECCBGGGTBCCEEECTTEES
T ss_pred cCCCC-EeeeecCCCCeEEEcCCCccc
Confidence 78886 784 3446899999999998
|
| >4aqs_A Laminin subunit beta-1; cell adhesion; HET: NAG BMA MAN FUL; 3.11A {Mus musculus} | Back alignment and structure |
|---|
Probab=81.02 E-value=0.81 Score=50.11 Aligned_cols=50 Identities=22% Similarity=0.568 Sum_probs=11.7
Q ss_pred CCceecCCCCcccCCCCCCCC--------cCCCcccCCCCCccc------cccccCCcceEEeCCCCccCC
Q 038345 201 SGYHCKCNKGYEGNPYLSDGC--------RDVNEFEDPSLNNCT------HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 201 ~~y~C~C~~Gy~gnpy~~~gC--------~~~~~c~~~~~~~c~------~~C~~~~g~~~C~C~~g~~~~ 257 (686)
..+.|.|++||.|.-- +.| .++++|.. .+|. +.|.. ..+.|.|++||.|.
T Consensus 458 ~tg~C~C~~g~~G~~C--e~C~~G~~g~~~~~~~C~~---C~C~~~gs~~~~C~~--~tG~C~C~~G~~G~ 521 (525)
T 4aqs_A 458 ETGYCYCKRLVTGQRC--DQCLPQHWGLSNDLDGCRP---CDCDLGGALNNSCSE--DSGQCSCLPHMIGR 521 (525)
T ss_dssp TTCCBCBCTTCCSTTT--CC---------------------------------------------------
T ss_pred CCCEEECCCCCcCCCc--ccCCCCccCCCCCCCCCcC---CCCCCCCccCCccCC--CCCeeECCCCCcCC
Confidence 3467999999988421 111 13445542 2232 33433 23479999999876
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.57 E-value=0.17 Score=54.61 Aligned_cols=61 Identities=10% Similarity=0.054 Sum_probs=18.4
Q ss_pred cccccCccceEEEEEEEeCC-CcEEEE------EEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee
Q 038345 353 ANRILGQGGQGTVYKGMLAD-GRIVAV------KKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLE 416 (686)
Q Consensus 353 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~ 416 (686)
..+.|| ||.||+|.+.. ..+||+ |..+. ...+....|.+|..++..++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999864 367888 66543 223344678899999999999999999888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 686 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 | |
| d1emoa1 | 43 | g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sa | 3e-08 | |
| d1dx5i3 | 40 | g.3.11.1 (I:423-462) Thrombomodulin, different EGF | 1e-07 | |
| d1uzka1 | 43 | g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sa | 2e-07 | |
| d1lmja2 | 42 | g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapien | 3e-07 | |
| d1lmja1 | 44 | g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens | 3e-07 | |
| d1uzka2 | 43 | g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sa | 3e-07 | |
| d1nzia2 | 42 | g.3.11.1 (A:118-159) Complement C1S component {Hum | 1e-06 | |
| d1i0ua2 | 41 | g.3.11.1 (A:42-82) Low density lipoprotein (LDL) r | 1e-06 | |
| d1szba2 | 45 | g.3.11.1 (A:124-168) Mannose-binding protein assoc | 9e-06 | |
| d1apqa_ | 53 | g.3.11.1 (A:) Complement protease C1R {Human (Homo | 1e-05 | |
| d1autl2 | 50 | g.3.11.1 (L:97-146) Activated protein c (autoproth | 1e-05 | |
| d2p3ua1 | 51 | g.3.11.1 (A:87-137) Factor X, N-terminal module {H | 2e-05 | |
| d1nt0a3 | 45 | g.3.11.1 (A:120-164) Mannose-binding protein assoc | 2e-05 | |
| d1kigl_ | 51 | g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bo | 2e-05 | |
| d3bpse1 | 40 | g.3.11.1 (E:293-332) Low density lipoprotein (LDL) | 3e-05 | |
| d2vj3a1 | 42 | g.3.11.1 (A:411-452) Neurogenic locus notch homolo | 4e-05 | |
| d1gl4a2 | 40 | g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 | 1e-04 | |
| d1gl4a2 | 40 | g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 | 0.002 | |
| d1ijqa2 | 50 | g.3.11.1 (A:643-692) Low density lipoprotein (LDL) | 2e-04 | |
| d1rfnb_ | 57 | g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens | 8e-04 | |
| d2bz6l1 | 53 | g.3.11.1 (L:90-142) Coagulation factor VIIa {Human | 9e-04 | |
| d2c4fl1 | 37 | g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrof | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-69
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 21/290 (7%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQI 402
D E + +G G GTVYKG V + ++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 403 NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALF 462
H NI+ +G ++ +V ++ +LY ++H E L+ IA + + +
Sbjct: 62 RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMD 118
Query: 463 YLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ-THLTTKVQGTFGYVDP 521
YLH+ SI RD+KS NI L + K+ DFG + + +H ++ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 522 EYFQSSQ---FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
E + ++ +SDVY+FG+VL E++TGQ P + + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSP 229
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628
L + + + L CL RP ++ + + S+
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 1e-67
Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 37/303 (12%)
Query: 344 LEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL-VDENNVEQFINEVVILSQ 401
+E D++ LG G G V+K G ++A K L + Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
N IV G + E + G+L Q + I ++L ++++ V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGL 117
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YL I RD+K +NIL++ + K+ DFG S + + GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED--------------------- 560
E Q + ++ +SD++S G+ LVE+ G+ PI + E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 561 --RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTM 614
R L Y + + +FE+LD +V + + + + +CL N R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 615 KEV 617
K++
Sbjct: 293 KQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 8e-66
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 21/273 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
+ LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+L + + ++ E++ NG+L + +T LL +A +++ + ++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
+ RD+++ANIL+ D K++DFG +R I ++ + + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
FT KSDV+SFG++L EI+T + M + + L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+ L + C ++RPT + L
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 1e-65
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 21/279 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+L G CLE LV+EF+ +G L + + E LL + ++V + YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
+ RD+ + N L+ + KVSDFG +R + DQ +T + + PE F S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
++ KSDV+SFGV++ E+ + K + + + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
R V + C ++RP + +L I S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (532), Expect = 5e-63
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 21/283 (7%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQ 401
E + LG G G VY+G+ VAVK K D VE+F+ E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
I H N+V+LLG C ++ EF+ G L + ++ +LL +A ++S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 128
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
YL + RD+ + N L+ + + KV+DFG SR +T D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
E ++F+ KSDV++FGV+L EI T ++ ++++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
E V L + C N +RP+ E+ +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 8e-63
Identities = 65/278 (23%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
+ +G+G G V G G VAVK + ++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 409 KLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
+LLG +E + L +V E++ G+L + + + + LL+ +++V A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 468 ASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSS 527
+ RD+ + N+L+ + AKVSDFG ++ + Q + + PE +
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREK 175
Query: 528 QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587
+F+ KSDV+SFG++L EI + + + + ++ +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDVVPRVEKGYKMD 220
Query: 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
A V + K C +L+ RP+ ++ +L I+
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-62
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
++Y +G G G K +DG+I+ K+ + E + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 406 NIVKLLGCCLETE--VPLLVYEFVPNGTLYQNIHNHIEEF-PITWELLLRIAVEVSGALF 462
NIV+ ++ +V E+ G L I +E + E +LR+ +++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 463 YLH--SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
H S ++ RD+K AN+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580
PE + EKSD++S G +L E+ P A + E + E + F +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-FRRI 234
Query: 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E + R LNL +RP+++E+
Sbjct: 235 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-62
Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 21/273 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
++ LGQG G V+ G VA+K K + E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+L E + +V E++ G+L + ++ L+ +A +++ + Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
+ RD+++ANIL+ + KV+DFG +R I ++ + + PE +
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
FT KSDV+SFG++L E+ T + M + + ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
E ++ L +C + RPT + + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 5e-62
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 21/269 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV 408
+ + LG G G V G VA+K K + ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+L G C + ++ E++ NG L + + LL + +V A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
RD+ + N L++D+ KVSDFG SR + D+ + + + PE S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 529 FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEA 588
F+ KSD+++FGV++ EI + K + + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222
Query: 589 EREEIMTVATLAKRCLNLNGKNRPTMKEV 617
V T+ C + RPT K +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-61
Identities = 74/271 (27%), Positives = 124/271 (45%), Gaps = 23/271 (8%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
Y +GQG GTVY M +A G+ VA+++ L + E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IV L L + +V E++ G+L + + + + E AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
+ RDIKS NILL K++DFG IT +Q+ +T V GT ++ PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
+ K D++S G++ +E++ G+ P N L + N E+ + L
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTPELQNPEKLS 243
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
R+ RCL+++ + R + KE+
Sbjct: 244 AIFRD-------FLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 7e-61
Identities = 73/275 (26%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
NI++L G + L+ E+ P GT+Y+ + + E++ AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS + RDIK N+LL K++DFG S + + GT Y+ PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+ EK D++S GV+ E L G+ P A E +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------------ETYKRIS 217
Query: 585 LKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEV 617
E + +T L R L N RP ++EV
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 252
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 9e-61
Identities = 64/304 (21%), Positives = 117/304 (38%), Gaps = 38/304 (12%)
Query: 339 FTSKDLEKATDN---------YNANRILGQGGQGTVYKGMLA----DGRIVAVKK-SKLV 384
FT +D +A +++G G G V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 385 DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFP 444
E F++E I+ Q +H N++ L G ++ +++ EF+ NG+L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 445 ITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504
T L+ + ++ + YL + RD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 505 QTHLTTK----VQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDED 560
+ T + + PE Q +FT SDV+S+G+V+ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232
Query: 561 RSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFE 620
M + ++ + + L C + +RP ++
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 621 LGGI 624
L +
Sbjct: 287 LDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 3e-60
Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 30/301 (9%)
Query: 351 YNANRILGQGGQGTVYKGMLAD----GRIVAVKK-SKLVDENNVEQFINEVVILSQINHR 405
+ N ++G+G G VY G L D AVK +++ D V QF+ E +I+ +H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 406 NIVKLLGCCLETE-VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
N++ LLG CL +E PL+V ++ +G L E T + L+ ++V+ + +L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT---VDQTHLTTKVQGTFGYVDP 521
S RD+ + N +LD+K+ KV+DFG +R + D H T + ++
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 522 EYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
E Q+ +FT KSDV+SFGV+L E++T P D + + + RL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL--QP 256
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS-IGASILQQNCGVI 640
+ +C + + RP+ E+ + I ++ IG + N +
Sbjct: 257 EYCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYV 308
Query: 641 D 641
+
Sbjct: 309 N 309
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (513), Expect = 5e-60
Identities = 64/291 (21%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 334 EKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNV 389
+ +LF D EK ++ R +G G G VY + + +VA+K S
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 390 EQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWEL 449
+ I EV L ++ H N ++ GC L LV E+ + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 450 LLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT 509
+ + L YLHS ++ RD+K+ NILL + K+ DFG++ +
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168
Query: 510 TKVQGTFGYVDPEYFQSS---QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566
GT ++ PE + Q+ K DV+S G+ +E+ + P+ +N
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------ 222
Query: 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L + +N + + CL ++RPT + +
Sbjct: 223 -LYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-60
Identities = 74/303 (24%), Positives = 136/303 (44%), Gaps = 30/303 (9%)
Query: 342 KDLEKATDNYN-ANRILGQGGQGTVYKGMLA---DGRIVAVKK-SKLVDENNVEQFINEV 396
K L DN A+ LG G G+V +G+ VA+K + ++ + E+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 397 VILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVE 456
I+ Q+++ IV+L+G C + E +LV E G L++ + EE P + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK--VQG 514
VS + YL + RD+ + N+LL +++ AK+SDFG S+++ D ++ T + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 515 TFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNE 573
+ PE +F+ +SDV+S+GV + E L+ GQKP + + E + + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633
+ E E L C ++RP V + S+ + +
Sbjct: 228 GKRME-CPPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278
Query: 634 QQN 636
+
Sbjct: 279 GHH 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-60
Identities = 74/276 (26%), Positives = 128/276 (46%), Gaps = 31/276 (11%)
Query: 354 NRILGQGGQGTVYKGMLAD---GRIVAVK--KSKLVDENNVEQFINEVVILSQINHRNIV 408
++ LG G GTV KG + VAVK K++ D ++ + E ++ Q+++ IV
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
+++G C E E +LV E G L + + + + + ++ + +VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTK--VQGTFGYVDPEYFQS 526
+ RD+ + N+LL ++ AK+SDFG S+++ D+ + + + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 527 SQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
+F+ KSDV+SFGV++ E + GQKP R + E + AM E A
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPAGCP 236
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+E L C + +NRP V L
Sbjct: 237 REMYD--------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 9e-60
Identities = 59/298 (19%), Positives = 114/298 (38%), Gaps = 29/298 (9%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCC 414
+G+G G V++G G VAVK +E + E+ + H NI+ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 415 LETE----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA-- 468
+ LV ++ +G+L+ ++ + +T E ++++A+ + L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 469 ---SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL---TTKVQGTFGYVDPE 522
+I RD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 523 YFQSS------QFTEKSDVYSFGVVLVEILTGQKPIRAINIDE----DRSLVGYFLQAMN 572
S + +++D+Y+ G+V EI + D ++ M
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 573 ENRLFEVLD-ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629
+ + L + + E + +A + + C NG R T + L + G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 3e-59
Identities = 67/312 (21%), Positives = 125/312 (40%), Gaps = 47/312 (15%)
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKK-SKLVDENNVEQFIN 394
LE +N R +G+G G V++ +VAVK + + F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 395 EVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF----------- 443
E ++++ ++ NIVKLLG C + L++E++ G L + + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 444 ----------PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493
P++ L IA +V+ + YL RD+ + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIA 182
Query: 494 DFGTSRSI-TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
DFG SR+I + D ++ PE +++T +SDV+++GVVL EI +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 553 RAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612
+ +E ++ V D +L E + + L + C + +RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADRP 287
Query: 613 TMKEVAFELGGI 624
+ + L +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-59
Identities = 58/273 (21%), Positives = 119/273 (43%), Gaps = 32/273 (11%)
Query: 354 NRILGQGGQGTVYKGMLAD-GRIVAVKK--SKLVDENNVEQFINEVVILSQINHRNIVKL 410
+ +G+G TVYKG+ + VA + + + ++ ++F E +L + H NIV+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 411 LGCCLET----EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
T + +LV E + +GTL + + ++L ++ L +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 467 AASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+ I RD+K NI + K+ D G + + + V GT ++ PE ++
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE-VLDALV 584
++ E DVY+FG+ ++E+ T + P + + N +++ V +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVK 230
Query: 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
++ I V + + C+ N R ++K++
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-59
Identities = 66/276 (23%), Positives = 104/276 (37%), Gaps = 26/276 (9%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRN 406
D + LG G G VYK + A K E +E ++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IVKLL ++ EF G + + E P+T + + + AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
I RD+K+ NIL K++DFG S T + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 527 SQ-----FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581
+ K+DV+S G+ L+E+ + P +N L+
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQP 238
Query: 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ + K+CL N R T ++
Sbjct: 239 SRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-58
Identities = 73/336 (21%), Positives = 135/336 (40%), Gaps = 51/336 (15%)
Query: 320 LLLQQELSSNKSS---VEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML------ 370
L + Q S+ + V+ + E +N ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 371 ADGRIVAVKK-SKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVP 428
VAVK + D + E ++E+ +++Q+ +H NIV LLG C + L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 429 NGTLYQNIHNHIEEF--------------------PITWELLLRIAVEVSGALFYLHSAA 468
G L + + E+F +T+E LL A +V+ + +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT-TKVQGTFGYVDPEYFQSS 527
S RD+ + N+L+ K+ DFG +R I D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 528 QFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586
+T KSDV+S+G++L EI + G P I +D + ++++
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN---------------FYKLIQNGFKM 286
Query: 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622
+ + + + C + + RP+ + LG
Sbjct: 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 69/273 (25%), Positives = 109/273 (39%), Gaps = 24/273 (8%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNVEQFINEVVILSQINHRN 406
++++ + LG+G G V + VAVK + E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+VK G E + L E+ G L+ I I + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD-QTHLTTKVQGTFGYVDPEYFQ 525
I RDIK N+LLD++ K+SDFG + + + L K+ GT YV PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 526 SSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+F E DV+S G+VL +L G+ P + S E + + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
L + L N R T+ ++
Sbjct: 233 DSAPLA--------LLHKILVENPSARITIPDI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-57
Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 28/291 (9%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGMLADG-----RIVAVKK-SKLVDENNVEQFINEVVI 398
E +++G G G VYKGML VA+K E F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 399 LSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVS 458
+ Q +H NI++L G + + +++ E++ NG L + + EF L+ + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 459 GALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ--THLTTKVQGTF 516
+ YL + + RD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 517 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576
+ PE +FT SDV+SFG+V+ E++T + ++ + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627
+ ++ + + L +C RP ++ L + +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 69/287 (24%), Positives = 117/287 (40%), Gaps = 26/287 (9%)
Query: 343 DLEKATDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKK-SKLVDENNVEQFINEVV 397
D E + R +G+G G V++G+ VA+K ++ E+F+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 398 ILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEV 457
+ Q +H +IVKL+G E V ++ E G L + ++ + L+ A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQL 117
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
S AL YL S RDI + N+L+ K+ DFG SR + + +K +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
++ PE +FT SDV+ FGV + EIL Q + N +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK---------------PFQGVKNNDVI 219
Query: 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
++ T+ +L +C + RP E+ +L I
Sbjct: 220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-56
Identities = 57/283 (20%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 346 KATDNYNANRILGQGGQGTVYKGMLAD-----GRIVAVKK-SKLVDENNVEQFINEVVIL 399
K T+ + ++LG G GTVYKG+ VA+K+ + ++ ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 400 SQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
+ +++ ++ +LLG CL + V L+ + +P G L + H + I + LL V+++
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAK 122
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGY 518
+ YL + RD+ + N+L+ K++DFG ++ + ++ + + +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
+ E +T +SDV+S+GV + E++T + + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFEL 621
+L+ + V + +C ++ +RP +E+ E
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-56
Identities = 66/320 (20%), Positives = 123/320 (38%), Gaps = 41/320 (12%)
Query: 329 NKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKK-S 381
N ++ T+L E + + + LG G G V + VAVK
Sbjct: 3 NYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 382 KLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHI 440
E ++E+ +LS + NH NIV LLG C L++ E+ G L +
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 441 EEF---------------PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD 485
+ F + E LL + +V+ + +L S + RD+ + NILL
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179
Query: 486 DKYRAKVSDFGTSRSITVDQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVE 544
K+ DFG +R I D + + + ++ PE + +T +SDV+S+G+ L E
Sbjct: 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239
Query: 545 ILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCL 604
+ + + +++ ++++ + + + K C
Sbjct: 240 LFSLGSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCW 285
Query: 605 NLNGKNRPTMKEVAFELGGI 624
+ + RPT K++ +
Sbjct: 286 DADPLKRPTFKQIVQLIEKQ 305
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 193 bits (491), Expect = 3e-56
Identities = 57/272 (20%), Positives = 109/272 (40%), Gaps = 23/272 (8%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
D+Y+ + LG G G V++ A G A K E++ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
V L + +++YEF+ G L++ + + E ++ + + +V L ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 468 ASISIYRRDIKSANILLDDKY--RAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+ D+K NI+ K K+ DFG + + Q+ T GT + PE +
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
+D++S GV+ +L+G P N DE V M+++ + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK- 257
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
++ L + R T+ +
Sbjct: 258 ------------DFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-56
Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 32/280 (11%)
Query: 345 EKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILS 400
+K +++ +ILG+G TV LA R A+K K ++ EN V E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 401 QINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGA 460
+++H VKL + E + NG L + I E+ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 461 LFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD-QTHLTTKVQGTFGYV 519
L YLH I RD+K NILL++ +++DFGT++ ++ + + GT YV
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
PE + SD+++ G ++ +++ G P RA N + +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------------------YLI 218
Query: 580 LDALVLKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEV 617
++ E + E L ++ L L+ R +E+
Sbjct: 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 38/295 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADG---RIVAVKK-SKLVDENNVEQFINEVVILSQI-N 403
++ ++G+G G V K + A+K+ + +++ F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-------------PITWELL 450
H NI+ LLG C L E+ P+G L + ++ + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510
L A +V+ + YL RD+ + NIL+ + Y AK++DFG SR V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQA 570
+ ++ E S +T SDV+S+GV+L EI++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 571 MNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625
M L+E L E V L ++C RP+ ++ L +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-55
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 31/279 (11%)
Query: 349 DNYNANRILGQGGQGTVYKGML----ADGRIVAVK---KSKLVDENNVEQFINEVVILSQ 401
+ LG G G V +G VAVK L ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
++HRN+++L G L + +V E P G+L + H F L R AV+V+ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH--LTTKVQGTFGYV 519
YL S RD+ + N+LL + K+ DFG R++ + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
PE ++ F+ SD + FGV L E+ T + +N +++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE---------------PWIGLNGSQILHK 226
Query: 580 LDALVLKEAEREEIMT-VATLAKRCLNLNGKNRPTMKEV 617
+D + E+ + + +C ++RPT +
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 185 bits (471), Expect = 2e-54
Identities = 79/289 (27%), Positives = 116/289 (40%), Gaps = 30/289 (10%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQIN 403
+D Y ILG GG V+ L R VAVK D + +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 404 HRNIVKLLGCCLETE----VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
H IV + +P +V E+V TL +H P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQ 122
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL--TTKVQGTFG 517
AL + H I RD+K ANI++ KV DFG +R+I + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
Y+ PE + +SDVYS G VL E+LTG+ P S V Q + E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIR 625
L + + L N +NR T E+ +L +
Sbjct: 234 PSARHEGLSADLDA-------VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (458), Expect = 3e-52
Identities = 62/278 (22%), Positives = 105/278 (37%), Gaps = 20/278 (7%)
Query: 342 KDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNVEQFINEVVIL 399
K E D Y+ +LG G V ++VA+K +K E NE+ +L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 400 SQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
+I H NIV L L+ + V G L+ I T R+ +V
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLD 118
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
A+ YLH + + LD+ + +SDFG S+ D + + GT GYV
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 176
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579
PE +++ D +S GV+ +L G P N + F Q + F+
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYEFDS 230
Query: 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ ++ ++ + + + + R T ++
Sbjct: 231 PYWDDISDSAKD-------FIRHLMEKDPEKRFTCEQA 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (462), Expect = 3e-52
Identities = 53/272 (19%), Positives = 101/272 (37%), Gaps = 23/272 (8%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
D Y+ LG G G V++ + A GR+ K + NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
+ L + +L+ EF+ G L+ I ++ ++ ++ + L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 468 ASISIYRRDIKSANILLD--DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
SI DIK NI+ + K+ DFG + + + + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVD 201
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
+D+++ GV+ +L+G P + E V +E+ V
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK- 260
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
K L + R T+ +
Sbjct: 261 ------------DFIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 5e-52
Identities = 74/299 (24%), Positives = 118/299 (39%), Gaps = 40/299 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM------LADGRIVAVKK-SKLVDENNVEQFINEVVILSQ 401
D + LG+G G V + A R VAVK + + ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 402 INHR-NIVKLLGCCLETEVPL-LVYEFVPNGTLYQNIHNHIEEF-------------PIT 446
I H N+V LLG C + PL ++ EF G L + + EF +T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506
E L+ + +V+ + +L S RD+ + NILL +K K+ DFG +R I D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 507 HL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG 565
++ + ++ PE +T +SDV+SFGV+L EI + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 566 YFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
F + + E D + + C + RPT E+ LG +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-52
Identities = 55/272 (20%), Positives = 103/272 (37%), Gaps = 24/272 (8%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
+ Y LG+G G V++ + + + K K+ + E+ IL+ HRNI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
+ L E ++++EF+ +++ I+ F + ++ +V AL +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH 121
Query: 468 ASISIYRRDIKSANILLDDK--YRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
+I DI+ NI+ + K+ +FG +R + Y PE Q
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQ 176
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585
+ +D++S G ++ +L+G P A + + +E E+ +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM- 235
Query: 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
R L K+R T E
Sbjct: 236 ------------DFVDRLLVKERKSRMTASEA 255
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 67/307 (21%), Positives = 126/307 (41%), Gaps = 33/307 (10%)
Query: 333 VEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGML------ADGRIVAVKK-SKLVD 385
++ + E A + +R LGQG G VY+G+ VA+K ++
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 386 ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-- 443
+F+NE ++ + N ++V+LLG + + L++ E + G L + +
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 444 -----PITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498
P + ++++A E++ + YL++ RD+ + N ++ + + K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 499 RSIT-VDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINI 557
R I D K ++ PE + FT SDV+SFGVVL EI T +
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------ 234
Query: 558 DEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
Q ++ ++ + L + + L + C N K RP+ E+
Sbjct: 235 ---------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 618 AFELGGI 624
+
Sbjct: 286 ISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 69/302 (22%), Positives = 118/302 (39%), Gaps = 42/302 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGML--------ADGRIVAVKKSKL-VDENNVEQFINEVVIL 399
D + LG+G G V VAVK K E ++ I+E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 400 SQI-NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHN-------------HIEEFPI 445
I H+NI+ LLG C + ++ E+ G L + + H E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 446 TWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505
+ + L+ A +V+ + YL S RD+ + N+L+ + K++DFG +R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 506 THLTTKVQ-GTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV 564
+ T ++ PE +T +SDV+SFGV+L EI T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 565 GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624
+ LF++L + + + + C + RPT K++ +L I
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 625 RA 626
A
Sbjct: 295 VA 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (443), Expect = 2e-50
Identities = 66/286 (23%), Positives = 114/286 (39%), Gaps = 38/286 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK---------SKLVDENNVEQFINEVVI 398
+NY ILG+G V + + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 399 LSQIN-HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEV 457
L +++ H NI++L LV++ + G L+ + + ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFG 517
+ LH +I RD+K NILLDD K++DFG S + D +V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174
Query: 518 YVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571
Y+ PE + S + ++ D++S GV++ +L G P M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIM 228
Query: 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ N F + + ++ L R L + + R T +E
Sbjct: 229 SGNYQFGSPEWDDYSDTVKD-------LVSRFLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 167 bits (423), Expect = 2e-47
Identities = 58/283 (20%), Positives = 108/283 (38%), Gaps = 20/283 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRN 406
+ Y+ +G+G G VYK G A+KK +L DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 407 IVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
IVKL + +LV+E + E + +++ + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 467 AASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQS 526
+ RD+K N+L++ + K++DFG +R+ + T ++ + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 527 SQFTEKSDVYSFGVVLVEILTGQKP------------IRAINIDEDRSLVGYFLQAMNEN 574
+++ D++S G + E++ G I I + + +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
F V + L + + + L + L L+ R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 2e-47
Identities = 63/273 (23%), Positives = 110/273 (40%), Gaps = 29/273 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILS-QIN 403
+++ +++LG+G G V+ + A+K K ++ +++VE + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 404 HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFY 463
H + + E V E++ G L +I + A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118
Query: 464 LHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
LHS I RD+K NILLD K++DFG + + T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 524 FQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583
++ D +SFGV+L E+L GQ P + +E ++ + F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRW 225
Query: 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKE 616
+ KEA+ L + + R ++
Sbjct: 226 LEKEAKD--------LLVKLFVREPEKRLGVRG 250
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 2e-46
Identities = 58/282 (20%), Positives = 115/282 (40%), Gaps = 35/282 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVK---KSKLVDENNVEQFINEVV---ILSQ 401
++++ +RI+G+GG G VY AD G++ A+K K ++ + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 402 INHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+ IV + + + + + G L+ ++ H + + A E+ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 462 FYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDP 521
++H+ + RD+K ANILLD+ ++SD G + + + H GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 522 EYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580
E Q + +D +S G +L ++L G P + E+
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP----------------FRQHKTKDKHEID 218
Query: 581 DALVLKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEVAFE 620
+ E + + + +L + L + R +
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 2e-46
Identities = 60/281 (21%), Positives = 106/281 (37%), Gaps = 25/281 (8%)
Query: 355 RILGQGGQGTVYKGM-LADGRIVAVKKSKL-----VDENNVEQFINEVVILSQINHRNIV 408
LG+G TVYK +IVA+KK KL + + E+ +L +++H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 409 KLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA 468
LL LV++F+ N +T + + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 469 SISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ 528
I RD+K N+LLD+ K++DFG ++S T +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 529 -FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587
+ D+++ G +L E+L + + + + + L E + ++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 588 AEREEIMTVAT-----------LAKRCLNLNGKNRPTMKEV 617
+ + + L + N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 54/289 (18%), Positives = 112/289 (38%), Gaps = 22/289 (7%)
Query: 348 TDNYNANRILGQGGQGTVYKGM-LADGRIVAVKK-SKLVDENNVEQFINEVVILSQINHR 405
Y +G+G G V + VA+KK S + ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
NI+ + + + ++ + +++ ++ ++ + + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLT--TKVQGTFGYVDPEY 523
SA ++ RD+K +N+LL+ K+ DFG +R D H T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 524 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAIN--------------IDEDRSLVGYFL 568
+S+ +T+ D++S G +L E+L+ + + ++ L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 569 QAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+A N + + L + L N R +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-46
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
+N+ +G+G G VYK G +VA+KK +L E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
NIVKLL LV+EF+ + + P L+ ++ L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
S + RD+K N+L++ + K++DFG +R+ V T +V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKP------------IRAINIDEDRSLVGYFLQAMNE 573
++ D++S G + E++T + I D + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 574 NRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
F + +L + L+ + R + K
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 66/291 (22%), Positives = 107/291 (36%), Gaps = 35/291 (12%)
Query: 338 LFTSKDLEKATDNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENN---VE 390
+F ++++ D Y+ LG G V K + G A K K + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 391 QFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELL 450
EV IL +I H N++ L +L+ E V G L+ + +T E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEA 115
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD----KYRAKVSDFGTSRSITVDQT 506
++ ++YLHS I D+K NI+L D K R K+ DFG + I D
Sbjct: 116 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFG 170
Query: 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGY 566
+ + GT +V PE ++D++S GV+ +L+G P E + V
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230
Query: 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ +R L + K R T+++
Sbjct: 231 VNYEFEDEYFSNTSALAK-------------DFIRRLLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (411), Expect = 2e-45
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
++ R LG G G V+ +GR A+K K +V VE +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
I+++ G + + ++ +++ G L+ + + A EV AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS I RD+K NILLD K++DFG ++ + +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ + + D +SFG+++ E+L G P N +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-44
Identities = 61/292 (20%), Positives = 108/292 (36%), Gaps = 25/292 (8%)
Query: 346 KATDNYNANRILGQGGQGTVYKG--MLADGRIVAVK--KSKLVDENNVEQFINEVVILSQ 401
+A Y +G+G G V+K + GR VA+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 402 I---NHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHI---EEFPITWELLLRIAV 455
+ H N+V+L C + + + Q++ ++ E + E + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 456 EVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGT 515
++ L +LHS + RD+K NIL+ + K++DFG +R + T V T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 516 FGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575
Y PE S + D++S G + E+ + R + + + + E
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 576 LFEV--LDALVLKEAEREEIMTVAT--------LAKRCLNLNGKNRPTMKEV 617
L + I T L +CL N R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-44
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 30/279 (10%)
Query: 349 DNYN-ANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHR 405
D+Y +++LG G G V + A+K + + + EV + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 65
Query: 406 NIVKLLGCC----LETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
+IV+++ + L+V E + G L+ I + ++ T I + A+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAI 124
Query: 462 FYLHSAASISIYRRDIKSANILLDDKY---RAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
YLHS I+I RD+K N+L K K++DFG ++ T + T T Y
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 179
Query: 519 VDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578
V PE ++ + D++S GV++ +L G P + + + M +
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPN 238
Query: 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
+ V +E + L + L R T+ E
Sbjct: 239 PEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-44
Identities = 66/289 (22%), Positives = 114/289 (39%), Gaps = 28/289 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGMLAD-GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
+Y +++G G G VY+ L D G +VA+KK + E+ I+ +++H NI
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 408 VKLLGCCLETEVP------LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGAL 461
V+L + LV ++VP H + + + ++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 462 FYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVD 520
Y+HS I RDIK N+LLD D K+ DFG+++ + + +++ + +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 521 PEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL---- 576
F ++ +T DV+S G VL E+L GQ + + + L ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 577 -------FEVLDALVLKEAEREEIMTVAT-LAKRCLNLNGKNRPTMKEV 617
F + A + R A L R L R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 55/285 (19%), Positives = 110/285 (38%), Gaps = 22/285 (7%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
Y +G+G GTV+K IVA+K+ +L DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 406 NIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLH 465
NIV+L + LV+EF + + E++ ++ L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 466 SAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQ 525
S ++ RD+K N+L++ K+++FG +R+ + + +V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 526 SSQFTEKSDVYSFGVVLVEILTGQKPI-RAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584
+ ++ D++S G + E+ +P+ ++D+ + L E + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 585 LKEAEREEIMTVAT------------LAKRCLNLNGKNRPTMKEV 617
K T L + L N R + +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (382), Expect = 1e-41
Identities = 52/280 (18%), Positives = 94/280 (33%), Gaps = 28/280 (10%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
+ Y R +G G G +Y G +A G VA+K + + Q E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 408 VKLLG-CCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS 466
+ + C E + ++V E + + + +L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS 121
Query: 467 AASISIYRRDIKSANIL---LDDKYRAKVSDFGTSRSITVDQTH------LTTKVQGTFG 517
+ RD+K N L + DFG ++ +TH + GT
Sbjct: 122 K---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 518 YVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
Y + + + D+ S G VL+ G P + + R + +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KKMSTPI 237
Query: 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
EVL E C +L ++P +
Sbjct: 238 EVLCKGYPSEFAT--------YLNFCRSLRFDDKPDYSYL 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 56/301 (18%), Positives = 118/301 (39%), Gaps = 28/301 (9%)
Query: 339 FTSKDLEKAT----DNYNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQ 391
F +++ K Y + +G G G V + G VA+K E ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 392 FINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEF-PITWELL 450
E+ +L + H N++ LL E +F + + + + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 451 LRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTT 510
+ ++ L Y+H+A I RD+K N+ +++ K+ DFG +R + +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV------ 564
V + ++T+ D++S G ++ E++TG+ + + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 565 --GYFLQAMNENRLFEVLDALV-LKEAEREEIMTVAT-----LAKRCLNLNGKNRPTMKE 616
F+Q + + + L L++ + I+T A+ L ++ L L+ + R T E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 617 V 617
Sbjct: 298 A 298
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-41
Identities = 63/282 (22%), Positives = 118/282 (41%), Gaps = 46/282 (16%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK------SKLVDENNVEQFINEVVILSQ 401
Y +LG GG G+VY G+ ++D VA+K S + N + EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 402 IN--HRNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
++ +++LL + +L+ E + E + EL +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121
Query: 460 ALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGY 518
A+ + H+ + RDIK NIL+D ++ K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 519 VDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577
PE+ + ++ + V+S G++L +++ G P F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-------------------------F 210
Query: 578 EVLDALVLKEAEREEIMT--VATLAKRCLNLNGKNRPTMKEV 617
E + ++ + + ++ L + CL L +RPT +E+
Sbjct: 211 EHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-41
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 11/215 (5%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVK---KSKLVDENNVEQFINEVVILSQINH 404
++++ ++LG+G G V A GR A+K K ++ ++ V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
+ L + V E+ G L+ ++ T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYL 121
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYF 524
HS + RDIK N++LD K++DFG + D + T GT Y+ PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 525 QSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDE 559
+ + + D + GVV+ E++ G+ P + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 58/299 (19%), Positives = 114/299 (38%), Gaps = 36/299 (12%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKL--VDENNVEQFINEVVILSQINHR 405
Y +GQG G V+K G+ VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 406 NIVKLLGCCLETEVP--------LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEV 457
N+V L+ C P LV++F + + + T + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 458 SGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT---HLTTKVQG 514
L L+ I RD+K+AN+L+ K++DFG +R+ ++ + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 515 TFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFL----- 568
T Y PE + + D++ G ++ E+ T ++ +L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 569 ---QAMNENRLFEVLDALVLKEAEREEIMTVAT-------LAKRCLNLNGKNRPTMKEV 617
++ L+E L+ + ++ + ++ + L + L L+ R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 2e-39
Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 323 QQELSSNKSSVEKTKLFTSKDLEKAT------DNYNANRILGQGGQGTVYKGM-LADGRI 375
E S K + K K K E + D ++ + LG G G V G
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 376 VAVK---KSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPNGTL 432
A+K K K+V +E +NE IL +N +VKL + +V E+V G +
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKV 492
+ ++ + A ++ YLHS + RD+K N+L+D + +V
Sbjct: 129 FSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182
Query: 493 SDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPI 552
+DFG ++ + + GT + PE S + + D ++ GV++ E+ G P
Sbjct: 183 TDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 553 RAINIDE 559
A +
Sbjct: 239 FADQPIQ 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 6e-38
Identities = 43/281 (15%), Positives = 91/281 (32%), Gaps = 28/281 (9%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI 407
+Y R +G+G G +++G L + + VA+K ++ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 408 VKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA 467
+ + + + ++ + +L + + + + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 468 ASISIYRRDIKSANILLDDKYR-----AKVSDFGTSRSITVDQT------HLTTKVQGTF 516
S+ RDIK N L+ V DFG + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 517 GYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576
Y+ + + + D+ + G V + L G P + + ++ R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERI 228
Query: 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEV 617
E + L+E NL P +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (350), Expect = 6e-37
Identities = 54/296 (18%), Positives = 104/296 (35%), Gaps = 41/296 (13%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRN 406
D+Y R LG+G V++ + + + V VK + ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 407 IVKLLGCCLE--TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
I+ L + + P LV+E V N Q +T + E+ AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 465 HSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEY 523
HS I RD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 524 FQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAIN----------------IDEDRSLVGY 566
Q + D++S G +L ++ ++P + D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVAT-----LAKRCLNLNGKNRPTMKEV 617
N + + E + + + L + ++R T +E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 2e-35
Identities = 60/303 (19%), Positives = 112/303 (36%), Gaps = 45/303 (14%)
Query: 349 DNYNANRILGQGGQGTVYKGM-LADGRIVAVKK--SKLVDENNVEQFINEVVILSQINHR 405
Y + +G G QG V R VA+KK ++ + ++ E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 406 NIVKLLGCCL------ETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSG 459
NI+ LL E + LV E + E + + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 460 ALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHLTTKVQGTFGYV 519
+ +LHSA I RD+K +NI++ K+ DFG +R+ + + T T Y
Sbjct: 131 GIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 520 DPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL--- 576
PE + E D++S G ++ E++ + + + + V L +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 577 ------------------FEVLDALVLKEAEREEIMTVATLAK----RCLNLNGKNRPTM 614
F L L A+ E A+ A+ + L ++ R ++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 615 KEV 617
+
Sbjct: 306 DDA 308
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 69/314 (21%), Positives = 117/314 (37%), Gaps = 42/314 (13%)
Query: 320 LLLQQELSSNKSSVEKTKLFTSKDLEKATDNYNANRILGQGGQGTVYKGMLA----DGRI 375
L ++ EL + + K+ +N+ ++LG G G V+ G++
Sbjct: 3 LTVKHELRTANLTGHAEKV--------GIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 54
Query: 376 VAVK---KSKLV-DENNVEQFINEVVILSQINHR-NIVKLLGCCLETEVPLLVYEFVPNG 430
A+K K+ +V E E +L I +V L L+ +++ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 431 TLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490
L+ ++ T + E+ AL +LH I RDIK NILLD
Sbjct: 115 ELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 168
Query: 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQ--FTEKSDVYSFGVVLVEILTG 548
++DFG S+ D+T GT Y+ P+ + + D +S GV++ E+LTG
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 549 QKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMT--VATLAKRCLNL 606
P F +N E+ ++ E + M+ L +R L
Sbjct: 229 ASP---------------FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 607 NGKNRPTMKEVAFE 620
+ K R +
Sbjct: 274 DPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 6e-35
Identities = 55/305 (18%), Positives = 107/305 (35%), Gaps = 36/305 (11%)
Query: 339 FTSKDLEKA----TDNYNANRILGQGGQGTVYKGM-LADGRIVAVK--KSKLVDENNVEQ 391
F ++L K + Y +G G G+V G VAVK + ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 392 FINEVVILSQINHRNIVKLLGCC-----LETEVPLLVYEFVPNGTLYQNIHNHIEEFPIT 446
E+ +L + H N++ LL LE + + + L + +T
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 447 WELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506
+ + + ++ L Y+HSA I RD+K +N+ +++ K+ DFG +R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV-- 564
+T V + + + D++S G ++ E+LTG+ + + L+
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 565 ------------GYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP 612
A N + + + L ++ L L+ R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 613 TMKEV 617
T +
Sbjct: 294 TAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 7e-29
Identities = 53/318 (16%), Positives = 101/318 (31%), Gaps = 58/318 (18%)
Query: 351 YNANRILGQGGQGTVYKGM-LADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVK 409
Y R LG G TV+ + + VA+K + D+ E +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 410 LLGCCLETEVPLLVY-------------EFVPNGTLYQNIHNHIEEFPITWELLLRIAVE 456
+ LL + F G + E I + +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 457 VSGALFYLHSAASISIYRRDIKSANILLD------DKYRAKVSDFGTSRSITVDQTHLTT 510
+ L Y+H I DIK N+L++ + + K++D G + T+
Sbjct: 134 LLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188
Query: 511 KVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAIN-------------- 556
T Y PE + + +D++S ++ E++TG
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 557 ----------IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVAT-------L 599
+ + F + R L L++ E+
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 600 AKRCLNLNGKNRPTMKEV 617
L L+ + R +
Sbjct: 308 LSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 5e-18
Identities = 29/202 (14%), Positives = 65/202 (32%), Gaps = 28/202 (13%)
Query: 355 RILGQGGQGTVYKGMLADGRIVAVK----------KSKLVDENNVEQFINEVVILSQINH 404
+++G+G + V+ VK K K + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 405 RNIVKLLGCCLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYL 464
R + KL G + Y + N + + + E + + E + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNA-VLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 465 HSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT--VDQTHLTTKVQGTFGYVDPE 522
+ I D+ N+L+ + + DF S + + L V+
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI-----IT 170
Query: 523 YFQSSQFTEKSDVYSFGVVLVE 544
YF + + D+ S +++
Sbjct: 171 YFS-RTYRTEKDINSAIDRILQ 191
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (115), Expect = 3e-08
Identities = 13/40 (32%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 221 CRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRR 260
D++E ++P C NT G+Y C CP G+ G
Sbjct: 2 AVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAGNE 40
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (109), Expect = 1e-07
Identities = 12/43 (27%), Positives = 19/43 (44%), Gaps = 3/43 (6%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
D++E E+ C+ +C N G + C C G + G C
Sbjct: 1 DIDECENG--GFCSGVCHNLPGTFECICGPDSALAG-QIGTDC 40
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (109), Expect = 2e-07
Identities = 17/44 (38%), Positives = 22/44 (50%), Gaps = 3/44 (6%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
DVNE DP+ + C NT G+Y C CP F + GC+
Sbjct: 2 DVNECLDPT-TCISGNCVNTPGSYICDCPPDFELNP--TRVGCV 42
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (107), Expect = 3e-07
Identities = 14/44 (31%), Positives = 21/44 (47%), Gaps = 2/44 (4%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
D++E + L +C NT G+Y C CP G + + CI
Sbjct: 1 DIDECQRDPLLCRGGVCHNTEGSYRCECPPGHQLSP--NISACI 42
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 44 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (107), Expect = 3e-07
Identities = 10/44 (22%), Positives = 18/44 (40%), Gaps = 1/44 (2%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266
D++E C NT G++ C+C +G+ C+
Sbjct: 2 DIDECRISPDLCGRGQCVNTPGDFECKCDEGYESGF-MMMKNCM 44
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 43 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (107), Expect = 3e-07
Identities = 13/43 (30%), Positives = 21/43 (48%), Gaps = 2/43 (4%)
Query: 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
D++E ++ C NT G++ CRCP G+ + D C
Sbjct: 2 DIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLNE--DTRVC 42
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (103), Expect = 1e-06
Identities = 15/44 (34%), Positives = 18/44 (40%), Gaps = 2/44 (4%)
Query: 225 NEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPN 268
NE D C+H C+N G Y C CP + D C N
Sbjct: 1 NECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLHD--DMKNCGVN 42
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 41 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (102), Expect = 1e-06
Identities = 14/42 (33%), Positives = 23/42 (54%), Gaps = 4/42 (9%)
Query: 224 VNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
++E +DP + C+ +C N G Y C+C +GF+ D C
Sbjct: 1 IDECQDP--DTCSQLCVNLEGGYKCQCEEGFQLDP--HTKAC 38
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 45 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (96), Expect = 9e-06
Identities = 10/40 (25%), Positives = 16/40 (40%), Gaps = 4/40 (10%)
Query: 224 VNEFEDPSLNN--CTHICDNTAGNYTCRCPKGFR--GDGR 259
++E + C H C N G + C C G+ + R
Sbjct: 1 IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHRNKR 40
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (96), Expect = 1e-05
Identities = 14/50 (28%), Positives = 19/50 (38%), Gaps = 9/50 (18%)
Query: 223 DVNEFEDPSLN-------NCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
D++E S + C H+C N G Y C C G+ D C
Sbjct: 3 DLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQE--DRHSC 50
|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} Length = 50 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (95), Expect = 1e-05
Identities = 15/42 (35%), Positives = 18/42 (42%), Gaps = 4/42 (9%)
Query: 231 SLNN--CTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQK 270
SL+N CTH C G C C G++ D C P K
Sbjct: 3 SLDNGGCTHYCLEEVGWRRCSCAPGYKLGD--DLLQCHPAVK 42
|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} Length = 51 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (95), Expect = 2e-05
Identities = 12/39 (30%), Positives = 17/39 (43%), Gaps = 4/39 (10%)
Query: 231 SLNN--CTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267
SL+N C C + C C +G+ +G CIP
Sbjct: 4 SLDNGDCDQFCHEEQNSVVCSCARGYTLAD--NGKACIP 40
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 45 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.9 bits (93), Expect = 2e-05
Identities = 12/44 (27%), Positives = 17/44 (38%), Gaps = 4/44 (9%)
Query: 224 VNEFEDPSLNN--CTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265
V+E ++ C H C N G Y C C G+ + C
Sbjct: 1 VDECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILHQ--NKHTC 42
|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} Length = 51 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.2 bits (94), Expect = 2e-05
Identities = 10/39 (25%), Positives = 13/39 (33%), Gaps = 4/39 (10%)
Query: 231 SLNN--CTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267
SL+N C C C C G+ D C+
Sbjct: 2 SLDNGGCDQFCREERSEVRCSCAHGYVLGD--DSKSCVS 38
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (92), Expect = 3e-05
Identities = 13/37 (35%), Positives = 19/37 (51%), Gaps = 2/37 (5%)
Query: 224 VNEFEDPSLNNCTHICDNTAGNYTCRCPKGFR-GDGR 259
NE D + C+H+C++ Y C CP GF+ R
Sbjct: 2 TNECLDNN-GGCSHVCNDLKIGYECLCPDGFQLVAQR 37
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} Length = 42 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (91), Expect = 4e-05
Identities = 14/38 (36%), Positives = 22/38 (57%), Gaps = 3/38 (7%)
Query: 222 RDVNEFEDPSLNNCTH--ICDNTAGNYTCRCPKGFRGD 257
+DV+E + N C H C NT G++ C+C +G+ G
Sbjct: 1 QDVDECSLGA-NPCEHAGKCINTLGSFECQCLQGYTGP 37
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.9 bits (88), Expect = 1e-04
Identities = 10/37 (27%), Positives = 18/37 (48%), Gaps = 6/37 (16%)
Query: 233 NNCTH--ICDNTAGNYTCRCPKGFRGDGRRDGGGCIP 267
+ C+ C + A + CRC + G+GR+ C+
Sbjct: 7 HQCSVHAECRDYATGFCCRCVANYTGNGRQ----CVA 39
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 40 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 34.4 bits (79), Expect = 0.002
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 7/39 (17%)
Query: 177 TCEEAK-ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGN 214
TC + C +A C ++G+ C+C Y GN
Sbjct: 1 TCANNRHQCSVHAEC------RDYATGFCCRCVANYTGN 33
|
| >d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} Length = 50 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (86), Expect = 2e-04
Identities = 14/51 (27%), Positives = 22/51 (43%), Gaps = 10/51 (19%)
Query: 224 VNEFEDPSLNN--CTHIC------DNTAGNYTCRCPKGFRGDGRRDGGGCI 266
VN E +L+N C ++C + + +TC CP G D C+
Sbjct: 1 VNWCERTTLSNGGCQYLCLPAPQINPHSPKFTCACPDGMLLAR--DMRSCL 49
|
| >d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} Length = 57 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.9 bits (83), Expect = 8e-04
Identities = 12/40 (30%), Positives = 18/40 (45%), Gaps = 5/40 (12%)
Query: 231 SLNN--CTHICDNTAGN-YTCRCPKGFRGDGRRDGGGCIP 267
++ N C C N+A N C C +G+R + C P
Sbjct: 4 NIKNGRCEQFCKNSADNKVVCSCTEGYRLA--ENQKSCEP 41
|
| >d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]} Length = 53 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Coagulation factor VIIa species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.6 bits (82), Expect = 9e-04
Identities = 12/40 (30%), Positives = 16/40 (40%), Gaps = 5/40 (12%)
Query: 231 SLNN--CTHICDNTAGN-YTCRCPKGFRGDGRRDGGGCIP 267
N C C + G +CRC +G+ DG C P
Sbjct: 3 VNENGGCEQYCSDHTGTKRSCRCHEGYSLL--ADGVSCTP 40
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} Length = 37 | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Score = 33.1 bits (76), Expect = 0.004
Identities = 9/36 (25%), Positives = 14/36 (38%), Gaps = 3/36 (8%)
Query: 223 DVNE-FEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257
D ++ P N + C + +Y C C F G
Sbjct: 1 DGDQCASSPCQNGGS--CKDQLQSYICFCLPAFEGR 34
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 686 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.5 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.44 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.43 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.42 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.4 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 98.38 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 98.36 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 98.33 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 98.26 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 98.14 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 98.11 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 98.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.92 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 97.86 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.81 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.8 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 97.75 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.58 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 97.55 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 97.54 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.53 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 97.52 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 97.49 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 97.43 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.33 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 97.21 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 97.2 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 97.2 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 97.18 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 97.12 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 97.09 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 97.06 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 96.98 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 96.95 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 96.92 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 96.81 | |
| d1ijqa2 | 50 | Low density lipoprotein (LDL) receptor, different | 96.8 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 96.76 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 96.74 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 96.71 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 96.7 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.53 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 96.53 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.36 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 96.29 | |
| d1rfnb_ | 57 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 96.09 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 96.02 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 96.01 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 95.9 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 95.9 | |
| d2bz6l1 | 53 | Coagulation factor VIIa {Human (Homo sapiens) [Tax | 95.89 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.8 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.79 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 95.77 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 95.59 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.56 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 95.21 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 95.11 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 94.78 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 94.67 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 94.56 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 94.44 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 93.75 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 93.62 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 92.91 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 90.42 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 89.79 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 89.36 | |
| d1ioxa_ | 50 | Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606] | 89.18 | |
| d1moxc_ | 49 | Transforming growth factor alpha {Human (Homo sapi | 88.91 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 88.33 | |
| d1ijqa2 | 50 | Low density lipoprotein (LDL) receptor, different | 88.21 | |
| d1rfnb_ | 57 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 87.43 | |
| d1k36a_ | 46 | Epiregulin, EGF-domain {Human (Homo sapiens) [TaxI | 84.54 | |
| d2bz6l1 | 53 | Coagulation factor VIIa {Human (Homo sapiens) [Tax | 84.18 | |
| d2i9aa1 | 40 | Plasminogen activator (urokinase-type) {Human (Hom | 84.1 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 81.83 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=423.45 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=202.9
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|+.++++++|||||+++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999999888999999987533 344789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|+|.+++.... ..+++..++.|+.|||+||+|||+. +|+||||||+|||+++++++||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999987643 3589999999999999999999999 99999999999999999999999999998775544444
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhC-CCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....||+.|+|||++.+..++.++||||||++||||+|+ ++||..... .. +...+..+ ....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~-~~~~i~~~---------~~~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SE-VVEDISTG---------FRLY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HH-HHHHHHHT---------CCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HH-HHHHHHhc---------CCCC
Confidence 4456789999999999999999999999999999999995 555432211 11 11111111 1111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.+...+.++.+|+.+||+.||++||||+||++.|++|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 2223345789999999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=421.86 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=213.9
Q ss_pred HHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 344 LEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 344 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++...++|.+.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 334456899999999999999999999888999999986543 345789999999999999999999998854 567999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... ..++++..+++|+.||++||+|||+. +|+||||||+||||++++.+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence 99999999999886543 23599999999999999999999998 999999999999999999999999999998765
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
..........||+.|+|||++.++.++.++||||||++||||+||..|+..... .. .....+..+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~-~~~~~i~~~--------- 226 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NP-EVIQNLERG--------- 226 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HH-HHHHHHHTT---------
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HH-HHHHHHHhc---------
Confidence 554455556799999999999999999999999999999999996665532211 11 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.....+...+.++.+|+.+||+.||++||||++|++.|+.+..
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111222345578999999999999999999999999988654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=422.03 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=207.9
Q ss_pred hhccccccccccCccceEEEEEEEeCCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++|.+.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|+.++++++|||||+++|++.+ ...+||
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 345678999999999999999998653 5999997643 45567889999999999999999999998754 567999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.++|+... ..+++..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+|+....
T Consensus 82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999997643 3599999999999999999999998 999999999999999999999999999987653
Q ss_pred CC-ceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 504 DQ-THLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 504 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
.. ........||+.|||||++.+ ..++.++|||||||+||||+||+.||......+ .+......+.....
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCc
Confidence 32 223345679999999999864 358999999999999999999999997543211 11111111110000
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....+...+..+.+|+.+||+.||++|||++||++.|+.|++..
T Consensus 231 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 231 -----LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -----GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 01122234567899999999999999999999999999988653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-52 Score=424.10 Aligned_cols=264 Identities=28% Similarity=0.400 Sum_probs=219.6
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
+++...++|.+.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+.+|++++|||||+++|++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34444568999999999999999999976 5889999998653 334578999999999999999999999999999999
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.++|.... ...+++..++.|+.||++||+|||++ +|+||||||+||||++++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999997643 34699999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
..+.........|++.|+|||++.+..++.++||||||+++|||++|+.|+..... .. .+.+.+.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~----------~~~~~i~ 230 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS----------QVYELLE 230 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH----------HHHHHHH
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HH----------HHHHHHh
Confidence 66555555556789999999999999999999999999999999997777642211 11 1112222
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.......+...+.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 222222333445678999999999999999999999999988753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-51 Score=421.81 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=202.0
Q ss_pred cccccccccCccceEEEEEEEeCC-C---cEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-G---RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.++||+|+||+||+|.+.. + ..||||++.. ......+.|.+|+.+|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 457778899999999999999753 2 3689998765 3455567899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... ..++|.+++.|+.||++||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999887643 3599999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcee----eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 504 DQTHL----TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 504 ~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
..... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||......+ ....+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~----- 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQ----- 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHT-----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc-----
Confidence 33221 122457899999999999999999999999999999998 899997543211 1111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
......+...+..+.+|+.+||+.||++||||.||++.|+.+...
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 249 ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111122334556789999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=409.01 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=215.1
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEecc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVP 428 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~ 428 (686)
++|.+.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999875433 44789999999999999999999999999999999999999
Q ss_pred CCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee
Q 038345 429 NGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL 508 (686)
Q Consensus 429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 508 (686)
+|+|.+++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999987643 3589999999999999999999998 99999999999999999999999999998766554444
Q ss_pred eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 509 TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 509 ~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ....+..+ ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~---------~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQG---------LRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTT---------CCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhC---------CCCC
Confidence 455679999999999999999999999999999999998 899997654321 11111111 1111
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.+...+.++.+|+.+||+.||++|||+++|++.|.+|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2223445789999999999999999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=409.18 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=203.0
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 68999999876432 2334679999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+++|+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999753 3699999999999999999999999 99999999999999999999999999998765333
Q ss_pred -ceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 506 -THLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 506 -~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
........||+.|||||++.+..+ +.++|||||||+||||++|+.||....... ............
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~~~------- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTY------- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTCTT-------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCC-------
Confidence 223445679999999999988776 678999999999999999999997543211 011111111100
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.......+.++.+|+.+||+.||++|||++|++
T Consensus 226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 111122345678999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=412.29 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=210.7
Q ss_pred cccccccc-cCccceEEEEEEEeC---CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRI-LGQGGQGTVYKGMLA---DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+. ||+|+||+||+|.++ ++..||||.++.. .....++|.+|+.+|++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 55666664 999999999999864 3557999998653 44556889999999999999999999999864 567999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999986533 3699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCcee--eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 504 DQTHL--TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 504 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+..+.
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~----- 229 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGK----- 229 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTC-----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 43322 233468999999999999999999999999999999998 999997543221 112222211
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
....+...+.++.+|+.+||+.||++||||.+|++.|+.+....
T Consensus 230 ----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11223344567899999999999999999999999998776543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-50 Score=409.15 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=208.0
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
++|.+.++||+|+||+||+|.. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999996 469999999987655555678999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.+. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999988653 499999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~--------~~~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT--------PELQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS--------CCCS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC--------CCCC
Confidence 234557999999999999999999999999999999999999999743321 11111111110 0011
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.+...+..+.+|+.+||+.||++|||++|++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2223456788999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=409.98 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=203.5
Q ss_pred cccccccccCccceEEEEEEEeCCC-----cEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADG-----RIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 422 (686)
..|+..++||+|+||+||+|.++.. ..||||++... ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4578889999999999999997642 37999987643 34455679999999999999999999999999999999
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSIT 502 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 502 (686)
||||+.+++|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999887543 3599999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 503 VDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 503 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
..... ......||+.|||||++.+..++.++||||||++||||++|..|+...... . .+...+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~----------~~~~~i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H----------EVMKAI 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H----------HHHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----H----------HHHHHH
Confidence 43222 223456899999999999999999999999999999999976665422111 1 111112
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
........+...+..+.+|+.+||+.||++||||.||++.|+.+.+
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2222222333455678999999999999999999999999998765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=411.48 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=206.5
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
.++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 46799999999999999999999988899999986543 345789999999999999999999999854 5679999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|..++..... ..++|..++.|+.||+.||+|||+. +|+||||||+||||+.++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 99999998876432 3599999999999999999999999 9999999999999999999999999999877554444
Q ss_pred eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccCh
Q 038345 508 LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKE 587 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~ 587 (686)
......||+.|+|||++..+.++.++||||||++||||++|..|+...... .. ....+.. .....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~-~~~~i~~---------~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE-VLDQVER---------GYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHT---------TCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHh---------cCCCC
Confidence 445567999999999999999999999999999999999977665432211 11 1111111 11112
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 588 AEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 588 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
.+...+.++.+|+.+||+.||++||+|.+|+++|+......
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 23344567899999999999999999999999998876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=405.43 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=201.5
Q ss_pred cccCccceEEEEEEEeCC---CcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEeccC
Q 038345 355 RILGQGGQGTVYKGMLAD---GRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFVPN 429 (686)
Q Consensus 355 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~~~ 429 (686)
++||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+.+|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 468999987542 33445789999999999999999999999854 567899999999
Q ss_pred CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCcee-
Q 038345 430 GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTHL- 508 (686)
Q Consensus 430 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 508 (686)
|+|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998543 599999999999999999999998 99999999999999999999999999998765443332
Q ss_pred -eeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhccC
Q 038345 509 -TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLK 586 (686)
Q Consensus 509 -~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~ 586 (686)
.....||+.|||||.+.+..++.++||||||+++|||+| |+.||......+ ....+..+ ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~---------~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG---------ERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---------CCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcC---------CCC
Confidence 234568999999999999999999999999999999998 899997543211 11112111 111
Q ss_pred hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 587 EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 587 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
..+...+.++.+|+.+||+.||++|||+++|+++|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 222334567899999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=415.00 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=208.5
Q ss_pred hccccccccccCccceEEEEEEEeCC-C-----cEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCC
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD-G-----RIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETE 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 418 (686)
..++|.+.++||+|+||+||+|++.. + ..||+|.+... .......|.+|+.++.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 44679999999999999999999643 2 36999987543 344456899999999998 8999999999999999
Q ss_pred cceEEEEeccCCchhhhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCC
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIE--------------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 478 (686)
..+|||||+++|+|.++|+.... ...+++..++.++.||++||+|||++ +|+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999976432 13589999999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCC
Q 038345 479 SANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAIN 556 (686)
Q Consensus 479 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~ 556 (686)
|+|||++.++.+||+|||+|+....... .......||+.|||||++.++.++.++|||||||+||||+| |+.||.+..
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333 23345668999999999999999999999999999999998 899997543
Q ss_pred cccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 038345 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELG 622 (686)
Q Consensus 557 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~ 622 (686)
..+ .+...+.. ......+...+.++.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~~------~~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA------NFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH------HHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH------HHHHHHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 11111111 1111222334567899999999999999999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=402.54 Aligned_cols=245 Identities=28% Similarity=0.408 Sum_probs=205.6
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999975 6889999987532 2233567899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.++|.+.. .+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998643 599999999999999999999999 9999999999999999999999999999865432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+ ..+...+
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~-~~i~~~~--------- 220 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETY-KRISRVE--------- 220 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHTTC---------
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCC---------
Confidence 2 33457999999999999999999999999999999999999999753321 111 1111111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 0112233456889999999999999999999984
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=407.46 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=195.8
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee--CCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE--TEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lV 423 (686)
++|++.+.||+|+||+||+|+.. +|+.||||.+... .+...+.+.+|++++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999965 6899999987543 34456779999999999999999999999875 4567999
Q ss_pred EEeccCCchhhhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 424 YEFVPNGTLYQNIHNHI-EEFPITWELLLRIAVEVSGALFYLHSAA--SISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
|||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999997532 2346999999999999999999999972 12499999999999999999999999999987
Q ss_pred ccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||......+ ....+.....
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~---- 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCC----
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 65432 23345679999999999999999999999999999999999999997543211 1111221111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122234557899999999999999999999973
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=406.55 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=207.1
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+.|++.+.||+|+||+||+|... +++.||||++........+.|.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999965 68999999987766677788999999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.+.. .++++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999987543 3599999999999999999999999 99999999999999999999999999997653221 1
Q ss_pred eeeeeeccccccCccccc-----cCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhh
Q 038345 508 LTTKVQGTFGYVDPEYFQ-----SSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDA 582 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 582 (686)
......||+.|+|||++. ...++.++|||||||+||||++|+.||......+ .+....... .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~-~------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSE-P------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSC-C------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCC-C------
Confidence 223457999999999984 4568899999999999999999999997543221 111111111 0
Q ss_pred hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 583 LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 583 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.....+...+.++.+|+.+||+.||++|||++|++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00111223456789999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=401.66 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=202.2
Q ss_pred hccccccccccCccceEEEEEEEeCC----CcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD----GRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
..++|.+.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++|||||+++|++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 34689999999999999999998653 356899987653 3444577999999999999999999999986 46789
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999999887543 3699999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVL 580 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 580 (686)
............||+.|+|||++.+..++.++||||||+++|||++ |++||......+ ....+..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~~~~~---- 227 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCC----
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 5544444556678999999999999999999999999999999998 899997654322 1111111111
Q ss_pred hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhh
Q 038345 581 DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASI 628 (686)
Q Consensus 581 d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~ 628 (686)
...+...+.++.+|+.+||+.||++|||++||++.|+.+....
T Consensus 228 -----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 228 -----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1122334567899999999999999999999999999887553
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=414.19 Aligned_cols=266 Identities=26% Similarity=0.405 Sum_probs=207.1
Q ss_pred hhccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 346 KATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 346 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
...++|.+.++||+|+||+||+|+.. +|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+....+||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999965 6899999987653 344457899999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.+ +|+||||||+||||++++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999998643 5999999999999999999999732 899999999999999999999999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhh----------------
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYF---------------- 567 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~---------------- 567 (686)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 223467999999999999999999999999999999999999999764322110000000
Q ss_pred -------HHHhhcchhhhhhhhhccC----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 568 -------LQAMNENRLFEVLDALVLK----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 568 -------~~~~~~~~~~~~~d~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+.++..... ......+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000011111110000 000112356889999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-49 Score=406.06 Aligned_cols=265 Identities=24% Similarity=0.376 Sum_probs=215.3
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeC------CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEE
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCC 414 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~ 414 (686)
.+++...++|.+.+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445666788999999999999999999864 35789999986543 33456799999999999999999999999
Q ss_pred eeCCcceEEEEeccCCchhhhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeE
Q 038345 415 LETEVPLLVYEFVPNGTLYQNIHNHIE---------------------EFPITWELLLRIAVEVSGALFYLHSAASISIY 473 (686)
Q Consensus 415 ~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~iv 473 (686)
.+....++||||+++|+|.++|+.... ...+++..++.|+.|++.||+|||+. +||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 999999999999999999999964321 22489999999999999999999999 999
Q ss_pred eeCCCCCCeeecCCCcEEEEecCCcccccCCC-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCC-CC
Q 038345 474 RRDIKSANILLDDKYRAKVSDFGTSRSITVDQ-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KP 551 (686)
Q Consensus 474 H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~-~p 551 (686)
||||||+||||+.++.+||+|||+++...... ........||+.|+|||.+.+..++.++||||||++||||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998664332 22334566899999999999999999999999999999999986 56
Q ss_pred CccCCcccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 552 IRAINIDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 552 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
|......+ +...+..+.. ...+...+.++.+|+.+||+.+|++||||.||+++|++|.
T Consensus 243 ~~~~~~~e-------~~~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHH-------HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 76443221 1122222211 1122234457899999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=394.95 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=196.1
Q ss_pred ccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEee----CCcceEEE
Q 038345 352 NANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLE----TEVPLLVY 424 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lV~ 424 (686)
...++||+|+||+||+|+.. ++..||+|++... .....+.|.+|+++|++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999975 5889999986543 44556789999999999999999999999875 34578999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec-CCCcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD-DKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~ 503 (686)
||+++|+|.+++.+.. .+++..++.++.||++||+|||++. .+|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997643 5999999999999999999999981 1299999999999996 578999999999986433
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ......||+.|||||++.+ .++.++|||||||+||||++|+.||...... .. ....+..+...
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~-~~~~i~~~~~~------ 231 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKP------ 231 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCC------
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HH-HHHHHHcCCCC------
Confidence 2 2345679999999999865 6999999999999999999999999643211 11 11111111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+.....++.+|+.+||+.||++|||++|+++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111223446889999999999999999999973
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=395.09 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=202.3
Q ss_pred ccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-CcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~ 426 (686)
.++|.+.+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|+.++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356888899999999999999985 788999998653 3457899999999999999999999999764 567999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+++|+|.++|.... ...++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 99999999997542 22589999999999999999999998 9999999999999999999999999999865322
Q ss_pred eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhcc
Q 038345 507 HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALVL 585 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~~ 585 (686)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.||......+ + ...+..+ ..
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~----~~~i~~~---------~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKG---------YK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTT---------CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcC---------CC
Confidence 233458899999999999999999999999999999998 788876543221 1 1111111 11
Q ss_pred ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 586 KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 586 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
.+.+...+.++.+|+.+||+.||++||||.+|++.|+.++..
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 222333456789999999999999999999999999998753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=397.69 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=203.9
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999974 6899999987532 2334577999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987543 599999999999999999999999 9999999999999999999999999999876533
Q ss_pred C-ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 505 Q-THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 505 ~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
. ........||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+ ..+...++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~-~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIF-QKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHH-HHHHcCCC-------
Confidence 2 22334567999999999999999999999999999999999999999753221 111 11111110
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..+.....++.+|+.+||+.||++|||++|++.
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 112233456889999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-47 Score=403.22 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=209.4
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|.+.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 458999999999999999999964 6899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec--CCCcEEEEecCCcccccCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD--DKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~ 504 (686)
+++|+|.++|.+.. ..+++..++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999996532 3599999999999999999999999 999999999999995 4678999999999876543
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.... ..+....... . ..
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~-~------~~ 244 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD-W------NM 244 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-C------CS
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C------CC
Confidence 3 234567999999999999999999999999999999999999999754321 1111111110 0 00
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111233456889999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-48 Score=400.84 Aligned_cols=245 Identities=23% Similarity=0.353 Sum_probs=200.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccC---hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD---ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..|+..+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35889999999999999999964 68899999876432 334567999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|..++... .++++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 999999997766543 3699999999999999999999999 999999999999999999999999999986542
Q ss_pred CceeeeeeeccccccCcccccc---CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQS---SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||...... ..+...... ...
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~-~~~---- 232 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-ESP---- 232 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-CCC----
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhC-CCC----
Confidence 233569999999999864 46899999999999999999999999743221 111111111 100
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 0111223456889999999999999999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=400.81 Aligned_cols=256 Identities=23% Similarity=0.459 Sum_probs=204.8
Q ss_pred ccccccccCccceEEEEEEEeC-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGR----IVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
+|++.++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|+.++++++|||||+++|++.+. ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 5999999999999999999965 343 6899987643 344567899999999999999999999999865 56788
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
+|++.+|+|.+++.... ..+++..+++|+.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 99999999999887643 3699999999999999999999998 999999999999999999999999999987754
Q ss_pred CCce-eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 504 DQTH-LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 504 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.... ......||+.|+|||++.++.++.++||||||++||||+| |+.||......+ +...+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~-------- 228 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEK-------- 228 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHH--------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHc--------
Confidence 4333 2334568999999999999999999999999999999999 889987544322 1111111
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
......+...+..+.+|+.+||+.||++|||+.||++.|..+...
T Consensus 229 -~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 -GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111122233456789999999999999999999999999887643
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=397.14 Aligned_cols=269 Identities=28% Similarity=0.395 Sum_probs=206.2
Q ss_pred hHHHHhhccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEe
Q 038345 341 SKDLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLG 412 (686)
Q Consensus 341 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g 412 (686)
..+++...++|.+.++||+|+||.||+|.+. +++.||||+++.. .....+.+.+|..++.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3445555578999999999999999999853 2468999998653 344556788888888887 6899999999
Q ss_pred EEeeC-CcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCC
Q 038345 413 CCLET-EVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIK 478 (686)
Q Consensus 413 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dik 478 (686)
++.+. ...++||||+++|+|.++|+.... ...+++..++.++.||++||+|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98765 467999999999999999975421 23589999999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhC-CCCCccCC
Q 038345 479 SANILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTG-QKPIRAIN 556 (686)
Q Consensus 479 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg-~~p~~~~~ 556 (686)
|+||||++++.+||+|||+|+....... .......||+.|+|||++.+..++.++||||||+++|||+|| ..||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987653332 223446799999999999999999999999999999999996 46776433
Q ss_pred cccCCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 557 IDEDRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 557 ~~~~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
..+ .+...+..+. ....+...+.++.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 242 ~~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH------HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 211 1222222211 1112223445689999999999999999999999999998653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-48 Score=400.65 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=190.8
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC-hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD-ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
..+.|.+.+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4567999999999999999999975 68999999875432 233456889999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEEEecCCcccc
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSI 501 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~ 501 (686)
||+++|+|.++|... ..+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999753 3699999999999999999999999 999999999999994 5789999999999865
Q ss_pred cCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLD 581 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 581 (686)
.... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+.....
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~----- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEY----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCC-----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCC-----
Confidence 4322 2344679999999999999999999999999999999999999997532211 1111111100
Q ss_pred hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 582 ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 582 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+.++.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011112234456889999999999999999999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-47 Score=400.39 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=209.3
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
.++|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999964 6999999998766556667889999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec--CCCcEEEEecCCcccccCC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD--DKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~ 504 (686)
+++|+|.+++.... .++++..++.|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+|+.....
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998876542 3599999999999999999999998 999999999999997 6789999999999877543
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+ .+. .+.... ...
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~-~i~~~~------~~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQ-NVKRCD------WEF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHHCC------CCC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHHhCC------CCC
Confidence 3 2344679999999999999999999999999999999999999997543211 111 111110 001
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........+.++.+|+.+||+.||.+|||++|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112234456889999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=390.88 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=198.3
Q ss_pred cccccccccCccceEEEEEEEeCC--C--cEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcce
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD--G--RIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPL 421 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 421 (686)
++|++.+.||+|+||.||+|++.. + ..||||+++.. .....++|.+|+.+|++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 468899999999999999998642 2 37899987642 34446789999999999999999999999965 4678
Q ss_pred EEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccc
Q 038345 422 LVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSI 501 (686)
Q Consensus 422 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 501 (686)
+||||+++|+|.+++.... .++++..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999887643 3599999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCce--eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCCchhHhhHHHhhcchhhh
Q 038345 502 TVDQTH--LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDRSLVGYFLQAMNENRLFE 578 (686)
Q Consensus 502 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 578 (686)
...... ......||..|+|||++.+..++.++||||||+++|||+| |+.||......+ .+......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~---- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG---- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCC----
Confidence 544332 2234557889999999999999999999999999999998 899997543221 111111111
Q ss_pred hhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 038345 579 VLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGI 624 (686)
Q Consensus 579 ~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i 624 (686)
.....+...+..+.+|+.+||+.||++||||.||++.|++.
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11112223345789999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=393.92 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=214.4
Q ss_pred HhhccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee
Q 038345 345 EKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLE 416 (686)
Q Consensus 345 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 416 (686)
+...++|.+.++||+|+||.||+|++. +++.||||+++.. .......|.+|+.+++++ +|||||+++|++.+
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 334568899999999999999999852 3578999998653 344556799999999999 69999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCC
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE---------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSAN 481 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~N 481 (686)
....++||||+++|+|.++|+.... ...+++..++.++.||++||+|||++ +|+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 9999999999999999999976431 23589999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCccc
Q 038345 482 ILLDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDE 559 (686)
Q Consensus 482 Ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~ 559 (686)
||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |.+||......+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987654332 33445679999999999999999999999999999999999 455554332211
Q ss_pred CCchhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 560 DRSLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 560 ~~~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.+. .++........+...+..+.+|+.+||+.||++||||.+|+++|+++..
T Consensus 256 ------~~~---------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 ------KFY---------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp ------HHH---------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------HHH---------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111 1222222222223345678999999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=393.06 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=204.4
Q ss_pred ccccCccceEEEEEEEeCCC----cEEEEEEccc-cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-CcceEEEEec
Q 038345 354 NRILGQGGQGTVYKGMLADG----RIVAVKKSKL-VDENNVEQFINEVVILSQINHRNIVKLLGCCLET-EVPLLVYEFV 427 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lV~e~~ 427 (686)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997542 3689998864 4555678899999999999999999999998764 5789999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
++|+|.+++.... ..+++..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999988643 3578899999999999999999999 9999999999999999999999999999876533222
Q ss_pred ---eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 508 ---LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 508 ---~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
......||+.|+|||.+.+..++.++||||||++||||+||+.||...... ..... .+..+..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~----~i~~g~~-------- 252 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV----YLLQGRR-------- 252 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTCC--------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH----HHHcCCC--------
Confidence 223356899999999999999999999999999999999988887542211 11111 1111110
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhh
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRAS 627 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~ 627 (686)
...+...+.++.+|+.+||+.||++||+|.||++.|+.+...
T Consensus 253 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 253 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111122345688999999999999999999999999999764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=395.30 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=207.2
Q ss_pred cccccccccCccceEEEEEEEeCC-Cc--EEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLAD-GR--IVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lV 423 (686)
++|++.++||+|+||+||+|++.+ +. .||||+++.. .....+.|.+|+++|+++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999754 43 5788886543 344556899999999999 799999999999999999999
Q ss_pred EEeccCCchhhhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcE
Q 038345 424 YEFVPNGTLYQNIHNH-------------IEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRA 490 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 490 (686)
|||+++|+|.++|+.. .....+++..+++++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999764 1234699999999999999999999999 99999999999999999999
Q ss_pred EEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCC-CCCccCCcccCCchhHhhHH
Q 038345 491 KVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 491 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~-~p~~~~~~~~~~~l~~~~~~ 569 (686)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|. .||......+ +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence 999999997654222 223446899999999999999999999999999999999976 5665432211 111
Q ss_pred HhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 570 AMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 570 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
.+..+ .....+...+.++.+|+.+||+.||++||||+||++.|+++....+
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11111 1112223345679999999999999999999999999999876443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=389.97 Aligned_cols=251 Identities=25% Similarity=0.324 Sum_probs=205.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccC------hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVD------ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.|.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999974 68999999865321 12357899999999999999999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC----cEEEEecC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY----RAKVSDFG 496 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 496 (686)
+|||||+++|+|.++|.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997643 599999999999999999999999 999999999999998776 59999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchh
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRL 576 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 576 (686)
+++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+ .+ ..+.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HH-HHHHhcCC
Confidence 998764332 2344568999999999999999999999999999999999999997543211 11 11111100
Q ss_pred hhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 577 FEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 577 ~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
..........+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 ------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111223456889999999999999999999973
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=392.50 Aligned_cols=269 Identities=22% Similarity=0.288 Sum_probs=203.9
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHH--HHHHHHhcCCCCeeeEEeEEeeCC----cceE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFIN--EVVILSQINHRNIVKLLGCCLETE----VPLL 422 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~l~g~~~~~~----~~~l 422 (686)
..|...+.||+|+||.||+|++ +|+.||||+++.. ..+.+.. |+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577889999999999999997 5889999987643 2234444 455556789999999999998754 5789
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSA-----ASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
||||+++|+|.++|++. .++|..+++++.|+|.||+|||+. +..+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999864 499999999999999999999973 134999999999999999999999999999
Q ss_pred cccccCCCce---eeeeeeccccccCccccccCC------CCccccEeehHHHHHHHHhCCCCCccCCcccCCc------
Q 038345 498 SRSITVDQTH---LTTKVQGTFGYVDPEYFQSSQ------FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRS------ 562 (686)
Q Consensus 498 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~------ 562 (686)
++........ ......||+.|+|||++.+.. ++.++||||||++||||+||..|+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9877543322 223457999999999987642 6779999999999999999998875433222110
Q ss_pred --hhHhhHHHhhcchhhhhhhhhccC-hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhc
Q 038345 563 --LVGYFLQAMNENRLFEVLDALVLK-EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIG 629 (686)
Q Consensus 563 --l~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~ 629 (686)
...........+ .+++.+.. ....+....+.+|+.+||+.||++|||+.||++.|++|....+
T Consensus 235 ~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 011111111111 11111111 1123456779999999999999999999999999999987654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-47 Score=390.19 Aligned_cols=261 Identities=26% Similarity=0.411 Sum_probs=209.3
Q ss_pred hccccccccccCccceEEEEEEEeCC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLAD--------GRIVAVKKSKLV-DENNVEQFINEVVILSQI-NHRNIVKLLGCCLE 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~ 416 (686)
..++|.+.+.||+|+||.||+|+... +..||||+++.. ......++.+|+..+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34678899999999999999998532 247999998653 344567899999999998 79999999999999
Q ss_pred CCcceEEEEeccCCchhhhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCee
Q 038345 417 TEVPLLVYEFVPNGTLYQNIHNHIE-------------EFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANIL 483 (686)
Q Consensus 417 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIl 483 (686)
+...++||||+++|+|.++|..... ...+++..++.++.||+.||+|||+. +||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeeccccee
Confidence 9999999999999999999975431 23589999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEEecCCcccccCCCc-eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHh-CCCCCccCCcccCC
Q 038345 484 LDDKYRAKVSDFGTSRSITVDQT-HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILT-GQKPIRAINIDEDR 561 (686)
Q Consensus 484 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ellt-g~~p~~~~~~~~~~ 561 (686)
++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++ |..||......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999999987654332 22344568999999999999999999999999999999998 78888643321
Q ss_pred chhHhhHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 038345 562 SLVGYFLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRA 626 (686)
Q Consensus 562 ~l~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~ 626 (686)
.....+..+ .....+...+.++.+|+.+||+.||++|||+.||++.|++|.+
T Consensus 245 ----~~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ----ELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111222211 1112223345678999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-46 Score=384.63 Aligned_cols=259 Identities=29% Similarity=0.380 Sum_probs=204.6
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----c
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETE----V 419 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~ 419 (686)
.++|.+.+.||+|+||+||+|.. .+++.||||.++.. +....+.|.+|+.++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999996 46899999997642 3344567999999999999999999999998654 3
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.+|||||+++++|.+++.... ++++.+++.++.||+.||+|||+. +|+||||||+|||++.++..+|+|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999887543 599999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCC--ceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 500 SITVDQ--THLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 500 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
...... ........||+.|+|||++.+..++.++|||||||+||||+||+.||..... ...+..........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 654322 2233456799999999999999999999999999999999999999975332 11222222222111
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRP-TMKEVAFELGGIR 625 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~ev~~~L~~i~ 625 (686)
. .......+.++.+++.+||+.||++|| |++++++.|.+++
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 111123345688999999999999999 8999999998875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=391.22 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=213.9
Q ss_pred HHHhhccccccccccCccceEEEEEEEeC------CCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEe
Q 038345 343 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCL 415 (686)
Q Consensus 343 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 415 (686)
+++...++|.+.+.||+|+||+||+|.+. +++.||||+++.. .......|.+|+.++++++||||++++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34444578899999999999999999864 2578999998653 3444567999999999999999999999999
Q ss_pred eCCcceEEEEeccCCchhhhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC
Q 038345 416 ETEVPLLVYEFVPNGTLYQNIHNHI-------EEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY 488 (686)
Q Consensus 416 ~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 488 (686)
..+..++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+. +|+||||||+|||+++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCc
Confidence 9999999999999999999987532 223579999999999999999999998 999999999999999999
Q ss_pred cEEEEecCCcccccCCCcee-eeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCC-CCCccCCcccCCchhHh
Q 038345 489 RAKVSDFGTSRSITVDQTHL-TTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQ-KPIRAINIDEDRSLVGY 566 (686)
Q Consensus 489 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~-~p~~~~~~~~~~~l~~~ 566 (686)
++||+|||+++......... .....||+.|+|||.+.+..++.++||||||++||||+||. .||...... ..
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 99999999998765433322 33446899999999999999999999999999999999985 677543221 11
Q ss_pred hHHHhhcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 038345 567 FLQAMNENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIR 625 (686)
Q Consensus 567 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~ 625 (686)
+ ..+..+.. ...+...+..+.+|+.+||+.+|++||||++|++.|++..
T Consensus 245 ~-~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 245 L-RFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp H-HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-HHHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 11111111 1122234467999999999999999999999999997764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=391.19 Aligned_cols=248 Identities=24% Similarity=0.329 Sum_probs=207.1
Q ss_pred ccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV 423 (686)
.++|.+.+.||+|+||.||+|+. .+++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999996 46899999987532 234467889999999999999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998643 589999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+ ....+....
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~-------- 221 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEE-------- 221 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC--------
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCC--------
Confidence 32 23345679999999999999999999999999999999999999997543211 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
-..+...+.++.+|+.+||+.||++||+ ++|+++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1112234456889999999999999995 677764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-46 Score=385.22 Aligned_cols=244 Identities=26% Similarity=0.364 Sum_probs=204.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999974 6899999987532 2334578999999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887543 588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... ........ ..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~-~~--------- 217 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN-AE--------- 217 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-CC---------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHc-CC---------
Confidence 23467999999999999999999999999999999999999999754321 11111111 10
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+...+.++.+++.+||+.||.+|| |++++++
T Consensus 218 -~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 -LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 111223345688999999999999996 8888874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=383.26 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=206.1
Q ss_pred hccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
..++|.+.+.||+|+||+||+|... +++.||||.++.... ....+.+|+.+|++++|||||++++++.+.+..|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999975 688999999875433 34568899999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC--CCcEEEEecCCcccccC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD--KYRAKVSDFGTSRSITV 503 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~ 503 (686)
|+++|+|.++|.... ..+++.+++.|+.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999997543 3599999999999999999999998 9999999999999974 45899999999987643
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+....... . .
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~-~------~ 221 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAE-Y------T 221 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-C------C
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-C------C
Confidence 32 234456899999999999999999999999999999999999999754321 1111111110 0 0
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.........+.++.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111123456889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-45 Score=375.49 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=203.1
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccCh---------hhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDE---------NNVEQFINEVVILSQIN-HRNIVKLLGCCLET 417 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 417 (686)
++|.+.+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6799999999999999999996 4689999998754221 12346889999999997 99999999999999
Q ss_pred CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCC
Q 038345 418 EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGT 497 (686)
Q Consensus 418 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 497 (686)
+..+|||||+++|+|.++|.... ++++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999997543 699999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCceeeeeeeccccccCcccccc------CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQS------SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAM 571 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~ 571 (686)
++...... ......||+.|+|||.+.+ ..++.++||||+|++|+||++|+.||......+ ....+
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i 227 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMI 227 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHH
Confidence 98765432 2344679999999999853 356889999999999999999999997543211 11111
Q ss_pred hcchhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 572 NENRLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 572 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...+. ..........++++.+|+.+||+.||++|||++||+
T Consensus 228 ~~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 228 MSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HhCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 11110 001111223456789999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-45 Score=385.57 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=204.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~ 424 (686)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 6999999987532 2334577899999999999999999999999999999999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVD 504 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 504 (686)
||+.+|+|..++.+.. .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997643 599999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhhc
Q 038345 505 QTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDALV 584 (686)
Q Consensus 505 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~~ 584 (686)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.+... ...+. .+....
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~-~i~~~~--------- 254 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYE-KIVSGK--------- 254 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHCC---------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHH-HHhcCC---------
Confidence 2346799999999999999999999999999999999999999975321 11111 111111
Q ss_pred cChhhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038345 585 LKEAEREEIMTVATLAKRCLNLNGKNRP-----TMKEVAF 619 (686)
Q Consensus 585 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~ev~~ 619 (686)
...+...+.++.+|+.+||+.||.+|+ |++++++
T Consensus 255 -~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 -VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 011223345688999999999999994 8888874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=382.99 Aligned_cols=252 Identities=23% Similarity=0.272 Sum_probs=199.4
Q ss_pred cccccccc-ccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhc-CCCCeeeEEeEEee----CCcc
Q 038345 348 TDNYNANR-ILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQI-NHRNIVKLLGCCLE----TEVP 420 (686)
Q Consensus 348 ~~~~~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~ 420 (686)
.++|.+.. .||+|+||+||+|.. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788764 699999999999996 4689999998753 25677899987665 89999999999875 4568
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC---CCcEEEEecCC
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD---KYRAKVSDFGT 497 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 497 (686)
+|||||+++|+|.++|.+.. ...+++.+++.|+.||+.||+|||+. +|+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 99999999999999998643 23699999999999999999999999 9999999999999975 56799999999
Q ss_pred cccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 498 SRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 498 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
++....... .....||+.|+|||++.+..++.++|||||||+||||+||+.||.+....+. ............
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~-- 233 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ-- 233 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS--
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC--
Confidence 987654332 3445799999999999999999999999999999999999999976432221 101111111100
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111122344567899999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-45 Score=387.25 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=198.1
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHH---HHHHHHhcCCCCeeeEEeEEeeCCcc
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFIN---EVVILSQINHRNIVKLLGCCLETEVP 420 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~---E~~~l~~l~h~niv~l~g~~~~~~~~ 420 (686)
.++|.+.++||+|+||.||+|+.. +|+.||||++... .......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999965 6899999987531 1112233444 46677777899999999999999999
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
++||||+++|+|.++|.+.. .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999998643 589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh
Q 038345 501 ITVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV 579 (686)
Q Consensus 501 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 579 (686)
..... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||......+ ... ........
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~-~~~~~~~~----- 224 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTLTM----- 224 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHH-HHHHSSSC-----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHH-HHHhcccC-----
Confidence 65432 234579999999999875 568999999999999999999999997643322 111 11111100
Q ss_pred hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038345 580 LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVAF 619 (686)
Q Consensus 580 ~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~~ 619 (686)
....+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 225 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -----CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 01111223456889999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=383.29 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=203.2
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc---ChhhHHHHHHHHHHHH-hcCCCCeeeEEeEEeeCCcceEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV---DENNVEQFINEVVILS-QINHRNIVKLLGCCLETEVPLLV 423 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lV 423 (686)
++|.+.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|..++. .++|||||++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999975 6899999987532 2334566777777765 68999999999999999999999
Q ss_pred EEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccC
Q 038345 424 YEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 503 (686)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998643 589999999999999999999999 999999999999999999999999999986653
Q ss_pred CCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhhhhhh
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEVLDAL 583 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 583 (686)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~-------- 219 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDN-------- 219 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCC--------
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC--------
Confidence 332 2344579999999999999999999999999999999999999997543211 111111111
Q ss_pred ccChhhHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 038345 584 VLKEAEREEIMTVATLAKRCLNLNGKNRPTMK-EVAF 619 (686)
Q Consensus 584 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-ev~~ 619 (686)
...+...+.++.+|+.+||+.||++||+++ ++++
T Consensus 220 --~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 --PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 011223345688999999999999999986 6653
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=378.66 Aligned_cols=255 Identities=23% Similarity=0.246 Sum_probs=193.1
Q ss_pred ccccCccceEEEEEEEeC-CCcEEEEEEccccChh-----hHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEec
Q 038345 354 NRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDEN-----NVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEFV 427 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~~ 427 (686)
+++||+|+||+||+|... +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 6899999987643222 1346889999999999999999999999999999999999
Q ss_pred cCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCce
Q 038345 428 PNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQTH 507 (686)
Q Consensus 428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 507 (686)
.++++..++.. ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98877766543 23588999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhhhh------h
Q 038345 508 LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLFEV------L 580 (686)
Q Consensus 508 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~ 580 (686)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+....+ ................. .
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 234569999999999865 467999999999999999999999997543211 11111111100000000 0
Q ss_pred hhh---cc-----ChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 581 DAL---VL-----KEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 581 d~~---~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
... .. .........++.+|+.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 000 00 000112245688999999999999999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=377.03 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=198.3
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|.+.++||+|+||+||+|+. .+++.||||+++... +...+++.+|+.+|++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999996 468999999875432 2335789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
|+.++ +.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99754 44444332 233599999999999999999999999 99999999999999999999999999998765333
Q ss_pred ceeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc-h----hhhh
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-R----LFEV 579 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-~----~~~~ 579 (686)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+ .+........... . ....
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence 2 233456999999999877655 5789999999999999999999997543211 0110000000000 0 0000
Q ss_pred ------hhhhccCh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 580 ------LDALVLKE---AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 580 ------~d~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
........ .......++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000000 01122357889999999999999999999984
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.5e-45 Score=373.50 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=199.8
Q ss_pred cccccccccCccceEEEEEEEeCCCcEEEEEEccccC--hhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD--ENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.++||+|+||+||+|+.++++.||||+++... ....+.+.+|+.+|++++||||+++++++...+..++|||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999976532 33357899999999999999999999999999999999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCCc
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQT 506 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 506 (686)
+.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9877776665533 3699999999999999999999998 999999999999999999999999999987643322
Q ss_pred eeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch------hhhh
Q 038345 507 HLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR------LFEV 579 (686)
Q Consensus 507 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~~ 579 (686)
......|++.|+|||.+.. ..++.++||||||+++|||++|+.||......+ ............. ....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhhh
Confidence 2334468999999999875 456899999999999999999999997543211 1111111100000 0000
Q ss_pred ---------hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 580 ---------LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 580 ---------~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+.............+.+|+.+||+.||++|||++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000111122345788999999999999999999997
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=369.24 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=194.8
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccCh------hhHHHHHHHHHHHHhcC--CCCeeeEEeEEeeCC
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDE------NNVEQFINEVVILSQIN--HRNIVKLLGCCLETE 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~ 418 (686)
.++|.+.++||+|+||+||+|+.. +++.||||++..... ....++.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 689999998653211 12245778999999997 899999999999999
Q ss_pred cceEEEEeccC-CchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-CCcEEEEecC
Q 038345 419 VPLLVYEFVPN-GTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-KYRAKVSDFG 496 (686)
Q Consensus 419 ~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfG 496 (686)
..++||||+.+ +++.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999976 5777777653 2599999999999999999999999 9999999999999985 4799999999
Q ss_pred CcccccCCCceeeeeeeccccccCccccccCCC-CccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch
Q 038345 497 TSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQF-TEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR 575 (686)
Q Consensus 497 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~ 575 (686)
+++..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... ..... .
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-~ 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-Q 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC-C
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc-c
Confidence 99865432 2345679999999999987765 677899999999999999999996421 00110 0
Q ss_pred hhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 576 LFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 576 ~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
. ..+...+.++.+|+.+||+.||++|||++|++
T Consensus 221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 0 01112345688999999999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-43 Score=364.40 Aligned_cols=269 Identities=16% Similarity=0.172 Sum_probs=212.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCcceEEEE
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINH-RNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lV~e 425 (686)
.++|.+.++||+|+||+||+|+.. +++.||||.+.... ..+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999965 68999999865432 23567889999999975 899999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecC-----CCcEEEEecCCccc
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDD-----KYRAKVSDFGTSRS 500 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~ 500 (686)
|+ +++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 689999887543 3589999999999999999999999 9999999999999964 57899999999987
Q ss_pred ccCCCc------eeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 501 ITVDQT------HLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 501 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
...... .......||+.|||||.+.+..++.++||||||+++|||++|+.||.+....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643321 12334579999999999999999999999999999999999999998654322111111111110000
Q ss_pred hhhhhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhccccc
Q 038345 575 RLFEVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASIL 633 (686)
Q Consensus 575 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~~ 633 (686)
.. .+.....+.++.+++..|++.+|++||+++.+.+.|+.+....+....
T Consensus 236 ~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 236 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred Ch---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCC
Confidence 00 111112345689999999999999999999999999998776665543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=364.16 Aligned_cols=267 Identities=19% Similarity=0.244 Sum_probs=203.3
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEEEe
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVYEF 426 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~e~ 426 (686)
++|.+.+.||+|+||+||+|+.. +++.||||.+.... ..+++..|++++++++|+|+ +.+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999964 68999999866532 23568899999999987665 5556666778888999999
Q ss_pred ccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeec---CCCcEEEEecCCcccccC
Q 038345 427 VPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLD---DKYRAKVSDFGTSRSITV 503 (686)
Q Consensus 427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~~~ 503 (686)
+ +++|.+.+.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 456666665432 3599999999999999999999999 999999999999875 456799999999987654
Q ss_pred CCce------eeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 504 DQTH------LTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 504 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 237 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-
Confidence 3321 233457999999999999999999999999999999999999999865443322211111100000000
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhhhcccc
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAFELGGIRASIGASI 632 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~~L~~i~~~~~~~~ 632 (686)
.......+.++.+++.+||+.+|++||++.++.+.|+.+....+...
T Consensus 238 --------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 238 --------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp --------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred --------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence 01112234668999999999999999999999999998866555444
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=371.96 Aligned_cols=262 Identities=24% Similarity=0.334 Sum_probs=197.0
Q ss_pred hccccccccccCccceEEEEEEEeC-C-CcEEEEEEcccc--ChhhHHHHHHHHHHHHhc---CCCCeeeEEeEEee---
Q 038345 347 ATDNYNANRILGQGGQGTVYKGMLA-D-GRIVAVKKSKLV--DENNVEQFINEVVILSQI---NHRNIVKLLGCCLE--- 416 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~--- 416 (686)
..++|.+.++||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+|+.| +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3468999999999999999999963 4 667999987542 222334567788877766 79999999999863
Q ss_pred --CCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEe
Q 038345 417 --TEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSD 494 (686)
Q Consensus 417 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 494 (686)
....+++|||+.++.+....... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 34679999999988776554432 33589999999999999999999999 999999999999999999999999
Q ss_pred cCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc
Q 038345 495 FGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN 574 (686)
Q Consensus 495 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~ 574 (686)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ............
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~ 234 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 234 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCC
Confidence 99998654322 2345679999999999999999999999999999999999999997543221 111111110000
Q ss_pred hhhhh-------------hhhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 575 RLFEV-------------LDALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 575 ~~~~~-------------~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..... ................+.+|+.+||+.||++|||++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 00000 000000111122345688999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=367.77 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=196.9
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC----cc
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV-DENNVEQFINEVVILSQINHRNIVKLLGCCLETE----VP 420 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~ 420 (686)
...+|.+.++||+|+||+||+|+. .+|+.||||++... .....+.+++|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999995 47999999997643 3445678999999999999999999999997654 23
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+++++++.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 5566777899999999753 499999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCce--eeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcch--
Q 038345 501 ITVDQTH--LTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENR-- 575 (686)
Q Consensus 501 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~-- 575 (686)
....... ......||+.|+|||++.. ..++.++||||+|++++||++|+.||......+.. ...........
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChh
Confidence 6433221 2344569999999999854 56789999999999999999999999754322111 00000000000
Q ss_pred ---------hhhhhhhhc-cC-----hhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 ---------LFEVLDALV-LK-----EAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ---------~~~~~d~~~-~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......... .. ........++.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00 000112346889999999999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=364.12 Aligned_cols=265 Identities=22% Similarity=0.330 Sum_probs=193.9
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET------- 417 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------- 417 (686)
.++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.+|++++||||+++++.+...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999964 7999999986543 333457789999999999999999999998653
Q ss_pred -CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecC
Q 038345 418 -EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFG 496 (686)
Q Consensus 418 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 496 (686)
...++||||+.++.+..+... ...+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457899999987776654443 23588999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCce---eeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhh
Q 038345 497 TSRSITVDQTH---LTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMN 572 (686)
Q Consensus 497 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~ 572 (686)
+++.+...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876533221 22334699999999998765 689999999999999999999999975432211111000000000
Q ss_pred cc--------hhhhhhhhhcc-C-hhh-----HHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 573 EN--------RLFEVLDALVL-K-EAE-----REEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 573 ~~--------~~~~~~d~~~~-~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.. .....+..... . ... ......+.+|+.+||+.||++|||++|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 00 00000000000 0 000 11134577899999999999999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=365.37 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=192.7
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCC------
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLETE------ 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------ 418 (686)
.++|.+.++||+|+||+||+|... +|+.||||+++. ......+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 699999999764 23445678999999999999999999999998655
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+ +.+|..+++.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 56777766542 599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhH--------hhHH
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVG--------YFLQ 569 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~--------~~~~ 569 (686)
+..... .+...||+.|+|||++.+. .++.++|||||||+++||++|+.||......+...... .+..
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 876432 2345699999999998764 56899999999999999999999997543211000000 0000
Q ss_pred Hhhcchhhhh---hhhhc---cChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 570 AMNENRLFEV---LDALV---LKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 570 ~~~~~~~~~~---~d~~~---~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
.......... +.... ...........+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000 00000 00111122356789999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-43 Score=368.75 Aligned_cols=258 Identities=25% Similarity=0.332 Sum_probs=192.7
Q ss_pred ccccccccCccceEEEEEEEeC-CCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------CcceE
Q 038345 350 NYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIVKLLGCCLET------EVPLL 422 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 422 (686)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999975 689999999765322 234799999999999999999998643 24689
Q ss_pred EEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC-cEEEEecCCcccc
Q 038345 423 VYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY-RAKVSDFGTSRSI 501 (686)
Q Consensus 423 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~ 501 (686)
||||++++.+..+.+.......+++..+..|+.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444443333345799999999999999999999998 999999999999999765 8999999999876
Q ss_pred cCCCceeeeeeeccccccCcccccc-CCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---hhh
Q 038345 502 TVDQTHLTTKVQGTFGYVDPEYFQS-SQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---RLF 577 (686)
Q Consensus 502 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~ 577 (686)
..... .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ .+.. ........ .+.
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~-i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHH-HHHHHCCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHH-HHHHhCCChHHhhh
Confidence 54332 234569999999998765 578999999999999999999999997543211 0110 00000000 000
Q ss_pred hhh----h--------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 578 EVL----D--------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 578 ~~~----d--------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
... + .............++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0 00000111223456889999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=354.48 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=202.7
Q ss_pred cccccccccCccceEEEEEEEeC-CCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeCCcceEEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLETEVPLLVYE 425 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lV~e 425 (686)
++|++.++||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999964 6899999987543 34456789999999999999999999999999999999999
Q ss_pred eccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcccccCCC
Q 038345 426 FVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSRSITVDQ 505 (686)
Q Consensus 426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 505 (686)
++.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 99999998877644 3588999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeeeeeccccccCccccccCC-CCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc---h---hhh
Q 038345 506 THLTTKVQGTFGYVDPEYFQSSQ-FTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN---R---LFE 578 (686)
Q Consensus 506 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~~~ 578 (686)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.||....... .....+....... . ...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhh
Confidence 2 223345788999999987655 6899999999999999999999975322111 1111111111100 0 000
Q ss_pred hhh---------hhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 579 VLD---------ALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 579 ~~d---------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
..+ ..............+.+|+.+||+.||++|||++||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 0000111123345688999999999999999999997
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=359.27 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=202.1
Q ss_pred cccccccccCccceEEEEEEEeC----CCcEEEEEEcccc----ChhhHHHHHHHHHHHHhcCC-CCeeeEEeEEeeCCc
Q 038345 349 DNYNANRILGQGGQGTVYKGMLA----DGRIVAVKKSKLV----DENNVEQFINEVVILSQINH-RNIVKLLGCCLETEV 419 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~ 419 (686)
++|++.++||+|+||+||+|... +|+.||||.++.. +....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 57999999999999999999852 4789999987542 22335678899999999977 899999999999999
Q ss_pred ceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 420 PLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 420 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
.++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998654 478899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCceeeeeeeccccccCccccccC--CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcchhh
Q 038345 500 SITVDQTHLTTKVQGTFGYVDPEYFQSS--QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNENRLF 577 (686)
Q Consensus 500 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 577 (686)
.+............|++.|+|||.+... .++.++|||||||+||||++|+.||......+ ............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~---~~~~i~~~~~~~--- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKS--- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHHC---
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcccC---
Confidence 7654444444556799999999998764 46889999999999999999999997654322 111111111100
Q ss_pred hhhhhhccChhhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 038345 578 EVLDALVLKEAEREEIMTVATLAKRCLNLNGKNRPT-----MKEVA 618 (686)
Q Consensus 578 ~~~d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~ev~ 618 (686)
....+.....++.+|+.+||+.||++||| ++|++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 01122234567899999999999999995 67776
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-41 Score=355.39 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=195.5
Q ss_pred cccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeC--CcceEEE
Q 038345 349 DNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLET--EVPLLVY 424 (686)
Q Consensus 349 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lV~ 424 (686)
++|.+.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 46899999997643 3467889999999995 99999999999743 5689999
Q ss_pred EeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCC-CcEEEEecCCcccccC
Q 038345 425 EFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDK-YRAKVSDFGTSRSITV 503 (686)
Q Consensus 425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~~ 503 (686)
||+++++|..+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977643 489999999999999999999999 99999999999999865 4699999999987654
Q ss_pred CCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--------
Q 038345 504 DQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN-------- 574 (686)
Q Consensus 504 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 574 (686)
... .....||+.|+|||.+.+. .++.++||||+|++++||++|+.||........ ....+.......
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHH
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhhhhh
Confidence 322 3445689999999998765 479999999999999999999999975432111 000000000000
Q ss_pred -------hhhhhh--------hhhccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 575 -------RLFEVL--------DALVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 575 -------~~~~~~--------d~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
...... ..............++.+|+.+||+.||++|||++|++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000000 00011111122345688999999999999999999997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-42 Score=360.53 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=194.8
Q ss_pred hccccccccccCccceEEEEEEEe-CCCcEEEEEEcccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC-----C
Q 038345 347 ATDNYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLV--DENNVEQFINEVVILSQINHRNIVKLLGCCLET-----E 418 (686)
Q Consensus 347 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~ 418 (686)
..++|.+.++||+|+||+||+|+. .+|+.||||++... +....+++.+|+.+|++++|||||++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 356899999999999999999995 47999999997643 344556789999999999999999999998643 3
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..+++|+++.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 457778888999999998643 499999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCceeeeeeeccccccCccccccC-CCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHHHhhcc--h
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSS-QFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQAMNEN--R 575 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~~~~~~--~ 575 (686)
..... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.+..... ............ .
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~ 241 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAE 241 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHH
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChH
Confidence 75432 22345689999999987765 46889999999999999999999997543211 111111100000 0
Q ss_pred ---------hhhhhhhhc---cCh---hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038345 576 ---------LFEVLDALV---LKE---AEREEIMTVATLAKRCLNLNGKNRPTMKEVAF 619 (686)
Q Consensus 576 ---------~~~~~d~~~---~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~~ 619 (686)
......... ... ........+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000 000 00122356889999999999999999999983
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=353.45 Aligned_cols=260 Identities=22% Similarity=0.294 Sum_probs=190.5
Q ss_pred ccccccccccCccceEEEEEEEeC-CCcEEEEEEccc--cChhhHHHHHHHHHHHHhcCCCCeeeEEeEEeeC------C
Q 038345 348 TDNYNANRILGQGGQGTVYKGMLA-DGRIVAVKKSKL--VDENNVEQFINEVVILSQINHRNIVKLLGCCLET------E 418 (686)
Q Consensus 348 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~ 418 (686)
.++|++.++||+|+||+||+|... +|+.||||++.. ......+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999965 699999999764 3445567799999999999999999999999643 5
Q ss_pred cceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEEecCCc
Q 038345 419 VPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVSDFGTS 498 (686)
Q Consensus 419 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 498 (686)
..++||||+.++.+ +.+.. .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 77999999976544 44432 488999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchh--------------
Q 038345 499 RSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLV-------------- 564 (686)
Q Consensus 499 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~-------------- 564 (686)
+..... .......||+.|+|||++.+..++.++||||+||+++||++|+.||.+..........
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 865432 2334456899999999999999999999999999999999999999754311100000
Q ss_pred --HhhHHHhhcc------hhhhhhhh---hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 565 --GYFLQAMNEN------RLFEVLDA---LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 565 --~~~~~~~~~~------~~~~~~d~---~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.......... ........ .............+.+|+.+||+.||++|||++||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0000000000 00000000 011122334567899999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=322.25 Aligned_cols=262 Identities=20% Similarity=0.216 Sum_probs=190.7
Q ss_pred ccccccccCccceEEEEEEEe-CCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEeEEeeC
Q 038345 350 NYNANRILGQGGQGTVYKGML-ADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-----------HRNIVKLLGCCLET 417 (686)
Q Consensus 350 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~ 417 (686)
+|.+.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999999996 47899999998643 233467888999998885 57899999988653
Q ss_pred --CcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCC------c
Q 038345 418 --EVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKY------R 489 (686)
Q Consensus 418 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~------~ 489 (686)
...+++|++...+..............+++..+..++.||+.||+|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 456677777766554444443344456899999999999999999999832 899999999999997654 4
Q ss_pred EEEEecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHHHHHhCCCCCccCCcccCCchhHhhHH
Q 038345 490 AKVSDFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLVEILTGQKPIRAINIDEDRSLVGYFLQ 569 (686)
Q Consensus 490 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~elltg~~p~~~~~~~~~~~l~~~~~~ 569 (686)
+|++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||.................
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999765322 2345699999999999999999999999999999999999999975432221111111111
Q ss_pred Hhh---c--------ch-hhhhhh---------h----------hccChhhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038345 570 AMN---E--------NR-LFEVLD---------A----------LVLKEAEREEIMTVATLAKRCLNLNGKNRPTMKEVA 618 (686)
Q Consensus 570 ~~~---~--------~~-~~~~~d---------~----------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev~ 618 (686)
.+. . .. .....+ . ............++.+|+.+||+.||.+|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 000 0 00 000000 0 001122345677899999999999999999999987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.4e-23 Score=198.51 Aligned_cols=170 Identities=15% Similarity=0.149 Sum_probs=121.5
Q ss_pred ccccccCccceEEEEEEEeCCCcEEEEEEccccC------------------hhhHHHHHHHHHHHHhcCCCCeeeEEeE
Q 038345 352 NANRILGQGGQGTVYKGMLADGRIVAVKKSKLVD------------------ENNVEQFINEVVILSQINHRNIVKLLGC 413 (686)
Q Consensus 352 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g~ 413 (686)
.+.++||+|+||+||+|...+|+.||||..+... ......+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999998899999999754210 0112345578899999999999998865
Q ss_pred EeeCCcceEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeEeeCCCCCCeeecCCCcEEEE
Q 038345 414 CLETEVPLLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAASISIYRRDIKSANILLDDKYRAKVS 493 (686)
Q Consensus 414 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 493 (686)
. ..++||||+++..+.+ ++......++.|++++|+|||+. +|+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998766543 33344567999999999999999 99999999999999965 58999
Q ss_pred ecCCcccccCCCceeeeeeeccccccCccccccCCCCccccEeehHHHHH
Q 038345 494 DFGTSRSITVDQTHLTTKVQGTFGYVDPEYFQSSQFTEKSDVYSFGVVLV 543 (686)
Q Consensus 494 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDv~S~Gv~l~ 543 (686)
|||+|........... ...+... ..+. ..+.|+.++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999976542221100 0000000 0111 2356788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=3.8e-07 Score=89.10 Aligned_cols=149 Identities=14% Similarity=0.105 Sum_probs=104.0
Q ss_pred HHHHhhccccccccccCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcC-CCCeeeEEeEEeeCCcc
Q 038345 342 KDLEKATDNYNANRILGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQIN-HRNIVKLLGCCLETEVP 420 (686)
Q Consensus 342 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~ 420 (686)
.++.+....|+..+..+-++...||+... +++.+.||+...........+.+|...+..+. +--+.+++.+....+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46666667787777655555578998764 45667788765544444456788999888874 44467888888888899
Q ss_pred eEEEEeccCCchhhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------
Q 038345 421 LLVYEFVPNGTLYQNIHNHIEEFPITWELLLRIAVEVSGALFYLHSAA-------------------------------- 468 (686)
Q Consensus 421 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-------------------------------- 468 (686)
++||+++++.++.+..... . ....++.++++.|+.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999998886544321 1 12234555555566666421
Q ss_pred ------------------------CCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 469 ------------------------SISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 469 ------------------------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
...++|+|+.|.|||++++...-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1147999999999999987667799999874
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.6e-08 Score=68.25 Aligned_cols=42 Identities=31% Similarity=0.620 Sum_probs=32.2
Q ss_pred cCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCc
Q 038345 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
+|||||.......+.+.|+|++|+|.|.|++||..+ .++..|
T Consensus 1 qDinEC~~~~~~c~~~~C~Nt~Gsy~C~C~~Gy~l~--~~~~~C 42 (43)
T d1uzka2 1 EDIDECQELPGLCQGGKCINTFGSFQCRCPTGYYLN--EDTRVC 42 (43)
T ss_dssp EECCHHHHCGGGGBTSEEEECSSCEEEECCTTCCBC--TTTCBB
T ss_pred CCcccccCCCCCcCCCEEECCCCCeEeECCCCCeEC--cCCCcc
Confidence 589999864433345899999999999999999876 344444
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=3.4e-08 Score=66.55 Aligned_cols=37 Identities=32% Similarity=0.617 Sum_probs=32.2
Q ss_pred CCcCCCcccCCCCCccccccccCCcceEEeCCCCccCC
Q 038345 220 GCRDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 220 gC~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.|.|||||+.+ ...|.+.|.|++|+|.|.|++||.++
T Consensus 1 sCvDidEC~~~-~~~~~~~C~Nt~Gsy~C~C~~Gy~~~ 37 (43)
T d1emoa1 1 SAVDMDECKEP-DVCKHGQCINTDGSYRCECPFGYILA 37 (43)
T ss_dssp CCCCCCSSSST-TSCSSSCCCCCSSCCCCCCCTTEEES
T ss_pred CCcceeccCCc-CCCCCCEeECCCCCeEeECCCCcccC
Confidence 38999999864 45678899999999999999999875
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=3.7e-08 Score=66.32 Aligned_cols=35 Identities=29% Similarity=0.775 Sum_probs=29.4
Q ss_pred cCCCcccCCCCCccc-cccccCCcceEEeCCCCccCC
Q 038345 222 RDVNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~ 257 (686)
+|||||... ...|. +.|.|++|+|.|.|++||.++
T Consensus 1 TDidEC~~~-~~~C~~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 1 TDIDECRIS-PDLCGRGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CCCCTTTTC-SSTTTTSCEEEETTEEEECCCSSEEEC
T ss_pred CcccccCCC-CCCCCCCEeEcCCCCeEEeCCCCCccC
Confidence 489999864 35564 599999999999999999876
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=4.4e-08 Score=66.19 Aligned_cols=41 Identities=41% Similarity=0.775 Sum_probs=33.5
Q ss_pred cCCCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCc
Q 038345 222 RDVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
.|||||+.+ ...|++.|+|++|+|.|.|++||..+ .++..|
T Consensus 1 TDidEC~~~-~~~c~~~C~Nt~G~y~C~C~~Gy~l~--~d~~~C 41 (43)
T d1uzka1 1 TDVNECLDP-TTCISGNCVNTPGSYICDCPPDFELN--PTRVGC 41 (43)
T ss_dssp CCCCGGGST-TSSBTSEEEEETTEEEEECCTTCEEC--TTSSBE
T ss_pred CCccccCCC-CcCcCCEeECCCCCEEEecCCCCEEC--CCCCcc
Confidence 489999875 46688999999999999999999876 344444
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=4.7e-08 Score=65.49 Aligned_cols=40 Identities=33% Similarity=0.808 Sum_probs=31.4
Q ss_pred CCCcccCCCCCcc-ccccccCCcceEEeCCCCccCCCCCCCCCc
Q 038345 223 DVNEFEDPSLNNC-THICDNTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 223 ~~~~c~~~~~~~c-~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
|||||+... ..| ++.|.|++|+|.|.|++||..+ .++..|
T Consensus 1 DidEC~~~~-~~C~~~~C~Nt~Gsy~C~C~~Gy~l~--~d~~~C 41 (42)
T d1lmja2 1 DIDECQRDP-LLCRGGVCHNTEGSYRCECPPGHQLS--PNISAC 41 (42)
T ss_dssp ECCHHHHCS-STTTTSEEEEETTEEEEESCTTSCCC--SSSCCC
T ss_pred CccccCCCC-CCCCCCEeECCCCCeEEeCCCCCeEC--cCCCcc
Confidence 689998743 455 4599999999999999999876 344444
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=2.3e-08 Score=65.43 Aligned_cols=33 Identities=27% Similarity=0.669 Sum_probs=29.9
Q ss_pred CCCcccCCCCCccccccccCCcceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|||||+.+ .+|++.|+|++|+|.|.|++||..+
T Consensus 1 DidEC~~~--~~C~~~C~N~~Gsy~C~C~~Gy~l~ 33 (40)
T d1dx5i3 1 DIDECENG--GFCSGVCHNLPGTFECICGPDSALA 33 (40)
T ss_dssp ECCHHHHC--SSCSSEEEECSSSEEEEECSSSSCE
T ss_pred CccccCCC--cCccCEeeCCCCCeEeECCCCCeeC
Confidence 68999863 7899999999999999999999875
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.36 E-value=7.5e-08 Score=64.18 Aligned_cols=40 Identities=35% Similarity=0.671 Sum_probs=33.0
Q ss_pred CcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 225 NEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 225 ~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
|||+......|++.|.|++|+|.|.|++||... .++..|.
T Consensus 1 dEC~~~~~~~C~~~C~n~~Gsy~C~C~~Gy~L~--~d~~tC~ 40 (42)
T d1nzia2 1 NECTDFVDVPCSHFCNNFIGGYFCSCPPEYFLH--DDMKNCG 40 (42)
T ss_dssp CTTTC-CCCCSSSEEEEETTEEEEECCTTCEEC--TTSSCEE
T ss_pred CCCCCCCCcCCCCEeecCCCCEEEeCCCCCEEC--CCCCeec
Confidence 688765667899999999999999999999876 5666664
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=9.4e-08 Score=67.91 Aligned_cols=43 Identities=33% Similarity=0.763 Sum_probs=32.2
Q ss_pred cCCCcccCCCC-------CccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 222 RDVNEFEDPSL-------NNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 222 ~~~~~c~~~~~-------~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
.|||||..... ..|++.|+|++|+|.|.|++||..+ .++..|.
T Consensus 2 vDidEC~~~~~~c~~~~~~~c~~~C~Nt~GsY~C~C~~Gy~l~--~d~~tC~ 51 (53)
T d1apqa_ 2 VDLDECASRSKSGEEDPQPQCQHLCHNYVGGYFCSCRPGYELQ--EDRHSCQ 51 (53)
T ss_dssp CSCCTTTCSTTTCCCSSSCTTSSEEEEETTEEEEECSTTCEEC--TTSSCEE
T ss_pred eecccccCCCCCcccCCCCCccCEeEcCCCCeEeECCCCCeEC--CCCCcee
Confidence 47888876432 2356789999999999999999865 4555564
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=1.6e-07 Score=62.51 Aligned_cols=39 Identities=33% Similarity=0.903 Sum_probs=32.5
Q ss_pred CCcccCCCCCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 224 VNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 224 ~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
||||+. ..+|.+.|.|++|+|.|.|++||..+ .++..|.
T Consensus 1 idEC~~--~~~C~~~C~n~~Gsy~C~C~~Gy~L~--~d~~~C~ 39 (41)
T d1i0ua2 1 IDECQD--PDTCSQLCVNLEGGYKCQCEEGFQLD--PHTKACK 39 (41)
T ss_dssp CCTTTT--TTSCSSCEECSSSCCEECCCTTEEEC--TTTCCEE
T ss_pred CccCCC--CCCCCCEeECCCCCEEeECCCCCeEC--CCCCccc
Confidence 689975 37899999999999999999999876 4555664
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.14 E-value=3.1e-07 Score=62.54 Aligned_cols=41 Identities=29% Similarity=0.647 Sum_probs=29.8
Q ss_pred CCcccCCC--CCccccccccCCcceEEeCCCCccCCCCCCCCCcc
Q 038345 224 VNEFEDPS--LNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCI 266 (686)
Q Consensus 224 ~~~c~~~~--~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~ 266 (686)
||||+..+ ..+|++.|.|++|+|.|.|++||... .++..|.
T Consensus 1 IdEC~~~~~~~~~C~~~C~Nt~gsy~C~C~~Gy~L~--~d~~tC~ 43 (45)
T d1nt0a3 1 VDECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILH--QNKHTCS 43 (45)
T ss_dssp CCTTC-------CCSSEEEEETTEEEEECCTTEEEC--TTSSCEE
T ss_pred CcCCccCCCCcCCCCCEeecCCCCEEEeCCCCCEEC--CCCCccc
Confidence 68887642 34689999999999999999999865 4555563
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=4.8e-07 Score=61.57 Aligned_cols=40 Identities=28% Similarity=0.734 Sum_probs=31.1
Q ss_pred CCcccCCC--CCccccccccCCcceEEeCCCCccCCCCCCCCCc
Q 038345 224 VNEFEDPS--LNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 224 ~~~c~~~~--~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
||||+... ...|.+.|.|++|+|.|.|++||... .++..|
T Consensus 1 IdEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~--~d~~tC 42 (45)
T d1szba2 1 IDECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLH--RNKRTC 42 (45)
T ss_dssp CCTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEEC--TTSSCE
T ss_pred CcCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeEC--CCCCCc
Confidence 68887643 23689999999999999999999865 345555
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.09 E-value=6.9e-07 Score=59.93 Aligned_cols=43 Identities=23% Similarity=0.462 Sum_probs=33.5
Q ss_pred ccccccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC
Q 038345 177 TCEEAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD 223 (686)
Q Consensus 177 ~c~~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~ 223 (686)
+|.+++||..+. |..++.|+|+.++|.|.|++||+++. ..|+|
T Consensus 1 sCvDidEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~~g---~~C~D 43 (43)
T d1emoa1 1 SAVDMDECKEPD-VCKHGQCINTDGSYRCECPFGYILAG---NECVD 43 (43)
T ss_dssp CCCCCCSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEESS---SCEEE
T ss_pred CCcceeccCCcC-CCCCCEeECCCCCeEeECCCCcccCC---CcccC
Confidence 477889997654 33468899999999999999999754 45654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.2e-05 Score=77.60 Aligned_cols=130 Identities=16% Similarity=0.150 Sum_probs=86.1
Q ss_pred ccCccc-eEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCC--CCeeeEEeEEeeCCcceEEEEeccCCch
Q 038345 356 ILGQGG-QGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINH--RNIVKLLGCCLETEVPLLVYEFVPNGTL 432 (686)
Q Consensus 356 ~lG~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lV~e~~~~gsL 432 (686)
.+..|. .+.||+....++..+++|...... ...+..|+..++.+.. -.+.+++++..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344444 367999988888888999765432 2456778888887753 3357788888888889999999998766
Q ss_pred hhhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------------
Q 038345 433 YQNIHNHIEEFPITWELLLRIAVEVSGALFYLHS---------------------------------------------- 466 (686)
Q Consensus 433 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~yLH~---------------------------------------------- 466 (686)
.+.. +.. ..++.++++.|+-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4311 000 1112222233333332
Q ss_pred -----c----CCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 467 -----A----ASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 467 -----~----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
. ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 12248999999999999987667899999874
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.92 E-value=3e-06 Score=56.60 Aligned_cols=35 Identities=37% Similarity=0.830 Sum_probs=29.9
Q ss_pred cCCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 222 RDVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 222 ~~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
+|||||.. ...+|. ++|.|+.|+|+|.|++||.|.
T Consensus 1 qDideC~~-~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 1 QDVDECSL-GANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CCCCTTTS-SSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred CCCccccC-CCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 58999975 346785 599999999999999999986
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=3.1e-06 Score=55.54 Aligned_cols=33 Identities=36% Similarity=0.876 Sum_probs=29.4
Q ss_pred CCCcccCCCCCccccccccCCcceEEeCCCCccC
Q 038345 223 DVNEFEDPSLNNCTHICDNTAGNYTCRCPKGFRG 256 (686)
Q Consensus 223 ~~~~c~~~~~~~c~~~C~~~~g~~~C~C~~g~~~ 256 (686)
++|||.. +...|++.|.|++|+|.|.|++||..
T Consensus 1 G~neC~~-~nggC~h~C~n~~g~~~C~C~~Gy~L 33 (40)
T d3bpse1 1 GTNECLD-NNGGCSHVCNDLKIGYECLCPDGFQL 33 (40)
T ss_dssp CSCGGGT-GGGGCSSEEEECSSSEEEECCTTCCE
T ss_pred CcccCCC-CCCCCcCEEEcCCCCEEEECCCCCEE
Confidence 3689986 56889999999999999999999976
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.81 E-value=3.3e-06 Score=56.60 Aligned_cols=35 Identities=26% Similarity=0.668 Sum_probs=28.5
Q ss_pred cccccCCCC-CCCCCCCCccCCCCceecCCCCcccCC
Q 038345 180 EAKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 180 ~~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
+++||.... .|. ++.|.|+.+||+|.|++||+++.
T Consensus 2 DidEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~~ 37 (44)
T d1lmja1 2 DIDECRISPDLCG-RGQCVNTPGDFECKCDEGYESGF 37 (44)
T ss_dssp CCCTTTTCSSTTT-TSCEEEETTEEEECCCSSEEECT
T ss_pred cccccCCCCCCCC-CCEeEcCCCCeEEeCCCCCccCC
Confidence 567786654 674 57899999999999999999864
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.80 E-value=4.2e-06 Score=55.86 Aligned_cols=35 Identities=23% Similarity=0.703 Sum_probs=29.6
Q ss_pred cccccCCC-CCCCCCCCCccCCCCceecCCCCcccC
Q 038345 180 EAKICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEGN 214 (686)
Q Consensus 180 ~~~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~gn 214 (686)
++++|... .+|.+++.|++..++|+|.|++||+|.
T Consensus 2 DideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 2 DVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CCCTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred CCccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 45677643 389999999999999999999999983
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.75 E-value=6.3e-06 Score=54.54 Aligned_cols=40 Identities=28% Similarity=0.795 Sum_probs=30.5
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCC
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV 224 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~ 224 (686)
++|..+..| .+.|.++.+||+|.|++||+.++ ....|++|
T Consensus 2 dEC~~~~~C--~~~C~n~~Gsy~C~C~~Gy~L~~-d~~~C~ai 41 (41)
T d1i0ua2 2 DECQDPDTC--SQLCVNLEGGYKCQCEEGFQLDP-HTKACKAV 41 (41)
T ss_dssp CTTTTTTSC--SSCEECSSSCCEECCCTTEEECT-TTCCEEEC
T ss_pred ccCCCCCCC--CCEeECCCCCEEeECCCCCeECC-CCCccccC
Confidence 566655578 46899999999999999999876 33456543
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.58 E-value=6.6e-06 Score=55.16 Aligned_cols=42 Identities=31% Similarity=0.644 Sum_probs=30.6
Q ss_pred cccccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcC
Q 038345 180 EAKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD 223 (686)
Q Consensus 180 ~~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~ 223 (686)
+++||.....|. ++.|+++.+||+|.|++||+.++- ...|+|
T Consensus 2 DidEC~~~~~~c-~~~C~Nt~G~y~C~C~~Gy~l~~d-~~~C~D 43 (43)
T d1uzka1 2 DVNECLDPTTCI-SGNCVNTPGSYICDCPPDFELNPT-RVGCVD 43 (43)
T ss_dssp CCCGGGSTTSSB-TSEEEEETTEEEEECCTTCEECTT-SSBEEC
T ss_pred CccccCCCCcCc-CCEeECCCCCEEEecCCCCEECCC-CCcccC
Confidence 467776554442 578999999999999999998763 345543
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.55 E-value=1.3e-05 Score=52.24 Aligned_cols=32 Identities=28% Similarity=0.685 Sum_probs=28.4
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
.++|.++ +|.+++.|++..++|.|.|++||+|
T Consensus 3 ~d~C~~~-PC~ngg~C~~~~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 3 GDQCESN-PCLNGGSCKDDINSYECWCPFGFEG 34 (39)
T ss_dssp CCTTTTC-CCCTTCEEEEETTEEEEECCTTCCS
T ss_pred cccCCCC-CCCCCcEEEcCCCCEEEECCCCCCC
Confidence 4667765 8999999999999999999999998
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.54 E-value=8.8e-06 Score=52.36 Aligned_cols=32 Identities=22% Similarity=0.626 Sum_probs=28.2
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
.++|.++ +|.+++.|++...+|.|.|++||+|
T Consensus 2 ~d~C~~~-PC~ngg~C~~~~~~y~C~C~~g~~G 33 (37)
T d2c4fl1 2 GDQCASS-PCQNGGSCKDQLQSYICFCLPAFEG 33 (37)
T ss_dssp CCGGGGC-CCCTTCEEEEETTEEEEECCTTEES
T ss_pred cccCCCC-CCCCCCEEECCCCCeEEECCCCCcC
Confidence 4667665 8999999999999999999999998
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.53 E-value=1.7e-05 Score=51.62 Aligned_cols=31 Identities=29% Similarity=0.730 Sum_probs=27.7
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
++|.++ +|.+++.|++..++|+|.|++||.|
T Consensus 2 d~C~~~-PC~n~g~C~~~~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 2 NECVSN-PCQNDATCLDQIGEFQCICMPGYEG 32 (39)
T ss_dssp CTTTTC-CCCSSCEEEECSSCEEEECCTTEES
T ss_pred cCCcCC-CCCCCCEEECCCCCEEEeCCCCCcc
Confidence 567665 8999999999999999999999998
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.52 E-value=3.4e-06 Score=54.96 Aligned_cols=33 Identities=12% Similarity=0.282 Sum_probs=26.4
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCcccCC
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
++||..+..|. ..|+|+.+||+|.|++||+.++
T Consensus 2 idEC~~~~~C~--~~C~N~~Gsy~C~C~~Gy~l~g 34 (40)
T d1dx5i3 2 IDECENGGFCS--GVCHNLPGTFECICGPDSALAG 34 (40)
T ss_dssp CCHHHHCSSCS--SEEEECSSSEEEEECSSSSCEE
T ss_pred ccccCCCcCcc--CEeeCCCCCeEeECCCCCeeCC
Confidence 45665555784 6899999999999999999764
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.49 E-value=2.4e-05 Score=50.89 Aligned_cols=31 Identities=26% Similarity=0.741 Sum_probs=27.3
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
++|.++ +|.+++.|.+..++|.|.|++||+|
T Consensus 1 D~C~~~-PC~ngg~C~~~~~~y~C~C~~G~~G 31 (39)
T d1xkba1 1 DQCETS-PCQNQGKCKDGLGEYTCTCLEGFEG 31 (39)
T ss_dssp CTTTTC-CCCSSCEECCCSSSCCEECCTTEET
T ss_pred CcCCCC-CCCCCcEEECCCCCEEEECCCCCCc
Confidence 356665 8999999999999999999999998
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.43 E-value=2.7e-05 Score=49.33 Aligned_cols=31 Identities=19% Similarity=0.670 Sum_probs=27.0
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
++|.++ +|.+++.|++...+|.|.|++||.|
T Consensus 1 d~C~~~-PC~ngg~C~~~~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 1 DECASS-PCLHNGRCLDKINEFQCECPTGFTG 31 (35)
T ss_dssp CTTTTC-CSTTTCEEEECSSCEEEECCTTEES
T ss_pred CCCCCC-CCCCCcEEECCCCCeEEECCCCCCC
Confidence 356655 8999999998889999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.0004 Score=71.25 Aligned_cols=77 Identities=17% Similarity=0.219 Sum_probs=49.6
Q ss_pred ccccCccceEEEEEEEeCC-CcEEEEEEccc----cC---hhhHHHHHHHHHHHHhcC-C--CCeeeEEeEEeeCCcceE
Q 038345 354 NRILGQGGQGTVYKGMLAD-GRIVAVKKSKL----VD---ENNVEQFINEVVILSQIN-H--RNIVKLLGCCLETEVPLL 422 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~l 422 (686)
.+.||.|....||+....+ ++.|+||.... .. .....+...|...|+.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999998654 67899996332 11 112344567888887763 2 345666654 4566789
Q ss_pred EEEeccCCch
Q 038345 423 VYEFVPNGTL 432 (686)
Q Consensus 423 V~e~~~~gsL 432 (686)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.33 E-value=1.7e-05 Score=53.03 Aligned_cols=35 Identities=23% Similarity=0.548 Sum_probs=27.4
Q ss_pred cccccCCCC-CCCCCCCCccCCCCceecCCCCcccCC
Q 038345 180 EAKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 180 ~~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
+++||.... .|. ++.|+|+.++|+|.|.+||..++
T Consensus 2 DinEC~~~~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 2 DIDECQELPGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp ECCHHHHCGGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred CcccccCCCCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 466775433 664 46899999999999999999765
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.21 E-value=2.5e-05 Score=50.94 Aligned_cols=27 Identities=26% Similarity=0.762 Sum_probs=24.2
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCC
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
.|..++.|+++.++|.|.|++||.||.
T Consensus 8 ~C~~~A~C~Nt~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 8 QCSVHAECRDYATGFCCRCVANYTGNG 34 (40)
T ss_dssp GSCTTEEEEECSSCEEEEECTTEEECS
T ss_pred CCCCCCEeecCCCCeEeECCCCCcCCC
Confidence 677788889999999999999999975
|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=6e-05 Score=51.92 Aligned_cols=38 Identities=32% Similarity=0.636 Sum_probs=31.5
Q ss_pred CCCccccccccCCcceEEeCCCCccCCCCCCCCCccCCcc
Q 038345 231 SLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQK 270 (686)
Q Consensus 231 ~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~~~~ 270 (686)
+...|++.|++++++|+|.|++||... .|+..|.+...
T Consensus 5 ~NGgC~~~C~~~~g~~~C~C~~Gy~L~--~D~~tC~~~~~ 42 (50)
T d1autl2 5 DNGGCTHYCLEEVGWRRCSCAPGYKLG--DDLLQCHPAVK 42 (50)
T ss_dssp GGGGCSSEEEECSSSEEEECCTTEEEC--TTSSCEEECSS
T ss_pred CCCCcccEeecCCCCeEEECCCCCEEC--CCCCccccCCC
Confidence 346899999999999999999999886 57778866443
|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=5.1e-05 Score=52.52 Aligned_cols=38 Identities=24% Similarity=0.781 Sum_probs=31.7
Q ss_pred CCCccccccccCCcceEEeCCCCccCCCCCCCCCccCCcc
Q 038345 231 SLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQK 270 (686)
Q Consensus 231 ~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~~~~ 270 (686)
++..|++.|.|++|+|.|.|++||..+ .|+..|.+...
T Consensus 6 ~NGgC~h~C~n~~g~~~C~C~~Gy~L~--~D~~tC~~~~~ 43 (51)
T d2p3ua1 6 DNGDCDQFCHEEQNSVVCSCARGYTLA--DNGKACIPTGP 43 (51)
T ss_dssp GGGGCSSEEEEETTEEEEECCTTEEEC--TTSSCEEESSS
T ss_pred CCCCcccEeecCCCCeEeEcCCCCEEC--CCCCccccCCc
Confidence 346899999999999999999999876 57778876544
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=3.3e-05 Score=51.28 Aligned_cols=34 Identities=24% Similarity=0.567 Sum_probs=26.4
Q ss_pred ccccCCCC-CCCCCCCCccCCCCceecCCCCcccCC
Q 038345 181 AKICGPNA-SCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 181 ~~~c~~~~-~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
++||.... .|. ++.|+|+.+||+|.|++||..++
T Consensus 2 idEC~~~~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 2 IDECQRDPLLCR-GGVCHNTEGSYRCECPPGHQLSP 36 (42)
T ss_dssp CCHHHHCSSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred ccccCCCCCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence 45664443 674 56899999999999999999765
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=3.5e-05 Score=50.47 Aligned_cols=36 Identities=33% Similarity=0.727 Sum_probs=29.1
Q ss_pred ccCCCCCCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCC
Q 038345 183 ICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDV 224 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~ 224 (686)
.|.++ +|.+++.|+...++|+|.|++||.| ..|+.+
T Consensus 3 ~C~~~-pC~ngg~C~~~~~~y~C~C~~g~~G-----~~Ce~~ 38 (40)
T d1g1sa2 3 SCQDM-SCSKQGECLETIGNYTCSCYPGFYG-----PECEYV 38 (40)
T ss_dssp CCCTT-GGGGSEEEEECSSSEEEEECTTEES-----TTSCEE
T ss_pred cccCC-cCCCCcEEECCCCCeEEeCCCCccC-----CCCCCC
Confidence 45555 8998999998899999999999998 456543
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.09 E-value=0.00012 Score=46.93 Aligned_cols=32 Identities=25% Similarity=0.672 Sum_probs=27.9
Q ss_pred CCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|+|+|.. .+|. ++|++..++|.|.|++||.|.
T Consensus 1 D~d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 1 DGDQCAS---SPCQNGGSCKDQLQSYICFCLPAFEGR 34 (37)
T ss_dssp TCCGGGG---CCCCTTCEEEEETTEEEEECCTTEEST
T ss_pred CcccCCC---CCCCCCCEEECCCCCeEEECCCCCcCC
Confidence 6788975 6885 599999999999999999986
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.06 E-value=0.0001 Score=51.68 Aligned_cols=23 Identities=30% Similarity=0.632 Sum_probs=20.1
Q ss_pred CCCCccCCCCceecCCCCcccCC
Q 038345 193 SKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 193 ~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
.+.|+|+.+||+|.|++||+.++
T Consensus 23 ~~~C~Nt~GsY~C~C~~Gy~l~~ 45 (53)
T d1apqa_ 23 QHLCHNYVGGYFCSCRPGYELQE 45 (53)
T ss_dssp SSEEEEETTEEEEECSTTCEECT
T ss_pred cCEeEcCCCCeEeECCCCCeECC
Confidence 45799999999999999999655
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.98 E-value=0.00022 Score=46.19 Aligned_cols=32 Identities=38% Similarity=0.913 Sum_probs=28.0
Q ss_pred CCCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 223 DVNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 223 ~~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|+|+|.. .+|. ++|++..++|.|.|++||.|.
T Consensus 2 d~d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 2 DGDQCES---NPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CCCTTTT---CCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred ccccCCC---CCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 6788875 6885 599999999999999999986
|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.95 E-value=0.0001 Score=51.00 Aligned_cols=38 Identities=18% Similarity=0.671 Sum_probs=31.3
Q ss_pred CCCccccccccCCcceEEeCCCCccCCCCCCCCCccCCcc
Q 038345 231 SLNNCTHICDNTAGNYTCRCPKGFRGDGRRDGGGCIPNQK 270 (686)
Q Consensus 231 ~~~~c~~~C~~~~g~~~C~C~~g~~~~~~~~~~~C~~~~~ 270 (686)
++..|++.|.|++++|.|.|+.||... .|+..|.+...
T Consensus 4 ~NGgC~h~C~~~~~~~~C~C~~Gy~L~--~D~~tC~~~~~ 41 (51)
T d1kigl_ 4 DNGGCDQFCREERSEVRCSCAHGYVLG--DDSKSCVSTER 41 (51)
T ss_dssp TTTSSSSCCCEETTEECCCCCTTEEEC--TTSSCEEECSS
T ss_pred CCCCcccEeEcCCCcEEeEcCCCCEEC--CCCCccccCCc
Confidence 456799999999999999999999876 56777876544
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.92 E-value=5.3e-05 Score=49.24 Aligned_cols=30 Identities=33% Similarity=0.862 Sum_probs=26.3
Q ss_pred ccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 183 ICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
.|.++ +|.+++.|++..++|.|.|++||.|
T Consensus 3 ~C~~~-pC~ngg~C~~~~~~~~C~C~~g~~G 32 (39)
T d1g1ta2 3 ACTNT-SCSGHGECVETINNYTCKCDPGFSG 32 (39)
T ss_dssp CCCTT-GGGGSEEEEEETTEEEEEECTTEES
T ss_pred cccCC-cCCCCcEEECCCCCEEEeCCCCCcC
Confidence 45554 8999999998899999999999998
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.81 E-value=0.00033 Score=45.30 Aligned_cols=31 Identities=35% Similarity=0.822 Sum_probs=26.7
Q ss_pred CCcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 224 VNEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 224 ~~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
||+|.. .+|. ++|++..++|.|.|++||.|.
T Consensus 1 Id~C~~---~PC~n~g~C~~~~~~y~C~C~~G~~G~ 33 (39)
T d2vj3a2 1 VNECVS---NPCQNDATCLDQIGEFQCICMPGYEGV 33 (39)
T ss_dssp CCTTTT---CCCCSSCEEEECSSCEEEECCTTEESS
T ss_pred CcCCcC---CCCCCCCEEECCCCCEEEeCCCCCccC
Confidence 578864 6785 599999999999999999986
|
| >d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.80 E-value=0.0003 Score=48.26 Aligned_cols=38 Identities=29% Similarity=0.614 Sum_probs=29.1
Q ss_pred CcccCCCCCccccccc------cCCcceEEeCCCCccCCCCCCCCCc
Q 038345 225 NEFEDPSLNNCTHICD------NTAGNYTCRCPKGFRGDGRRDGGGC 265 (686)
Q Consensus 225 ~~c~~~~~~~c~~~C~------~~~g~~~C~C~~g~~~~~~~~~~~C 265 (686)
|||.. +...|++.|+ ++.++|.|.|+.||... .|+..|
T Consensus 5 neC~~-~NGGC~h~Cl~~p~~~n~~~~y~C~C~~G~~L~--~D~~tC 48 (50)
T d1ijqa2 5 ERTTL-SNGGCQYLCLPAPQINPHSPKFTCACPDGMLLA--RDMRSC 48 (50)
T ss_dssp SSSSS-GGGGCSSEEEECCCCSTTCCSEEEECCTTCEEC--TTSSCE
T ss_pred cccCC-CCCCCcCccCCCcCcccCCCCEEEeCCCCCEEC--CCCCcc
Confidence 56655 4578999996 56689999999999876 455555
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.76 E-value=0.00018 Score=48.47 Aligned_cols=30 Identities=20% Similarity=0.540 Sum_probs=23.2
Q ss_pred CCCCccCCCCceecCCCCcccCCCCCCCCcC
Q 038345 193 SKDNTTTSSGYHCKCNKGYEGNPYLSDGCRD 223 (686)
Q Consensus 193 ~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~ 223 (686)
...|.++.+||+|.|++||+.++ ....|+|
T Consensus 15 ~~~C~Nt~Gsy~C~C~~Gy~l~~-d~~tC~D 44 (45)
T d1szba2 15 DHHCHNHLGGFYCSCRAGYVLHR-NKRTCSE 44 (45)
T ss_dssp SSEEEEETTEEEEECCTTEEECT-TSSCEEE
T ss_pred CCCCccCCCCeEEECCCCCeECC-CCCCccC
Confidence 56899999999999999998655 2234554
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.74 E-value=0.00015 Score=48.86 Aligned_cols=29 Identities=24% Similarity=0.495 Sum_probs=22.5
Q ss_pred CCCCccCCCCceecCCCCcccCCCCCCCCc
Q 038345 193 SKDNTTTSSGYHCKCNKGYEGNPYLSDGCR 222 (686)
Q Consensus 193 ~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~ 222 (686)
.+.|+++.+||+|.|++||+.++ ....|+
T Consensus 15 ~~~C~Nt~gsy~C~C~~Gy~L~~-d~~tC~ 43 (45)
T d1nt0a3 15 DHYCHNYLGGYYCSCRVGYILHQ-NKHTCS 43 (45)
T ss_dssp SSEEEEETTEEEEECCTTEEECT-TSSCEE
T ss_pred CCEeecCCCCEEEeCCCCCEECC-CCCccc
Confidence 56899999999999999998655 223454
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.71 E-value=0.0005 Score=45.05 Aligned_cols=25 Identities=24% Similarity=0.652 Sum_probs=21.8
Q ss_pred CCCCCCCCcc--CCCCceecCCCCccc
Q 038345 189 SCDKSKDNTT--TSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~~--~~~~y~C~C~~Gy~g 213 (686)
+|.+++.|+. ...+|+|.|++||.|
T Consensus 5 PC~ngG~C~~~~~~~~y~C~C~~g~~G 31 (41)
T d1tpga1 5 RCFNGGTCQQALYFSDFVCQCPEGFAG 31 (41)
T ss_dssp CSCTTCEEEEESSSSCEEEECCTTCBS
T ss_pred CCCCCCEEecCCCCCCeEECCCCCCCC
Confidence 8999999974 457899999999998
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.70 E-value=0.00022 Score=46.38 Aligned_cols=26 Identities=31% Similarity=0.966 Sum_probs=22.2
Q ss_pred Cccc--cccccCCcceEEeCCCCccCCC
Q 038345 233 NNCT--HICDNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 233 ~~c~--~~C~~~~g~~~C~C~~g~~~~~ 258 (686)
+.|. ++|.|++|+|.|.|++||.+|+
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTGNG 34 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEECS
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcCCC
Confidence 4553 5899999999999999999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.53 E-value=0.0029 Score=62.72 Aligned_cols=135 Identities=18% Similarity=0.162 Sum_probs=77.8
Q ss_pred EEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCee--eEE-----eEEeeCCcceEEEEeccCCchhh-
Q 038345 363 GTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNIV--KLL-----GCCLETEVPLLVYEFVPNGTLYQ- 434 (686)
Q Consensus 363 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----g~~~~~~~~~lV~e~~~~gsL~~- 434 (686)
-.||+....+|..+++|..... ....+++..|...+..|...++. ..+ .........+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999986532 22346678899888888533321 111 11234556788999998754321
Q ss_pred -------------hhhcc------CCCCCCCHH----------------------HHHHHHHHHHHHHHHh-hhcCCCCe
Q 038345 435 -------------NIHNH------IEEFPITWE----------------------LLLRIAVEVSGALFYL-HSAASISI 472 (686)
Q Consensus 435 -------------~l~~~------~~~~~l~~~----------------------~~~~i~~qi~~~L~yL-H~~~~~~i 472 (686)
.+|.. ..+..+++. .....+.++...+.-+ .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11110 001111111 1122223333322221 22234578
Q ss_pred EeeCCCCCCeeecCCCcEEEEecCCccc
Q 038345 473 YRRDIKSANILLDDKYRAKVSDFGTSRS 500 (686)
Q Consensus 473 vH~Dikp~NIll~~~~~~kl~DfGla~~ 500 (686)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998753
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.53 E-value=0.0004 Score=47.08 Aligned_cols=31 Identities=23% Similarity=0.686 Sum_probs=25.9
Q ss_pred ccccCCCCCCCCCCCCccCCCCceecCCCCccc
Q 038345 181 AKICGPNASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 181 ~~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
.+.|.++ +|.+ +.|.+..++|.|.|++||.|
T Consensus 8 ~~~C~~~-PC~n-G~C~~~~~~y~C~C~~G~~G 38 (48)
T d1autl1 8 EHPCASL-CCGH-GTCIDGIGSFSCDCRSGWEG 38 (48)
T ss_dssp CCSSSST-TTTS-EEECCCSSCCCEEECTTEES
T ss_pred CCcccCC-CCCC-CEEECCCCCCeEeCCCCCcC
Confidence 3466665 8986 68998899999999999998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.36 E-value=0.0056 Score=62.37 Aligned_cols=74 Identities=18% Similarity=0.229 Sum_probs=49.7
Q ss_pred ccccCccceEEEEEEEeCC--------CcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe-eeEEeEEeeCCcceEEE
Q 038345 354 NRILGQGGQGTVYKGMLAD--------GRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI-VKLLGCCLETEVPLLVY 424 (686)
Q Consensus 354 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lV~ 424 (686)
.+.|+.|-.=.+|+....+ .+.|.++..... ...-...+|..+++.+.-.++ .++++++.. .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567778888999988654 346777765432 222345688999888853344 577777643 6899
Q ss_pred EeccCCchh
Q 038345 425 EFVPNGTLY 433 (686)
Q Consensus 425 e~~~~gsL~ 433 (686)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999876553
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.29 E-value=0.00052 Score=45.12 Aligned_cols=26 Identities=27% Similarity=0.526 Sum_probs=22.2
Q ss_pred CCCCCCCCCccCCCCceecCCCCcccCC
Q 038345 188 ASCDKSKDNTTTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 188 ~~C~~~~~c~~~~~~y~C~C~~Gy~gnp 215 (686)
..| ...|.++.+||+|.|++||+.++
T Consensus 9 ~~C--~~~C~n~~Gsy~C~C~~Gy~L~~ 34 (42)
T d1nzia2 9 VPC--SHFCNNFIGGYFCSCPPEYFLHD 34 (42)
T ss_dssp CCS--SSEEEEETTEEEEECCTTCEECT
T ss_pred cCC--CCEeecCCCCEEEeCCCCCEECC
Confidence 368 45899999999999999999765
|
| >d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.09 E-value=0.001 Score=46.82 Aligned_cols=39 Identities=26% Similarity=0.671 Sum_probs=31.0
Q ss_pred CCCccccccccCCc-ceEEeCCCCccCCCCCCCCCccCCccc
Q 038345 231 SLNNCTHICDNTAG-NYTCRCPKGFRGDGRRDGGGCIPNQKN 271 (686)
Q Consensus 231 ~~~~c~~~C~~~~g-~~~C~C~~g~~~~~~~~~~~C~~~~~~ 271 (686)
++..|++.|.++++ +|.|.|+.||... .|+..|.+....
T Consensus 6 ~NGgC~h~C~~~~~~~~~C~C~~Gy~L~--~D~~tC~~~~~f 45 (57)
T d1rfnb_ 6 KNGRCEQFCKNSADNKVVCSCTEGYRLA--ENQKSCEPAVPF 45 (57)
T ss_dssp GGGGCSSEEEECTTSCEEEECCTTEEEC--TTSSSEEECSSS
T ss_pred CCCCcccEeeeCCCCCeEeECCCCCEEC--CCCCccccCCCc
Confidence 34789999999965 8999999999876 577788765443
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.02 E-value=0.0015 Score=42.06 Aligned_cols=30 Identities=37% Similarity=0.968 Sum_probs=25.0
Q ss_pred CcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 225 NEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 225 ~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|+|.. .+|+ ++|++..++|.|.|++||.|.
T Consensus 1 D~C~~---~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCET---SPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTTT---CCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCCC---CCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 45653 6785 599999999999999999986
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=96.01 E-value=0.00076 Score=44.37 Aligned_cols=31 Identities=26% Similarity=0.679 Sum_probs=25.2
Q ss_pred cccCCCCCCCCCCCCcc-CCCCceecCCC-Cccc
Q 038345 182 KICGPNASCDKSKDNTT-TSSGYHCKCNK-GYEG 213 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~-~~~~y~C~C~~-Gy~g 213 (686)
+.|..+ +|.+++.|+. ..++|.|.|+. ||.|
T Consensus 3 d~C~~n-PC~ngG~C~~~~~~~y~C~C~~~G~~G 35 (42)
T d1q4ga2 3 NPCCYY-PCQHQGICVRFGLDRYQCDCTRTGYSG 35 (42)
T ss_dssp CGGGGC-CCCTTCEEEEETTTEEEEECTTSSEET
T ss_pred ccCcCC-CCCCCCEeeeCCCCCEEEECCCCCcCC
Confidence 456655 8999999985 46789999986 9998
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.90 E-value=0.0017 Score=43.88 Aligned_cols=31 Identities=23% Similarity=0.678 Sum_probs=25.6
Q ss_pred CCcccCCCCCccc-cccccCCcceEEeCCCCccCC
Q 038345 224 VNEFEDPSLNNCT-HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 224 ~~~c~~~~~~~c~-~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.|+|.. ++|. ++|.+..++|.|.|++||.|.
T Consensus 8 ~~~C~~---~PC~nG~C~~~~~~y~C~C~~G~~G~ 39 (48)
T d1autl1 8 EHPCAS---LCCGHGTCIDGIGSFSCDCRSGWEGR 39 (48)
T ss_dssp CCSSSS---TTTTSEEECCCSSCCCEEECTTEEST
T ss_pred CCcccC---CCCCCCEEECCCCCCeEeCCCCCcCC
Confidence 456654 5774 699999999999999999987
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.90 E-value=0.0022 Score=40.20 Aligned_cols=30 Identities=30% Similarity=0.875 Sum_probs=24.5
Q ss_pred CcccCCCCCccc--cccccCCcceEEeCCCCccCC
Q 038345 225 NEFEDPSLNNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 225 ~~c~~~~~~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
|+|.. .+|. ++|++..++|.|.|++||.|.
T Consensus 1 d~C~~---~PC~ngg~C~~~~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 1 DECAS---SPCLHNGRCLDKINEFQCECPTGFTGH 32 (35)
T ss_dssp CTTTT---CCSTTTCEEEECSSCEEEECCTTEESS
T ss_pred CCCCC---CCCCCCcEEECCCCCeEEECCCCCCCC
Confidence 45643 6775 599999999999999999886
|
| >d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Coagulation factor VIIa species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.89 E-value=0.0013 Score=45.61 Aligned_cols=38 Identities=29% Similarity=0.780 Sum_probs=30.1
Q ss_pred CCCccccccccCCc-ceEEeCCCCccCCCCCCCCCccCCcc
Q 038345 231 SLNNCTHICDNTAG-NYTCRCPKGFRGDGRRDGGGCIPNQK 270 (686)
Q Consensus 231 ~~~~c~~~C~~~~g-~~~C~C~~g~~~~~~~~~~~C~~~~~ 270 (686)
++..|++.|.++++ +|.|.|+.||... .|+..|.+...
T Consensus 5 ~NGGC~h~C~~~~~~~~~C~C~~Gy~L~--~D~~tC~~~~~ 43 (53)
T d2bz6l1 5 ENGGCEQYCSDHTGTKRSCRCHEGYSLL--ADGVSCTPTVE 43 (53)
T ss_dssp GGGGCSSEEEEETTTEEEEECCTTEEEC--TTSSCEEECSS
T ss_pred CCCCCcCEeeeCCCCCEEeECCCCCEEC--CCCCcccCCCc
Confidence 34679999999987 5899999999876 56777876544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.80 E-value=0.0024 Score=38.80 Aligned_cols=30 Identities=33% Similarity=0.850 Sum_probs=24.6
Q ss_pred CcccCCCCCcc-ccccccCCcceEEeCCCCccC
Q 038345 225 NEFEDPSLNNC-THICDNTAGNYTCRCPKGFRG 256 (686)
Q Consensus 225 ~~c~~~~~~~c-~~~C~~~~g~~~C~C~~g~~~ 256 (686)
|||+-. ++| .++|.|..|+|.|.|.+||..
T Consensus 2 dECsig--npCGnGTCtNviGgFec~C~~GFep 32 (39)
T d1emoa2 2 DECSVG--NPCGNGTCKNVIGGFECTCEEGFEP 32 (39)
T ss_dssp CGGGTT--CSSSSSCEEECSSSEEECCSSSSCC
T ss_pred CccccC--CccCCceeeecccceEEeecCCcCC
Confidence 577652 677 479999999999999999864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.79 E-value=0.0024 Score=38.81 Aligned_cols=34 Identities=24% Similarity=0.745 Sum_probs=27.2
Q ss_pred cccCCCCCCCCCCCCccCCCCceecCCCCcccCCC
Q 038345 182 KICGPNASCDKSKDNTTTSSGYHCKCNKGYEGNPY 216 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~~~~y~C~C~~Gy~gnpy 216 (686)
++|.-..+|. +..|.+..+||.|.|.+||+--|-
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgpm 35 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGPM 35 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCSS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCcc
Confidence 4566666786 468899999999999999987664
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.77 E-value=0.0015 Score=42.71 Aligned_cols=31 Identities=29% Similarity=0.788 Sum_probs=25.0
Q ss_pred cccCCCCCCCCCCCCccC-CCCceecCC-CCccc
Q 038345 182 KICGPNASCDKSKDNTTT-SSGYHCKCN-KGYEG 213 (686)
Q Consensus 182 ~~c~~~~~C~~~~~c~~~-~~~y~C~C~-~Gy~g 213 (686)
+.|..+ +|.+++.|+.. .++|+|.|+ .||.|
T Consensus 2 d~C~~~-PC~ngG~C~~~~~~~y~C~C~~~gy~G 34 (41)
T d1cvua2 2 NPCCSN-PCQNRGECMSTGFDQYKCDCTRTGFYG 34 (41)
T ss_dssp CTTTTC-CCCTTCEEEEEETTEEEEECTTSSEET
T ss_pred CcCcCC-CCCCCCEEEECCCCCEEEeCcCCCcCC
Confidence 456665 89999999854 578999997 69998
|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.59 E-value=0.0022 Score=44.06 Aligned_cols=36 Identities=25% Similarity=0.524 Sum_probs=28.5
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCcc
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNEF 227 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~c 227 (686)
.| ...|.++.++|+|.|.+||+..+ ....|+++++|
T Consensus 7 gC--~h~C~~~~~~~~C~C~~Gy~L~~-D~~tC~~~~~~ 42 (51)
T d1kigl_ 7 GC--DQFCREERSEVRCSCAHGYVLGD-DSKSCVSTERF 42 (51)
T ss_dssp SS--SSCCCEETTEECCCCCTTEEECT-TSSCEEECSSS
T ss_pred Cc--ccEeEcCCCcEEeEcCCCCEECC-CCCccccCCcc
Confidence 57 45688889999999999999766 34678877765
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.56 E-value=0.045 Score=53.25 Aligned_cols=158 Identities=10% Similarity=0.057 Sum_probs=81.9
Q ss_pred cChHHHHhhccccccccc-----cCccceEEEEEEEeCCCcEEEEEEccccChhhHHHHHHHHHHHHhcCCCCe--eeEE
Q 038345 339 FTSKDLEKATDNYNANRI-----LGQGGQGTVYKGMLADGRIVAVKKSKLVDENNVEQFINEVVILSQINHRNI--VKLL 411 (686)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~ 411 (686)
.+.+|++....+|.+.+. |..|---+.|+....+|+ +++|+.... ...+++..|+.++..|...++ +..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 356677777777876443 445655778998876654 788876432 122344556777777743322 1111
Q ss_pred e------EEeeCCcceEEEEeccCCchhh--------------hhhccCC----C--CCC------------------CH
Q 038345 412 G------CCLETEVPLLVYEFVPNGTLYQ--------------NIHNHIE----E--FPI------------------TW 447 (686)
Q Consensus 412 g------~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~----~--~~l------------------~~ 447 (686)
. +.........++.++.+..... .++.... . ... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1112345567777776543321 0110000 0 000 00
Q ss_pred HHHHHHHHHHHHHHHHhhh-cCCCCeEeeCCCCCCeeecCCCcEEEEecCCcc
Q 038345 448 ELLLRIAVEVSGALFYLHS-AASISIYRRDIKSANILLDDKYRAKVSDFGTSR 499 (686)
Q Consensus 448 ~~~~~i~~qi~~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 499 (686)
......+..+...+.-.+. .-+.+++|+|+.+.||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222221 123489999999999999988777899999874
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.21 E-value=0.0024 Score=41.32 Aligned_cols=30 Identities=30% Similarity=0.674 Sum_probs=23.3
Q ss_pred cccCCC-CCCCCCCCCccCCCCceecCCCCccc
Q 038345 182 KICGPN-ASCDKSKDNTTTSSGYHCKCNKGYEG 213 (686)
Q Consensus 182 ~~c~~~-~~C~~~~~c~~~~~~y~C~C~~Gy~g 213 (686)
++|..+ ..| ...|.++.++|+|.|++||+.
T Consensus 3 neC~~~nggC--~h~C~n~~g~~~C~C~~Gy~L 33 (40)
T d3bpse1 3 NECLDNNGGC--SHVCNDLKIGYECLCPDGFQL 33 (40)
T ss_dssp CGGGTGGGGC--SSEEEECSSSEEEECCTTCCE
T ss_pred ccCCCCCCCC--cCEEEcCCCCEEEECCCCCEE
Confidence 455443 367 458899999999999999985
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.11 E-value=0.0025 Score=46.10 Aligned_cols=34 Identities=26% Similarity=0.610 Sum_probs=25.9
Q ss_pred ccCCCCCCCCCCCCc-----cCCCCceecCCCCcccCCCCCCCCc
Q 038345 183 ICGPNASCDKSKDNT-----TTSSGYHCKCNKGYEGNPYLSDGCR 222 (686)
Q Consensus 183 ~c~~~~~C~~~~~c~-----~~~~~y~C~C~~Gy~gnpy~~~gC~ 222 (686)
+|..+ .|.+++.|. +..++|.|.|++||.| ..|+
T Consensus 8 ec~~~-~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G-----~~Ce 46 (63)
T d1haea_ 8 EKEKT-FCVNGGECFMVKDLSNPSRYLCKCQPGFTG-----ARCT 46 (63)
T ss_dssp HHHHT-TSCTTCEEEEEESSSSSCCEEEECCTTEES-----TTSC
T ss_pred CCcCC-cCCCCCEEeecccccCCCCEEeECCCCCCC-----CCcC
Confidence 34433 798888884 4567999999999998 5575
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.78 E-value=0.01 Score=40.97 Aligned_cols=25 Identities=28% Similarity=0.651 Sum_probs=22.0
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
.|.+++.|. ....+|.|.|++||.|
T Consensus 13 ~C~NgG~C~~~~~~~~~~C~C~~gy~G 39 (53)
T d3egfa_ 13 YCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp CSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred CCCCCcEeeccCCCCCeEeECCCCCcC
Confidence 799999996 4567999999999998
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.67 E-value=0.0068 Score=38.92 Aligned_cols=25 Identities=44% Similarity=1.018 Sum_probs=22.3
Q ss_pred Cccc--cccccCCcceEEeCCCCccCC
Q 038345 233 NNCT--HICDNTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 233 ~~c~--~~C~~~~g~~~C~C~~g~~~~ 257 (686)
.+|. ++|++..++|.|.|++||.|.
T Consensus 7 ~pC~ngg~C~~~~~~~~C~C~~g~~G~ 33 (39)
T d1g1ta2 7 TSCSGHGECVETINNYTCKCDPGFSGL 33 (39)
T ss_dssp TGGGGSEEEEEETTEEEEEECTTEEST
T ss_pred CcCCCCcEEECCCCCEEEeCCCCCcCc
Confidence 5775 599999999999999999987
|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.56 E-value=0.0051 Score=41.91 Aligned_cols=35 Identities=17% Similarity=0.331 Sum_probs=27.1
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCc
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNE 226 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~ 226 (686)
.| ...|.++.++|+|.|..||+.++ ....|+.+++
T Consensus 8 gC--~~~C~~~~g~~~C~C~~Gy~L~~-D~~tC~~~~~ 42 (50)
T d1autl2 8 GC--THYCLEEVGWRRCSCAPGYKLGD-DLLQCHPAVK 42 (50)
T ss_dssp GC--SSEEEECSSSEEEECCTTEEECT-TSSCEEECSS
T ss_pred Cc--ccEeecCCCCeEEECCCCCEECC-CCCccccCCC
Confidence 56 46788888999999999999776 3466766655
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.44 E-value=0.01 Score=38.34 Aligned_cols=26 Identities=46% Similarity=0.953 Sum_probs=22.6
Q ss_pred Cccc--cccccCCcceEEeCCCCccCCC
Q 038345 233 NNCT--HICDNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 233 ~~c~--~~C~~~~g~~~C~C~~g~~~~~ 258 (686)
++|. ++|++..++|.|.|++||.|..
T Consensus 7 ~pC~ngg~C~~~~~~y~C~C~~g~~G~~ 34 (40)
T d1g1sa2 7 MSCSKQGECLETIGNYTCSCYPGFYGPE 34 (40)
T ss_dssp TGGGGSEEEEECSSSEEEEECTTEESTT
T ss_pred CcCCCCcEEECCCCCeEEeCCCCccCCC
Confidence 5674 5899999999999999999873
|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.75 E-value=0.006 Score=41.76 Aligned_cols=35 Identities=17% Similarity=0.446 Sum_probs=27.1
Q ss_pred CCCCCCCCccCCCCceecCCCCcccCCCCCCCCcCCCc
Q 038345 189 SCDKSKDNTTTSSGYHCKCNKGYEGNPYLSDGCRDVNE 226 (686)
Q Consensus 189 ~C~~~~~c~~~~~~y~C~C~~Gy~gnpy~~~gC~~~~~ 226 (686)
.| ...|.++.++|+|.|..||+.++ ....|...++
T Consensus 9 gC--~h~C~n~~g~~~C~C~~Gy~L~~-D~~tC~~~~~ 43 (51)
T d2p3ua1 9 DC--DQFCHEEQNSVVCSCARGYTLAD-NGKACIPTGP 43 (51)
T ss_dssp GC--SSEEEEETTEEEEECCTTEEECT-TSSCEEESSS
T ss_pred Cc--ccEeecCCCCeEeEcCCCCEECC-CCCccccCCc
Confidence 57 45788889999999999999776 3456766554
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.62 E-value=0.0085 Score=40.44 Aligned_cols=25 Identities=28% Similarity=0.578 Sum_probs=21.6
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
.|.+++.|. ....+|.|.|..||+|
T Consensus 11 ~C~ngG~C~~~~~~~~~~C~C~~gy~G 37 (48)
T d1nqlb_ 11 YCLHDGVCMYIEALDKYACNCVVGYIG 37 (48)
T ss_dssp EECTTCEEEEETTTTEEEEEECTTEES
T ss_pred CCCCCcEEeeeCCCCCeEEeCCCCccc
Confidence 799889996 3557899999999998
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=92.91 E-value=0.025 Score=36.84 Aligned_cols=31 Identities=32% Similarity=0.736 Sum_probs=24.1
Q ss_pred CCcccCCCCCccc--cccccC-CcceEEeCCC-CccCC
Q 038345 224 VNEFEDPSLNNCT--HICDNT-AGNYTCRCPK-GFRGD 257 (686)
Q Consensus 224 ~~~c~~~~~~~c~--~~C~~~-~g~~~C~C~~-g~~~~ 257 (686)
+|.|.. ++|+ ++|++. .++|.|.|+. ||.|.
T Consensus 2 id~C~~---nPC~ngG~C~~~~~~~y~C~C~~~G~~G~ 36 (42)
T d1q4ga2 2 VNPCCY---YPCQHQGICVRFGLDRYQCDCTRTGYSGP 36 (42)
T ss_dssp CCGGGG---CCCCTTCEEEEETTTEEEEECTTSSEETT
T ss_pred CccCcC---CCCCCCCEeeeCCCCCEEEECCCCCcCCc
Confidence 567764 6785 599875 7899999986 89886
|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epiregulin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.42 E-value=0.047 Score=36.10 Aligned_cols=24 Identities=29% Similarity=0.634 Sum_probs=19.2
Q ss_pred CCCCCCCCc--cCCCCceecCCCCccc
Q 038345 189 SCDKSKDNT--TTSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~--~~~~~y~C~C~~Gy~g 213 (686)
.|.+ +.|. ....+|.|.|.+||.|
T Consensus 13 yC~n-G~C~~~~~~~~~~C~C~~gY~G 38 (46)
T d1k36a_ 13 YCLH-GQCIYLVDMSQNYCRCEVGYTG 38 (46)
T ss_dssp SCSS-EEEEEETTTTEEEEEECTTCSS
T ss_pred cCcC-CEEEEeCCCCccEeECCCCcee
Confidence 7887 4564 4567899999999998
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.79 E-value=0.079 Score=34.11 Aligned_cols=25 Identities=40% Similarity=0.967 Sum_probs=19.8
Q ss_pred Cccc--cccccC-CcceEEeCC-CCccCC
Q 038345 233 NNCT--HICDNT-AGNYTCRCP-KGFRGD 257 (686)
Q Consensus 233 ~~c~--~~C~~~-~g~~~C~C~-~g~~~~ 257 (686)
.+|. ++|++. .++|.|.|+ +||.|.
T Consensus 7 ~PC~ngG~C~~~~~~~y~C~C~~~gy~G~ 35 (41)
T d1cvua2 7 NPCQNRGECMSTGFDQYKCDCTRTGFYGE 35 (41)
T ss_dssp CCCCTTCEEEEEETTEEEEECTTSSEETT
T ss_pred CCCCCCCEEEECCCCCEEEeCcCCCcCCc
Confidence 5674 589875 688999997 599886
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.36 E-value=0.065 Score=38.28 Aligned_cols=26 Identities=31% Similarity=0.830 Sum_probs=20.3
Q ss_pred Cccc--ccc-----ccCCcceEEeCCCCccCCC
Q 038345 233 NNCT--HIC-----DNTAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 233 ~~c~--~~C-----~~~~g~~~C~C~~g~~~~~ 258 (686)
++|. ++| .+..++|.|.|++||.|..
T Consensus 12 ~~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G~~ 44 (63)
T d1haea_ 12 TFCVNGGECFMVKDLSNPSRYLCKCQPGFTGAR 44 (63)
T ss_dssp TTSCTTCEEEEEESSSSSCCEEEECCTTEESTT
T ss_pred CcCCCCCEEeecccccCCCCEEeECCCCCCCCC
Confidence 4563 477 4677899999999999873
|
| >d1ioxa_ g.3.11.1 (A:) Betacellulin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Betacellulin-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.18 E-value=0.055 Score=36.52 Aligned_cols=31 Identities=29% Similarity=0.649 Sum_probs=23.9
Q ss_pred CCCCCCCCc-cCCCCceecCCCCcccCCCCCCCCcCC
Q 038345 189 SCDKSKDNT-TTSSGYHCKCNKGYEGNPYLSDGCRDV 224 (686)
Q Consensus 189 ~C~~~~~c~-~~~~~y~C~C~~Gy~gnpy~~~gC~~~ 224 (686)
.|.++..|. .....+.|.|+.||.| ..|+-.
T Consensus 15 yC~nGgcc~~~~~~~~~C~C~~gy~G-----~rCe~~ 46 (50)
T d1ioxa_ 15 YCIKGRCRFVVAEQTPSCVCDEGYIG-----ARCERV 46 (50)
T ss_dssp SCTTCCEEEETTTTEEEECCCTTEET-----TTTCEE
T ss_pred CccCCeEEEeCCCCCcEeECCCCCee-----CCCccc
Confidence 698887774 5667799999999998 456543
|
| >d1moxc_ g.3.11.1 (C:) Transforming growth factor alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Transforming growth factor alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.91 E-value=0.046 Score=36.73 Aligned_cols=31 Identities=23% Similarity=0.524 Sum_probs=23.5
Q ss_pred CCCCCCCCc-cCCCCceecCCCCcccCCCCCCCCcCC
Q 038345 189 SCDKSKDNT-TTSSGYHCKCNKGYEGNPYLSDGCRDV 224 (686)
Q Consensus 189 ~C~~~~~c~-~~~~~y~C~C~~Gy~gnpy~~~gC~~~ 224 (686)
.|.++..|. .....+.|.|++||.| ..|+-.
T Consensus 14 yClnGgcc~~~~~~~~~C~C~~gy~G-----~RCe~~ 45 (49)
T d1moxc_ 14 FCFHGTCRFLVQEDKPACVCHSGYVG-----ARCEHA 45 (49)
T ss_dssp SSTTEEEEEETTTTEEEEEECTTEES-----TTSCEE
T ss_pred EeeCCeEEecCCCCCcEeECCCCCEe-----cCCccc
Confidence 688777664 5567899999999998 457643
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.33 E-value=0.18 Score=32.30 Aligned_cols=26 Identities=31% Similarity=1.020 Sum_probs=20.0
Q ss_pred Cccc--cccccC--CcceEEeCCCCccCCC
Q 038345 233 NNCT--HICDNT--AGNYTCRCPKGFRGDG 258 (686)
Q Consensus 233 ~~c~--~~C~~~--~g~~~C~C~~g~~~~~ 258 (686)
.+|+ ++|++. .++|.|.|++||.|..
T Consensus 4 nPC~ngG~C~~~~~~~~y~C~C~~g~~G~~ 33 (41)
T d1tpga1 4 PRCFNGGTCQQALYFSDFVCQCPEGFAGKS 33 (41)
T ss_dssp CCSCTTCEEEEESSSSCEEEECCTTCBSSS
T ss_pred CCCCCCCEEecCCCCCCeEECCCCCCCCCC
Confidence 4564 588865 4679999999999873
|
| >d1ijqa2 g.3.11.1 (A:643-692) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.21 E-value=0.11 Score=35.05 Aligned_cols=18 Identities=22% Similarity=0.488 Sum_probs=15.3
Q ss_pred cCCCCceecCCCCcccCC
Q 038345 198 TTSSGYHCKCNKGYEGNP 215 (686)
Q Consensus 198 ~~~~~y~C~C~~Gy~gnp 215 (686)
+..++|+|.|+.||+..+
T Consensus 26 n~~~~y~C~C~~G~~L~~ 43 (50)
T d1ijqa2 26 PHSPKFTCACPDGMLLAR 43 (50)
T ss_dssp TTCCSEEEECCTTCEECT
T ss_pred cCCCCEEEeCCCCCEECC
Confidence 456899999999999765
|
| >d1rfnb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.43 E-value=0.082 Score=36.74 Aligned_cols=36 Identities=19% Similarity=0.502 Sum_probs=25.8
Q ss_pred CCCCCCCCccC-CCCceecCCCCcccCCCCCCCCcCCCcc
Q 038345 189 SCDKSKDNTTT-SSGYHCKCNKGYEGNPYLSDGCRDVNEF 227 (686)
Q Consensus 189 ~C~~~~~c~~~-~~~y~C~C~~Gy~gnpy~~~gC~~~~~c 227 (686)
.| ...|.++ .++|+|.|..||+..+ ....|..++++
T Consensus 9 gC--~h~C~~~~~~~~~C~C~~Gy~L~~-D~~tC~~~~~f 45 (57)
T d1rfnb_ 9 RC--EQFCKNSADNKVVCSCTEGYRLAE-NQKSCEPAVPF 45 (57)
T ss_dssp GC--SSEEEECTTSCEEEECCTTEEECT-TSSSEEECSSS
T ss_pred Cc--ccEeeeCCCCCeEeECCCCCEECC-CCCccccCCCc
Confidence 56 3567665 4589999999999766 45677766653
|
| >d1k36a_ g.3.11.1 (A:) Epiregulin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epiregulin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.54 E-value=0.31 Score=31.96 Aligned_cols=32 Identities=22% Similarity=0.482 Sum_probs=21.3
Q ss_pred cccCCCCCcc-ccccc--cCCcceEEeCCCCccCC
Q 038345 226 EFEDPSLNNC-THICD--NTAGNYTCRCPKGFRGD 257 (686)
Q Consensus 226 ~c~~~~~~~c-~~~C~--~~~g~~~C~C~~g~~~~ 257 (686)
+|.......| +|.|. ...+.+.|.|++||.|+
T Consensus 5 ~C~~~~~~yC~nG~C~~~~~~~~~~C~C~~gY~G~ 39 (46)
T d1k36a_ 5 KCSSDMNGYCLHGQCIYLVDMSQNYCRCEVGYTGV 39 (46)
T ss_dssp CCCTTCCSSCSSEEEEEETTTTEEEEEECTTCSST
T ss_pred eCCCcCCCcCcCCEEEEeCCCCccEeECCCCceec
Confidence 4443333445 35674 45668999999999987
|
| >d2bz6l1 g.3.11.1 (L:90-142) Coagulation factor VIIa {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Coagulation factor VIIa species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.18 E-value=0.18 Score=34.31 Aligned_cols=32 Identities=19% Similarity=0.512 Sum_probs=21.6
Q ss_pred CCCCCCCCccCCC-CceecCCCCcccCCCCCCCCcC
Q 038345 189 SCDKSKDNTTTSS-GYHCKCNKGYEGNPYLSDGCRD 223 (686)
Q Consensus 189 ~C~~~~~c~~~~~-~y~C~C~~Gy~gnpy~~~gC~~ 223 (686)
.| .+.|.++.+ .|+|.|..||+.++ ....|+.
T Consensus 8 GC--~h~C~~~~~~~~~C~C~~Gy~L~~-D~~tC~~ 40 (53)
T d2bz6l1 8 GC--EQYCSDHTGTKRSCRCHEGYSLLA-DGVSCTP 40 (53)
T ss_dssp GC--SSEEEEETTTEEEEECCTTEEECT-TSSCEEE
T ss_pred CC--cCEeeeCCCCCEEeECCCCCEECC-CCCcccC
Confidence 56 346766654 58999999999766 3345543
|
| >d2i9aa1 g.3.11.1 (A:10-49) Plasminogen activator (urokinase-type) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (urokinase-type) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.10 E-value=0.25 Score=30.01 Aligned_cols=25 Identities=24% Similarity=0.496 Sum_probs=17.7
Q ss_pred CCCCCCCCcc---CCCCceecCCCCccc
Q 038345 189 SCDKSKDNTT---TSSGYHCKCNKGYEG 213 (686)
Q Consensus 189 ~C~~~~~c~~---~~~~y~C~C~~Gy~g 213 (686)
.|.++..|++ -..-.+|.|++||+|
T Consensus 3 ~ClNGG~Cvsyk~FS~I~rC~CPk~f~G 30 (40)
T d2i9aa1 3 DCLNGGTCVSNKYFSNIHWCNCPKKFGG 30 (40)
T ss_dssp CCCTTCEEEECSSSTTCEEEECCTTEES
T ss_pred ccccCCEEEEEehhcCCEEecCCcccCc
Confidence 3666666653 234568999999998
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.83 E-value=0.78 Score=31.05 Aligned_cols=26 Identities=35% Similarity=0.940 Sum_probs=19.3
Q ss_pred Cccc--ccccc--CCcceEEeCCCCccCCC
Q 038345 233 NNCT--HICDN--TAGNYTCRCPKGFRGDG 258 (686)
Q Consensus 233 ~~c~--~~C~~--~~g~~~C~C~~g~~~~~ 258 (686)
.+|. ++|.+ ...+|.|.|+.||.|..
T Consensus 12 ~~C~NgG~C~~~~~~~~~~C~C~~gy~G~~ 41 (53)
T d3egfa_ 12 GYCLNGGVCMHIESLDSYTCNCVIGYSGDR 41 (53)
T ss_dssp CCSCSSCEEEEESSSSCEEEECCTTCCSSS
T ss_pred CCCCCCcEeeccCCCCCeEeECCCCCcCCC
Confidence 3563 57864 45689999999999873
|